data_2lbf_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2lbf _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 3' ' ' SER . . . . . 0.617 ' HB2' ' HG3' ' A' ' 6' ' ' GLU . 4.0 m . . . . . 0 N--CA 1.438 -1.041 0 N-CA-C 107.254 -1.388 . . . . 0.0 107.254 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.698 HG11 ' HG ' ' B' ' 112' ' ' LEU . 2.0 t -52.29 -23.49 4.42 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.704 -179.382 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' SER . . . . . 0.679 ' HB2' ' HA ' ' A' ' 39' ' ' VAL . 15.8 p -68.08 -53.89 22.21 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.633 0.73 . . . . 0.0 109.328 175.212 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.617 ' HG3' ' HB2' ' A' ' 3' ' ' SER . 31.0 mt-10 -57.74 -52.06 66.99 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 115.009 -0.996 . . . . 0.0 109.661 178.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.701 ' HA ' HD12 ' A' ' 10' ' ' ILE . 2.0 tp -57.79 -35.88 71.42 Favored 'General case' 0 N--CA 1.447 -0.575 0 CA-C-N 115.085 -0.961 . . . . 0.0 111.789 177.762 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.432 ' HB3' ' O ' ' A' ' 4' ' ' VAL . . . -66.33 -40.26 89.75 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-O 121.245 0.545 . . . . 0.0 110.938 178.52 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.546 ' HB2' HG12 ' A' ' 39' ' ' VAL . 8.4 t -65.88 -40.89 92.01 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 179.856 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.701 HD12 ' HA ' ' A' ' 7' ' ' LEU . 57.6 mt -47.9 -57.25 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.851 0 CA-C-N 113.646 -1.616 . . . . 0.0 109.927 172.85 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.738 ' HB2' HD11 ' B' ' 109' ' ' LEU . 21.2 m-85 -65.95 -40.83 91.66 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.604 -173.696 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.494 ' HB2' HG23 ' A' ' 28' ' ' ILE . 14.9 m -53.78 -43.27 69.12 Favored 'General case' 0 C--O 1.243 0.738 0 CA-C-O 121.709 0.766 . . . . 0.0 109.49 176.259 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -67.53 -32.52 73.35 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-N 115.192 -0.913 . . . . 0.0 110.166 176.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.631 ' HB3' ' CB ' ' B' ' 105' ' ' ALA . 0.3 OUTLIER -62.51 -56.87 13.93 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.113 179.467 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.465 HG12 ' O ' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -54.36 -42.19 56.75 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 N-CA-C 109.897 -0.408 . . . . 0.0 109.897 177.421 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.56 HD12 HG11 ' A' ' 21' ' ' VAL . 3.9 tp -56.64 -37.81 71.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.26 176.832 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . 0.777 ' HE2' HD22 ' A' ' 51' ' ' LEU . 72.0 m-70 -77.78 -9.64 59.13 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 112.493 0.553 . . . . 0.0 112.493 178.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -78.61 -29.14 45.87 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 119.513 -0.875 . . . . 0.0 109.807 -177.511 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -107.32 -8.15 16.45 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 173.666 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.407 ' HG2' ' O ' ' A' ' 17' ' ' HIS . 5.2 mm-40 51.89 50.14 19.25 Favored 'General case' 0 CA--C 1.511 -0.545 0 CA-C-N 113.925 -1.489 . . . . 0.0 110.633 -174.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.56 HG11 HD12 ' A' ' 16' ' ' LEU . 7.3 p -99.13 168.76 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.424 -1.743 0 CA-C-N 114.678 -1.147 . . . . 0.0 108.624 -174.439 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 48.5 p -52.45 139.73 24.23 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-O 121.958 0.885 . . . . 0.0 113.377 -169.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.489 HG13 ' HB2' ' A' ' 51' ' ' LEU . 58.7 t -109.32 106.39 20.61 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.012 0 CA-C-N 114.339 -1.301 . . . . 0.0 110.536 -174.638 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.542 ' OG1' ' HB2' ' A' ' 27' ' ' LYS . 70.8 p -131.23 156.04 46.06 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.979 178.465 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -54.35 -43.57 71.39 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.226 0.536 . . . . 0.0 109.856 178.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -68.49 -25.58 65.04 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.295 -0.866 . . . . 0.0 111.458 -179.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.542 ' HB2' ' OG1' ' A' ' 24' ' ' THR . 3.7 tppt? -70.34 -52.24 24.13 Favored 'General case' 0 C--O 1.239 0.53 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 178.894 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.494 HG23 ' HB2' ' A' ' 12' ' ' SER . 70.9 mt -61.08 -40.68 86.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 114.547 -1.206 . . . . 0.0 110.315 177.9 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.584 ' HA ' HD12 ' A' ' 32' ' ' ILE . 44.7 t-20 -60.19 -39.45 86.59 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.936 176.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -60.98 -44.6 97.14 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.016 177.549 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.561 HD12 HG22 ' B' ' 126' ' ' ILE . 1.4 mm? -59.79 -49.39 77.9 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 121.01 0.434 . . . . 0.0 110.315 173.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.589 HG22 ' O ' ' A' ' 37' ' ' VAL . 75.5 mt -46.98 -52.53 4.04 Favored 'Isoleucine or valine' 0 C--O 1.239 0.538 0 CA-C-N 115.184 -0.916 . . . . 0.0 111.366 178.037 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 46.5 mmtm -72.37 -33.41 67.23 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.542 -0.753 . . . . 0.0 111.543 -176.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -62.85 -44.34 96.39 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.062 -179.089 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.51 ' HB3' HG13 ' A' ' 37' ' ' VAL . . . -82.01 -30.61 31.44 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.918 178.743 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 95.3 15.64 43.51 Favored Glycine 0 N--CA 1.447 -0.62 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.75 -178.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 1.003 ' HB ' ' HA3' ' B' ' 113' ' ' GLY . 5.1 p -115.8 118.85 60.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.758 0.79 . . . . 0.0 110.708 -174.778 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.455 ' HA ' HG22 ' A' ' 32' ' ' ILE . 64.3 t30 -96.52 158.59 15.36 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 114.581 -1.19 . . . . 0.0 111.256 -167.486 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.679 ' HA ' ' HB2' ' A' ' 5' ' ' SER . 67.9 t -127.75 163.42 31.38 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.972 0 CA-C-N 114.966 -1.015 . . . . 0.0 110.551 -172.07 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.524 ' HB3' ' HD1' ' A' ' 43' ' ' TRP . 8.2 tp10 -71.24 106.46 1.89 Allowed Pre-proline 0 N--CA 1.44 -0.928 0 N-CA-C 107.429 -1.323 . . . . 0.0 107.429 167.721 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.529 ' C ' ' HD2' ' A' ' 44' ' ' PRO . 77.6 Cg_exo -51.26 -27.69 23.98 Favored 'Trans proline' 0 C--O 1.25 1.112 0 C-N-CA 123.883 3.055 . . . . 0.0 115.532 -164.221 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -61.38 -28.17 69.05 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 177.471 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . 0.619 ' CE3' ' HE1' ' A' ' 47' ' ' PHE . 18.8 m95 -64.56 -59.65 10.16 Favored Pre-proline 0 C--O 1.205 -1.26 0 CA-C-O 118.383 -0.817 . . . . 0.0 110.949 176.068 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.529 ' HD2' ' C ' ' A' ' 41' ' ' PRO . 97.6 Cg_exo -45.81 -42.84 19.67 Favored 'Trans proline' 0 C--N 1.359 1.119 0 C-N-CA 121.766 1.644 . . . . 0.0 111.871 174.532 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -60.4 -61.0 7.56 Favored Glycine 0 CA--C 1.525 0.701 0 C-N-CA 120.231 -0.985 . . . . 0.0 112.516 175.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.559 ' O ' ' HB2' ' A' ' 49' ' ' LYS . 8.7 tp -63.26 -32.1 73.42 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.196 0.599 . . . . 0.0 111.973 -177.417 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.619 ' HE1' ' CE3' ' A' ' 43' ' ' TRP . 3.6 m-85 -64.14 -48.13 77.24 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.192 176.237 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.465 ' HA ' HG12 ' A' ' 23' ' ' VAL . . . -65.25 -31.44 72.59 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.56 0.695 . . . . 0.0 109.396 -179.516 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.559 ' HB2' ' O ' ' A' ' 46' ' ' LEU . 9.3 mmmt -59.28 -54.92 41.27 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 114.589 -1.187 . . . . 0.0 111.748 172.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -86.61 -43.49 12.62 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 113.802 1.038 . . . . 0.0 113.802 -168.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.777 HD22 ' HE2' ' A' ' 17' ' ' HIS . 21.5 mt -65.87 -7.23 15.26 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 113.721 1.008 . . . . 0.0 113.721 -168.556 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -81.01 -2.2 46.97 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.892 0.377 . . . . 0.0 110.425 176.374 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 10.5 t30 -143.01 -41.71 0.31 Allowed 'General case' 0 C--O 1.235 0.294 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.251 -179.568 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 4.3 m -83.01 -179.6 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 121.429 0.633 . . . . 0.0 110.61 -178.542 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 11.5 m120 -112.15 155.98 23.03 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 115.505 -0.771 . . . . 0.0 111.135 177.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.572 HD13 HD22 ' A' ' 14' ' ' LEU . 3.5 tp -60.01 -21.3 21.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 114.773 -1.103 . . . . 0.0 110.83 179.732 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -69.67 -15.4 71.0 Favored Glycine 0 N--CA 1.444 -0.821 0 C-N-CA 120.779 -0.724 . . . . 0.0 111.392 177.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 35.1 t -75.99 -22.77 55.49 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-O 121.477 0.656 . . . . 0.0 109.76 178.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.482 HD12 HD12 ' A' ' 56' ' ' ILE . 19.7 mt -65.12 -25.67 67.87 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.958 -178.423 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.867 HG13 ' HB ' ' B' ' 159' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--N 1.323 -0.586 0 CA-C-N 114.935 -1.03 . . . . 0.0 110.595 178.539 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 103' ' ' TYR . . . . . 1.012 ' HB2' HG12 ' B' ' 142' ' ' VAL . 43.2 m-85 . . . . . 0 C--O 1.242 0.671 0 N-CA-C 113.119 0.785 . . . . 0.0 113.119 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 104' ' ' VAL . . . . . 0.592 ' O ' HD23 ' B' ' 108' ' ' LEU . 44.9 t -50.51 -49.99 23.09 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.448 0 CA-C-O 121.639 0.733 . . . . 0.0 110.034 177.316 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 105' ' ' ALA . . . . . 0.631 ' CB ' ' HB3' ' A' ' 14' ' ' LEU . . . -64.68 -39.36 93.54 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 114.683 -1.144 . . . . 0.0 111.798 -173.249 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 106' ' ' SER . . . . . 0.581 ' HB2' HD12 ' B' ' 123' ' ' ILE . 0.7 OUTLIER -61.06 -38.92 87.91 Favored 'General case' 0 C--O 1.24 0.582 0 CA-C-O 121.786 0.803 . . . . 0.0 109.123 177.905 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 107' ' ' TYR . . . . . 0.742 ' HD2' HG12 ' B' ' 143' ' ' ILE . 41.5 t80 -61.88 -48.7 79.32 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-N 114.08 -1.418 . . . . 0.0 109.067 179.037 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 108' ' ' LEU . . . . . 0.934 ' HG ' HD12 ' B' ' 155' ' ' ILE . 0.0 OUTLIER -58.14 -46.18 86.08 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-N 115.327 -0.852 . . . . 0.0 111.417 179.553 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 109' ' ' LEU . . . . . 0.738 HD11 ' HB2' ' A' ' 11' ' ' TYR . 8.5 tp -54.19 -56.07 21.77 Favored 'General case' 0 C--O 1.247 0.929 0 CA-C-O 121.393 0.616 . . . . 0.0 110.777 178.54 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -56.05 -41.38 74.94 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 114.991 -1.004 . . . . 0.0 110.372 -177.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 111' ' ' ALA . . . . . 0.778 ' HA ' ' O ' ' B' ' 115' ' ' ASN . . . -75.03 -22.25 58.56 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.881 -177.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 112' ' ' LEU . . . . . 0.698 ' HG ' HG11 ' A' ' 4' ' ' VAL . 4.3 tp -77.66 -39.51 44.8 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.415 -177.661 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 113' ' ' GLY . . . . . 1.003 ' HA3' ' HB ' ' A' ' 37' ' ' VAL . . . -140.01 33.09 2.14 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 118.652 -1.737 . . . . 0.0 115.155 -174.652 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 114' ' ' GLY . . . . . . . . . . . . . . . -159.45 -47.1 0.01 OUTLIER Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 119.299 -1.429 . . . . 0.0 112.969 176.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 115' ' ' ASN . . . . . 0.778 ' O ' ' HA ' ' B' ' 111' ' ' ALA . 8.0 t30 -158.33 112.34 2.49 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 -173.055 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 5.9 m -80.77 28.36 0.35 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 122.083 0.944 . . . . 0.0 111.019 -169.051 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 117' ' ' SER . . . . . 0.514 ' N ' ' HD3' ' B' ' 118' ' ' PRO . 28.3 t -168.01 68.88 0.83 Allowed Pre-proline 0 C--N 1.312 -1.044 0 CA-C-N 113.857 -1.52 . . . . 0.0 108.045 177.65 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 118' ' ' PRO . . . . . 0.672 ' HD2' ' CZ ' ' B' ' 107' ' ' TYR . 34.5 Cg_exo -65.7 155.43 69.15 Favored 'Trans proline' 0 CA--C 1.514 -0.512 0 C-N-CA 125.281 3.988 . . . . 0.0 112.389 -172.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 119' ' ' SER . . . . . 0.5 ' O ' HG12 ' B' ' 123' ' ' ILE . 89.8 p -126.57 -176.14 3.59 Favored 'General case' 0 N--CA 1.443 -0.821 0 C-N-CA 120.18 -0.608 . . . . 0.0 111.525 177.74 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 120' ' ' ALA . . . . . 0.692 ' HB3' HD12 ' B' ' 139' ' ' LEU . . . -63.21 -36.5 83.85 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 122.222 1.011 . . . . 0.0 109.409 -169.617 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 121' ' ' LYS . . . . . 0.463 ' HD2' ' N ' ' B' ' 121' ' ' LYS . 0.9 OUTLIER -68.14 -32.91 73.51 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 113.489 -1.687 . . . . 0.0 110.898 178.91 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 122' ' ' ASP . . . . . 0.499 ' O ' ' HB3' ' B' ' 125' ' ' LYS . 10.6 m-20 -71.66 -36.75 70.76 Favored 'General case' 0 CA--C 1.515 -0.372 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 178.412 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 123' ' ' ILE . . . . . 0.757 ' O ' ' HG ' ' B' ' 127' ' ' LEU . 36.9 mm -62.9 -48.38 88.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.108 176.591 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 124' ' ' LYS . . . . . 0.807 ' HD3' HD23 ' B' ' 139' ' ' LEU . 2.9 mmmp? -57.59 -45.21 85.55 Favored 'General case' 0 C--O 1.21 -0.996 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 -179.357 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 125' ' ' LYS . . . . . 0.499 ' HB3' ' O ' ' B' ' 122' ' ' ASP . 0.1 OUTLIER -47.18 -63.99 0.9 Allowed 'General case' 0 N--CA 1.416 -2.149 0 N-CA-C 112.777 0.658 . . . . 0.0 112.777 172.743 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 126' ' ' ILE . . . . . 0.561 HG22 HD12 ' A' ' 31' ' ' LEU . 1.7 mp -56.69 -46.01 82.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.298 -0.865 . . . . 0.0 111.367 -174.859 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 127' ' ' LEU . . . . . 0.757 ' HG ' ' O ' ' B' ' 123' ' ' ILE . 2.2 pp -78.47 -24.82 45.77 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 120.284 -0.567 . . . . 0.0 111.909 -177.822 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 128' ' ' ASP . . . . . 0.487 ' HB2' ' O ' ' B' ' 124' ' ' LYS . 17.0 t70 -67.1 -35.92 80.82 Favored 'General case' 0 CA--C 1.514 -0.407 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 179.861 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 129' ' ' SER . . . . . . . . . . . . . 83.3 p -58.71 -30.14 67.21 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 115.75 -0.659 . . . . 0.0 112.32 -179.23 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 130' ' ' VAL . . . . . . . . . . . . . 3.1 m -108.41 6.02 9.45 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 CA-C-O 120.856 0.36 . . . . 0.0 111.506 177.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 131' ' ' GLY . . . . . . . . . . . . . . . 74.32 30.42 60.62 Favored Glycine 0 CA--C 1.52 0.357 0 C-N-CA 121.075 -0.583 . . . . 0.0 113.722 175.531 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 132' ' ' ILE . . . . . 0.522 ' O ' HD11 ' B' ' 127' ' ' LEU . 18.6 mt -90.08 130.11 39.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.955 0.377 . . . . 0.0 110.026 176.691 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 133' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -81.15 146.73 30.39 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-O 120.922 0.392 . . . . 0.0 110.937 -174.536 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 134' ' ' ALA . . . . . 0.424 ' HB2' HD21 ' B' ' 127' ' ' LEU . . . -146.23 144.07 29.64 Favored 'General case' 0 N--CA 1.442 -0.849 0 CA-C-N 115.795 -0.638 . . . . 0.0 111.639 -176.033 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 135' ' ' ASP . . . . . 0.742 ' HB2' ' HG3' ' B' ' 138' ' ' ARG . 16.3 m-20 -94.03 132.91 38.04 Favored 'General case' 0 C--O 1.251 1.146 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 174.114 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 136' ' ' ASP . . . . . 0.615 ' HA ' HD11 ' B' ' 139' ' ' LEU . 5.5 m-20 -71.53 -11.45 60.87 Favored 'General case' 0 CA--C 1.511 -0.525 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.547 -167.042 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 137' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -97.32 -31.06 12.6 Favored 'General case' 0 N--CA 1.434 -1.228 0 C-N-CA 120.103 -0.639 . . . . 0.0 110.444 174.441 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 138' ' ' ARG . . . . . 0.742 ' HG3' ' HB2' ' B' ' 135' ' ' ASP . 52.4 mmt-85 -66.02 -43.96 86.12 Favored 'General case' 0 CA--C 1.506 -0.725 0 CA-C-O 121.553 0.692 . . . . 0.0 109.565 -174.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 139' ' ' LEU . . . . . 0.807 HD23 ' HD3' ' B' ' 124' ' ' LYS . 0.3 OUTLIER -75.91 -36.71 59.34 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.152 -0.931 . . . . 0.0 111.417 179.688 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 140' ' ' ASN . . . . . . . . . . . . . 61.6 t30 -63.19 -25.95 68.58 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 177.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 141' ' ' LYS . . . . . . . . . . . . . 35.9 tptt -76.26 -49.09 17.96 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.632 -1.167 . . . . 0.0 110.838 177.639 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 142' ' ' VAL . . . . . 1.012 HG12 ' HB2' ' B' ' 103' ' ' TYR . 13.7 p -57.92 -45.95 87.61 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.367 0 CA-C-O 121.212 0.53 . . . . 0.0 109.716 179.561 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 143' ' ' ILE . . . . . 0.742 HG12 ' HD2' ' B' ' 107' ' ' TYR . 34.7 mt -58.56 -46.25 90.05 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.802 0 C-N-CA 124.124 0.97 . . . . 0.0 112.198 173.581 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 144' ' ' SER . . . . . . . . . . . . . 46.5 t -51.59 -39.23 57.52 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.917 176.225 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 145' ' ' GLU . . . . . . . . . . . . . 15.6 mm-40 -73.86 -50.86 18.3 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 121.765 0.793 . . . . 0.0 110.431 175.505 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 146' ' ' LEU . . . . . 0.586 HD23 ' O ' ' B' ' 142' ' ' VAL . 2.2 mm? -61.28 -32.7 72.53 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 114.56 -1.2 . . . . 0.0 112.973 -175.879 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 147' ' ' ASN . . . . . 0.504 ' HA ' ' HH ' ' B' ' 107' ' ' TYR . 50.6 t30 -54.69 116.99 3.0 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.74 -172.823 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 148' ' ' GLY . . . . . 0.44 ' O ' ' HD3' ' B' ' 149' ' ' LYS . . . 98.97 36.15 4.57 Favored Glycine 0 N--CA 1.448 -0.533 0 CA-C-N 115.52 -0.764 . . . . 0.0 112.446 -179.577 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 149' ' ' LYS . . . . . 0.555 ' HE2' ' O ' ' B' ' 146' ' ' LEU . 0.5 OUTLIER -130.48 164.02 25.71 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 110.04 -0.355 . . . . 0.0 110.04 177.898 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 150' ' ' ASN . . . . . 0.489 ' O ' HG21 ' B' ' 154' ' ' VAL . 4.8 m-20 -102.14 90.13 3.83 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 -178.437 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 151' ' ' ILE . . . . . 0.78 HG13 HD12 ' B' ' 108' ' ' LEU . 1.8 mp -34.58 -68.52 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 O-C-N 124.734 1.271 . . . . 0.0 113.251 -172.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 152' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -46.14 -56.68 5.32 Favored 'General case' 0 C--O 1.213 -0.84 0 N-CA-C 112.549 0.574 . . . . 0.0 112.549 -179.482 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 153' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -57.3 -35.67 70.13 Favored 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 120.85 -0.34 . . . . 0.0 111.673 -178.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 154' ' ' VAL . . . . . 0.735 ' HB ' HD11 ' B' ' 155' ' ' ILE . 64.4 t -57.87 -53.94 38.52 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 CA-C-O 121.273 0.558 . . . . 0.0 110.1 177.37 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 155' ' ' ILE . . . . . 0.934 HD12 ' HG ' ' B' ' 108' ' ' LEU . 3.6 mp -87.76 -19.78 7.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.56 -0.746 . . . . 0.0 111.729 -173.542 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . -57.21 -16.67 8.72 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.022 0.439 . . . . 0.0 110.919 179.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 157' ' ' GLN . . . . . . . . . . . . . 49.8 mt-30 -130.89 26.77 4.95 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.921 170.231 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 158' ' ' GLY . . . . . . . . . . . . . . . -160.04 46.85 0.41 Allowed Glycine 0 CA--C 1.526 0.76 0 CA-C-N 115.989 -0.551 . . . . 0.0 113.943 -172.297 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 159' ' ' ILE . . . . . 0.867 ' HB ' HG13 ' A' ' 60' ' ' ILE . 1.9 mp -61.16 -12.17 5.53 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 CA-C-O 121.875 0.845 . . . . 0.0 110.162 171.748 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 160' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.439 -1.143 0 N-CA-C 109.977 -1.249 . . . . 0.0 109.977 -178.806 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' SER . . . . . 0.504 ' HB2' ' HG3' ' A' ' 6' ' ' GLU . 1.5 m . . . . . 0 N--CA 1.449 -0.525 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.956 HG13 ' HG ' ' B' ' 112' ' ' LEU . 2.1 t -54.33 -24.86 12.82 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-N 115.128 -0.942 . . . . 0.0 112.348 -177.446 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' SER . . . . . 0.827 ' HB3' ' HA ' ' A' ' 39' ' ' VAL . 49.7 m -71.27 -48.55 50.21 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.446 0.641 . . . . 0.0 109.304 175.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.551 ' HG2' ' HE1' ' A' ' 43' ' ' TRP . 28.4 mt-10 -61.57 -49.42 76.72 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.322 -0.853 . . . . 0.0 109.274 179.18 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.712 ' O ' ' HB ' ' A' ' 10' ' ' ILE . 4.7 tp -60.24 -35.12 74.76 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 114.831 -1.077 . . . . 0.0 111.47 177.136 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.611 ' HB3' HD23 ' B' ' 112' ' ' LEU . . . -67.87 -37.15 81.45 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 120.933 0.397 . . . . 0.0 110.871 179.029 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.436 ' HB2' HG13 ' A' ' 39' ' ' VAL . 8.4 t -67.81 -39.58 83.95 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 178.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.712 ' HB ' ' O ' ' A' ' 7' ' ' LEU . 68.9 mt -48.48 -55.56 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.694 0 CA-C-N 114.264 -1.335 . . . . 0.0 109.726 170.03 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.869 ' HB2' HD13 ' B' ' 109' ' ' LEU . 23.0 m-85 -67.11 -39.03 86.63 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.698 -173.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.468 ' OG ' HG23 ' A' ' 28' ' ' ILE . 73.1 p -57.1 -40.42 76.97 Favored 'General case' 0 C--O 1.237 0.395 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 177.209 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -65.94 -33.02 74.87 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 115.195 -0.911 . . . . 0.0 110.574 173.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.89 HD22 HD11 ' A' ' 56' ' ' ILE . 0.4 OUTLIER -66.12 -50.52 63.73 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.967 -179.774 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.506 HG12 ' O ' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -63.11 -42.43 96.56 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 177.497 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.687 HD21 ' HA ' ' A' ' 23' ' ' VAL . 6.1 tp -56.12 -38.16 70.4 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.37 0.605 . . . . 0.0 110.388 173.859 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 45.9 t60 -78.78 -7.61 57.98 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.018 -0.992 . . . . 0.0 111.598 178.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -66.62 -52.74 41.84 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 175.188 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -93.1 -10.84 34.56 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 122.098 0.952 . . . . 0.0 108.896 178.512 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 55.79 53.45 9.4 Favored 'General case' 0 CA--C 1.51 -0.576 0 CA-C-N 113.871 -1.513 . . . . 0.0 109.597 -175.026 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.614 HG11 HD13 ' A' ' 16' ' ' LEU . 7.6 p -99.87 160.07 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.723 0 CA-C-N 113.971 -1.468 . . . . 0.0 108.667 -176.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.504 ' O ' ' HG3' ' A' ' 27' ' ' LYS . 50.8 p -43.37 131.28 4.84 Favored 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 113.525 0.935 . . . . 0.0 113.525 -171.661 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.687 ' HA ' HD21 ' A' ' 16' ' ' LEU . 57.7 t -96.82 109.31 22.83 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.04 0 CA-C-N 114.283 -1.326 . . . . 0.0 110.863 -177.071 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.735 ' OG1' ' HG2' ' A' ' 27' ' ' LYS . 21.3 p -133.31 157.13 46.24 Favored 'General case' 0 C--O 1.245 0.855 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.186 179.457 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -53.27 -44.71 68.42 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.601 177.313 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -68.76 -24.97 64.5 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.282 179.589 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.735 ' HG2' ' OG1' ' A' ' 24' ' ' THR . 2.8 mmtm -61.44 -56.43 20.24 Favored 'General case' 0 CA--C 1.514 -0.407 0 N-CA-C 107.937 -1.135 . . . . 0.0 107.937 173.644 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.468 HG23 ' OG ' ' A' ' 12' ' ' SER . 83.5 mt -55.73 -43.3 73.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 113.728 -1.578 . . . . 0.0 110.818 -178.894 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 29.4 m-80 -65.52 -33.17 75.3 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.065 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.23 -48.88 76.41 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.333 176.072 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.66 ' HB3' HD23 ' B' ' 109' ' ' LEU . 1.9 mm? -59.53 -47.6 84.92 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-O 120.917 0.389 . . . . 0.0 110.617 175.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.554 HG22 ' O ' ' A' ' 37' ' ' VAL . 44.0 mt -48.58 -48.98 14.47 Favored 'Isoleucine or valine' 0 C--O 1.241 0.647 0 CA-C-N 115.227 -0.897 . . . . 0.0 111.277 178.166 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 42.5 tptt -72.57 -42.46 64.6 Favored 'General case' 0 N--CA 1.431 -1.399 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.607 -176.461 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -60.74 -40.4 92.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.948 0.404 . . . . 0.0 111.217 -177.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.478 ' HA ' HD13 ' B' ' 126' ' ' ILE . . . -79.96 -34.79 38.44 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.178 0.513 . . . . 0.0 111.105 178.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 97.75 17.66 29.93 Favored Glycine 0 N--CA 1.448 -0.548 0 CA-C-N 115.672 -0.695 . . . . 0.0 112.003 -179.567 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.915 ' HB ' ' HA2' ' B' ' 113' ' ' GLY . 2.9 p -119.69 119.32 60.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-O 121.599 0.714 . . . . 0.0 110.618 -176.567 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.476 ' HA ' HG22 ' A' ' 32' ' ' ILE . 13.6 t-20 -97.57 150.99 20.52 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 114.816 -1.084 . . . . 0.0 110.342 -170.345 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.827 ' HA ' ' HB3' ' A' ' 5' ' ' SER . 99.0 t -121.56 162.55 20.59 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.028 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.381 -169.497 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.492 ' N ' HG12 ' A' ' 39' ' ' VAL . 5.1 tp10 -70.69 106.58 1.84 Allowed Pre-proline 0 N--CA 1.438 -1.04 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 169.665 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.503 ' C ' ' HD2' ' A' ' 44' ' ' PRO . 77.7 Cg_exo -51.71 -26.36 23.09 Favored 'Trans proline' 0 C--O 1.247 0.925 0 C-N-CA 123.818 3.012 . . . . 0.0 115.503 -164.199 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.91 -27.32 68.73 Favored 'General case' 0 CA--C 1.526 0.048 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 177.898 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . 0.553 ' CE3' ' HE1' ' A' ' 47' ' ' PHE . 20.8 m95 -64.31 -59.63 10.48 Favored Pre-proline 0 C--O 1.208 -1.107 0 CA-C-O 118.626 -0.702 . . . . 0.0 110.977 176.04 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.503 ' HD2' ' C ' ' A' ' 41' ' ' PRO . 90.7 Cg_exo -45.26 -43.97 16.29 Favored 'Trans proline' 0 C--N 1.358 1.035 0 C-N-CA 121.733 1.622 . . . . 0.0 112.031 173.474 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -60.21 -59.11 10.95 Favored Glycine 0 CA--C 1.525 0.671 0 C-N-CA 120.36 -0.924 . . . . 0.0 112.581 176.649 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.425 ' O ' ' HB2' ' A' ' 49' ' ' LYS . 5.9 tp -67.46 -26.9 66.61 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 122.909 0.483 . . . . 0.0 112.108 -176.785 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.553 ' HE1' ' CE3' ' A' ' 43' ' ' TRP . 3.0 m-85 -69.05 -46.78 67.01 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 110.19 -0.3 . . . . 0.0 110.19 176.317 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.47 -32.02 73.42 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.322 -0.622 . . . . 0.0 109.322 178.229 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.425 ' HB2' ' O ' ' A' ' 46' ' ' LEU . 8.0 mmmt -60.44 -55.33 34.83 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 114.832 -1.077 . . . . 0.0 111.707 171.289 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.596 ' O ' HG22 ' A' ' 54' ' ' VAL . . . -76.4 -41.09 49.01 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 -170.211 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.51 ' HB2' HG13 ' A' ' 23' ' ' VAL . 12.7 mt -74.21 45.47 0.22 Allowed 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 121.473 0.654 . . . . 0.0 111.925 -173.279 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.439 ' H ' ' C ' ' A' ' 50' ' ' ALA . . . -134.68 -24.58 1.52 Allowed 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.05 -0.977 . . . . 0.0 109.026 172.837 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -121.39 -25.28 5.23 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 115.56 -0.746 . . . . 0.0 111.13 178.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.596 HG22 ' O ' ' A' ' 50' ' ' ALA . 10.4 m -99.64 -170.37 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 174.853 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 34.9 p30 -129.67 -178.39 4.67 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.794 175.59 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.89 HD11 HD22 ' A' ' 14' ' ' LEU . 3.1 tp -68.32 -28.69 41.58 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-O 120.642 0.258 . . . . 0.0 110.94 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -72.14 -11.05 74.74 Favored Glycine 0 N--CA 1.448 -0.5 0 C-N-CA 120.447 -0.882 . . . . 0.0 111.016 177.326 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 14.8 t -82.46 -19.21 39.34 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-O 121.598 0.713 . . . . 0.0 109.356 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.462 ' HB2' ' CG2' ' B' ' 159' ' ' ILE . 22.0 mt -64.0 -31.65 72.92 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.208 -0.906 . . . . 0.0 110.258 177.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.817 HG13 ' HB ' ' B' ' 159' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--N 1.323 -0.574 0 CA-C-N 114.898 -1.047 . . . . 0.0 110.483 177.798 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 103' ' ' TYR . . . . . 0.887 ' HB2' HG13 ' B' ' 142' ' ' VAL . 39.8 m-85 . . . . . 0 C--O 1.24 0.556 0 CA-C-O 120.722 0.296 . . . . 0.0 111.076 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 104' ' ' VAL . . . . . 0.558 ' HA ' HD12 ' B' ' 146' ' ' LEU . 97.8 t -43.64 -49.31 1.66 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.242 0 CA-C-O 121.701 0.763 . . . . 0.0 109.099 172.399 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 105' ' ' ALA . . . . . 0.633 ' CB ' ' HB3' ' A' ' 14' ' ' LEU . . . -64.17 -42.34 96.76 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 114.273 -1.331 . . . . 0.0 112.175 -173.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 106' ' ' SER . . . . . 0.641 ' HB2' HG22 ' B' ' 123' ' ' ILE . 0.8 OUTLIER -62.59 -37.68 87.17 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.687 0.756 . . . . 0.0 109.666 -179.747 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 107' ' ' TYR . . . . . 0.666 ' O ' ' HG2' ' B' ' 118' ' ' PRO . 43.6 t80 -63.41 -47.44 81.97 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 114.652 -1.158 . . . . 0.0 108.662 178.235 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 108' ' ' LEU . . . . . 0.764 HD12 HG13 ' B' ' 151' ' ' ILE . 0.0 OUTLIER -57.87 -46.44 84.85 Favored 'General case' 0 N--CA 1.442 -0.842 0 CA-C-N 114.766 -1.106 . . . . 0.0 110.866 177.194 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 109' ' ' LEU . . . . . 0.869 HD13 ' HB2' ' A' ' 11' ' ' TYR . 8.4 tp -54.85 -47.32 74.33 Favored 'General case' 0 CA--C 1.511 -0.543 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.916 179.047 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 110' ' ' ALA . . . . . 0.477 ' HB2' ' HB3' ' B' ' 118' ' ' PRO . . . -68.01 -36.61 80.27 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.59 -0.444 . . . . 0.0 111.334 -176.772 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 111' ' ' ALA . . . . . 0.793 ' HA ' ' O ' ' B' ' 115' ' ' ASN . . . -70.91 -20.0 62.53 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.411 0.624 . . . . 0.0 110.703 178.51 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 112' ' ' LEU . . . . . 0.956 ' HG ' HG13 ' A' ' 4' ' ' VAL . 2.8 mp -84.5 -40.18 17.97 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 114.962 -1.017 . . . . 0.0 109.762 172.191 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 113' ' ' GLY . . . . . 0.915 ' HA2' ' HB ' ' A' ' 37' ' ' VAL . . . -61.54 -53.65 42.22 Favored Glycine 0 N--CA 1.442 -0.904 0 CA-C-N 114.928 -1.033 . . . . 0.0 112.155 -177.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 114' ' ' GLY . . . . . . . . . . . . . . . 177.33 4.03 0.02 OUTLIER Glycine 0 N--CA 1.441 -1.01 0 C-N-CA 119.55 -1.31 . . . . 0.0 113.909 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 115' ' ' ASN . . . . . 0.793 ' O ' ' HA ' ' B' ' 111' ' ' ALA . 38.2 m-20 -126.78 98.89 5.54 Favored 'General case' 0 CA--C 1.497 -1.076 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 14.1 m -77.04 26.8 0.14 Allowed 'General case' 0 C--N 1.315 -0.9 0 CA-C-O 122.107 0.956 . . . . 0.0 109.763 -175.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 117' ' ' SER . . . . . 0.627 ' H ' ' C ' ' B' ' 115' ' ' ASN . 34.8 t -168.8 70.39 0.75 Allowed Pre-proline 0 C--N 1.321 -0.633 0 CA-C-N 113.738 -1.573 . . . . 0.0 108.385 178.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 118' ' ' PRO . . . . . 0.666 ' HG2' ' O ' ' B' ' 107' ' ' TYR . 34.1 Cg_exo -66.82 158.77 54.73 Favored 'Trans proline' 0 C--N 1.328 -0.547 0 C-N-CA 125.167 3.911 . . . . 0.0 111.675 -176.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 119' ' ' SER . . . . . 0.583 ' O ' HG12 ' B' ' 123' ' ' ILE . 8.6 m -122.31 -179.39 4.17 Favored 'General case' 0 C--N 1.316 -0.882 0 C-N-CA 120.555 -0.458 . . . . 0.0 110.875 176.175 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 120' ' ' ALA . . . . . 0.736 ' HB3' HD13 ' B' ' 139' ' ' LEU . . . -65.99 -36.46 83.36 Favored 'General case' 0 CA--C 1.504 -0.812 0 CA-C-O 122.219 1.009 . . . . 0.0 109.236 -173.347 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 121' ' ' LYS . . . . . 0.433 ' HD2' ' N ' ' B' ' 121' ' ' LYS . 0.4 OUTLIER -63.61 -34.86 78.77 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 113.332 -1.758 . . . . 0.0 110.101 176.782 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 122' ' ' ASP . . . . . 0.427 ' O ' HD11 ' B' ' 126' ' ' ILE . 18.5 m-20 -71.1 -37.6 72.38 Favored 'General case' 0 CA--C 1.517 -0.314 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 176.486 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 123' ' ' ILE . . . . . 0.741 ' O ' ' HG ' ' B' ' 127' ' ' LEU . 34.1 mm -61.83 -49.9 82.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.132 177.453 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 124' ' ' LYS . . . . . 0.814 ' HD3' HD22 ' B' ' 139' ' ' LEU . 4.2 mmmp? -58.91 -43.61 91.12 Favored 'General case' 0 C--O 1.213 -0.839 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.228 -178.862 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 125' ' ' LYS . . . . . 0.533 ' HD3' ' HA ' ' B' ' 125' ' ' LYS . 10.0 tppt? -50.51 -59.82 3.64 Favored 'General case' 0 N--CA 1.418 -2.056 0 O-C-N 123.721 0.638 . . . . 0.0 112.132 174.105 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 126' ' ' ILE . . . . . 0.557 HG23 HD12 ' A' ' 31' ' ' LEU . 1.7 mp -56.53 -47.63 81.61 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 CA-C-N 115.426 -0.806 . . . . 0.0 111.487 -176.282 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 127' ' ' LEU . . . . . 0.741 ' HG ' ' O ' ' B' ' 123' ' ' ILE . 2.2 pp -80.59 -19.59 45.2 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.306 -0.557 . . . . 0.0 112.103 -177.11 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 128' ' ' ASP . . . . . 0.493 ' HB2' ' O ' ' B' ' 124' ' ' LYS . 13.6 t70 -73.98 -31.16 62.86 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 179.367 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 129' ' ' SER . . . . . . . . . . . . . 84.1 p -52.63 -37.62 58.77 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.219 176.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 130' ' ' VAL . . . . . 0.55 HG22 HG13 ' B' ' 132' ' ' ILE . 7.5 m -103.95 5.85 10.35 Favored 'Isoleucine or valine' 0 C--O 1.232 0.137 0 CA-C-O 120.801 0.334 . . . . 0.0 111.536 179.324 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 131' ' ' GLY . . . . . . . . . . . . . . . 67.83 48.97 52.07 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 121.192 -0.528 . . . . 0.0 113.163 177.308 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 132' ' ' ILE . . . . . 0.55 HG13 HG22 ' B' ' 130' ' ' VAL . 8.7 mt -101.54 128.58 53.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-O 120.919 0.39 . . . . 0.0 110.963 178.229 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 133' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -67.47 136.45 54.65 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.187 -177.558 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 134' ' ' ALA . . . . . . . . . . . . . . . -152.57 143.61 23.07 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.182 -177.137 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 135' ' ' ASP . . . . . 0.719 ' HB2' ' HG3' ' B' ' 138' ' ' ARG . 34.1 m-20 -93.27 129.51 39.31 Favored 'General case' 0 C--O 1.251 1.149 0 CA-C-O 120.973 0.416 . . . . 0.0 110.12 174.772 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 136' ' ' ASP . . . . . 0.556 ' HA ' HD12 ' B' ' 139' ' ' LEU . 3.1 m-20 -71.22 -5.37 31.48 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-N 115.239 -0.892 . . . . 0.0 111.191 -169.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 137' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -100.53 -34.99 9.68 Favored 'General case' 0 N--CA 1.433 -1.282 0 C-N-CA 120.487 -0.485 . . . . 0.0 110.097 175.662 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 138' ' ' ARG . . . . . 0.719 ' HG3' ' HB2' ' B' ' 135' ' ' ASP . 43.7 mmt-85 -63.91 -46.23 85.74 Favored 'General case' 0 CA--C 1.503 -0.841 0 CA-C-O 122.118 0.961 . . . . 0.0 109.234 -176.323 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 139' ' ' LEU . . . . . 0.839 ' O ' HG12 ' B' ' 143' ' ' ILE . 0.3 OUTLIER -74.16 -34.39 63.8 Favored 'General case' 0 C--O 1.209 -1.037 0 CA-C-N 114.529 -1.214 . . . . 0.0 111.6 -178.828 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 140' ' ' ASN . . . . . 0.569 ' O ' ' HB ' ' B' ' 143' ' ' ILE . 60.8 t30 -65.02 -27.98 69.18 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 122.331 1.062 . . . . 0.0 108.703 177.538 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 141' ' ' LYS . . . . . 0.576 ' O ' ' HG2' ' B' ' 145' ' ' GLU . 30.0 tttp -67.89 -56.0 10.72 Favored 'General case' 0 N--CA 1.44 -0.959 0 CA-C-N 114.141 -1.39 . . . . 0.0 108.882 175.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 142' ' ' VAL . . . . . 0.887 HG13 ' HB2' ' B' ' 103' ' ' TYR . 8.5 p -57.93 -31.57 41.22 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.236 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.449 178.827 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 143' ' ' ILE . . . . . 0.839 HG12 ' O ' ' B' ' 139' ' ' LEU . 28.1 mm -51.99 -67.41 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.513 -0.45 0 CA-C-O 121.151 0.501 . . . . 0.0 110.514 170.873 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 144' ' ' SER . . . . . . . . . . . . . 79.2 p -57.42 -25.42 59.58 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 114.96 -1.018 . . . . 0.0 111.89 -178.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 145' ' ' GLU . . . . . 0.576 ' HG2' ' O ' ' B' ' 141' ' ' LYS . 5.8 mm-40 -73.16 -46.47 50.6 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 120.898 0.38 . . . . 0.0 110.555 178.143 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 146' ' ' LEU . . . . . 0.707 ' HG ' ' O ' ' B' ' 142' ' ' VAL . 6.9 mt -82.63 -17.05 46.06 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.486 -0.324 . . . . 0.0 111.09 -176.593 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 147' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -56.54 111.84 1.11 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.207 0.527 . . . . 0.0 111.426 -175.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . 111.72 7.76 23.43 Favored Glycine 0 CA--C 1.519 0.33 0 CA-C-N 115.527 -0.76 . . . . 0.0 112.806 -179.285 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 149' ' ' LYS . . . . . 0.501 ' HE2' ' O ' ' B' ' 146' ' ' LEU . 0.8 OUTLIER -104.19 167.88 9.47 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.1 0.476 . . . . 0.0 111.038 -179.749 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 150' ' ' ASN . . . . . 0.513 ' O ' HG22 ' B' ' 154' ' ' VAL . 0.9 OUTLIER -103.93 91.01 3.79 Favored 'General case' 0 CA--C 1.511 -0.545 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 176.788 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 151' ' ' ILE . . . . . 0.764 HG13 HD12 ' B' ' 108' ' ' LEU . 1.8 mp -41.9 -62.87 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 O-C-N 124.376 1.048 . . . . 0.0 113.247 -168.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 152' ' ' GLU . . . . . 0.653 ' HG3' HD11 ' B' ' 112' ' ' LEU . 3.0 mp0 -57.42 -33.22 67.67 Favored 'General case' 0 C--O 1.219 -0.532 0 N-CA-C 111.839 0.311 . . . . 0.0 111.839 -174.487 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 153' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -78.52 -33.4 48.01 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.609 179.498 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 154' ' ' VAL . . . . . 0.807 ' HB ' HD11 ' B' ' 155' ' ' ILE . 58.2 t -54.84 -46.31 75.17 Favored 'Isoleucine or valine' 0 C--O 1.233 0.185 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 172.253 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 155' ' ' ILE . . . . . 0.859 ' HB ' ' HH ' ' A' ' 11' ' ' TYR . 2.3 mp -106.71 33.84 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 114.97 -1.014 . . . . 0.0 110.448 -179.314 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . -101.75 2.99 39.1 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 167.526 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 157' ' ' GLN . . . . . . . . . . . . . 46.4 mt-30 -138.93 -1.42 1.79 Allowed 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 113.55 -1.659 . . . . 0.0 109.844 173.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 158' ' ' GLY . . . . . . . . . . . . . . . -139.62 46.34 0.96 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.379 -0.915 . . . . 0.0 114.575 -167.274 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 159' ' ' ILE . . . . . 0.817 ' HB ' HG13 ' A' ' 60' ' ' ILE . 1.8 mp -61.59 -15.56 13.43 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 CA-C-O 122.039 0.923 . . . . 0.0 109.733 173.584 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 160' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.437 -1.29 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 178.509 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' SER . . . . . 0.742 ' HB2' ' HG3' ' A' ' 6' ' ' GLU . 6.2 m . . . . . 0 N--CA 1.439 -1.023 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.9 HG13 ' HG ' ' B' ' 112' ' ' LEU . 2.2 t -52.93 -28.22 13.64 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.78 0 CA-C-N 115.294 -0.866 . . . . 0.0 112.073 -179.573 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' SER . . . . . 0.727 ' HB3' ' HA ' ' A' ' 39' ' ' VAL . 71.7 m -68.45 -43.99 75.85 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.229 0.538 . . . . 0.0 109.784 175.723 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.742 ' HG3' ' HB2' ' A' ' 3' ' ' SER . 30.2 mt-10 -68.21 -49.04 63.44 Favored 'General case' 0 N--CA 1.444 -0.726 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 -178.209 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.723 ' HA ' HD12 ' A' ' 10' ' ' ILE . 2.9 tp -58.34 -35.01 71.27 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 114.443 -1.253 . . . . 0.0 111.949 175.396 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.55 ' HB1' HD22 ' B' ' 112' ' ' LEU . . . -68.37 -37.25 80.26 Favored 'General case' 0 CA--C 1.512 -0.484 0 CA-C-O 121.04 0.448 . . . . 0.0 110.786 179.054 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.501 ' HB2' HG11 ' A' ' 39' ' ' VAL . 4.6 t -67.35 -40.79 85.86 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 178.633 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.723 HD12 ' HA ' ' A' ' 7' ' ' LEU . 73.8 mt -48.92 -55.76 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.685 0 CA-C-N 113.896 -1.502 . . . . 0.0 110.051 171.896 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.886 ' HH ' ' HB ' ' B' ' 155' ' ' ILE . 23.9 m-85 -66.36 -41.46 89.46 Favored 'General case' 0 C--O 1.22 -0.455 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.557 -174.103 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 15.6 m -54.01 -42.09 68.7 Favored 'General case' 0 C--O 1.242 0.692 0 CA-C-O 121.489 0.661 . . . . 0.0 109.27 175.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -68.67 -28.94 67.32 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.39 176.154 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.659 ' HB2' ' HA ' ' A' ' 11' ' ' TYR . 0.2 OUTLIER -67.25 -55.58 13.41 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.49 179.34 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.413 HG12 ' O ' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -55.72 -43.84 74.99 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 176.889 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.761 HD12 HG12 ' A' ' 21' ' ' VAL . 3.8 tp -57.69 -44.27 85.73 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.501 177.75 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 25.1 t60 -75.73 -13.43 60.31 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.258 -0.883 . . . . 0.0 111.726 178.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 12.1 t0 -69.09 -42.31 76.34 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.247 0.546 . . . . 0.0 109.61 179.377 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -100.08 -7.04 25.4 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 122.032 0.92 . . . . 0.0 109.226 177.014 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 52.29 56.55 7.56 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-N 113.784 -1.553 . . . . 0.0 110.262 -175.286 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.761 HG12 HD12 ' A' ' 16' ' ' LEU . 6.1 p -106.21 159.45 6.18 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.679 0 CA-C-N 114.13 -1.396 . . . . 0.0 108.814 -178.825 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 82.2 p -49.8 139.1 13.74 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 114.193 1.183 . . . . 0.0 114.193 -169.48 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.451 HG22 HD21 ' A' ' 16' ' ' LEU . 63.1 t -103.77 111.86 35.06 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-N 114.216 -1.356 . . . . 0.0 110.986 -177.094 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.491 ' OG1' ' HE2' ' A' ' 27' ' ' LYS . 77.3 p -135.66 157.83 45.89 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 175.575 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -57.49 -41.23 80.29 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 120.71 -0.396 . . . . 0.0 110.094 -177.434 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -65.16 -29.92 70.8 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.08 178.344 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.522 ' HG2' HD13 ' A' ' 16' ' ' LEU . 3.8 tppt? -66.53 -53.0 39.72 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 179.844 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 66.4 mt -60.41 -39.69 81.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 114.394 -1.275 . . . . 0.0 110.491 178.321 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 -61.97 -36.01 80.16 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.74 176.045 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.67 -45.59 92.1 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-N 116.552 -0.294 . . . . 0.0 110.484 177.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.547 ' HB3' HD23 ' B' ' 109' ' ' LEU . 1.3 mm? -58.35 -51.15 71.02 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 121.085 0.469 . . . . 0.0 110.13 173.838 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.55 HG23 ' O ' ' A' ' 37' ' ' VAL . 57.1 mt -48.28 -50.86 10.99 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 CA-C-N 114.873 -1.058 . . . . 0.0 111.646 178.686 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -69.82 -40.08 76.13 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.079 -0.51 . . . . 0.0 112.03 -176.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -64.2 -45.54 87.86 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-O 120.918 0.39 . . . . 0.0 111.093 -177.384 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.437 ' HB3' HG12 ' A' ' 37' ' ' VAL . . . -74.84 -34.82 62.36 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.429 178.669 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 96.96 18.48 29.36 Favored Glycine 0 N--CA 1.448 -0.554 0 CA-C-N 115.379 -0.828 . . . . 0.0 112.019 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.86 ' HB ' ' HA3' ' B' ' 113' ' ' GLY . 5.5 p -121.04 121.92 66.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 121.422 0.63 . . . . 0.0 111.059 -173.061 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 62.9 t30 -99.33 157.33 16.48 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.049 -0.978 . . . . 0.0 111.035 -169.308 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.727 ' HA ' ' HB3' ' A' ' 5' ' ' SER . 94.6 t -125.28 161.66 29.19 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.759 0 CA-C-N 115.056 -0.974 . . . . 0.0 110.937 -170.214 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.53 ' HB3' ' HD1' ' A' ' 43' ' ' TRP . 3.9 tp10 -67.65 105.41 0.9 Allowed Pre-proline 0 N--CA 1.441 -0.884 0 N-CA-C 107.756 -1.201 . . . . 0.0 107.756 169.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.519 ' C ' ' HD2' ' A' ' 44' ' ' PRO . 86.0 Cg_exo -49.54 -29.73 19.58 Favored 'Trans proline' 0 C--O 1.252 1.195 0 C-N-CA 123.602 2.868 . . . . 0.0 115.675 -163.767 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -60.76 -27.65 68.13 Favored 'General case' 0 C--N 1.333 -0.14 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 177.647 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . 0.53 ' HD1' ' HB3' ' A' ' 40' ' ' GLU . 9.6 m95 -65.08 -59.41 10.09 Favored Pre-proline 0 C--O 1.204 -1.337 0 CA-C-O 118.303 -0.856 . . . . 0.0 111.147 176.416 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.519 ' HD2' ' C ' ' A' ' 41' ' ' PRO . 83.3 Cg_exo -45.52 -44.46 17.0 Favored 'Trans proline' 0 C--N 1.359 1.086 0 C-N-CA 121.652 1.568 . . . . 0.0 111.913 174.622 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -60.4 -60.56 8.34 Favored Glycine 0 CA--C 1.525 0.68 0 C-N-CA 120.176 -1.012 . . . . 0.0 112.322 175.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 12.7 tp -65.79 -21.92 66.53 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.136 0.574 . . . . 0.0 112.11 -177.057 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.713 ' HD2' HD11 ' A' ' 51' ' ' LEU . 2.6 m-85 -74.72 -45.07 46.59 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 176.625 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.417 ' HA ' HG12 ' A' ' 23' ' ' VAL . . . -64.8 -30.23 71.22 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-O 121.821 0.82 . . . . 0.0 108.864 177.602 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 9.6 mmmt -66.27 -58.0 6.32 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 114.276 -1.329 . . . . 0.0 111.713 172.167 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.471 ' O ' HG21 ' A' ' 54' ' ' VAL . . . -76.03 -39.1 56.38 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 113.457 0.91 . . . . 0.0 113.457 -168.786 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.713 HD11 ' HD2' ' A' ' 47' ' ' PHE . 12.3 mt -68.85 -4.51 16.57 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 117.922 0.328 . . . . 0.0 111.7 -173.641 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -95.67 9.68 39.45 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.138 0.494 . . . . 0.0 110.296 174.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -143.62 -48.2 0.29 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.505 -178.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.471 HG21 ' O ' ' A' ' 50' ' ' ALA . 9.2 m -94.77 -169.55 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.282 179.851 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 11.3 m120 -121.59 -175.94 3.2 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.962 0.411 . . . . 0.0 111.3 178.199 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.596 HD13 HD22 ' A' ' 14' ' ' LEU . 3.0 tp -75.06 -28.46 20.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.356 -179.669 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -69.84 -15.5 71.49 Favored Glycine 0 N--CA 1.447 -0.571 0 N-CA-C 110.613 -0.995 . . . . 0.0 110.613 175.461 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 16.5 m -78.02 -19.61 54.05 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-O 121.174 0.511 . . . . 0.0 110.201 179.594 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 25.0 mt -64.16 -30.47 71.53 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.589 179.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.669 ' CD1' ' HB ' ' B' ' 159' ' ' ILE . 0.4 OUTLIER . . . . . 0 C--N 1.318 -0.783 0 CA-C-N 115.147 -0.933 . . . . 0.0 109.955 176.574 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 103' ' ' TYR . . . . . 0.655 ' HB2' HG12 ' B' ' 142' ' ' VAL . 47.6 m-85 . . . . . 0 N--CA 1.475 0.805 0 N-CA-C 112.087 0.403 . . . . 0.0 112.087 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 104' ' ' VAL . . . . . 0.648 HG12 HD21 ' B' ' 108' ' ' LEU . 82.9 t -45.42 -44.34 3.76 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.256 0 CA-C-O 121.515 0.674 . . . . 0.0 110.404 175.777 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 105' ' ' ALA . . . . . 0.654 ' CB ' ' HB3' ' A' ' 14' ' ' LEU . . . -67.41 -38.78 85.16 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 114.925 -1.034 . . . . 0.0 111.559 -174.853 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 106' ' ' SER . . . . . 0.771 ' HB2' HG23 ' B' ' 123' ' ' ILE . 1.8 m -60.79 -38.44 85.34 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-O 121.784 0.802 . . . . 0.0 109.189 175.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 107' ' ' TYR . . . . . 0.738 ' O ' ' HG2' ' B' ' 118' ' ' PRO . 38.4 t80 -63.27 -49.33 74.52 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-N 114.016 -1.447 . . . . 0.0 108.706 178.814 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 108' ' ' LEU . . . . . 0.653 ' HG ' HD12 ' B' ' 155' ' ' ILE . 0.0 OUTLIER -56.4 -50.49 71.44 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.164 -0.926 . . . . 0.0 111.711 178.772 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 109' ' ' LEU . . . . . 0.743 HD11 ' HB2' ' A' ' 11' ' ' TYR . 7.8 tp -53.93 -54.91 32.25 Favored 'General case' 0 C--O 1.246 0.906 0 CA-C-O 121.4 0.619 . . . . 0.0 111.011 178.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -57.05 -39.14 74.3 Favored 'General case' 0 C--O 1.22 -0.458 0 CA-C-N 114.975 -1.011 . . . . 0.0 110.423 -178.259 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 111' ' ' ALA . . . . . 0.735 ' HA ' ' O ' ' B' ' 115' ' ' ASN . . . -77.83 -19.54 54.74 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.706 -178.915 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 112' ' ' LEU . . . . . 0.9 ' HG ' HG13 ' A' ' 4' ' ' VAL . 4.4 tp -77.19 -40.0 46.78 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.418 -179.047 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 113' ' ' GLY . . . . . 0.86 ' HA3' ' HB ' ' A' ' 37' ' ' VAL . . . -144.95 44.68 0.88 Allowed Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 118.819 -1.658 . . . . 0.0 114.354 -176.75 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 114' ' ' GLY . . . . . . . . . . . . . . . -166.25 -49.21 0.02 OUTLIER Glycine 0 N--CA 1.444 -0.792 0 C-N-CA 119.214 -1.47 . . . . 0.0 113.139 175.489 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 115' ' ' ASN . . . . . 0.735 ' O ' ' HA ' ' B' ' 111' ' ' ALA . 10.0 t30 -155.47 113.63 3.43 Favored 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 109.227 -0.656 . . . . 0.0 109.227 -171.757 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 4.0 m -79.97 26.01 0.35 Allowed 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 122.152 0.977 . . . . 0.0 111.02 -168.33 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 117' ' ' SER . . . . . 0.523 ' N ' ' HD3' ' B' ' 118' ' ' PRO . 8.9 t -172.31 69.82 0.43 Allowed Pre-proline 0 C--N 1.312 -1.022 0 CA-C-N 113.789 -1.55 . . . . 0.0 108.346 178.668 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 118' ' ' PRO . . . . . 0.738 ' HG2' ' O ' ' B' ' 107' ' ' TYR . 33.3 Cg_exo -62.07 157.44 44.25 Favored 'Trans proline' 0 CA--C 1.511 -0.651 1 C-N-CA 125.605 4.203 . . . . 0.0 112.155 -173.934 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 119' ' ' SER . . . . . 0.544 ' O ' HG12 ' B' ' 123' ' ' ILE . 14.7 m -131.73 -174.98 3.57 Favored 'General case' 0 C--N 1.317 -0.828 0 C-N-CA 119.715 -0.794 . . . . 0.0 111.842 178.784 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 120' ' ' ALA . . . . . 0.672 ' HB3' HD13 ' B' ' 139' ' ' LEU . . . -63.27 -40.77 98.33 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.719 0.771 . . . . 0.0 109.611 -165.177 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 121' ' ' LYS . . . . . . . . . . . . . 1.8 mptm? -62.71 -36.83 84.22 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 114.078 -1.419 . . . . 0.0 110.86 177.304 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 122' ' ' ASP . . . . . . . . . . . . . 44.8 m-20 -70.42 -40.13 74.01 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 120.182 -0.607 . . . . 0.0 109.55 -178.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 123' ' ' ILE . . . . . 0.771 HG23 ' HB2' ' B' ' 106' ' ' SER . 23.3 mm -60.19 -42.94 92.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.52 175.581 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 124' ' ' LYS . . . . . 0.817 ' HD3' HD22 ' B' ' 139' ' ' LEU . 2.2 mmmp? -59.02 -39.73 82.84 Favored 'General case' 0 CA--C 1.504 -0.819 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 -178.875 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 125' ' ' LYS . . . . . . . . . . . . . 86.8 mttt -56.81 -61.69 2.26 Favored 'General case' 0 CA--C 1.489 -1.382 0 C-N-CA 119.274 -0.97 . . . . 0.0 110.841 173.653 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 126' ' ' ILE . . . . . 0.478 HG21 HD11 ' A' ' 31' ' ' LEU . 1.8 mp -57.44 -36.99 55.26 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.118 0 CA-C-N 114.282 -1.326 . . . . 0.0 110.951 -166.855 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 127' ' ' LEU . . . . . 0.752 ' HG ' ' O ' ' B' ' 123' ' ' ILE . 1.2 pp -80.68 -39.29 27.47 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.172 -0.611 . . . . 0.0 111.648 178.126 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 128' ' ' ASP . . . . . 0.448 ' N ' HD13 ' B' ' 127' ' ' LEU . 9.8 m-20 -70.0 -26.39 64.05 Favored 'General case' 0 N--CA 1.466 0.331 0 O-C-N 122.096 -0.377 . . . . 0.0 111.109 -179.438 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 129' ' ' SER . . . . . . . . . . . . . 84.4 p -60.11 -33.86 72.69 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.72 -177.169 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 130' ' ' VAL . . . . . . . . . . . . . 4.7 m -99.11 -34.16 4.3 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.398 175.679 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 131' ' ' GLY . . . . . . . . . . . . . . . 122.11 45.01 0.34 Allowed Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.233 179.664 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 132' ' ' ILE . . . . . . . . . . . . . 24.4 mt -112.17 136.32 48.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 179.424 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 133' ' ' GLU . . . . . . . . . . . . . 26.9 mm-40 -89.86 154.65 19.72 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.235 0.541 . . . . 0.0 111.743 -174.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 134' ' ' ALA . . . . . 0.509 ' HB1' HD22 ' B' ' 127' ' ' LEU . . . -153.21 145.26 23.74 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.078 -0.964 . . . . 0.0 112.049 -172.771 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 135' ' ' ASP . . . . . 0.664 ' HB2' ' CG ' ' B' ' 138' ' ' ARG . 53.9 m-20 -93.91 133.52 37.25 Favored 'General case' 0 C--O 1.251 1.161 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 170.728 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 136' ' ' ASP . . . . . 0.69 ' HA ' HD12 ' B' ' 139' ' ' LEU . 10.1 p-10 -72.03 -5.15 33.03 Favored 'General case' 0 CA--C 1.513 -0.464 0 CA-C-N 115.109 -0.951 . . . . 0.0 111.006 -169.654 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 137' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -101.04 -30.74 11.44 Favored 'General case' 0 N--CA 1.433 -1.293 0 C-N-CA 120.225 -0.59 . . . . 0.0 110.286 173.018 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 138' ' ' ARG . . . . . 0.664 ' CG ' ' HB2' ' B' ' 135' ' ' ASP . 36.3 mmt180 -66.22 -44.89 82.53 Favored 'General case' 0 CA--C 1.503 -0.855 0 CA-C-O 121.59 0.71 . . . . 0.0 109.86 -175.849 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 139' ' ' LEU . . . . . 0.817 HD22 ' HD3' ' B' ' 124' ' ' LYS . 0.3 OUTLIER -74.55 -33.79 62.81 Favored 'General case' 0 C--N 1.313 -0.981 0 C-N-CA 119.53 -0.868 . . . . 0.0 111.238 178.271 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 140' ' ' ASN . . . . . . . . . . . . . 58.8 t30 -68.97 -27.61 65.88 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 -176.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 141' ' ' LYS . . . . . 0.649 ' HG3' ' O ' ' B' ' 138' ' ' ARG . 0.0 OUTLIER -86.2 -38.25 17.85 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.02 -0.991 . . . . 0.0 110.46 -177.944 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 142' ' ' VAL . . . . . 0.655 HG12 ' HB2' ' B' ' 103' ' ' TYR . 11.1 p -60.99 -44.8 98.95 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.636 0 N-CA-C 108.82 -0.808 . . . . 0.0 108.82 175.679 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 143' ' ' ILE . . . . . 0.695 HD13 ' CG1' ' B' ' 123' ' ' ILE . 16.1 mt -58.9 -45.61 91.71 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.88 0 C-N-CA 123.752 0.821 . . . . 0.0 112.36 171.219 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 144' ' ' SER . . . . . . . . . . . . . 30.9 t -52.82 -34.77 55.38 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.983 177.188 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 145' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -86.26 -40.49 15.48 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.369 177.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 146' ' ' LEU . . . . . 0.557 ' HB3' ' CZ ' ' B' ' 107' ' ' TYR . 2.6 mm? -61.72 -41.25 97.38 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 123.557 0.743 . . . . 0.0 112.388 177.878 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 147' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -45.84 124.3 5.16 Favored 'General case' 0 C--O 1.233 0.202 0 O-C-N 123.906 0.754 . . . . 0.0 111.788 -171.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . 86.96 59.2 1.8 Allowed Glycine 0 N--CA 1.447 -0.589 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.301 -175.544 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 149' ' ' LYS . . . . . 0.519 ' HB2' ' O ' ' B' ' 146' ' ' LEU . 3.3 tppt? -143.25 160.22 40.88 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 -177.538 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 150' ' ' ASN . . . . . 0.586 ' O ' HG22 ' B' ' 154' ' ' VAL . 17.5 m120 -105.33 88.72 2.92 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 176.901 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 151' ' ' ILE . . . . . 0.628 HG12 ' HB3' ' B' ' 111' ' ' ALA . 1.7 mp -42.92 -61.46 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 114.694 -1.139 . . . . 0.0 113.445 -168.59 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 152' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -54.6 -41.24 69.71 Favored 'General case' 0 C--O 1.216 -0.687 0 N-CA-C 112.271 0.471 . . . . 0.0 112.271 -174.038 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 153' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -74.78 -30.77 61.55 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.816 -0.354 . . . . 0.0 110.589 -177.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 154' ' ' VAL . . . . . 0.907 ' HB ' HD11 ' B' ' 155' ' ' ILE . 44.9 t -56.01 -48.58 78.59 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 CA-C-O 121.86 0.838 . . . . 0.0 109.141 171.077 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 155' ' ' ILE . . . . . 0.907 HD11 ' HB ' ' B' ' 154' ' ' VAL . 1.8 mp -109.15 44.1 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.096 -0.956 . . . . 0.0 110.961 -178.479 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . -112.65 3.02 16.39 Favored 'General case' 0 C--N 1.306 -1.283 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 167.428 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 157' ' ' GLN . . . . . . . . . . . . . 24.3 mt-30 -138.51 -5.02 1.6 Allowed 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 113.5 -1.682 . . . . 0.0 110.002 176.276 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 158' ' ' GLY . . . . . . . . . . . . . . . -137.85 44.9 1.09 Allowed Glycine 0 C--O 1.223 -0.539 0 C-N-CA 120.153 -1.023 . . . . 0.0 113.86 -172.503 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 159' ' ' ILE . . . . . 0.669 ' HB ' ' CD1' ' A' ' 60' ' ' ILE . 1.8 mp -57.62 -28.49 32.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 CA-C-O 121.015 0.436 . . . . 0.0 110.983 175.7 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 160' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.438 0 C-N-CA 120.524 -0.846 . . . . 0.0 112.944 -179.814 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' SER . . . . . 0.576 ' HB2' ' HG3' ' A' ' 6' ' ' GLU . 14.5 m . . . . . 0 N--CA 1.448 -0.572 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.822 HG12 ' HG ' ' B' ' 112' ' ' LEU . 2.4 t -58.04 -23.72 22.02 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 CA-C-N 115.005 -0.998 . . . . 0.0 111.693 -177.084 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' SER . . . . . 0.645 ' HB2' ' HA ' ' A' ' 39' ' ' VAL . 11.4 p -70.5 -53.92 14.27 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.855 0.836 . . . . 0.0 109.044 174.662 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.576 ' HG3' ' HB2' ' A' ' 3' ' ' SER . 32.1 mt-10 -56.29 -47.74 78.04 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 114.862 -1.063 . . . . 0.0 109.899 177.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.644 ' HA ' HD11 ' A' ' 10' ' ' ILE . 3.6 tp -61.22 -39.73 91.35 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.522 178.791 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -60.94 -37.72 83.32 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 121.162 0.506 . . . . 0.0 110.937 176.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.64 ' HB2' HG11 ' A' ' 39' ' ' VAL . 7.4 t -69.94 -43.09 72.31 Favored 'General case' 0 C--O 1.24 0.587 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.644 HD11 ' HA ' ' A' ' 7' ' ' LEU . 72.6 mt -46.2 -56.4 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 CA-C-N 113.993 -1.458 . . . . 0.0 109.715 171.703 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.969 ' HH ' ' HB ' ' B' ' 155' ' ' ILE . 23.5 m-85 -63.33 -40.03 96.17 Favored 'General case' 0 C--O 1.216 -0.689 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.448 -175.413 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.596 ' HB2' HG21 ' A' ' 28' ' ' ILE . 19.4 m -56.76 -41.49 77.71 Favored 'General case' 0 C--O 1.24 0.593 0 CA-C-O 121.482 0.658 . . . . 0.0 109.403 179.005 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -65.85 -34.32 77.87 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.124 174.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.773 HD21 HD11 ' A' ' 56' ' ' ILE . 0.3 OUTLIER -63.01 -53.37 54.94 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.437 179.719 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.773 HD13 HD11 ' B' ' 109' ' ' LEU . 0.0 OUTLIER -58.9 -37.6 68.04 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.542 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 178.146 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.518 HD21 ' HA ' ' A' ' 23' ' ' VAL . 1.6 tp -58.88 -35.04 72.35 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.429 175.805 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . 0.491 ' O ' ' HG2' ' A' ' 20' ' ' GLU . 80.4 m-70 -73.76 -16.5 61.17 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 112.776 0.658 . . . . 0.0 112.776 175.243 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -59.07 -46.96 86.94 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 121.063 0.459 . . . . 0.0 109.829 178.422 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.596 ' HB2' HG23 ' B' ' 132' ' ' ILE . 29.9 t70 -100.91 -13.06 18.49 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.597 0.713 . . . . 0.0 109.397 177.407 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.491 ' HG2' ' O ' ' A' ' 17' ' ' HIS . 5.3 mm-40 63.18 44.56 5.63 Favored 'General case' 0 CA--C 1.519 -0.245 0 CA-C-N 114.496 -1.229 . . . . 0.0 109.689 -175.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.681 HG23 ' H ' ' A' ' 22' ' ' THR . 14.8 p -99.92 177.96 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.134 0 CA-C-N 114.518 -1.219 . . . . 0.0 110.233 -168.873 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.681 ' H ' HG23 ' A' ' 21' ' ' VAL . 23.6 p -49.62 137.88 14.9 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 113.874 1.065 . . . . 0.0 113.874 -174.372 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.518 ' HA ' HD21 ' A' ' 16' ' ' LEU . 46.2 t -109.7 109.07 27.03 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.177 0 CA-C-N 113.961 -1.472 . . . . 0.0 110.193 -179.546 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.584 ' OG1' ' HB2' ' A' ' 27' ' ' LYS . 69.1 p -136.08 158.23 44.91 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.158 178.284 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -52.87 -46.57 67.94 Favored 'General case' 0 C--N 1.32 -0.7 0 O-C-N 123.508 0.505 . . . . 0.0 110.094 178.09 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -67.39 -26.3 66.38 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.582 -0.735 . . . . 0.0 111.364 -179.543 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.584 ' HB2' ' OG1' ' A' ' 24' ' ' THR . 3.7 tppt? -70.67 -54.43 11.91 Favored 'General case' 0 C--O 1.24 0.597 0 CA-C-O 121.856 0.836 . . . . 0.0 108.823 -179.1 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.596 HG21 ' HB2' ' A' ' 12' ' ' SER . 77.7 mt -59.04 -43.17 88.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 114.253 -1.339 . . . . 0.0 110.349 178.498 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.462 ' HA ' ' HB ' ' A' ' 32' ' ' ILE . 6.1 m-20 -68.61 -26.53 65.4 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.212 178.705 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.62 -47.73 80.19 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 174.144 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.529 ' HG ' HG13 ' A' ' 15' ' ' ILE . 1.5 mm? -58.48 -51.54 69.43 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 121.296 0.569 . . . . 0.0 110.093 174.204 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.662 HG22 ' O ' ' A' ' 37' ' ' VAL . 64.7 mt -48.42 -48.46 13.97 Favored 'Isoleucine or valine' 0 C--O 1.243 0.747 0 CA-C-N 114.652 -1.158 . . . . 0.0 112.111 179.099 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 53.0 tptt -75.34 -43.6 49.79 Favored 'General case' 0 N--CA 1.434 -1.231 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.781 -175.619 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -62.21 -37.26 84.67 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.619 0.247 . . . . 0.0 110.855 -178.252 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -80.04 -36.83 35.15 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.03 0.443 . . . . 0.0 110.951 177.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 103.11 16.03 22.16 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.599 176.462 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.799 ' HB ' ' HA2' ' B' ' 113' ' ' GLY . 2.7 p -118.24 118.27 57.52 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.546 0 CA-C-O 121.385 0.612 . . . . 0.0 110.455 -177.642 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 -95.87 158.85 15.26 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 114.85 -1.068 . . . . 0.0 110.832 -169.169 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.645 ' HA ' ' HB2' ' A' ' 5' ' ' SER . 96.0 t -129.63 164.95 30.86 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.781 0 CA-C-N 115.055 -0.975 . . . . 0.0 110.442 -168.836 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.544 ' HB2' ' CD1' ' A' ' 43' ' ' TRP . 21.9 mt-10 -65.85 111.88 7.48 Favored Pre-proline 0 CA--C 1.489 -1.367 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 167.481 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.487 ' HD3' ' HA ' ' A' ' 40' ' ' GLU . 69.9 Cg_exo -54.41 -29.64 59.71 Favored 'Trans proline' 0 C--N 1.311 -1.421 0 C-N-CA 123.244 2.629 . . . . 0.0 113.713 -167.776 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 1.7 p90 -61.36 -29.07 69.68 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 175.332 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . 0.544 ' CD1' ' HB2' ' A' ' 40' ' ' GLU . 8.2 m95 -62.72 -60.31 10.23 Favored Pre-proline 0 C--O 1.208 -1.119 0 CA-C-O 118.474 -0.774 . . . . 0.0 110.677 176.646 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.448 ' HD2' ' C ' ' A' ' 41' ' ' PRO . 86.7 Cg_exo -47.15 -43.26 25.76 Favored 'Trans proline' 0 C--N 1.361 1.209 0 C-N-CA 121.894 1.73 . . . . 0.0 112.224 174.261 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -60.74 -59.18 10.64 Favored Glycine 0 CA--C 1.526 0.736 0 C-N-CA 120.124 -1.036 . . . . 0.0 112.444 176.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 4.5 tp -66.91 -26.57 66.93 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.467 0.707 . . . . 0.0 111.912 -176.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.776 ' HD2' HD11 ' A' ' 51' ' ' LEU . 2.9 m-85 -70.7 -46.67 62.69 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 175.615 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.503 ' HA ' HG12 ' A' ' 23' ' ' VAL . . . -62.66 -32.96 74.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.738 0.78 . . . . 0.0 109.115 179.198 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 9.2 mmmt -63.49 -62.77 1.45 Allowed 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 114.34 -1.3 . . . . 0.0 111.666 172.493 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -75.62 -31.68 59.99 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 113.709 1.003 . . . . 0.0 113.709 -167.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.776 HD11 ' HD2' ' A' ' 47' ' ' PHE . 13.1 mt -70.96 7.41 1.18 Allowed 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 112.843 0.683 . . . . 0.0 112.843 -174.136 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -101.88 5.26 40.88 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.49 0.662 . . . . 0.0 109.821 171.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 25.8 t30 -139.52 -52.8 0.54 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.421 -178.117 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 4.3 m -82.2 175.08 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.012 -179.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -113.69 165.31 12.66 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.253 176.511 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.773 HD11 HD21 ' A' ' 14' ' ' LEU . 3.9 tp -62.03 -25.18 36.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 120.838 0.352 . . . . 0.0 110.638 179.296 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -70.46 -14.95 72.53 Favored Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.816 -0.707 . . . . 0.0 111.548 177.048 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 20.4 t -78.04 -20.34 52.59 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-O 121.543 0.687 . . . . 0.0 109.549 179.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.55 HD13 HD13 ' A' ' 56' ' ' ILE . 19.8 mt -64.63 -29.63 70.64 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.434 179.515 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.775 HG13 ' HB ' ' B' ' 159' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--N 1.318 -0.768 0 CA-C-N 114.737 -1.12 . . . . 0.0 110.613 179.358 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 103' ' ' TYR . . . . . 0.641 ' HB2' HG12 ' B' ' 142' ' ' VAL . 51.7 m-85 . . . . . 0 C--O 1.239 0.501 0 CA-C-O 121.102 0.477 . . . . 0.0 110.275 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 104' ' ' VAL . . . . . 0.594 ' O ' HD23 ' B' ' 108' ' ' LEU . 61.2 t -46.61 -47.21 7.44 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.534 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.088 174.798 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 105' ' ' ALA . . . . . 0.594 ' CB ' ' HB3' ' A' ' 14' ' ' LEU . . . -67.0 -38.1 85.38 Favored 'General case' 0 N--CA 1.443 -0.81 0 CA-C-N 114.826 -1.079 . . . . 0.0 111.425 -173.776 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 106' ' ' SER . . . . . 0.789 ' HB2' HG23 ' B' ' 123' ' ' ILE . 1.3 m -60.48 -38.83 85.54 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 121.815 0.817 . . . . 0.0 109.251 176.167 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 107' ' ' TYR . . . . . 0.785 ' HD2' HG12 ' B' ' 143' ' ' ILE . 32.5 t80 -63.07 -49.11 75.81 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 114.272 -1.331 . . . . 0.0 108.945 179.097 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 108' ' ' LEU . . . . . 0.672 HD12 HG13 ' B' ' 151' ' ' ILE . 0.0 OUTLIER -58.92 -49.2 78.7 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 114.987 -1.006 . . . . 0.0 111.337 179.029 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 109' ' ' LEU . . . . . 0.773 HD11 HD13 ' A' ' 15' ' ' ILE . 0.3 OUTLIER -55.42 -43.16 75.05 Favored 'General case' 0 CA--C 1.506 -0.746 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.613 178.671 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.5 -43.45 90.09 Favored 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 120.496 -0.482 . . . . 0.0 110.819 -178.514 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 111' ' ' ALA . . . . . 0.677 ' HA ' ' O ' ' B' ' 115' ' ' ASN . . . -64.71 -26.23 68.28 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.607 179.174 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 112' ' ' LEU . . . . . 0.822 ' HG ' HG12 ' A' ' 4' ' ' VAL . 3.5 mp -80.39 -38.32 30.52 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.245 -0.889 . . . . 0.0 110.244 174.128 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 113' ' ' GLY . . . . . 0.799 ' HA2' ' HB ' ' A' ' 37' ' ' VAL . . . -68.5 -17.21 70.47 Favored Glycine 0 N--CA 1.449 -0.497 0 CA-C-N 115.263 -0.88 . . . . 0.0 112.348 -176.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 114' ' ' GLY . . . . . . . . . . . . . . . 133.33 3.4 3.45 Favored Glycine 0 N--CA 1.437 -1.299 0 C-N-CA 120.394 -0.908 . . . . 0.0 113.168 176.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 115' ' ' ASN . . . . . 0.677 ' O ' ' HA ' ' B' ' 111' ' ' ALA . 47.9 t30 -118.69 86.27 2.51 Favored 'General case' 0 N--CA 1.441 -0.884 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 178.224 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 7.4 m -80.23 31.09 0.27 Allowed 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 122.488 1.137 . . . . 0.0 110.748 -167.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 117' ' ' SER . . . . . 0.563 ' N ' ' HD3' ' B' ' 118' ' ' PRO . 15.6 t -171.0 67.64 0.47 Allowed Pre-proline 0 C--N 1.309 -1.172 0 CA-C-N 113.12 -1.855 . . . . 0.0 107.971 178.248 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 118' ' ' PRO . . . . . 0.601 ' HD2' ' CZ ' ' B' ' 107' ' ' TYR . 31.9 Cg_exo -66.08 166.67 20.17 Favored 'Trans proline' 0 CA--C 1.515 -0.431 0 C-N-CA 125.275 3.983 . . . . 0.0 111.58 -174.72 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 119' ' ' SER . . . . . 0.653 ' O ' HG12 ' B' ' 123' ' ' ILE . 16.4 m -145.59 -178.51 6.13 Favored 'General case' 0 C--N 1.317 -0.809 0 C-N-CA 120.225 -0.59 . . . . 0.0 111.592 178.622 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 120' ' ' ALA . . . . . 0.528 ' HB2' ' CD1' ' B' ' 139' ' ' LEU . . . -62.68 -45.8 91.12 Favored 'General case' 0 CA--C 1.508 -0.639 0 CA-C-O 122.036 0.922 . . . . 0.0 110.173 -163.888 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 121' ' ' LYS . . . . . . . . . . . . . 12.9 mptt -66.72 -30.39 70.61 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 113.674 -1.603 . . . . 0.0 110.871 178.538 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 122' ' ' ASP . . . . . 0.424 ' O ' ' HB2' ' B' ' 125' ' ' LYS . 18.0 t0 -72.91 -39.09 66.61 Favored 'General case' 0 C--O 1.24 0.58 0 CA-C-O 122.004 0.907 . . . . 0.0 109.025 179.744 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 123' ' ' ILE . . . . . 0.789 HG23 ' HB2' ' B' ' 106' ' ' SER . 39.8 mm -59.93 -42.97 91.18 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.264 0 CA-C-N 114.549 -1.205 . . . . 0.0 109.657 173.236 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 124' ' ' LYS . . . . . 0.797 ' HD3' HD23 ' B' ' 139' ' ' LEU . 3.9 mmmp? -59.17 -42.52 90.97 Favored 'General case' 0 CA--C 1.504 -0.797 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.444 -178.784 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 125' ' ' LYS . . . . . 0.425 ' HA ' ' HD3' ' B' ' 125' ' ' LYS . 30.3 mmtt -50.38 -64.72 0.72 Allowed 'General case' 0 CA--C 1.502 -0.879 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 169.72 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 126' ' ' ILE . . . . . 0.461 HG23 HD11 ' A' ' 31' ' ' LEU . 1.7 mp -53.96 -44.41 61.58 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.857 0 CA-C-N 114.841 -1.072 . . . . 0.0 111.256 -170.217 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 127' ' ' LEU . . . . . 0.628 ' HG ' ' O ' ' B' ' 123' ' ' ILE . 3.6 pp -80.31 -24.74 39.74 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 -177.387 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 128' ' ' ASP . . . . . 0.426 ' N ' HD12 ' B' ' 127' ' ' LEU . 34.6 t70 -71.39 -27.51 63.37 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.584 -0.525 . . . . 0.0 109.584 178.831 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 129' ' ' SER . . . . . . . . . . . . . 17.4 t -60.92 -27.73 68.41 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.602 177.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 130' ' ' VAL . . . . . 0.45 HG22 HG13 ' B' ' 132' ' ' ILE . 3.7 m -107.38 -13.42 10.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 C-N-CA 120.813 -0.355 . . . . 0.0 111.483 177.521 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 131' ' ' GLY . . . . . . . . . . . . . . . 85.15 49.16 4.57 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 121.149 -0.548 . . . . 0.0 112.389 177.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 132' ' ' ILE . . . . . 0.596 HG23 ' HB2' ' A' ' 19' ' ' ASP . 11.5 mt -105.5 138.89 28.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-O 120.462 0.172 . . . . 0.0 111.078 -179.321 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 133' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -69.65 127.31 32.51 Favored 'General case' 0 CA--C 1.513 -0.456 0 CA-C-O 121.47 0.652 . . . . 0.0 111.478 -176.226 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 134' ' ' ALA . . . . . 0.493 ' HA ' ' OH ' ' B' ' 103' ' ' TYR . . . -136.21 141.04 43.96 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.15 -0.932 . . . . 0.0 111.473 -177.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 135' ' ' ASP . . . . . 0.79 ' HB2' ' HG3' ' B' ' 138' ' ' ARG . 49.3 m-20 -103.56 132.77 49.53 Favored 'General case' 0 C--O 1.25 1.094 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.024 172.892 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 136' ' ' ASP . . . . . 0.58 ' HA ' HD11 ' B' ' 139' ' ' LEU . 32.5 t70 -71.26 -7.92 50.2 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 115.095 -0.957 . . . . 0.0 111.236 -168.271 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 137' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -101.27 -30.16 11.67 Favored 'General case' 0 N--CA 1.438 -1.069 0 C-N-CA 120.017 -0.673 . . . . 0.0 110.653 174.555 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 138' ' ' ARG . . . . . 0.79 ' HG3' ' HB2' ' B' ' 135' ' ' ASP . 20.9 mmt180 -65.31 -45.92 82.43 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.793 0.806 . . . . 0.0 109.513 -176.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 139' ' ' LEU . . . . . 0.797 HD23 ' HD3' ' B' ' 124' ' ' LYS . 0.3 OUTLIER -74.2 -37.77 63.79 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 114.933 -1.03 . . . . 0.0 111.001 178.928 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 140' ' ' ASN . . . . . 0.608 ' N ' HD13 ' B' ' 139' ' ' LEU . 57.0 t30 -61.49 -31.25 71.23 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.687 0.756 . . . . 0.0 109.148 -179.773 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 141' ' ' LYS . . . . . 0.441 ' O ' ' HD3' ' B' ' 141' ' ' LYS . 4.3 tppt? -76.4 -50.06 15.14 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 114.585 -1.189 . . . . 0.0 110.43 179.279 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 142' ' ' VAL . . . . . 0.641 HG12 ' HB2' ' B' ' 103' ' ' TYR . 12.6 p -56.0 -44.48 78.51 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.581 0 C-N-CA 120.359 -0.537 . . . . 0.0 109.814 -179.716 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 143' ' ' ILE . . . . . 0.785 HG12 ' HD2' ' B' ' 107' ' ' TYR . 38.7 mt -58.55 -46.21 90.05 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 C-N-CA 124.163 0.985 . . . . 0.0 112.498 172.869 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 144' ' ' SER . . . . . . . . . . . . . 47.1 t -54.19 -33.68 58.73 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.927 176.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 145' ' ' GLU . . . . . 0.401 ' HG2' ' O ' ' B' ' 141' ' ' LYS . 6.9 mm-40 -83.98 -42.31 16.37 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 121.498 0.666 . . . . 0.0 110.63 178.029 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 146' ' ' LEU . . . . . 0.548 HD23 ' O ' ' B' ' 142' ' ' VAL . 2.2 mm? -62.7 -38.81 91.89 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 114.977 -1.01 . . . . 0.0 112.345 179.817 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 147' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -54.16 120.03 5.91 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.124 -172.212 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . 99.4 40.33 3.24 Favored Glycine 0 N--CA 1.445 -0.703 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.549 -176.307 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 149' ' ' LYS . . . . . 0.472 ' HB2' ' O ' ' B' ' 146' ' ' LEU . 0.1 OUTLIER -134.79 168.56 18.83 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 -179.964 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 150' ' ' ASN . . . . . 0.582 ' O ' HG22 ' B' ' 154' ' ' VAL . 31.9 m-20 -106.82 90.57 3.36 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 107.702 -1.222 . . . . 0.0 107.702 179.068 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 151' ' ' ILE . . . . . 0.672 HG13 HD12 ' B' ' 108' ' ' LEU . 1.8 mp -41.69 -64.17 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 N-CA-C 113.571 0.952 . . . . 0.0 113.571 -168.089 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 152' ' ' GLU . . . . . 0.663 ' HG3' HD11 ' B' ' 112' ' ' LEU . 3.4 mp0 -57.31 -42.92 82.72 Favored 'General case' 0 C--O 1.209 -1.03 0 C-N-CA 120.93 -0.308 . . . . 0.0 111.365 -175.301 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 153' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -66.94 -29.57 69.47 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 120.548 0.214 . . . . 0.0 111.363 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 154' ' ' VAL . . . . . 0.824 ' HB ' HD11 ' B' ' 155' ' ' ILE . 61.8 t -61.15 -51.07 77.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 171.907 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 155' ' ' ILE . . . . . 0.969 ' HB ' ' HH ' ' A' ' 11' ' ' TYR . 1.6 mp -104.66 36.19 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-O 121.979 0.895 . . . . 0.0 110.368 -177.718 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . -100.96 0.42 38.24 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 107.246 -1.391 . . . . 0.0 107.246 169.168 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 157' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -137.36 -34.83 0.69 Allowed 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 113.043 -1.889 . . . . 0.0 109.357 173.346 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 158' ' ' GLY . . . . . . . . . . . . . . . -98.36 47.44 1.46 Allowed Glycine 0 CA--C 1.521 0.468 0 CA-C-N 115.548 -0.751 . . . . 0.0 114.357 -172.444 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 159' ' ' ILE . . . . . 0.775 ' HB ' HG13 ' A' ' 60' ' ' ILE . 1.8 mp -59.52 -18.0 13.76 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 CA-C-O 121.244 0.545 . . . . 0.0 111.045 176.213 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 160' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.584 0 N-CA-C 111.384 -0.686 . . . . 0.0 111.384 -178.664 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.7 p . . . . . 0 N--CA 1.446 -0.629 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.636 HG11 ' HG ' ' B' ' 112' ' ' LEU . 2.2 t -53.6 -27.2 14.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 115.191 -0.913 . . . . 0.0 112.238 -175.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' SER . . . . . 0.725 ' HB3' ' HA ' ' A' ' 39' ' ' VAL . 2.1 m -67.46 -52.68 36.52 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 122.204 1.002 . . . . 0.0 108.468 176.068 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.516 ' O ' HG13 ' A' ' 10' ' ' ILE . 33.9 tt0 -55.83 -52.84 62.61 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-N 113.985 -1.461 . . . . 0.0 110.171 177.205 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.669 ' O ' ' HB ' ' A' ' 10' ' ' ILE . 4.4 tp -59.46 -34.97 73.2 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.091 -0.958 . . . . 0.0 111.758 179.178 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.584 ' HB1' HD23 ' B' ' 112' ' ' LEU . . . -69.85 -33.25 72.02 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-O 121.011 0.434 . . . . 0.0 110.847 179.252 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.577 ' HB2' HG11 ' A' ' 39' ' ' VAL . 7.5 t -70.88 -37.43 73.02 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 177.38 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.669 ' HB ' ' O ' ' A' ' 7' ' ' LEU . 74.2 mt -51.67 -55.53 8.6 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.887 0 CA-C-N 114.168 -1.378 . . . . 0.0 109.824 170.682 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.737 ' HB2' HD13 ' B' ' 109' ' ' LEU . 23.4 m-85 -67.04 -41.0 87.29 Favored 'General case' 0 C--O 1.22 -0.479 0 CA-C-N 115.615 -0.721 . . . . 0.0 111.596 -173.741 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.444 ' O ' ' HB2' ' A' ' 16' ' ' LEU . 2.5 p -57.43 -41.45 80.47 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 176.612 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.04 -33.43 75.42 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.895 172.471 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.781 HD21 HD13 ' A' ' 56' ' ' ILE . 0.3 OUTLIER -64.87 -57.99 7.36 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.488 -179.612 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.406 HG12 ' O ' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -54.82 -47.34 74.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 177.277 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.849 HD13 HG12 ' A' ' 21' ' ' VAL . 6.2 tp -53.19 -41.47 65.3 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.928 178.65 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 26.3 t60 -78.89 -13.68 59.66 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.178 -0.919 . . . . 0.0 112.065 -178.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -70.62 -47.99 57.32 Favored 'General case' 0 N--CA 1.467 0.389 0 O-C-N 121.895 -0.503 . . . . 0.0 110.051 176.558 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.75 ' HB2' HG22 ' B' ' 132' ' ' ILE . 28.7 t70 -91.31 -11.19 38.74 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.938 0.875 . . . . 0.0 109.575 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 55.61 52.43 11.06 Favored 'General case' 0 CA--C 1.509 -0.604 0 CA-C-N 113.641 -1.618 . . . . 0.0 110.125 -176.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.849 HG12 HD13 ' A' ' 16' ' ' LEU . 2.9 p -100.03 152.64 4.69 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.739 0 CA-C-N 113.581 -1.645 . . . . 0.0 109.073 -176.072 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.473 ' O ' ' HG2' ' A' ' 27' ' ' LYS . 30.6 p -34.96 127.97 0.5 Allowed 'General case' 0 C--N 1.317 -0.808 0 O-C-N 124.672 1.232 . . . . 0.0 114.077 -174.064 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.439 HG13 ' HB2' ' A' ' 51' ' ' LEU . 51.2 t -100.55 106.03 18.65 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.927 0 CA-C-N 114.376 -1.283 . . . . 0.0 110.473 -176.898 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.428 ' OG1' ' HB2' ' A' ' 27' ' ' LYS . 80.6 p -141.05 153.77 45.65 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.769 -179.169 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -51.42 -46.49 62.96 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.12 0.486 . . . . 0.0 110.773 179.633 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -58.26 -38.38 76.82 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.382 -0.826 . . . . 0.0 111.356 177.482 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.5 ' HG2' HD11 ' A' ' 16' ' ' LEU . 4.3 tppt? -64.48 -50.03 69.07 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-O 121.965 0.888 . . . . 0.0 109.285 -178.229 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 80.8 mt -61.7 -38.96 81.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 114.393 -1.276 . . . . 0.0 110.458 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.666 ' HA ' HD13 ' A' ' 32' ' ' ILE . 30.7 m-80 -68.41 -30.0 68.8 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.862 176.436 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -65.98 -38.91 89.73 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.562 -0.29 . . . . 0.0 110.397 176.21 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.599 ' HB3' HD21 ' B' ' 109' ' ' LEU . 1.2 mm? -65.17 -45.79 83.49 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 120.646 -0.422 . . . . 0.0 110.106 171.747 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.666 HD13 ' HA ' ' A' ' 29' ' ' ASN . 57.8 mt -49.23 -50.0 16.22 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 CA-C-N 115.294 -0.867 . . . . 0.0 111.361 177.917 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 23.0 tptp -71.89 -37.7 70.1 Favored 'General case' 0 N--CA 1.435 -1.177 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.624 -179.384 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.624 ' HB1' ' HA ' ' B' ' 126' ' ' ILE . . . -59.26 -41.97 90.08 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.001 0.429 . . . . 0.0 111.451 179.526 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.459 ' CB ' ' HG ' ' B' ' 109' ' ' LEU . . . -84.61 -33.19 23.38 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.254 179.756 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 96.29 19.23 28.67 Favored Glycine 0 N--CA 1.447 -0.569 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.765 -179.041 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.817 ' HB ' ' HA2' ' B' ' 113' ' ' GLY . 2.9 p -121.6 117.73 53.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 121.981 0.896 . . . . 0.0 111.204 -177.079 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.43 ' HA ' HG21 ' A' ' 32' ' ' ILE . 57.8 t30 -88.51 157.06 18.75 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 113.966 -1.47 . . . . 0.0 110.726 -172.051 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.725 ' HA ' ' HB3' ' A' ' 5' ' ' SER . 97.3 t -126.91 161.38 33.82 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.002 0 CA-C-N 114.878 -1.056 . . . . 0.0 110.381 -173.257 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.505 ' HB3' ' HD1' ' A' ' 43' ' ' TRP . 7.5 tp10 -68.54 106.45 1.38 Allowed Pre-proline 0 N--CA 1.439 -1.012 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 170.151 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.461 ' C ' ' HD2' ' A' ' 44' ' ' PRO . 83.0 Cg_exo -50.22 -31.06 27.78 Favored 'Trans proline' 0 C--O 1.252 1.179 0 C-N-CA 123.698 2.932 . . . . 0.0 115.478 -163.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -59.93 -26.8 66.23 Favored 'General case' 0 C--N 1.334 -0.107 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 178.456 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . 0.505 ' HD1' ' HB3' ' A' ' 40' ' ' GLU . 11.2 m95 -65.02 -61.67 5.9 Favored Pre-proline 0 C--O 1.207 -1.138 0 CA-C-O 118.423 -0.799 . . . . 0.0 110.723 176.313 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.461 ' HD2' ' C ' ' A' ' 41' ' ' PRO . 85.5 Cg_exo -43.92 -45.04 11.73 Favored 'Trans proline' 0 C--N 1.358 1.069 0 C-N-CA 121.837 1.691 . . . . 0.0 112.242 174.747 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -60.55 -60.36 8.65 Favored Glycine 0 CA--C 1.526 0.757 0 C-N-CA 120.088 -1.054 . . . . 0.0 112.315 176.598 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 10.2 tp -64.29 -24.02 67.51 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 123.069 0.547 . . . . 0.0 111.988 -177.527 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.588 ' HD2' HD11 ' A' ' 51' ' ' LEU . 2.7 m-85 -73.66 -43.91 58.16 Favored 'General case' 0 C--N 1.315 -0.899 0 C-N-CA 122.296 0.238 . . . . 0.0 110.375 177.511 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.41 ' HA ' HG12 ' A' ' 23' ' ' VAL . . . -64.81 -32.13 73.68 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 176.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 9.5 mmmt -65.29 -51.56 59.89 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 114.247 -1.342 . . . . 0.0 111.815 173.243 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.432 ' O ' HG22 ' A' ' 54' ' ' VAL . . . -80.03 -40.72 27.19 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 113.187 0.81 . . . . 0.0 113.187 -170.069 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.588 HD11 ' HD2' ' A' ' 47' ' ' PHE . 8.7 mt -66.9 0.77 2.25 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 -172.099 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -88.16 -17.92 29.88 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.883 0.373 . . . . 0.0 110.607 174.484 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 91.4 m-20 -130.69 -38.26 1.31 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.823 -175.225 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.432 HG22 ' O ' ' A' ' 50' ' ' ALA . 4.6 m -85.39 -176.62 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 121.022 0.439 . . . . 0.0 110.141 -179.833 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 23.1 t-20 -119.41 168.39 11.0 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.76 -0.654 . . . . 0.0 109.585 176.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.781 HD13 HD21 ' A' ' 14' ' ' LEU . 3.2 tp -66.29 -27.94 42.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-O 121.058 0.456 . . . . 0.0 109.934 178.406 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -72.25 -14.81 76.78 Favored Glycine 0 N--CA 1.446 -0.666 0 N-CA-C 111.05 -0.82 . . . . 0.0 111.05 175.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 20.3 m -78.68 -21.31 48.42 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-O 121.229 0.537 . . . . 0.0 109.849 179.07 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.465 HD13 HD12 ' A' ' 56' ' ' ILE . 30.0 mt -60.78 -36.41 78.91 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.617 -179.736 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.71 HG13 ' HB ' ' B' ' 159' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--N 1.322 -0.617 0 CA-C-N 115.041 -0.981 . . . . 0.0 110.829 179.131 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 103' ' ' TYR . . . . . 0.982 ' HB2' HG13 ' B' ' 142' ' ' VAL . 69.4 m-85 . . . . . 0 N--CA 1.468 0.441 0 CA-C-O 120.705 0.288 . . . . 0.0 111.688 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 104' ' ' VAL . . . . . 0.707 HG11 HD22 ' B' ' 146' ' ' LEU . 4.1 m -45.03 -45.43 2.97 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.221 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.161 171.765 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 105' ' ' ALA . . . . . 0.544 ' CB ' ' HB3' ' A' ' 14' ' ' LEU . . . -64.31 -30.25 71.31 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 115.291 -0.868 . . . . 0.0 111.289 -174.051 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 106' ' ' SER . . . . . 0.788 ' HB2' HG21 ' B' ' 123' ' ' ILE . 1.4 m -76.53 -36.39 57.74 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.796 0.808 . . . . 0.0 108.971 -178.529 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 107' ' ' TYR . . . . . 0.666 ' CG ' HD13 ' B' ' 146' ' ' LEU . 36.5 t80 -63.96 -46.02 86.51 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 114.139 -1.391 . . . . 0.0 108.336 176.883 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 108' ' ' LEU . . . . . 0.797 HD12 HG13 ' B' ' 151' ' ' ILE . 0.0 OUTLIER -58.62 -45.93 88.13 Favored 'General case' 0 N--CA 1.443 -0.801 0 CA-C-N 114.393 -1.276 . . . . 0.0 110.792 177.072 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 109' ' ' LEU . . . . . 0.737 HD13 ' HB2' ' A' ' 11' ' ' TYR . 8.6 tp -55.65 -50.96 68.83 Favored 'General case' 0 CA--C 1.514 -0.426 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.893 178.445 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 110' ' ' ALA . . . . . 0.457 ' HB2' ' HB3' ' B' ' 118' ' ' PRO . . . -63.18 -40.58 97.94 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.24 -176.135 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 111' ' ' ALA . . . . . 0.678 ' HA ' ' O ' ' B' ' 115' ' ' ASN . . . -64.61 -33.98 77.19 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.559 178.884 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 112' ' ' LEU . . . . . 0.766 ' HB3' HG21 ' A' ' 37' ' ' VAL . 5.5 mp -71.47 -38.23 71.27 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.053 173.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 113' ' ' GLY . . . . . 0.817 ' HA2' ' HB ' ' A' ' 37' ' ' VAL . . . -61.87 -23.53 63.56 Favored Glycine 0 N--CA 1.446 -0.643 0 CA-C-N 115.198 -0.91 . . . . 0.0 111.843 179.548 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 114' ' ' GLY . . . . . . . . . . . . . . . 133.48 4.66 3.11 Favored Glycine 0 N--CA 1.436 -1.344 0 C-N-CA 120.569 -0.824 . . . . 0.0 112.876 177.496 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 115' ' ' ASN . . . . . 0.678 ' O ' ' HA ' ' B' ' 111' ' ' ALA . 47.2 t30 -116.94 91.15 3.5 Favored 'General case' 0 N--CA 1.439 -0.988 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 -179.533 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -76.96 25.61 0.15 Allowed 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 122.211 1.005 . . . . 0.0 110.787 -167.815 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 117' ' ' SER . . . . . 0.575 ' H ' ' C ' ' B' ' 115' ' ' ASN . 35.2 t -169.83 68.12 0.59 Allowed Pre-proline 0 C--N 1.311 -1.102 0 CA-C-N 113.648 -1.614 . . . . 0.0 108.809 -178.198 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 118' ' ' PRO . . . . . 0.645 ' HD2' ' CZ ' ' B' ' 107' ' ' TYR . 26.7 Cg_exo -67.71 154.15 74.03 Favored 'Trans proline' 0 C--N 1.327 -0.583 0 C-N-CA 125.066 3.844 . . . . 0.0 111.572 -176.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 119' ' ' SER . . . . . 0.592 ' O ' HG12 ' B' ' 123' ' ' ILE . 92.0 p -121.73 -178.58 3.86 Favored 'General case' 0 C--N 1.315 -0.892 0 C-N-CA 120.104 -0.639 . . . . 0.0 110.958 178.327 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 120' ' ' ALA . . . . . 0.744 ' HB3' HD12 ' B' ' 139' ' ' LEU . . . -64.95 -38.74 91.97 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-O 121.886 0.851 . . . . 0.0 109.366 -172.061 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 121' ' ' LYS . . . . . 0.485 ' HD2' ' N ' ' B' ' 121' ' ' LYS . 4.7 mptp? -64.83 -31.96 73.43 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 113.952 -1.476 . . . . 0.0 110.912 176.718 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 122' ' ' ASP . . . . . 0.812 ' HA ' ' HE3' ' B' ' 125' ' ' LYS . 19.2 m-20 -72.61 -43.6 63.09 Favored 'General case' 0 CA--C 1.515 -0.377 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 176.282 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 123' ' ' ILE . . . . . 0.788 HG21 ' HB2' ' B' ' 106' ' ' SER . 33.8 mm -55.38 -50.36 66.01 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.421 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 175.798 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 124' ' ' LYS . . . . . 0.473 ' HD3' HD12 ' B' ' 127' ' ' LEU . 4.0 tppp? -61.21 -35.92 78.51 Favored 'General case' 0 N--CA 1.443 -0.788 0 CA-C-N 114.38 -1.282 . . . . 0.0 109.486 -177.628 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 125' ' ' LYS . . . . . 0.812 ' HE3' ' HA ' ' B' ' 122' ' ' ASP . 0.0 OUTLIER -72.44 -44.14 62.81 Favored 'General case' 0 N--CA 1.432 -1.359 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.931 -177.328 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 126' ' ' ILE . . . . . 0.677 HD12 ' HD2' ' B' ' 125' ' ' LYS . 1.4 mp -54.93 -51.81 49.51 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 CA-C-N 116.539 -0.301 . . . . 0.0 110.726 173.745 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 127' ' ' LEU . . . . . 0.9 ' HB2' ' HB ' ' B' ' 132' ' ' ILE . 3.1 pp -77.14 -25.97 52.6 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.614 -0.435 . . . . 0.0 111.788 -175.704 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 128' ' ' ASP . . . . . 0.455 ' HB2' ' O ' ' B' ' 124' ' ' LYS . 19.5 t70 -67.18 -33.5 75.54 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 110.024 -0.362 . . . . 0.0 110.024 177.606 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 129' ' ' SER . . . . . 0.411 ' CB ' ' HB3' ' A' ' 34' ' ' ALA . 22.7 t -51.97 -43.06 63.37 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.351 176.619 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 130' ' ' VAL . . . . . 0.571 HG22 HG13 ' B' ' 132' ' ' ILE . 5.0 m -100.76 -6.34 9.13 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 N-CA-C 112.242 0.46 . . . . 0.0 112.242 -179.589 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 131' ' ' GLY . . . . . . . . . . . . . . . 83.22 46.55 6.12 Favored Glycine 0 CA--C 1.518 0.257 0 C-N-CA 120.941 -0.647 . . . . 0.0 113.112 177.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 132' ' ' ILE . . . . . 0.9 ' HB ' ' HB2' ' B' ' 127' ' ' LEU . 14.9 mt -95.35 134.53 32.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 120.671 0.272 . . . . 0.0 110.46 176.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 133' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -79.98 131.73 35.87 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.895 0.379 . . . . 0.0 111.114 -178.047 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 134' ' ' ALA . . . . . . . . . . . . . . . -145.29 154.14 42.03 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.493 -175.544 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 135' ' ' ASP . . . . . 0.73 ' HB2' ' CG ' ' B' ' 138' ' ' ARG . 18.1 m-20 -102.11 135.17 44.15 Favored 'General case' 0 C--O 1.252 1.19 0 CA-C-O 121.124 0.488 . . . . 0.0 109.736 172.241 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 136' ' ' ASP . . . . . 0.597 ' HA ' HD11 ' B' ' 139' ' ' LEU . 10.4 t70 -73.28 -11.61 60.56 Favored 'General case' 0 CA--C 1.514 -0.426 0 CA-C-N 115.14 -0.936 . . . . 0.0 110.995 -166.649 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 137' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -96.79 -30.06 13.39 Favored 'General case' 0 N--CA 1.438 -1.062 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.723 175.334 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 138' ' ' ARG . . . . . 0.73 ' CG ' ' HB2' ' B' ' 135' ' ' ASP . 17.5 mmt180 -66.81 -46.26 75.75 Favored 'General case' 0 CA--C 1.504 -0.79 0 CA-C-O 121.977 0.894 . . . . 0.0 109.224 -175.624 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 139' ' ' LEU . . . . . 0.859 ' O ' HG12 ' B' ' 143' ' ' ILE . 0.3 OUTLIER -72.46 -36.68 68.55 Favored 'General case' 0 C--O 1.209 -1.072 0 CA-C-N 114.607 -1.179 . . . . 0.0 111.148 179.03 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 140' ' ' ASN . . . . . 0.57 ' O ' ' HB ' ' B' ' 143' ' ' ILE . 9.7 t30 -64.27 -26.92 68.71 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.925 0.869 . . . . 0.0 109.565 177.75 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 141' ' ' LYS . . . . . . . . . . . . . 44.4 tttt -69.93 -51.63 31.25 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 114.391 -1.277 . . . . 0.0 109.354 177.226 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 142' ' ' VAL . . . . . 0.982 HG13 ' HB2' ' B' ' 103' ' ' TYR . 8.6 p -62.55 -32.12 54.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.889 177.853 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 143' ' ' ILE . . . . . 0.859 HG12 ' O ' ' B' ' 139' ' ' LEU . 34.6 mm -50.47 -66.62 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.513 -0.455 0 CA-C-O 121.082 0.467 . . . . 0.0 110.439 170.388 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 144' ' ' SER . . . . . . . . . . . . . 70.6 p -54.41 -31.56 55.34 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.188 -0.915 . . . . 0.0 111.838 -178.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 145' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -74.97 -37.07 62.02 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 112.072 0.397 . . . . 0.0 112.072 179.254 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 146' ' ' LEU . . . . . 0.707 HD22 HG11 ' B' ' 104' ' ' VAL . 6.9 mt -86.98 -19.53 28.59 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.813 -0.355 . . . . 0.0 110.712 -178.325 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 147' ' ' ASN . . . . . 0.405 ' HA ' ' OH ' ' B' ' 107' ' ' TYR . 26.3 t-20 -54.31 117.96 3.71 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.041 -176.335 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . 96.9 36.25 5.07 Favored Glycine 0 N--CA 1.448 -0.52 0 CA-C-N 115.544 -0.753 . . . . 0.0 112.275 -178.297 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 149' ' ' LYS . . . . . 0.467 ' HB2' ' O ' ' B' ' 146' ' ' LEU . 0.3 OUTLIER -130.08 165.28 22.57 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.837 0.351 . . . . 0.0 110.601 179.842 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 150' ' ' ASN . . . . . 0.506 ' O ' HG21 ' B' ' 154' ' ' VAL . 85.3 m-20 -104.28 88.84 3.08 Favored 'General case' 0 CA--C 1.513 -0.468 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 177.893 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 151' ' ' ILE . . . . . 0.797 HG13 HD12 ' B' ' 108' ' ' LEU . 1.8 mp -39.26 -64.52 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 113.845 1.054 . . . . 0.0 113.845 -169.806 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 152' ' ' GLU . . . . . 0.683 ' HG3' HD11 ' B' ' 112' ' ' LEU . 3.1 mp0 -57.97 -35.38 71.09 Favored 'General case' 0 C--O 1.216 -0.66 0 O-C-N 122.355 -0.216 . . . . 0.0 111.263 -174.268 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 153' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -71.28 -37.98 71.84 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.855 177.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 154' ' ' VAL . . . . . 0.835 ' HB ' HD11 ' B' ' 155' ' ' ILE . 62.0 t -53.47 -47.97 58.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 121.49 0.662 . . . . 0.0 109.321 173.76 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 155' ' ' ILE . . . . . 0.835 HD11 ' HB ' ' B' ' 154' ' ' VAL . 1.6 mp -107.51 35.73 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-O 121.929 0.871 . . . . 0.0 110.804 -178.613 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . -100.85 1.9 40.51 Favored 'General case' 0 C--N 1.311 -1.096 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 169.062 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 157' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 -142.05 16.08 2.09 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 113.946 -1.479 . . . . 0.0 110.515 177.378 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 158' ' ' GLY . . . . . . . . . . . . . . . -159.5 45.54 0.44 Allowed Glycine 0 C--N 1.338 0.69 0 C-N-CA 119.507 -1.33 . . . . 0.0 115.204 -172.64 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 159' ' ' ILE . . . . . 0.71 ' HB ' HG13 ' A' ' 60' ' ' ILE . 1.8 mp -58.57 -25.88 29.48 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 C-N-CA 122.959 0.504 . . . . 0.0 111.736 176.638 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 160' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.51 0 C-N-CA 120.048 -1.072 . . . . 0.0 112.993 -178.321 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 11.4 m . . . . . 0 N--CA 1.441 -0.904 0 N-CA-C 107.783 -1.191 . . . . 0.0 107.783 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.847 HG12 ' HG ' ' B' ' 112' ' ' LEU . 2.1 t -51.85 -24.58 4.85 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-N 114.947 -1.024 . . . . 0.0 112.17 -178.63 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' SER . . . . . 0.687 ' HB3' ' HA ' ' A' ' 39' ' ' VAL . 8.5 m -69.65 -51.86 31.04 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 176.219 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.5 ' O ' HG13 ' A' ' 10' ' ' ILE . 30.6 mt-10 -58.85 -52.15 66.97 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 115.008 -0.996 . . . . 0.0 109.796 178.239 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.721 HD11 HD12 ' A' ' 10' ' ' ILE . 3.2 tp -57.83 -36.85 72.84 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 115.317 -0.856 . . . . 0.0 112.097 178.279 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.571 ' HB1' HD21 ' B' ' 112' ' ' LEU . . . -67.09 -35.47 79.88 Favored 'General case' 0 CA--C 1.516 -0.361 0 CA-C-O 120.957 0.408 . . . . 0.0 110.855 178.927 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.626 ' HB2' HG12 ' A' ' 39' ' ' VAL . 5.6 t -69.7 -41.09 75.85 Favored 'General case' 0 C--O 1.242 0.672 0 N-CA-C 108.188 -1.042 . . . . 0.0 108.188 178.467 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.721 HD12 HD11 ' A' ' 7' ' ' LEU . 68.0 mt -47.14 -54.1 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.671 0 CA-C-N 114.214 -1.357 . . . . 0.0 109.627 170.532 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.86 ' HH ' ' HB ' ' B' ' 155' ' ' ILE . 23.4 m-85 -66.32 -39.48 89.29 Favored 'General case' 0 C--O 1.219 -0.511 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.877 -174.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.551 ' HB2' HD22 ' A' ' 31' ' ' LEU . 79.4 p -56.78 -44.79 82.22 Favored 'General case' 0 C--O 1.243 0.739 0 CA-C-O 121.475 0.655 . . . . 0.0 109.383 179.148 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.57 ' HB1' ' HG ' ' A' ' 51' ' ' LEU . . . -63.2 -34.32 77.38 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 115.09 -0.959 . . . . 0.0 110.42 173.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.649 ' HB2' ' HA ' ' A' ' 11' ' ' TYR . 0.2 OUTLIER -61.36 -55.49 31.05 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.456 179.342 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.49 HG12 ' O ' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -55.27 -41.5 61.59 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 178.322 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.694 HD22 ' HA ' ' A' ' 23' ' ' VAL . 2.3 tp -55.46 -38.64 69.33 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.31 176.212 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . 0.474 ' HE2' HD12 ' A' ' 51' ' ' LEU . 93.8 m-70 -73.77 -14.28 61.09 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 176.228 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -68.96 -44.4 73.05 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.911 0.386 . . . . 0.0 110.281 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.729 ' HB2' HG22 ' B' ' 132' ' ' ILE . 37.7 t70 -97.92 -6.99 31.11 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.835 0.826 . . . . 0.0 109.178 177.639 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 53.32 52.57 13.27 Favored 'General case' 0 CA--C 1.516 -0.359 0 CA-C-N 113.803 -1.544 . . . . 0.0 109.976 -177.034 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.602 HG12 HD13 ' A' ' 16' ' ' LEU . 7.3 p -106.62 163.97 4.73 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 CA-C-N 114.319 -1.31 . . . . 0.0 109.365 -174.051 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 18.6 p -48.32 142.01 5.98 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 113.312 0.856 . . . . 0.0 113.312 -174.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.694 ' HA ' HD22 ' A' ' 16' ' ' LEU . 58.3 t -107.27 114.29 45.79 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 CA-C-N 114.305 -1.316 . . . . 0.0 110.769 -175.471 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.48 ' OG1' ' HD2' ' A' ' 27' ' ' LYS . 22.1 p -136.69 159.57 41.44 Favored 'General case' 0 C--O 1.245 0.848 0 CA-C-O 120.925 0.393 . . . . 0.0 110.511 176.346 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -56.57 -34.14 66.83 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.596 176.106 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -68.79 -31.95 71.33 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.17 177.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.681 ' HG2' HD11 ' A' ' 16' ' ' LEU . 0.3 OUTLIER -62.67 -58.1 8.69 Favored 'General case' 0 CA--C 1.512 -0.505 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 175.043 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.505 HG23 ' OG ' ' A' ' 12' ' ' SER . 37.0 mt -56.51 -40.95 71.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 114.184 -1.371 . . . . 0.0 110.999 -178.348 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 41.1 t-20 -59.37 -45.53 91.16 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.934 -0.575 . . . . 0.0 109.955 177.272 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -59.31 -47.79 84.06 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.405 179.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.704 ' HB3' HD21 ' B' ' 109' ' ' LEU . 0.9 OUTLIER -57.61 -50.43 73.17 Favored 'General case' 0 C--O 1.239 0.504 0 CA-C-O 121.006 0.431 . . . . 0.0 110.595 177.174 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.582 HG21 ' O ' ' A' ' 37' ' ' VAL . 67.1 mt -47.76 -51.48 7.95 Favored 'Isoleucine or valine' 0 C--O 1.242 0.698 0 CA-C-N 115.067 -0.97 . . . . 0.0 111.267 177.839 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 47.5 mmtm -74.2 -39.49 63.12 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.022 -0.99 . . . . 0.0 111.781 -174.036 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -63.24 -41.39 99.07 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-O 120.783 0.325 . . . . 0.0 110.97 -178.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.482 ' HA ' HD12 ' B' ' 126' ' ' ILE . . . -79.41 -31.8 42.77 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.079 179.784 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 97.38 16.16 35.58 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 121.021 -0.609 . . . . 0.0 111.91 178.316 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.869 ' HB ' ' HA2' ' B' ' 113' ' ' GLY . 2.5 p -119.57 119.99 62.14 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 CA-C-O 121.433 0.635 . . . . 0.0 110.458 -176.694 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.573 ' HA ' HG21 ' A' ' 32' ' ' ILE . 12.8 t30 -96.59 153.71 17.69 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 114.826 -1.079 . . . . 0.0 111.142 -167.673 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.687 ' HA ' ' HB3' ' A' ' 5' ' ' SER . 93.5 t -130.03 158.79 42.49 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.964 0 CA-C-N 114.982 -1.008 . . . . 0.0 109.923 -170.347 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.582 ' HB2' ' CD1' ' A' ' 43' ' ' TRP . 30.6 mt-10 -63.83 112.7 7.9 Favored Pre-proline 0 CA--C 1.487 -1.454 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 170.003 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.452 ' C ' ' HD2' ' A' ' 44' ' ' PRO . 54.4 Cg_exo -55.8 -27.75 63.73 Favored 'Trans proline' 0 C--N 1.312 -1.349 0 C-N-CA 123.042 2.495 . . . . 0.0 113.509 -167.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 1.6 p90 -62.0 -28.95 69.93 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.746 175.03 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . 0.582 ' CD1' ' HB2' ' A' ' 40' ' ' GLU . 9.8 m95 -62.47 -59.35 13.08 Favored Pre-proline 0 C--O 1.204 -1.338 0 CA-C-O 118.374 -0.822 . . . . 0.0 110.32 175.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.452 ' HD2' ' C ' ' A' ' 41' ' ' PRO . 84.8 Cg_exo -44.38 -45.28 12.72 Favored 'Trans proline' 0 C--N 1.36 1.165 0 C-N-CA 121.716 1.61 . . . . 0.0 112.527 172.483 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -60.26 -59.36 10.49 Favored Glycine 0 CA--C 1.529 0.962 0 C-N-CA 120.025 -1.084 . . . . 0.0 112.759 177.367 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 5.4 tp -65.41 -32.03 73.44 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 123.276 0.63 . . . . 0.0 111.791 -177.388 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.505 ' HE1' ' CE3' ' A' ' 43' ' ' TRP . 2.7 m-85 -65.32 -49.02 71.04 Favored 'General case' 0 C--N 1.317 -0.81 0 C-N-CA 122.685 0.394 . . . . 0.0 110.263 176.533 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.6 -31.11 72.18 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.505 0.669 . . . . 0.0 109.539 -179.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.552 ' HD2' ' O ' ' A' ' 49' ' ' LYS . 0.4 OUTLIER -66.82 -35.76 80.81 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 114.883 -1.053 . . . . 0.0 110.622 173.094 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.425 ' C ' HG22 ' A' ' 54' ' ' VAL . . . -85.03 -58.71 2.58 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.809 0.67 . . . . 0.0 112.809 -175.253 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.57 ' HG ' ' HB1' ' A' ' 13' ' ' ALA . 3.2 mm? -62.0 -11.71 14.95 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 112.746 0.647 . . . . 0.0 112.746 -170.437 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -74.34 -26.41 60.12 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.061 0.457 . . . . 0.0 110.426 175.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 84.1 m-20 -116.4 -39.13 3.41 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.048 -177.284 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.425 HG22 ' C ' ' A' ' 50' ' ' ALA . 4.1 m -98.43 -174.28 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.949 0.404 . . . . 0.0 110.789 -176.435 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 26.9 p-10 -111.71 178.71 4.23 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.334 179.364 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.57 HG12 ' CD1' ' A' ' 14' ' ' LEU . 4.7 tp -74.57 -25.1 18.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 120.971 0.415 . . . . 0.0 109.992 -179.183 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -70.32 -13.75 70.92 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.435 -0.888 . . . . 0.0 110.937 175.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 32.2 t -77.53 -21.75 52.17 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-O 121.27 0.557 . . . . 0.0 109.677 179.284 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 20.0 mt -64.98 -26.38 68.27 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.565 179.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.569 HG13 ' HB ' ' B' ' 159' ' ' ILE . 0.1 OUTLIER . . . . . 0 C--N 1.314 -0.936 0 CA-C-N 114.602 -1.181 . . . . 0.0 110.558 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 103' ' ' TYR . . . . . 0.59 ' HB2' HG11 ' B' ' 142' ' ' VAL . 41.5 m-85 . . . . . 0 C--O 1.237 0.425 0 CA-C-O 120.902 0.382 . . . . 0.0 111.234 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 104' ' ' VAL . . . . . 0.611 ' O ' HD23 ' B' ' 108' ' ' LEU . 63.4 t -44.15 -47.06 2.24 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.269 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.973 170.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 105' ' ' ALA . . . . . 0.61 ' CB ' ' HB3' ' A' ' 14' ' ' LEU . . . -65.95 -38.91 89.83 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.008 -0.996 . . . . 0.0 111.593 -173.879 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 106' ' ' SER . . . . . 0.795 ' HB2' HG23 ' B' ' 123' ' ' ILE . 1.4 m -63.75 -36.38 83.69 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-O 121.596 0.712 . . . . 0.0 109.683 177.427 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 107' ' ' TYR . . . . . 0.645 ' CZ ' ' HD2' ' B' ' 118' ' ' PRO . 31.8 t80 -62.93 -51.06 68.39 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 114.509 -1.223 . . . . 0.0 108.665 178.583 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 108' ' ' LEU . . . . . 0.848 ' HG ' HD12 ' B' ' 155' ' ' ILE . 0.0 OUTLIER -56.96 -45.36 82.92 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 114.652 -1.158 . . . . 0.0 110.971 178.341 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 109' ' ' LEU . . . . . 0.833 HD13 ' HB2' ' A' ' 11' ' ' TYR . 7.7 tp -56.41 -47.49 78.93 Favored 'General case' 0 CA--C 1.51 -0.574 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.033 179.099 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 110' ' ' ALA . . . . . 0.549 ' HB2' ' HB3' ' B' ' 118' ' ' PRO . . . -65.73 -38.98 90.63 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-O 120.998 0.428 . . . . 0.0 111.155 -177.358 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 111' ' ' ALA . . . . . 0.659 ' HA ' ' O ' ' B' ' 115' ' ' ASN . . . -69.01 -23.74 64.12 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.637 178.733 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 112' ' ' LEU . . . . . 0.847 ' HG ' HG12 ' A' ' 4' ' ' VAL . 1.4 mp -80.23 -37.54 32.87 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.058 172.831 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 113' ' ' GLY . . . . . 0.869 ' HA2' ' HB ' ' A' ' 37' ' ' VAL . . . -64.07 -20.99 65.43 Favored Glycine 0 N--CA 1.449 -0.499 0 CA-C-N 115.204 -0.907 . . . . 0.0 111.801 177.809 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 114' ' ' GLY . . . . . . . . . . . . . . . 130.01 9.64 3.02 Favored Glycine 0 N--CA 1.439 -1.16 0 C-N-CA 120.354 -0.927 . . . . 0.0 113.416 174.563 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 115' ' ' ASN . . . . . 0.659 ' O ' ' HA ' ' B' ' 111' ' ' ALA . 33.7 t30 -115.11 95.31 5.14 Favored 'General case' 0 N--CA 1.44 -0.962 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 178.5 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 2.3 p -80.21 29.87 0.28 Allowed 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 114.895 -1.048 . . . . 0.0 110.75 -167.024 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 117' ' ' SER . . . . . 0.56 ' N ' ' HD3' ' B' ' 118' ' ' PRO . 41.9 t -175.78 67.96 0.25 Allowed Pre-proline 0 C--N 1.307 -1.252 0 CA-C-N 113.377 -1.738 . . . . 0.0 108.411 -179.05 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 118' ' ' PRO . . . . . 0.645 ' HD2' ' CZ ' ' B' ' 107' ' ' TYR . 32.1 Cg_exo -66.04 148.7 85.86 Favored 'Trans proline' 0 CA--C 1.513 -0.557 0 C-N-CA 125.115 3.877 . . . . 0.0 111.827 -175.268 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 119' ' ' SER . . . . . 0.648 ' O ' HG12 ' B' ' 123' ' ' ILE . 78.6 p -116.39 -178.42 3.41 Favored 'General case' 0 C--N 1.316 -0.858 0 C-N-CA 120.221 -0.591 . . . . 0.0 111.324 178.318 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 120' ' ' ALA . . . . . 0.694 ' HB3' HD13 ' B' ' 139' ' ' LEU . . . -66.81 -34.19 77.28 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 122.057 0.932 . . . . 0.0 109.77 -173.868 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 121' ' ' LYS . . . . . 0.595 ' HD2' ' N ' ' B' ' 121' ' ' LYS . 0.0 OUTLIER -69.74 -29.97 67.46 Favored 'General case' 0 N--CA 1.437 -1.084 0 CA-C-N 113.956 -1.475 . . . . 0.0 110.173 177.805 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 122' ' ' ASP . . . . . 0.463 ' O ' HD13 ' B' ' 126' ' ' ILE . 20.1 m-20 -70.41 -44.73 67.34 Favored 'General case' 0 CA--C 1.517 -0.306 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 174.517 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 123' ' ' ILE . . . . . 0.795 HG23 ' HB2' ' B' ' 106' ' ' SER . 25.1 mm -54.19 -49.57 61.57 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 CA-C-N 114.944 -1.026 . . . . 0.0 109.869 176.38 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 124' ' ' LYS . . . . . 0.963 ' HD2' HD12 ' B' ' 127' ' ' LEU . 1.7 mmmm -62.34 -41.59 98.7 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.23 -175.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 125' ' ' LYS . . . . . . . . . . . . . 44.3 mmtt -49.73 -60.95 2.41 Favored 'General case' 0 CA--C 1.496 -1.134 0 CA-C-O 121.931 0.872 . . . . 0.0 111.225 171.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 126' ' ' ILE . . . . . 0.609 HG23 HD13 ' A' ' 31' ' ' LEU . 1.6 mp -59.03 -41.89 84.68 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.667 0 CA-C-N 113.706 -1.588 . . . . 0.0 110.694 -169.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 127' ' ' LEU . . . . . 0.963 HD12 ' HD2' ' B' ' 124' ' ' LYS . 3.5 pp -78.94 -32.25 45.45 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 111.924 0.342 . . . . 0.0 111.924 -178.628 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 128' ' ' ASP . . . . . 0.478 ' N ' HD11 ' B' ' 127' ' ' LEU . 11.5 m-20 -70.33 -24.58 63.02 Favored 'General case' 0 CA--C 1.518 -0.281 0 O-C-N 122.232 -0.293 . . . . 0.0 111.03 -178.588 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 129' ' ' SER . . . . . . . . . . . . . 94.4 p -59.45 -42.83 92.87 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-O 120.715 0.293 . . . . 0.0 111.206 177.217 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 130' ' ' VAL . . . . . 0.559 HG22 HG13 ' B' ' 132' ' ' ILE . 13.1 m -93.41 -7.4 10.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.814 0.34 . . . . 0.0 111.776 -179.745 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 131' ' ' GLY . . . . . . . . . . . . . . . 85.62 39.75 8.08 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.478 177.474 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 132' ' ' ILE . . . . . 0.729 HG22 ' HB2' ' A' ' 19' ' ' ASP . 14.3 mt -94.7 126.94 47.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 110.195 -0.298 . . . . 0.0 110.195 176.617 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 133' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -80.53 127.04 31.98 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.227 0.536 . . . . 0.0 111.283 -176.171 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 134' ' ' ALA . . . . . 0.439 ' HB2' ' CE1' ' B' ' 103' ' ' TYR . . . -140.37 146.13 38.01 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.706 -173.253 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 135' ' ' ASP . . . . . 0.699 ' HB3' ' HG3' ' B' ' 138' ' ' ARG . 7.7 t70 -93.65 131.04 39.34 Favored 'General case' 0 C--O 1.253 1.253 0 CA-C-O 121.173 0.511 . . . . 0.0 110.447 175.352 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 136' ' ' ASP . . . . . 0.644 ' HA ' ' CD1' ' B' ' 139' ' ' LEU . 6.2 p-10 -77.42 5.21 9.23 Favored 'General case' 0 CA--C 1.517 -0.297 0 CA-C-N 115.029 -0.987 . . . . 0.0 111.627 -168.276 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 137' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -108.83 -30.94 7.89 Favored 'General case' 0 N--CA 1.434 -1.255 0 CA-C-O 121.059 0.457 . . . . 0.0 110.372 172.013 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 138' ' ' ARG . . . . . 0.706 ' HA ' ' HE2' ' B' ' 141' ' ' LYS . 9.3 mmt180 -67.4 -48.44 67.36 Favored 'General case' 0 CA--C 1.505 -0.76 0 CA-C-O 122.179 0.99 . . . . 0.0 109.155 -178.69 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 139' ' ' LEU . . . . . 0.898 ' O ' HG12 ' B' ' 143' ' ' ILE . 0.3 OUTLIER -69.63 -26.09 64.25 Favored 'General case' 0 C--O 1.207 -1.147 0 CA-C-N 114.588 -1.187 . . . . 0.0 111.025 179.112 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 140' ' ' ASN . . . . . 0.587 ' O ' ' HB ' ' B' ' 143' ' ' ILE . 32.9 t30 -79.26 -26.44 42.42 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.875 0.845 . . . . 0.0 109.938 -178.39 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 141' ' ' LYS . . . . . 0.706 ' HE2' ' HA ' ' B' ' 138' ' ' ARG . 0.2 OUTLIER -80.69 -35.35 33.76 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 115.435 -0.802 . . . . 0.0 108.972 179.907 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 142' ' ' VAL . . . . . 0.626 HG13 ' O ' ' B' ' 139' ' ' LEU . 9.8 p -66.6 -39.12 83.09 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.444 0 C-N-CA 119.922 -0.711 . . . . 0.0 109.204 172.127 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 143' ' ' ILE . . . . . 0.898 HG12 ' O ' ' B' ' 139' ' ' LEU . 32.2 mm -45.51 -59.82 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.36 0 CA-C-O 121.778 0.799 . . . . 0.0 110.081 168.762 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 144' ' ' SER . . . . . . . . . . . . . 20.8 m -51.8 -42.61 62.6 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 113.97 -1.468 . . . . 0.0 112.298 -179.656 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 145' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -76.16 -23.63 54.77 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 120.948 0.404 . . . . 0.0 111.625 179.35 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 146' ' ' LEU . . . . . 0.562 ' HB3' ' CZ ' ' B' ' 107' ' ' TYR . 0.3 OUTLIER -86.0 -36.96 19.44 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.569 -177.416 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 147' ' ' ASN . . . . . 0.464 ' HA ' ' HH ' ' B' ' 107' ' ' TYR . 16.0 t-20 -43.6 113.04 0.45 Allowed 'General case' 0 C--N 1.331 -0.203 0 O-C-N 124.157 0.911 . . . . 0.0 112.424 -173.168 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . 97.23 61.22 0.94 Allowed Glycine 0 N--CA 1.448 -0.56 0 CA-C-N 115.277 -0.874 . . . . 0.0 111.807 -178.14 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 149' ' ' LYS . . . . . . . . . . . . . 2.5 tppt? -144.49 162.54 36.29 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 -178.168 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 150' ' ' ASN . . . . . 0.606 ' O ' HG21 ' B' ' 154' ' ' VAL . 42.2 m-80 -106.08 90.26 3.32 Favored 'General case' 0 CA--C 1.514 -0.427 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 178.079 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 151' ' ' ILE . . . . . 0.776 HG13 HD12 ' B' ' 108' ' ' LEU . 1.8 mp -43.45 -66.01 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 O-C-N 124.528 1.142 . . . . 0.0 113.744 -169.028 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 152' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -48.94 -52.61 23.7 Favored 'General case' 0 C--O 1.207 -1.149 0 CA-C-N 118.249 0.477 . . . . 0.0 111.981 -177.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 153' ' ' ASP . . . . . 0.443 ' HA ' ' HB3' ' B' ' 156' ' ' ALA . 26.5 m-20 -64.76 -27.77 69.12 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 119.983 -0.687 . . . . 0.0 111.103 -176.014 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 154' ' ' VAL . . . . . 0.911 ' HB ' HD11 ' B' ' 155' ' ' ILE . 49.6 t -57.6 -52.97 50.7 Favored 'Isoleucine or valine' 0 C--O 1.233 0.189 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 170.374 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 155' ' ' ILE . . . . . 0.911 HD11 ' HB ' ' B' ' 154' ' ' VAL . 1.8 mp -105.25 34.4 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.706 -176.613 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 156' ' ' ALA . . . . . 0.443 ' HB3' ' HA ' ' B' ' 153' ' ' ASP . . . -105.03 0.59 27.79 Favored 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 171.405 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 157' ' ' GLN . . . . . . . . . . . . . 49.9 mt-30 -141.69 1.85 1.55 Allowed 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 113.353 -1.749 . . . . 0.0 109.908 175.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 158' ' ' GLY . . . . . . . . . . . . . . . -142.34 46.26 0.88 Allowed Glycine 0 C--N 1.334 0.456 0 C-N-CA 120.695 -0.764 . . . . 0.0 113.588 -170.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 159' ' ' ILE . . . . . 0.569 ' HB ' HG13 ' A' ' 60' ' ' ILE . 1.8 mp -60.41 -15.81 11.3 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.775 0 C-N-CA 123.127 0.571 . . . . 0.0 111.721 178.859 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 160' ' ' GLY . . . . . 0.429 ' HA2' HG21 ' A' ' 56' ' ' ILE . . . . . . . . 0 N--CA 1.446 -0.676 0 C-N-CA 120.59 -0.814 . . . . 0.0 112.204 -174.591 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' SER . . . . . 0.498 ' HB2' ' HG3' ' A' ' 6' ' ' GLU . 5.8 m . . . . . 0 N--CA 1.448 -0.538 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.578 HG12 ' HG ' ' B' ' 112' ' ' LEU . 2.1 t -52.57 -26.59 10.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.053 -0.976 . . . . 0.0 112.496 -178.301 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 10.9 p -68.71 -53.26 23.21 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 177.471 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.545 ' O ' HG13 ' A' ' 10' ' ' ILE . 31.3 mt-10 -56.95 -50.27 73.13 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 114.816 -1.083 . . . . 0.0 109.614 176.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.714 ' O ' ' HB ' ' A' ' 10' ' ' ILE . 4.4 tp -61.61 -36.6 81.19 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 115.12 -0.945 . . . . 0.0 111.841 -179.404 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.679 ' HB1' HD22 ' B' ' 112' ' ' LEU . . . -69.21 -35.11 75.85 Favored 'General case' 0 CA--C 1.513 -0.456 0 CA-C-O 121.023 0.439 . . . . 0.0 110.719 179.11 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 5.0 t -67.63 -41.11 84.44 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 178.337 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.714 ' HB ' ' O ' ' A' ' 7' ' ' LEU . 68.5 mt -47.92 -56.57 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 CA-C-N 113.859 -1.518 . . . . 0.0 109.905 170.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.905 ' HH ' ' HB ' ' B' ' 155' ' ' ILE . 22.9 m-85 -65.13 -39.64 93.32 Favored 'General case' 0 C--O 1.218 -0.586 0 CA-C-N 115.685 -0.688 . . . . 0.0 111.413 -174.194 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.44 ' HB2' HG23 ' A' ' 28' ' ' ILE . 16.0 m -57.34 -40.84 78.87 Favored 'General case' 0 C--O 1.24 0.588 0 CA-C-O 121.463 0.649 . . . . 0.0 109.315 177.197 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.516 ' CB ' HD12 ' A' ' 51' ' ' LEU . . . -67.13 -30.93 71.07 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 115.186 -0.915 . . . . 0.0 110.212 175.067 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.641 ' HB3' ' CB ' ' B' ' 105' ' ' ALA . 0.3 OUTLIER -66.98 -53.63 29.68 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.591 179.684 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.451 HG12 ' O ' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -57.77 -41.66 80.13 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 CA-C-O 120.961 0.41 . . . . 0.0 109.955 176.8 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.695 HD11 HG11 ' A' ' 21' ' ' VAL . 2.6 tp -60.08 -41.94 93.54 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.821 176.816 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 47.4 t60 -80.47 -8.31 59.5 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.316 179.594 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -73.8 -43.34 59.15 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 178.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -97.71 -14.55 20.81 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-O 121.991 0.901 . . . . 0.0 109.045 177.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 61.0 52.69 3.97 Favored 'General case' 0 CA--C 1.51 -0.566 0 CA-C-N 113.753 -1.567 . . . . 0.0 109.979 -174.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.695 HG11 HD11 ' A' ' 16' ' ' LEU . 7.3 p -102.08 171.64 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.426 -1.643 0 CA-C-N 114.445 -1.252 . . . . 0.0 108.506 -178.216 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.461 ' H ' HG23 ' A' ' 21' ' ' VAL . 41.2 p -54.19 138.65 37.87 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 113.365 0.876 . . . . 0.0 113.365 -170.595 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.484 HG12 ' HB2' ' A' ' 51' ' ' LEU . 59.4 t -107.19 108.7 25.85 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.995 0 CA-C-N 114.371 -1.286 . . . . 0.0 110.54 -176.649 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.488 ' OG1' ' HE2' ' A' ' 27' ' ' LYS . 68.5 p -140.24 155.14 47.0 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.61 179.029 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -54.83 -43.36 72.92 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.228 0.537 . . . . 0.0 109.788 178.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 -60.5 -34.55 74.24 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.168 -0.923 . . . . 0.0 110.76 178.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.584 ' HG2' HD12 ' A' ' 16' ' ' LEU . 3.9 tppt? -67.53 -54.12 22.74 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-O 121.881 0.848 . . . . 0.0 109.233 -178.66 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.44 HG23 ' HB2' ' A' ' 12' ' ' SER . 88.1 mt -58.76 -39.35 76.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 114.459 -1.246 . . . . 0.0 110.287 178.262 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 42.8 t-20 -58.14 -42.85 86.76 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.109 176.538 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -60.42 -46.85 88.53 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.243 177.636 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.5 ' HB3' HD22 ' B' ' 109' ' ' LEU . 1.1 mm? -55.54 -51.46 66.98 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 121.221 0.534 . . . . 0.0 110.216 175.348 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.615 HG23 ' O ' ' A' ' 37' ' ' VAL . 67.8 mt -47.71 -49.46 10.24 Favored 'Isoleucine or valine' 0 C--O 1.242 0.665 0 CA-C-N 114.655 -1.157 . . . . 0.0 111.936 179.199 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 3.0 mmmp? -78.45 -31.26 47.93 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.528 0.566 . . . . 0.0 112.528 -173.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.47 ' HB1' ' HB3' ' B' ' 129' ' ' SER . . . -68.83 -38.15 79.66 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 120.641 -0.423 . . . . 0.0 110.463 177.719 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.529 ' CB ' ' HG ' ' B' ' 109' ' ' LEU . . . -77.6 -36.3 51.96 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.412 177.02 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 97.62 13.25 44.83 Favored Glycine 0 N--CA 1.445 -0.715 0 CA-C-N 115.427 -0.806 . . . . 0.0 111.959 178.6 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.948 ' HB ' ' HA2' ' B' ' 113' ' ' GLY . 2.6 p -116.13 116.96 53.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-O 121.818 0.818 . . . . 0.0 110.969 -175.126 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -90.12 152.82 20.95 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 114.268 -1.333 . . . . 0.0 110.551 -171.684 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.558 HG11 ' N ' ' A' ' 40' ' ' GLU . 96.3 t -120.51 166.13 15.26 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.07 0 CA-C-N 114.555 -1.202 . . . . 0.0 109.935 -173.056 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.602 ' HB3' ' HD1' ' A' ' 43' ' ' TRP . 28.3 tp10 -72.62 106.35 2.11 Favored Pre-proline 0 N--CA 1.439 -1.023 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 168.872 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.53 ' C ' ' HD2' ' A' ' 44' ' ' PRO . 86.8 Cg_exo -50.09 -30.71 25.81 Favored 'Trans proline' 0 C--O 1.253 1.243 0 C-N-CA 123.709 2.94 . . . . 0.0 115.65 -163.9 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -59.43 -28.4 66.91 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 177.246 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . 0.602 ' HD1' ' HB3' ' A' ' 40' ' ' GLU . 17.4 m95 -64.2 -60.44 8.72 Favored Pre-proline 0 C--O 1.206 -1.214 0 CA-C-O 118.369 -0.824 . . . . 0.0 111.153 176.083 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.53 ' HD2' ' C ' ' A' ' 41' ' ' PRO . 93.1 Cg_exo -44.99 -44.89 14.61 Favored 'Trans proline' 0 C--N 1.36 1.155 0 C-N-CA 121.849 1.699 . . . . 0.0 112.167 175.094 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -61.55 -55.77 26.95 Favored Glycine 0 CA--C 1.525 0.68 0 C-N-CA 120.035 -1.079 . . . . 0.0 112.525 177.17 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 8.9 tp -67.42 -27.92 67.47 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 122.849 0.459 . . . . 0.0 112.025 -177.366 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.521 ' HE1' ' CE3' ' A' ' 43' ' ' TRP . 2.8 m-85 -69.89 -46.8 64.66 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 177.112 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.475 ' HA ' HG11 ' A' ' 23' ' ' VAL . . . -62.84 -34.34 77.13 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.81 0.814 . . . . 0.0 109.592 178.26 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.509 ' HD2' ' C ' ' A' ' 49' ' ' LYS . 0.3 OUTLIER -70.85 -42.26 70.36 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 114.291 -1.322 . . . . 0.0 111.484 177.085 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -82.23 -44.96 15.68 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 112.687 0.625 . . . . 0.0 112.687 -173.569 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.516 HD12 ' CB ' ' A' ' 13' ' ' ALA . 11.1 mt -63.71 -13.15 40.65 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 112.87 0.693 . . . . 0.0 112.87 -171.835 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -83.1 -10.25 58.78 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.135 0.493 . . . . 0.0 110.579 176.623 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 33.9 m-80 -122.6 -47.6 2.08 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.261 -176.55 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 13.7 m -99.55 -169.93 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 176.601 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -130.59 -173.1 2.98 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 120.484 -0.486 . . . . 0.0 111.338 178.149 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.588 HD12 HD22 ' A' ' 14' ' ' LEU . 3.4 tp -66.03 -26.99 39.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-O 121.006 0.431 . . . . 0.0 111.08 -174.262 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -71.15 -14.99 74.26 Favored Glycine 0 N--CA 1.442 -0.904 0 C-N-CA 120.459 -0.877 . . . . 0.0 111.21 179.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 14.8 t -79.99 -21.27 43.85 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-O 121.157 0.504 . . . . 0.0 110.054 179.631 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 26.0 mt -62.67 -33.05 74.28 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.518 -0.764 . . . . 0.0 110.848 -178.298 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.63 ' CD1' ' HB ' ' B' ' 159' ' ' ILE . 0.1 OUTLIER . . . . . 0 C--N 1.319 -0.752 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.914 -179.299 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 103' ' ' TYR . . . . . 0.857 ' HB2' HG12 ' B' ' 142' ' ' VAL . 52.2 m-85 . . . . . 0 N--CA 1.477 0.886 0 CA-C-O 120.778 0.323 . . . . 0.0 111.807 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 104' ' ' VAL . . . . . 0.529 ' O ' HD23 ' B' ' 108' ' ' LEU . 50.1 t -43.17 -50.28 1.24 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.371 0 CA-C-O 121.736 0.779 . . . . 0.0 110.255 174.069 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 105' ' ' ALA . . . . . 0.641 ' CB ' ' HB3' ' A' ' 14' ' ' LEU . . . -64.67 -37.85 88.98 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-N 114.519 -1.219 . . . . 0.0 111.669 -174.306 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 106' ' ' SER . . . . . 0.682 ' HB2' HG21 ' B' ' 123' ' ' ILE . 1.4 m -62.82 -37.78 88.11 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.533 0.682 . . . . 0.0 109.391 178.533 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 107' ' ' TYR . . . . . 0.67 ' CG ' HD12 ' B' ' 146' ' ' LEU . 34.2 t80 -63.99 -47.58 79.81 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 114.727 -1.124 . . . . 0.0 108.689 178.285 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 108' ' ' LEU . . . . . 1.05 ' HG ' HD12 ' B' ' 155' ' ' ILE . 0.0 OUTLIER -58.21 -47.54 83.17 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.103 -0.953 . . . . 0.0 110.943 177.522 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 109' ' ' LEU . . . . . 0.877 HD13 ' HB2' ' A' ' 11' ' ' TYR . 8.1 tp -54.19 -48.76 70.61 Favored 'General case' 0 CA--C 1.511 -0.541 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.193 179.11 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.65 -41.13 96.33 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.975 0.417 . . . . 0.0 111.044 -177.442 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 111' ' ' ALA . . . . . 0.678 ' HA ' ' O ' ' B' ' 115' ' ' ASN . . . -68.65 -20.17 64.44 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.275 0.56 . . . . 0.0 110.802 179.318 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 112' ' ' LEU . . . . . 0.679 HD22 ' HB1' ' A' ' 8' ' ' ALA . 1.4 mp -85.14 -37.11 20.59 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.966 173.723 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 113' ' ' GLY . . . . . 0.948 ' HA2' ' HB ' ' A' ' 37' ' ' VAL . . . -62.81 -39.23 97.73 Favored Glycine 0 N--CA 1.445 -0.705 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.769 -179.123 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 114' ' ' GLY . . . . . . . . . . . . . . . 155.09 6.21 0.08 OUTLIER Glycine 0 N--CA 1.44 -1.09 0 C-N-CA 120.217 -0.992 . . . . 0.0 112.928 177.216 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 115' ' ' ASN . . . . . 0.678 ' O ' ' HA ' ' B' ' 111' ' ' ALA . 37.4 t30 -119.63 92.62 3.83 Favored 'General case' 0 N--CA 1.444 -0.77 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 -179.454 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 5.2 p -80.59 27.53 0.36 Allowed 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 122.325 1.059 . . . . 0.0 111.038 -166.049 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 117' ' ' SER . . . . . 0.552 ' N ' ' HD3' ' B' ' 118' ' ' PRO . 33.0 t -172.14 68.29 0.42 Allowed Pre-proline 0 C--N 1.31 -1.137 0 CA-C-N 113.419 -1.719 . . . . 0.0 108.098 178.55 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 118' ' ' PRO . . . . . 0.656 ' HG2' ' O ' ' B' ' 107' ' ' TYR . 37.1 Cg_exo -64.09 156.25 60.07 Favored 'Trans proline' 0 CA--C 1.512 -0.611 0 C-N-CA 125.028 3.818 . . . . 0.0 111.718 -174.291 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 119' ' ' SER . . . . . 0.661 ' O ' HG12 ' B' ' 123' ' ' ILE . 90.2 p -123.75 179.78 4.67 Favored 'General case' 0 C--N 1.314 -0.961 0 C-N-CA 120.079 -0.648 . . . . 0.0 110.831 177.837 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 120' ' ' ALA . . . . . 0.74 ' HB3' HD12 ' B' ' 139' ' ' LEU . . . -65.9 -39.2 90.39 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-O 121.75 0.786 . . . . 0.0 109.617 -172.577 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 121' ' ' LYS . . . . . . . . . . . . . 13.9 mptt -60.33 -37.91 82.12 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 114.076 -1.42 . . . . 0.0 110.538 175.169 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 122' ' ' ASP . . . . . 0.615 ' O ' ' HB2' ' B' ' 125' ' ' LYS . 2.6 t0 -74.44 -35.06 63.33 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 121.665 0.745 . . . . 0.0 109.105 -178.644 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 123' ' ' ILE . . . . . 0.745 ' O ' ' HG ' ' B' ' 127' ' ' LEU . 42.7 mm -60.01 -44.3 94.43 Favored 'Isoleucine or valine' 0 C--O 1.235 0.301 0 CA-C-N 115.43 -0.805 . . . . 0.0 109.511 172.762 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 124' ' ' LYS . . . . . 0.658 ' HD3' HD22 ' B' ' 139' ' ' LEU . 5.2 mmmp? -58.66 -44.59 90.18 Favored 'General case' 0 CA--C 1.503 -0.864 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 -179.27 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 125' ' ' LYS . . . . . 0.615 ' HB2' ' O ' ' B' ' 122' ' ' ASP . 17.6 mmtp -45.03 -66.76 0.36 Allowed 'General case' 0 C--O 1.248 0.975 0 CA-C-O 121.609 0.719 . . . . 0.0 112.54 169.724 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 126' ' ' ILE . . . . . 0.453 HD13 ' HA ' ' A' ' 35' ' ' ALA . 1.7 mp -54.65 -43.23 64.76 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.13 0 CA-C-N 113.801 -1.545 . . . . 0.0 111.112 -168.701 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 127' ' ' LEU . . . . . 0.745 ' HG ' ' O ' ' B' ' 123' ' ' ILE . 1.5 pp -84.27 -23.46 30.35 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.505 0.557 . . . . 0.0 112.505 -178.299 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 128' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -70.44 -27.88 64.6 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 120.784 0.326 . . . . 0.0 110.22 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 129' ' ' SER . . . . . 0.47 ' HB3' ' HB1' ' A' ' 34' ' ' ALA . 89.2 p -55.87 -45.86 78.43 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.292 177.556 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 130' ' ' VAL . . . . . 0.538 HG21 HG13 ' B' ' 132' ' ' ILE . 10.9 m -88.88 -17.93 8.11 Favored 'Isoleucine or valine' 0 C--O 1.231 0.083 0 CA-C-O 120.727 0.299 . . . . 0.0 111.563 179.369 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 131' ' ' GLY . . . . . . . . . . . . . . . 100.74 18.76 19.65 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.661 -0.78 . . . . 0.0 112.686 177.321 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 132' ' ' ILE . . . . . 0.538 HG13 HG21 ' B' ' 130' ' ' VAL . 27.5 mt -78.16 114.93 19.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.788 0.327 . . . . 0.0 110.271 178.334 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 133' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -79.02 138.47 38.03 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.386 -175.263 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 134' ' ' ALA . . . . . . . . . . . . . . . -139.79 143.69 37.0 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.774 -0.648 . . . . 0.0 112.103 -169.442 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 135' ' ' ASP . . . . . 0.78 ' HB2' ' HG3' ' B' ' 138' ' ' ARG . 6.3 m-20 -84.05 128.17 34.38 Favored 'General case' 0 C--O 1.252 1.201 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 175.104 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 136' ' ' ASP . . . . . 0.601 ' HA ' HD11 ' B' ' 139' ' ' LEU . 1.3 p-10 -77.14 -0.34 24.55 Favored 'General case' 0 CA--C 1.518 -0.261 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.26 -166.438 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 137' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -103.22 -31.74 9.96 Favored 'General case' 0 N--CA 1.439 -1.01 0 CA-C-O 121.186 0.517 . . . . 0.0 110.14 172.44 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 138' ' ' ARG . . . . . 0.78 ' HG3' ' HB2' ' B' ' 135' ' ' ASP . 44.9 mmt-85 -63.26 -54.37 38.28 Favored 'General case' 0 CA--C 1.504 -0.803 0 CA-C-O 122.108 0.956 . . . . 0.0 109.177 -177.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 139' ' ' LEU . . . . . 0.88 ' O ' HG12 ' B' ' 143' ' ' ILE . 0.3 OUTLIER -66.88 -28.02 67.99 Favored 'General case' 0 C--O 1.211 -0.96 0 CA-C-N 114.383 -1.28 . . . . 0.0 110.996 -179.942 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 140' ' ' ASN . . . . . 0.702 ' O ' ' HB ' ' B' ' 143' ' ' ILE . 11.1 t30 -75.98 -25.77 56.13 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.712 0.768 . . . . 0.0 110.029 -177.461 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 141' ' ' LYS . . . . . 0.516 ' HG2' ' O ' ' B' ' 138' ' ' ARG . 10.5 ptmt -84.34 -31.39 24.84 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.364 -0.835 . . . . 0.0 109.649 -179.477 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 142' ' ' VAL . . . . . 0.857 HG12 ' HB2' ' B' ' 103' ' ' TYR . 9.6 p -70.22 -33.68 55.58 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.119 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 170.583 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 143' ' ' ILE . . . . . 0.88 HG12 ' O ' ' B' ' 139' ' ' LEU . 29.5 mm -47.84 -61.87 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.376 0 CA-C-O 121.463 0.649 . . . . 0.0 109.375 166.514 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 144' ' ' SER . . . . . . . . . . . . . 25.4 m -49.27 -44.38 43.86 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 114.545 -1.207 . . . . 0.0 112.355 177.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 145' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -70.88 -30.36 66.71 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 112.368 0.507 . . . . 0.0 112.368 -177.606 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 146' ' ' LEU . . . . . 0.67 HD12 ' CG ' ' B' ' 107' ' ' TYR . 5.3 mt -93.55 -17.88 22.86 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.346 -0.541 . . . . 0.0 111.023 -177.763 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 147' ' ' ASN . . . . . . . . . . . . . 39.3 t30 -57.79 115.46 2.84 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.08 -177.702 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . 104.27 15.93 20.0 Favored Glycine 0 N--CA 1.448 -0.536 0 CA-C-N 115.745 -0.662 . . . . 0.0 112.518 -179.248 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 149' ' ' LYS . . . . . 0.422 ' HB2' ' O ' ' B' ' 146' ' ' LEU . 0.6 OUTLIER -112.6 158.59 19.78 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.599 0.238 . . . . 0.0 110.659 179.11 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 150' ' ' ASN . . . . . 0.524 ' O ' HG21 ' B' ' 154' ' ' VAL . 25.9 t-20 -97.7 95.87 7.87 Favored 'General case' 0 CA--C 1.511 -0.529 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 175.523 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 151' ' ' ILE . . . . . 0.78 HG13 HD12 ' B' ' 108' ' ' LEU . 1.8 mp -43.61 -60.79 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 O-C-N 124.621 1.2 . . . . 0.0 113.148 -169.4 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 152' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -56.2 -39.93 73.19 Favored 'General case' 0 C--O 1.212 -0.87 0 N-CA-C 111.708 0.262 . . . . 0.0 111.708 -174.426 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 153' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -74.56 -26.4 59.93 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 120.707 -0.397 . . . . 0.0 110.96 -179.051 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 154' ' ' VAL . . . . . 0.524 HG21 ' O ' ' B' ' 150' ' ' ASN . 53.9 t -59.56 -50.06 81.36 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 170.172 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 155' ' ' ILE . . . . . 1.05 HD12 ' HG ' ' B' ' 108' ' ' LEU . 3.0 mp -107.47 34.29 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.19 -177.05 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . -95.77 -4.29 44.21 Favored 'General case' 0 C--N 1.309 -1.157 0 N-CA-C 107.505 -1.294 . . . . 0.0 107.505 169.51 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 157' ' ' GLN . . . . . . . . . . . . . 70.0 mm-40 -135.63 -27.83 1.14 Allowed 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 113.289 -1.778 . . . . 0.0 110.682 175.415 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 158' ' ' GLY . . . . . . . . . . . . . . . -105.85 46.56 1.16 Allowed Glycine 0 C--O 1.222 -0.595 0 CA-C-O 119.581 -0.566 . . . . 0.0 114.511 -171.377 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 159' ' ' ILE . . . . . 0.63 ' HB ' ' CD1' ' A' ' 60' ' ' ILE . 1.8 mp -56.5 -24.0 18.01 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.094 0 CA-C-N 117.385 0.593 . . . . 0.0 110.876 176.043 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 160' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.694 0 C-N-CA 120.835 -0.698 . . . . 0.0 111.805 179.382 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' SER . . . . . 0.541 ' HB2' ' OE1' ' A' ' 6' ' ' GLU . 0.7 OUTLIER . . . . . 0 N--CA 1.448 -0.556 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 . . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.538 HG11 ' HG ' ' B' ' 112' ' ' LEU . 2.1 t -51.77 -22.86 2.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-N 114.189 -1.368 . . . . 0.0 112.825 -177.215 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' SER . . . . . 0.48 ' HB3' ' HA ' ' A' ' 39' ' ' VAL . 16.8 m -71.32 -58.22 3.74 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 179.162 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.542 ' O ' HG13 ' A' ' 10' ' ' ILE . 2.3 mp0 -54.69 -52.45 62.36 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.657 176.004 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.716 ' HA ' HD12 ' A' ' 10' ' ' ILE . 3.6 tp -56.42 -37.14 69.79 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 115.344 -0.843 . . . . 0.0 112.503 179.782 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.587 ' HB1' HD21 ' B' ' 112' ' ' LEU . . . -70.04 -33.38 71.9 Favored 'General case' 0 N--CA 1.468 0.447 0 O-C-N 122.007 -0.433 . . . . 0.0 110.849 179.059 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.611 ' HB2' HG13 ' A' ' 39' ' ' VAL . 8.2 t -70.32 -38.7 74.97 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 177.686 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.716 HD12 ' HA ' ' A' ' 7' ' ' LEU . 67.4 mt -49.22 -55.88 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.74 0 CA-C-N 114.071 -1.422 . . . . 0.0 109.661 170.679 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.939 ' HH ' ' HB ' ' B' ' 155' ' ' ILE . 23.1 m-85 -67.59 -44.18 78.76 Favored 'General case' 0 C--O 1.22 -0.458 0 CA-C-N 115.771 -0.65 . . . . 0.0 112.164 -173.043 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.0 p -54.56 -46.06 73.58 Favored 'General case' 0 C--O 1.243 0.754 0 CA-C-O 121.447 0.642 . . . . 0.0 109.802 177.305 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.04 -36.94 78.39 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.57 172.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.634 HD22 HD11 ' A' ' 56' ' ' ILE . 0.2 OUTLIER -60.84 -55.85 28.2 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.264 -179.537 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.474 HG12 ' O ' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -52.85 -44.81 49.54 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.54 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 177.612 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.733 HD11 HG12 ' A' ' 21' ' ' VAL . 3.4 tp -54.7 -35.6 63.8 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.282 178.135 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . 0.754 ' HE2' HD21 ' A' ' 51' ' ' LEU . 30.5 m-70 -83.48 -14.71 51.84 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 177.574 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -76.4 -33.69 58.85 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.314 0.578 . . . . 0.0 109.593 -178.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.795 ' HB2' HG22 ' B' ' 132' ' ' ILE . 15.1 t70 -96.07 -12.34 25.0 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 174.625 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 55.24 50.05 15.91 Favored 'General case' 0 CA--C 1.518 -0.274 0 CA-C-N 113.861 -1.518 . . . . 0.0 109.979 -175.191 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.733 HG12 HD11 ' A' ' 16' ' ' LEU . 7.9 p -108.08 175.08 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.321 0 CA-C-N 114.589 -1.187 . . . . 0.0 109.286 -174.204 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.574 ' H ' HG21 ' A' ' 21' ' ' VAL . 63.2 p -54.53 137.61 42.66 Favored 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 113.606 0.965 . . . . 0.0 113.606 -170.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.536 ' HA ' HD21 ' A' ' 16' ' ' LEU . 54.0 t -104.91 109.01 26.28 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.758 0 CA-C-N 114.182 -1.372 . . . . 0.0 110.469 -177.484 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.581 ' OG1' ' HB2' ' A' ' 27' ' ' LYS . 82.4 p -144.77 155.8 43.72 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.719 -179.429 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 49.7 tt0 -57.2 -41.7 79.87 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.429 -0.351 . . . . 0.0 110.748 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -66.7 -27.42 67.63 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-O 120.962 0.41 . . . . 0.0 110.449 179.547 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.581 ' HB2' ' OG1' ' A' ' 24' ' ' THR . 3.3 tppt? -71.12 -52.17 20.88 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 -179.195 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 45.9 mt -58.98 -38.65 74.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 114.547 -1.206 . . . . 0.0 110.401 176.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 7.8 m-20 -58.02 -43.5 86.77 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.868 173.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -58.02 -46.61 85.01 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.675 178.015 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.567 ' HB3' HD21 ' B' ' 109' ' ' LEU . 1.3 mm? -59.03 -51.99 67.7 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 121.045 0.45 . . . . 0.0 110.65 175.495 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.606 HG23 ' O ' ' A' ' 37' ' ' VAL . 56.0 mt -49.91 -51.19 17.15 Favored 'Isoleucine or valine' 0 C--O 1.239 0.543 0 CA-C-N 115.155 -0.929 . . . . 0.0 111.916 -178.842 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.585 ' HD2' HG21 ' A' ' 32' ' ' ILE . 14.0 mptt -77.16 -28.14 54.02 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.66 -0.7 . . . . 0.0 112.103 -175.598 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -68.45 -41.43 80.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.902 0.382 . . . . 0.0 110.525 177.464 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -79.26 -38.65 34.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.255 0.55 . . . . 0.0 110.858 178.231 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 101.15 16.94 23.98 Favored Glycine 0 N--CA 1.447 -0.614 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.848 -179.313 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.906 ' HB ' ' HA2' ' B' ' 113' ' ' GLY . 3.0 p -121.11 121.17 64.24 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.423 0 CA-C-O 121.241 0.543 . . . . 0.0 110.827 -177.264 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.536 ' HA ' HG23 ' A' ' 32' ' ' ILE . 8.0 t-20 -100.59 167.65 10.21 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.153 -0.931 . . . . 0.0 110.869 -171.356 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.611 HG13 ' HB2' ' A' ' 9' ' ' CYS . 94.7 t -132.79 165.07 33.47 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 CA-C-N 115.01 -0.996 . . . . 0.0 110.477 -170.585 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.515 ' HB3' ' HD1' ' A' ' 43' ' ' TRP . 4.7 tp10 -68.44 108.07 2.53 Favored Pre-proline 0 N--CA 1.444 -0.726 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 168.353 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.488 ' C ' ' HD2' ' A' ' 44' ' ' PRO . 81.1 Cg_exo -51.77 -28.77 31.55 Favored 'Trans proline' 0 C--O 1.251 1.145 0 C-N-CA 123.582 2.855 . . . . 0.0 115.855 -164.243 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -61.41 -27.77 68.78 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 120.39 -0.524 . . . . 0.0 109.627 177.562 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . 0.571 ' CE3' ' HE1' ' A' ' 47' ' ' PHE . 14.1 m95 -64.46 -60.63 8.08 Favored Pre-proline 0 C--O 1.206 -1.222 0 CA-C-O 118.467 -0.778 . . . . 0.0 110.914 176.566 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.488 ' HD2' ' C ' ' A' ' 41' ' ' PRO . 96.8 Cg_exo -46.13 -44.37 19.55 Favored 'Trans proline' 0 C--N 1.359 1.13 0 C-N-CA 121.811 1.674 . . . . 0.0 111.88 175.176 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -58.7 -62.24 6.47 Favored Glycine 0 CA--C 1.525 0.684 0 C-N-CA 120.187 -1.006 . . . . 0.0 112.631 176.428 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.404 ' O ' ' HB2' ' A' ' 49' ' ' LYS . 4.2 tp -64.44 -32.31 73.89 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 123.081 0.552 . . . . 0.0 111.99 -176.789 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.571 ' HE1' ' CE3' ' A' ' 43' ' ' TRP . 3.2 m-85 -61.81 -50.69 71.31 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 120.826 0.346 . . . . 0.0 110.089 175.483 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.46 ' HA ' HG11 ' A' ' 23' ' ' VAL . . . -66.37 -28.58 68.76 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.572 0.701 . . . . 0.0 109.891 -178.645 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.404 ' HB2' ' O ' ' A' ' 46' ' ' LEU . 9.4 mmmt -65.66 -51.08 62.25 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 114.546 -1.206 . . . . 0.0 112.08 174.538 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.402 ' O ' HG23 ' A' ' 54' ' ' VAL . . . -88.36 -36.69 16.45 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 113.215 0.821 . . . . 0.0 113.215 -169.471 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.754 HD21 ' HE2' ' A' ' 17' ' ' HIS . 24.0 mt -68.65 -0.7 5.53 Favored 'General case' 0 N--CA 1.464 0.227 0 N-CA-C 112.456 0.539 . . . . 0.0 112.456 -172.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -84.96 -1.75 57.08 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.818 0.342 . . . . 0.0 110.307 173.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 9.6 t30 -143.97 -39.66 0.29 Allowed 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.228 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.402 HG23 ' O ' ' A' ' 50' ' ' ALA . 6.4 m -82.27 -171.49 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 178.309 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 18.3 m120 -121.32 175.93 5.9 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.044 0.45 . . . . 0.0 110.758 177.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.634 HD11 HD22 ' A' ' 14' ' ' LEU . 4.3 tp -75.78 -26.22 17.78 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 177.69 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -72.64 -9.52 74.44 Favored Glycine 0 N--CA 1.445 -0.713 0 N-CA-C 111.058 -0.817 . . . . 0.0 111.058 175.167 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 21.2 m -80.48 -24.56 39.37 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-O 121.346 0.593 . . . . 0.0 109.523 177.045 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.577 HD13 HD13 ' A' ' 56' ' ' ILE . 24.9 mt -60.79 -32.83 72.16 Favored 'General case' 0 CA--C 1.517 -0.304 0 CA-C-N 115.443 -0.798 . . . . 0.0 110.957 -178.848 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.596 ' CD1' ' HB ' ' B' ' 159' ' ' ILE . 0.1 OUTLIER . . . . . 0 C--N 1.316 -0.878 0 CA-C-N 114.786 -1.097 . . . . 0.0 111.18 -177.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 103' ' ' TYR . . . . . 0.602 ' HB2' HG11 ' B' ' 142' ' ' VAL . 39.6 m-85 . . . . . 0 N--CA 1.478 0.944 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 104' ' ' VAL . . . . . 0.47 HG12 ' CD2' ' B' ' 108' ' ' LEU . 96.1 t -44.42 -46.45 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 CA-C-O 121.864 0.84 . . . . 0.0 109.391 174.153 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 105' ' ' ALA . . . . . 0.623 ' CB ' ' HB3' ' A' ' 14' ' ' LEU . . . -66.8 -38.47 86.57 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-N 114.288 -1.324 . . . . 0.0 112.226 -173.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 106' ' ' SER . . . . . 0.709 ' HB2' HG21 ' B' ' 123' ' ' ILE . 3.2 m -63.82 -37.86 88.96 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-O 121.625 0.726 . . . . 0.0 109.611 178.536 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 107' ' ' TYR . . . . . 0.72 ' CG ' HD12 ' B' ' 146' ' ' LEU . 33.1 t80 -62.28 -49.57 75.14 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 114.684 -1.144 . . . . 0.0 108.316 177.549 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 108' ' ' LEU . . . . . 0.786 HD12 HG13 ' B' ' 151' ' ' ILE . 0.0 OUTLIER -56.28 -47.49 78.5 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 114.542 -1.208 . . . . 0.0 111.313 177.866 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 109' ' ' LEU . . . . . 0.567 HD21 ' HB3' ' A' ' 31' ' ' LEU . 8.9 tp -56.6 -47.75 78.93 Favored 'General case' 0 CA--C 1.515 -0.398 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.908 179.759 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 110' ' ' ALA . . . . . 0.413 ' HB2' ' HB3' ' B' ' 118' ' ' PRO . . . -64.26 -39.76 94.62 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.583 -0.447 . . . . 0.0 110.985 -177.149 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 111' ' ' ALA . . . . . 0.691 ' HA ' ' O ' ' B' ' 115' ' ' ASN . . . -66.66 -28.89 68.83 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.53 179.862 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 112' ' ' LEU . . . . . 0.587 HD21 ' HB1' ' A' ' 8' ' ' ALA . 1.8 mp -80.37 -34.85 36.13 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.35 175.558 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 113' ' ' GLY . . . . . 0.906 ' HA2' ' HB ' ' A' ' 37' ' ' VAL . . . -64.15 -25.05 69.32 Favored Glycine 0 CA--C 1.504 -0.619 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.814 179.363 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 114' ' ' GLY . . . . . . . . . . . . . . . 144.17 -4.73 1.6 Allowed Glycine 0 N--CA 1.436 -1.326 0 C-N-CA 120.25 -0.976 . . . . 0.0 112.993 176.604 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 115' ' ' ASN . . . . . 0.691 ' O ' ' HA ' ' B' ' 111' ' ' ALA . 8.9 t30 -117.06 90.83 3.42 Favored 'General case' 0 CA--C 1.507 -0.688 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 -176.236 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 7.5 p -77.44 23.64 0.21 Allowed 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.062 -0.972 . . . . 0.0 111.836 -164.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 117' ' ' SER . . . . . 0.577 ' N ' ' HD3' ' B' ' 118' ' ' PRO . 8.5 t -164.92 66.93 1.25 Allowed Pre-proline 0 C--N 1.311 -1.092 0 CA-C-N 114.293 -1.321 . . . . 0.0 108.664 179.648 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 118' ' ' PRO . . . . . 0.715 ' HG2' ' O ' ' B' ' 107' ' ' TYR . 33.9 Cg_exo -64.56 157.8 53.32 Favored 'Trans proline' 0 C--N 1.328 -0.517 1 C-N-CA 125.444 4.096 . . . . 0.0 112.351 -174.091 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 119' ' ' SER . . . . . 0.625 ' O ' HG12 ' B' ' 123' ' ' ILE . 27.2 m -126.02 -175.56 3.39 Favored 'General case' 0 C--N 1.316 -0.856 0 C-N-CA 120.597 -0.441 . . . . 0.0 110.943 177.076 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 120' ' ' ALA . . . . . 0.785 ' HB3' HD11 ' B' ' 139' ' ' LEU . . . -67.84 -35.24 78.24 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 122.214 1.007 . . . . 0.0 110.014 -166.532 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 121' ' ' LYS . . . . . 0.462 ' HD2' ' N ' ' B' ' 121' ' ' LYS . 4.4 mptp? -74.24 -26.76 60.42 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 113.681 -1.6 . . . . 0.0 109.756 -179.07 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 122' ' ' ASP . . . . . . . . . . . . . 25.8 m-20 -72.57 -41.31 65.85 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 174.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 123' ' ' ILE . . . . . 0.709 HG21 ' HB2' ' B' ' 106' ' ' SER . 36.8 mm -54.11 -48.05 65.78 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.368 0 CA-C-N 114.988 -1.005 . . . . 0.0 109.489 173.655 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 124' ' ' LYS . . . . . 0.827 ' HD2' HD13 ' B' ' 127' ' ' LEU . 2.7 mmmt -62.58 -40.71 97.75 Favored 'General case' 0 N--CA 1.439 -1.011 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.785 -176.545 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 125' ' ' LYS . . . . . . . . . . . . . 42.0 mmtt -50.65 -62.68 1.45 Allowed 'General case' 0 CA--C 1.498 -1.023 0 CA-C-O 121.776 0.798 . . . . 0.0 111.367 170.421 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 126' ' ' ILE . . . . . 0.406 HG23 HD11 ' A' ' 31' ' ' LEU . 1.7 mp -56.77 -41.48 75.35 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 CA-C-N 113.756 -1.565 . . . . 0.0 110.758 -169.733 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 127' ' ' LEU . . . . . 0.827 HD13 ' HD2' ' B' ' 124' ' ' LYS . 3.9 pp -79.08 -32.73 44.79 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 -178.548 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 128' ' ' ASP . . . . . 0.524 ' HB2' ' O ' ' B' ' 124' ' ' LYS . 0.6 OUTLIER -70.24 -24.78 63.14 Favored 'General case' 0 CA--C 1.517 -0.323 0 C-N-CA 121.326 -0.15 . . . . 0.0 111.261 -177.587 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 129' ' ' SER . . . . . . . . . . . . . 93.7 p -56.72 -37.19 70.6 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-O 120.928 0.394 . . . . 0.0 111.2 176.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 130' ' ' VAL . . . . . 0.775 HG22 HG13 ' B' ' 132' ' ' ILE . 13.0 m -104.69 -2.9 9.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.391 179.471 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 131' ' ' GLY . . . . . . . . . . . . . . . 81.01 36.04 22.76 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 121.029 -0.605 . . . . 0.0 112.882 177.328 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 132' ' ' ILE . . . . . 0.795 HG22 ' HB2' ' A' ' 19' ' ' ASP . 18.6 mt -78.86 131.94 33.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 110.443 -0.206 . . . . 0.0 110.443 177.402 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 133' ' ' GLU . . . . . . . . . . . . . 87.5 mt-10 -77.0 125.24 29.0 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.361 0.6 . . . . 0.0 110.663 -176.197 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 134' ' ' ALA . . . . . 0.495 ' HB3' ' HD3' ' B' ' 124' ' ' LYS . . . -134.99 143.7 46.97 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.381 -0.827 . . . . 0.0 112.135 -173.202 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 135' ' ' ASP . . . . . 0.755 ' HB2' ' HG3' ' B' ' 138' ' ' ARG . 16.2 m-20 -103.11 132.43 49.37 Favored 'General case' 0 C--O 1.252 1.223 0 CA-C-N 115.65 -0.704 . . . . 0.0 109.358 170.515 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 136' ' ' ASP . . . . . 0.662 ' HA ' HD13 ' B' ' 139' ' ' LEU . 17.4 t70 -73.8 -8.61 56.69 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.061 -166.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 137' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -96.11 -29.77 13.9 Favored 'General case' 0 N--CA 1.44 -0.953 0 C-N-CA 120.17 -0.612 . . . . 0.0 110.54 174.374 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 138' ' ' ARG . . . . . 0.755 ' HG3' ' HB2' ' B' ' 135' ' ' ASP . 12.8 mmt180 -68.26 -52.12 37.41 Favored 'General case' 0 CA--C 1.503 -0.86 0 CA-C-O 122.176 0.988 . . . . 0.0 108.665 -175.595 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 139' ' ' LEU . . . . . 0.879 ' O ' HG12 ' B' ' 143' ' ' ILE . 0.4 OUTLIER -67.47 -30.3 69.97 Favored 'General case' 0 C--O 1.209 -1.038 0 CA-C-N 114.024 -1.444 . . . . 0.0 110.878 -179.528 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 140' ' ' ASN . . . . . 0.602 ' O ' ' HB ' ' B' ' 143' ' ' ILE . 12.1 t30 -75.94 -25.41 55.92 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.591 0.71 . . . . 0.0 109.805 -177.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 141' ' ' LYS . . . . . 0.52 ' HG2' ' O ' ' B' ' 138' ' ' ARG . 2.6 ptmm? -77.94 -38.55 45.13 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 179.056 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 142' ' ' VAL . . . . . 0.649 HG13 ' O ' ' B' ' 139' ' ' LEU . 7.2 p -69.38 -32.98 55.38 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.401 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 175.05 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 143' ' ' ILE . . . . . 0.879 HG12 ' O ' ' B' ' 139' ' ' LEU . 23.5 mm -49.14 -62.56 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.512 -0.486 0 CA-C-O 121.41 0.624 . . . . 0.0 110.001 166.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 144' ' ' SER . . . . . . . . . . . . . 47.4 t -54.08 -34.2 59.52 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 114.608 -1.178 . . . . 0.0 111.695 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 145' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -79.52 -30.79 42.02 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.426 0.528 . . . . 0.0 112.426 -178.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 146' ' ' LEU . . . . . 0.72 HD12 ' CG ' ' B' ' 107' ' ' TYR . 6.6 mt -89.55 -31.79 17.44 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.63 -0.428 . . . . 0.0 110.99 179.021 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 147' ' ' ASN . . . . . 0.471 ' HA ' ' OH ' ' B' ' 107' ' ' TYR . 8.3 t30 -40.52 120.34 1.23 Allowed 'General case' 0 N--CA 1.471 0.587 0 O-C-N 124.079 0.862 . . . . 0.0 112.838 -169.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . 90.89 36.36 6.79 Favored Glycine 0 N--CA 1.447 -0.57 0 CA-C-N 115.342 -0.844 . . . . 0.0 111.905 -177.7 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 149' ' ' LYS . . . . . 0.67 ' HB2' ' O ' ' B' ' 146' ' ' LEU . 5.2 tppt? -116.92 159.29 22.66 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 110.231 -0.285 . . . . 0.0 110.231 -177.45 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 150' ' ' ASN . . . . . 0.57 ' O ' HG21 ' B' ' 154' ' ' VAL . 92.5 m-20 -106.19 89.95 3.21 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 177.056 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 151' ' ' ILE . . . . . 0.786 HG13 HD12 ' B' ' 108' ' ' LEU . 1.8 mp -46.69 -61.87 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 114.223 -1.353 . . . . 0.0 113.604 -166.797 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 152' ' ' GLU . . . . . 0.408 ' HA ' HD23 ' A' ' 7' ' ' LEU . 22.5 mt-10 -53.96 -34.1 58.75 Favored 'General case' 0 C--O 1.216 -0.672 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 -173.281 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 153' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -81.36 -32.94 32.69 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 120.744 -0.382 . . . . 0.0 110.794 -179.575 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 154' ' ' VAL . . . . . 0.959 ' HB ' HD11 ' B' ' 155' ' ' ILE . 40.0 t -53.26 -48.83 54.73 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 169.828 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 155' ' ' ILE . . . . . 0.959 HD11 ' HB ' ' B' ' 154' ' ' VAL . 1.5 mp -108.5 38.6 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.005 -0.998 . . . . 0.0 110.893 -178.069 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . -99.25 7.14 45.97 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 107.115 -1.439 . . . . 0.0 107.115 166.179 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 157' ' ' GLN . . . . . . . . . . . . . 25.5 mt-30 -143.05 -43.83 0.3 Allowed 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 112.844 -1.98 . . . . 0.0 109.459 175.748 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 158' ' ' GLY . . . . . . . . . . . . . . . -86.57 47.2 3.69 Favored Glycine 0 CA--C 1.521 0.46 0 CA-C-N 115.439 -0.801 . . . . 0.0 114.217 -173.577 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 159' ' ' ILE . . . . . 0.596 ' HB ' ' CD1' ' A' ' 60' ' ' ILE . 1.8 mp -63.63 -14.6 15.04 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 CA-C-O 121.8 0.81 . . . . 0.0 110.104 176.395 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 160' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.441 -0.994 0 N-CA-C 110.349 -1.1 . . . . 0.0 110.349 179.648 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 12.0 m . . . . . 0 N--CA 1.449 -0.477 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.798 HG13 ' HG ' ' B' ' 112' ' ' LEU . 2.0 t -47.05 -28.61 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.254 -0.884 . . . . 0.0 113.38 -177.027 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' SER . . . . . 0.883 ' HB3' ' HA ' ' A' ' 39' ' ' VAL . 69.1 m -70.64 -50.93 31.59 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.864 0.84 . . . . 0.0 109.001 176.278 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.475 ' O ' HG13 ' A' ' 10' ' ' ILE . 40.4 tt0 -57.31 -51.18 70.41 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 114.598 -1.183 . . . . 0.0 109.81 176.454 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.686 ' O ' ' HB ' ' A' ' 10' ' ' ILE . 5.7 tp -58.9 -36.28 74.44 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.547 177.568 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.502 ' HB3' HD21 ' B' ' 112' ' ' LEU . . . -66.65 -35.99 81.49 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 121.199 0.523 . . . . 0.0 110.889 178.532 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.53 ' HB2' HG11 ' A' ' 39' ' ' VAL . 7.4 t -68.0 -42.97 79.9 Favored 'General case' 0 C--O 1.242 0.687 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 179.027 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.686 ' HB ' ' O ' ' A' ' 7' ' ' LEU . 72.0 mt -46.34 -56.77 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.605 0 CA-C-N 113.669 -1.605 . . . . 0.0 109.982 170.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.859 ' HB2' HD13 ' B' ' 109' ' ' LEU . 23.9 m-85 -64.3 -36.76 85.15 Favored 'General case' 0 CA--C 1.512 -0.484 0 CA-C-N 115.441 -0.799 . . . . 0.0 111.271 -174.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.421 ' HA ' ' HG ' ' A' ' 31' ' ' LEU . 18.9 m -56.97 -42.93 81.05 Favored 'General case' 0 C--O 1.243 0.712 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 177.574 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.41 ' CB ' HD13 ' A' ' 51' ' ' LEU . . . -67.17 -31.97 72.74 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.195 175.846 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.761 HD23 HD13 ' A' ' 56' ' ' ILE . 0.3 OUTLIER -63.58 -54.3 38.2 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.316 179.689 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.55 HG12 ' O ' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -60.23 -35.85 64.65 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.412 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 178.868 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.507 HD21 ' HA ' ' A' ' 23' ' ' VAL . 2.3 tp -59.85 -36.06 76.06 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.904 175.616 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . 0.515 ' CD2' ' HB ' ' A' ' 56' ' ' ILE . 70.2 m-70 -73.12 -18.7 61.26 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 116.145 -0.48 . . . . 0.0 112.254 176.479 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -59.37 -38.48 80.56 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 121.074 0.464 . . . . 0.0 110.171 179.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.424 ' CB ' HG12 ' B' ' 132' ' ' ILE . 32.0 t70 -111.25 -4.75 14.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.822 0.82 . . . . 0.0 109.827 176.92 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.449 ' HG2' ' O ' ' A' ' 17' ' ' HIS . 5.5 mm-40 53.1 48.38 22.39 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-N 114.446 -1.252 . . . . 0.0 110.266 -175.398 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.715 HG21 ' H ' ' A' ' 22' ' ' THR . 13.8 p -100.84 -179.55 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.156 0 CA-C-N 114.903 -1.044 . . . . 0.0 109.966 -170.327 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.715 ' H ' HG21 ' A' ' 21' ' ' VAL . 32.6 p -50.2 141.8 10.82 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 113.608 0.966 . . . . 0.0 113.608 -173.456 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.535 HG12 ' HA ' ' A' ' 48' ' ' ALA . 58.3 t -118.86 111.01 31.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 114.343 -1.298 . . . . 0.0 110.332 -175.2 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.528 ' OG1' ' HE2' ' A' ' 27' ' ' LYS . 77.0 p -143.54 156.67 44.67 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.002 177.84 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -56.64 -40.23 75.06 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.954 0.407 . . . . 0.0 110.259 177.309 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -56.95 -39.26 74.21 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.294 173.314 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.528 ' HE2' ' OG1' ' A' ' 24' ' ' THR . 1.6 tppt? -63.31 -52.04 63.53 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-O 121.94 0.876 . . . . 0.0 109.093 -179.178 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 27.8 mt -61.0 -38.96 80.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 114.628 -1.169 . . . . 0.0 110.72 179.144 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 11.3 m-80 -61.27 -35.49 77.43 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.782 175.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.91 -47.92 78.67 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.513 176.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.745 ' HB3' HD23 ' B' ' 109' ' ' LEU . 1.2 mm? -58.01 -50.13 74.46 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 121.113 0.482 . . . . 0.0 110.418 174.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.617 HG22 ' O ' ' A' ' 37' ' ' VAL . 57.7 mt -48.34 -48.18 13.77 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 CA-C-N 115.039 -0.982 . . . . 0.0 111.925 178.387 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 22.8 tptm -75.95 -38.82 57.15 Favored 'General case' 0 N--CA 1.433 -1.306 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.799 -174.343 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -67.39 -33.59 75.52 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.964 0.411 . . . . 0.0 110.787 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.511 ' CB ' ' HG ' ' B' ' 109' ' ' LEU . . . -82.44 -36.57 26.49 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.856 177.625 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 97.29 18.15 29.57 Favored Glycine 0 N--CA 1.447 -0.591 0 CA-C-N 115.733 -0.667 . . . . 0.0 112.017 179.483 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.903 ' HB ' ' HA2' ' B' ' 113' ' ' GLY . 2.7 p -121.91 120.84 62.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 121.583 0.706 . . . . 0.0 111.104 -176.216 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -93.69 155.22 17.37 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 114.504 -1.226 . . . . 0.0 110.891 -170.599 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.883 ' HA ' ' HB3' ' A' ' 5' ' ' SER . 97.8 t -127.22 161.3 34.72 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-N 115.102 -0.954 . . . . 0.0 110.593 -170.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.482 ' HB3' ' HD1' ' A' ' 43' ' ' TRP . 3.8 tp10 -67.55 105.49 0.92 Allowed Pre-proline 0 N--CA 1.444 -0.731 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 170.882 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.492 ' C ' ' HD2' ' A' ' 44' ' ' PRO . 76.9 Cg_exo -50.93 -30.5 30.69 Favored 'Trans proline' 0 C--O 1.252 1.175 0 C-N-CA 123.599 2.866 . . . . 0.0 115.6 -163.657 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -60.04 -28.3 67.65 Favored 'General case' 0 C--N 1.334 -0.097 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 178.167 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . 0.482 ' HD1' ' HB3' ' A' ' 40' ' ' GLU . 7.9 m95 -62.82 -61.66 7.09 Favored Pre-proline 0 C--O 1.205 -1.24 0 CA-C-O 118.27 -0.871 . . . . 0.0 110.725 176.56 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.492 ' HD2' ' C ' ' A' ' 41' ' ' PRO . 99.3 Cg_exo -44.98 -46.24 13.27 Favored 'Trans proline' 0 C--N 1.36 1.145 0 C-N-CA 121.811 1.674 . . . . 0.0 111.981 175.346 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -59.12 -61.58 7.18 Favored Glycine 0 CA--C 1.525 0.68 0 C-N-CA 120.172 -1.013 . . . . 0.0 112.491 177.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 4.5 tp -67.08 -22.61 65.83 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 122.887 0.475 . . . . 0.0 111.714 -176.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.44 ' HE1' ' CE3' ' A' ' 43' ' ' TRP . 2.0 m-85 -69.76 -46.41 65.88 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 175.895 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.535 ' HA ' HG12 ' A' ' 23' ' ' VAL . . . -65.05 -32.22 73.83 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.805 0.812 . . . . 0.0 109.237 178.216 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 11.1 mmmt -66.72 -49.44 66.03 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 114.303 -1.317 . . . . 0.0 111.938 174.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -84.74 -34.75 22.81 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 113.3 0.852 . . . . 0.0 113.3 -169.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.455 ' HB2' HG13 ' A' ' 23' ' ' VAL . 9.7 mt -67.07 -0.8 3.51 Favored 'General case' 0 N--CA 1.462 0.165 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 -175.281 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -85.89 -14.99 43.18 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.974 0.416 . . . . 0.0 110.353 174.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 91.8 m-20 -123.05 -49.89 1.94 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.717 -179.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 3.8 m -88.28 166.97 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.584 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.399 -179.242 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 -113.95 179.38 3.97 Favored 'General case' 0 C--N 1.312 -1.023 0 C-N-CA 120.475 -0.49 . . . . 0.0 109.783 176.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.761 HD13 HD23 ' A' ' 14' ' ' LEU . 4.6 tp -64.16 -25.35 37.86 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 CA-C-O 120.868 0.366 . . . . 0.0 111.025 -176.345 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -70.47 -15.26 72.79 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.631 -0.795 . . . . 0.0 111.151 178.132 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 33.3 t -78.64 -20.98 49.08 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-O 120.911 0.386 . . . . 0.0 110.184 179.544 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.575 HD13 HD12 ' A' ' 56' ' ' ILE . 20.9 mt -65.98 -26.96 67.8 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.859 0.838 . . . . 0.0 110.482 -178.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.728 HG13 ' HB ' ' B' ' 159' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--N 1.317 -0.819 0 CA-C-N 114.418 -1.264 . . . . 0.0 110.509 178.685 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 103' ' ' TYR . . . . . 0.936 ' HB2' HG12 ' B' ' 142' ' ' VAL . 58.1 m-85 . . . . . 0 C--O 1.242 0.662 0 CA-C-O 121.023 0.439 . . . . 0.0 110.616 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 104' ' ' VAL . . . . . 0.714 ' HA ' HD11 ' B' ' 146' ' ' LEU . 90.2 t -45.0 -49.08 2.72 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.353 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.31 172.201 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 105' ' ' ALA . . . . . 0.629 ' CB ' ' HB3' ' A' ' 14' ' ' LEU . . . -62.86 -41.1 99.24 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.271 -1.331 . . . . 0.0 112.088 -174.323 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 106' ' ' SER . . . . . 0.806 ' HB2' HG23 ' B' ' 123' ' ' ILE . 1.0 OUTLIER -62.73 -38.92 92.42 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.58 0.705 . . . . 0.0 109.538 179.296 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 107' ' ' TYR . . . . . 0.692 ' CG ' HD13 ' B' ' 146' ' ' LEU . 39.5 t80 -62.04 -46.71 87.94 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 114.443 -1.253 . . . . 0.0 108.748 178.48 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 108' ' ' LEU . . . . . 1.082 ' HG ' HD12 ' B' ' 155' ' ' ILE . 0.0 OUTLIER -58.66 -46.92 86.12 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 114.409 -1.268 . . . . 0.0 111.088 177.882 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 109' ' ' LEU . . . . . 0.859 HD13 ' HB2' ' A' ' 11' ' ' TYR . 7.2 tp -55.43 -49.33 72.7 Favored 'General case' 0 CA--C 1.513 -0.474 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.793 179.672 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -62.76 -42.63 99.77 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.809 -177.625 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 111' ' ' ALA . . . . . 0.616 ' HA ' ' O ' ' B' ' 115' ' ' ASN . . . -65.64 -27.66 68.55 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.874 179.659 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 112' ' ' LEU . . . . . 0.798 ' HG ' HG13 ' A' ' 4' ' ' VAL . 2.3 mp -78.5 -37.79 42.35 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.007 175.351 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 113' ' ' GLY . . . . . 0.903 ' HA2' ' HB ' ' A' ' 37' ' ' VAL . . . -63.5 -38.88 97.01 Favored Glycine 0 CA--C 1.503 -0.657 0 CA-C-N 115.125 -0.943 . . . . 0.0 111.972 -179.038 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 114' ' ' GLY . . . . . . . . . . . . . . . 159.78 -4.08 0.1 Allowed Glycine 0 N--CA 1.44 -1.072 0 C-N-CA 120.144 -1.027 . . . . 0.0 113.029 177.456 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 115' ' ' ASN . . . . . 0.616 ' O ' ' HA ' ' B' ' 111' ' ' ALA . 45.0 t30 -116.18 86.04 2.41 Favored 'General case' 0 N--CA 1.44 -0.956 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 -176.571 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 116' ' ' SER . . . . . 0.463 ' HA ' ' CB ' ' B' ' 111' ' ' ALA . 3.3 m -78.56 28.46 0.2 Allowed 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 122.239 1.019 . . . . 0.0 110.763 -169.181 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 117' ' ' SER . . . . . 0.569 ' N ' ' HD3' ' B' ' 118' ' ' PRO . 22.7 t -166.19 67.3 1.05 Allowed Pre-proline 0 C--N 1.308 -1.222 0 CA-C-N 113.495 -1.684 . . . . 0.0 107.92 178.211 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 118' ' ' PRO . . . . . 0.633 ' HD2' ' CZ ' ' B' ' 107' ' ' TYR . 26.9 Cg_exo -67.36 165.35 27.24 Favored 'Trans proline' 0 C--O 1.235 0.36 1 C-N-CA 125.44 4.093 . . . . 0.0 112.257 -173.36 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 119' ' ' SER . . . . . 0.665 ' O ' HG12 ' B' ' 123' ' ' ILE . 96.9 p -130.82 -178.5 4.83 Favored 'General case' 0 C--N 1.319 -0.753 0 C-N-CA 120.464 -0.494 . . . . 0.0 110.784 176.258 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 120' ' ' ALA . . . . . 0.748 ' HB3' HD12 ' B' ' 139' ' ' LEU . . . -67.7 -37.75 82.72 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 122.117 0.96 . . . . 0.0 109.387 -172.886 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 121' ' ' LYS . . . . . 0.425 ' HD2' ' N ' ' B' ' 121' ' ' LYS . 0.5 OUTLIER -61.51 -36.26 80.03 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 113.588 -1.642 . . . . 0.0 109.944 176.046 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 122' ' ' ASP . . . . . 0.411 ' O ' ' HB2' ' B' ' 125' ' ' LYS . 16.8 t0 -71.94 -39.01 69.72 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 115.529 -0.76 . . . . 0.0 109.18 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 123' ' ' ILE . . . . . 0.806 HG23 ' HB2' ' B' ' 106' ' ' SER . 27.9 mm -59.93 -45.66 94.9 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 CA-C-N 115.43 -0.805 . . . . 0.0 109.847 175.243 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 124' ' ' LYS . . . . . 0.654 ' HD3' HD23 ' B' ' 139' ' ' LEU . 5.5 mmmp? -59.21 -41.62 89.03 Favored 'General case' 0 CA--C 1.501 -0.927 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.559 -178.771 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 125' ' ' LYS . . . . . 0.411 ' HB2' ' O ' ' B' ' 122' ' ' ASP . 43.5 mmtt -52.45 -63.49 1.13 Allowed 'General case' 0 CA--C 1.496 -1.111 0 CA-C-O 121.668 0.747 . . . . 0.0 111.502 172.793 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 126' ' ' ILE . . . . . . . . . . . . . 1.7 mp -55.3 -42.73 68.01 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.416 0 CA-C-N 113.963 -1.471 . . . . 0.0 111.368 -168.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 127' ' ' LEU . . . . . 0.716 ' HG ' ' O ' ' B' ' 123' ' ' ILE . 2.6 pp -82.04 -26.17 33.98 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.619 -0.433 . . . . 0.0 112.117 -177.901 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 128' ' ' ASP . . . . . 0.41 ' N ' HD12 ' B' ' 127' ' ' LEU . 20.4 t70 -71.83 -30.11 65.12 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 120.982 -0.287 . . . . 0.0 110.478 -179.283 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 129' ' ' SER . . . . . . . . . . . . . 90.2 p -52.81 -44.26 66.52 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.382 179.144 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 130' ' ' VAL . . . . . 0.406 ' CG2' HD13 ' B' ' 132' ' ' ILE . 12.7 m -88.03 -24.58 6.16 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 116.539 -0.301 . . . . 0.0 111.447 178.851 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 131' ' ' GLY . . . . . . . . . . . . . . . 109.74 25.06 5.58 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.306 -0.95 . . . . 0.0 113.175 176.04 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 132' ' ' ILE . . . . . 0.424 HG12 ' CB ' ' A' ' 19' ' ' ASP . 3.2 mt -85.26 132.82 30.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 116.943 0.371 . . . . 0.0 110.092 176.334 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 133' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -91.03 137.11 32.61 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.192 0.52 . . . . 0.0 110.457 -177.614 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 134' ' ' ALA . . . . . . . . . . . . . . . -143.14 143.83 31.97 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.608 -172.397 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 135' ' ' ASP . . . . . 0.745 ' HB2' ' CG ' ' B' ' 138' ' ' ARG . 4.1 m-20 -80.53 125.6 30.18 Favored 'General case' 0 C--O 1.258 1.523 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 172.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 136' ' ' ASP . . . . . 0.605 ' HA ' HD11 ' B' ' 139' ' ' LEU . 5.4 p-10 -72.11 2.06 6.43 Favored 'General case' 0 CA--C 1.514 -0.406 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.524 -173.261 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 137' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -102.93 -36.49 8.19 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.398 174.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 138' ' ' ARG . . . . . 0.745 ' CG ' ' HB2' ' B' ' 135' ' ' ASP . 24.9 mmt180 -67.23 -43.5 81.85 Favored 'General case' 0 CA--C 1.505 -0.766 0 CA-C-O 122.317 1.056 . . . . 0.0 108.626 -174.544 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 139' ' ' LEU . . . . . 0.867 ' O ' HG12 ' B' ' 143' ' ' ILE . 0.4 OUTLIER -72.96 -32.29 65.13 Favored 'General case' 0 C--O 1.209 -1.053 0 CA-C-N 114.423 -1.262 . . . . 0.0 111.034 179.183 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 140' ' ' ASN . . . . . 0.562 ' O ' ' HB ' ' B' ' 143' ' ' ILE . 67.1 t30 -66.36 -25.53 66.85 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 122.29 1.043 . . . . 0.0 108.871 177.41 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 141' ' ' LYS . . . . . 0.51 ' HB3' ' O ' ' B' ' 138' ' ' ARG . 11.8 tppt? -70.4 -52.24 23.79 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 114.199 -1.364 . . . . 0.0 109.707 176.027 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 142' ' ' VAL . . . . . 0.936 HG12 ' HB2' ' B' ' 103' ' ' TYR . 7.9 p -61.82 -33.07 56.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.181 -0.463 . . . . 0.0 109.92 177.422 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 143' ' ' ILE . . . . . 0.867 HG12 ' O ' ' B' ' 139' ' ' LEU . 29.9 mm -50.24 -61.75 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.374 0 CA-C-O 121.426 0.632 . . . . 0.0 110.052 169.532 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 144' ' ' SER . . . . . . . . . . . . . 45.3 t -54.88 -32.26 60.68 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 114.331 -1.304 . . . . 0.0 111.716 -179.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 145' ' ' GLU . . . . . . . . . . . . . 68.4 mm-40 -80.01 -34.69 38.25 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.378 0.51 . . . . 0.0 112.378 -179.281 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 146' ' ' LEU . . . . . 0.714 HD11 ' HA ' ' B' ' 104' ' ' VAL . 7.2 mt -87.63 -19.99 26.97 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 121.021 -0.272 . . . . 0.0 110.832 -178.568 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 147' ' ' ASN . . . . . 0.402 ' HA ' ' HH ' ' B' ' 107' ' ' TYR . 3.5 t-20 -53.97 108.79 0.39 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.13 -177.255 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . 108.99 18.99 8.84 Favored Glycine 0 N--CA 1.449 -0.436 0 CA-C-N 115.356 -0.838 . . . . 0.0 112.454 -179.283 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 149' ' ' LYS . . . . . 0.443 ' HB2' ' O ' ' B' ' 146' ' ' LEU . 0.2 OUTLIER -109.09 171.54 7.37 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.87 0.367 . . . . 0.0 110.646 -178.937 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 150' ' ' ASN . . . . . 0.583 ' O ' HG22 ' B' ' 154' ' ' VAL . 10.6 m-80 -110.24 89.12 2.93 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 178.423 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 151' ' ' ILE . . . . . 0.777 HG13 HD12 ' B' ' 108' ' ' LEU . 1.8 mp -41.87 -63.74 0.17 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.357 0 N-CA-C 113.775 1.028 . . . . 0.0 113.775 -166.447 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 152' ' ' GLU . . . . . 0.652 ' HG3' HD11 ' B' ' 112' ' ' LEU . 3.3 mp0 -59.85 -36.4 76.77 Favored 'General case' 0 C--O 1.209 -1.046 0 C-N-CA 120.508 -0.477 . . . . 0.0 111.105 -174.698 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 153' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -73.51 -27.72 61.51 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 120.73 0.3 . . . . 0.0 110.815 -179.329 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 154' ' ' VAL . . . . . 0.583 HG22 ' O ' ' B' ' 150' ' ' ASN . 46.4 t -60.3 -48.78 86.84 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 171.15 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 155' ' ' ILE . . . . . 1.082 HD12 ' HG ' ' B' ' 108' ' ' LEU . 3.3 mp -106.65 33.94 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 122.11 0.957 . . . . 0.0 110.973 -177.887 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . -99.37 -1.34 39.01 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 169.531 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 157' ' ' GLN . . . . . . . . . . . . . 23.2 mt-30 -139.55 -2.76 1.55 Allowed 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 113.333 -1.758 . . . . 0.0 109.678 175.141 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 158' ' ' GLY . . . . . . . . . . . . . . . -134.48 45.79 1.09 Allowed Glycine 0 C--O 1.225 -0.411 0 C-N-CA 120.603 -0.808 . . . . 0.0 114.077 -168.383 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 159' ' ' ILE . . . . . 0.728 ' HB ' HG13 ' A' ' 60' ' ' ILE . 1.8 mp -59.26 -25.76 31.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 CA-C-O 121.011 0.434 . . . . 0.0 110.854 176.757 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 160' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.517 0 C-N-CA 120.562 -0.828 . . . . 0.0 112.653 179.279 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 92.9 p . . . . . 0 N--CA 1.443 -0.803 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.621 HG11 ' HG ' ' B' ' 112' ' ' LEU . 1.9 t -50.85 -22.47 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 CA-C-N 114.373 -1.285 . . . . 0.0 112.442 -179.773 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' SER . . . . . 0.796 ' HB3' ' HA ' ' A' ' 39' ' ' VAL . 63.0 m -73.17 -52.25 14.86 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.209 0.528 . . . . 0.0 109.598 175.773 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.611 ' HG2' ' NE1' ' A' ' 43' ' ' TRP . 36.7 mt-10 -57.86 -51.22 70.52 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.67 177.805 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.686 ' O ' ' HB ' ' A' ' 10' ' ' ILE . 3.6 tp -58.2 -37.28 74.47 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.178 -0.919 . . . . 0.0 111.746 177.741 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.564 ' HB1' HD21 ' B' ' 112' ' ' LEU . . . -67.43 -34.0 76.33 Favored 'General case' 0 N--CA 1.468 0.428 0 O-C-N 121.958 -0.464 . . . . 0.0 111.115 178.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.467 ' HB2' HG12 ' A' ' 39' ' ' VAL . 6.8 t -71.29 -37.2 71.85 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 178.877 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.686 ' HB ' ' O ' ' A' ' 7' ' ' LEU . 66.9 mt -50.53 -55.57 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.809 0 CA-C-N 114.29 -1.323 . . . . 0.0 109.684 170.202 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.922 ' HH ' ' HB ' ' B' ' 155' ' ' ILE . 23.5 m-85 -67.04 -43.7 82.09 Favored 'General case' 0 C--O 1.219 -0.514 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.964 -173.454 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.7 p -55.08 -41.82 72.03 Favored 'General case' 0 C--O 1.239 0.526 0 CA-C-O 121.15 0.5 . . . . 0.0 109.947 176.409 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.483 ' HB2' HD13 ' A' ' 51' ' ' LEU . . . -62.64 -35.33 79.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.913 172.681 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.74 HD23 HD12 ' A' ' 56' ' ' ILE . 0.4 OUTLIER -62.73 -54.48 38.5 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.868 179.573 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.41 ' H ' HG12 ' A' ' 15' ' ' ILE . 0.0 OUTLIER -57.39 -45.65 85.48 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 CA-C-O 121.048 0.451 . . . . 0.0 110.048 177.302 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.626 HD11 HG11 ' A' ' 21' ' ' VAL . 5.7 tp -55.85 -40.54 73.03 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.577 0.703 . . . . 0.0 110.845 177.589 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 15.0 t60 -75.68 -11.28 59.97 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 114.722 -1.126 . . . . 0.0 111.999 -179.294 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -74.93 -45.83 39.82 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 121.871 -0.518 . . . . 0.0 110.437 178.178 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.491 ' OD2' ' HB ' ' A' ' 21' ' ' VAL . 29.3 t70 -88.89 -11.49 44.45 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.732 0.777 . . . . 0.0 109.085 177.713 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 56.18 48.98 16.3 Favored 'General case' 0 CA--C 1.516 -0.348 0 CA-C-N 113.975 -1.466 . . . . 0.0 109.626 -175.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.626 HG11 HD11 ' A' ' 16' ' ' LEU . 7.6 p -101.75 168.41 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.479 0 CA-C-N 114.519 -1.219 . . . . 0.0 109.586 -170.596 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 45.5 p -43.97 129.52 5.89 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-O 121.77 0.795 . . . . 0.0 113.105 -175.147 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.574 HG13 ' HA ' ' A' ' 48' ' ' ALA . 60.0 t -103.97 108.63 25.06 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.041 0 CA-C-N 114.299 -1.319 . . . . 0.0 110.182 -176.058 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.523 ' OG1' ' HB2' ' A' ' 27' ' ' LYS . 70.4 p -140.61 151.98 45.09 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.02 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -51.78 -45.56 63.84 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.082 0.467 . . . . 0.0 110.258 177.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -62.54 -31.13 71.87 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.736 179.163 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.578 ' HG2' HD12 ' A' ' 16' ' ' LEU . 4.0 tppt? -67.48 -49.42 63.59 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-O 122.032 0.92 . . . . 0.0 108.573 178.075 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 86.3 mt -60.75 -40.54 85.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 114.296 -1.32 . . . . 0.0 110.445 177.549 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -61.15 -35.41 77.01 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.567 175.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.82 -45.69 91.44 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.724 175.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.655 ' HB3' HD23 ' B' ' 109' ' ' LEU . 1.4 mm? -61.99 -46.31 89.8 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 121.017 0.437 . . . . 0.0 110.438 174.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.571 HG23 ' O ' ' A' ' 37' ' ' VAL . 44.2 mt -50.07 -48.18 23.63 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 CA-C-N 115.273 -0.876 . . . . 0.0 111.412 177.799 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 22.7 tptp -72.78 -39.68 66.55 Favored 'General case' 0 N--CA 1.438 -1.055 0 CA-C-N 115.707 -0.678 . . . . 0.0 111.45 -178.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.632 ' HB1' ' HA ' ' B' ' 126' ' ' ILE . . . -56.89 -48.75 77.45 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.195 0.521 . . . . 0.0 110.845 179.842 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.423 ' CB ' ' HG ' ' B' ' 109' ' ' LEU . . . -76.83 -37.41 55.71 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.066 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 99.06 20.74 17.44 Favored Glycine 0 N--CA 1.449 -0.438 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.767 -178.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.831 ' HB ' ' HA2' ' B' ' 113' ' ' GLY . 3.0 p -122.57 121.87 64.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 121.443 0.639 . . . . 0.0 110.646 -176.742 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.445 ' HA ' HG23 ' A' ' 32' ' ' ILE . 61.5 t30 -96.41 156.54 16.3 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 114.773 -1.103 . . . . 0.0 111.0 -170.012 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.796 ' HA ' ' HB3' ' A' ' 5' ' ' SER . 93.3 t -126.82 159.95 35.85 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.075 0 CA-C-N 115.01 -0.995 . . . . 0.0 110.356 -172.561 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.484 ' HB3' ' HD1' ' A' ' 43' ' ' TRP . 3.5 tp10 -67.44 107.23 1.61 Allowed Pre-proline 0 N--CA 1.44 -0.932 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 169.6 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.483 ' C ' ' HD2' ' A' ' 44' ' ' PRO . 73.7 Cg_exo -51.35 -28.07 25.84 Favored 'Trans proline' 0 C--O 1.249 1.034 0 C-N-CA 123.598 2.866 . . . . 0.0 115.304 -164.828 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.427 ' HD2' ' CG ' ' A' ' 40' ' ' GLU . 0.5 OUTLIER -60.19 -27.01 66.79 Favored 'General case' 0 C--N 1.333 -0.15 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 177.645 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . 0.611 ' NE1' ' HG2' ' A' ' 6' ' ' GLU . 22.5 m95 -65.36 -60.12 8.33 Favored Pre-proline 0 C--O 1.204 -1.331 0 CA-C-O 118.373 -0.822 . . . . 0.0 110.743 175.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.483 ' HD2' ' C ' ' A' ' 41' ' ' PRO . 74.7 Cg_exo -44.1 -44.66 12.37 Favored 'Trans proline' 0 C--N 1.357 1.004 0 C-N-CA 121.671 1.58 . . . . 0.0 112.203 173.654 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -62.0 -56.49 22.13 Favored Glycine 0 CA--C 1.525 0.712 0 C-N-CA 120.238 -0.982 . . . . 0.0 112.952 176.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.447 ' O ' ' HB2' ' A' ' 49' ' ' LYS . 9.4 tp -69.78 -23.01 63.28 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 122.91 0.484 . . . . 0.0 111.821 -176.861 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.526 ' HE1' ' CE3' ' A' ' 43' ' ' TRP . 3.1 m-85 -73.48 -43.78 59.4 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 109.962 -0.384 . . . . 0.0 109.962 175.605 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.574 ' HA ' HG13 ' A' ' 23' ' ' VAL . . . -63.67 -33.14 74.97 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 177.074 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.447 ' HB2' ' O ' ' A' ' 46' ' ' LEU . 9.6 mmmt -62.68 -62.26 1.85 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 114.569 -1.196 . . . . 0.0 111.701 171.187 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.445 ' O ' HG21 ' A' ' 54' ' ' VAL . . . -69.77 -41.26 75.4 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 113.114 0.783 . . . . 0.0 113.114 -169.408 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.483 HD13 ' HB2' ' A' ' 13' ' ' ALA . 12.4 mt -65.64 -10.98 40.78 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.75 0.309 . . . . 0.0 111.792 -174.37 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -84.59 0.22 50.86 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.303 177.217 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -141.22 -47.03 0.39 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.234 -179.119 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.445 HG21 ' O ' ' A' ' 50' ' ' ALA . 5.8 m -91.08 -175.19 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.847 0.356 . . . . 0.0 110.33 -177.473 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 16.4 m120 -116.03 169.47 9.23 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.734 178.16 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.74 HD12 HD23 ' A' ' 14' ' ' LEU . 3.2 tp -61.35 -25.09 35.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.551 178.603 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -70.83 -11.94 70.18 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.691 -0.766 . . . . 0.0 111.36 179.277 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 22.9 t -81.34 -23.71 37.59 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-O 121.323 0.582 . . . . 0.0 109.817 179.433 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 26.3 mt -62.32 -31.19 71.78 Favored 'General case' 0 CA--C 1.517 -0.314 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.751 -178.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.898 HG13 ' HB ' ' B' ' 159' ' ' ILE . 0.1 OUTLIER . . . . . 0 C--N 1.321 -0.653 0 CA-C-N 114.904 -1.044 . . . . 0.0 110.888 -179.647 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 103' ' ' TYR . . . . . 0.582 ' HB2' HG13 ' B' ' 142' ' ' VAL . 47.3 m-85 . . . . . 0 CA--C 1.521 -0.135 0 CA-C-O 121.354 0.597 . . . . 0.0 109.766 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 104' ' ' VAL . . . . . 0.558 HG12 HD11 ' B' ' 146' ' ' LEU . 48.2 t -46.45 -45.95 6.78 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.519 0 CA-C-N 114.71 -1.132 . . . . 0.0 110.13 173.806 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 105' ' ' ALA . . . . . 0.596 ' CB ' ' HB3' ' A' ' 14' ' ' LEU . . . -66.22 -39.37 89.54 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 114.822 -1.081 . . . . 0.0 111.656 -174.703 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 106' ' ' SER . . . . . 0.699 ' HB2' HG21 ' B' ' 123' ' ' ILE . 1.0 OUTLIER -62.87 -35.39 79.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.666 0.746 . . . . 0.0 109.066 176.567 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 107' ' ' TYR . . . . . 0.763 ' HD2' HG12 ' B' ' 143' ' ' ILE . 32.7 t80 -65.23 -51.61 59.86 Favored 'General case' 0 N--CA 1.445 -0.722 0 CA-C-N 114.483 -1.235 . . . . 0.0 108.625 179.093 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 108' ' ' LEU . . . . . 0.764 HD12 HG13 ' B' ' 151' ' ' ILE . 0.0 OUTLIER -56.62 -46.83 80.71 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-N 114.99 -1.004 . . . . 0.0 110.769 177.227 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 109' ' ' LEU . . . . . 0.655 HD23 ' HB3' ' A' ' 31' ' ' LEU . 9.4 tp -52.98 -49.06 66.9 Favored 'General case' 0 CA--C 1.512 -0.494 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.665 178.434 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 110' ' ' ALA . . . . . 0.488 ' HB3' ' HB3' ' B' ' 118' ' ' PRO . . . -66.45 -36.43 82.75 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.134 -176.719 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 111' ' ' ALA . . . . . 0.82 ' HA ' ' O ' ' B' ' 115' ' ' ASN . . . -70.63 -19.99 62.77 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.354 0.597 . . . . 0.0 111.023 179.101 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 112' ' ' LEU . . . . . 0.768 ' HB3' HG22 ' A' ' 37' ' ' VAL . 5.6 mp -86.53 -37.24 18.39 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.084 171.284 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 113' ' ' GLY . . . . . 0.831 ' HA2' ' HB ' ' A' ' 37' ' ' VAL . . . -66.26 -39.35 94.36 Favored Glycine 0 N--CA 1.444 -0.798 0 CA-C-N 115.054 -0.975 . . . . 0.0 113.117 -176.389 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 114' ' ' GLY . . . . . . . . . . . . . . . 164.17 6.97 0.04 OUTLIER Glycine 0 N--CA 1.442 -0.901 0 C-N-CA 119.514 -1.327 . . . . 0.0 114.051 178.457 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 115' ' ' ASN . . . . . 0.82 ' O ' ' HA ' ' B' ' 111' ' ' ALA . 95.7 m-20 -130.92 98.0 4.48 Favored 'General case' 0 CA--C 1.494 -1.183 0 CA-C-N 118.061 0.93 . . . . 0.0 108.827 178.165 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 2.5 p -76.02 29.08 0.11 Allowed 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 122.533 1.158 . . . . 0.0 109.818 -178.352 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 117' ' ' SER . . . . . 0.659 ' H ' ' C ' ' B' ' 115' ' ' ASN . 23.2 t -169.95 71.18 0.63 Allowed Pre-proline 0 N--CA 1.447 -0.61 0 CA-C-N 113.261 -1.79 . . . . 0.0 107.93 179.694 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 118' ' ' PRO . . . . . 0.607 ' HD2' ' CZ ' ' B' ' 107' ' ' TYR . 21.0 Cg_exo -71.81 152.39 58.23 Favored 'Trans proline' 0 C--N 1.33 -0.42 1 C-N-CA 125.352 4.034 . . . . 0.0 111.722 -177.102 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 119' ' ' SER . . . . . 0.536 ' O ' HG12 ' B' ' 123' ' ' ILE . 78.9 p -123.09 -175.47 3.19 Favored 'General case' 0 C--N 1.317 -0.824 0 C-N-CA 119.998 -0.681 . . . . 0.0 111.606 178.003 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 120' ' ' ALA . . . . . 0.683 ' HB3' HD12 ' B' ' 139' ' ' LEU . . . -66.58 -39.98 88.72 Favored 'General case' 0 CA--C 1.507 -0.682 0 CA-C-O 121.785 0.802 . . . . 0.0 109.315 -170.347 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 121' ' ' LYS . . . . . . . . . . . . . 13.8 mptt -58.99 -37.38 76.71 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 113.932 -1.485 . . . . 0.0 111.108 174.642 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 122' ' ' ASP . . . . . 0.411 ' O ' ' HD2' ' B' ' 125' ' ' LYS . 21.1 m-20 -69.56 -40.04 77.02 Favored 'General case' 0 CA--C 1.517 -0.299 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.33 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 123' ' ' ILE . . . . . 0.701 ' CG1' HD12 ' B' ' 143' ' ' ILE . 33.2 mm -59.29 -50.84 78.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.959 176.236 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 124' ' ' LYS . . . . . 0.828 ' HD3' HD23 ' B' ' 139' ' ' LEU . 3.7 mmmp? -59.91 -31.66 70.03 Favored 'General case' 0 C--O 1.216 -0.686 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.789 -178.802 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 125' ' ' LYS . . . . . 0.702 ' HD2' HD12 ' B' ' 126' ' ' ILE . 0.0 OUTLIER -71.92 -48.08 47.94 Favored 'General case' 0 N--CA 1.431 -1.384 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.935 -179.773 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 126' ' ' ILE . . . . . 0.702 HD12 ' HD2' ' B' ' 125' ' ' LYS . 1.1 mp -55.56 -51.01 62.54 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 CA-C-O 120.604 0.24 . . . . 0.0 110.941 176.031 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 127' ' ' LEU . . . . . 0.688 ' HG ' ' O ' ' B' ' 123' ' ' ILE . 1.8 pp -76.82 -24.09 52.76 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.605 -0.438 . . . . 0.0 111.629 -175.852 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 128' ' ' ASP . . . . . 0.509 ' HB2' ' O ' ' B' ' 124' ' ' LYS . 24.9 t70 -65.53 -32.86 74.69 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 175.589 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 129' ' ' SER . . . . . 0.489 ' CB ' ' HB3' ' A' ' 34' ' ' ALA . 7.1 t -56.5 -33.12 65.71 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-N 115.714 -0.676 . . . . 0.0 111.827 176.835 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 130' ' ' VAL . . . . . 0.463 HG22 HG13 ' B' ' 132' ' ' ILE . 2.5 m -108.63 -8.48 11.12 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 O-C-N 122.098 -0.376 . . . . 0.0 111.904 178.89 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 131' ' ' GLY . . . . . . . . . . . . . . . 87.26 27.11 28.86 Favored Glycine 0 CA--C 1.519 0.342 0 C-N-CA 121.036 -0.602 . . . . 0.0 113.18 175.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 132' ' ' ILE . . . . . 0.546 ' O ' HD12 ' B' ' 127' ' ' LEU . 17.9 mt -85.09 128.3 39.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.669 0.234 . . . . 0.0 110.854 -179.059 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 133' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -76.53 133.16 39.81 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.124 0.487 . . . . 0.0 111.385 -176.185 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 134' ' ' ALA . . . . . 0.46 ' HB2' HD22 ' B' ' 127' ' ' LEU . . . -139.9 143.94 36.92 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.769 -174.677 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 135' ' ' ASP . . . . . 0.804 ' HB2' ' HG3' ' B' ' 138' ' ' ARG . 5.5 m-20 -88.88 127.97 35.65 Favored 'General case' 0 C--O 1.256 1.416 0 CA-C-O 121.261 0.553 . . . . 0.0 109.712 176.234 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 136' ' ' ASP . . . . . 0.616 ' HA ' HD11 ' B' ' 139' ' ' LEU . 9.0 p-10 -78.07 2.08 18.99 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-N 115.127 -0.942 . . . . 0.0 111.587 -166.593 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 137' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -105.57 -32.76 8.34 Favored 'General case' 0 N--CA 1.44 -0.932 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.189 170.65 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 138' ' ' ARG . . . . . 0.804 ' HG3' ' HB2' ' B' ' 135' ' ' ASP . 11.8 mmt85 -63.32 -47.6 81.53 Favored 'General case' 0 CA--C 1.504 -0.803 0 CA-C-O 121.781 0.8 . . . . 0.0 109.425 -175.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 139' ' ' LEU . . . . . 0.828 HD23 ' HD3' ' B' ' 124' ' ' LYS . 0.3 OUTLIER -71.81 -39.43 69.84 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 114.653 -1.158 . . . . 0.0 111.356 -179.151 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 140' ' ' ASN . . . . . . . . . . . . . 11.0 t30 -62.98 -29.38 70.77 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-O 121.571 0.701 . . . . 0.0 109.11 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 141' ' ' LYS . . . . . . . . . . . . . 18.4 tttm -72.09 -52.42 16.86 Favored 'General case' 0 C--O 1.242 0.699 0 CA-C-N 114.672 -1.149 . . . . 0.0 110.358 178.271 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 142' ' ' VAL . . . . . 0.682 HG12 ' O ' ' B' ' 139' ' ' LEU . 11.7 p -56.93 -42.34 78.48 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.743 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.721 -179.013 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 143' ' ' ILE . . . . . 0.763 HG12 ' HD2' ' B' ' 107' ' ' TYR . 34.6 mt -59.39 -49.73 82.45 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 C-N-CA 123.554 0.742 . . . . 0.0 112.792 174.845 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 144' ' ' SER . . . . . . . . . . . . . 66.3 m -53.26 -33.93 55.14 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 115.668 -0.697 . . . . 0.0 111.294 178.191 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 145' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -87.5 -33.63 18.92 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 120.981 0.419 . . . . 0.0 111.606 176.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 146' ' ' LEU . . . . . 0.558 HD11 HG12 ' B' ' 104' ' ' VAL . 0.3 OUTLIER -70.83 -31.92 68.8 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 123.374 0.67 . . . . 0.0 111.511 -179.01 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 147' ' ' ASN . . . . . 0.441 ' HA ' ' HH ' ' B' ' 107' ' ' TYR . 23.3 t-20 -56.04 124.86 19.19 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.973 -177.502 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . 101.86 28.37 6.62 Favored Glycine 0 N--CA 1.449 -0.495 0 CA-C-N 115.636 -0.711 . . . . 0.0 112.563 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 149' ' ' LYS . . . . . 0.489 ' HE2' ' O ' ' B' ' 146' ' ' LEU . 1.0 OUTLIER -127.79 175.01 8.66 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 110.21 -0.292 . . . . 0.0 110.21 177.13 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 150' ' ' ASN . . . . . 0.552 ' O ' HG22 ' B' ' 154' ' ' VAL . 44.0 m-80 -111.7 93.15 4.32 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 108.582 -0.895 . . . . 0.0 108.582 179.48 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 151' ' ' ILE . . . . . 0.764 HG13 HD12 ' B' ' 108' ' ' LEU . 1.8 mp -41.74 -65.03 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 O-C-N 124.366 1.041 . . . . 0.0 113.662 -169.167 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 152' ' ' GLU . . . . . 0.504 ' HG3' HD11 ' B' ' 112' ' ' LEU . 1.7 mp0 -55.14 -42.83 73.54 Favored 'General case' 0 C--O 1.219 -0.535 0 CA-C-N 117.879 0.309 . . . . 0.0 111.52 -174.26 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 153' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -69.05 -28.61 66.7 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.523 179.696 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 154' ' ' VAL . . . . . 0.861 ' HB ' HD11 ' B' ' 155' ' ' ILE . 61.1 t -61.29 -51.36 73.88 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 CA-C-O 121.691 0.757 . . . . 0.0 109.071 171.208 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 155' ' ' ILE . . . . . 0.922 ' HB ' ' HH ' ' A' ' 11' ' ' TYR . 1.9 mp -101.15 33.29 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.496 -177.223 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . -98.69 -4.97 32.47 Favored 'General case' 0 C--N 1.308 -1.228 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 168.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 157' ' ' GLN . . . . . . . . . . . . . 67.5 mm-40 -142.85 14.72 1.92 Allowed 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 113.563 -1.653 . . . . 0.0 110.047 174.648 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 158' ' ' GLY . . . . . . . . . . . . . . . -146.83 46.34 0.74 Allowed Glycine 0 C--N 1.336 0.567 0 C-N-CA 120.707 -0.758 . . . . 0.0 113.727 -170.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 159' ' ' ILE . . . . . 0.898 ' HB ' HG13 ' A' ' 60' ' ' ILE . 1.8 mp -66.79 -14.76 18.44 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 CA-C-O 121.244 0.545 . . . . 0.0 110.889 178.29 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 160' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.616 0 C-N-CA 120.848 -0.691 . . . . 0.0 111.908 -176.122 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.556 ' HE2' ' HA ' ' B' ' 153' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.481 1.082 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 . . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.545 ' HB3' HD13 ' A' ' 7' ' ' LEU . . . -115.83 -167.59 1.28 Allowed 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 175.792 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.617 ' HB2' ' HG3' ' A' ' 6' ' ' GLU . 4.0 m -89.91 125.06 35.22 Favored 'General case' 0 N--CA 1.438 -1.041 0 N-CA-C 107.254 -1.388 . . . . 0.0 107.254 165.186 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.698 HG11 ' HG ' ' B' ' 112' ' ' LEU . 2.0 t -52.29 -23.49 4.42 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.704 -179.382 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.679 ' HB2' ' HA ' ' A' ' 39' ' ' VAL . 15.8 p -68.08 -53.89 22.21 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.633 0.73 . . . . 0.0 109.328 175.212 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.617 ' HG3' ' HB2' ' A' ' 3' ' ' SER . 31.0 mt-10 -57.74 -52.06 66.99 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 115.009 -0.996 . . . . 0.0 109.661 178.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.701 ' HA ' HD12 ' A' ' 10' ' ' ILE . 2.0 tp -57.79 -35.88 71.42 Favored 'General case' 0 N--CA 1.447 -0.575 0 CA-C-N 115.085 -0.961 . . . . 0.0 111.789 177.762 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.432 ' HB3' ' O ' ' A' ' 4' ' ' VAL . . . -66.33 -40.26 89.75 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-O 121.245 0.545 . . . . 0.0 110.938 178.52 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.546 ' HB2' HG12 ' A' ' 39' ' ' VAL . 8.4 t -65.88 -40.89 92.01 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 179.856 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.701 HD12 ' HA ' ' A' ' 7' ' ' LEU . 57.6 mt -47.9 -57.25 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.851 0 CA-C-N 113.646 -1.616 . . . . 0.0 109.927 172.85 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.738 ' HB2' HD11 ' B' ' 109' ' ' LEU . 21.2 m-85 -65.95 -40.83 91.66 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.604 -173.696 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.494 ' HB2' HG23 ' A' ' 28' ' ' ILE . 14.9 m -53.78 -43.27 69.12 Favored 'General case' 0 C--O 1.243 0.738 0 CA-C-O 121.709 0.766 . . . . 0.0 109.49 176.259 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -67.53 -32.52 73.35 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-N 115.192 -0.913 . . . . 0.0 110.166 176.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.631 ' HB3' ' CB ' ' B' ' 105' ' ' ALA . 0.3 OUTLIER -62.51 -56.87 13.93 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.113 179.467 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.465 HG12 ' O ' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -54.36 -42.19 56.75 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 N-CA-C 109.897 -0.408 . . . . 0.0 109.897 177.421 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.56 HD12 HG11 ' A' ' 21' ' ' VAL . 3.9 tp -56.64 -37.81 71.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.26 176.832 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . 0.777 ' HE2' HD22 ' A' ' 51' ' ' LEU . 72.0 m-70 -77.78 -9.64 59.13 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 112.493 0.553 . . . . 0.0 112.493 178.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.508 ' HA ' ' N ' ' B' ' 100' ' ' ALA . 5.4 t70 -78.61 -29.14 45.87 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 119.513 -0.875 . . . . 0.0 109.807 -177.511 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -107.32 -8.15 16.45 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 173.666 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.407 ' HG2' ' O ' ' A' ' 17' ' ' HIS . 5.2 mm-40 51.89 50.14 19.25 Favored 'General case' 0 CA--C 1.511 -0.545 0 CA-C-N 113.925 -1.489 . . . . 0.0 110.633 -174.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.56 HG11 HD12 ' A' ' 16' ' ' LEU . 7.3 p -99.13 168.76 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.424 -1.743 0 CA-C-N 114.678 -1.147 . . . . 0.0 108.624 -174.439 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 48.5 p -52.45 139.73 24.23 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-O 121.958 0.885 . . . . 0.0 113.377 -169.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.489 HG13 ' HB2' ' A' ' 51' ' ' LEU . 58.7 t -109.32 106.39 20.61 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.012 0 CA-C-N 114.339 -1.301 . . . . 0.0 110.536 -174.638 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.542 ' OG1' ' HB2' ' A' ' 27' ' ' LYS . 70.8 p -131.23 156.04 46.06 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.979 178.465 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -54.35 -43.57 71.39 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.226 0.536 . . . . 0.0 109.856 178.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -68.49 -25.58 65.04 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.295 -0.866 . . . . 0.0 111.458 -179.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.542 ' HB2' ' OG1' ' A' ' 24' ' ' THR . 3.7 tppt? -70.34 -52.24 24.13 Favored 'General case' 0 C--O 1.239 0.53 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 178.894 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.494 HG23 ' HB2' ' A' ' 12' ' ' SER . 70.9 mt -61.08 -40.68 86.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 114.547 -1.206 . . . . 0.0 110.315 177.9 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.584 ' HA ' HD12 ' A' ' 32' ' ' ILE . 44.7 t-20 -60.19 -39.45 86.59 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.936 176.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -60.98 -44.6 97.14 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.016 177.549 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.561 HD12 HG22 ' B' ' 126' ' ' ILE . 1.4 mm? -59.79 -49.39 77.9 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 121.01 0.434 . . . . 0.0 110.315 173.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.589 HG22 ' O ' ' A' ' 37' ' ' VAL . 75.5 mt -46.98 -52.53 4.04 Favored 'Isoleucine or valine' 0 C--O 1.239 0.538 0 CA-C-N 115.184 -0.916 . . . . 0.0 111.366 178.037 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 46.5 mmtm -72.37 -33.41 67.23 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.542 -0.753 . . . . 0.0 111.543 -176.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -62.85 -44.34 96.39 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.062 -179.089 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.51 ' HB3' HG13 ' A' ' 37' ' ' VAL . . . -82.01 -30.61 31.44 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.918 178.743 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 95.3 15.64 43.51 Favored Glycine 0 N--CA 1.447 -0.62 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.75 -178.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 1.003 ' HB ' ' HA3' ' B' ' 113' ' ' GLY . 5.1 p -115.8 118.85 60.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.758 0.79 . . . . 0.0 110.708 -174.778 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.455 ' HA ' HG22 ' A' ' 32' ' ' ILE . 64.3 t30 -96.52 158.59 15.36 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 114.581 -1.19 . . . . 0.0 111.256 -167.486 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.679 ' HA ' ' HB2' ' A' ' 5' ' ' SER . 67.9 t -127.75 163.42 31.38 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.972 0 CA-C-N 114.966 -1.015 . . . . 0.0 110.551 -172.07 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.524 ' HB3' ' HD1' ' A' ' 43' ' ' TRP . 8.2 tp10 -71.24 106.46 1.89 Allowed Pre-proline 0 N--CA 1.44 -0.928 0 N-CA-C 107.429 -1.323 . . . . 0.0 107.429 167.721 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.529 ' C ' ' HD2' ' A' ' 44' ' ' PRO . 77.6 Cg_exo -51.26 -27.69 23.98 Favored 'Trans proline' 0 C--O 1.25 1.112 0 C-N-CA 123.883 3.055 . . . . 0.0 115.532 -164.221 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -61.38 -28.17 69.05 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 177.471 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . 0.619 ' CE3' ' HE1' ' A' ' 47' ' ' PHE . 18.8 m95 -64.56 -59.65 10.16 Favored Pre-proline 0 C--O 1.205 -1.26 0 CA-C-O 118.383 -0.817 . . . . 0.0 110.949 176.068 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.529 ' HD2' ' C ' ' A' ' 41' ' ' PRO . 97.6 Cg_exo -45.81 -42.84 19.67 Favored 'Trans proline' 0 C--N 1.359 1.119 0 C-N-CA 121.766 1.644 . . . . 0.0 111.871 174.532 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -60.4 -61.0 7.56 Favored Glycine 0 CA--C 1.525 0.701 0 C-N-CA 120.231 -0.985 . . . . 0.0 112.516 175.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.559 ' O ' ' HB2' ' A' ' 49' ' ' LYS . 8.7 tp -63.26 -32.1 73.42 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.196 0.599 . . . . 0.0 111.973 -177.417 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.619 ' HE1' ' CE3' ' A' ' 43' ' ' TRP . 3.6 m-85 -64.14 -48.13 77.24 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.192 176.237 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.465 ' HA ' HG12 ' A' ' 23' ' ' VAL . . . -65.25 -31.44 72.59 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.56 0.695 . . . . 0.0 109.396 -179.516 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.559 ' HB2' ' O ' ' A' ' 46' ' ' LEU . 9.3 mmmt -59.28 -54.92 41.27 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 114.589 -1.187 . . . . 0.0 111.748 172.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -86.61 -43.49 12.62 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 113.802 1.038 . . . . 0.0 113.802 -168.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.777 HD22 ' HE2' ' A' ' 17' ' ' HIS . 21.5 mt -65.87 -7.23 15.26 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 113.721 1.008 . . . . 0.0 113.721 -168.556 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -81.01 -2.2 46.97 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.892 0.377 . . . . 0.0 110.425 176.374 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 10.5 t30 -143.01 -41.71 0.31 Allowed 'General case' 0 C--O 1.235 0.294 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.251 -179.568 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 4.3 m -83.01 -179.6 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 121.429 0.633 . . . . 0.0 110.61 -178.542 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 11.5 m120 -112.15 155.98 23.03 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 115.505 -0.771 . . . . 0.0 111.135 177.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.572 HD13 HD22 ' A' ' 14' ' ' LEU . 3.5 tp -60.01 -21.3 21.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 114.773 -1.103 . . . . 0.0 110.83 179.732 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -69.67 -15.4 71.0 Favored Glycine 0 N--CA 1.444 -0.821 0 C-N-CA 120.779 -0.724 . . . . 0.0 111.392 177.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 35.1 t -75.99 -22.77 55.49 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-O 121.477 0.656 . . . . 0.0 109.76 178.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.482 HD12 HD12 ' A' ' 56' ' ' ILE . 19.7 mt -65.12 -25.67 67.87 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.958 -178.423 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.867 HG13 ' HB ' ' B' ' 159' ' ' ILE . 0.2 OUTLIER -67.85 -19.72 25.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 114.935 -1.03 . . . . 0.0 110.595 178.539 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 41.3 t -98.67 -37.73 9.39 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.063 -0.972 . . . . 0.0 110.395 178.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 5.3 p30 35.25 59.81 0.74 Allowed 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.107 0.879 . . . . 0.0 113.0 -176.287 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.404 HG21 ' O ' ' A' ' 63' ' ' VAL . 11.5 p 34.19 43.7 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.795 0 CA-C-N 113.725 -1.579 . . . . 0.0 113.243 179.857 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -161.57 -54.72 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.021 178.375 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . 52.03 50.91 17.51 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.172 0.51 . . . . 0.0 111.673 179.423 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -97.2 152.76 20.11 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.057 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -114.74 -80.63 0.92 Allowed Glycine 0 N--CA 1.448 -0.526 0 N-CA-C 111.224 -0.75 . . . . 0.0 111.224 177.532 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_endo -81.81 -169.46 0.77 Allowed 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 122.698 2.265 . . . . 0.0 111.276 174.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.002 0 CA-C-O 118.762 -0.637 . . . . 0.0 110.183 178.122 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 100' ' ' ALA . . . . . 0.508 ' N ' ' HA ' ' A' ' 18' ' ' ASP . . . . . . . . 0 N--CA 1.481 1.076 0 CA-C-O 120.693 0.282 . . . . 0.0 111.221 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 101' ' ' MET . . . . . 0.592 ' HE1' ' O ' ' A' ' 14' ' ' LEU . 0.0 OUTLIER -131.12 -3.39 3.95 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.092 0.472 . . . . 0.0 109.877 -178.447 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 102' ' ' ARG . . . . . 0.434 ' HB2' ' O ' ' B' ' 101' ' ' MET . 59.4 mtm180 79.36 -162.84 0.03 OUTLIER 'General case' 0 C--O 1.232 0.176 0 CA-C-N 114.961 -1.018 . . . . 0.0 111.928 174.53 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 103' ' ' TYR . . . . . 1.012 ' HB2' HG12 ' B' ' 142' ' ' VAL . 43.2 m-85 -73.67 6.41 3.17 Favored 'General case' 0 C--O 1.242 0.671 0 CA-C-N 114.698 -1.137 . . . . 0.0 113.119 -163.787 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 104' ' ' VAL . . . . . 0.592 ' O ' HD23 ' B' ' 108' ' ' LEU . 44.9 t -50.51 -49.99 23.09 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.448 0 CA-C-O 121.639 0.733 . . . . 0.0 110.034 177.316 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 105' ' ' ALA . . . . . 0.631 ' CB ' ' HB3' ' A' ' 14' ' ' LEU . . . -64.68 -39.36 93.54 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 114.683 -1.144 . . . . 0.0 111.798 -173.249 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 106' ' ' SER . . . . . 0.581 ' HB2' HD12 ' B' ' 123' ' ' ILE . 0.7 OUTLIER -61.06 -38.92 87.91 Favored 'General case' 0 C--O 1.24 0.582 0 CA-C-O 121.786 0.803 . . . . 0.0 109.123 177.905 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 107' ' ' TYR . . . . . 0.742 ' HD2' HG12 ' B' ' 143' ' ' ILE . 41.5 t80 -61.88 -48.7 79.32 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-N 114.08 -1.418 . . . . 0.0 109.067 179.037 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 108' ' ' LEU . . . . . 0.934 ' HG ' HD12 ' B' ' 155' ' ' ILE . 0.0 OUTLIER -58.14 -46.18 86.08 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-N 115.327 -0.852 . . . . 0.0 111.417 179.553 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 109' ' ' LEU . . . . . 0.738 HD11 ' HB2' ' A' ' 11' ' ' TYR . 8.5 tp -54.19 -56.07 21.77 Favored 'General case' 0 C--O 1.247 0.929 0 CA-C-O 121.393 0.616 . . . . 0.0 110.777 178.54 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -56.05 -41.38 74.94 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 114.991 -1.004 . . . . 0.0 110.372 -177.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 111' ' ' ALA . . . . . 0.778 ' HA ' ' O ' ' B' ' 115' ' ' ASN . . . -75.03 -22.25 58.56 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.881 -177.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 112' ' ' LEU . . . . . 0.698 ' HG ' HG11 ' A' ' 4' ' ' VAL . 4.3 tp -77.66 -39.51 44.8 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.415 -177.661 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 113' ' ' GLY . . . . . 1.003 ' HA3' ' HB ' ' A' ' 37' ' ' VAL . . . -140.01 33.09 2.14 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 118.652 -1.737 . . . . 0.0 115.155 -174.652 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 114' ' ' GLY . . . . . . . . . . . . . . . -159.45 -47.1 0.01 OUTLIER Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 119.299 -1.429 . . . . 0.0 112.969 176.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 115' ' ' ASN . . . . . 0.778 ' O ' ' HA ' ' B' ' 111' ' ' ALA . 8.0 t30 -158.33 112.34 2.49 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 -173.055 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 5.9 m -80.77 28.36 0.35 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 122.083 0.944 . . . . 0.0 111.019 -169.051 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 117' ' ' SER . . . . . 0.514 ' N ' ' HD3' ' B' ' 118' ' ' PRO . 28.3 t -168.01 68.88 0.83 Allowed Pre-proline 0 C--N 1.312 -1.044 0 CA-C-N 113.857 -1.52 . . . . 0.0 108.045 177.65 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 118' ' ' PRO . . . . . 0.672 ' HD2' ' CZ ' ' B' ' 107' ' ' TYR . 34.5 Cg_exo -65.7 155.43 69.15 Favored 'Trans proline' 0 CA--C 1.514 -0.512 0 C-N-CA 125.281 3.988 . . . . 0.0 112.389 -172.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 119' ' ' SER . . . . . 0.5 ' O ' HG12 ' B' ' 123' ' ' ILE . 89.8 p -126.57 -176.14 3.59 Favored 'General case' 0 N--CA 1.443 -0.821 0 C-N-CA 120.18 -0.608 . . . . 0.0 111.525 177.74 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 120' ' ' ALA . . . . . 0.692 ' HB3' HD12 ' B' ' 139' ' ' LEU . . . -63.21 -36.5 83.85 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 122.222 1.011 . . . . 0.0 109.409 -169.617 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 121' ' ' LYS . . . . . 0.463 ' HD2' ' N ' ' B' ' 121' ' ' LYS . 0.9 OUTLIER -68.14 -32.91 73.51 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 113.489 -1.687 . . . . 0.0 110.898 178.91 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 122' ' ' ASP . . . . . 0.499 ' O ' ' HB3' ' B' ' 125' ' ' LYS . 10.6 m-20 -71.66 -36.75 70.76 Favored 'General case' 0 CA--C 1.515 -0.372 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 178.412 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 123' ' ' ILE . . . . . 0.757 ' O ' ' HG ' ' B' ' 127' ' ' LEU . 36.9 mm -62.9 -48.38 88.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.108 176.591 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 124' ' ' LYS . . . . . 0.807 ' HD3' HD23 ' B' ' 139' ' ' LEU . 2.9 mmmp? -57.59 -45.21 85.55 Favored 'General case' 0 C--O 1.21 -0.996 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 -179.357 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 125' ' ' LYS . . . . . 0.499 ' HB3' ' O ' ' B' ' 122' ' ' ASP . 0.1 OUTLIER -47.18 -63.99 0.9 Allowed 'General case' 0 N--CA 1.416 -2.149 0 N-CA-C 112.777 0.658 . . . . 0.0 112.777 172.743 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 126' ' ' ILE . . . . . 0.561 HG22 HD12 ' A' ' 31' ' ' LEU . 1.7 mp -56.69 -46.01 82.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.298 -0.865 . . . . 0.0 111.367 -174.859 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 127' ' ' LEU . . . . . 0.757 ' HG ' ' O ' ' B' ' 123' ' ' ILE . 2.2 pp -78.47 -24.82 45.77 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 120.284 -0.567 . . . . 0.0 111.909 -177.822 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 128' ' ' ASP . . . . . 0.487 ' HB2' ' O ' ' B' ' 124' ' ' LYS . 17.0 t70 -67.1 -35.92 80.82 Favored 'General case' 0 CA--C 1.514 -0.407 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 179.861 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 129' ' ' SER . . . . . . . . . . . . . 83.3 p -58.71 -30.14 67.21 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 115.75 -0.659 . . . . 0.0 112.32 -179.23 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 130' ' ' VAL . . . . . . . . . . . . . 3.1 m -108.41 6.02 9.45 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 CA-C-O 120.856 0.36 . . . . 0.0 111.506 177.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 131' ' ' GLY . . . . . . . . . . . . . . . 74.32 30.42 60.62 Favored Glycine 0 CA--C 1.52 0.357 0 C-N-CA 121.075 -0.583 . . . . 0.0 113.722 175.531 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 132' ' ' ILE . . . . . 0.522 ' O ' HD11 ' B' ' 127' ' ' LEU . 18.6 mt -90.08 130.11 39.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.955 0.377 . . . . 0.0 110.026 176.691 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 133' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -81.15 146.73 30.39 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-O 120.922 0.392 . . . . 0.0 110.937 -174.536 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 134' ' ' ALA . . . . . 0.424 ' HB2' HD21 ' B' ' 127' ' ' LEU . . . -146.23 144.07 29.64 Favored 'General case' 0 N--CA 1.442 -0.849 0 CA-C-N 115.795 -0.638 . . . . 0.0 111.639 -176.033 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 135' ' ' ASP . . . . . 0.742 ' HB2' ' HG3' ' B' ' 138' ' ' ARG . 16.3 m-20 -94.03 132.91 38.04 Favored 'General case' 0 C--O 1.251 1.146 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 174.114 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 136' ' ' ASP . . . . . 0.615 ' HA ' HD11 ' B' ' 139' ' ' LEU . 5.5 m-20 -71.53 -11.45 60.87 Favored 'General case' 0 CA--C 1.511 -0.525 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.547 -167.042 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 137' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -97.32 -31.06 12.6 Favored 'General case' 0 N--CA 1.434 -1.228 0 C-N-CA 120.103 -0.639 . . . . 0.0 110.444 174.441 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 138' ' ' ARG . . . . . 0.742 ' HG3' ' HB2' ' B' ' 135' ' ' ASP . 52.4 mmt-85 -66.02 -43.96 86.12 Favored 'General case' 0 CA--C 1.506 -0.725 0 CA-C-O 121.553 0.692 . . . . 0.0 109.565 -174.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 139' ' ' LEU . . . . . 0.807 HD23 ' HD3' ' B' ' 124' ' ' LYS . 0.3 OUTLIER -75.91 -36.71 59.34 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.152 -0.931 . . . . 0.0 111.417 179.688 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 140' ' ' ASN . . . . . . . . . . . . . 61.6 t30 -63.19 -25.95 68.58 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 177.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 141' ' ' LYS . . . . . . . . . . . . . 35.9 tptt -76.26 -49.09 17.96 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.632 -1.167 . . . . 0.0 110.838 177.639 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 142' ' ' VAL . . . . . 1.012 HG12 ' HB2' ' B' ' 103' ' ' TYR . 13.7 p -57.92 -45.95 87.61 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.367 0 CA-C-O 121.212 0.53 . . . . 0.0 109.716 179.561 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 143' ' ' ILE . . . . . 0.742 HG12 ' HD2' ' B' ' 107' ' ' TYR . 34.7 mt -58.56 -46.25 90.05 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.802 0 C-N-CA 124.124 0.97 . . . . 0.0 112.198 173.581 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 144' ' ' SER . . . . . . . . . . . . . 46.5 t -51.59 -39.23 57.52 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.917 176.225 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 145' ' ' GLU . . . . . . . . . . . . . 15.6 mm-40 -73.86 -50.86 18.3 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 121.765 0.793 . . . . 0.0 110.431 175.505 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 146' ' ' LEU . . . . . 0.586 HD23 ' O ' ' B' ' 142' ' ' VAL . 2.2 mm? -61.28 -32.7 72.53 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 114.56 -1.2 . . . . 0.0 112.973 -175.879 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 147' ' ' ASN . . . . . 0.504 ' HA ' ' HH ' ' B' ' 107' ' ' TYR . 50.6 t30 -54.69 116.99 3.0 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.74 -172.823 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 148' ' ' GLY . . . . . 0.44 ' O ' ' HD3' ' B' ' 149' ' ' LYS . . . 98.97 36.15 4.57 Favored Glycine 0 N--CA 1.448 -0.533 0 CA-C-N 115.52 -0.764 . . . . 0.0 112.446 -179.577 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 149' ' ' LYS . . . . . 0.555 ' HE2' ' O ' ' B' ' 146' ' ' LEU . 0.5 OUTLIER -130.48 164.02 25.71 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 110.04 -0.355 . . . . 0.0 110.04 177.898 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 150' ' ' ASN . . . . . 0.489 ' O ' HG21 ' B' ' 154' ' ' VAL . 4.8 m-20 -102.14 90.13 3.83 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 -178.437 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 151' ' ' ILE . . . . . 0.78 HG13 HD12 ' B' ' 108' ' ' LEU . 1.8 mp -34.58 -68.52 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 O-C-N 124.734 1.271 . . . . 0.0 113.251 -172.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 152' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -46.14 -56.68 5.32 Favored 'General case' 0 C--O 1.213 -0.84 0 N-CA-C 112.549 0.574 . . . . 0.0 112.549 -179.482 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 153' ' ' ASP . . . . . 0.556 ' HA ' ' HE2' ' A' ' 1' ' ' MET . 3.5 m-20 -57.3 -35.67 70.13 Favored 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 120.85 -0.34 . . . . 0.0 111.673 -178.683 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 154' ' ' VAL . . . . . 0.735 ' HB ' HD11 ' B' ' 155' ' ' ILE . 64.4 t -57.87 -53.94 38.52 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 CA-C-O 121.273 0.558 . . . . 0.0 110.1 177.37 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 155' ' ' ILE . . . . . 0.934 HD12 ' HG ' ' B' ' 108' ' ' LEU . 3.6 mp -87.76 -19.78 7.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.56 -0.746 . . . . 0.0 111.729 -173.542 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . -57.21 -16.67 8.72 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.022 0.439 . . . . 0.0 110.919 179.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 157' ' ' GLN . . . . . . . . . . . . . 49.8 mt-30 -130.89 26.77 4.95 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.921 170.231 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 158' ' ' GLY . . . . . . . . . . . . . . . -160.04 46.85 0.41 Allowed Glycine 0 CA--C 1.526 0.76 0 CA-C-N 115.989 -0.551 . . . . 0.0 113.943 -172.297 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 159' ' ' ILE . . . . . 0.867 ' HB ' HG13 ' A' ' 60' ' ' ILE . 1.9 mp -61.16 -12.17 5.53 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 CA-C-O 121.875 0.845 . . . . 0.0 110.162 171.748 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 160' ' ' GLY . . . . . . . . . . . . . . . -134.24 162.2 24.51 Favored Glycine 0 N--CA 1.439 -1.143 0 N-CA-C 109.977 -1.249 . . . . 0.0 109.977 -178.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 161' ' ' LYS . . . . . 0.541 ' HB3' HG23 ' B' ' 165' ' ' VAL . 3.7 mppt? 52.07 29.41 6.31 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.589 0.589 . . . . 0.0 112.589 -174.184 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 162' ' ' LEU . . . . . 0.472 ' HB3' HG12 ' B' ' 104' ' ' VAL . 9.1 mp -38.08 116.82 0.55 Allowed 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 113.037 0.754 . . . . 0.0 113.037 175.183 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 163' ' ' ALA . . . . . 0.45 ' HB1' HG23 ' B' ' 104' ' ' VAL . . . 46.39 -78.29 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 114.588 1.329 . . . . 0.0 114.588 179.586 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 164' ' ' SER . . . . . . . . . . . . . 5.4 m -89.43 109.3 20.23 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 121.018 0.437 . . . . 0.0 110.955 -179.179 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 165' ' ' VAL . . . . . 0.541 HG23 ' HB3' ' B' ' 161' ' ' LYS . 27.9 t -79.21 125.06 84.09 Favored Pre-proline 0 C--N 1.325 -0.479 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.074 179.068 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 166' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_exo -16.99 115.74 0.01 OUTLIER 'Trans proline' 0 N--CA 1.438 -1.751 1 C-N-CA 127.438 5.425 . . . . 0.0 115.545 179.235 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 167' ' ' ALA . . . . . . . . . . . . . . . -84.18 115.66 22.54 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.826 -176.345 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 168' ' ' GLY . . . . . . . . . . . . . . . -109.33 103.55 1.79 Allowed Glycine 0 N--CA 1.446 -0.7 0 CA-C-N 115.899 -0.591 . . . . 0.0 112.212 -178.251 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 169' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.106 0 CA-C-O 118.819 -0.99 . . . . 0.0 112.076 178.536 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 49.3 ttm . . . . . 0 N--CA 1.483 1.2 0 CA-C-O 121.021 0.438 . . . . 0.0 110.577 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.579 ' HB1' HD11 ' A' ' 7' ' ' LEU . . . -76.61 158.33 31.21 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.1 179.51 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.504 ' HB2' ' HG3' ' A' ' 6' ' ' GLU . 1.5 m -70.87 135.43 48.03 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 171.86 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.956 HG13 ' HG ' ' B' ' 112' ' ' LEU . 2.1 t -54.33 -24.86 12.82 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-N 115.128 -0.942 . . . . 0.0 112.348 -177.446 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.827 ' HB3' ' HA ' ' A' ' 39' ' ' VAL . 49.7 m -71.27 -48.55 50.21 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.446 0.641 . . . . 0.0 109.304 175.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.551 ' HG2' ' HE1' ' A' ' 43' ' ' TRP . 28.4 mt-10 -61.57 -49.42 76.72 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.322 -0.853 . . . . 0.0 109.274 179.18 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.712 ' O ' ' HB ' ' A' ' 10' ' ' ILE . 4.7 tp -60.24 -35.12 74.76 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 114.831 -1.077 . . . . 0.0 111.47 177.136 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.611 ' HB3' HD23 ' B' ' 112' ' ' LEU . . . -67.87 -37.15 81.45 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 120.933 0.397 . . . . 0.0 110.871 179.029 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.436 ' HB2' HG13 ' A' ' 39' ' ' VAL . 8.4 t -67.81 -39.58 83.95 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 178.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.712 ' HB ' ' O ' ' A' ' 7' ' ' LEU . 68.9 mt -48.48 -55.56 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.694 0 CA-C-N 114.264 -1.335 . . . . 0.0 109.726 170.03 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.869 ' HB2' HD13 ' B' ' 109' ' ' LEU . 23.0 m-85 -67.11 -39.03 86.63 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.698 -173.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.468 ' OG ' HG23 ' A' ' 28' ' ' ILE . 73.1 p -57.1 -40.42 76.97 Favored 'General case' 0 C--O 1.237 0.395 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 177.209 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -65.94 -33.02 74.87 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 115.195 -0.911 . . . . 0.0 110.574 173.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.89 HD22 HD11 ' A' ' 56' ' ' ILE . 0.4 OUTLIER -66.12 -50.52 63.73 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.967 -179.774 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.506 HG12 ' O ' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -63.11 -42.43 96.56 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 177.497 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.687 HD21 ' HA ' ' A' ' 23' ' ' VAL . 6.1 tp -56.12 -38.16 70.4 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.37 0.605 . . . . 0.0 110.388 173.859 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 45.9 t60 -78.78 -7.61 57.98 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.018 -0.992 . . . . 0.0 111.598 178.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -66.62 -52.74 41.84 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 175.188 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -93.1 -10.84 34.56 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 122.098 0.952 . . . . 0.0 108.896 178.512 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 55.79 53.45 9.4 Favored 'General case' 0 CA--C 1.51 -0.576 0 CA-C-N 113.871 -1.513 . . . . 0.0 109.597 -175.026 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.614 HG11 HD13 ' A' ' 16' ' ' LEU . 7.6 p -99.87 160.07 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.723 0 CA-C-N 113.971 -1.468 . . . . 0.0 108.667 -176.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.504 ' O ' ' HG3' ' A' ' 27' ' ' LYS . 50.8 p -43.37 131.28 4.84 Favored 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 113.525 0.935 . . . . 0.0 113.525 -171.661 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.687 ' HA ' HD21 ' A' ' 16' ' ' LEU . 57.7 t -96.82 109.31 22.83 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.04 0 CA-C-N 114.283 -1.326 . . . . 0.0 110.863 -177.071 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.735 ' OG1' ' HG2' ' A' ' 27' ' ' LYS . 21.3 p -133.31 157.13 46.24 Favored 'General case' 0 C--O 1.245 0.855 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.186 179.457 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -53.27 -44.71 68.42 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.601 177.313 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -68.76 -24.97 64.5 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.282 179.589 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.735 ' HG2' ' OG1' ' A' ' 24' ' ' THR . 2.8 mmtm -61.44 -56.43 20.24 Favored 'General case' 0 CA--C 1.514 -0.407 0 N-CA-C 107.937 -1.135 . . . . 0.0 107.937 173.644 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.468 HG23 ' OG ' ' A' ' 12' ' ' SER . 83.5 mt -55.73 -43.3 73.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 113.728 -1.578 . . . . 0.0 110.818 -178.894 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 29.4 m-80 -65.52 -33.17 75.3 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.065 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.23 -48.88 76.41 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.333 176.072 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.66 ' HB3' HD23 ' B' ' 109' ' ' LEU . 1.9 mm? -59.53 -47.6 84.92 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-O 120.917 0.389 . . . . 0.0 110.617 175.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.554 HG22 ' O ' ' A' ' 37' ' ' VAL . 44.0 mt -48.58 -48.98 14.47 Favored 'Isoleucine or valine' 0 C--O 1.241 0.647 0 CA-C-N 115.227 -0.897 . . . . 0.0 111.277 178.166 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 42.5 tptt -72.57 -42.46 64.6 Favored 'General case' 0 N--CA 1.431 -1.399 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.607 -176.461 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -60.74 -40.4 92.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.948 0.404 . . . . 0.0 111.217 -177.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.478 ' HA ' HD13 ' B' ' 126' ' ' ILE . . . -79.96 -34.79 38.44 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.178 0.513 . . . . 0.0 111.105 178.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 97.75 17.66 29.93 Favored Glycine 0 N--CA 1.448 -0.548 0 CA-C-N 115.672 -0.695 . . . . 0.0 112.003 -179.567 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.915 ' HB ' ' HA2' ' B' ' 113' ' ' GLY . 2.9 p -119.69 119.32 60.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-O 121.599 0.714 . . . . 0.0 110.618 -176.567 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.476 ' HA ' HG22 ' A' ' 32' ' ' ILE . 13.6 t-20 -97.57 150.99 20.52 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 114.816 -1.084 . . . . 0.0 110.342 -170.345 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.827 ' HA ' ' HB3' ' A' ' 5' ' ' SER . 99.0 t -121.56 162.55 20.59 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.028 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.381 -169.497 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.492 ' N ' HG12 ' A' ' 39' ' ' VAL . 5.1 tp10 -70.69 106.58 1.84 Allowed Pre-proline 0 N--CA 1.438 -1.04 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 169.665 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.503 ' C ' ' HD2' ' A' ' 44' ' ' PRO . 77.7 Cg_exo -51.71 -26.36 23.09 Favored 'Trans proline' 0 C--O 1.247 0.925 0 C-N-CA 123.818 3.012 . . . . 0.0 115.503 -164.199 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.91 -27.32 68.73 Favored 'General case' 0 CA--C 1.526 0.048 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 177.898 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . 0.553 ' CE3' ' HE1' ' A' ' 47' ' ' PHE . 20.8 m95 -64.31 -59.63 10.48 Favored Pre-proline 0 C--O 1.208 -1.107 0 CA-C-O 118.626 -0.702 . . . . 0.0 110.977 176.04 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.503 ' HD2' ' C ' ' A' ' 41' ' ' PRO . 90.7 Cg_exo -45.26 -43.97 16.29 Favored 'Trans proline' 0 C--N 1.358 1.035 0 C-N-CA 121.733 1.622 . . . . 0.0 112.031 173.474 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -60.21 -59.11 10.95 Favored Glycine 0 CA--C 1.525 0.671 0 C-N-CA 120.36 -0.924 . . . . 0.0 112.581 176.649 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.425 ' O ' ' HB2' ' A' ' 49' ' ' LYS . 5.9 tp -67.46 -26.9 66.61 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 122.909 0.483 . . . . 0.0 112.108 -176.785 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.553 ' HE1' ' CE3' ' A' ' 43' ' ' TRP . 3.0 m-85 -69.05 -46.78 67.01 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 110.19 -0.3 . . . . 0.0 110.19 176.317 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.47 -32.02 73.42 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.322 -0.622 . . . . 0.0 109.322 178.229 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.425 ' HB2' ' O ' ' A' ' 46' ' ' LEU . 8.0 mmmt -60.44 -55.33 34.83 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 114.832 -1.077 . . . . 0.0 111.707 171.289 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.596 ' O ' HG22 ' A' ' 54' ' ' VAL . . . -76.4 -41.09 49.01 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 -170.211 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.51 ' HB2' HG13 ' A' ' 23' ' ' VAL . 12.7 mt -74.21 45.47 0.22 Allowed 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 121.473 0.654 . . . . 0.0 111.925 -173.279 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.439 ' H ' ' C ' ' A' ' 50' ' ' ALA . . . -134.68 -24.58 1.52 Allowed 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.05 -0.977 . . . . 0.0 109.026 172.837 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -121.39 -25.28 5.23 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 115.56 -0.746 . . . . 0.0 111.13 178.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.596 HG22 ' O ' ' A' ' 50' ' ' ALA . 10.4 m -99.64 -170.37 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 174.853 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 34.9 p30 -129.67 -178.39 4.67 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.794 175.59 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.89 HD11 HD22 ' A' ' 14' ' ' LEU . 3.1 tp -68.32 -28.69 41.58 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-O 120.642 0.258 . . . . 0.0 110.94 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -72.14 -11.05 74.74 Favored Glycine 0 N--CA 1.448 -0.5 0 C-N-CA 120.447 -0.882 . . . . 0.0 111.016 177.326 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 14.8 t -82.46 -19.21 39.34 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-O 121.598 0.713 . . . . 0.0 109.356 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.462 ' HB2' ' CG2' ' B' ' 159' ' ' ILE . 22.0 mt -64.0 -31.65 72.92 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.208 -0.906 . . . . 0.0 110.258 177.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.817 HG13 ' HB ' ' B' ' 159' ' ' ILE . 0.2 OUTLIER -63.22 -16.22 17.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 114.898 -1.047 . . . . 0.0 110.483 177.798 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 7.1 t -96.73 16.19 19.77 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 115.117 -0.947 . . . . 0.0 110.834 -178.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.413 ' C ' ' H ' ' A' ' 64' ' ' GLY . 8.6 p30 -56.86 -23.79 46.84 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.802 0.334 . . . . 0.0 111.451 -176.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 23.2 m -80.23 32.67 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 121.452 0.644 . . . . 0.0 111.475 178.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.413 ' H ' ' C ' ' A' ' 62' ' ' ASN . . . 179.59 -67.64 0.07 OUTLIER Glycine 0 N--CA 1.444 -0.768 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.879 -178.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . 53.47 30.66 10.88 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 123.02 0.528 . . . . 0.0 111.672 -178.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 138.12 -95.57 0.22 Allowed Glycine 0 N--CA 1.445 -0.712 0 N-CA-C 111.225 -0.75 . . . . 0.0 111.225 -176.151 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 170.47 115.67 0.35 Allowed Glycine 0 N--CA 1.446 -0.665 0 C-N-CA 120.714 -0.755 . . . . 0.0 111.852 178.494 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -61.24 109.26 0.69 Allowed 'Trans proline' 0 C--O 1.235 0.342 0 C-N-CA 122.591 2.194 . . . . 0.0 111.917 179.501 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.993 0 CA-C-O 118.732 -0.651 . . . . 0.0 110.082 -179.404 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 0.976 0 CA-C-O 120.704 0.288 . . . . 0.0 110.658 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 101' ' ' MET . . . . . 0.788 ' HE1' HD12 ' A' ' 14' ' ' LEU . 1.2 tmt? -127.02 128.19 45.94 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.54 177.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 102' ' ' ARG . . . . . . . . . . . . . 74.3 mtt180 -152.99 -92.15 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 O-C-N 123.759 0.662 . . . . 0.0 110.31 172.636 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 103' ' ' TYR . . . . . 0.887 ' HB2' HG13 ' B' ' 142' ' ' VAL . 39.8 m-85 -79.1 -10.06 59.72 Favored 'General case' 0 C--O 1.24 0.556 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.076 -174.847 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 104' ' ' VAL . . . . . 0.767 HG12 ' HB3' ' B' ' 162' ' ' LEU . 97.8 t -43.64 -49.31 1.66 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.242 0 CA-C-O 121.701 0.763 . . . . 0.0 109.099 172.399 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 105' ' ' ALA . . . . . 0.633 ' CB ' ' HB3' ' A' ' 14' ' ' LEU . . . -64.17 -42.34 96.76 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 114.273 -1.331 . . . . 0.0 112.175 -173.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 106' ' ' SER . . . . . 0.641 ' HB2' HG22 ' B' ' 123' ' ' ILE . 0.8 OUTLIER -62.59 -37.68 87.17 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.687 0.756 . . . . 0.0 109.666 -179.747 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 107' ' ' TYR . . . . . 0.666 ' O ' ' HG2' ' B' ' 118' ' ' PRO . 43.6 t80 -63.41 -47.44 81.97 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 114.652 -1.158 . . . . 0.0 108.662 178.235 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 108' ' ' LEU . . . . . 0.764 HD12 HG13 ' B' ' 151' ' ' ILE . 0.0 OUTLIER -57.87 -46.44 84.85 Favored 'General case' 0 N--CA 1.442 -0.842 0 CA-C-N 114.766 -1.106 . . . . 0.0 110.866 177.194 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 109' ' ' LEU . . . . . 0.869 HD13 ' HB2' ' A' ' 11' ' ' TYR . 8.4 tp -54.85 -47.32 74.33 Favored 'General case' 0 CA--C 1.511 -0.543 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.916 179.047 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 110' ' ' ALA . . . . . 0.477 ' HB2' ' HB3' ' B' ' 118' ' ' PRO . . . -68.01 -36.61 80.27 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.59 -0.444 . . . . 0.0 111.334 -176.772 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 111' ' ' ALA . . . . . 0.793 ' HA ' ' O ' ' B' ' 115' ' ' ASN . . . -70.91 -20.0 62.53 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.411 0.624 . . . . 0.0 110.703 178.51 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 112' ' ' LEU . . . . . 0.956 ' HG ' HG13 ' A' ' 4' ' ' VAL . 2.8 mp -84.5 -40.18 17.97 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 114.962 -1.017 . . . . 0.0 109.762 172.191 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 113' ' ' GLY . . . . . 0.915 ' HA2' ' HB ' ' A' ' 37' ' ' VAL . . . -61.54 -53.65 42.22 Favored Glycine 0 N--CA 1.442 -0.904 0 CA-C-N 114.928 -1.033 . . . . 0.0 112.155 -177.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 114' ' ' GLY . . . . . . . . . . . . . . . 177.33 4.03 0.02 OUTLIER Glycine 0 N--CA 1.441 -1.01 0 C-N-CA 119.55 -1.31 . . . . 0.0 113.909 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 115' ' ' ASN . . . . . 0.793 ' O ' ' HA ' ' B' ' 111' ' ' ALA . 38.2 m-20 -126.78 98.89 5.54 Favored 'General case' 0 CA--C 1.497 -1.076 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 14.1 m -77.04 26.8 0.14 Allowed 'General case' 0 C--N 1.315 -0.9 0 CA-C-O 122.107 0.956 . . . . 0.0 109.763 -175.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 117' ' ' SER . . . . . 0.627 ' H ' ' C ' ' B' ' 115' ' ' ASN . 34.8 t -168.8 70.39 0.75 Allowed Pre-proline 0 C--N 1.321 -0.633 0 CA-C-N 113.738 -1.573 . . . . 0.0 108.385 178.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 118' ' ' PRO . . . . . 0.666 ' HG2' ' O ' ' B' ' 107' ' ' TYR . 34.1 Cg_exo -66.82 158.77 54.73 Favored 'Trans proline' 0 C--N 1.328 -0.547 0 C-N-CA 125.167 3.911 . . . . 0.0 111.675 -176.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 119' ' ' SER . . . . . 0.583 ' O ' HG12 ' B' ' 123' ' ' ILE . 8.6 m -122.31 -179.39 4.17 Favored 'General case' 0 C--N 1.316 -0.882 0 C-N-CA 120.555 -0.458 . . . . 0.0 110.875 176.175 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 120' ' ' ALA . . . . . 0.736 ' HB3' HD13 ' B' ' 139' ' ' LEU . . . -65.99 -36.46 83.36 Favored 'General case' 0 CA--C 1.504 -0.812 0 CA-C-O 122.219 1.009 . . . . 0.0 109.236 -173.347 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 121' ' ' LYS . . . . . 0.433 ' HD2' ' N ' ' B' ' 121' ' ' LYS . 0.4 OUTLIER -63.61 -34.86 78.77 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 113.332 -1.758 . . . . 0.0 110.101 176.782 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 122' ' ' ASP . . . . . 0.427 ' O ' HD11 ' B' ' 126' ' ' ILE . 18.5 m-20 -71.1 -37.6 72.38 Favored 'General case' 0 CA--C 1.517 -0.314 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 176.486 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 123' ' ' ILE . . . . . 0.741 ' O ' ' HG ' ' B' ' 127' ' ' LEU . 34.1 mm -61.83 -49.9 82.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.132 177.453 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 124' ' ' LYS . . . . . 0.814 ' HD3' HD22 ' B' ' 139' ' ' LEU . 4.2 mmmp? -58.91 -43.61 91.12 Favored 'General case' 0 C--O 1.213 -0.839 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.228 -178.862 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 125' ' ' LYS . . . . . 0.533 ' HD3' ' HA ' ' B' ' 125' ' ' LYS . 10.0 tppt? -50.51 -59.82 3.64 Favored 'General case' 0 N--CA 1.418 -2.056 0 O-C-N 123.721 0.638 . . . . 0.0 112.132 174.105 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 126' ' ' ILE . . . . . 0.557 HG23 HD12 ' A' ' 31' ' ' LEU . 1.7 mp -56.53 -47.63 81.61 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 CA-C-N 115.426 -0.806 . . . . 0.0 111.487 -176.282 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 127' ' ' LEU . . . . . 0.741 ' HG ' ' O ' ' B' ' 123' ' ' ILE . 2.2 pp -80.59 -19.59 45.2 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.306 -0.557 . . . . 0.0 112.103 -177.11 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 128' ' ' ASP . . . . . 0.493 ' HB2' ' O ' ' B' ' 124' ' ' LYS . 13.6 t70 -73.98 -31.16 62.86 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 179.367 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 129' ' ' SER . . . . . . . . . . . . . 84.1 p -52.63 -37.62 58.77 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.219 176.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 130' ' ' VAL . . . . . 0.55 HG22 HG13 ' B' ' 132' ' ' ILE . 7.5 m -103.95 5.85 10.35 Favored 'Isoleucine or valine' 0 C--O 1.232 0.137 0 CA-C-O 120.801 0.334 . . . . 0.0 111.536 179.324 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 131' ' ' GLY . . . . . . . . . . . . . . . 67.83 48.97 52.07 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 121.192 -0.528 . . . . 0.0 113.163 177.308 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 132' ' ' ILE . . . . . 0.55 HG13 HG22 ' B' ' 130' ' ' VAL . 8.7 mt -101.54 128.58 53.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-O 120.919 0.39 . . . . 0.0 110.963 178.229 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 133' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -67.47 136.45 54.65 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.187 -177.558 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 134' ' ' ALA . . . . . . . . . . . . . . . -152.57 143.61 23.07 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.182 -177.137 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 135' ' ' ASP . . . . . 0.719 ' HB2' ' HG3' ' B' ' 138' ' ' ARG . 34.1 m-20 -93.27 129.51 39.31 Favored 'General case' 0 C--O 1.251 1.149 0 CA-C-O 120.973 0.416 . . . . 0.0 110.12 174.772 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 136' ' ' ASP . . . . . 0.556 ' HA ' HD12 ' B' ' 139' ' ' LEU . 3.1 m-20 -71.22 -5.37 31.48 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-N 115.239 -0.892 . . . . 0.0 111.191 -169.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 137' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -100.53 -34.99 9.68 Favored 'General case' 0 N--CA 1.433 -1.282 0 C-N-CA 120.487 -0.485 . . . . 0.0 110.097 175.662 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 138' ' ' ARG . . . . . 0.719 ' HG3' ' HB2' ' B' ' 135' ' ' ASP . 43.7 mmt-85 -63.91 -46.23 85.74 Favored 'General case' 0 CA--C 1.503 -0.841 0 CA-C-O 122.118 0.961 . . . . 0.0 109.234 -176.323 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 139' ' ' LEU . . . . . 0.839 ' O ' HG12 ' B' ' 143' ' ' ILE . 0.3 OUTLIER -74.16 -34.39 63.8 Favored 'General case' 0 C--O 1.209 -1.037 0 CA-C-N 114.529 -1.214 . . . . 0.0 111.6 -178.828 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 140' ' ' ASN . . . . . 0.569 ' O ' ' HB ' ' B' ' 143' ' ' ILE . 60.8 t30 -65.02 -27.98 69.18 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 122.331 1.062 . . . . 0.0 108.703 177.538 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 141' ' ' LYS . . . . . 0.576 ' O ' ' HG2' ' B' ' 145' ' ' GLU . 30.0 tttp -67.89 -56.0 10.72 Favored 'General case' 0 N--CA 1.44 -0.959 0 CA-C-N 114.141 -1.39 . . . . 0.0 108.882 175.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 142' ' ' VAL . . . . . 0.887 HG13 ' HB2' ' B' ' 103' ' ' TYR . 8.5 p -57.93 -31.57 41.22 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.236 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.449 178.827 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 143' ' ' ILE . . . . . 0.839 HG12 ' O ' ' B' ' 139' ' ' LEU . 28.1 mm -51.99 -67.41 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.513 -0.45 0 CA-C-O 121.151 0.501 . . . . 0.0 110.514 170.873 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 144' ' ' SER . . . . . . . . . . . . . 79.2 p -57.42 -25.42 59.58 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 114.96 -1.018 . . . . 0.0 111.89 -178.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 145' ' ' GLU . . . . . 0.576 ' HG2' ' O ' ' B' ' 141' ' ' LYS . 5.8 mm-40 -73.16 -46.47 50.6 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 120.898 0.38 . . . . 0.0 110.555 178.143 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 146' ' ' LEU . . . . . 0.707 ' HG ' ' O ' ' B' ' 142' ' ' VAL . 6.9 mt -82.63 -17.05 46.06 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.486 -0.324 . . . . 0.0 111.09 -176.593 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 147' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -56.54 111.84 1.11 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.207 0.527 . . . . 0.0 111.426 -175.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . 111.72 7.76 23.43 Favored Glycine 0 CA--C 1.519 0.33 0 CA-C-N 115.527 -0.76 . . . . 0.0 112.806 -179.285 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 149' ' ' LYS . . . . . 0.501 ' HE2' ' O ' ' B' ' 146' ' ' LEU . 0.8 OUTLIER -104.19 167.88 9.47 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.1 0.476 . . . . 0.0 111.038 -179.749 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 150' ' ' ASN . . . . . 0.513 ' O ' HG22 ' B' ' 154' ' ' VAL . 0.9 OUTLIER -103.93 91.01 3.79 Favored 'General case' 0 CA--C 1.511 -0.545 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 176.788 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 151' ' ' ILE . . . . . 0.764 HG13 HD12 ' B' ' 108' ' ' LEU . 1.8 mp -41.9 -62.87 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 O-C-N 124.376 1.048 . . . . 0.0 113.247 -168.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 152' ' ' GLU . . . . . 0.653 ' HG3' HD11 ' B' ' 112' ' ' LEU . 3.0 mp0 -57.42 -33.22 67.67 Favored 'General case' 0 C--O 1.219 -0.532 0 N-CA-C 111.839 0.311 . . . . 0.0 111.839 -174.487 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 153' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -78.52 -33.4 48.01 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.609 179.498 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 154' ' ' VAL . . . . . 0.807 ' HB ' HD11 ' B' ' 155' ' ' ILE . 58.2 t -54.84 -46.31 75.17 Favored 'Isoleucine or valine' 0 C--O 1.233 0.185 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 172.253 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 155' ' ' ILE . . . . . 0.859 ' HB ' ' HH ' ' A' ' 11' ' ' TYR . 2.3 mp -106.71 33.84 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 114.97 -1.014 . . . . 0.0 110.448 -179.314 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . -101.75 2.99 39.1 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 167.526 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 157' ' ' GLN . . . . . . . . . . . . . 46.4 mt-30 -138.93 -1.42 1.79 Allowed 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 113.55 -1.659 . . . . 0.0 109.844 173.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 158' ' ' GLY . . . . . . . . . . . . . . . -139.62 46.34 0.96 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.379 -0.915 . . . . 0.0 114.575 -167.274 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 159' ' ' ILE . . . . . 0.817 ' HB ' HG13 ' A' ' 60' ' ' ILE . 1.8 mp -61.59 -15.56 13.43 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 CA-C-O 122.039 0.923 . . . . 0.0 109.733 173.584 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 160' ' ' GLY . . . . . . . . . . . . . . . -129.49 144.57 15.62 Favored Glycine 0 N--CA 1.437 -1.29 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 178.509 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 161' ' ' LYS . . . . . 0.809 ' HZ2' ' HB2' ' B' ' 161' ' ' LYS . 0.1 OUTLIER 51.8 41.83 29.53 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.777 0.289 . . . . 0.0 111.395 -168.343 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 162' ' ' LEU . . . . . 0.767 ' HB3' HG12 ' B' ' 104' ' ' VAL . 9.8 mp -29.12 123.39 0.13 Allowed 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 113.2 0.815 . . . . 0.0 113.2 172.302 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 163' ' ' ALA . . . . . . . . . . . . . . . 61.05 -68.58 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 O-C-N 124.383 1.052 . . . . 0.0 113.491 -178.542 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 164' ' ' SER . . . . . . . . . . . . . 7.1 t -103.5 132.22 49.95 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-O 121.554 0.693 . . . . 0.0 112.173 -174.623 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 165' ' ' VAL . . . . . . . . . . . . . 23.0 t -114.37 132.48 22.78 Favored Pre-proline 0 C--N 1.317 -0.818 0 CA-C-N 114.763 -1.108 . . . . 0.0 109.217 178.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 166' ' ' PRO . . . . . 0.595 ' HD2' ' HG2' ' B' ' 161' ' ' LYS . 19.6 Cg_exo -12.51 116.44 0.01 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.369 1 C-N-CA 127.155 5.237 . . . . 0.0 117.009 -175.772 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 167' ' ' ALA . . . . . . . . . . . . . . . -130.96 66.41 1.53 Allowed 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 114.862 -1.063 . . . . 0.0 110.13 -179.239 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 168' ' ' GLY . . . . . . . . . . . . . . . 119.79 57.2 0.25 Allowed Glycine 0 N--CA 1.446 -0.654 0 CA-C-N 115.674 -0.693 . . . . 0.0 111.626 -176.29 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 169' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.984 0 CA-C-O 118.537 -1.146 . . . . 0.0 111.763 -179.049 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.707 ' HE2' ' HA ' ' A' ' 1' ' ' MET . 0.8 OUTLIER . . . . . 0 N--CA 1.481 1.116 0 N-CA-C 110.108 -0.33 . . . . 0.0 110.108 . . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.445 ' CB ' HD11 ' A' ' 7' ' ' LEU . . . 176.35 149.38 0.12 Allowed 'General case' 0 CA--C 1.508 -0.64 0 CA-C-N 115.45 -0.795 . . . . 0.0 109.21 178.618 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.742 ' HB2' ' HG3' ' A' ' 6' ' ' GLU . 6.2 m -83.27 119.16 24.24 Favored 'General case' 0 N--CA 1.439 -1.023 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 167.673 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.9 HG13 ' HG ' ' B' ' 112' ' ' LEU . 2.2 t -52.93 -28.22 13.64 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.78 0 CA-C-N 115.294 -0.866 . . . . 0.0 112.073 -179.573 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.727 ' HB3' ' HA ' ' A' ' 39' ' ' VAL . 71.7 m -68.45 -43.99 75.85 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.229 0.538 . . . . 0.0 109.784 175.723 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.742 ' HG3' ' HB2' ' A' ' 3' ' ' SER . 30.2 mt-10 -68.21 -49.04 63.44 Favored 'General case' 0 N--CA 1.444 -0.726 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 -178.209 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.723 ' HA ' HD12 ' A' ' 10' ' ' ILE . 2.9 tp -58.34 -35.01 71.27 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 114.443 -1.253 . . . . 0.0 111.949 175.396 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.55 ' HB1' HD22 ' B' ' 112' ' ' LEU . . . -68.37 -37.25 80.26 Favored 'General case' 0 CA--C 1.512 -0.484 0 CA-C-O 121.04 0.448 . . . . 0.0 110.786 179.054 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.501 ' HB2' HG11 ' A' ' 39' ' ' VAL . 4.6 t -67.35 -40.79 85.86 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 178.633 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.723 HD12 ' HA ' ' A' ' 7' ' ' LEU . 73.8 mt -48.92 -55.76 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.685 0 CA-C-N 113.896 -1.502 . . . . 0.0 110.051 171.896 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.886 ' HH ' ' HB ' ' B' ' 155' ' ' ILE . 23.9 m-85 -66.36 -41.46 89.46 Favored 'General case' 0 C--O 1.22 -0.455 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.557 -174.103 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 15.6 m -54.01 -42.09 68.7 Favored 'General case' 0 C--O 1.242 0.692 0 CA-C-O 121.489 0.661 . . . . 0.0 109.27 175.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -68.67 -28.94 67.32 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.39 176.154 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.659 ' HB2' ' HA ' ' A' ' 11' ' ' TYR . 0.2 OUTLIER -67.25 -55.58 13.41 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.49 179.34 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.413 HG12 ' O ' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -55.72 -43.84 74.99 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 176.889 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.761 HD12 HG12 ' A' ' 21' ' ' VAL . 3.8 tp -57.69 -44.27 85.73 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.501 177.75 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 25.1 t60 -75.73 -13.43 60.31 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.258 -0.883 . . . . 0.0 111.726 178.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.538 ' OD2' ' HA ' ' B' ' 102' ' ' ARG . 12.1 t0 -69.09 -42.31 76.34 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.247 0.546 . . . . 0.0 109.61 179.377 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -100.08 -7.04 25.4 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 122.032 0.92 . . . . 0.0 109.226 177.014 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 52.29 56.55 7.56 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-N 113.784 -1.553 . . . . 0.0 110.262 -175.286 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.761 HG12 HD12 ' A' ' 16' ' ' LEU . 6.1 p -106.21 159.45 6.18 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.679 0 CA-C-N 114.13 -1.396 . . . . 0.0 108.814 -178.825 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 82.2 p -49.8 139.1 13.74 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 114.193 1.183 . . . . 0.0 114.193 -169.48 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.451 HG22 HD21 ' A' ' 16' ' ' LEU . 63.1 t -103.77 111.86 35.06 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-N 114.216 -1.356 . . . . 0.0 110.986 -177.094 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.491 ' OG1' ' HE2' ' A' ' 27' ' ' LYS . 77.3 p -135.66 157.83 45.89 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 175.575 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -57.49 -41.23 80.29 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 120.71 -0.396 . . . . 0.0 110.094 -177.434 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -65.16 -29.92 70.8 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.08 178.344 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.522 ' HG2' HD13 ' A' ' 16' ' ' LEU . 3.8 tppt? -66.53 -53.0 39.72 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 179.844 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 66.4 mt -60.41 -39.69 81.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 114.394 -1.275 . . . . 0.0 110.491 178.321 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 -61.97 -36.01 80.16 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.74 176.045 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.67 -45.59 92.1 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-N 116.552 -0.294 . . . . 0.0 110.484 177.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.547 ' HB3' HD23 ' B' ' 109' ' ' LEU . 1.3 mm? -58.35 -51.15 71.02 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 121.085 0.469 . . . . 0.0 110.13 173.838 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.55 HG23 ' O ' ' A' ' 37' ' ' VAL . 57.1 mt -48.28 -50.86 10.99 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 CA-C-N 114.873 -1.058 . . . . 0.0 111.646 178.686 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -69.82 -40.08 76.13 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.079 -0.51 . . . . 0.0 112.03 -176.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -64.2 -45.54 87.86 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-O 120.918 0.39 . . . . 0.0 111.093 -177.384 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.437 ' HB3' HG12 ' A' ' 37' ' ' VAL . . . -74.84 -34.82 62.36 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.429 178.669 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 96.96 18.48 29.36 Favored Glycine 0 N--CA 1.448 -0.554 0 CA-C-N 115.379 -0.828 . . . . 0.0 112.019 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.86 ' HB ' ' HA3' ' B' ' 113' ' ' GLY . 5.5 p -121.04 121.92 66.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 121.422 0.63 . . . . 0.0 111.059 -173.061 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 62.9 t30 -99.33 157.33 16.48 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.049 -0.978 . . . . 0.0 111.035 -169.308 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.727 ' HA ' ' HB3' ' A' ' 5' ' ' SER . 94.6 t -125.28 161.66 29.19 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.759 0 CA-C-N 115.056 -0.974 . . . . 0.0 110.937 -170.214 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.53 ' HB3' ' HD1' ' A' ' 43' ' ' TRP . 3.9 tp10 -67.65 105.41 0.9 Allowed Pre-proline 0 N--CA 1.441 -0.884 0 N-CA-C 107.756 -1.201 . . . . 0.0 107.756 169.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.519 ' C ' ' HD2' ' A' ' 44' ' ' PRO . 86.0 Cg_exo -49.54 -29.73 19.58 Favored 'Trans proline' 0 C--O 1.252 1.195 0 C-N-CA 123.602 2.868 . . . . 0.0 115.675 -163.767 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -60.76 -27.65 68.13 Favored 'General case' 0 C--N 1.333 -0.14 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 177.647 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . 0.53 ' HD1' ' HB3' ' A' ' 40' ' ' GLU . 9.6 m95 -65.08 -59.41 10.09 Favored Pre-proline 0 C--O 1.204 -1.337 0 CA-C-O 118.303 -0.856 . . . . 0.0 111.147 176.416 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.519 ' HD2' ' C ' ' A' ' 41' ' ' PRO . 83.3 Cg_exo -45.52 -44.46 17.0 Favored 'Trans proline' 0 C--N 1.359 1.086 0 C-N-CA 121.652 1.568 . . . . 0.0 111.913 174.622 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -60.4 -60.56 8.34 Favored Glycine 0 CA--C 1.525 0.68 0 C-N-CA 120.176 -1.012 . . . . 0.0 112.322 175.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 12.7 tp -65.79 -21.92 66.53 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.136 0.574 . . . . 0.0 112.11 -177.057 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.713 ' HD2' HD11 ' A' ' 51' ' ' LEU . 2.6 m-85 -74.72 -45.07 46.59 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 176.625 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.417 ' HA ' HG12 ' A' ' 23' ' ' VAL . . . -64.8 -30.23 71.22 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-O 121.821 0.82 . . . . 0.0 108.864 177.602 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 9.6 mmmt -66.27 -58.0 6.32 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 114.276 -1.329 . . . . 0.0 111.713 172.167 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.471 ' O ' HG21 ' A' ' 54' ' ' VAL . . . -76.03 -39.1 56.38 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 113.457 0.91 . . . . 0.0 113.457 -168.786 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.713 HD11 ' HD2' ' A' ' 47' ' ' PHE . 12.3 mt -68.85 -4.51 16.57 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 117.922 0.328 . . . . 0.0 111.7 -173.641 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -95.67 9.68 39.45 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.138 0.494 . . . . 0.0 110.296 174.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -143.62 -48.2 0.29 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.505 -178.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.471 HG21 ' O ' ' A' ' 50' ' ' ALA . 9.2 m -94.77 -169.55 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.282 179.851 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 11.3 m120 -121.59 -175.94 3.2 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.962 0.411 . . . . 0.0 111.3 178.199 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.596 HD13 HD22 ' A' ' 14' ' ' LEU . 3.0 tp -75.06 -28.46 20.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.356 -179.669 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -69.84 -15.5 71.49 Favored Glycine 0 N--CA 1.447 -0.571 0 N-CA-C 110.613 -0.995 . . . . 0.0 110.613 175.461 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 16.5 m -78.02 -19.61 54.05 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-O 121.174 0.511 . . . . 0.0 110.201 179.594 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 25.0 mt -64.16 -30.47 71.53 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.589 179.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.669 ' CD1' ' HB ' ' B' ' 159' ' ' ILE . 0.4 OUTLIER -67.11 -26.65 37.02 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-N 115.147 -0.933 . . . . 0.0 109.955 176.574 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 0.466 ' C ' ' H ' ' A' ' 63' ' ' VAL . 23.8 t -82.07 -45.12 15.66 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-N 115.168 -0.924 . . . . 0.0 110.065 178.746 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 10.1 p30 54.53 -13.83 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 116.247 1.944 . . . . 0.0 116.247 173.675 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.466 ' H ' ' C ' ' A' ' 61' ' ' CYS . 31.0 m -82.6 34.62 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-O 121.27 0.557 . . . . 0.0 111.597 179.369 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 57.94 62.94 5.73 Favored Glycine 0 N--CA 1.451 -0.301 0 CA-C-N 115.474 -0.785 . . . . 0.0 112.787 178.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -84.24 52.65 2.39 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.169 0.509 . . . . 0.0 110.846 -178.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -161.78 32.69 0.34 Allowed Glycine 0 N--CA 1.447 -0.602 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.802 -179.062 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -176.96 73.75 0.08 OUTLIER Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 120.684 -0.77 . . . . 0.0 111.975 -179.679 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -60.41 -52.26 4.21 Favored 'Trans proline' 0 C--O 1.233 0.271 0 C-N-CA 122.793 2.329 . . . . 0.0 112.267 -179.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.905 0 CA-C-O 118.658 -0.687 . . . . 0.0 110.411 179.211 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.971 0 CA-C-O 120.637 0.256 . . . . 0.0 110.493 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 101' ' ' MET . . . . . 0.593 ' HE2' ' HB3' ' B' ' 105' ' ' ALA . 4.3 ttt -137.57 129.22 28.45 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 111.884 0.327 . . . . 0.0 111.884 179.579 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 102' ' ' ARG . . . . . 0.538 ' HA ' ' OD2' ' A' ' 18' ' ' ASP . 4.7 ptp180 -170.02 125.9 0.81 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.303 166.713 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 103' ' ' TYR . . . . . 0.655 ' HB2' HG12 ' B' ' 142' ' ' VAL . 47.6 m-85 71.66 -25.66 0.17 Allowed 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.97 0.908 . . . . 0.0 112.087 177.762 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 104' ' ' VAL . . . . . 0.648 HG12 HD21 ' B' ' 108' ' ' LEU . 82.9 t -45.42 -44.34 3.76 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.256 0 CA-C-O 121.515 0.674 . . . . 0.0 110.404 175.777 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 105' ' ' ALA . . . . . 0.654 ' CB ' ' HB3' ' A' ' 14' ' ' LEU . . . -67.41 -38.78 85.16 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 114.925 -1.034 . . . . 0.0 111.559 -174.853 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 106' ' ' SER . . . . . 0.771 ' HB2' HG23 ' B' ' 123' ' ' ILE . 1.8 m -60.79 -38.44 85.34 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-O 121.784 0.802 . . . . 0.0 109.189 175.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 107' ' ' TYR . . . . . 0.738 ' O ' ' HG2' ' B' ' 118' ' ' PRO . 38.4 t80 -63.27 -49.33 74.52 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-N 114.016 -1.447 . . . . 0.0 108.706 178.814 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 108' ' ' LEU . . . . . 0.653 ' HG ' HD12 ' B' ' 155' ' ' ILE . 0.0 OUTLIER -56.4 -50.49 71.44 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.164 -0.926 . . . . 0.0 111.711 178.772 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 109' ' ' LEU . . . . . 0.743 HD11 ' HB2' ' A' ' 11' ' ' TYR . 7.8 tp -53.93 -54.91 32.25 Favored 'General case' 0 C--O 1.246 0.906 0 CA-C-O 121.4 0.619 . . . . 0.0 111.011 178.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -57.05 -39.14 74.3 Favored 'General case' 0 C--O 1.22 -0.458 0 CA-C-N 114.975 -1.011 . . . . 0.0 110.423 -178.259 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 111' ' ' ALA . . . . . 0.735 ' HA ' ' O ' ' B' ' 115' ' ' ASN . . . -77.83 -19.54 54.74 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.706 -178.915 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 112' ' ' LEU . . . . . 0.9 ' HG ' HG13 ' A' ' 4' ' ' VAL . 4.4 tp -77.19 -40.0 46.78 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.418 -179.047 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 113' ' ' GLY . . . . . 0.86 ' HA3' ' HB ' ' A' ' 37' ' ' VAL . . . -144.95 44.68 0.88 Allowed Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 118.819 -1.658 . . . . 0.0 114.354 -176.75 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 114' ' ' GLY . . . . . . . . . . . . . . . -166.25 -49.21 0.02 OUTLIER Glycine 0 N--CA 1.444 -0.792 0 C-N-CA 119.214 -1.47 . . . . 0.0 113.139 175.489 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 115' ' ' ASN . . . . . 0.735 ' O ' ' HA ' ' B' ' 111' ' ' ALA . 10.0 t30 -155.47 113.63 3.43 Favored 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 109.227 -0.656 . . . . 0.0 109.227 -171.757 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 4.0 m -79.97 26.01 0.35 Allowed 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 122.152 0.977 . . . . 0.0 111.02 -168.33 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 117' ' ' SER . . . . . 0.523 ' N ' ' HD3' ' B' ' 118' ' ' PRO . 8.9 t -172.31 69.82 0.43 Allowed Pre-proline 0 C--N 1.312 -1.022 0 CA-C-N 113.789 -1.55 . . . . 0.0 108.346 178.668 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 118' ' ' PRO . . . . . 0.738 ' HG2' ' O ' ' B' ' 107' ' ' TYR . 33.3 Cg_exo -62.07 157.44 44.25 Favored 'Trans proline' 0 CA--C 1.511 -0.651 1 C-N-CA 125.605 4.203 . . . . 0.0 112.155 -173.934 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 119' ' ' SER . . . . . 0.544 ' O ' HG12 ' B' ' 123' ' ' ILE . 14.7 m -131.73 -174.98 3.57 Favored 'General case' 0 C--N 1.317 -0.828 0 C-N-CA 119.715 -0.794 . . . . 0.0 111.842 178.784 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 120' ' ' ALA . . . . . 0.672 ' HB3' HD13 ' B' ' 139' ' ' LEU . . . -63.27 -40.77 98.33 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.719 0.771 . . . . 0.0 109.611 -165.177 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 121' ' ' LYS . . . . . . . . . . . . . 1.8 mptm? -62.71 -36.83 84.22 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 114.078 -1.419 . . . . 0.0 110.86 177.304 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 122' ' ' ASP . . . . . . . . . . . . . 44.8 m-20 -70.42 -40.13 74.01 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 120.182 -0.607 . . . . 0.0 109.55 -178.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 123' ' ' ILE . . . . . 0.771 HG23 ' HB2' ' B' ' 106' ' ' SER . 23.3 mm -60.19 -42.94 92.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.52 175.581 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 124' ' ' LYS . . . . . 0.817 ' HD3' HD22 ' B' ' 139' ' ' LEU . 2.2 mmmp? -59.02 -39.73 82.84 Favored 'General case' 0 CA--C 1.504 -0.819 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 -178.875 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 125' ' ' LYS . . . . . . . . . . . . . 86.8 mttt -56.81 -61.69 2.26 Favored 'General case' 0 CA--C 1.489 -1.382 0 C-N-CA 119.274 -0.97 . . . . 0.0 110.841 173.653 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 126' ' ' ILE . . . . . 0.478 HG21 HD11 ' A' ' 31' ' ' LEU . 1.8 mp -57.44 -36.99 55.26 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.118 0 CA-C-N 114.282 -1.326 . . . . 0.0 110.951 -166.855 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 127' ' ' LEU . . . . . 0.752 ' HG ' ' O ' ' B' ' 123' ' ' ILE . 1.2 pp -80.68 -39.29 27.47 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.172 -0.611 . . . . 0.0 111.648 178.126 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 128' ' ' ASP . . . . . 0.448 ' N ' HD13 ' B' ' 127' ' ' LEU . 9.8 m-20 -70.0 -26.39 64.05 Favored 'General case' 0 N--CA 1.466 0.331 0 O-C-N 122.096 -0.377 . . . . 0.0 111.109 -179.438 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 129' ' ' SER . . . . . . . . . . . . . 84.4 p -60.11 -33.86 72.69 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.72 -177.169 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 130' ' ' VAL . . . . . . . . . . . . . 4.7 m -99.11 -34.16 4.3 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.398 175.679 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 131' ' ' GLY . . . . . . . . . . . . . . . 122.11 45.01 0.34 Allowed Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.233 179.664 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 132' ' ' ILE . . . . . . . . . . . . . 24.4 mt -112.17 136.32 48.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 179.424 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 133' ' ' GLU . . . . . . . . . . . . . 26.9 mm-40 -89.86 154.65 19.72 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.235 0.541 . . . . 0.0 111.743 -174.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 134' ' ' ALA . . . . . 0.509 ' HB1' HD22 ' B' ' 127' ' ' LEU . . . -153.21 145.26 23.74 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.078 -0.964 . . . . 0.0 112.049 -172.771 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 135' ' ' ASP . . . . . 0.664 ' HB2' ' CG ' ' B' ' 138' ' ' ARG . 53.9 m-20 -93.91 133.52 37.25 Favored 'General case' 0 C--O 1.251 1.161 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 170.728 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 136' ' ' ASP . . . . . 0.69 ' HA ' HD12 ' B' ' 139' ' ' LEU . 10.1 p-10 -72.03 -5.15 33.03 Favored 'General case' 0 CA--C 1.513 -0.464 0 CA-C-N 115.109 -0.951 . . . . 0.0 111.006 -169.654 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 137' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -101.04 -30.74 11.44 Favored 'General case' 0 N--CA 1.433 -1.293 0 C-N-CA 120.225 -0.59 . . . . 0.0 110.286 173.018 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 138' ' ' ARG . . . . . 0.664 ' CG ' ' HB2' ' B' ' 135' ' ' ASP . 36.3 mmt180 -66.22 -44.89 82.53 Favored 'General case' 0 CA--C 1.503 -0.855 0 CA-C-O 121.59 0.71 . . . . 0.0 109.86 -175.849 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 139' ' ' LEU . . . . . 0.817 HD22 ' HD3' ' B' ' 124' ' ' LYS . 0.3 OUTLIER -74.55 -33.79 62.81 Favored 'General case' 0 C--N 1.313 -0.981 0 C-N-CA 119.53 -0.868 . . . . 0.0 111.238 178.271 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 140' ' ' ASN . . . . . . . . . . . . . 58.8 t30 -68.97 -27.61 65.88 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 -176.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 141' ' ' LYS . . . . . 0.649 ' HG3' ' O ' ' B' ' 138' ' ' ARG . 0.0 OUTLIER -86.2 -38.25 17.85 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.02 -0.991 . . . . 0.0 110.46 -177.944 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 142' ' ' VAL . . . . . 0.655 HG12 ' HB2' ' B' ' 103' ' ' TYR . 11.1 p -60.99 -44.8 98.95 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.636 0 N-CA-C 108.82 -0.808 . . . . 0.0 108.82 175.679 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 143' ' ' ILE . . . . . 0.695 HD13 ' CG1' ' B' ' 123' ' ' ILE . 16.1 mt -58.9 -45.61 91.71 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.88 0 C-N-CA 123.752 0.821 . . . . 0.0 112.36 171.219 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 144' ' ' SER . . . . . . . . . . . . . 30.9 t -52.82 -34.77 55.38 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.983 177.188 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 145' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -86.26 -40.49 15.48 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.369 177.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 146' ' ' LEU . . . . . 0.557 ' HB3' ' CZ ' ' B' ' 107' ' ' TYR . 2.6 mm? -61.72 -41.25 97.38 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 123.557 0.743 . . . . 0.0 112.388 177.878 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 147' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -45.84 124.3 5.16 Favored 'General case' 0 C--O 1.233 0.202 0 O-C-N 123.906 0.754 . . . . 0.0 111.788 -171.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . 86.96 59.2 1.8 Allowed Glycine 0 N--CA 1.447 -0.589 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.301 -175.544 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 149' ' ' LYS . . . . . 0.519 ' HB2' ' O ' ' B' ' 146' ' ' LEU . 3.3 tppt? -143.25 160.22 40.88 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 -177.538 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 150' ' ' ASN . . . . . 0.586 ' O ' HG22 ' B' ' 154' ' ' VAL . 17.5 m120 -105.33 88.72 2.92 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 176.901 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 151' ' ' ILE . . . . . 0.628 HG12 ' HB3' ' B' ' 111' ' ' ALA . 1.7 mp -42.92 -61.46 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 114.694 -1.139 . . . . 0.0 113.445 -168.59 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 152' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -54.6 -41.24 69.71 Favored 'General case' 0 C--O 1.216 -0.687 0 N-CA-C 112.271 0.471 . . . . 0.0 112.271 -174.038 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 153' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -74.78 -30.77 61.55 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.816 -0.354 . . . . 0.0 110.589 -177.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 154' ' ' VAL . . . . . 0.907 ' HB ' HD11 ' B' ' 155' ' ' ILE . 44.9 t -56.01 -48.58 78.59 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 CA-C-O 121.86 0.838 . . . . 0.0 109.141 171.077 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 155' ' ' ILE . . . . . 0.907 HD11 ' HB ' ' B' ' 154' ' ' VAL . 1.8 mp -109.15 44.1 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.096 -0.956 . . . . 0.0 110.961 -178.479 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 156' ' ' ALA . . . . . 0.544 ' CB ' ' HE3' ' A' ' 1' ' ' MET . . . -112.65 3.02 16.39 Favored 'General case' 0 C--N 1.306 -1.283 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 167.428 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 157' ' ' GLN . . . . . . . . . . . . . 24.3 mt-30 -138.51 -5.02 1.6 Allowed 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 113.5 -1.682 . . . . 0.0 110.002 176.276 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 158' ' ' GLY . . . . . 0.54 ' O ' HD13 ' B' ' 162' ' ' LEU . . . -137.85 44.9 1.09 Allowed Glycine 0 C--O 1.223 -0.539 0 C-N-CA 120.153 -1.023 . . . . 0.0 113.86 -172.503 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 159' ' ' ILE . . . . . 0.669 ' HB ' ' CD1' ' A' ' 60' ' ' ILE . 1.8 mp -57.62 -28.49 32.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 CA-C-O 121.015 0.436 . . . . 0.0 110.983 175.7 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 160' ' ' GLY . . . . . . . . . . . . . . . -96.92 -54.78 1.26 Allowed Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.524 -0.846 . . . . 0.0 112.944 -179.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 161' ' ' LYS . . . . . 0.434 ' HZ3' ' HB2' ' B' ' 161' ' ' LYS . 0.1 OUTLIER -65.75 -34.47 78.26 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 113.905 1.076 . . . . 0.0 113.905 -177.652 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 162' ' ' LEU . . . . . 0.54 HD13 ' O ' ' B' ' 158' ' ' GLY . 5.3 mp 45.03 -162.7 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 113.914 1.079 . . . . 0.0 113.914 -171.295 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 163' ' ' ALA . . . . . 0.51 ' H ' HG13 ' B' ' 104' ' ' VAL . . . 50.56 -90.85 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.168 0 C-N-CA 124.191 0.996 . . . . 0.0 113.257 -179.776 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 164' ' ' SER . . . . . . . . . . . . . 7.3 p -144.39 111.82 6.04 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.202 0.525 . . . . 0.0 110.748 179.317 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 165' ' ' VAL . . . . . 0.458 ' HA ' ' HD2' ' B' ' 166' ' ' PRO . 2.2 t -106.34 123.67 38.17 Favored Pre-proline 0 C--N 1.322 -0.62 0 CA-C-N 115.692 -0.686 . . . . 0.0 109.265 178.002 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 166' ' ' PRO . . . . . 0.458 ' HD2' ' HA ' ' B' ' 165' ' ' VAL . 45.0 Cg_exo -17.1 110.65 0.01 OUTLIER 'Trans proline' 0 N--CA 1.44 -1.671 1 C-N-CA 126.964 5.11 . . . . 0.0 115.727 -178.328 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 167' ' ' ALA . . . . . . . . . . . . . . . -115.42 -24.33 8.43 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.509 -176.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 168' ' ' GLY . . . . . . . . . . . . . . . -129.75 -40.78 0.26 Allowed Glycine 0 N--CA 1.446 -0.653 0 N-CA-C 111.169 -0.772 . . . . 0.0 111.169 175.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 169' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.934 0 CA-C-O 118.635 -1.092 . . . . 0.0 111.363 176.269 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.582 ' HA ' ' HB2' ' B' ' 156' ' ' ALA . 23.6 ttt . . . . . 0 N--CA 1.479 1.011 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.576 ' HB3' HD13 ' A' ' 7' ' ' LEU . . . -130.75 157.49 42.68 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.087 -177.831 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.576 ' HB2' ' HG3' ' A' ' 6' ' ' GLU . 14.5 m -69.57 139.33 53.71 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 170.134 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.822 HG12 ' HG ' ' B' ' 112' ' ' LEU . 2.4 t -58.04 -23.72 22.02 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 CA-C-N 115.005 -0.998 . . . . 0.0 111.693 -177.084 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.645 ' HB2' ' HA ' ' A' ' 39' ' ' VAL . 11.4 p -70.5 -53.92 14.27 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.855 0.836 . . . . 0.0 109.044 174.662 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.576 ' HG3' ' HB2' ' A' ' 3' ' ' SER . 32.1 mt-10 -56.29 -47.74 78.04 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 114.862 -1.063 . . . . 0.0 109.899 177.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.644 ' HA ' HD11 ' A' ' 10' ' ' ILE . 3.6 tp -61.22 -39.73 91.35 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.522 178.791 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -60.94 -37.72 83.32 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 121.162 0.506 . . . . 0.0 110.937 176.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.64 ' HB2' HG11 ' A' ' 39' ' ' VAL . 7.4 t -69.94 -43.09 72.31 Favored 'General case' 0 C--O 1.24 0.587 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.644 HD11 ' HA ' ' A' ' 7' ' ' LEU . 72.6 mt -46.2 -56.4 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 CA-C-N 113.993 -1.458 . . . . 0.0 109.715 171.703 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.969 ' HH ' ' HB ' ' B' ' 155' ' ' ILE . 23.5 m-85 -63.33 -40.03 96.17 Favored 'General case' 0 C--O 1.216 -0.689 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.448 -175.413 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.596 ' HB2' HG21 ' A' ' 28' ' ' ILE . 19.4 m -56.76 -41.49 77.71 Favored 'General case' 0 C--O 1.24 0.593 0 CA-C-O 121.482 0.658 . . . . 0.0 109.403 179.005 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -65.85 -34.32 77.87 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.124 174.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.774 HD12 ' HE2' ' B' ' 101' ' ' MET . 0.3 OUTLIER -63.01 -53.37 54.94 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.437 179.719 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.773 HD13 HD11 ' B' ' 109' ' ' LEU . 0.0 OUTLIER -58.9 -37.6 68.04 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.542 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 178.146 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.518 HD21 ' HA ' ' A' ' 23' ' ' VAL . 1.6 tp -58.88 -35.04 72.35 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.429 175.805 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . 0.491 ' O ' ' HG2' ' A' ' 20' ' ' GLU . 80.4 m-70 -73.76 -16.5 61.17 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 112.776 0.658 . . . . 0.0 112.776 175.243 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.476 ' OD2' ' HG2' ' B' ' 102' ' ' ARG . 6.8 t70 -59.07 -46.96 86.94 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 121.063 0.459 . . . . 0.0 109.829 178.422 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.596 ' HB2' HG23 ' B' ' 132' ' ' ILE . 29.9 t70 -100.91 -13.06 18.49 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.597 0.713 . . . . 0.0 109.397 177.407 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.491 ' HG2' ' O ' ' A' ' 17' ' ' HIS . 5.3 mm-40 63.18 44.56 5.63 Favored 'General case' 0 CA--C 1.519 -0.245 0 CA-C-N 114.496 -1.229 . . . . 0.0 109.689 -175.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.681 HG23 ' H ' ' A' ' 22' ' ' THR . 14.8 p -99.92 177.96 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.134 0 CA-C-N 114.518 -1.219 . . . . 0.0 110.233 -168.873 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.681 ' H ' HG23 ' A' ' 21' ' ' VAL . 23.6 p -49.62 137.88 14.9 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 113.874 1.065 . . . . 0.0 113.874 -174.372 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.518 ' HA ' HD21 ' A' ' 16' ' ' LEU . 46.2 t -109.7 109.07 27.03 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.177 0 CA-C-N 113.961 -1.472 . . . . 0.0 110.193 -179.546 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.584 ' OG1' ' HB2' ' A' ' 27' ' ' LYS . 69.1 p -136.08 158.23 44.91 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.158 178.284 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -52.87 -46.57 67.94 Favored 'General case' 0 C--N 1.32 -0.7 0 O-C-N 123.508 0.505 . . . . 0.0 110.094 178.09 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -67.39 -26.3 66.38 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.582 -0.735 . . . . 0.0 111.364 -179.543 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.584 ' HB2' ' OG1' ' A' ' 24' ' ' THR . 3.7 tppt? -70.67 -54.43 11.91 Favored 'General case' 0 C--O 1.24 0.597 0 CA-C-O 121.856 0.836 . . . . 0.0 108.823 -179.1 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.596 HG21 ' HB2' ' A' ' 12' ' ' SER . 77.7 mt -59.04 -43.17 88.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 114.253 -1.339 . . . . 0.0 110.349 178.498 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.462 ' HA ' ' HB ' ' A' ' 32' ' ' ILE . 6.1 m-20 -68.61 -26.53 65.4 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.212 178.705 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.62 -47.73 80.19 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 174.144 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.529 ' HG ' HG13 ' A' ' 15' ' ' ILE . 1.5 mm? -58.48 -51.54 69.43 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 121.296 0.569 . . . . 0.0 110.093 174.204 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.662 HG22 ' O ' ' A' ' 37' ' ' VAL . 64.7 mt -48.42 -48.46 13.97 Favored 'Isoleucine or valine' 0 C--O 1.243 0.747 0 CA-C-N 114.652 -1.158 . . . . 0.0 112.111 179.099 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 53.0 tptt -75.34 -43.6 49.79 Favored 'General case' 0 N--CA 1.434 -1.231 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.781 -175.619 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -62.21 -37.26 84.67 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.619 0.247 . . . . 0.0 110.855 -178.252 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -80.04 -36.83 35.15 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.03 0.443 . . . . 0.0 110.951 177.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 103.11 16.03 22.16 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.599 176.462 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.799 ' HB ' ' HA2' ' B' ' 113' ' ' GLY . 2.7 p -118.24 118.27 57.52 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.546 0 CA-C-O 121.385 0.612 . . . . 0.0 110.455 -177.642 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 -95.87 158.85 15.26 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 114.85 -1.068 . . . . 0.0 110.832 -169.169 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.645 ' HA ' ' HB2' ' A' ' 5' ' ' SER . 96.0 t -129.63 164.95 30.86 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.781 0 CA-C-N 115.055 -0.975 . . . . 0.0 110.442 -168.836 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.544 ' HB2' ' CD1' ' A' ' 43' ' ' TRP . 21.9 mt-10 -65.85 111.88 7.48 Favored Pre-proline 0 CA--C 1.489 -1.367 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 167.481 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.487 ' HD3' ' HA ' ' A' ' 40' ' ' GLU . 69.9 Cg_exo -54.41 -29.64 59.71 Favored 'Trans proline' 0 C--N 1.311 -1.421 0 C-N-CA 123.244 2.629 . . . . 0.0 113.713 -167.776 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 1.7 p90 -61.36 -29.07 69.68 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 175.332 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . 0.544 ' CD1' ' HB2' ' A' ' 40' ' ' GLU . 8.2 m95 -62.72 -60.31 10.23 Favored Pre-proline 0 C--O 1.208 -1.119 0 CA-C-O 118.474 -0.774 . . . . 0.0 110.677 176.646 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.448 ' HD2' ' C ' ' A' ' 41' ' ' PRO . 86.7 Cg_exo -47.15 -43.26 25.76 Favored 'Trans proline' 0 C--N 1.361 1.209 0 C-N-CA 121.894 1.73 . . . . 0.0 112.224 174.261 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -60.74 -59.18 10.64 Favored Glycine 0 CA--C 1.526 0.736 0 C-N-CA 120.124 -1.036 . . . . 0.0 112.444 176.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 4.5 tp -66.91 -26.57 66.93 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.467 0.707 . . . . 0.0 111.912 -176.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.776 ' HD2' HD11 ' A' ' 51' ' ' LEU . 2.9 m-85 -70.7 -46.67 62.69 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 175.615 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.503 ' HA ' HG12 ' A' ' 23' ' ' VAL . . . -62.66 -32.96 74.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.738 0.78 . . . . 0.0 109.115 179.198 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 9.2 mmmt -63.49 -62.77 1.45 Allowed 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 114.34 -1.3 . . . . 0.0 111.666 172.493 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -75.62 -31.68 59.99 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 113.709 1.003 . . . . 0.0 113.709 -167.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.776 HD11 ' HD2' ' A' ' 47' ' ' PHE . 13.1 mt -70.96 7.41 1.18 Allowed 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 112.843 0.683 . . . . 0.0 112.843 -174.136 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -101.88 5.26 40.88 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.49 0.662 . . . . 0.0 109.821 171.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 25.8 t30 -139.52 -52.8 0.54 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.421 -178.117 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 4.3 m -82.2 175.08 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.012 -179.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -113.69 165.31 12.66 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.253 176.511 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.773 HD11 HD21 ' A' ' 14' ' ' LEU . 3.9 tp -62.03 -25.18 36.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 120.838 0.352 . . . . 0.0 110.638 179.296 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -70.46 -14.95 72.53 Favored Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.816 -0.707 . . . . 0.0 111.548 177.048 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 20.4 t -78.04 -20.34 52.59 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-O 121.543 0.687 . . . . 0.0 109.549 179.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.55 HD13 HD13 ' A' ' 56' ' ' ILE . 19.8 mt -64.63 -29.63 70.64 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.434 179.515 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.775 HG13 ' HB ' ' B' ' 159' ' ' ILE . 0.2 OUTLIER -65.99 -16.28 20.34 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-N 114.737 -1.12 . . . . 0.0 110.613 179.358 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 14.4 t -95.68 -5.54 42.02 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.646 -178.116 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 7.4 m120 -65.05 -19.09 65.82 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-O 121.076 0.465 . . . . 0.0 111.188 -175.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 9.0 p -82.89 60.87 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 122.894 1.331 . . . . 0.0 109.351 173.727 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 154.15 -41.99 0.63 Allowed Glycine 0 N--CA 1.447 -0.571 0 CA-C-N 114.146 -1.388 . . . . 0.0 111.398 -177.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -96.6 64.15 2.12 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.339 0.59 . . . . 0.0 109.937 177.682 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 173.82 43.02 0.05 OUTLIER Glycine 0 N--CA 1.448 -0.537 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.966 178.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.452 ' HA3' ' HD3' ' A' ' 68' ' ' PRO . . . -116.32 -98.82 2.11 Favored Glycine 0 N--CA 1.446 -0.633 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.143 -179.389 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.452 ' HD3' ' HA3' ' A' ' 67' ' ' GLY . 10.4 Cg_exo -71.47 77.46 1.72 Allowed 'Trans proline' 0 C--O 1.235 0.336 0 C-N-CA 123.362 2.708 . . . . 0.0 112.745 -177.801 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.921 0 CA-C-O 118.41 -0.805 . . . . 0.0 109.747 175.981 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 100' ' ' ALA . . . . . 0.506 ' O ' HG23 ' B' ' 104' ' ' VAL . . . . . . . . 0 N--CA 1.478 0.943 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 101' ' ' MET . . . . . 0.774 ' HE2' HD12 ' A' ' 14' ' ' LEU . 1.4 tmt? -119.61 130.86 55.31 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 120.761 -0.375 . . . . 0.0 111.381 -177.12 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 102' ' ' ARG . . . . . 0.476 ' HG2' ' OD2' ' A' ' 18' ' ' ASP . 1.0 OUTLIER -172.52 -91.12 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.236 -0.893 . . . . 0.0 109.189 171.039 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 103' ' ' TYR . . . . . 0.641 ' HB2' HG12 ' B' ' 142' ' ' VAL . 51.7 m-85 -81.01 -10.08 59.75 Favored 'General case' 0 C--O 1.239 0.501 0 CA-C-O 121.102 0.477 . . . . 0.0 110.275 179.024 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 104' ' ' VAL . . . . . 0.594 ' O ' HD23 ' B' ' 108' ' ' LEU . 61.2 t -46.61 -47.21 7.44 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.534 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.088 174.798 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 105' ' ' ALA . . . . . 0.594 ' CB ' ' HB3' ' A' ' 14' ' ' LEU . . . -67.0 -38.1 85.38 Favored 'General case' 0 N--CA 1.443 -0.81 0 CA-C-N 114.826 -1.079 . . . . 0.0 111.425 -173.776 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 106' ' ' SER . . . . . 0.789 ' HB2' HG23 ' B' ' 123' ' ' ILE . 1.3 m -60.48 -38.83 85.54 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 121.815 0.817 . . . . 0.0 109.251 176.167 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 107' ' ' TYR . . . . . 0.785 ' HD2' HG12 ' B' ' 143' ' ' ILE . 32.5 t80 -63.07 -49.11 75.81 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 114.272 -1.331 . . . . 0.0 108.945 179.097 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 108' ' ' LEU . . . . . 0.672 HD12 HG13 ' B' ' 151' ' ' ILE . 0.0 OUTLIER -58.92 -49.2 78.7 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 114.987 -1.006 . . . . 0.0 111.337 179.029 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 109' ' ' LEU . . . . . 0.773 HD11 HD13 ' A' ' 15' ' ' ILE . 0.3 OUTLIER -55.42 -43.16 75.05 Favored 'General case' 0 CA--C 1.506 -0.746 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.613 178.671 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.5 -43.45 90.09 Favored 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 120.496 -0.482 . . . . 0.0 110.819 -178.514 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 111' ' ' ALA . . . . . 0.677 ' HA ' ' O ' ' B' ' 115' ' ' ASN . . . -64.71 -26.23 68.28 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.607 179.174 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 112' ' ' LEU . . . . . 0.822 ' HG ' HG12 ' A' ' 4' ' ' VAL . 3.5 mp -80.39 -38.32 30.52 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.245 -0.889 . . . . 0.0 110.244 174.128 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 113' ' ' GLY . . . . . 0.799 ' HA2' ' HB ' ' A' ' 37' ' ' VAL . . . -68.5 -17.21 70.47 Favored Glycine 0 N--CA 1.449 -0.497 0 CA-C-N 115.263 -0.88 . . . . 0.0 112.348 -176.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 114' ' ' GLY . . . . . . . . . . . . . . . 133.33 3.4 3.45 Favored Glycine 0 N--CA 1.437 -1.299 0 C-N-CA 120.394 -0.908 . . . . 0.0 113.168 176.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 115' ' ' ASN . . . . . 0.677 ' O ' ' HA ' ' B' ' 111' ' ' ALA . 47.9 t30 -118.69 86.27 2.51 Favored 'General case' 0 N--CA 1.441 -0.884 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 178.224 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 7.4 m -80.23 31.09 0.27 Allowed 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 122.488 1.137 . . . . 0.0 110.748 -167.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 117' ' ' SER . . . . . 0.563 ' N ' ' HD3' ' B' ' 118' ' ' PRO . 15.6 t -171.0 67.64 0.47 Allowed Pre-proline 0 C--N 1.309 -1.172 0 CA-C-N 113.12 -1.855 . . . . 0.0 107.971 178.248 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 118' ' ' PRO . . . . . 0.601 ' HD2' ' CZ ' ' B' ' 107' ' ' TYR . 31.9 Cg_exo -66.08 166.67 20.17 Favored 'Trans proline' 0 CA--C 1.515 -0.431 0 C-N-CA 125.275 3.983 . . . . 0.0 111.58 -174.72 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 119' ' ' SER . . . . . 0.653 ' O ' HG12 ' B' ' 123' ' ' ILE . 16.4 m -145.59 -178.51 6.13 Favored 'General case' 0 C--N 1.317 -0.809 0 C-N-CA 120.225 -0.59 . . . . 0.0 111.592 178.622 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 120' ' ' ALA . . . . . 0.528 ' HB2' ' CD1' ' B' ' 139' ' ' LEU . . . -62.68 -45.8 91.12 Favored 'General case' 0 CA--C 1.508 -0.639 0 CA-C-O 122.036 0.922 . . . . 0.0 110.173 -163.888 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 121' ' ' LYS . . . . . . . . . . . . . 12.9 mptt -66.72 -30.39 70.61 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 113.674 -1.603 . . . . 0.0 110.871 178.538 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 122' ' ' ASP . . . . . 0.424 ' O ' ' HB2' ' B' ' 125' ' ' LYS . 18.0 t0 -72.91 -39.09 66.61 Favored 'General case' 0 C--O 1.24 0.58 0 CA-C-O 122.004 0.907 . . . . 0.0 109.025 179.744 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 123' ' ' ILE . . . . . 0.789 HG23 ' HB2' ' B' ' 106' ' ' SER . 39.8 mm -59.93 -42.97 91.18 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.264 0 CA-C-N 114.549 -1.205 . . . . 0.0 109.657 173.236 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 124' ' ' LYS . . . . . 0.797 ' HD3' HD23 ' B' ' 139' ' ' LEU . 3.9 mmmp? -59.17 -42.52 90.97 Favored 'General case' 0 CA--C 1.504 -0.797 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.444 -178.784 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 125' ' ' LYS . . . . . 0.425 ' HA ' ' HD3' ' B' ' 125' ' ' LYS . 30.3 mmtt -50.38 -64.72 0.72 Allowed 'General case' 0 CA--C 1.502 -0.879 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 169.72 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 126' ' ' ILE . . . . . 0.461 HG23 HD11 ' A' ' 31' ' ' LEU . 1.7 mp -53.96 -44.41 61.58 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.857 0 CA-C-N 114.841 -1.072 . . . . 0.0 111.256 -170.217 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 127' ' ' LEU . . . . . 0.628 ' HG ' ' O ' ' B' ' 123' ' ' ILE . 3.6 pp -80.31 -24.74 39.74 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 -177.387 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 128' ' ' ASP . . . . . 0.426 ' N ' HD12 ' B' ' 127' ' ' LEU . 34.6 t70 -71.39 -27.51 63.37 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.584 -0.525 . . . . 0.0 109.584 178.831 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 129' ' ' SER . . . . . . . . . . . . . 17.4 t -60.92 -27.73 68.41 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.602 177.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 130' ' ' VAL . . . . . 0.45 HG22 HG13 ' B' ' 132' ' ' ILE . 3.7 m -107.38 -13.42 10.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 C-N-CA 120.813 -0.355 . . . . 0.0 111.483 177.521 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 131' ' ' GLY . . . . . . . . . . . . . . . 85.15 49.16 4.57 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 121.149 -0.548 . . . . 0.0 112.389 177.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 132' ' ' ILE . . . . . 0.596 HG23 ' HB2' ' A' ' 19' ' ' ASP . 11.5 mt -105.5 138.89 28.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-O 120.462 0.172 . . . . 0.0 111.078 -179.321 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 133' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -69.65 127.31 32.51 Favored 'General case' 0 CA--C 1.513 -0.456 0 CA-C-O 121.47 0.652 . . . . 0.0 111.478 -176.226 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 134' ' ' ALA . . . . . 0.493 ' HA ' ' OH ' ' B' ' 103' ' ' TYR . . . -136.21 141.04 43.96 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.15 -0.932 . . . . 0.0 111.473 -177.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 135' ' ' ASP . . . . . 0.79 ' HB2' ' HG3' ' B' ' 138' ' ' ARG . 49.3 m-20 -103.56 132.77 49.53 Favored 'General case' 0 C--O 1.25 1.094 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.024 172.892 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 136' ' ' ASP . . . . . 0.58 ' HA ' HD11 ' B' ' 139' ' ' LEU . 32.5 t70 -71.26 -7.92 50.2 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 115.095 -0.957 . . . . 0.0 111.236 -168.271 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 137' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -101.27 -30.16 11.67 Favored 'General case' 0 N--CA 1.438 -1.069 0 C-N-CA 120.017 -0.673 . . . . 0.0 110.653 174.555 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 138' ' ' ARG . . . . . 0.79 ' HG3' ' HB2' ' B' ' 135' ' ' ASP . 20.9 mmt180 -65.31 -45.92 82.43 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.793 0.806 . . . . 0.0 109.513 -176.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 139' ' ' LEU . . . . . 0.797 HD23 ' HD3' ' B' ' 124' ' ' LYS . 0.3 OUTLIER -74.2 -37.77 63.79 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 114.933 -1.03 . . . . 0.0 111.001 178.928 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 140' ' ' ASN . . . . . 0.608 ' N ' HD13 ' B' ' 139' ' ' LEU . 57.0 t30 -61.49 -31.25 71.23 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.687 0.756 . . . . 0.0 109.148 -179.773 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 141' ' ' LYS . . . . . 0.441 ' O ' ' HD3' ' B' ' 141' ' ' LYS . 4.3 tppt? -76.4 -50.06 15.14 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 114.585 -1.189 . . . . 0.0 110.43 179.279 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 142' ' ' VAL . . . . . 0.641 HG12 ' HB2' ' B' ' 103' ' ' TYR . 12.6 p -56.0 -44.48 78.51 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.581 0 C-N-CA 120.359 -0.537 . . . . 0.0 109.814 -179.716 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 143' ' ' ILE . . . . . 0.785 HG12 ' HD2' ' B' ' 107' ' ' TYR . 38.7 mt -58.55 -46.21 90.05 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 C-N-CA 124.163 0.985 . . . . 0.0 112.498 172.869 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 144' ' ' SER . . . . . . . . . . . . . 47.1 t -54.19 -33.68 58.73 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.927 176.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 145' ' ' GLU . . . . . 0.401 ' HG2' ' O ' ' B' ' 141' ' ' LYS . 6.9 mm-40 -83.98 -42.31 16.37 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 121.498 0.666 . . . . 0.0 110.63 178.029 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 146' ' ' LEU . . . . . 0.548 HD23 ' O ' ' B' ' 142' ' ' VAL . 2.2 mm? -62.7 -38.81 91.89 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 114.977 -1.01 . . . . 0.0 112.345 179.817 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 147' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -54.16 120.03 5.91 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.124 -172.212 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . 99.4 40.33 3.24 Favored Glycine 0 N--CA 1.445 -0.703 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.549 -176.307 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 149' ' ' LYS . . . . . 0.472 ' HB2' ' O ' ' B' ' 146' ' ' LEU . 0.1 OUTLIER -134.79 168.56 18.83 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 -179.964 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 150' ' ' ASN . . . . . 0.582 ' O ' HG22 ' B' ' 154' ' ' VAL . 31.9 m-20 -106.82 90.57 3.36 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 107.702 -1.222 . . . . 0.0 107.702 179.068 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 151' ' ' ILE . . . . . 0.672 HG13 HD12 ' B' ' 108' ' ' LEU . 1.8 mp -41.69 -64.17 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 N-CA-C 113.571 0.952 . . . . 0.0 113.571 -168.089 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 152' ' ' GLU . . . . . 0.663 ' HG3' HD11 ' B' ' 112' ' ' LEU . 3.4 mp0 -57.31 -42.92 82.72 Favored 'General case' 0 C--O 1.209 -1.03 0 C-N-CA 120.93 -0.308 . . . . 0.0 111.365 -175.301 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 153' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -66.94 -29.57 69.47 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 120.548 0.214 . . . . 0.0 111.363 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 154' ' ' VAL . . . . . 0.824 ' HB ' HD11 ' B' ' 155' ' ' ILE . 61.8 t -61.15 -51.07 77.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 171.907 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 155' ' ' ILE . . . . . 0.969 ' HB ' ' HH ' ' A' ' 11' ' ' TYR . 1.6 mp -104.66 36.19 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-O 121.979 0.895 . . . . 0.0 110.368 -177.718 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 156' ' ' ALA . . . . . 0.582 ' HB2' ' HA ' ' A' ' 1' ' ' MET . . . -100.96 0.42 38.24 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 107.246 -1.391 . . . . 0.0 107.246 169.168 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 157' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -137.36 -34.83 0.69 Allowed 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 113.043 -1.889 . . . . 0.0 109.357 173.346 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 158' ' ' GLY . . . . . 0.439 ' O ' HD12 ' B' ' 162' ' ' LEU . . . -98.36 47.44 1.46 Allowed Glycine 0 CA--C 1.521 0.468 0 CA-C-N 115.548 -0.751 . . . . 0.0 114.357 -172.444 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 159' ' ' ILE . . . . . 0.775 ' HB ' HG13 ' A' ' 60' ' ' ILE . 1.8 mp -59.52 -18.0 13.76 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 CA-C-O 121.244 0.545 . . . . 0.0 111.045 176.213 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 160' ' ' GLY . . . . . . . . . . . . . . . -111.16 -65.05 0.51 Allowed Glycine 0 N--CA 1.447 -0.584 0 N-CA-C 111.384 -0.686 . . . . 0.0 111.384 -178.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 161' ' ' LYS . . . . . 0.498 ' HD3' ' N ' ' B' ' 161' ' ' LYS . 2.8 mppt? -78.14 61.74 2.73 Favored 'General case' 0 N--CA 1.441 -0.879 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 175.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 162' ' ' LEU . . . . . 0.602 HD22 ' HG2' ' B' ' 101' ' ' MET . 10.9 mp -46.8 146.32 1.65 Allowed 'General case' 0 C--O 1.236 0.345 0 CA-C-N 115.69 -0.687 . . . . 0.0 111.751 170.55 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 163' ' ' ALA . . . . . . . . . . . . . . . 50.55 51.82 16.1 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 115.505 -0.771 . . . . 0.0 112.75 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 164' ' ' SER . . . . . . . . . . . . . 90.2 p 62.43 159.13 0.07 Allowed 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.267 1.027 . . . . 0.0 113.32 173.521 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 165' ' ' VAL . . . . . . . . . . . . . 4.0 t -91.41 132.09 34.61 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 115.41 -0.813 . . . . 0.0 109.546 178.267 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 166' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_exo -13.7 121.13 0.01 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.371 1 C-N-CA 127.237 5.292 . . . . 0.0 116.104 -179.165 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 167' ' ' ALA . . . . . . . . . . . . . . . -91.76 -54.81 3.72 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.772 -177.202 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 168' ' ' GLY . . . . . . . . . . . . . . . -119.51 -2.36 13.25 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.106 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 169' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.121 0 CA-C-O 118.234 -1.315 . . . . 0.0 111.243 -179.111 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 47.9 ttm . . . . . 0 N--CA 1.478 0.972 0 CA-C-O 120.848 0.356 . . . . 0.0 110.131 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.553 ' HB3' HD11 ' A' ' 7' ' ' LEU . . . -86.29 166.87 15.31 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.257 -179.164 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.7 p -78.72 131.82 36.74 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 171.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.636 HG11 ' HG ' ' B' ' 112' ' ' LEU . 2.2 t -53.6 -27.2 14.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 115.191 -0.913 . . . . 0.0 112.238 -175.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.725 ' HB3' ' HA ' ' A' ' 39' ' ' VAL . 2.1 m -67.46 -52.68 36.52 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 122.204 1.002 . . . . 0.0 108.468 176.068 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.516 ' O ' HG13 ' A' ' 10' ' ' ILE . 33.9 tt0 -55.83 -52.84 62.61 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-N 113.985 -1.461 . . . . 0.0 110.171 177.205 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.669 ' O ' ' HB ' ' A' ' 10' ' ' ILE . 4.4 tp -59.46 -34.97 73.2 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.091 -0.958 . . . . 0.0 111.758 179.178 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.584 ' HB1' HD23 ' B' ' 112' ' ' LEU . . . -69.85 -33.25 72.02 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-O 121.011 0.434 . . . . 0.0 110.847 179.252 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.577 ' HB2' HG11 ' A' ' 39' ' ' VAL . 7.5 t -70.88 -37.43 73.02 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 177.38 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.669 ' HB ' ' O ' ' A' ' 7' ' ' LEU . 74.2 mt -51.67 -55.53 8.6 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.887 0 CA-C-N 114.168 -1.378 . . . . 0.0 109.824 170.682 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.737 ' HB2' HD13 ' B' ' 109' ' ' LEU . 23.4 m-85 -67.04 -41.0 87.29 Favored 'General case' 0 C--O 1.22 -0.479 0 CA-C-N 115.615 -0.721 . . . . 0.0 111.596 -173.741 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.444 ' O ' ' HB2' ' A' ' 16' ' ' LEU . 2.5 p -57.43 -41.45 80.47 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 176.612 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.04 -33.43 75.42 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.895 172.471 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.781 HD21 HD13 ' A' ' 56' ' ' ILE . 0.3 OUTLIER -64.87 -57.99 7.36 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.488 -179.612 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.406 HG12 ' O ' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -54.82 -47.34 74.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 177.277 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.849 HD13 HG12 ' A' ' 21' ' ' VAL . 6.2 tp -53.19 -41.47 65.3 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.928 178.65 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 26.3 t60 -78.89 -13.68 59.66 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.178 -0.919 . . . . 0.0 112.065 -178.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -70.62 -47.99 57.32 Favored 'General case' 0 N--CA 1.467 0.389 0 O-C-N 121.895 -0.503 . . . . 0.0 110.051 176.558 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.75 ' HB2' HG22 ' B' ' 132' ' ' ILE . 28.7 t70 -91.31 -11.19 38.74 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.938 0.875 . . . . 0.0 109.575 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 55.61 52.43 11.06 Favored 'General case' 0 CA--C 1.509 -0.604 0 CA-C-N 113.641 -1.618 . . . . 0.0 110.125 -176.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.849 HG12 HD13 ' A' ' 16' ' ' LEU . 2.9 p -100.03 152.64 4.69 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.739 0 CA-C-N 113.581 -1.645 . . . . 0.0 109.073 -176.072 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.473 ' O ' ' HG2' ' A' ' 27' ' ' LYS . 30.6 p -34.96 127.97 0.5 Allowed 'General case' 0 C--N 1.317 -0.808 0 O-C-N 124.672 1.232 . . . . 0.0 114.077 -174.064 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.439 HG13 ' HB2' ' A' ' 51' ' ' LEU . 51.2 t -100.55 106.03 18.65 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.927 0 CA-C-N 114.376 -1.283 . . . . 0.0 110.473 -176.898 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.428 ' OG1' ' HB2' ' A' ' 27' ' ' LYS . 80.6 p -141.05 153.77 45.65 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.769 -179.169 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -51.42 -46.49 62.96 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.12 0.486 . . . . 0.0 110.773 179.633 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -58.26 -38.38 76.82 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.382 -0.826 . . . . 0.0 111.356 177.482 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.5 ' HG2' HD11 ' A' ' 16' ' ' LEU . 4.3 tppt? -64.48 -50.03 69.07 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-O 121.965 0.888 . . . . 0.0 109.285 -178.229 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 80.8 mt -61.7 -38.96 81.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 114.393 -1.276 . . . . 0.0 110.458 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.666 ' HA ' HD13 ' A' ' 32' ' ' ILE . 30.7 m-80 -68.41 -30.0 68.8 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.862 176.436 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -65.98 -38.91 89.73 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.562 -0.29 . . . . 0.0 110.397 176.21 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.599 ' HB3' HD21 ' B' ' 109' ' ' LEU . 1.2 mm? -65.17 -45.79 83.49 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 120.646 -0.422 . . . . 0.0 110.106 171.747 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.666 HD13 ' HA ' ' A' ' 29' ' ' ASN . 57.8 mt -49.23 -50.0 16.22 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 CA-C-N 115.294 -0.867 . . . . 0.0 111.361 177.917 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 23.0 tptp -71.89 -37.7 70.1 Favored 'General case' 0 N--CA 1.435 -1.177 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.624 -179.384 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.624 ' HB1' ' HA ' ' B' ' 126' ' ' ILE . . . -59.26 -41.97 90.08 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.001 0.429 . . . . 0.0 111.451 179.526 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.459 ' CB ' ' HG ' ' B' ' 109' ' ' LEU . . . -84.61 -33.19 23.38 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.254 179.756 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 96.29 19.23 28.67 Favored Glycine 0 N--CA 1.447 -0.569 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.765 -179.041 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.817 ' HB ' ' HA2' ' B' ' 113' ' ' GLY . 2.9 p -121.6 117.73 53.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 121.981 0.896 . . . . 0.0 111.204 -177.079 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.43 ' HA ' HG21 ' A' ' 32' ' ' ILE . 57.8 t30 -88.51 157.06 18.75 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 113.966 -1.47 . . . . 0.0 110.726 -172.051 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.725 ' HA ' ' HB3' ' A' ' 5' ' ' SER . 97.3 t -126.91 161.38 33.82 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.002 0 CA-C-N 114.878 -1.056 . . . . 0.0 110.381 -173.257 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.505 ' HB3' ' HD1' ' A' ' 43' ' ' TRP . 7.5 tp10 -68.54 106.45 1.38 Allowed Pre-proline 0 N--CA 1.439 -1.012 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 170.151 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.461 ' C ' ' HD2' ' A' ' 44' ' ' PRO . 83.0 Cg_exo -50.22 -31.06 27.78 Favored 'Trans proline' 0 C--O 1.252 1.179 0 C-N-CA 123.698 2.932 . . . . 0.0 115.478 -163.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -59.93 -26.8 66.23 Favored 'General case' 0 C--N 1.334 -0.107 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 178.456 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . 0.505 ' HD1' ' HB3' ' A' ' 40' ' ' GLU . 11.2 m95 -65.02 -61.67 5.9 Favored Pre-proline 0 C--O 1.207 -1.138 0 CA-C-O 118.423 -0.799 . . . . 0.0 110.723 176.313 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.461 ' HD2' ' C ' ' A' ' 41' ' ' PRO . 85.5 Cg_exo -43.92 -45.04 11.73 Favored 'Trans proline' 0 C--N 1.358 1.069 0 C-N-CA 121.837 1.691 . . . . 0.0 112.242 174.747 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -60.55 -60.36 8.65 Favored Glycine 0 CA--C 1.526 0.757 0 C-N-CA 120.088 -1.054 . . . . 0.0 112.315 176.598 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 10.2 tp -64.29 -24.02 67.51 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 123.069 0.547 . . . . 0.0 111.988 -177.527 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.588 ' HD2' HD11 ' A' ' 51' ' ' LEU . 2.7 m-85 -73.66 -43.91 58.16 Favored 'General case' 0 C--N 1.315 -0.899 0 C-N-CA 122.296 0.238 . . . . 0.0 110.375 177.511 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.41 ' HA ' HG12 ' A' ' 23' ' ' VAL . . . -64.81 -32.13 73.68 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 176.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 9.5 mmmt -65.29 -51.56 59.89 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 114.247 -1.342 . . . . 0.0 111.815 173.243 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.432 ' O ' HG22 ' A' ' 54' ' ' VAL . . . -80.03 -40.72 27.19 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 113.187 0.81 . . . . 0.0 113.187 -170.069 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.588 HD11 ' HD2' ' A' ' 47' ' ' PHE . 8.7 mt -66.9 0.77 2.25 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 -172.099 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -88.16 -17.92 29.88 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.883 0.373 . . . . 0.0 110.607 174.484 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 91.4 m-20 -130.69 -38.26 1.31 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.823 -175.225 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.432 HG22 ' O ' ' A' ' 50' ' ' ALA . 4.6 m -85.39 -176.62 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 121.022 0.439 . . . . 0.0 110.141 -179.833 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 23.1 t-20 -119.41 168.39 11.0 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.76 -0.654 . . . . 0.0 109.585 176.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.781 HD13 HD21 ' A' ' 14' ' ' LEU . 3.2 tp -66.29 -27.94 42.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-O 121.058 0.456 . . . . 0.0 109.934 178.406 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -72.25 -14.81 76.78 Favored Glycine 0 N--CA 1.446 -0.666 0 N-CA-C 111.05 -0.82 . . . . 0.0 111.05 175.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 20.3 m -78.68 -21.31 48.42 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-O 121.229 0.537 . . . . 0.0 109.849 179.07 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.465 HD13 HD12 ' A' ' 56' ' ' ILE . 30.0 mt -60.78 -36.41 78.91 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.617 -179.736 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.71 HG13 ' HB ' ' B' ' 159' ' ' ILE . 0.2 OUTLIER -60.11 -20.89 20.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 115.041 -0.981 . . . . 0.0 110.829 179.131 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 5.6 t -95.76 13.79 25.37 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.417 -0.811 . . . . 0.0 111.285 -175.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.477 ' OD1' HG13 ' A' ' 63' ' ' VAL . 9.0 p30 -57.9 -35.15 70.64 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.961 -0.296 . . . . 0.0 111.456 -175.841 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.477 HG13 ' OD1' ' A' ' 62' ' ' ASN . 14.9 m -101.5 19.26 3.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.609 0.719 . . . . 0.0 110.994 176.792 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -121.75 0.93 11.07 Favored Glycine 0 C--N 1.312 -0.753 0 CA-C-N 114.946 -1.025 . . . . 0.0 111.522 179.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -87.31 -6.54 58.47 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.226 0.536 . . . . 0.0 110.275 178.225 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -105.11 116.85 5.4 Favored Glycine 0 N--CA 1.445 -0.756 0 N-CA-C 111.104 -0.799 . . . . 0.0 111.104 175.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 150.74 -79.39 0.21 Allowed Glycine 0 N--CA 1.447 -0.63 0 N-CA-C 111.617 -0.593 . . . . 0.0 111.617 -176.226 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -86.55 38.63 0.58 Allowed 'Trans proline' 0 N--CA 1.459 -0.506 0 C-N-CA 122.959 2.44 . . . . 0.0 112.458 178.34 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.909 0 CA-C-O 118.387 -0.816 . . . . 0.0 110.513 -179.584 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.061 0 CA-C-O 121.162 0.506 . . . . 0.0 110.572 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 101' ' ' MET . . . . . 0.751 ' HE1' HD12 ' A' ' 14' ' ' LEU . 1.3 tmt? -90.61 135.78 33.49 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.057 -178.358 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 102' ' ' ARG . . . . . 0.47 HH12 ' HE2' ' B' ' 141' ' ' LYS . 29.1 ptt180 -170.24 -147.26 0.05 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.834 -175.198 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 103' ' ' TYR . . . . . 0.982 ' HB2' HG13 ' B' ' 142' ' ' VAL . 69.4 m-85 -61.89 -8.19 4.7 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 120.705 0.288 . . . . 0.0 111.688 179.276 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 104' ' ' VAL . . . . . 0.738 HG21 HD21 ' B' ' 162' ' ' LEU . 4.1 m -45.03 -45.43 2.97 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.221 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.161 171.765 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 105' ' ' ALA . . . . . 0.544 ' CB ' ' HB3' ' A' ' 14' ' ' LEU . . . -64.31 -30.25 71.31 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 115.291 -0.868 . . . . 0.0 111.289 -174.051 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 106' ' ' SER . . . . . 0.788 ' HB2' HG21 ' B' ' 123' ' ' ILE . 1.4 m -76.53 -36.39 57.74 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.796 0.808 . . . . 0.0 108.971 -178.529 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 107' ' ' TYR . . . . . 0.666 ' CG ' HD13 ' B' ' 146' ' ' LEU . 36.5 t80 -63.96 -46.02 86.51 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 114.139 -1.391 . . . . 0.0 108.336 176.883 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 108' ' ' LEU . . . . . 0.797 HD12 HG13 ' B' ' 151' ' ' ILE . 0.0 OUTLIER -58.62 -45.93 88.13 Favored 'General case' 0 N--CA 1.443 -0.801 0 CA-C-N 114.393 -1.276 . . . . 0.0 110.792 177.072 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 109' ' ' LEU . . . . . 0.737 HD13 ' HB2' ' A' ' 11' ' ' TYR . 8.6 tp -55.65 -50.96 68.83 Favored 'General case' 0 CA--C 1.514 -0.426 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.893 178.445 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 110' ' ' ALA . . . . . 0.457 ' HB2' ' HB3' ' B' ' 118' ' ' PRO . . . -63.18 -40.58 97.94 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.24 -176.135 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 111' ' ' ALA . . . . . 0.678 ' HA ' ' O ' ' B' ' 115' ' ' ASN . . . -64.61 -33.98 77.19 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.559 178.884 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 112' ' ' LEU . . . . . 0.766 ' HB3' HG21 ' A' ' 37' ' ' VAL . 5.5 mp -71.47 -38.23 71.27 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.053 173.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 113' ' ' GLY . . . . . 0.817 ' HA2' ' HB ' ' A' ' 37' ' ' VAL . . . -61.87 -23.53 63.56 Favored Glycine 0 N--CA 1.446 -0.643 0 CA-C-N 115.198 -0.91 . . . . 0.0 111.843 179.548 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 114' ' ' GLY . . . . . . . . . . . . . . . 133.48 4.66 3.11 Favored Glycine 0 N--CA 1.436 -1.344 0 C-N-CA 120.569 -0.824 . . . . 0.0 112.876 177.496 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 115' ' ' ASN . . . . . 0.678 ' O ' ' HA ' ' B' ' 111' ' ' ALA . 47.2 t30 -116.94 91.15 3.5 Favored 'General case' 0 N--CA 1.439 -0.988 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 -179.533 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -76.96 25.61 0.15 Allowed 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 122.211 1.005 . . . . 0.0 110.787 -167.815 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 117' ' ' SER . . . . . 0.575 ' H ' ' C ' ' B' ' 115' ' ' ASN . 35.2 t -169.83 68.12 0.59 Allowed Pre-proline 0 C--N 1.311 -1.102 0 CA-C-N 113.648 -1.614 . . . . 0.0 108.809 -178.198 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 118' ' ' PRO . . . . . 0.645 ' HD2' ' CZ ' ' B' ' 107' ' ' TYR . 26.7 Cg_exo -67.71 154.15 74.03 Favored 'Trans proline' 0 C--N 1.327 -0.583 0 C-N-CA 125.066 3.844 . . . . 0.0 111.572 -176.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 119' ' ' SER . . . . . 0.592 ' O ' HG12 ' B' ' 123' ' ' ILE . 92.0 p -121.73 -178.58 3.86 Favored 'General case' 0 C--N 1.315 -0.892 0 C-N-CA 120.104 -0.639 . . . . 0.0 110.958 178.327 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 120' ' ' ALA . . . . . 0.744 ' HB3' HD12 ' B' ' 139' ' ' LEU . . . -64.95 -38.74 91.97 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-O 121.886 0.851 . . . . 0.0 109.366 -172.061 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 121' ' ' LYS . . . . . 0.485 ' HD2' ' N ' ' B' ' 121' ' ' LYS . 4.7 mptp? -64.83 -31.96 73.43 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 113.952 -1.476 . . . . 0.0 110.912 176.718 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 122' ' ' ASP . . . . . 0.812 ' HA ' ' HE3' ' B' ' 125' ' ' LYS . 19.2 m-20 -72.61 -43.6 63.09 Favored 'General case' 0 CA--C 1.515 -0.377 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 176.282 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 123' ' ' ILE . . . . . 0.788 HG21 ' HB2' ' B' ' 106' ' ' SER . 33.8 mm -55.38 -50.36 66.01 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.421 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 175.798 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 124' ' ' LYS . . . . . 0.473 ' HD3' HD12 ' B' ' 127' ' ' LEU . 4.0 tppp? -61.21 -35.92 78.51 Favored 'General case' 0 N--CA 1.443 -0.788 0 CA-C-N 114.38 -1.282 . . . . 0.0 109.486 -177.628 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 125' ' ' LYS . . . . . 0.812 ' HE3' ' HA ' ' B' ' 122' ' ' ASP . 0.0 OUTLIER -72.44 -44.14 62.81 Favored 'General case' 0 N--CA 1.432 -1.359 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.931 -177.328 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 126' ' ' ILE . . . . . 0.677 HD12 ' HD2' ' B' ' 125' ' ' LYS . 1.4 mp -54.93 -51.81 49.51 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 CA-C-N 116.539 -0.301 . . . . 0.0 110.726 173.745 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 127' ' ' LEU . . . . . 0.9 ' HB2' ' HB ' ' B' ' 132' ' ' ILE . 3.1 pp -77.14 -25.97 52.6 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.614 -0.435 . . . . 0.0 111.788 -175.704 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 128' ' ' ASP . . . . . 0.455 ' HB2' ' O ' ' B' ' 124' ' ' LYS . 19.5 t70 -67.18 -33.5 75.54 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 110.024 -0.362 . . . . 0.0 110.024 177.606 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 129' ' ' SER . . . . . 0.411 ' CB ' ' HB3' ' A' ' 34' ' ' ALA . 22.7 t -51.97 -43.06 63.37 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.351 176.619 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 130' ' ' VAL . . . . . 0.571 HG22 HG13 ' B' ' 132' ' ' ILE . 5.0 m -100.76 -6.34 9.13 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 N-CA-C 112.242 0.46 . . . . 0.0 112.242 -179.589 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 131' ' ' GLY . . . . . . . . . . . . . . . 83.22 46.55 6.12 Favored Glycine 0 CA--C 1.518 0.257 0 C-N-CA 120.941 -0.647 . . . . 0.0 113.112 177.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 132' ' ' ILE . . . . . 0.9 ' HB ' ' HB2' ' B' ' 127' ' ' LEU . 14.9 mt -95.35 134.53 32.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 120.671 0.272 . . . . 0.0 110.46 176.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 133' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -79.98 131.73 35.87 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.895 0.379 . . . . 0.0 111.114 -178.047 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 134' ' ' ALA . . . . . . . . . . . . . . . -145.29 154.14 42.03 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.493 -175.544 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 135' ' ' ASP . . . . . 0.73 ' HB2' ' CG ' ' B' ' 138' ' ' ARG . 18.1 m-20 -102.11 135.17 44.15 Favored 'General case' 0 C--O 1.252 1.19 0 CA-C-O 121.124 0.488 . . . . 0.0 109.736 172.241 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 136' ' ' ASP . . . . . 0.597 ' HA ' HD11 ' B' ' 139' ' ' LEU . 10.4 t70 -73.28 -11.61 60.56 Favored 'General case' 0 CA--C 1.514 -0.426 0 CA-C-N 115.14 -0.936 . . . . 0.0 110.995 -166.649 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 137' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -96.79 -30.06 13.39 Favored 'General case' 0 N--CA 1.438 -1.062 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.723 175.334 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 138' ' ' ARG . . . . . 0.73 ' CG ' ' HB2' ' B' ' 135' ' ' ASP . 17.5 mmt180 -66.81 -46.26 75.75 Favored 'General case' 0 CA--C 1.504 -0.79 0 CA-C-O 121.977 0.894 . . . . 0.0 109.224 -175.624 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 139' ' ' LEU . . . . . 0.859 ' O ' HG12 ' B' ' 143' ' ' ILE . 0.3 OUTLIER -72.46 -36.68 68.55 Favored 'General case' 0 C--O 1.209 -1.072 0 CA-C-N 114.607 -1.179 . . . . 0.0 111.148 179.03 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 140' ' ' ASN . . . . . 0.57 ' O ' ' HB ' ' B' ' 143' ' ' ILE . 9.7 t30 -64.27 -26.92 68.71 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.925 0.869 . . . . 0.0 109.565 177.75 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 141' ' ' LYS . . . . . 0.47 ' HE2' HH12 ' B' ' 102' ' ' ARG . 44.4 tttt -69.93 -51.63 31.25 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 114.391 -1.277 . . . . 0.0 109.354 177.226 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 142' ' ' VAL . . . . . 0.982 HG13 ' HB2' ' B' ' 103' ' ' TYR . 8.6 p -62.55 -32.12 54.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.889 177.853 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 143' ' ' ILE . . . . . 0.859 HG12 ' O ' ' B' ' 139' ' ' LEU . 34.6 mm -50.47 -66.62 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.513 -0.455 0 CA-C-O 121.082 0.467 . . . . 0.0 110.439 170.388 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 144' ' ' SER . . . . . . . . . . . . . 70.6 p -54.41 -31.56 55.34 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.188 -0.915 . . . . 0.0 111.838 -178.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 145' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -74.97 -37.07 62.02 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 112.072 0.397 . . . . 0.0 112.072 179.254 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 146' ' ' LEU . . . . . 0.707 HD22 HG11 ' B' ' 104' ' ' VAL . 6.9 mt -86.98 -19.53 28.59 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.813 -0.355 . . . . 0.0 110.712 -178.325 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 147' ' ' ASN . . . . . 0.405 ' HA ' ' OH ' ' B' ' 107' ' ' TYR . 26.3 t-20 -54.31 117.96 3.71 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.041 -176.335 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . 96.9 36.25 5.07 Favored Glycine 0 N--CA 1.448 -0.52 0 CA-C-N 115.544 -0.753 . . . . 0.0 112.275 -178.297 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 149' ' ' LYS . . . . . 0.467 ' HB2' ' O ' ' B' ' 146' ' ' LEU . 0.3 OUTLIER -130.08 165.28 22.57 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.837 0.351 . . . . 0.0 110.601 179.842 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 150' ' ' ASN . . . . . 0.506 ' O ' HG21 ' B' ' 154' ' ' VAL . 85.3 m-20 -104.28 88.84 3.08 Favored 'General case' 0 CA--C 1.513 -0.468 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 177.893 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 151' ' ' ILE . . . . . 0.797 HG13 HD12 ' B' ' 108' ' ' LEU . 1.8 mp -39.26 -64.52 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 113.845 1.054 . . . . 0.0 113.845 -169.806 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 152' ' ' GLU . . . . . 0.683 ' HG3' HD11 ' B' ' 112' ' ' LEU . 3.1 mp0 -57.97 -35.38 71.09 Favored 'General case' 0 C--O 1.216 -0.66 0 O-C-N 122.355 -0.216 . . . . 0.0 111.263 -174.268 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 153' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -71.28 -37.98 71.84 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.855 177.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 154' ' ' VAL . . . . . 0.835 ' HB ' HD11 ' B' ' 155' ' ' ILE . 62.0 t -53.47 -47.97 58.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 121.49 0.662 . . . . 0.0 109.321 173.76 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 155' ' ' ILE . . . . . 0.835 HD11 ' HB ' ' B' ' 154' ' ' VAL . 1.6 mp -107.51 35.73 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-O 121.929 0.871 . . . . 0.0 110.804 -178.613 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . -100.85 1.9 40.51 Favored 'General case' 0 C--N 1.311 -1.096 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 169.062 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 157' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 -142.05 16.08 2.09 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 113.946 -1.479 . . . . 0.0 110.515 177.378 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 158' ' ' GLY . . . . . 0.765 ' HA3' HG21 ' B' ' 165' ' ' VAL . . . -159.5 45.54 0.44 Allowed Glycine 0 C--N 1.338 0.69 0 C-N-CA 119.507 -1.33 . . . . 0.0 115.204 -172.64 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 159' ' ' ILE . . . . . 0.71 ' HB ' HG13 ' A' ' 60' ' ' ILE . 1.8 mp -58.57 -25.88 29.48 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 C-N-CA 122.959 0.504 . . . . 0.0 111.736 176.638 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 160' ' ' GLY . . . . . . . . . . . . . . . -91.71 -67.21 1.14 Allowed Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.048 -1.072 . . . . 0.0 112.993 -178.321 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 161' ' ' LYS . . . . . 0.642 ' HB2' HG23 ' B' ' 165' ' ' VAL . 31.3 mmmt -65.11 -30.02 70.93 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 113.469 0.915 . . . . 0.0 113.469 -174.709 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 162' ' ' LEU . . . . . 0.738 HD21 HG21 ' B' ' 104' ' ' VAL . 7.4 mp 48.27 175.88 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 114.504 1.298 . . . . 0.0 114.504 -171.013 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 163' ' ' ALA . . . . . . . . . . . . . . . 55.13 -88.57 0.02 OUTLIER 'General case' 0 C--N 1.339 0.147 0 CA-C-N 115.092 -0.958 . . . . 0.0 112.748 -175.401 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 164' ' ' SER . . . . . . . . . . . . . 6.7 m -117.95 116.2 26.45 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 120.877 0.37 . . . . 0.0 110.156 178.025 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 165' ' ' VAL . . . . . 0.765 HG21 ' HA3' ' B' ' 158' ' ' GLY . 5.2 t -128.77 120.25 20.47 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.546 -176.439 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 166' ' ' PRO . . . . . 0.448 ' HD2' ' HA ' ' B' ' 165' ' ' VAL . 50.1 Cg_exo -19.63 114.85 0.02 OUTLIER 'Trans proline' 0 N--CA 1.437 -1.831 1 C-N-CA 127.154 5.236 . . . . 0.0 116.003 177.516 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 167' ' ' ALA . . . . . . . . . . . . . . . -105.85 -24.84 12.37 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.832 179.171 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 168' ' ' GLY . . . . . . . . . . . . . . . -141.87 100.4 0.26 Allowed Glycine 0 N--CA 1.445 -0.702 0 CA-C-N 115.152 -0.931 . . . . 0.0 111.422 175.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 169' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.927 0 CA-C-O 119.047 -0.863 . . . . 0.0 111.776 -179.99 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.545 ' HG2' ' H ' ' A' ' 2' ' ' ALA . 17.3 ttt . . . . . 0 N--CA 1.481 1.091 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.545 ' H ' ' HG2' ' A' ' 1' ' ' MET . . . -116.09 167.92 10.56 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 120.936 0.398 . . . . 0.0 111.07 -176.727 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 11.4 m -90.15 136.66 32.91 Favored 'General case' 0 N--CA 1.441 -0.904 0 N-CA-C 107.783 -1.191 . . . . 0.0 107.783 164.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.847 HG12 ' HG ' ' B' ' 112' ' ' LEU . 2.1 t -51.85 -24.58 4.85 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-N 114.947 -1.024 . . . . 0.0 112.17 -178.63 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.687 ' HB3' ' HA ' ' A' ' 39' ' ' VAL . 8.5 m -69.65 -51.86 31.04 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 176.219 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.5 ' O ' HG13 ' A' ' 10' ' ' ILE . 30.6 mt-10 -58.85 -52.15 66.97 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 115.008 -0.996 . . . . 0.0 109.796 178.239 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.721 HD11 HD12 ' A' ' 10' ' ' ILE . 3.2 tp -57.83 -36.85 72.84 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 115.317 -0.856 . . . . 0.0 112.097 178.279 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.571 ' HB1' HD21 ' B' ' 112' ' ' LEU . . . -67.09 -35.47 79.88 Favored 'General case' 0 CA--C 1.516 -0.361 0 CA-C-O 120.957 0.408 . . . . 0.0 110.855 178.927 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.626 ' HB2' HG12 ' A' ' 39' ' ' VAL . 5.6 t -69.7 -41.09 75.85 Favored 'General case' 0 C--O 1.242 0.672 0 N-CA-C 108.188 -1.042 . . . . 0.0 108.188 178.467 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.721 HD12 HD11 ' A' ' 7' ' ' LEU . 68.0 mt -47.14 -54.1 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.671 0 CA-C-N 114.214 -1.357 . . . . 0.0 109.627 170.532 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.86 ' HH ' ' HB ' ' B' ' 155' ' ' ILE . 23.4 m-85 -66.32 -39.48 89.29 Favored 'General case' 0 C--O 1.219 -0.511 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.877 -174.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.551 ' HB2' HD22 ' A' ' 31' ' ' LEU . 79.4 p -56.78 -44.79 82.22 Favored 'General case' 0 C--O 1.243 0.739 0 CA-C-O 121.475 0.655 . . . . 0.0 109.383 179.148 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.57 ' HB1' ' HG ' ' A' ' 51' ' ' LEU . . . -63.2 -34.32 77.38 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 115.09 -0.959 . . . . 0.0 110.42 173.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.791 HD12 ' HE1' ' B' ' 101' ' ' MET . 0.2 OUTLIER -61.36 -55.49 31.05 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.456 179.342 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.49 HG12 ' O ' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -55.27 -41.5 61.59 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 178.322 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.694 HD22 ' HA ' ' A' ' 23' ' ' VAL . 2.3 tp -55.46 -38.64 69.33 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.31 176.212 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . 0.474 ' HE2' HD12 ' A' ' 51' ' ' LEU . 93.8 m-70 -73.77 -14.28 61.09 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 176.228 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -68.96 -44.4 73.05 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.911 0.386 . . . . 0.0 110.281 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.729 ' HB2' HG22 ' B' ' 132' ' ' ILE . 37.7 t70 -97.92 -6.99 31.11 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.835 0.826 . . . . 0.0 109.178 177.639 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 53.32 52.57 13.27 Favored 'General case' 0 CA--C 1.516 -0.359 0 CA-C-N 113.803 -1.544 . . . . 0.0 109.976 -177.034 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.602 HG12 HD13 ' A' ' 16' ' ' LEU . 7.3 p -106.62 163.97 4.73 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 CA-C-N 114.319 -1.31 . . . . 0.0 109.365 -174.051 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 18.6 p -48.32 142.01 5.98 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 113.312 0.856 . . . . 0.0 113.312 -174.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.694 ' HA ' HD22 ' A' ' 16' ' ' LEU . 58.3 t -107.27 114.29 45.79 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 CA-C-N 114.305 -1.316 . . . . 0.0 110.769 -175.471 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.48 ' OG1' ' HD2' ' A' ' 27' ' ' LYS . 22.1 p -136.69 159.57 41.44 Favored 'General case' 0 C--O 1.245 0.848 0 CA-C-O 120.925 0.393 . . . . 0.0 110.511 176.346 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -56.57 -34.14 66.83 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.596 176.106 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -68.79 -31.95 71.33 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.17 177.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.681 ' HG2' HD11 ' A' ' 16' ' ' LEU . 0.3 OUTLIER -62.67 -58.1 8.69 Favored 'General case' 0 CA--C 1.512 -0.505 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 175.043 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.505 HG23 ' OG ' ' A' ' 12' ' ' SER . 37.0 mt -56.51 -40.95 71.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 114.184 -1.371 . . . . 0.0 110.999 -178.348 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 41.1 t-20 -59.37 -45.53 91.16 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.934 -0.575 . . . . 0.0 109.955 177.272 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -59.31 -47.79 84.06 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.405 179.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.704 ' HB3' HD21 ' B' ' 109' ' ' LEU . 0.9 OUTLIER -57.61 -50.43 73.17 Favored 'General case' 0 C--O 1.239 0.504 0 CA-C-O 121.006 0.431 . . . . 0.0 110.595 177.174 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.582 HG21 ' O ' ' A' ' 37' ' ' VAL . 67.1 mt -47.76 -51.48 7.95 Favored 'Isoleucine or valine' 0 C--O 1.242 0.698 0 CA-C-N 115.067 -0.97 . . . . 0.0 111.267 177.839 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 47.5 mmtm -74.2 -39.49 63.12 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.022 -0.99 . . . . 0.0 111.781 -174.036 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -63.24 -41.39 99.07 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-O 120.783 0.325 . . . . 0.0 110.97 -178.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.482 ' HA ' HD12 ' B' ' 126' ' ' ILE . . . -79.41 -31.8 42.77 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.079 179.784 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 97.38 16.16 35.58 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 121.021 -0.609 . . . . 0.0 111.91 178.316 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.869 ' HB ' ' HA2' ' B' ' 113' ' ' GLY . 2.5 p -119.57 119.99 62.14 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 CA-C-O 121.433 0.635 . . . . 0.0 110.458 -176.694 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.573 ' HA ' HG21 ' A' ' 32' ' ' ILE . 12.8 t30 -96.59 153.71 17.69 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 114.826 -1.079 . . . . 0.0 111.142 -167.673 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.687 ' HA ' ' HB3' ' A' ' 5' ' ' SER . 93.5 t -130.03 158.79 42.49 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.964 0 CA-C-N 114.982 -1.008 . . . . 0.0 109.923 -170.347 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.582 ' HB2' ' CD1' ' A' ' 43' ' ' TRP . 30.6 mt-10 -63.83 112.7 7.9 Favored Pre-proline 0 CA--C 1.487 -1.454 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 170.003 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.452 ' C ' ' HD2' ' A' ' 44' ' ' PRO . 54.4 Cg_exo -55.8 -27.75 63.73 Favored 'Trans proline' 0 C--N 1.312 -1.349 0 C-N-CA 123.042 2.495 . . . . 0.0 113.509 -167.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 1.6 p90 -62.0 -28.95 69.93 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.746 175.03 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . 0.582 ' CD1' ' HB2' ' A' ' 40' ' ' GLU . 9.8 m95 -62.47 -59.35 13.08 Favored Pre-proline 0 C--O 1.204 -1.338 0 CA-C-O 118.374 -0.822 . . . . 0.0 110.32 175.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.452 ' HD2' ' C ' ' A' ' 41' ' ' PRO . 84.8 Cg_exo -44.38 -45.28 12.72 Favored 'Trans proline' 0 C--N 1.36 1.165 0 C-N-CA 121.716 1.61 . . . . 0.0 112.527 172.483 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -60.26 -59.36 10.49 Favored Glycine 0 CA--C 1.529 0.962 0 C-N-CA 120.025 -1.084 . . . . 0.0 112.759 177.367 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 5.4 tp -65.41 -32.03 73.44 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 123.276 0.63 . . . . 0.0 111.791 -177.388 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.505 ' HE1' ' CE3' ' A' ' 43' ' ' TRP . 2.7 m-85 -65.32 -49.02 71.04 Favored 'General case' 0 C--N 1.317 -0.81 0 C-N-CA 122.685 0.394 . . . . 0.0 110.263 176.533 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.6 -31.11 72.18 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.505 0.669 . . . . 0.0 109.539 -179.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.552 ' HD2' ' O ' ' A' ' 49' ' ' LYS . 0.4 OUTLIER -66.82 -35.76 80.81 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 114.883 -1.053 . . . . 0.0 110.622 173.094 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.425 ' C ' HG22 ' A' ' 54' ' ' VAL . . . -85.03 -58.71 2.58 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.809 0.67 . . . . 0.0 112.809 -175.253 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.57 ' HG ' ' HB1' ' A' ' 13' ' ' ALA . 3.2 mm? -62.0 -11.71 14.95 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 112.746 0.647 . . . . 0.0 112.746 -170.437 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -74.34 -26.41 60.12 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.061 0.457 . . . . 0.0 110.426 175.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 84.1 m-20 -116.4 -39.13 3.41 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.048 -177.284 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.425 HG22 ' C ' ' A' ' 50' ' ' ALA . 4.1 m -98.43 -174.28 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.949 0.404 . . . . 0.0 110.789 -176.435 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 26.9 p-10 -111.71 178.71 4.23 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.334 179.364 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.57 HG12 ' CD1' ' A' ' 14' ' ' LEU . 4.7 tp -74.57 -25.1 18.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 120.971 0.415 . . . . 0.0 109.992 -179.183 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -70.32 -13.75 70.92 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.435 -0.888 . . . . 0.0 110.937 175.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 32.2 t -77.53 -21.75 52.17 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-O 121.27 0.557 . . . . 0.0 109.677 179.284 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 20.0 mt -64.98 -26.38 68.27 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.565 179.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.569 HG13 ' HB ' ' B' ' 159' ' ' ILE . 0.1 OUTLIER -66.01 -12.37 14.11 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 CA-C-N 114.602 -1.181 . . . . 0.0 110.558 179.867 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 0.467 ' HA ' ' HB3' ' A' ' 65' ' ' ALA . 16.4 t -93.41 -5.91 48.29 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.036 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 13.2 m120 -78.0 -7.13 56.45 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.655 -177.175 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 18.8 m -122.98 29.49 2.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.284 0.564 . . . . 0.0 110.691 177.61 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 131.52 -120.06 2.76 Favored Glycine 0 N--CA 1.451 -0.331 0 CA-C-N 115.544 -0.753 . . . . 0.0 112.518 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.467 ' HB3' ' HA ' ' A' ' 61' ' ' CYS . . . 52.03 48.8 22.01 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 123.015 0.526 . . . . 0.0 111.781 -179.263 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -122.85 -43.94 0.35 Allowed Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.847 -0.692 . . . . 0.0 111.952 179.14 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 127.89 -142.48 13.56 Favored Glycine 0 N--CA 1.445 -0.75 0 C-N-CA 120.866 -0.683 . . . . 0.0 111.752 -178.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -63.81 -45.39 10.91 Favored 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 122.754 2.303 . . . . 0.0 111.505 178.026 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.025 0 CA-C-O 118.246 -0.883 . . . . 0.0 109.914 178.308 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.126 0 CA-C-O 120.796 0.332 . . . . 0.0 110.977 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 101' ' ' MET . . . . . 0.791 ' HE1' HD12 ' A' ' 14' ' ' LEU . 1.3 tmt? -79.83 124.56 28.74 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.15 -0.477 . . . . 0.0 109.883 178.3 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 102' ' ' ARG . . . . . . . . . . . . . 29.8 ptt180 -162.74 -122.74 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.707 -0.678 . . . . 0.0 109.766 176.414 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 103' ' ' TYR . . . . . 0.59 ' HB2' HG11 ' B' ' 142' ' ' VAL . 41.5 m-85 -61.51 -10.17 7.31 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-O 120.902 0.382 . . . . 0.0 111.234 179.581 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 104' ' ' VAL . . . . . 0.611 ' O ' HD23 ' B' ' 108' ' ' LEU . 63.4 t -44.15 -47.06 2.24 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.269 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.973 170.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 105' ' ' ALA . . . . . 0.61 ' CB ' ' HB3' ' A' ' 14' ' ' LEU . . . -65.95 -38.91 89.83 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.008 -0.996 . . . . 0.0 111.593 -173.879 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 106' ' ' SER . . . . . 0.795 ' HB2' HG23 ' B' ' 123' ' ' ILE . 1.4 m -63.75 -36.38 83.69 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-O 121.596 0.712 . . . . 0.0 109.683 177.427 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 107' ' ' TYR . . . . . 0.645 ' CZ ' ' HD2' ' B' ' 118' ' ' PRO . 31.8 t80 -62.93 -51.06 68.39 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 114.509 -1.223 . . . . 0.0 108.665 178.583 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 108' ' ' LEU . . . . . 0.848 ' HG ' HD12 ' B' ' 155' ' ' ILE . 0.0 OUTLIER -56.96 -45.36 82.92 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 114.652 -1.158 . . . . 0.0 110.971 178.341 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 109' ' ' LEU . . . . . 0.833 HD13 ' HB2' ' A' ' 11' ' ' TYR . 7.7 tp -56.41 -47.49 78.93 Favored 'General case' 0 CA--C 1.51 -0.574 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.033 179.099 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 110' ' ' ALA . . . . . 0.549 ' HB2' ' HB3' ' B' ' 118' ' ' PRO . . . -65.73 -38.98 90.63 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-O 120.998 0.428 . . . . 0.0 111.155 -177.358 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 111' ' ' ALA . . . . . 0.659 ' HA ' ' O ' ' B' ' 115' ' ' ASN . . . -69.01 -23.74 64.12 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.637 178.733 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 112' ' ' LEU . . . . . 0.847 ' HG ' HG12 ' A' ' 4' ' ' VAL . 1.4 mp -80.23 -37.54 32.87 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.058 172.831 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 113' ' ' GLY . . . . . 0.869 ' HA2' ' HB ' ' A' ' 37' ' ' VAL . . . -64.07 -20.99 65.43 Favored Glycine 0 N--CA 1.449 -0.499 0 CA-C-N 115.204 -0.907 . . . . 0.0 111.801 177.809 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 114' ' ' GLY . . . . . . . . . . . . . . . 130.01 9.64 3.02 Favored Glycine 0 N--CA 1.439 -1.16 0 C-N-CA 120.354 -0.927 . . . . 0.0 113.416 174.563 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 115' ' ' ASN . . . . . 0.659 ' O ' ' HA ' ' B' ' 111' ' ' ALA . 33.7 t30 -115.11 95.31 5.14 Favored 'General case' 0 N--CA 1.44 -0.962 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 178.5 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 2.3 p -80.21 29.87 0.28 Allowed 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 114.895 -1.048 . . . . 0.0 110.75 -167.024 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 117' ' ' SER . . . . . 0.56 ' N ' ' HD3' ' B' ' 118' ' ' PRO . 41.9 t -175.78 67.96 0.25 Allowed Pre-proline 0 C--N 1.307 -1.252 0 CA-C-N 113.377 -1.738 . . . . 0.0 108.411 -179.05 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 118' ' ' PRO . . . . . 0.645 ' HD2' ' CZ ' ' B' ' 107' ' ' TYR . 32.1 Cg_exo -66.04 148.7 85.86 Favored 'Trans proline' 0 CA--C 1.513 -0.557 0 C-N-CA 125.115 3.877 . . . . 0.0 111.827 -175.268 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 119' ' ' SER . . . . . 0.648 ' O ' HG12 ' B' ' 123' ' ' ILE . 78.6 p -116.39 -178.42 3.41 Favored 'General case' 0 C--N 1.316 -0.858 0 C-N-CA 120.221 -0.591 . . . . 0.0 111.324 178.318 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 120' ' ' ALA . . . . . 0.694 ' HB3' HD13 ' B' ' 139' ' ' LEU . . . -66.81 -34.19 77.28 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 122.057 0.932 . . . . 0.0 109.77 -173.868 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 121' ' ' LYS . . . . . 0.595 ' HD2' ' N ' ' B' ' 121' ' ' LYS . 0.0 OUTLIER -69.74 -29.97 67.46 Favored 'General case' 0 N--CA 1.437 -1.084 0 CA-C-N 113.956 -1.475 . . . . 0.0 110.173 177.805 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 122' ' ' ASP . . . . . 0.463 ' O ' HD13 ' B' ' 126' ' ' ILE . 20.1 m-20 -70.41 -44.73 67.34 Favored 'General case' 0 CA--C 1.517 -0.306 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 174.517 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 123' ' ' ILE . . . . . 0.795 HG23 ' HB2' ' B' ' 106' ' ' SER . 25.1 mm -54.19 -49.57 61.57 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 CA-C-N 114.944 -1.026 . . . . 0.0 109.869 176.38 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 124' ' ' LYS . . . . . 0.963 ' HD2' HD12 ' B' ' 127' ' ' LEU . 1.7 mmmm -62.34 -41.59 98.7 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.23 -175.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 125' ' ' LYS . . . . . . . . . . . . . 44.3 mmtt -49.73 -60.95 2.41 Favored 'General case' 0 CA--C 1.496 -1.134 0 CA-C-O 121.931 0.872 . . . . 0.0 111.225 171.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 126' ' ' ILE . . . . . 0.609 HG23 HD13 ' A' ' 31' ' ' LEU . 1.6 mp -59.03 -41.89 84.68 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.667 0 CA-C-N 113.706 -1.588 . . . . 0.0 110.694 -169.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 127' ' ' LEU . . . . . 0.963 HD12 ' HD2' ' B' ' 124' ' ' LYS . 3.5 pp -78.94 -32.25 45.45 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 111.924 0.342 . . . . 0.0 111.924 -178.628 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 128' ' ' ASP . . . . . 0.478 ' N ' HD11 ' B' ' 127' ' ' LEU . 11.5 m-20 -70.33 -24.58 63.02 Favored 'General case' 0 CA--C 1.518 -0.281 0 O-C-N 122.232 -0.293 . . . . 0.0 111.03 -178.588 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 129' ' ' SER . . . . . . . . . . . . . 94.4 p -59.45 -42.83 92.87 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-O 120.715 0.293 . . . . 0.0 111.206 177.217 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 130' ' ' VAL . . . . . 0.559 HG22 HG13 ' B' ' 132' ' ' ILE . 13.1 m -93.41 -7.4 10.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.814 0.34 . . . . 0.0 111.776 -179.745 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 131' ' ' GLY . . . . . . . . . . . . . . . 85.62 39.75 8.08 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.478 177.474 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 132' ' ' ILE . . . . . 0.729 HG22 ' HB2' ' A' ' 19' ' ' ASP . 14.3 mt -94.7 126.94 47.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 110.195 -0.298 . . . . 0.0 110.195 176.617 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 133' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -80.53 127.04 31.98 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.227 0.536 . . . . 0.0 111.283 -176.171 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 134' ' ' ALA . . . . . 0.439 ' HB2' ' CE1' ' B' ' 103' ' ' TYR . . . -140.37 146.13 38.01 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.706 -173.253 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 135' ' ' ASP . . . . . 0.699 ' HB3' ' HG3' ' B' ' 138' ' ' ARG . 7.7 t70 -93.65 131.04 39.34 Favored 'General case' 0 C--O 1.253 1.253 0 CA-C-O 121.173 0.511 . . . . 0.0 110.447 175.352 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 136' ' ' ASP . . . . . 0.644 ' HA ' ' CD1' ' B' ' 139' ' ' LEU . 6.2 p-10 -77.42 5.21 9.23 Favored 'General case' 0 CA--C 1.517 -0.297 0 CA-C-N 115.029 -0.987 . . . . 0.0 111.627 -168.276 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 137' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -108.83 -30.94 7.89 Favored 'General case' 0 N--CA 1.434 -1.255 0 CA-C-O 121.059 0.457 . . . . 0.0 110.372 172.013 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 138' ' ' ARG . . . . . 0.706 ' HA ' ' HE2' ' B' ' 141' ' ' LYS . 9.3 mmt180 -67.4 -48.44 67.36 Favored 'General case' 0 CA--C 1.505 -0.76 0 CA-C-O 122.179 0.99 . . . . 0.0 109.155 -178.69 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 139' ' ' LEU . . . . . 0.898 ' O ' HG12 ' B' ' 143' ' ' ILE . 0.3 OUTLIER -69.63 -26.09 64.25 Favored 'General case' 0 C--O 1.207 -1.147 0 CA-C-N 114.588 -1.187 . . . . 0.0 111.025 179.112 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 140' ' ' ASN . . . . . 0.587 ' O ' ' HB ' ' B' ' 143' ' ' ILE . 32.9 t30 -79.26 -26.44 42.42 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.875 0.845 . . . . 0.0 109.938 -178.39 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 141' ' ' LYS . . . . . 0.706 ' HE2' ' HA ' ' B' ' 138' ' ' ARG . 0.2 OUTLIER -80.69 -35.35 33.76 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 115.435 -0.802 . . . . 0.0 108.972 179.907 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 142' ' ' VAL . . . . . 0.626 HG13 ' O ' ' B' ' 139' ' ' LEU . 9.8 p -66.6 -39.12 83.09 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.444 0 C-N-CA 119.922 -0.711 . . . . 0.0 109.204 172.127 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 143' ' ' ILE . . . . . 0.898 HG12 ' O ' ' B' ' 139' ' ' LEU . 32.2 mm -45.51 -59.82 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.36 0 CA-C-O 121.778 0.799 . . . . 0.0 110.081 168.762 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 144' ' ' SER . . . . . . . . . . . . . 20.8 m -51.8 -42.61 62.6 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 113.97 -1.468 . . . . 0.0 112.298 -179.656 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 145' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -76.16 -23.63 54.77 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 120.948 0.404 . . . . 0.0 111.625 179.35 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 146' ' ' LEU . . . . . 0.562 ' HB3' ' CZ ' ' B' ' 107' ' ' TYR . 0.3 OUTLIER -86.0 -36.96 19.44 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.569 -177.416 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 147' ' ' ASN . . . . . 0.464 ' HA ' ' HH ' ' B' ' 107' ' ' TYR . 16.0 t-20 -43.6 113.04 0.45 Allowed 'General case' 0 C--N 1.331 -0.203 0 O-C-N 124.157 0.911 . . . . 0.0 112.424 -173.168 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . 97.23 61.22 0.94 Allowed Glycine 0 N--CA 1.448 -0.56 0 CA-C-N 115.277 -0.874 . . . . 0.0 111.807 -178.14 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 149' ' ' LYS . . . . . . . . . . . . . 2.5 tppt? -144.49 162.54 36.29 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 -178.168 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 150' ' ' ASN . . . . . 0.606 ' O ' HG21 ' B' ' 154' ' ' VAL . 42.2 m-80 -106.08 90.26 3.32 Favored 'General case' 0 CA--C 1.514 -0.427 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 178.079 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 151' ' ' ILE . . . . . 0.776 HG13 HD12 ' B' ' 108' ' ' LEU . 1.8 mp -43.45 -66.01 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 O-C-N 124.528 1.142 . . . . 0.0 113.744 -169.028 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 152' ' ' GLU . . . . . 0.416 ' HB3' ' HE1' ' A' ' 1' ' ' MET . 2.4 mt-10 -48.94 -52.61 23.7 Favored 'General case' 0 C--O 1.207 -1.149 0 CA-C-N 118.249 0.477 . . . . 0.0 111.981 -177.775 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 153' ' ' ASP . . . . . 0.443 ' HA ' ' HB3' ' B' ' 156' ' ' ALA . 26.5 m-20 -64.76 -27.77 69.12 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 119.983 -0.687 . . . . 0.0 111.103 -176.014 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 154' ' ' VAL . . . . . 0.911 ' HB ' HD11 ' B' ' 155' ' ' ILE . 49.6 t -57.6 -52.97 50.7 Favored 'Isoleucine or valine' 0 C--O 1.233 0.189 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 170.374 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 155' ' ' ILE . . . . . 0.911 HD11 ' HB ' ' B' ' 154' ' ' VAL . 1.8 mp -105.25 34.4 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.706 -176.613 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 156' ' ' ALA . . . . . 0.443 ' HB3' ' HA ' ' B' ' 153' ' ' ASP . . . -105.03 0.59 27.79 Favored 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 171.405 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 157' ' ' GLN . . . . . . . . . . . . . 49.9 mt-30 -141.69 1.85 1.55 Allowed 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 113.353 -1.749 . . . . 0.0 109.908 175.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 158' ' ' GLY . . . . . . . . . . . . . . . -142.34 46.26 0.88 Allowed Glycine 0 C--N 1.334 0.456 0 C-N-CA 120.695 -0.764 . . . . 0.0 113.588 -170.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 159' ' ' ILE . . . . . 0.569 ' HB ' HG13 ' A' ' 60' ' ' ILE . 1.8 mp -60.41 -15.81 11.3 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.775 0 C-N-CA 123.127 0.571 . . . . 0.0 111.721 178.859 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 160' ' ' GLY . . . . . 0.429 ' HA2' HG21 ' A' ' 56' ' ' ILE . . . -105.56 -80.35 1.35 Allowed Glycine 0 N--CA 1.446 -0.676 0 C-N-CA 120.59 -0.814 . . . . 0.0 112.204 -174.591 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 161' ' ' LYS . . . . . 0.481 ' HA ' ' HD2' ' B' ' 161' ' ' LYS . 31.0 mmmt -77.18 61.4 2.08 Favored 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 113.178 0.807 . . . . 0.0 113.178 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 162' ' ' LEU . . . . . 0.435 ' HB2' ' HG2' ' B' ' 101' ' ' MET . 9.9 mp -41.3 136.7 1.61 Allowed 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.828 168.801 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 163' ' ' ALA . . . . . 0.441 ' C ' ' HG ' ' B' ' 164' ' ' SER . . . 55.82 44.44 26.02 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 115.716 -0.675 . . . . 0.0 112.789 179.839 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 164' ' ' SER . . . . . 0.441 ' HG ' ' C ' ' B' ' 163' ' ' ALA . 80.1 p 56.9 169.49 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 113.968 1.099 . . . . 0.0 113.968 173.685 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 165' ' ' VAL . . . . . . . . . . . . . 11.0 t -102.17 129.96 25.22 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-N 114.831 -1.077 . . . . 0.0 108.968 175.155 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 166' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -13.52 112.96 0.01 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.421 1 C-N-CA 127.112 5.208 . . . . 0.0 116.149 -174.693 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 167' ' ' ALA . . . . . . . . . . . . . . . -103.88 46.43 0.92 Allowed 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.968 -175.283 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 168' ' ' GLY . . . . . . . . . . . . . . . 128.01 -41.86 1.52 Allowed Glycine 0 N--CA 1.448 -0.525 0 N-CA-C 111.071 -0.812 . . . . 0.0 111.071 -176.554 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 169' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.192 -1.338 . . . . 0.0 111.223 178.183 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.6 ttm . . . . . 0 N--CA 1.479 1.02 0 N-CA-C 110.249 -0.278 . . . . 0.0 110.249 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.57 ' HB3' HD11 ' A' ' 7' ' ' LEU . . . -84.4 166.96 16.91 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.379 -178.247 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.498 ' HB2' ' HG3' ' A' ' 6' ' ' GLU . 5.8 m -74.53 130.0 38.78 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 173.285 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.578 HG12 ' HG ' ' B' ' 112' ' ' LEU . 2.1 t -52.57 -26.59 10.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.053 -0.976 . . . . 0.0 112.496 -178.301 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 10.9 p -68.71 -53.26 23.21 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 177.471 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.545 ' O ' HG13 ' A' ' 10' ' ' ILE . 31.3 mt-10 -56.95 -50.27 73.13 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 114.816 -1.083 . . . . 0.0 109.614 176.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.714 ' O ' ' HB ' ' A' ' 10' ' ' ILE . 4.4 tp -61.61 -36.6 81.19 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 115.12 -0.945 . . . . 0.0 111.841 -179.404 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.679 ' HB1' HD22 ' B' ' 112' ' ' LEU . . . -69.21 -35.11 75.85 Favored 'General case' 0 CA--C 1.513 -0.456 0 CA-C-O 121.023 0.439 . . . . 0.0 110.719 179.11 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 5.0 t -67.63 -41.11 84.44 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 178.337 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.714 ' HB ' ' O ' ' A' ' 7' ' ' LEU . 68.5 mt -47.92 -56.57 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 CA-C-N 113.859 -1.518 . . . . 0.0 109.905 170.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.905 ' HH ' ' HB ' ' B' ' 155' ' ' ILE . 22.9 m-85 -65.13 -39.64 93.32 Favored 'General case' 0 C--O 1.218 -0.586 0 CA-C-N 115.685 -0.688 . . . . 0.0 111.413 -174.194 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.44 ' HB2' HG23 ' A' ' 28' ' ' ILE . 16.0 m -57.34 -40.84 78.87 Favored 'General case' 0 C--O 1.24 0.588 0 CA-C-O 121.463 0.649 . . . . 0.0 109.315 177.197 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.516 ' CB ' HD12 ' A' ' 51' ' ' LEU . . . -67.13 -30.93 71.07 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 115.186 -0.915 . . . . 0.0 110.212 175.067 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.641 ' HB3' ' CB ' ' B' ' 105' ' ' ALA . 0.3 OUTLIER -66.98 -53.63 29.68 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.591 179.684 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.451 HG12 ' O ' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -57.77 -41.66 80.13 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 CA-C-O 120.961 0.41 . . . . 0.0 109.955 176.8 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.695 HD11 HG11 ' A' ' 21' ' ' VAL . 2.6 tp -60.08 -41.94 93.54 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.821 176.816 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 47.4 t60 -80.47 -8.31 59.5 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.316 179.594 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -73.8 -43.34 59.15 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 178.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -97.71 -14.55 20.81 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-O 121.991 0.901 . . . . 0.0 109.045 177.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 61.0 52.69 3.97 Favored 'General case' 0 CA--C 1.51 -0.566 0 CA-C-N 113.753 -1.567 . . . . 0.0 109.979 -174.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.695 HG11 HD11 ' A' ' 16' ' ' LEU . 7.3 p -102.08 171.64 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.426 -1.643 0 CA-C-N 114.445 -1.252 . . . . 0.0 108.506 -178.216 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.461 ' H ' HG23 ' A' ' 21' ' ' VAL . 41.2 p -54.19 138.65 37.87 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 113.365 0.876 . . . . 0.0 113.365 -170.595 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.484 HG12 ' HB2' ' A' ' 51' ' ' LEU . 59.4 t -107.19 108.7 25.85 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.995 0 CA-C-N 114.371 -1.286 . . . . 0.0 110.54 -176.649 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.488 ' OG1' ' HE2' ' A' ' 27' ' ' LYS . 68.5 p -140.24 155.14 47.0 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.61 179.029 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -54.83 -43.36 72.92 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.228 0.537 . . . . 0.0 109.788 178.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 -60.5 -34.55 74.24 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.168 -0.923 . . . . 0.0 110.76 178.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.584 ' HG2' HD12 ' A' ' 16' ' ' LEU . 3.9 tppt? -67.53 -54.12 22.74 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-O 121.881 0.848 . . . . 0.0 109.233 -178.66 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.44 HG23 ' HB2' ' A' ' 12' ' ' SER . 88.1 mt -58.76 -39.35 76.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 114.459 -1.246 . . . . 0.0 110.287 178.262 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 42.8 t-20 -58.14 -42.85 86.76 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.109 176.538 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -60.42 -46.85 88.53 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.243 177.636 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.5 ' HB3' HD22 ' B' ' 109' ' ' LEU . 1.1 mm? -55.54 -51.46 66.98 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 121.221 0.534 . . . . 0.0 110.216 175.348 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.615 HG23 ' O ' ' A' ' 37' ' ' VAL . 67.8 mt -47.71 -49.46 10.24 Favored 'Isoleucine or valine' 0 C--O 1.242 0.665 0 CA-C-N 114.655 -1.157 . . . . 0.0 111.936 179.199 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 3.0 mmmp? -78.45 -31.26 47.93 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.528 0.566 . . . . 0.0 112.528 -173.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.47 ' HB1' ' HB3' ' B' ' 129' ' ' SER . . . -68.83 -38.15 79.66 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 120.641 -0.423 . . . . 0.0 110.463 177.719 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.529 ' CB ' ' HG ' ' B' ' 109' ' ' LEU . . . -77.6 -36.3 51.96 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.412 177.02 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 97.62 13.25 44.83 Favored Glycine 0 N--CA 1.445 -0.715 0 CA-C-N 115.427 -0.806 . . . . 0.0 111.959 178.6 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.948 ' HB ' ' HA2' ' B' ' 113' ' ' GLY . 2.6 p -116.13 116.96 53.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-O 121.818 0.818 . . . . 0.0 110.969 -175.126 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -90.12 152.82 20.95 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 114.268 -1.333 . . . . 0.0 110.551 -171.684 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.558 HG11 ' N ' ' A' ' 40' ' ' GLU . 96.3 t -120.51 166.13 15.26 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.07 0 CA-C-N 114.555 -1.202 . . . . 0.0 109.935 -173.056 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.602 ' HB3' ' HD1' ' A' ' 43' ' ' TRP . 28.3 tp10 -72.62 106.35 2.11 Favored Pre-proline 0 N--CA 1.439 -1.023 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 168.872 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.53 ' C ' ' HD2' ' A' ' 44' ' ' PRO . 86.8 Cg_exo -50.09 -30.71 25.81 Favored 'Trans proline' 0 C--O 1.253 1.243 0 C-N-CA 123.709 2.94 . . . . 0.0 115.65 -163.9 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -59.43 -28.4 66.91 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 177.246 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . 0.602 ' HD1' ' HB3' ' A' ' 40' ' ' GLU . 17.4 m95 -64.2 -60.44 8.72 Favored Pre-proline 0 C--O 1.206 -1.214 0 CA-C-O 118.369 -0.824 . . . . 0.0 111.153 176.083 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.53 ' HD2' ' C ' ' A' ' 41' ' ' PRO . 93.1 Cg_exo -44.99 -44.89 14.61 Favored 'Trans proline' 0 C--N 1.36 1.155 0 C-N-CA 121.849 1.699 . . . . 0.0 112.167 175.094 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -61.55 -55.77 26.95 Favored Glycine 0 CA--C 1.525 0.68 0 C-N-CA 120.035 -1.079 . . . . 0.0 112.525 177.17 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 8.9 tp -67.42 -27.92 67.47 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 122.849 0.459 . . . . 0.0 112.025 -177.366 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.521 ' HE1' ' CE3' ' A' ' 43' ' ' TRP . 2.8 m-85 -69.89 -46.8 64.66 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 177.112 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.475 ' HA ' HG11 ' A' ' 23' ' ' VAL . . . -62.84 -34.34 77.13 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.81 0.814 . . . . 0.0 109.592 178.26 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.509 ' HD2' ' C ' ' A' ' 49' ' ' LYS . 0.3 OUTLIER -70.85 -42.26 70.36 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 114.291 -1.322 . . . . 0.0 111.484 177.085 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -82.23 -44.96 15.68 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 112.687 0.625 . . . . 0.0 112.687 -173.569 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.516 HD12 ' CB ' ' A' ' 13' ' ' ALA . 11.1 mt -63.71 -13.15 40.65 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 112.87 0.693 . . . . 0.0 112.87 -171.835 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -83.1 -10.25 58.78 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.135 0.493 . . . . 0.0 110.579 176.623 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 33.9 m-80 -122.6 -47.6 2.08 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.261 -176.55 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 13.7 m -99.55 -169.93 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 176.601 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -130.59 -173.1 2.98 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 120.484 -0.486 . . . . 0.0 111.338 178.149 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.588 HD12 HD22 ' A' ' 14' ' ' LEU . 3.4 tp -66.03 -26.99 39.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-O 121.006 0.431 . . . . 0.0 111.08 -174.262 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -71.15 -14.99 74.26 Favored Glycine 0 N--CA 1.442 -0.904 0 C-N-CA 120.459 -0.877 . . . . 0.0 111.21 179.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 14.8 t -79.99 -21.27 43.85 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-O 121.157 0.504 . . . . 0.0 110.054 179.631 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 26.0 mt -62.67 -33.05 74.28 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.518 -0.764 . . . . 0.0 110.848 -178.298 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.63 ' CD1' ' HB ' ' B' ' 159' ' ' ILE . 0.1 OUTLIER -65.64 -15.36 18.55 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.914 -179.299 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 25.8 t -96.45 -7.9 33.64 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.69 -178.237 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.478 ' HB3' ' HH2' ' A' ' 43' ' ' TRP . 9.4 m120 -63.24 -30.92 71.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.914 0.387 . . . . 0.0 111.228 -175.06 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 18.2 m -100.91 29.93 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 121.415 0.626 . . . . 0.0 111.095 -179.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -175.15 55.1 0.12 Allowed Glycine 0 N--CA 1.447 -0.598 0 CA-C-N 115.427 -0.806 . . . . 0.0 111.561 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -116.02 20.12 14.61 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.935 0.398 . . . . 0.0 110.769 -177.199 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -91.67 53.24 3.02 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.951 -0.642 . . . . 0.0 111.634 178.597 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.415 ' HA2' ' HD3' ' A' ' 68' ' ' PRO . . . 132.26 124.92 2.6 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.911 -0.662 . . . . 0.0 111.986 -178.372 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.415 ' HD3' ' HA2' ' A' ' 67' ' ' GLY . 13.7 Cg_exo -69.64 170.37 16.6 Favored 'Trans proline' 0 C--O 1.237 0.43 0 C-N-CA 122.912 2.408 . . . . 0.0 112.533 -179.496 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.039 0 CA-C-O 118.509 -0.757 . . . . 0.0 110.068 179.795 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.067 0 CA-C-O 120.968 0.413 . . . . 0.0 110.732 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 101' ' ' MET . . . . . 0.581 ' HE1' ' O ' ' A' ' 14' ' ' LEU . 0.6 OUTLIER -97.12 99.73 11.22 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 120.878 -0.329 . . . . 0.0 111.287 -178.868 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 102' ' ' ARG . . . . . 0.459 ' C ' ' H ' ' B' ' 104' ' ' VAL . 14.9 mmt180 -143.67 112.28 6.49 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 170.042 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 103' ' ' TYR . . . . . 0.857 ' HB2' HG12 ' B' ' 142' ' ' VAL . 52.2 m-85 72.91 -15.16 0.53 Allowed 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.478 0.711 . . . . 0.0 111.807 178.765 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 104' ' ' VAL . . . . . 0.529 ' O ' HD23 ' B' ' 108' ' ' LEU . 50.1 t -43.17 -50.28 1.24 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.371 0 CA-C-O 121.736 0.779 . . . . 0.0 110.255 174.069 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 105' ' ' ALA . . . . . 0.641 ' CB ' ' HB3' ' A' ' 14' ' ' LEU . . . -64.67 -37.85 88.98 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-N 114.519 -1.219 . . . . 0.0 111.669 -174.306 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 106' ' ' SER . . . . . 0.682 ' HB2' HG21 ' B' ' 123' ' ' ILE . 1.4 m -62.82 -37.78 88.11 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.533 0.682 . . . . 0.0 109.391 178.533 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 107' ' ' TYR . . . . . 0.67 ' CG ' HD12 ' B' ' 146' ' ' LEU . 34.2 t80 -63.99 -47.58 79.81 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 114.727 -1.124 . . . . 0.0 108.689 178.285 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 108' ' ' LEU . . . . . 1.05 ' HG ' HD12 ' B' ' 155' ' ' ILE . 0.0 OUTLIER -58.21 -47.54 83.17 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.103 -0.953 . . . . 0.0 110.943 177.522 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 109' ' ' LEU . . . . . 0.877 HD13 ' HB2' ' A' ' 11' ' ' TYR . 8.1 tp -54.19 -48.76 70.61 Favored 'General case' 0 CA--C 1.511 -0.541 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.193 179.11 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.65 -41.13 96.33 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.975 0.417 . . . . 0.0 111.044 -177.442 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 111' ' ' ALA . . . . . 0.678 ' HA ' ' O ' ' B' ' 115' ' ' ASN . . . -68.65 -20.17 64.44 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.275 0.56 . . . . 0.0 110.802 179.318 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 112' ' ' LEU . . . . . 0.679 HD22 ' HB1' ' A' ' 8' ' ' ALA . 1.4 mp -85.14 -37.11 20.59 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.966 173.723 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 113' ' ' GLY . . . . . 0.948 ' HA2' ' HB ' ' A' ' 37' ' ' VAL . . . -62.81 -39.23 97.73 Favored Glycine 0 N--CA 1.445 -0.705 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.769 -179.123 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 114' ' ' GLY . . . . . . . . . . . . . . . 155.09 6.21 0.08 OUTLIER Glycine 0 N--CA 1.44 -1.09 0 C-N-CA 120.217 -0.992 . . . . 0.0 112.928 177.216 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 115' ' ' ASN . . . . . 0.678 ' O ' ' HA ' ' B' ' 111' ' ' ALA . 37.4 t30 -119.63 92.62 3.83 Favored 'General case' 0 N--CA 1.444 -0.77 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 -179.454 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 5.2 p -80.59 27.53 0.36 Allowed 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 122.325 1.059 . . . . 0.0 111.038 -166.049 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 117' ' ' SER . . . . . 0.552 ' N ' ' HD3' ' B' ' 118' ' ' PRO . 33.0 t -172.14 68.29 0.42 Allowed Pre-proline 0 C--N 1.31 -1.137 0 CA-C-N 113.419 -1.719 . . . . 0.0 108.098 178.55 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 118' ' ' PRO . . . . . 0.656 ' HG2' ' O ' ' B' ' 107' ' ' TYR . 37.1 Cg_exo -64.09 156.25 60.07 Favored 'Trans proline' 0 CA--C 1.512 -0.611 0 C-N-CA 125.028 3.818 . . . . 0.0 111.718 -174.291 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 119' ' ' SER . . . . . 0.661 ' O ' HG12 ' B' ' 123' ' ' ILE . 90.2 p -123.75 179.78 4.67 Favored 'General case' 0 C--N 1.314 -0.961 0 C-N-CA 120.079 -0.648 . . . . 0.0 110.831 177.837 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 120' ' ' ALA . . . . . 0.74 ' HB3' HD12 ' B' ' 139' ' ' LEU . . . -65.9 -39.2 90.39 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-O 121.75 0.786 . . . . 0.0 109.617 -172.577 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 121' ' ' LYS . . . . . . . . . . . . . 13.9 mptt -60.33 -37.91 82.12 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 114.076 -1.42 . . . . 0.0 110.538 175.169 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 122' ' ' ASP . . . . . 0.615 ' O ' ' HB2' ' B' ' 125' ' ' LYS . 2.6 t0 -74.44 -35.06 63.33 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 121.665 0.745 . . . . 0.0 109.105 -178.644 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 123' ' ' ILE . . . . . 0.745 ' O ' ' HG ' ' B' ' 127' ' ' LEU . 42.7 mm -60.01 -44.3 94.43 Favored 'Isoleucine or valine' 0 C--O 1.235 0.301 0 CA-C-N 115.43 -0.805 . . . . 0.0 109.511 172.762 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 124' ' ' LYS . . . . . 0.658 ' HD3' HD22 ' B' ' 139' ' ' LEU . 5.2 mmmp? -58.66 -44.59 90.18 Favored 'General case' 0 CA--C 1.503 -0.864 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 -179.27 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 125' ' ' LYS . . . . . 0.615 ' HB2' ' O ' ' B' ' 122' ' ' ASP . 17.6 mmtp -45.03 -66.76 0.36 Allowed 'General case' 0 C--O 1.248 0.975 0 CA-C-O 121.609 0.719 . . . . 0.0 112.54 169.724 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 126' ' ' ILE . . . . . 0.453 HD13 ' HA ' ' A' ' 35' ' ' ALA . 1.7 mp -54.65 -43.23 64.76 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.13 0 CA-C-N 113.801 -1.545 . . . . 0.0 111.112 -168.701 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 127' ' ' LEU . . . . . 0.745 ' HG ' ' O ' ' B' ' 123' ' ' ILE . 1.5 pp -84.27 -23.46 30.35 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.505 0.557 . . . . 0.0 112.505 -178.299 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 128' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -70.44 -27.88 64.6 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 120.784 0.326 . . . . 0.0 110.22 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 129' ' ' SER . . . . . 0.47 ' HB3' ' HB1' ' A' ' 34' ' ' ALA . 89.2 p -55.87 -45.86 78.43 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.292 177.556 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 130' ' ' VAL . . . . . 0.538 HG21 HG13 ' B' ' 132' ' ' ILE . 10.9 m -88.88 -17.93 8.11 Favored 'Isoleucine or valine' 0 C--O 1.231 0.083 0 CA-C-O 120.727 0.299 . . . . 0.0 111.563 179.369 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 131' ' ' GLY . . . . . . . . . . . . . . . 100.74 18.76 19.65 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.661 -0.78 . . . . 0.0 112.686 177.321 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 132' ' ' ILE . . . . . 0.538 HG13 HG21 ' B' ' 130' ' ' VAL . 27.5 mt -78.16 114.93 19.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.788 0.327 . . . . 0.0 110.271 178.334 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 133' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -79.02 138.47 38.03 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.386 -175.263 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 134' ' ' ALA . . . . . . . . . . . . . . . -139.79 143.69 37.0 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.774 -0.648 . . . . 0.0 112.103 -169.442 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 135' ' ' ASP . . . . . 0.78 ' HB2' ' HG3' ' B' ' 138' ' ' ARG . 6.3 m-20 -84.05 128.17 34.38 Favored 'General case' 0 C--O 1.252 1.201 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 175.104 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 136' ' ' ASP . . . . . 0.601 ' HA ' HD11 ' B' ' 139' ' ' LEU . 1.3 p-10 -77.14 -0.34 24.55 Favored 'General case' 0 CA--C 1.518 -0.261 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.26 -166.438 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 137' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -103.22 -31.74 9.96 Favored 'General case' 0 N--CA 1.439 -1.01 0 CA-C-O 121.186 0.517 . . . . 0.0 110.14 172.44 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 138' ' ' ARG . . . . . 0.78 ' HG3' ' HB2' ' B' ' 135' ' ' ASP . 44.9 mmt-85 -63.26 -54.37 38.28 Favored 'General case' 0 CA--C 1.504 -0.803 0 CA-C-O 122.108 0.956 . . . . 0.0 109.177 -177.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 139' ' ' LEU . . . . . 0.88 ' O ' HG12 ' B' ' 143' ' ' ILE . 0.3 OUTLIER -66.88 -28.02 67.99 Favored 'General case' 0 C--O 1.211 -0.96 0 CA-C-N 114.383 -1.28 . . . . 0.0 110.996 -179.942 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 140' ' ' ASN . . . . . 0.702 ' O ' ' HB ' ' B' ' 143' ' ' ILE . 11.1 t30 -75.98 -25.77 56.13 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.712 0.768 . . . . 0.0 110.029 -177.461 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 141' ' ' LYS . . . . . 0.516 ' HG2' ' O ' ' B' ' 138' ' ' ARG . 10.5 ptmt -84.34 -31.39 24.84 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.364 -0.835 . . . . 0.0 109.649 -179.477 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 142' ' ' VAL . . . . . 0.857 HG12 ' HB2' ' B' ' 103' ' ' TYR . 9.6 p -70.22 -33.68 55.58 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.119 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 170.583 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 143' ' ' ILE . . . . . 0.88 HG12 ' O ' ' B' ' 139' ' ' LEU . 29.5 mm -47.84 -61.87 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.376 0 CA-C-O 121.463 0.649 . . . . 0.0 109.375 166.514 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 144' ' ' SER . . . . . . . . . . . . . 25.4 m -49.27 -44.38 43.86 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 114.545 -1.207 . . . . 0.0 112.355 177.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 145' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -70.88 -30.36 66.71 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 112.368 0.507 . . . . 0.0 112.368 -177.606 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 146' ' ' LEU . . . . . 0.67 HD12 ' CG ' ' B' ' 107' ' ' TYR . 5.3 mt -93.55 -17.88 22.86 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.346 -0.541 . . . . 0.0 111.023 -177.763 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 147' ' ' ASN . . . . . . . . . . . . . 39.3 t30 -57.79 115.46 2.84 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.08 -177.702 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . 104.27 15.93 20.0 Favored Glycine 0 N--CA 1.448 -0.536 0 CA-C-N 115.745 -0.662 . . . . 0.0 112.518 -179.248 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 149' ' ' LYS . . . . . 0.422 ' HB2' ' O ' ' B' ' 146' ' ' LEU . 0.6 OUTLIER -112.6 158.59 19.78 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.599 0.238 . . . . 0.0 110.659 179.11 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 150' ' ' ASN . . . . . 0.524 ' O ' HG21 ' B' ' 154' ' ' VAL . 25.9 t-20 -97.7 95.87 7.87 Favored 'General case' 0 CA--C 1.511 -0.529 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 175.523 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 151' ' ' ILE . . . . . 0.78 HG13 HD12 ' B' ' 108' ' ' LEU . 1.8 mp -43.61 -60.79 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 O-C-N 124.621 1.2 . . . . 0.0 113.148 -169.4 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 152' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -56.2 -39.93 73.19 Favored 'General case' 0 C--O 1.212 -0.87 0 N-CA-C 111.708 0.262 . . . . 0.0 111.708 -174.426 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 153' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -74.56 -26.4 59.93 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 120.707 -0.397 . . . . 0.0 110.96 -179.051 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 154' ' ' VAL . . . . . 0.524 HG21 ' O ' ' B' ' 150' ' ' ASN . 53.9 t -59.56 -50.06 81.36 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 170.172 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 155' ' ' ILE . . . . . 1.05 HD12 ' HG ' ' B' ' 108' ' ' LEU . 3.0 mp -107.47 34.29 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.19 -177.05 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . -95.77 -4.29 44.21 Favored 'General case' 0 C--N 1.309 -1.157 0 N-CA-C 107.505 -1.294 . . . . 0.0 107.505 169.51 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 157' ' ' GLN . . . . . . . . . . . . . 70.0 mm-40 -135.63 -27.83 1.14 Allowed 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 113.289 -1.778 . . . . 0.0 110.682 175.415 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 158' ' ' GLY . . . . . 0.487 ' O ' HD13 ' B' ' 162' ' ' LEU . . . -105.85 46.56 1.16 Allowed Glycine 0 C--O 1.222 -0.595 0 CA-C-O 119.581 -0.566 . . . . 0.0 114.511 -171.377 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 159' ' ' ILE . . . . . 0.63 ' HB ' ' CD1' ' A' ' 60' ' ' ILE . 1.8 mp -56.5 -24.0 18.01 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.094 0 CA-C-N 117.385 0.593 . . . . 0.0 110.876 176.043 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 160' ' ' GLY . . . . . . . . . . . . . . . -113.88 -42.11 0.88 Allowed Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 120.835 -0.698 . . . . 0.0 111.805 179.382 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 161' ' ' LYS . . . . . 0.496 ' HD3' ' N ' ' B' ' 161' ' ' LYS . 3.3 mppt? -76.48 39.5 0.21 Allowed 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 112.813 0.671 . . . . 0.0 112.813 -179.736 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 162' ' ' LEU . . . . . 0.512 HD22 ' HG3' ' B' ' 101' ' ' MET . 11.2 mp -48.88 129.73 17.4 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 176.425 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 163' ' ' ALA . . . . . . . . . . . . . . . 47.99 54.75 9.6 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 115.24 -0.891 . . . . 0.0 112.877 178.776 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 164' ' ' SER . . . . . . . . . . . . . 55.3 p 59.2 113.57 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 113.924 1.083 . . . . 0.0 113.924 171.585 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 165' ' ' VAL . . . . . 0.452 HG23 ' HD2' ' B' ' 166' ' ' PRO . 7.8 p -69.2 132.09 90.16 Favored Pre-proline 0 C--N 1.326 -0.446 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 170.781 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 166' ' ' PRO . . . . . 0.452 ' HD2' HG23 ' B' ' 165' ' ' VAL . 10.2 Cg_exo -5.12 109.6 0.0 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.162 1 C-N-CA 127.03 5.153 . . . . 0.0 116.663 -165.364 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 167' ' ' ALA . . . . . . . . . . . . . . . -82.91 94.69 7.77 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 114.349 -1.296 . . . . 0.0 111.477 -171.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 168' ' ' GLY . . . . . . . . . . . . . . . 176.03 -152.55 13.07 Favored Glycine 0 N--CA 1.438 -1.216 0 C-N-CA 120.787 -0.72 . . . . 0.0 111.978 178.04 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 169' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.933 0 CA-C-O 118.781 -1.011 . . . . 0.0 111.618 -175.538 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 52.8 ttm . . . . . 0 N--CA 1.48 1.05 0 CA-C-O 121.026 0.441 . . . . 0.0 110.646 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.573 ' HB3' HD13 ' A' ' 7' ' ' LEU . . . -66.05 148.05 52.4 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.8 -0.637 . . . . 0.0 111.182 175.512 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.541 ' HB2' ' OE1' ' A' ' 6' ' ' GLU . 0.7 OUTLIER -70.2 143.65 52.16 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 173.165 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.538 HG11 ' HG ' ' B' ' 112' ' ' LEU . 2.1 t -51.77 -22.86 2.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-N 114.189 -1.368 . . . . 0.0 112.825 -177.215 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.48 ' HB3' ' HA ' ' A' ' 39' ' ' VAL . 16.8 m -71.32 -58.22 3.74 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 179.162 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.542 ' O ' HG13 ' A' ' 10' ' ' ILE . 2.3 mp0 -54.69 -52.45 62.36 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.657 176.004 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.716 ' HA ' HD12 ' A' ' 10' ' ' ILE . 3.6 tp -56.42 -37.14 69.79 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 115.344 -0.843 . . . . 0.0 112.503 179.782 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.587 ' HB1' HD21 ' B' ' 112' ' ' LEU . . . -70.04 -33.38 71.9 Favored 'General case' 0 N--CA 1.468 0.447 0 O-C-N 122.007 -0.433 . . . . 0.0 110.849 179.059 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.611 ' HB2' HG13 ' A' ' 39' ' ' VAL . 8.2 t -70.32 -38.7 74.97 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 177.686 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.716 HD12 ' HA ' ' A' ' 7' ' ' LEU . 67.4 mt -49.22 -55.88 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.74 0 CA-C-N 114.071 -1.422 . . . . 0.0 109.661 170.679 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.939 ' HH ' ' HB ' ' B' ' 155' ' ' ILE . 23.1 m-85 -67.59 -44.18 78.76 Favored 'General case' 0 C--O 1.22 -0.458 0 CA-C-N 115.771 -0.65 . . . . 0.0 112.164 -173.043 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.0 p -54.56 -46.06 73.58 Favored 'General case' 0 C--O 1.243 0.754 0 CA-C-O 121.447 0.642 . . . . 0.0 109.802 177.305 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.04 -36.94 78.39 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.57 172.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.652 ' HG ' HD23 ' B' ' 162' ' ' LEU . 0.2 OUTLIER -60.84 -55.85 28.2 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.264 -179.537 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.474 HG12 ' O ' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -52.85 -44.81 49.54 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.54 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 177.612 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.733 HD11 HG12 ' A' ' 21' ' ' VAL . 3.4 tp -54.7 -35.6 63.8 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.282 178.135 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . 0.754 ' HE2' HD21 ' A' ' 51' ' ' LEU . 30.5 m-70 -83.48 -14.71 51.84 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 177.574 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.986 ' HA ' ' HA ' ' B' ' 100' ' ' ALA . 6.1 t0 -76.4 -33.69 58.85 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.314 0.578 . . . . 0.0 109.593 -178.676 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.795 ' HB2' HG22 ' B' ' 132' ' ' ILE . 15.1 t70 -96.07 -12.34 25.0 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 174.625 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 55.24 50.05 15.91 Favored 'General case' 0 CA--C 1.518 -0.274 0 CA-C-N 113.861 -1.518 . . . . 0.0 109.979 -175.191 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.733 HG12 HD11 ' A' ' 16' ' ' LEU . 7.9 p -108.08 175.08 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.321 0 CA-C-N 114.589 -1.187 . . . . 0.0 109.286 -174.204 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.574 ' H ' HG21 ' A' ' 21' ' ' VAL . 63.2 p -54.53 137.61 42.66 Favored 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 113.606 0.965 . . . . 0.0 113.606 -170.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.536 ' HA ' HD21 ' A' ' 16' ' ' LEU . 54.0 t -104.91 109.01 26.28 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.758 0 CA-C-N 114.182 -1.372 . . . . 0.0 110.469 -177.484 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.581 ' OG1' ' HB2' ' A' ' 27' ' ' LYS . 82.4 p -144.77 155.8 43.72 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.719 -179.429 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 49.7 tt0 -57.2 -41.7 79.87 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.429 -0.351 . . . . 0.0 110.748 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -66.7 -27.42 67.63 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-O 120.962 0.41 . . . . 0.0 110.449 179.547 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.581 ' HB2' ' OG1' ' A' ' 24' ' ' THR . 3.3 tppt? -71.12 -52.17 20.88 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 -179.195 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 45.9 mt -58.98 -38.65 74.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 114.547 -1.206 . . . . 0.0 110.401 176.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 7.8 m-20 -58.02 -43.5 86.77 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.868 173.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -58.02 -46.61 85.01 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.675 178.015 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.567 ' HB3' HD21 ' B' ' 109' ' ' LEU . 1.3 mm? -59.03 -51.99 67.7 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 121.045 0.45 . . . . 0.0 110.65 175.495 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.606 HG23 ' O ' ' A' ' 37' ' ' VAL . 56.0 mt -49.91 -51.19 17.15 Favored 'Isoleucine or valine' 0 C--O 1.239 0.543 0 CA-C-N 115.155 -0.929 . . . . 0.0 111.916 -178.842 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.585 ' HD2' HG21 ' A' ' 32' ' ' ILE . 14.0 mptt -77.16 -28.14 54.02 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.66 -0.7 . . . . 0.0 112.103 -175.598 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -68.45 -41.43 80.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.902 0.382 . . . . 0.0 110.525 177.464 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -79.26 -38.65 34.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.255 0.55 . . . . 0.0 110.858 178.231 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 101.15 16.94 23.98 Favored Glycine 0 N--CA 1.447 -0.614 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.848 -179.313 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.906 ' HB ' ' HA2' ' B' ' 113' ' ' GLY . 3.0 p -121.11 121.17 64.24 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.423 0 CA-C-O 121.241 0.543 . . . . 0.0 110.827 -177.264 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.536 ' HA ' HG23 ' A' ' 32' ' ' ILE . 8.0 t-20 -100.59 167.65 10.21 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.153 -0.931 . . . . 0.0 110.869 -171.356 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.611 HG13 ' HB2' ' A' ' 9' ' ' CYS . 94.7 t -132.79 165.07 33.47 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 CA-C-N 115.01 -0.996 . . . . 0.0 110.477 -170.585 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.515 ' HB3' ' HD1' ' A' ' 43' ' ' TRP . 4.7 tp10 -68.44 108.07 2.53 Favored Pre-proline 0 N--CA 1.444 -0.726 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 168.353 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.488 ' C ' ' HD2' ' A' ' 44' ' ' PRO . 81.1 Cg_exo -51.77 -28.77 31.55 Favored 'Trans proline' 0 C--O 1.251 1.145 0 C-N-CA 123.582 2.855 . . . . 0.0 115.855 -164.243 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -61.41 -27.77 68.78 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 120.39 -0.524 . . . . 0.0 109.627 177.562 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . 0.571 ' CE3' ' HE1' ' A' ' 47' ' ' PHE . 14.1 m95 -64.46 -60.63 8.08 Favored Pre-proline 0 C--O 1.206 -1.222 0 CA-C-O 118.467 -0.778 . . . . 0.0 110.914 176.566 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.488 ' HD2' ' C ' ' A' ' 41' ' ' PRO . 96.8 Cg_exo -46.13 -44.37 19.55 Favored 'Trans proline' 0 C--N 1.359 1.13 0 C-N-CA 121.811 1.674 . . . . 0.0 111.88 175.176 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -58.7 -62.24 6.47 Favored Glycine 0 CA--C 1.525 0.684 0 C-N-CA 120.187 -1.006 . . . . 0.0 112.631 176.428 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.404 ' O ' ' HB2' ' A' ' 49' ' ' LYS . 4.2 tp -64.44 -32.31 73.89 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 123.081 0.552 . . . . 0.0 111.99 -176.789 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.571 ' HE1' ' CE3' ' A' ' 43' ' ' TRP . 3.2 m-85 -61.81 -50.69 71.31 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 120.826 0.346 . . . . 0.0 110.089 175.483 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.46 ' HA ' HG11 ' A' ' 23' ' ' VAL . . . -66.37 -28.58 68.76 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.572 0.701 . . . . 0.0 109.891 -178.645 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.404 ' HB2' ' O ' ' A' ' 46' ' ' LEU . 9.4 mmmt -65.66 -51.08 62.25 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 114.546 -1.206 . . . . 0.0 112.08 174.538 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.402 ' O ' HG23 ' A' ' 54' ' ' VAL . . . -88.36 -36.69 16.45 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 113.215 0.821 . . . . 0.0 113.215 -169.471 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.754 HD21 ' HE2' ' A' ' 17' ' ' HIS . 24.0 mt -68.65 -0.7 5.53 Favored 'General case' 0 N--CA 1.464 0.227 0 N-CA-C 112.456 0.539 . . . . 0.0 112.456 -172.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -84.96 -1.75 57.08 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.818 0.342 . . . . 0.0 110.307 173.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 9.6 t30 -143.97 -39.66 0.29 Allowed 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.228 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.402 HG23 ' O ' ' A' ' 50' ' ' ALA . 6.4 m -82.27 -171.49 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 178.309 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 18.3 m120 -121.32 175.93 5.9 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.044 0.45 . . . . 0.0 110.758 177.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.634 HD11 HD22 ' A' ' 14' ' ' LEU . 4.3 tp -75.78 -26.22 17.78 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 177.69 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -72.64 -9.52 74.44 Favored Glycine 0 N--CA 1.445 -0.713 0 N-CA-C 111.058 -0.817 . . . . 0.0 111.058 175.167 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 21.2 m -80.48 -24.56 39.37 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-O 121.346 0.593 . . . . 0.0 109.523 177.045 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.577 HD13 HD13 ' A' ' 56' ' ' ILE . 24.9 mt -60.79 -32.83 72.16 Favored 'General case' 0 CA--C 1.517 -0.304 0 CA-C-N 115.443 -0.798 . . . . 0.0 110.957 -178.848 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.596 ' CD1' ' HB ' ' B' ' 159' ' ' ILE . 0.1 OUTLIER -63.46 -14.72 15.02 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 CA-C-N 114.786 -1.097 . . . . 0.0 111.18 -177.999 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 25.3 t -88.37 -3.15 58.89 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.844 -176.494 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -58.6 -28.47 65.62 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.388 -173.531 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 16.5 m -87.99 29.66 0.12 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.201 0 CA-C-O 121.283 0.563 . . . . 0.0 111.639 -177.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 101.27 -94.1 1.21 Allowed Glycine 0 N--CA 1.446 -0.647 0 CA-C-N 115.564 -0.744 . . . . 0.0 112.438 177.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . 60.37 13.88 4.34 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 113.027 0.751 . . . . 0.0 113.027 179.11 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 59.07 56.21 26.59 Favored Glycine 0 C--N 1.332 0.339 0 CA-C-N 116.012 -0.54 . . . . 0.0 112.908 179.259 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.441 ' HA2' ' HD3' ' A' ' 68' ' ' PRO . . . -58.43 134.63 52.36 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.979 -0.629 . . . . 0.0 112.837 -177.614 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.441 ' HD3' ' HA2' ' A' ' 67' ' ' GLY . 26.0 Cg_exo -62.9 -58.51 0.31 Allowed 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.975 2.45 . . . . 0.0 111.876 179.593 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.097 0 CA-C-O 118.579 -0.724 . . . . 0.0 110.331 179.639 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 100' ' ' ALA . . . . . 0.986 ' HA ' ' HA ' ' A' ' 18' ' ' ASP . . . . . . . . 0 N--CA 1.478 0.958 0 CA-C-O 120.782 0.325 . . . . 0.0 110.532 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 101' ' ' MET . . . . . 0.598 ' CE ' HD12 ' A' ' 14' ' ' LEU . 0.0 OUTLIER -132.37 -81.19 0.5 Allowed 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.758 176.427 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 102' ' ' ARG . . . . . 0.58 ' HB2' ' O ' ' B' ' 101' ' ' MET . 54.3 ttp180 168.1 60.06 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.412 0 O-C-N 123.785 0.678 . . . . 0.0 111.568 176.582 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 103' ' ' TYR . . . . . 0.602 ' HB2' HG11 ' B' ' 142' ' ' VAL . 39.6 m-85 66.62 -4.2 0.78 Allowed 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 168.372 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 104' ' ' VAL . . . . . 0.737 HG13 ' HB3' ' B' ' 162' ' ' LEU . 96.1 t -44.42 -46.45 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 CA-C-O 121.864 0.84 . . . . 0.0 109.391 174.153 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 105' ' ' ALA . . . . . 0.623 ' CB ' ' HB3' ' A' ' 14' ' ' LEU . . . -66.8 -38.47 86.57 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-N 114.288 -1.324 . . . . 0.0 112.226 -173.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 106' ' ' SER . . . . . 0.709 ' HB2' HG21 ' B' ' 123' ' ' ILE . 3.2 m -63.82 -37.86 88.96 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-O 121.625 0.726 . . . . 0.0 109.611 178.536 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 107' ' ' TYR . . . . . 0.72 ' CG ' HD12 ' B' ' 146' ' ' LEU . 33.1 t80 -62.28 -49.57 75.14 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 114.684 -1.144 . . . . 0.0 108.316 177.549 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 108' ' ' LEU . . . . . 0.786 HD12 HG13 ' B' ' 151' ' ' ILE . 0.0 OUTLIER -56.28 -47.49 78.5 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 114.542 -1.208 . . . . 0.0 111.313 177.866 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 109' ' ' LEU . . . . . 0.567 HD21 ' HB3' ' A' ' 31' ' ' LEU . 8.9 tp -56.6 -47.75 78.93 Favored 'General case' 0 CA--C 1.515 -0.398 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.908 179.759 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 110' ' ' ALA . . . . . 0.413 ' HB2' ' HB3' ' B' ' 118' ' ' PRO . . . -64.26 -39.76 94.62 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.583 -0.447 . . . . 0.0 110.985 -177.149 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 111' ' ' ALA . . . . . 0.691 ' HA ' ' O ' ' B' ' 115' ' ' ASN . . . -66.66 -28.89 68.83 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.53 179.862 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 112' ' ' LEU . . . . . 0.587 HD21 ' HB1' ' A' ' 8' ' ' ALA . 1.8 mp -80.37 -34.85 36.13 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.35 175.558 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 113' ' ' GLY . . . . . 0.906 ' HA2' ' HB ' ' A' ' 37' ' ' VAL . . . -64.15 -25.05 69.32 Favored Glycine 0 CA--C 1.504 -0.619 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.814 179.363 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 114' ' ' GLY . . . . . . . . . . . . . . . 144.17 -4.73 1.6 Allowed Glycine 0 N--CA 1.436 -1.326 0 C-N-CA 120.25 -0.976 . . . . 0.0 112.993 176.604 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 115' ' ' ASN . . . . . 0.691 ' O ' ' HA ' ' B' ' 111' ' ' ALA . 8.9 t30 -117.06 90.83 3.42 Favored 'General case' 0 CA--C 1.507 -0.688 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 -176.236 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 7.5 p -77.44 23.64 0.21 Allowed 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.062 -0.972 . . . . 0.0 111.836 -164.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 117' ' ' SER . . . . . 0.577 ' N ' ' HD3' ' B' ' 118' ' ' PRO . 8.5 t -164.92 66.93 1.25 Allowed Pre-proline 0 C--N 1.311 -1.092 0 CA-C-N 114.293 -1.321 . . . . 0.0 108.664 179.648 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 118' ' ' PRO . . . . . 0.715 ' HG2' ' O ' ' B' ' 107' ' ' TYR . 33.9 Cg_exo -64.56 157.8 53.32 Favored 'Trans proline' 0 C--N 1.328 -0.517 1 C-N-CA 125.444 4.096 . . . . 0.0 112.351 -174.091 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 119' ' ' SER . . . . . 0.625 ' O ' HG12 ' B' ' 123' ' ' ILE . 27.2 m -126.02 -175.56 3.39 Favored 'General case' 0 C--N 1.316 -0.856 0 C-N-CA 120.597 -0.441 . . . . 0.0 110.943 177.076 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 120' ' ' ALA . . . . . 0.785 ' HB3' HD11 ' B' ' 139' ' ' LEU . . . -67.84 -35.24 78.24 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 122.214 1.007 . . . . 0.0 110.014 -166.532 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 121' ' ' LYS . . . . . 0.462 ' HD2' ' N ' ' B' ' 121' ' ' LYS . 4.4 mptp? -74.24 -26.76 60.42 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 113.681 -1.6 . . . . 0.0 109.756 -179.07 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 122' ' ' ASP . . . . . . . . . . . . . 25.8 m-20 -72.57 -41.31 65.85 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 174.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 123' ' ' ILE . . . . . 0.709 HG21 ' HB2' ' B' ' 106' ' ' SER . 36.8 mm -54.11 -48.05 65.78 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.368 0 CA-C-N 114.988 -1.005 . . . . 0.0 109.489 173.655 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 124' ' ' LYS . . . . . 0.827 ' HD2' HD13 ' B' ' 127' ' ' LEU . 2.7 mmmt -62.58 -40.71 97.75 Favored 'General case' 0 N--CA 1.439 -1.011 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.785 -176.545 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 125' ' ' LYS . . . . . . . . . . . . . 42.0 mmtt -50.65 -62.68 1.45 Allowed 'General case' 0 CA--C 1.498 -1.023 0 CA-C-O 121.776 0.798 . . . . 0.0 111.367 170.421 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 126' ' ' ILE . . . . . 0.406 HG23 HD11 ' A' ' 31' ' ' LEU . 1.7 mp -56.77 -41.48 75.35 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 CA-C-N 113.756 -1.565 . . . . 0.0 110.758 -169.733 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 127' ' ' LEU . . . . . 0.827 HD13 ' HD2' ' B' ' 124' ' ' LYS . 3.9 pp -79.08 -32.73 44.79 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 -178.548 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 128' ' ' ASP . . . . . 0.524 ' HB2' ' O ' ' B' ' 124' ' ' LYS . 0.6 OUTLIER -70.24 -24.78 63.14 Favored 'General case' 0 CA--C 1.517 -0.323 0 C-N-CA 121.326 -0.15 . . . . 0.0 111.261 -177.587 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 129' ' ' SER . . . . . . . . . . . . . 93.7 p -56.72 -37.19 70.6 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-O 120.928 0.394 . . . . 0.0 111.2 176.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 130' ' ' VAL . . . . . 0.775 HG22 HG13 ' B' ' 132' ' ' ILE . 13.0 m -104.69 -2.9 9.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.391 179.471 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 131' ' ' GLY . . . . . . . . . . . . . . . 81.01 36.04 22.76 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 121.029 -0.605 . . . . 0.0 112.882 177.328 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 132' ' ' ILE . . . . . 0.795 HG22 ' HB2' ' A' ' 19' ' ' ASP . 18.6 mt -78.86 131.94 33.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 110.443 -0.206 . . . . 0.0 110.443 177.402 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 133' ' ' GLU . . . . . . . . . . . . . 87.5 mt-10 -77.0 125.24 29.0 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.361 0.6 . . . . 0.0 110.663 -176.197 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 134' ' ' ALA . . . . . 0.495 ' HB3' ' HD3' ' B' ' 124' ' ' LYS . . . -134.99 143.7 46.97 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.381 -0.827 . . . . 0.0 112.135 -173.202 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 135' ' ' ASP . . . . . 0.755 ' HB2' ' HG3' ' B' ' 138' ' ' ARG . 16.2 m-20 -103.11 132.43 49.37 Favored 'General case' 0 C--O 1.252 1.223 0 CA-C-N 115.65 -0.704 . . . . 0.0 109.358 170.515 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 136' ' ' ASP . . . . . 0.662 ' HA ' HD13 ' B' ' 139' ' ' LEU . 17.4 t70 -73.8 -8.61 56.69 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.061 -166.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 137' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -96.11 -29.77 13.9 Favored 'General case' 0 N--CA 1.44 -0.953 0 C-N-CA 120.17 -0.612 . . . . 0.0 110.54 174.374 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 138' ' ' ARG . . . . . 0.755 ' HG3' ' HB2' ' B' ' 135' ' ' ASP . 12.8 mmt180 -68.26 -52.12 37.41 Favored 'General case' 0 CA--C 1.503 -0.86 0 CA-C-O 122.176 0.988 . . . . 0.0 108.665 -175.595 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 139' ' ' LEU . . . . . 0.879 ' O ' HG12 ' B' ' 143' ' ' ILE . 0.4 OUTLIER -67.47 -30.3 69.97 Favored 'General case' 0 C--O 1.209 -1.038 0 CA-C-N 114.024 -1.444 . . . . 0.0 110.878 -179.528 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 140' ' ' ASN . . . . . 0.602 ' O ' ' HB ' ' B' ' 143' ' ' ILE . 12.1 t30 -75.94 -25.41 55.92 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.591 0.71 . . . . 0.0 109.805 -177.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 141' ' ' LYS . . . . . 0.52 ' HG2' ' O ' ' B' ' 138' ' ' ARG . 2.6 ptmm? -77.94 -38.55 45.13 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 179.056 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 142' ' ' VAL . . . . . 0.649 HG13 ' O ' ' B' ' 139' ' ' LEU . 7.2 p -69.38 -32.98 55.38 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.401 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 175.05 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 143' ' ' ILE . . . . . 0.879 HG12 ' O ' ' B' ' 139' ' ' LEU . 23.5 mm -49.14 -62.56 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.512 -0.486 0 CA-C-O 121.41 0.624 . . . . 0.0 110.001 166.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 144' ' ' SER . . . . . . . . . . . . . 47.4 t -54.08 -34.2 59.52 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 114.608 -1.178 . . . . 0.0 111.695 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 145' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -79.52 -30.79 42.02 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.426 0.528 . . . . 0.0 112.426 -178.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 146' ' ' LEU . . . . . 0.72 HD12 ' CG ' ' B' ' 107' ' ' TYR . 6.6 mt -89.55 -31.79 17.44 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.63 -0.428 . . . . 0.0 110.99 179.021 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 147' ' ' ASN . . . . . 0.471 ' HA ' ' OH ' ' B' ' 107' ' ' TYR . 8.3 t30 -40.52 120.34 1.23 Allowed 'General case' 0 N--CA 1.471 0.587 0 O-C-N 124.079 0.862 . . . . 0.0 112.838 -169.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . 90.89 36.36 6.79 Favored Glycine 0 N--CA 1.447 -0.57 0 CA-C-N 115.342 -0.844 . . . . 0.0 111.905 -177.7 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 149' ' ' LYS . . . . . 0.67 ' HB2' ' O ' ' B' ' 146' ' ' LEU . 5.2 tppt? -116.92 159.29 22.66 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 110.231 -0.285 . . . . 0.0 110.231 -177.45 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 150' ' ' ASN . . . . . 0.57 ' O ' HG21 ' B' ' 154' ' ' VAL . 92.5 m-20 -106.19 89.95 3.21 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 177.056 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 151' ' ' ILE . . . . . 0.786 HG13 HD12 ' B' ' 108' ' ' LEU . 1.8 mp -46.69 -61.87 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 114.223 -1.353 . . . . 0.0 113.604 -166.797 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 152' ' ' GLU . . . . . 0.408 ' HA ' HD23 ' A' ' 7' ' ' LEU . 22.5 mt-10 -53.96 -34.1 58.75 Favored 'General case' 0 C--O 1.216 -0.672 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 -173.281 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 153' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -81.36 -32.94 32.69 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 120.744 -0.382 . . . . 0.0 110.794 -179.575 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 154' ' ' VAL . . . . . 0.959 ' HB ' HD11 ' B' ' 155' ' ' ILE . 40.0 t -53.26 -48.83 54.73 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 169.828 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 155' ' ' ILE . . . . . 0.959 HD11 ' HB ' ' B' ' 154' ' ' VAL . 1.5 mp -108.5 38.6 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.005 -0.998 . . . . 0.0 110.893 -178.069 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . -99.25 7.14 45.97 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 107.115 -1.439 . . . . 0.0 107.115 166.179 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 157' ' ' GLN . . . . . . . . . . . . . 25.5 mt-30 -143.05 -43.83 0.3 Allowed 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 112.844 -1.98 . . . . 0.0 109.459 175.748 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 158' ' ' GLY . . . . . . . . . . . . . . . -86.57 47.2 3.69 Favored Glycine 0 CA--C 1.521 0.46 0 CA-C-N 115.439 -0.801 . . . . 0.0 114.217 -173.577 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 159' ' ' ILE . . . . . 0.596 ' HB ' ' CD1' ' A' ' 60' ' ' ILE . 1.8 mp -63.63 -14.6 15.04 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 CA-C-O 121.8 0.81 . . . . 0.0 110.104 176.395 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 160' ' ' GLY . . . . . . . . . . . . . . . -130.8 139.51 11.0 Favored Glycine 0 N--CA 1.441 -0.994 0 N-CA-C 110.349 -1.1 . . . . 0.0 110.349 179.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 161' ' ' LYS . . . . . 0.733 ' HZ3' ' HB2' ' B' ' 161' ' ' LYS . 0.1 OUTLIER 55.14 40.31 31.75 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.931 0.396 . . . . 0.0 111.201 -172.355 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 162' ' ' LEU . . . . . 0.737 ' HB3' HG13 ' B' ' 104' ' ' VAL . 6.8 mp -28.29 119.23 0.11 Allowed 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 114.437 -1.256 . . . . 0.0 114.042 173.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 163' ' ' ALA . . . . . . . . . . . . . . . 46.1 -90.2 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 O-C-N 124.648 1.217 . . . . 0.0 113.646 177.394 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 164' ' ' SER . . . . . . . . . . . . . 13.7 p -79.55 104.27 10.03 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.176 0.512 . . . . 0.0 111.165 -178.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 165' ' ' VAL . . . . . 0.419 ' HA ' ' HD2' ' B' ' 166' ' ' PRO . 34.9 t -75.5 131.19 77.87 Favored Pre-proline 0 C--N 1.32 -0.703 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.869 -179.369 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 166' ' ' PRO . . . . . 0.419 ' HD2' ' HA ' ' B' ' 165' ' ' VAL . 40.3 Cg_exo -17.54 118.76 0.01 OUTLIER 'Trans proline' 0 N--CA 1.443 -1.47 1 C-N-CA 127.131 5.22 . . . . 0.0 115.545 177.976 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 167' ' ' ALA . . . . . . . . . . . . . . . 50.61 56.4 8.02 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.804 -176.413 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 168' ' ' GLY . . . . . . . . . . . . . . . -87.08 64.77 3.81 Favored Glycine 0 N--CA 1.447 -0.61 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.905 -178.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 169' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.919 0 CA-C-O 118.667 -1.074 . . . . 0.0 111.291 178.942 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.2 ttt . . . . . 0 N--CA 1.478 0.96 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.577 ' HB1' HD11 ' A' ' 7' ' ' LEU . . . -63.29 150.07 44.12 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.784 178.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 12.0 m -80.06 131.19 35.72 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 173.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.798 HG13 ' HG ' ' B' ' 112' ' ' LEU . 2.0 t -47.05 -28.61 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.254 -0.884 . . . . 0.0 113.38 -177.027 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.883 ' HB3' ' HA ' ' A' ' 39' ' ' VAL . 69.1 m -70.64 -50.93 31.59 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.864 0.84 . . . . 0.0 109.001 176.278 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.475 ' O ' HG13 ' A' ' 10' ' ' ILE . 40.4 tt0 -57.31 -51.18 70.41 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 114.598 -1.183 . . . . 0.0 109.81 176.454 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.686 ' O ' ' HB ' ' A' ' 10' ' ' ILE . 5.7 tp -58.9 -36.28 74.44 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.547 177.568 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.502 ' HB3' HD21 ' B' ' 112' ' ' LEU . . . -66.65 -35.99 81.49 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 121.199 0.523 . . . . 0.0 110.889 178.532 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.53 ' HB2' HG11 ' A' ' 39' ' ' VAL . 7.4 t -68.0 -42.97 79.9 Favored 'General case' 0 C--O 1.242 0.687 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 179.027 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.686 ' HB ' ' O ' ' A' ' 7' ' ' LEU . 72.0 mt -46.34 -56.77 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.605 0 CA-C-N 113.669 -1.605 . . . . 0.0 109.982 170.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.859 ' HB2' HD13 ' B' ' 109' ' ' LEU . 23.9 m-85 -64.3 -36.76 85.15 Favored 'General case' 0 CA--C 1.512 -0.484 0 CA-C-N 115.441 -0.799 . . . . 0.0 111.271 -174.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.421 ' HA ' ' HG ' ' A' ' 31' ' ' LEU . 18.9 m -56.97 -42.93 81.05 Favored 'General case' 0 C--O 1.243 0.712 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 177.574 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.41 ' CB ' HD13 ' A' ' 51' ' ' LEU . . . -67.17 -31.97 72.74 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.195 175.846 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.804 HD12 ' HE2' ' B' ' 101' ' ' MET . 0.3 OUTLIER -63.58 -54.3 38.2 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.316 179.689 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.55 HG12 ' O ' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -60.23 -35.85 64.65 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.412 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 178.868 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.507 HD21 ' HA ' ' A' ' 23' ' ' VAL . 2.3 tp -59.85 -36.06 76.06 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.904 175.616 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . 0.515 ' CD2' ' HB ' ' A' ' 56' ' ' ILE . 70.2 m-70 -73.12 -18.7 61.26 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 116.145 -0.48 . . . . 0.0 112.254 176.479 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -59.37 -38.48 80.56 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 121.074 0.464 . . . . 0.0 110.171 179.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.424 ' CB ' HG12 ' B' ' 132' ' ' ILE . 32.0 t70 -111.25 -4.75 14.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.822 0.82 . . . . 0.0 109.827 176.92 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.449 ' HG2' ' O ' ' A' ' 17' ' ' HIS . 5.5 mm-40 53.1 48.38 22.39 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-N 114.446 -1.252 . . . . 0.0 110.266 -175.398 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.715 HG21 ' H ' ' A' ' 22' ' ' THR . 13.8 p -100.84 -179.55 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.156 0 CA-C-N 114.903 -1.044 . . . . 0.0 109.966 -170.327 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.715 ' H ' HG21 ' A' ' 21' ' ' VAL . 32.6 p -50.2 141.8 10.82 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 113.608 0.966 . . . . 0.0 113.608 -173.456 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.535 HG12 ' HA ' ' A' ' 48' ' ' ALA . 58.3 t -118.86 111.01 31.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 114.343 -1.298 . . . . 0.0 110.332 -175.2 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.528 ' OG1' ' HE2' ' A' ' 27' ' ' LYS . 77.0 p -143.54 156.67 44.67 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.002 177.84 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -56.64 -40.23 75.06 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.954 0.407 . . . . 0.0 110.259 177.309 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -56.95 -39.26 74.21 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.294 173.314 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.528 ' HE2' ' OG1' ' A' ' 24' ' ' THR . 1.6 tppt? -63.31 -52.04 63.53 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-O 121.94 0.876 . . . . 0.0 109.093 -179.178 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 27.8 mt -61.0 -38.96 80.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 114.628 -1.169 . . . . 0.0 110.72 179.144 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 11.3 m-80 -61.27 -35.49 77.43 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.782 175.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.91 -47.92 78.67 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.513 176.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.745 ' HB3' HD23 ' B' ' 109' ' ' LEU . 1.2 mm? -58.01 -50.13 74.46 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 121.113 0.482 . . . . 0.0 110.418 174.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.617 HG22 ' O ' ' A' ' 37' ' ' VAL . 57.7 mt -48.34 -48.18 13.77 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 CA-C-N 115.039 -0.982 . . . . 0.0 111.925 178.387 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 22.8 tptm -75.95 -38.82 57.15 Favored 'General case' 0 N--CA 1.433 -1.306 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.799 -174.343 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -67.39 -33.59 75.52 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.964 0.411 . . . . 0.0 110.787 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.511 ' CB ' ' HG ' ' B' ' 109' ' ' LEU . . . -82.44 -36.57 26.49 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.856 177.625 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 97.29 18.15 29.57 Favored Glycine 0 N--CA 1.447 -0.591 0 CA-C-N 115.733 -0.667 . . . . 0.0 112.017 179.483 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.903 ' HB ' ' HA2' ' B' ' 113' ' ' GLY . 2.7 p -121.91 120.84 62.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 121.583 0.706 . . . . 0.0 111.104 -176.216 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -93.69 155.22 17.37 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 114.504 -1.226 . . . . 0.0 110.891 -170.599 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.883 ' HA ' ' HB3' ' A' ' 5' ' ' SER . 97.8 t -127.22 161.3 34.72 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-N 115.102 -0.954 . . . . 0.0 110.593 -170.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.482 ' HB3' ' HD1' ' A' ' 43' ' ' TRP . 3.8 tp10 -67.55 105.49 0.92 Allowed Pre-proline 0 N--CA 1.444 -0.731 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 170.882 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.492 ' C ' ' HD2' ' A' ' 44' ' ' PRO . 76.9 Cg_exo -50.93 -30.5 30.69 Favored 'Trans proline' 0 C--O 1.252 1.175 0 C-N-CA 123.599 2.866 . . . . 0.0 115.6 -163.657 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -60.04 -28.3 67.65 Favored 'General case' 0 C--N 1.334 -0.097 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 178.167 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . 0.482 ' HD1' ' HB3' ' A' ' 40' ' ' GLU . 7.9 m95 -62.82 -61.66 7.09 Favored Pre-proline 0 C--O 1.205 -1.24 0 CA-C-O 118.27 -0.871 . . . . 0.0 110.725 176.56 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.492 ' HD2' ' C ' ' A' ' 41' ' ' PRO . 99.3 Cg_exo -44.98 -46.24 13.27 Favored 'Trans proline' 0 C--N 1.36 1.145 0 C-N-CA 121.811 1.674 . . . . 0.0 111.981 175.346 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -59.12 -61.58 7.18 Favored Glycine 0 CA--C 1.525 0.68 0 C-N-CA 120.172 -1.013 . . . . 0.0 112.491 177.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 4.5 tp -67.08 -22.61 65.83 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 122.887 0.475 . . . . 0.0 111.714 -176.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.44 ' HE1' ' CE3' ' A' ' 43' ' ' TRP . 2.0 m-85 -69.76 -46.41 65.88 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 175.895 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.535 ' HA ' HG12 ' A' ' 23' ' ' VAL . . . -65.05 -32.22 73.83 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.805 0.812 . . . . 0.0 109.237 178.216 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 11.1 mmmt -66.72 -49.44 66.03 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 114.303 -1.317 . . . . 0.0 111.938 174.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -84.74 -34.75 22.81 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 113.3 0.852 . . . . 0.0 113.3 -169.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.455 ' HB2' HG13 ' A' ' 23' ' ' VAL . 9.7 mt -67.07 -0.8 3.51 Favored 'General case' 0 N--CA 1.462 0.165 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 -175.281 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -85.89 -14.99 43.18 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.974 0.416 . . . . 0.0 110.353 174.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 91.8 m-20 -123.05 -49.89 1.94 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.717 -179.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 3.8 m -88.28 166.97 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.584 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.399 -179.242 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 -113.95 179.38 3.97 Favored 'General case' 0 C--N 1.312 -1.023 0 C-N-CA 120.475 -0.49 . . . . 0.0 109.783 176.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.761 HD13 HD23 ' A' ' 14' ' ' LEU . 4.6 tp -64.16 -25.35 37.86 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 CA-C-O 120.868 0.366 . . . . 0.0 111.025 -176.345 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -70.47 -15.26 72.79 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.631 -0.795 . . . . 0.0 111.151 178.132 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 33.3 t -78.64 -20.98 49.08 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-O 120.911 0.386 . . . . 0.0 110.184 179.544 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.575 HD13 HD12 ' A' ' 56' ' ' ILE . 20.9 mt -65.98 -26.96 67.8 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.859 0.838 . . . . 0.0 110.482 -178.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.728 HG13 ' HB ' ' B' ' 159' ' ' ILE . 0.2 OUTLIER -67.27 -13.28 16.46 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-N 114.418 -1.264 . . . . 0.0 110.509 178.685 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 33.9 t -94.63 -15.41 24.03 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.782 179.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -75.82 -51.03 13.47 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.996 -175.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 9.1 p -88.19 33.01 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 122.239 1.019 . . . . 0.0 110.662 -177.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 97.39 111.31 2.88 Favored Glycine 0 N--CA 1.446 -0.657 0 CA-C-N 115.193 -0.912 . . . . 0.0 111.666 -177.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -77.08 51.09 0.79 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.247 0.546 . . . . 0.0 111.622 -176.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 175.63 153.64 10.57 Favored Glycine 0 N--CA 1.445 -0.736 0 N-CA-C 111.271 -0.732 . . . . 0.0 111.271 179.607 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -128.45 112.62 1.45 Allowed Glycine 0 N--CA 1.446 -0.676 0 C-N-CA 120.463 -0.875 . . . . 0.0 112.196 -178.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -71.04 148.48 56.92 Favored 'Trans proline' 0 C--O 1.235 0.35 0 C-N-CA 122.568 2.179 . . . . 0.0 111.932 178.07 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.932 0 CA-C-O 118.574 -0.727 . . . . 0.0 110.401 179.536 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.047 0 CA-C-O 121.198 0.523 . . . . 0.0 110.518 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 101' ' ' MET . . . . . 0.804 ' HE2' HD12 ' A' ' 14' ' ' LEU . 1.1 tmt? -81.86 124.18 29.47 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.167 179.849 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 102' ' ' ARG . . . . . 0.424 ' HG3' ' O ' ' B' ' 101' ' ' MET . 8.7 mtp180 -164.51 -99.41 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 O-C-N 123.792 0.682 . . . . 0.0 109.792 173.486 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 103' ' ' TYR . . . . . 0.936 ' HB2' HG12 ' B' ' 142' ' ' VAL . 58.1 m-85 -81.22 -8.79 59.82 Favored 'General case' 0 C--O 1.242 0.662 0 CA-C-O 121.023 0.439 . . . . 0.0 110.616 -178.388 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 104' ' ' VAL . . . . . 0.714 ' HA ' HD11 ' B' ' 146' ' ' LEU . 90.2 t -45.0 -49.08 2.72 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.353 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.31 172.201 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 105' ' ' ALA . . . . . 0.629 ' CB ' ' HB3' ' A' ' 14' ' ' LEU . . . -62.86 -41.1 99.24 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.271 -1.331 . . . . 0.0 112.088 -174.323 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 106' ' ' SER . . . . . 0.806 ' HB2' HG23 ' B' ' 123' ' ' ILE . 1.0 OUTLIER -62.73 -38.92 92.42 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.58 0.705 . . . . 0.0 109.538 179.296 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 107' ' ' TYR . . . . . 0.692 ' CG ' HD13 ' B' ' 146' ' ' LEU . 39.5 t80 -62.04 -46.71 87.94 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 114.443 -1.253 . . . . 0.0 108.748 178.48 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 108' ' ' LEU . . . . . 1.082 ' HG ' HD12 ' B' ' 155' ' ' ILE . 0.0 OUTLIER -58.66 -46.92 86.12 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 114.409 -1.268 . . . . 0.0 111.088 177.882 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 109' ' ' LEU . . . . . 0.859 HD13 ' HB2' ' A' ' 11' ' ' TYR . 7.2 tp -55.43 -49.33 72.7 Favored 'General case' 0 CA--C 1.513 -0.474 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.793 179.672 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -62.76 -42.63 99.77 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.809 -177.625 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 111' ' ' ALA . . . . . 0.616 ' HA ' ' O ' ' B' ' 115' ' ' ASN . . . -65.64 -27.66 68.55 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.874 179.659 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 112' ' ' LEU . . . . . 0.798 ' HG ' HG13 ' A' ' 4' ' ' VAL . 2.3 mp -78.5 -37.79 42.35 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.007 175.351 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 113' ' ' GLY . . . . . 0.903 ' HA2' ' HB ' ' A' ' 37' ' ' VAL . . . -63.5 -38.88 97.01 Favored Glycine 0 CA--C 1.503 -0.657 0 CA-C-N 115.125 -0.943 . . . . 0.0 111.972 -179.038 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 114' ' ' GLY . . . . . . . . . . . . . . . 159.78 -4.08 0.1 Allowed Glycine 0 N--CA 1.44 -1.072 0 C-N-CA 120.144 -1.027 . . . . 0.0 113.029 177.456 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 115' ' ' ASN . . . . . 0.616 ' O ' ' HA ' ' B' ' 111' ' ' ALA . 45.0 t30 -116.18 86.04 2.41 Favored 'General case' 0 N--CA 1.44 -0.956 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 -176.571 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 116' ' ' SER . . . . . 0.463 ' HA ' ' CB ' ' B' ' 111' ' ' ALA . 3.3 m -78.56 28.46 0.2 Allowed 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 122.239 1.019 . . . . 0.0 110.763 -169.181 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 117' ' ' SER . . . . . 0.569 ' N ' ' HD3' ' B' ' 118' ' ' PRO . 22.7 t -166.19 67.3 1.05 Allowed Pre-proline 0 C--N 1.308 -1.222 0 CA-C-N 113.495 -1.684 . . . . 0.0 107.92 178.211 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 118' ' ' PRO . . . . . 0.633 ' HD2' ' CZ ' ' B' ' 107' ' ' TYR . 26.9 Cg_exo -67.36 165.35 27.24 Favored 'Trans proline' 0 C--O 1.235 0.36 1 C-N-CA 125.44 4.093 . . . . 0.0 112.257 -173.36 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 119' ' ' SER . . . . . 0.665 ' O ' HG12 ' B' ' 123' ' ' ILE . 96.9 p -130.82 -178.5 4.83 Favored 'General case' 0 C--N 1.319 -0.753 0 C-N-CA 120.464 -0.494 . . . . 0.0 110.784 176.258 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 120' ' ' ALA . . . . . 0.748 ' HB3' HD12 ' B' ' 139' ' ' LEU . . . -67.7 -37.75 82.72 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 122.117 0.96 . . . . 0.0 109.387 -172.886 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 121' ' ' LYS . . . . . 0.425 ' HD2' ' N ' ' B' ' 121' ' ' LYS . 0.5 OUTLIER -61.51 -36.26 80.03 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 113.588 -1.642 . . . . 0.0 109.944 176.046 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 122' ' ' ASP . . . . . 0.411 ' O ' ' HB2' ' B' ' 125' ' ' LYS . 16.8 t0 -71.94 -39.01 69.72 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 115.529 -0.76 . . . . 0.0 109.18 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 123' ' ' ILE . . . . . 0.806 HG23 ' HB2' ' B' ' 106' ' ' SER . 27.9 mm -59.93 -45.66 94.9 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 CA-C-N 115.43 -0.805 . . . . 0.0 109.847 175.243 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 124' ' ' LYS . . . . . 0.654 ' HD3' HD23 ' B' ' 139' ' ' LEU . 5.5 mmmp? -59.21 -41.62 89.03 Favored 'General case' 0 CA--C 1.501 -0.927 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.559 -178.771 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 125' ' ' LYS . . . . . 0.411 ' HB2' ' O ' ' B' ' 122' ' ' ASP . 43.5 mmtt -52.45 -63.49 1.13 Allowed 'General case' 0 CA--C 1.496 -1.111 0 CA-C-O 121.668 0.747 . . . . 0.0 111.502 172.793 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 126' ' ' ILE . . . . . . . . . . . . . 1.7 mp -55.3 -42.73 68.01 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.416 0 CA-C-N 113.963 -1.471 . . . . 0.0 111.368 -168.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 127' ' ' LEU . . . . . 0.716 ' HG ' ' O ' ' B' ' 123' ' ' ILE . 2.6 pp -82.04 -26.17 33.98 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.619 -0.433 . . . . 0.0 112.117 -177.901 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 128' ' ' ASP . . . . . 0.41 ' N ' HD12 ' B' ' 127' ' ' LEU . 20.4 t70 -71.83 -30.11 65.12 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 120.982 -0.287 . . . . 0.0 110.478 -179.283 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 129' ' ' SER . . . . . . . . . . . . . 90.2 p -52.81 -44.26 66.52 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.382 179.144 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 130' ' ' VAL . . . . . 0.406 ' CG2' HD13 ' B' ' 132' ' ' ILE . 12.7 m -88.03 -24.58 6.16 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 116.539 -0.301 . . . . 0.0 111.447 178.851 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 131' ' ' GLY . . . . . . . . . . . . . . . 109.74 25.06 5.58 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.306 -0.95 . . . . 0.0 113.175 176.04 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 132' ' ' ILE . . . . . 0.424 HG12 ' CB ' ' A' ' 19' ' ' ASP . 3.2 mt -85.26 132.82 30.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 116.943 0.371 . . . . 0.0 110.092 176.334 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 133' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -91.03 137.11 32.61 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.192 0.52 . . . . 0.0 110.457 -177.614 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 134' ' ' ALA . . . . . . . . . . . . . . . -143.14 143.83 31.97 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.608 -172.397 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 135' ' ' ASP . . . . . 0.745 ' HB2' ' CG ' ' B' ' 138' ' ' ARG . 4.1 m-20 -80.53 125.6 30.18 Favored 'General case' 0 C--O 1.258 1.523 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 172.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 136' ' ' ASP . . . . . 0.605 ' HA ' HD11 ' B' ' 139' ' ' LEU . 5.4 p-10 -72.11 2.06 6.43 Favored 'General case' 0 CA--C 1.514 -0.406 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.524 -173.261 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 137' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -102.93 -36.49 8.19 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.398 174.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 138' ' ' ARG . . . . . 0.745 ' CG ' ' HB2' ' B' ' 135' ' ' ASP . 24.9 mmt180 -67.23 -43.5 81.85 Favored 'General case' 0 CA--C 1.505 -0.766 0 CA-C-O 122.317 1.056 . . . . 0.0 108.626 -174.544 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 139' ' ' LEU . . . . . 0.867 ' O ' HG12 ' B' ' 143' ' ' ILE . 0.4 OUTLIER -72.96 -32.29 65.13 Favored 'General case' 0 C--O 1.209 -1.053 0 CA-C-N 114.423 -1.262 . . . . 0.0 111.034 179.183 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 140' ' ' ASN . . . . . 0.562 ' O ' ' HB ' ' B' ' 143' ' ' ILE . 67.1 t30 -66.36 -25.53 66.85 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 122.29 1.043 . . . . 0.0 108.871 177.41 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 141' ' ' LYS . . . . . 0.51 ' HB3' ' O ' ' B' ' 138' ' ' ARG . 11.8 tppt? -70.4 -52.24 23.79 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 114.199 -1.364 . . . . 0.0 109.707 176.027 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 142' ' ' VAL . . . . . 0.936 HG12 ' HB2' ' B' ' 103' ' ' TYR . 7.9 p -61.82 -33.07 56.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.181 -0.463 . . . . 0.0 109.92 177.422 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 143' ' ' ILE . . . . . 0.867 HG12 ' O ' ' B' ' 139' ' ' LEU . 29.9 mm -50.24 -61.75 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.374 0 CA-C-O 121.426 0.632 . . . . 0.0 110.052 169.532 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 144' ' ' SER . . . . . . . . . . . . . 45.3 t -54.88 -32.26 60.68 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 114.331 -1.304 . . . . 0.0 111.716 -179.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 145' ' ' GLU . . . . . . . . . . . . . 68.4 mm-40 -80.01 -34.69 38.25 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.378 0.51 . . . . 0.0 112.378 -179.281 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 146' ' ' LEU . . . . . 0.714 HD11 ' HA ' ' B' ' 104' ' ' VAL . 7.2 mt -87.63 -19.99 26.97 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 121.021 -0.272 . . . . 0.0 110.832 -178.568 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 147' ' ' ASN . . . . . 0.402 ' HA ' ' HH ' ' B' ' 107' ' ' TYR . 3.5 t-20 -53.97 108.79 0.39 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.13 -177.255 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . 108.99 18.99 8.84 Favored Glycine 0 N--CA 1.449 -0.436 0 CA-C-N 115.356 -0.838 . . . . 0.0 112.454 -179.283 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 149' ' ' LYS . . . . . 0.443 ' HB2' ' O ' ' B' ' 146' ' ' LEU . 0.2 OUTLIER -109.09 171.54 7.37 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.87 0.367 . . . . 0.0 110.646 -178.937 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 150' ' ' ASN . . . . . 0.583 ' O ' HG22 ' B' ' 154' ' ' VAL . 10.6 m-80 -110.24 89.12 2.93 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 178.423 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 151' ' ' ILE . . . . . 0.777 HG13 HD12 ' B' ' 108' ' ' LEU . 1.8 mp -41.87 -63.74 0.17 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.357 0 N-CA-C 113.775 1.028 . . . . 0.0 113.775 -166.447 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 152' ' ' GLU . . . . . 0.652 ' HG3' HD11 ' B' ' 112' ' ' LEU . 3.3 mp0 -59.85 -36.4 76.77 Favored 'General case' 0 C--O 1.209 -1.046 0 C-N-CA 120.508 -0.477 . . . . 0.0 111.105 -174.698 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 153' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -73.51 -27.72 61.51 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 120.73 0.3 . . . . 0.0 110.815 -179.329 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 154' ' ' VAL . . . . . 0.583 HG22 ' O ' ' B' ' 150' ' ' ASN . 46.4 t -60.3 -48.78 86.84 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 171.15 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 155' ' ' ILE . . . . . 1.082 HD12 ' HG ' ' B' ' 108' ' ' LEU . 3.3 mp -106.65 33.94 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 122.11 0.957 . . . . 0.0 110.973 -177.887 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . -99.37 -1.34 39.01 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 169.531 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 157' ' ' GLN . . . . . . . . . . . . . 23.2 mt-30 -139.55 -2.76 1.55 Allowed 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 113.333 -1.758 . . . . 0.0 109.678 175.141 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 158' ' ' GLY . . . . . . . . . . . . . . . -134.48 45.79 1.09 Allowed Glycine 0 C--O 1.225 -0.411 0 C-N-CA 120.603 -0.808 . . . . 0.0 114.077 -168.383 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 159' ' ' ILE . . . . . 0.728 ' HB ' HG13 ' A' ' 60' ' ' ILE . 1.8 mp -59.26 -25.76 31.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 CA-C-O 121.011 0.434 . . . . 0.0 110.854 176.757 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 160' ' ' GLY . . . . . . . . . . . . . . . -104.67 -45.24 1.44 Allowed Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.562 -0.828 . . . . 0.0 112.653 179.279 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 161' ' ' LYS . . . . . 0.475 ' HA ' ' HD2' ' B' ' 161' ' ' LYS . 30.5 mmmt -81.51 -15.05 56.11 Favored 'General case' 0 N--CA 1.444 -0.741 0 N-CA-C 113.486 0.921 . . . . 0.0 113.486 -176.257 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 162' ' ' LEU . . . . . 0.739 HD22 ' HG2' ' B' ' 101' ' ' MET . 8.9 mp 42.28 -144.27 0.07 Allowed 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 123.346 0.658 . . . . 0.0 112.579 -173.911 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 163' ' ' ALA . . . . . 0.461 ' H ' HG11 ' B' ' 104' ' ' VAL . . . -73.19 60.38 0.58 Allowed 'General case' 0 N--CA 1.442 -0.831 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 -178.77 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 164' ' ' SER . . . . . . . . . . . . . 20.5 p -170.88 155.5 4.64 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.696 176.084 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 165' ' ' VAL . . . . . 0.478 ' HA ' ' HD2' ' B' ' 166' ' ' PRO . 3.8 t 61.61 121.51 0.02 OUTLIER Pre-proline 0 CA--C 1.538 0.502 0 N-CA-C 113.814 1.042 . . . . 0.0 113.814 -178.14 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 166' ' ' PRO . . . . . 0.478 ' HD2' ' HA ' ' B' ' 165' ' ' VAL . 53.2 Cg_exo -20.05 118.93 0.02 OUTLIER 'Trans proline' 0 N--CA 1.44 -1.636 1 C-N-CA 128.07 5.846 . . . . 0.0 116.395 179.869 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 167' ' ' ALA . . . . . . . . . . . . . . . -89.7 69.26 7.7 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.493 178.161 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 168' ' ' GLY . . . . . . . . . . . . . . . 138.95 150.63 5.6 Favored Glycine 0 N--CA 1.443 -0.838 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.153 -179.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 169' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.231 -1.316 . . . . 0.0 111.534 177.526 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.2 ttt . . . . . 0 N--CA 1.479 1.013 0 N-CA-C 109.503 -0.555 . . . . 0.0 109.503 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.552 ' HB3' HD13 ' A' ' 7' ' ' LEU . . . -63.4 138.59 58.58 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.679 0.276 . . . . 0.0 110.883 179.691 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 92.9 p -71.78 142.29 49.71 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 173.038 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.621 HG11 ' HG ' ' B' ' 112' ' ' LEU . 1.9 t -50.85 -22.47 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 CA-C-N 114.373 -1.285 . . . . 0.0 112.442 -179.773 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.796 ' HB3' ' HA ' ' A' ' 39' ' ' VAL . 63.0 m -73.17 -52.25 14.86 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.209 0.528 . . . . 0.0 109.598 175.773 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.611 ' HG2' ' NE1' ' A' ' 43' ' ' TRP . 36.7 mt-10 -57.86 -51.22 70.52 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.67 177.805 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.686 ' O ' ' HB ' ' A' ' 10' ' ' ILE . 3.6 tp -58.2 -37.28 74.47 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.178 -0.919 . . . . 0.0 111.746 177.741 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.564 ' HB1' HD21 ' B' ' 112' ' ' LEU . . . -67.43 -34.0 76.33 Favored 'General case' 0 N--CA 1.468 0.428 0 O-C-N 121.958 -0.464 . . . . 0.0 111.115 178.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.467 ' HB2' HG12 ' A' ' 39' ' ' VAL . 6.8 t -71.29 -37.2 71.85 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 178.877 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.686 ' HB ' ' O ' ' A' ' 7' ' ' LEU . 66.9 mt -50.53 -55.57 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.809 0 CA-C-N 114.29 -1.323 . . . . 0.0 109.684 170.202 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.922 ' HH ' ' HB ' ' B' ' 155' ' ' ILE . 23.5 m-85 -67.04 -43.7 82.09 Favored 'General case' 0 C--O 1.219 -0.514 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.964 -173.454 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.7 p -55.08 -41.82 72.03 Favored 'General case' 0 C--O 1.239 0.526 0 CA-C-O 121.15 0.5 . . . . 0.0 109.947 176.409 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.483 ' HB2' HD13 ' A' ' 51' ' ' LEU . . . -62.64 -35.33 79.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.913 172.681 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.783 HD11 ' HE1' ' B' ' 101' ' ' MET . 0.4 OUTLIER -62.73 -54.48 38.5 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.868 179.573 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.41 ' H ' HG12 ' A' ' 15' ' ' ILE . 0.0 OUTLIER -57.39 -45.65 85.48 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 CA-C-O 121.048 0.451 . . . . 0.0 110.048 177.302 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.626 HD11 HG11 ' A' ' 21' ' ' VAL . 5.7 tp -55.85 -40.54 73.03 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.577 0.703 . . . . 0.0 110.845 177.589 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 15.0 t60 -75.68 -11.28 59.97 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 114.722 -1.126 . . . . 0.0 111.999 -179.294 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.417 ' CG ' ' HG3' ' B' ' 102' ' ' ARG . 37.4 t70 -74.93 -45.83 39.82 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 121.871 -0.518 . . . . 0.0 110.437 178.178 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.491 ' OD2' ' HB ' ' A' ' 21' ' ' VAL . 29.3 t70 -88.89 -11.49 44.45 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.732 0.777 . . . . 0.0 109.085 177.713 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 56.18 48.98 16.3 Favored 'General case' 0 CA--C 1.516 -0.348 0 CA-C-N 113.975 -1.466 . . . . 0.0 109.626 -175.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.626 HG11 HD11 ' A' ' 16' ' ' LEU . 7.6 p -101.75 168.41 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.479 0 CA-C-N 114.519 -1.219 . . . . 0.0 109.586 -170.596 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 45.5 p -43.97 129.52 5.89 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-O 121.77 0.795 . . . . 0.0 113.105 -175.147 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.574 HG13 ' HA ' ' A' ' 48' ' ' ALA . 60.0 t -103.97 108.63 25.06 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.041 0 CA-C-N 114.299 -1.319 . . . . 0.0 110.182 -176.058 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.523 ' OG1' ' HB2' ' A' ' 27' ' ' LYS . 70.4 p -140.61 151.98 45.09 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.02 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -51.78 -45.56 63.84 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.082 0.467 . . . . 0.0 110.258 177.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -62.54 -31.13 71.87 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.736 179.163 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.578 ' HG2' HD12 ' A' ' 16' ' ' LEU . 4.0 tppt? -67.48 -49.42 63.59 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-O 122.032 0.92 . . . . 0.0 108.573 178.075 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 86.3 mt -60.75 -40.54 85.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 114.296 -1.32 . . . . 0.0 110.445 177.549 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -61.15 -35.41 77.01 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.567 175.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.82 -45.69 91.44 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.724 175.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.655 ' HB3' HD23 ' B' ' 109' ' ' LEU . 1.4 mm? -61.99 -46.31 89.8 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 121.017 0.437 . . . . 0.0 110.438 174.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.571 HG23 ' O ' ' A' ' 37' ' ' VAL . 44.2 mt -50.07 -48.18 23.63 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 CA-C-N 115.273 -0.876 . . . . 0.0 111.412 177.799 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 22.7 tptp -72.78 -39.68 66.55 Favored 'General case' 0 N--CA 1.438 -1.055 0 CA-C-N 115.707 -0.678 . . . . 0.0 111.45 -178.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.632 ' HB1' ' HA ' ' B' ' 126' ' ' ILE . . . -56.89 -48.75 77.45 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.195 0.521 . . . . 0.0 110.845 179.842 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.423 ' CB ' ' HG ' ' B' ' 109' ' ' LEU . . . -76.83 -37.41 55.71 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.066 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 99.06 20.74 17.44 Favored Glycine 0 N--CA 1.449 -0.438 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.767 -178.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.831 ' HB ' ' HA2' ' B' ' 113' ' ' GLY . 3.0 p -122.57 121.87 64.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 121.443 0.639 . . . . 0.0 110.646 -176.742 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.445 ' HA ' HG23 ' A' ' 32' ' ' ILE . 61.5 t30 -96.41 156.54 16.3 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 114.773 -1.103 . . . . 0.0 111.0 -170.012 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.796 ' HA ' ' HB3' ' A' ' 5' ' ' SER . 93.3 t -126.82 159.95 35.85 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.075 0 CA-C-N 115.01 -0.995 . . . . 0.0 110.356 -172.561 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.484 ' HB3' ' HD1' ' A' ' 43' ' ' TRP . 3.5 tp10 -67.44 107.23 1.61 Allowed Pre-proline 0 N--CA 1.44 -0.932 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 169.6 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.483 ' C ' ' HD2' ' A' ' 44' ' ' PRO . 73.7 Cg_exo -51.35 -28.07 25.84 Favored 'Trans proline' 0 C--O 1.249 1.034 0 C-N-CA 123.598 2.866 . . . . 0.0 115.304 -164.828 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.427 ' HD2' ' CG ' ' A' ' 40' ' ' GLU . 0.5 OUTLIER -60.19 -27.01 66.79 Favored 'General case' 0 C--N 1.333 -0.15 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 177.645 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . 0.611 ' NE1' ' HG2' ' A' ' 6' ' ' GLU . 22.5 m95 -65.36 -60.12 8.33 Favored Pre-proline 0 C--O 1.204 -1.331 0 CA-C-O 118.373 -0.822 . . . . 0.0 110.743 175.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.483 ' HD2' ' C ' ' A' ' 41' ' ' PRO . 74.7 Cg_exo -44.1 -44.66 12.37 Favored 'Trans proline' 0 C--N 1.357 1.004 0 C-N-CA 121.671 1.58 . . . . 0.0 112.203 173.654 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -62.0 -56.49 22.13 Favored Glycine 0 CA--C 1.525 0.712 0 C-N-CA 120.238 -0.982 . . . . 0.0 112.952 176.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.447 ' O ' ' HB2' ' A' ' 49' ' ' LYS . 9.4 tp -69.78 -23.01 63.28 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 122.91 0.484 . . . . 0.0 111.821 -176.861 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.526 ' HE1' ' CE3' ' A' ' 43' ' ' TRP . 3.1 m-85 -73.48 -43.78 59.4 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 109.962 -0.384 . . . . 0.0 109.962 175.605 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.574 ' HA ' HG13 ' A' ' 23' ' ' VAL . . . -63.67 -33.14 74.97 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 177.074 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.447 ' HB2' ' O ' ' A' ' 46' ' ' LEU . 9.6 mmmt -62.68 -62.26 1.85 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 114.569 -1.196 . . . . 0.0 111.701 171.187 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.445 ' O ' HG21 ' A' ' 54' ' ' VAL . . . -69.77 -41.26 75.4 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 113.114 0.783 . . . . 0.0 113.114 -169.408 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.483 HD13 ' HB2' ' A' ' 13' ' ' ALA . 12.4 mt -65.64 -10.98 40.78 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.75 0.309 . . . . 0.0 111.792 -174.37 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -84.59 0.22 50.86 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.303 177.217 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -141.22 -47.03 0.39 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.234 -179.119 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.445 HG21 ' O ' ' A' ' 50' ' ' ALA . 5.8 m -91.08 -175.19 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.847 0.356 . . . . 0.0 110.33 -177.473 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 16.4 m120 -116.03 169.47 9.23 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.734 178.16 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.74 HD12 HD23 ' A' ' 14' ' ' LEU . 3.2 tp -61.35 -25.09 35.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.551 178.603 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -70.83 -11.94 70.18 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.691 -0.766 . . . . 0.0 111.36 179.277 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 22.9 t -81.34 -23.71 37.59 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-O 121.323 0.582 . . . . 0.0 109.817 179.433 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 26.3 mt -62.32 -31.19 71.78 Favored 'General case' 0 CA--C 1.517 -0.314 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.751 -178.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.898 HG13 ' HB ' ' B' ' 159' ' ' ILE . 0.1 OUTLIER -62.3 -18.64 20.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 114.904 -1.044 . . . . 0.0 110.888 -179.647 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 0.462 ' O ' ' HB1' ' A' ' 65' ' ' ALA . 5.4 t -96.18 -10.02 29.14 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.315 -176.1 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 12.0 m120 -69.76 -26.36 64.26 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.909 0.385 . . . . 0.0 110.943 -177.096 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 16.5 m -93.97 36.63 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.053 179.321 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 141.1 96.83 0.29 Allowed Glycine 0 N--CA 1.447 -0.625 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.919 177.148 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.462 ' HB1' ' O ' ' A' ' 61' ' ' CYS . . . -142.84 -65.5 0.39 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.026 0.441 . . . . 0.0 111.549 -177.746 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 114.96 -135.01 12.0 Favored Glycine 0 N--CA 1.448 -0.541 0 N-CA-C 110.92 -0.872 . . . . 0.0 110.92 -174.615 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.45 ' HA2' ' HD3' ' A' ' 68' ' ' PRO . . . 166.88 140.9 3.0 Favored Glycine 0 N--CA 1.449 -0.433 0 C-N-CA 120.222 -0.99 . . . . 0.0 112.69 178.402 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.45 ' HD3' ' HA2' ' A' ' 67' ' ' GLY . 15.4 Cg_exo -68.65 99.76 0.65 Allowed 'Trans proline' 0 C--O 1.234 0.302 0 C-N-CA 123.024 2.483 . . . . 0.0 112.058 178.167 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.896 0 CA-C-O 118.445 -0.788 . . . . 0.0 110.1 178.453 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.122 0 CA-C-O 120.609 0.243 . . . . 0.0 110.349 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 101' ' ' MET . . . . . 0.783 ' HE1' HD11 ' A' ' 14' ' ' LEU . 1.3 tmt? -91.87 126.02 36.8 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.985 0.422 . . . . 0.0 111.445 -177.366 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 102' ' ' ARG . . . . . 0.417 ' HG3' ' CG ' ' A' ' 18' ' ' ASP . 18.9 ttt180 -164.67 -94.87 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.221 168.192 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 103' ' ' TYR . . . . . 0.582 ' HB2' HG13 ' B' ' 142' ' ' VAL . 47.3 m-85 -77.21 -11.29 59.8 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.354 0.597 . . . . 0.0 109.766 -177.888 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 104' ' ' VAL . . . . . 0.558 HG12 HD11 ' B' ' 146' ' ' LEU . 48.2 t -46.45 -45.95 6.78 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.519 0 CA-C-N 114.71 -1.132 . . . . 0.0 110.13 173.806 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 105' ' ' ALA . . . . . 0.596 ' CB ' ' HB3' ' A' ' 14' ' ' LEU . . . -66.22 -39.37 89.54 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 114.822 -1.081 . . . . 0.0 111.656 -174.703 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 106' ' ' SER . . . . . 0.699 ' HB2' HG21 ' B' ' 123' ' ' ILE . 1.0 OUTLIER -62.87 -35.39 79.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.666 0.746 . . . . 0.0 109.066 176.567 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 107' ' ' TYR . . . . . 0.763 ' HD2' HG12 ' B' ' 143' ' ' ILE . 32.7 t80 -65.23 -51.61 59.86 Favored 'General case' 0 N--CA 1.445 -0.722 0 CA-C-N 114.483 -1.235 . . . . 0.0 108.625 179.093 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 108' ' ' LEU . . . . . 0.764 HD12 HG13 ' B' ' 151' ' ' ILE . 0.0 OUTLIER -56.62 -46.83 80.71 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-N 114.99 -1.004 . . . . 0.0 110.769 177.227 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 109' ' ' LEU . . . . . 0.655 HD23 ' HB3' ' A' ' 31' ' ' LEU . 9.4 tp -52.98 -49.06 66.9 Favored 'General case' 0 CA--C 1.512 -0.494 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.665 178.434 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 110' ' ' ALA . . . . . 0.488 ' HB3' ' HB3' ' B' ' 118' ' ' PRO . . . -66.45 -36.43 82.75 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.134 -176.719 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 111' ' ' ALA . . . . . 0.82 ' HA ' ' O ' ' B' ' 115' ' ' ASN . . . -70.63 -19.99 62.77 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.354 0.597 . . . . 0.0 111.023 179.101 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 112' ' ' LEU . . . . . 0.768 ' HB3' HG22 ' A' ' 37' ' ' VAL . 5.6 mp -86.53 -37.24 18.39 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.084 171.284 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 113' ' ' GLY . . . . . 0.831 ' HA2' ' HB ' ' A' ' 37' ' ' VAL . . . -66.26 -39.35 94.36 Favored Glycine 0 N--CA 1.444 -0.798 0 CA-C-N 115.054 -0.975 . . . . 0.0 113.117 -176.389 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 114' ' ' GLY . . . . . . . . . . . . . . . 164.17 6.97 0.04 OUTLIER Glycine 0 N--CA 1.442 -0.901 0 C-N-CA 119.514 -1.327 . . . . 0.0 114.051 178.457 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 115' ' ' ASN . . . . . 0.82 ' O ' ' HA ' ' B' ' 111' ' ' ALA . 95.7 m-20 -130.92 98.0 4.48 Favored 'General case' 0 CA--C 1.494 -1.183 0 CA-C-N 118.061 0.93 . . . . 0.0 108.827 178.165 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 2.5 p -76.02 29.08 0.11 Allowed 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 122.533 1.158 . . . . 0.0 109.818 -178.352 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 117' ' ' SER . . . . . 0.659 ' H ' ' C ' ' B' ' 115' ' ' ASN . 23.2 t -169.95 71.18 0.63 Allowed Pre-proline 0 N--CA 1.447 -0.61 0 CA-C-N 113.261 -1.79 . . . . 0.0 107.93 179.694 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 118' ' ' PRO . . . . . 0.607 ' HD2' ' CZ ' ' B' ' 107' ' ' TYR . 21.0 Cg_exo -71.81 152.39 58.23 Favored 'Trans proline' 0 C--N 1.33 -0.42 1 C-N-CA 125.352 4.034 . . . . 0.0 111.722 -177.102 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 119' ' ' SER . . . . . 0.536 ' O ' HG12 ' B' ' 123' ' ' ILE . 78.9 p -123.09 -175.47 3.19 Favored 'General case' 0 C--N 1.317 -0.824 0 C-N-CA 119.998 -0.681 . . . . 0.0 111.606 178.003 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 120' ' ' ALA . . . . . 0.683 ' HB3' HD12 ' B' ' 139' ' ' LEU . . . -66.58 -39.98 88.72 Favored 'General case' 0 CA--C 1.507 -0.682 0 CA-C-O 121.785 0.802 . . . . 0.0 109.315 -170.347 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 121' ' ' LYS . . . . . . . . . . . . . 13.8 mptt -58.99 -37.38 76.71 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 113.932 -1.485 . . . . 0.0 111.108 174.642 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 122' ' ' ASP . . . . . 0.411 ' O ' ' HD2' ' B' ' 125' ' ' LYS . 21.1 m-20 -69.56 -40.04 77.02 Favored 'General case' 0 CA--C 1.517 -0.299 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.33 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 123' ' ' ILE . . . . . 0.701 ' CG1' HD12 ' B' ' 143' ' ' ILE . 33.2 mm -59.29 -50.84 78.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.959 176.236 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 124' ' ' LYS . . . . . 0.828 ' HD3' HD23 ' B' ' 139' ' ' LEU . 3.7 mmmp? -59.91 -31.66 70.03 Favored 'General case' 0 C--O 1.216 -0.686 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.789 -178.802 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 125' ' ' LYS . . . . . 0.702 ' HD2' HD12 ' B' ' 126' ' ' ILE . 0.0 OUTLIER -71.92 -48.08 47.94 Favored 'General case' 0 N--CA 1.431 -1.384 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.935 -179.773 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 126' ' ' ILE . . . . . 0.702 HD12 ' HD2' ' B' ' 125' ' ' LYS . 1.1 mp -55.56 -51.01 62.54 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 CA-C-O 120.604 0.24 . . . . 0.0 110.941 176.031 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 127' ' ' LEU . . . . . 0.688 ' HG ' ' O ' ' B' ' 123' ' ' ILE . 1.8 pp -76.82 -24.09 52.76 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.605 -0.438 . . . . 0.0 111.629 -175.852 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 128' ' ' ASP . . . . . 0.509 ' HB2' ' O ' ' B' ' 124' ' ' LYS . 24.9 t70 -65.53 -32.86 74.69 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 175.589 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 129' ' ' SER . . . . . 0.489 ' CB ' ' HB3' ' A' ' 34' ' ' ALA . 7.1 t -56.5 -33.12 65.71 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-N 115.714 -0.676 . . . . 0.0 111.827 176.835 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 130' ' ' VAL . . . . . 0.463 HG22 HG13 ' B' ' 132' ' ' ILE . 2.5 m -108.63 -8.48 11.12 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 O-C-N 122.098 -0.376 . . . . 0.0 111.904 178.89 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 131' ' ' GLY . . . . . . . . . . . . . . . 87.26 27.11 28.86 Favored Glycine 0 CA--C 1.519 0.342 0 C-N-CA 121.036 -0.602 . . . . 0.0 113.18 175.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 132' ' ' ILE . . . . . 0.546 ' O ' HD12 ' B' ' 127' ' ' LEU . 17.9 mt -85.09 128.3 39.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.669 0.234 . . . . 0.0 110.854 -179.059 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 133' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -76.53 133.16 39.81 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.124 0.487 . . . . 0.0 111.385 -176.185 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 134' ' ' ALA . . . . . 0.46 ' HB2' HD22 ' B' ' 127' ' ' LEU . . . -139.9 143.94 36.92 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.769 -174.677 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 135' ' ' ASP . . . . . 0.804 ' HB2' ' HG3' ' B' ' 138' ' ' ARG . 5.5 m-20 -88.88 127.97 35.65 Favored 'General case' 0 C--O 1.256 1.416 0 CA-C-O 121.261 0.553 . . . . 0.0 109.712 176.234 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 136' ' ' ASP . . . . . 0.616 ' HA ' HD11 ' B' ' 139' ' ' LEU . 9.0 p-10 -78.07 2.08 18.99 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-N 115.127 -0.942 . . . . 0.0 111.587 -166.593 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 137' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -105.57 -32.76 8.34 Favored 'General case' 0 N--CA 1.44 -0.932 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.189 170.65 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 138' ' ' ARG . . . . . 0.804 ' HG3' ' HB2' ' B' ' 135' ' ' ASP . 11.8 mmt85 -63.32 -47.6 81.53 Favored 'General case' 0 CA--C 1.504 -0.803 0 CA-C-O 121.781 0.8 . . . . 0.0 109.425 -175.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 139' ' ' LEU . . . . . 0.828 HD23 ' HD3' ' B' ' 124' ' ' LYS . 0.3 OUTLIER -71.81 -39.43 69.84 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 114.653 -1.158 . . . . 0.0 111.356 -179.151 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 140' ' ' ASN . . . . . . . . . . . . . 11.0 t30 -62.98 -29.38 70.77 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-O 121.571 0.701 . . . . 0.0 109.11 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 141' ' ' LYS . . . . . . . . . . . . . 18.4 tttm -72.09 -52.42 16.86 Favored 'General case' 0 C--O 1.242 0.699 0 CA-C-N 114.672 -1.149 . . . . 0.0 110.358 178.271 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 142' ' ' VAL . . . . . 0.682 HG12 ' O ' ' B' ' 139' ' ' LEU . 11.7 p -56.93 -42.34 78.48 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.743 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.721 -179.013 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 143' ' ' ILE . . . . . 0.763 HG12 ' HD2' ' B' ' 107' ' ' TYR . 34.6 mt -59.39 -49.73 82.45 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 C-N-CA 123.554 0.742 . . . . 0.0 112.792 174.845 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 144' ' ' SER . . . . . . . . . . . . . 66.3 m -53.26 -33.93 55.14 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 115.668 -0.697 . . . . 0.0 111.294 178.191 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 145' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -87.5 -33.63 18.92 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 120.981 0.419 . . . . 0.0 111.606 176.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 146' ' ' LEU . . . . . 0.558 HD11 HG12 ' B' ' 104' ' ' VAL . 0.3 OUTLIER -70.83 -31.92 68.8 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 123.374 0.67 . . . . 0.0 111.511 -179.01 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 147' ' ' ASN . . . . . 0.441 ' HA ' ' HH ' ' B' ' 107' ' ' TYR . 23.3 t-20 -56.04 124.86 19.19 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.973 -177.502 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . 101.86 28.37 6.62 Favored Glycine 0 N--CA 1.449 -0.495 0 CA-C-N 115.636 -0.711 . . . . 0.0 112.563 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 149' ' ' LYS . . . . . 0.489 ' HE2' ' O ' ' B' ' 146' ' ' LEU . 1.0 OUTLIER -127.79 175.01 8.66 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 110.21 -0.292 . . . . 0.0 110.21 177.13 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 150' ' ' ASN . . . . . 0.552 ' O ' HG22 ' B' ' 154' ' ' VAL . 44.0 m-80 -111.7 93.15 4.32 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 108.582 -0.895 . . . . 0.0 108.582 179.48 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 151' ' ' ILE . . . . . 0.764 HG13 HD12 ' B' ' 108' ' ' LEU . 1.8 mp -41.74 -65.03 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 O-C-N 124.366 1.041 . . . . 0.0 113.662 -169.167 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 152' ' ' GLU . . . . . 0.504 ' HG3' HD11 ' B' ' 112' ' ' LEU . 1.7 mp0 -55.14 -42.83 73.54 Favored 'General case' 0 C--O 1.219 -0.535 0 CA-C-N 117.879 0.309 . . . . 0.0 111.52 -174.26 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 153' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -69.05 -28.61 66.7 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.523 179.696 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 154' ' ' VAL . . . . . 0.861 ' HB ' HD11 ' B' ' 155' ' ' ILE . 61.1 t -61.29 -51.36 73.88 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 CA-C-O 121.691 0.757 . . . . 0.0 109.071 171.208 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 155' ' ' ILE . . . . . 0.922 ' HB ' ' HH ' ' A' ' 11' ' ' TYR . 1.9 mp -101.15 33.29 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.496 -177.223 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . -98.69 -4.97 32.47 Favored 'General case' 0 C--N 1.308 -1.228 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 168.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 157' ' ' GLN . . . . . . . . . . . . . 67.5 mm-40 -142.85 14.72 1.92 Allowed 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 113.563 -1.653 . . . . 0.0 110.047 174.648 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 158' ' ' GLY . . . . . . . . . . . . . . . -146.83 46.34 0.74 Allowed Glycine 0 C--N 1.336 0.567 0 C-N-CA 120.707 -0.758 . . . . 0.0 113.727 -170.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 159' ' ' ILE . . . . . 0.898 ' HB ' HG13 ' A' ' 60' ' ' ILE . 1.8 mp -66.79 -14.76 18.44 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 CA-C-O 121.244 0.545 . . . . 0.0 110.889 178.29 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 160' ' ' GLY . . . . . . . . . . . . . . . -114.86 -62.81 0.39 Allowed Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 120.848 -0.691 . . . . 0.0 111.908 -176.122 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 161' ' ' LYS . . . . . 0.522 ' HD3' ' N ' ' B' ' 161' ' ' LYS . 3.2 mppt? -78.66 57.45 2.04 Favored 'General case' 0 N--CA 1.442 -0.837 0 N-CA-C 111.822 0.304 . . . . 0.0 111.822 178.018 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 162' ' ' LEU . . . . . 0.609 HD22 ' HG2' ' B' ' 101' ' ' MET . 10.8 mp -49.72 142.24 8.81 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.165 -0.47 . . . . 0.0 112.022 173.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 163' ' ' ALA . . . . . . . . . . . . . . . 51.91 55.91 8.57 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.62 -0.718 . . . . 0.0 112.858 179.109 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 164' ' ' SER . . . . . . . . . . . . . 79.9 p 66.63 154.71 0.09 Allowed 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.308 1.043 . . . . 0.0 113.274 171.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 165' ' ' VAL . . . . . . . . . . . . . 12.8 t -86.32 135.83 36.26 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 114.766 -1.106 . . . . 0.0 109.974 -179.741 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 166' ' ' PRO . . . . . . . . . . . . . 17.5 Cg_exo -13.72 118.91 0.01 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.272 1 C-N-CA 127.355 5.37 . . . . 0.0 116.124 179.563 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 167' ' ' ALA . . . . . . . . . . . . . . . -72.24 95.6 1.71 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.337 -0.847 . . . . 0.0 111.753 -174.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 168' ' ' GLY . . . . . . . . . . . . . . . 86.67 -10.87 65.8 Favored Glycine 0 N--CA 1.452 -0.27 0 CA-C-N 115.788 -0.642 . . . . 0.0 112.292 177.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 169' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.855 0 CA-C-O 118.667 -1.074 . . . . 0.0 111.433 -178.156 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' SER . . . . . 0.62 ' HB2' ' HG3' ' A' ' 6' ' ' GLU . 4.0 m . . . . . 0 N--CA 1.438 -1.041 0 N-CA-C 107.254 -1.388 . . . . 0.0 107.254 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.767 HG13 ' HG ' ' B' ' 112' ' ' LEU . 2.0 t -52.29 -23.49 4.42 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.704 -179.382 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' SER . . . . . 0.739 ' HB2' ' HA ' ' A' ' 39' ' ' VAL . 15.8 p -68.08 -53.89 22.21 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.633 0.73 . . . . 0.0 109.328 175.212 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.62 ' HG3' ' HB2' ' A' ' 3' ' ' SER . 31.0 mt-10 -57.74 -52.06 66.99 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 115.009 -0.996 . . . . 0.0 109.661 178.931 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.821 ' HA ' HD12 ' A' ' 10' ' ' ILE . 2.0 tp -57.79 -35.88 71.42 Favored 'General case' 0 N--CA 1.447 -0.575 0 CA-C-N 115.085 -0.961 . . . . 0.0 111.789 177.762 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -66.33 -40.26 89.75 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-O 121.245 0.545 . . . . 0.0 110.938 178.52 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.575 ' HB2' HG11 ' A' ' 39' ' ' VAL . 8.4 t -65.88 -40.89 92.01 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 179.856 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.821 HD12 ' HA ' ' A' ' 7' ' ' LEU . 57.6 mt -47.9 -57.25 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.851 0 CA-C-N 113.646 -1.616 . . . . 0.0 109.927 172.85 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.903 ' HB2' HD13 ' B' ' 109' ' ' LEU . 21.2 m-85 -65.95 -40.83 91.66 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.604 -173.696 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.513 ' HB2' HG23 ' A' ' 28' ' ' ILE . 14.9 m -53.78 -43.27 69.12 Favored 'General case' 0 C--O 1.243 0.738 0 CA-C-O 121.709 0.766 . . . . 0.0 109.49 176.259 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -67.53 -32.52 73.35 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-N 115.192 -0.913 . . . . 0.0 110.166 176.907 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.645 ' HB3' ' CB ' ' B' ' 105' ' ' ALA . 0.3 OUTLIER -62.51 -56.87 13.93 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.113 179.467 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.466 HG12 ' H ' ' A' ' 15' ' ' ILE . 0.0 OUTLIER -54.36 -42.19 56.75 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 N-CA-C 109.897 -0.408 . . . . 0.0 109.897 177.421 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.483 ' HA ' HD12 ' A' ' 16' ' ' LEU . 3.9 tp -56.64 -37.81 71.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.26 176.832 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' HIS . . . . . 0.448 ' CD2' ' HB ' ' A' ' 56' ' ' ILE . 72.0 m-70 -77.78 -9.64 59.13 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 112.493 0.553 . . . . 0.0 112.493 178.957 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -78.61 -29.14 45.87 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 119.513 -0.875 . . . . 0.0 109.807 -177.511 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -107.32 -8.15 16.45 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 173.666 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.416 ' HG2' ' O ' ' A' ' 17' ' ' HIS . 5.2 mm-40 51.89 50.14 19.25 Favored 'General case' 0 CA--C 1.511 -0.545 0 CA-C-N 113.925 -1.489 . . . . 0.0 110.633 -174.93 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.442 HG22 ' H ' ' A' ' 22' ' ' THR . 7.3 p -99.13 168.76 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.424 -1.743 0 CA-C-N 114.678 -1.147 . . . . 0.0 108.624 -174.439 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.442 ' H ' HG22 ' A' ' 21' ' ' VAL . 48.5 p -52.45 139.73 24.23 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-O 121.958 0.885 . . . . 0.0 113.377 -169.677 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.609 HG12 ' HA ' ' A' ' 48' ' ' ALA . 58.7 t -109.32 106.39 20.61 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.012 0 CA-C-N 114.339 -1.301 . . . . 0.0 110.536 -174.638 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.556 ' OG1' ' HB2' ' A' ' 27' ' ' LYS . 70.8 p -131.23 156.04 46.06 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.979 178.465 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -54.35 -43.57 71.39 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.226 0.536 . . . . 0.0 109.856 178.806 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -68.49 -25.58 65.04 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.295 -0.866 . . . . 0.0 111.458 -179.794 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.556 ' HB2' ' OG1' ' A' ' 24' ' ' THR . 3.7 tppt? -70.34 -52.24 24.13 Favored 'General case' 0 C--O 1.239 0.53 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 178.894 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.513 HG23 ' HB2' ' A' ' 12' ' ' SER . 70.9 mt -61.08 -40.68 86.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 114.547 -1.206 . . . . 0.0 110.315 177.9 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.592 ' HA ' HD12 ' A' ' 32' ' ' ILE . 44.7 t-20 -60.19 -39.45 86.59 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.936 176.984 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -60.98 -44.6 97.14 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.016 177.549 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.579 HD12 HG23 ' B' ' 126' ' ' ILE . 1.4 mm? -59.79 -49.39 77.9 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 121.01 0.434 . . . . 0.0 110.315 173.975 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.602 HG23 ' O ' ' A' ' 37' ' ' VAL . 75.5 mt -46.98 -52.53 4.04 Favored 'Isoleucine or valine' 0 C--O 1.239 0.538 0 CA-C-N 115.184 -0.916 . . . . 0.0 111.366 178.037 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 46.5 mmtm -72.37 -33.41 67.23 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.542 -0.753 . . . . 0.0 111.543 -176.979 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -62.85 -44.34 96.39 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.062 -179.089 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.5 ' HB3' HG12 ' A' ' 37' ' ' VAL . . . -82.01 -30.61 31.44 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.918 178.743 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 95.3 15.64 43.51 Favored Glycine 0 N--CA 1.447 -0.62 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.75 -178.792 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.987 ' HB ' ' HA3' ' B' ' 113' ' ' GLY . 5.1 p -115.8 118.85 60.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.758 0.79 . . . . 0.0 110.708 -174.778 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.449 ' HA ' HG23 ' A' ' 32' ' ' ILE . 64.3 t30 -96.52 158.59 15.36 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 114.581 -1.19 . . . . 0.0 111.256 -167.486 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.739 ' HA ' ' HB2' ' A' ' 5' ' ' SER . 67.9 t -127.75 163.42 31.38 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.972 0 CA-C-N 114.966 -1.015 . . . . 0.0 110.551 -172.07 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.561 ' HB3' ' HD1' ' A' ' 43' ' ' TRP . 8.2 tp10 -71.24 106.46 1.89 Allowed Pre-proline 0 N--CA 1.44 -0.928 0 N-CA-C 107.429 -1.323 . . . . 0.0 107.429 167.721 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.529 ' C ' ' HD2' ' A' ' 44' ' ' PRO . 77.6 Cg_exo -51.26 -27.69 23.98 Favored 'Trans proline' 0 C--O 1.25 1.112 0 C-N-CA 123.883 3.055 . . . . 0.0 115.532 -164.221 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.432 ' HD2' ' HG3' ' A' ' 40' ' ' GLU . 0.5 OUTLIER -61.38 -28.17 69.05 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 177.471 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 43' ' ' TRP . . . . . 0.611 ' CE3' ' HE1' ' A' ' 47' ' ' PHE . 18.8 m95 -64.56 -59.65 10.16 Favored Pre-proline 0 C--O 1.205 -1.26 0 CA-C-O 118.383 -0.817 . . . . 0.0 110.949 176.068 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.529 ' HD2' ' C ' ' A' ' 41' ' ' PRO . 97.6 Cg_exo -45.81 -42.84 19.67 Favored 'Trans proline' 0 C--N 1.359 1.119 0 C-N-CA 121.766 1.644 . . . . 0.0 111.871 174.532 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -60.4 -61.0 7.56 Favored Glycine 0 CA--C 1.525 0.701 0 C-N-CA 120.231 -0.985 . . . . 0.0 112.516 175.949 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.567 ' O ' ' HB2' ' A' ' 49' ' ' LYS . 8.7 tp -63.26 -32.1 73.42 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.196 0.599 . . . . 0.0 111.973 -177.417 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.611 ' HE1' ' CE3' ' A' ' 43' ' ' TRP . 3.6 m-85 -64.14 -48.13 77.24 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.192 176.237 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.609 ' HA ' HG12 ' A' ' 23' ' ' VAL . . . -65.25 -31.44 72.59 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.56 0.695 . . . . 0.0 109.396 -179.516 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.567 ' HB2' ' O ' ' A' ' 46' ' ' LEU . 9.3 mmmt -59.28 -54.92 41.27 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 114.589 -1.187 . . . . 0.0 111.748 172.995 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -86.61 -43.49 12.62 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 113.802 1.038 . . . . 0.0 113.802 -168.811 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.587 HD11 ' CD2' ' A' ' 47' ' ' PHE . 21.5 mt -65.87 -7.23 15.26 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 113.721 1.008 . . . . 0.0 113.721 -168.556 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -81.01 -2.2 46.97 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.892 0.377 . . . . 0.0 110.425 176.374 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 10.5 t30 -143.01 -41.71 0.31 Allowed 'General case' 0 C--O 1.235 0.294 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.251 -179.568 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 4.3 m -83.01 -179.6 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 121.429 0.633 . . . . 0.0 110.61 -178.542 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 95.6 m-20 -112.15 155.98 23.03 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 115.505 -0.771 . . . . 0.0 111.135 177.788 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.632 HD11 HD22 ' A' ' 14' ' ' LEU . 3.5 tp -60.01 -21.3 21.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 114.773 -1.103 . . . . 0.0 110.83 179.732 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -69.67 -15.4 71.0 Favored Glycine 0 N--CA 1.444 -0.821 0 C-N-CA 120.779 -0.724 . . . . 0.0 111.392 177.789 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 35.1 t -75.99 -22.77 55.49 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-O 121.477 0.656 . . . . 0.0 109.76 178.782 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.828 ' HB2' HG21 ' B' ' 159' ' ' ILE . 19.7 mt -65.12 -25.67 67.87 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.958 -178.423 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.854 HG13 ' HB ' ' B' ' 159' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--N 1.323 -0.586 0 CA-C-N 114.935 -1.03 . . . . 0.0 110.595 178.539 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 103' ' ' TYR . . . . . 0.999 ' HB2' HG11 ' B' ' 142' ' ' VAL . 43.2 m-85 . . . . . 0 C--O 1.242 0.671 0 N-CA-C 113.119 0.785 . . . . 0.0 113.119 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 104' ' ' VAL . . . . . 0.596 ' O ' HD22 ' B' ' 108' ' ' LEU . 44.9 t -50.51 -49.99 23.09 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.448 0 CA-C-O 121.639 0.733 . . . . 0.0 110.034 177.316 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 105' ' ' ALA . . . . . 0.645 ' CB ' ' HB3' ' A' ' 14' ' ' LEU . . . -64.68 -39.36 93.54 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 114.683 -1.144 . . . . 0.0 111.798 -173.249 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 106' ' ' SER . . . . . 0.609 ' HB2' HG23 ' B' ' 123' ' ' ILE . 0.7 OUTLIER -61.06 -38.92 87.91 Favored 'General case' 0 C--O 1.24 0.582 0 CA-C-O 121.786 0.803 . . . . 0.0 109.123 177.905 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 107' ' ' TYR . . . . . 0.756 ' HD2' HG12 ' B' ' 143' ' ' ILE . 41.5 t80 -61.88 -48.7 79.32 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-N 114.08 -1.418 . . . . 0.0 109.067 179.037 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 108' ' ' LEU . . . . . 0.835 HD12 HG13 ' B' ' 151' ' ' ILE . 0.0 OUTLIER -58.14 -46.18 86.08 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-N 115.327 -0.852 . . . . 0.0 111.417 179.553 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 109' ' ' LEU . . . . . 0.903 HD13 ' HB2' ' A' ' 11' ' ' TYR . 8.5 tp -54.19 -56.07 21.77 Favored 'General case' 0 C--O 1.247 0.929 0 CA-C-O 121.393 0.616 . . . . 0.0 110.777 178.54 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 110' ' ' ALA . . . . . 0.427 ' HB3' ' HB3' ' B' ' 118' ' ' PRO . . . -56.05 -41.38 74.94 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 114.991 -1.004 . . . . 0.0 110.372 -177.96 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 111' ' ' ALA . . . . . 0.78 ' HA ' ' O ' ' B' ' 115' ' ' ASN . . . -75.03 -22.25 58.56 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.881 -177.917 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 112' ' ' LEU . . . . . 0.767 ' HG ' HG13 ' A' ' 4' ' ' VAL . 4.3 tp -77.66 -39.51 44.8 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.415 -177.661 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 113' ' ' GLY . . . . . 0.987 ' HA3' ' HB ' ' A' ' 37' ' ' VAL . . . -140.01 33.09 2.14 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 118.652 -1.737 . . . . 0.0 115.155 -174.652 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 114' ' ' GLY . . . . . . . . . . . . . . . -159.45 -47.1 0.01 OUTLIER Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 119.299 -1.429 . . . . 0.0 112.969 176.804 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 115' ' ' ASN . . . . . 0.78 ' O ' ' HA ' ' B' ' 111' ' ' ALA . 8.0 t30 -158.33 112.34 2.49 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 -173.055 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 5.9 m -80.77 28.36 0.35 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 122.083 0.944 . . . . 0.0 111.019 -169.051 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 117' ' ' SER . . . . . 0.478 ' N ' ' HD3' ' B' ' 118' ' ' PRO . 28.3 t -168.01 68.88 0.83 Allowed Pre-proline 0 C--N 1.312 -1.044 0 CA-C-N 113.857 -1.52 . . . . 0.0 108.045 177.65 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 118' ' ' PRO . . . . . 0.679 ' HD2' ' CZ ' ' B' ' 107' ' ' TYR . 34.5 Cg_exo -65.7 155.43 69.15 Favored 'Trans proline' 0 CA--C 1.514 -0.512 0 C-N-CA 125.281 3.988 . . . . 0.0 112.389 -172.975 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 119' ' ' SER . . . . . 0.534 ' C ' HD13 ' B' ' 143' ' ' ILE . 89.8 p -126.57 -176.14 3.59 Favored 'General case' 0 N--CA 1.443 -0.821 0 C-N-CA 120.18 -0.608 . . . . 0.0 111.525 177.74 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 120' ' ' ALA . . . . . 0.821 ' HB1' HD13 ' B' ' 139' ' ' LEU . . . -63.21 -36.5 83.85 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 122.222 1.011 . . . . 0.0 109.409 -169.617 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 121' ' ' LYS . . . . . 0.477 ' HD2' ' N ' ' B' ' 121' ' ' LYS . 0.9 OUTLIER -68.14 -32.91 73.51 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 113.489 -1.687 . . . . 0.0 110.898 178.91 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 122' ' ' ASP . . . . . 0.511 ' O ' ' HB3' ' B' ' 125' ' ' LYS . 10.6 m-20 -71.66 -36.75 70.76 Favored 'General case' 0 CA--C 1.515 -0.372 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 178.412 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 123' ' ' ILE . . . . . 0.779 ' CG1' HD11 ' B' ' 143' ' ' ILE . 36.9 mm -62.9 -48.38 88.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.108 176.591 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 124' ' ' LYS . . . . . 0.838 ' HD3' HD21 ' B' ' 139' ' ' LEU . 2.9 mmmp? -57.59 -45.21 85.55 Favored 'General case' 0 C--O 1.21 -0.996 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 -179.357 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 125' ' ' LYS . . . . . 0.511 ' HB3' ' O ' ' B' ' 122' ' ' ASP . 0.1 OUTLIER -47.18 -63.99 0.9 Allowed 'General case' 0 N--CA 1.416 -2.149 0 N-CA-C 112.777 0.658 . . . . 0.0 112.777 172.743 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 126' ' ' ILE . . . . . 0.579 HG23 HD12 ' A' ' 31' ' ' LEU . 1.7 mp -56.69 -46.01 82.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.298 -0.865 . . . . 0.0 111.367 -174.859 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 127' ' ' LEU . . . . . 0.757 ' HG ' ' O ' ' B' ' 123' ' ' ILE . 2.2 pp -78.47 -24.82 45.77 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 120.284 -0.567 . . . . 0.0 111.909 -177.822 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 128' ' ' ASP . . . . . 0.509 ' HB2' ' O ' ' B' ' 124' ' ' LYS . 17.0 t70 -67.1 -35.92 80.82 Favored 'General case' 0 CA--C 1.514 -0.407 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 179.861 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 129' ' ' SER . . . . . . . . . . . . . 83.3 p -58.71 -30.14 67.21 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 115.75 -0.659 . . . . 0.0 112.32 -179.23 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 130' ' ' VAL . . . . . . . . . . . . . 3.1 m -108.41 6.02 9.45 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 CA-C-O 120.856 0.36 . . . . 0.0 111.506 177.985 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 131' ' ' GLY . . . . . . . . . . . . . . . 74.32 30.42 60.62 Favored Glycine 0 CA--C 1.52 0.357 0 C-N-CA 121.075 -0.583 . . . . 0.0 113.722 175.531 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 132' ' ' ILE . . . . . 0.52 ' O ' HD13 ' B' ' 127' ' ' LEU . 18.6 mt -90.08 130.11 39.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.955 0.377 . . . . 0.0 110.026 176.691 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 133' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -81.15 146.73 30.39 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-O 120.922 0.392 . . . . 0.0 110.937 -174.536 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 134' ' ' ALA . . . . . 0.434 ' HB2' HD22 ' B' ' 127' ' ' LEU . . . -146.23 144.07 29.64 Favored 'General case' 0 N--CA 1.442 -0.849 0 CA-C-N 115.795 -0.638 . . . . 0.0 111.639 -176.033 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 135' ' ' ASP . . . . . 0.746 ' HB2' ' HG3' ' B' ' 138' ' ' ARG . 16.3 m-20 -94.03 132.91 38.04 Favored 'General case' 0 C--O 1.251 1.146 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 174.114 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 136' ' ' ASP . . . . . 0.952 ' HA ' HD11 ' B' ' 139' ' ' LEU . 5.5 m-20 -71.53 -11.45 60.87 Favored 'General case' 0 CA--C 1.511 -0.525 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.547 -167.042 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 137' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -97.32 -31.06 12.6 Favored 'General case' 0 N--CA 1.434 -1.228 0 C-N-CA 120.103 -0.639 . . . . 0.0 110.444 174.441 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 138' ' ' ARG . . . . . 0.746 ' HG3' ' HB2' ' B' ' 135' ' ' ASP . 52.4 mmt-85 -66.02 -43.96 86.12 Favored 'General case' 0 CA--C 1.506 -0.725 0 CA-C-O 121.553 0.692 . . . . 0.0 109.565 -174.956 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 139' ' ' LEU . . . . . 0.952 HD11 ' HA ' ' B' ' 136' ' ' ASP . 0.3 OUTLIER -75.91 -36.71 59.34 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.152 -0.931 . . . . 0.0 111.417 179.688 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 140' ' ' ASN . . . . . 0.615 ' H ' HD12 ' B' ' 139' ' ' LEU . 61.6 t30 -63.19 -25.95 68.58 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 177.699 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 141' ' ' LYS . . . . . . . . . . . . . 35.9 tptt -76.26 -49.09 17.96 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.632 -1.167 . . . . 0.0 110.838 177.639 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 142' ' ' VAL . . . . . 0.999 HG11 ' HB2' ' B' ' 103' ' ' TYR . 13.7 p -57.92 -45.95 87.61 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.367 0 CA-C-O 121.212 0.53 . . . . 0.0 109.716 179.561 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 143' ' ' ILE . . . . . 0.779 HD11 ' CG1' ' B' ' 123' ' ' ILE . 34.7 mt -58.56 -46.25 90.05 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.802 0 C-N-CA 124.124 0.97 . . . . 0.0 112.198 173.581 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 144' ' ' SER . . . . . . . . . . . . . 46.5 t -51.59 -39.23 57.52 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.917 176.225 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 145' ' ' GLU . . . . . . . . . . . . . 15.6 mm-40 -73.86 -50.86 18.3 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 121.765 0.793 . . . . 0.0 110.431 175.505 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 146' ' ' LEU . . . . . 0.57 ' O ' ' HE2' ' B' ' 149' ' ' LYS . 2.2 mm? -61.28 -32.7 72.53 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 114.56 -1.2 . . . . 0.0 112.973 -175.879 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 147' ' ' ASN . . . . . . . . . . . . . 50.6 t30 -54.69 116.99 3.0 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.74 -172.823 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 148' ' ' GLY . . . . . 0.44 ' O ' ' HD3' ' B' ' 149' ' ' LYS . . . 98.97 36.15 4.57 Favored Glycine 0 N--CA 1.448 -0.533 0 CA-C-N 115.52 -0.764 . . . . 0.0 112.446 -179.577 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 149' ' ' LYS . . . . . 0.57 ' HE2' ' O ' ' B' ' 146' ' ' LEU . 0.5 OUTLIER -130.48 164.02 25.71 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 110.04 -0.355 . . . . 0.0 110.04 177.898 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 150' ' ' ASN . . . . . 0.507 ' O ' HG23 ' B' ' 154' ' ' VAL . 4.8 m-20 -102.14 90.13 3.83 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 -178.437 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 151' ' ' ILE . . . . . 0.835 HG13 HD12 ' B' ' 108' ' ' LEU . 1.8 mp -34.58 -68.52 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 O-C-N 124.734 1.271 . . . . 0.0 113.251 -172.898 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 152' ' ' GLU . . . . . 0.49 ' N ' HG22 ' B' ' 151' ' ' ILE . 1.5 mm-40 -46.14 -56.68 5.32 Favored 'General case' 0 C--O 1.213 -0.84 0 N-CA-C 112.549 0.574 . . . . 0.0 112.549 -179.482 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 153' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -57.3 -35.67 70.13 Favored 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 120.85 -0.34 . . . . 0.0 111.673 -178.683 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 154' ' ' VAL . . . . . 0.738 ' HB ' HD12 ' B' ' 155' ' ' ILE . 64.4 t -57.87 -53.94 38.52 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 CA-C-O 121.273 0.558 . . . . 0.0 110.1 177.37 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 155' ' ' ILE . . . . . 0.738 HD12 ' HB ' ' B' ' 154' ' ' VAL . 3.6 mp -87.76 -19.78 7.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.56 -0.746 . . . . 0.0 111.729 -173.542 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . -57.21 -16.67 8.72 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.022 0.439 . . . . 0.0 110.919 179.585 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 157' ' ' GLN . . . . . . . . . . . . . 49.8 mt-30 -130.89 26.77 4.95 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.921 170.231 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 158' ' ' GLY . . . . . . . . . . . . . . . -160.04 46.85 0.41 Allowed Glycine 0 CA--C 1.526 0.76 0 CA-C-N 115.989 -0.551 . . . . 0.0 113.943 -172.297 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 159' ' ' ILE . . . . . 0.854 ' HB ' HG13 ' A' ' 60' ' ' ILE . 1.9 mp -61.16 -12.17 5.53 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 CA-C-O 121.875 0.845 . . . . 0.0 110.162 171.748 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 160' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.439 -1.143 0 N-CA-C 109.977 -1.249 . . . . 0.0 109.977 -178.806 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' SER . . . . . 0.503 ' HB2' ' HG3' ' A' ' 6' ' ' GLU . 1.5 m . . . . . 0 N--CA 1.449 -0.525 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.974 HG13 ' HG ' ' B' ' 112' ' ' LEU . 2.1 t -54.33 -24.86 12.82 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-N 115.128 -0.942 . . . . 0.0 112.348 -177.446 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' SER . . . . . 0.849 ' HB3' ' HA ' ' A' ' 39' ' ' VAL . 49.7 m -71.27 -48.55 50.21 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.446 0.641 . . . . 0.0 109.304 175.996 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.57 ' HG2' ' HE1' ' A' ' 43' ' ' TRP . 28.4 mt-10 -61.57 -49.42 76.72 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.322 -0.853 . . . . 0.0 109.274 179.18 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.856 HD12 HD12 ' A' ' 10' ' ' ILE . 4.7 tp -60.24 -35.12 74.76 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 114.831 -1.077 . . . . 0.0 111.47 177.136 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.686 ' HB2' HD23 ' B' ' 112' ' ' LEU . . . -67.87 -37.15 81.45 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 120.933 0.397 . . . . 0.0 110.871 179.029 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.508 ' HB2' HG11 ' A' ' 39' ' ' VAL . 8.4 t -67.81 -39.58 83.95 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 178.955 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.856 HD12 HD12 ' A' ' 7' ' ' LEU . 68.9 mt -48.48 -55.56 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.694 0 CA-C-N 114.264 -1.335 . . . . 0.0 109.726 170.03 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.858 ' HB2' HD13 ' B' ' 109' ' ' LEU . 23.0 m-85 -67.11 -39.03 86.63 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.698 -173.978 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.477 ' OG ' HG23 ' A' ' 28' ' ' ILE . 73.1 p -57.1 -40.42 76.97 Favored 'General case' 0 C--O 1.237 0.395 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 177.209 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -65.94 -33.02 74.87 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 115.195 -0.911 . . . . 0.0 110.574 173.834 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.899 HD22 HD11 ' A' ' 56' ' ' ILE . 0.4 OUTLIER -66.12 -50.52 63.73 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.967 -179.774 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.494 HG12 ' O ' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -63.11 -42.43 96.56 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 177.497 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.618 HD21 ' HA ' ' A' ' 23' ' ' VAL . 6.1 tp -56.12 -38.16 70.4 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.37 0.605 . . . . 0.0 110.388 173.859 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 45.9 t60 -78.78 -7.61 57.98 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.018 -0.992 . . . . 0.0 111.598 178.728 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -66.62 -52.74 41.84 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 175.188 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -93.1 -10.84 34.56 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 122.098 0.952 . . . . 0.0 108.896 178.512 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 55.79 53.45 9.4 Favored 'General case' 0 CA--C 1.51 -0.576 0 CA-C-N 113.871 -1.513 . . . . 0.0 109.597 -175.026 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.404 HG13 HD12 ' A' ' 16' ' ' LEU . 7.6 p -99.87 160.07 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.723 0 CA-C-N 113.971 -1.468 . . . . 0.0 108.667 -176.96 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.509 ' O ' ' HG3' ' A' ' 27' ' ' LYS . 50.8 p -43.37 131.28 4.84 Favored 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 113.525 0.935 . . . . 0.0 113.525 -171.661 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.618 ' HA ' HD21 ' A' ' 16' ' ' LEU . 57.7 t -96.82 109.31 22.83 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.04 0 CA-C-N 114.283 -1.326 . . . . 0.0 110.863 -177.071 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.747 ' OG1' ' HG2' ' A' ' 27' ' ' LYS . 21.3 p -133.31 157.13 46.24 Favored 'General case' 0 C--O 1.245 0.855 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.186 179.457 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -53.27 -44.71 68.42 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.601 177.313 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -68.76 -24.97 64.5 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.282 179.589 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.747 ' HG2' ' OG1' ' A' ' 24' ' ' THR . 2.8 mmtm -61.44 -56.43 20.24 Favored 'General case' 0 CA--C 1.514 -0.407 0 N-CA-C 107.937 -1.135 . . . . 0.0 107.937 173.644 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.477 HG23 ' OG ' ' A' ' 12' ' ' SER . 83.5 mt -55.73 -43.3 73.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 113.728 -1.578 . . . . 0.0 110.818 -178.894 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.418 ' HA ' HD12 ' A' ' 32' ' ' ILE . 29.4 m-80 -65.52 -33.17 75.3 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.065 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.23 -48.88 76.41 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.333 176.072 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.674 ' HB3' HD21 ' B' ' 109' ' ' LEU . 1.9 mm? -59.53 -47.6 84.92 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-O 120.917 0.389 . . . . 0.0 110.617 175.939 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.564 HG23 ' O ' ' A' ' 37' ' ' VAL . 44.0 mt -48.58 -48.98 14.47 Favored 'Isoleucine or valine' 0 C--O 1.241 0.647 0 CA-C-N 115.227 -0.897 . . . . 0.0 111.277 178.166 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 42.5 tptt -72.57 -42.46 64.6 Favored 'General case' 0 N--CA 1.431 -1.399 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.607 -176.461 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -60.74 -40.4 92.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.948 0.404 . . . . 0.0 111.217 -177.848 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.467 ' HA ' HD11 ' B' ' 126' ' ' ILE . . . -79.96 -34.79 38.44 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.178 0.513 . . . . 0.0 111.105 178.967 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 97.75 17.66 29.93 Favored Glycine 0 N--CA 1.448 -0.548 0 CA-C-N 115.672 -0.695 . . . . 0.0 112.003 -179.567 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.909 ' HB ' ' HA2' ' B' ' 113' ' ' GLY . 2.9 p -119.69 119.32 60.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-O 121.599 0.714 . . . . 0.0 110.618 -176.567 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.457 ' HA ' HG23 ' A' ' 32' ' ' ILE . 13.6 t-20 -97.57 150.99 20.52 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 114.816 -1.084 . . . . 0.0 110.342 -170.345 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.849 ' HA ' ' HB3' ' A' ' 5' ' ' SER . 99.0 t -121.56 162.55 20.59 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.028 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.381 -169.497 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.48 ' HB3' ' HD1' ' A' ' 43' ' ' TRP . 5.1 tp10 -70.69 106.58 1.84 Allowed Pre-proline 0 N--CA 1.438 -1.04 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 169.665 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.502 ' C ' ' HD2' ' A' ' 44' ' ' PRO . 77.7 Cg_exo -51.71 -26.36 23.09 Favored 'Trans proline' 0 C--O 1.247 0.925 0 C-N-CA 123.818 3.012 . . . . 0.0 115.503 -164.199 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.418 ' HD2' ' HG3' ' A' ' 40' ' ' GLU . 0.6 OUTLIER -61.91 -27.32 68.73 Favored 'General case' 0 CA--C 1.526 0.048 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 177.898 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 43' ' ' TRP . . . . . 0.57 ' HE1' ' HG2' ' A' ' 6' ' ' GLU . 20.8 m95 -64.31 -59.63 10.48 Favored Pre-proline 0 C--O 1.208 -1.107 0 CA-C-O 118.626 -0.702 . . . . 0.0 110.977 176.04 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.502 ' HD2' ' C ' ' A' ' 41' ' ' PRO . 90.7 Cg_exo -45.26 -43.97 16.29 Favored 'Trans proline' 0 C--N 1.358 1.035 0 C-N-CA 121.733 1.622 . . . . 0.0 112.031 173.474 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -60.21 -59.11 10.95 Favored Glycine 0 CA--C 1.525 0.671 0 C-N-CA 120.36 -0.924 . . . . 0.0 112.581 176.649 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.439 ' O ' ' HB2' ' A' ' 49' ' ' LYS . 5.9 tp -67.46 -26.9 66.61 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 122.909 0.483 . . . . 0.0 112.108 -176.785 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.545 ' HE1' ' CE3' ' A' ' 43' ' ' TRP . 3.0 m-85 -69.05 -46.78 67.01 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 110.19 -0.3 . . . . 0.0 110.19 176.317 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.436 ' HA ' HG12 ' A' ' 23' ' ' VAL . . . -65.47 -32.02 73.42 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.322 -0.622 . . . . 0.0 109.322 178.229 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.439 ' HB2' ' O ' ' A' ' 46' ' ' LEU . 8.0 mmmt -60.44 -55.33 34.83 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 114.832 -1.077 . . . . 0.0 111.707 171.289 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.605 ' O ' HG22 ' A' ' 54' ' ' VAL . . . -76.4 -41.09 49.01 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 -170.211 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.568 ' HB2' HG11 ' A' ' 23' ' ' VAL . 12.7 mt -74.21 45.47 0.22 Allowed 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 121.473 0.654 . . . . 0.0 111.925 -173.279 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -134.68 -24.58 1.52 Allowed 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.05 -0.977 . . . . 0.0 109.026 172.837 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -121.39 -25.28 5.23 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 115.56 -0.746 . . . . 0.0 111.13 178.826 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.605 HG22 ' O ' ' A' ' 50' ' ' ALA . 10.4 m -99.64 -170.37 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 174.853 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 34.9 p30 -129.67 -178.39 4.67 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.794 175.59 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.899 HD11 HD22 ' A' ' 14' ' ' LEU . 3.1 tp -68.32 -28.69 41.58 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-O 120.642 0.258 . . . . 0.0 110.94 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -72.14 -11.05 74.74 Favored Glycine 0 N--CA 1.448 -0.5 0 C-N-CA 120.447 -0.882 . . . . 0.0 111.016 177.326 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 14.8 t -82.46 -19.21 39.34 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-O 121.598 0.713 . . . . 0.0 109.356 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.703 ' HB2' HG21 ' B' ' 159' ' ' ILE . 22.0 mt -64.0 -31.65 72.92 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.208 -0.906 . . . . 0.0 110.258 177.995 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.789 HG13 ' HB ' ' B' ' 159' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--N 1.323 -0.574 0 CA-C-N 114.898 -1.047 . . . . 0.0 110.483 177.798 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 103' ' ' TYR . . . . . 0.88 ' HB2' HG11 ' B' ' 142' ' ' VAL . 39.8 m-85 . . . . . 0 C--O 1.24 0.556 0 CA-C-O 120.722 0.296 . . . . 0.0 111.076 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 104' ' ' VAL . . . . . 0.562 ' HA ' HD11 ' B' ' 146' ' ' LEU . 97.8 t -43.64 -49.31 1.66 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.242 0 CA-C-O 121.701 0.763 . . . . 0.0 109.099 172.399 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 105' ' ' ALA . . . . . 0.652 ' CB ' ' HB3' ' A' ' 14' ' ' LEU . . . -64.17 -42.34 96.76 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 114.273 -1.331 . . . . 0.0 112.175 -173.919 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 106' ' ' SER . . . . . 0.773 ' HB2' HG23 ' B' ' 123' ' ' ILE . 0.8 OUTLIER -62.59 -37.68 87.17 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.687 0.756 . . . . 0.0 109.666 -179.747 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 107' ' ' TYR . . . . . 0.685 ' O ' ' HG2' ' B' ' 118' ' ' PRO . 43.6 t80 -63.41 -47.44 81.97 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 114.652 -1.158 . . . . 0.0 108.662 178.235 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 108' ' ' LEU . . . . . 0.831 HD12 HG13 ' B' ' 151' ' ' ILE . 0.0 OUTLIER -57.87 -46.44 84.85 Favored 'General case' 0 N--CA 1.442 -0.842 0 CA-C-N 114.766 -1.106 . . . . 0.0 110.866 177.194 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 109' ' ' LEU . . . . . 0.858 HD13 ' HB2' ' A' ' 11' ' ' TYR . 8.4 tp -54.85 -47.32 74.33 Favored 'General case' 0 CA--C 1.511 -0.543 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.916 179.047 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 110' ' ' ALA . . . . . 0.48 ' HB3' ' HB3' ' B' ' 118' ' ' PRO . . . -68.01 -36.61 80.27 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.59 -0.444 . . . . 0.0 111.334 -176.772 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 111' ' ' ALA . . . . . 0.788 ' HA ' ' O ' ' B' ' 115' ' ' ASN . . . -70.91 -20.0 62.53 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.411 0.624 . . . . 0.0 110.703 178.51 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 112' ' ' LEU . . . . . 0.974 ' HG ' HG13 ' A' ' 4' ' ' VAL . 2.8 mp -84.5 -40.18 17.97 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 114.962 -1.017 . . . . 0.0 109.762 172.191 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 113' ' ' GLY . . . . . 0.909 ' HA2' ' HB ' ' A' ' 37' ' ' VAL . . . -61.54 -53.65 42.22 Favored Glycine 0 N--CA 1.442 -0.904 0 CA-C-N 114.928 -1.033 . . . . 0.0 112.155 -177.942 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 114' ' ' GLY . . . . . . . . . . . . . . . 177.33 4.03 0.02 OUTLIER Glycine 0 N--CA 1.441 -1.01 0 C-N-CA 119.55 -1.31 . . . . 0.0 113.909 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 115' ' ' ASN . . . . . 0.788 ' O ' ' HA ' ' B' ' 111' ' ' ALA . 38.2 m-20 -126.78 98.89 5.54 Favored 'General case' 0 CA--C 1.497 -1.076 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 14.1 m -77.04 26.8 0.14 Allowed 'General case' 0 C--N 1.315 -0.9 0 CA-C-O 122.107 0.956 . . . . 0.0 109.763 -175.562 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 117' ' ' SER . . . . . 0.579 ' H ' ' C ' ' B' ' 115' ' ' ASN . 34.8 t -168.8 70.39 0.75 Allowed Pre-proline 0 C--N 1.321 -0.633 0 CA-C-N 113.738 -1.573 . . . . 0.0 108.385 178.924 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 118' ' ' PRO . . . . . 0.685 ' HG2' ' O ' ' B' ' 107' ' ' TYR . 34.1 Cg_exo -66.82 158.77 54.73 Favored 'Trans proline' 0 C--N 1.328 -0.547 0 C-N-CA 125.167 3.911 . . . . 0.0 111.675 -176.916 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 119' ' ' SER . . . . . 0.58 ' O ' HG12 ' B' ' 123' ' ' ILE . 8.6 m -122.31 -179.39 4.17 Favored 'General case' 0 C--N 1.316 -0.882 0 C-N-CA 120.555 -0.458 . . . . 0.0 110.875 176.175 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 120' ' ' ALA . . . . . 0.904 ' HB1' HD13 ' B' ' 139' ' ' LEU . . . -65.99 -36.46 83.36 Favored 'General case' 0 CA--C 1.504 -0.812 0 CA-C-O 122.219 1.009 . . . . 0.0 109.236 -173.347 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 121' ' ' LYS . . . . . 0.447 ' HD2' ' N ' ' B' ' 121' ' ' LYS . 0.4 OUTLIER -63.61 -34.86 78.77 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 113.332 -1.758 . . . . 0.0 110.101 176.782 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 122' ' ' ASP . . . . . 0.475 ' O ' HD13 ' B' ' 126' ' ' ILE . 18.5 m-20 -71.1 -37.6 72.38 Favored 'General case' 0 CA--C 1.517 -0.314 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 176.486 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 123' ' ' ILE . . . . . 0.773 HG23 ' HB2' ' B' ' 106' ' ' SER . 34.1 mm -61.83 -49.9 82.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.132 177.453 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 124' ' ' LYS . . . . . 0.818 ' HD3' HD21 ' B' ' 139' ' ' LEU . 4.2 mmmp? -58.91 -43.61 91.12 Favored 'General case' 0 C--O 1.213 -0.839 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.228 -178.862 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 125' ' ' LYS . . . . . 0.523 ' HA ' ' HD3' ' B' ' 125' ' ' LYS . 10.0 tppt? -50.51 -59.82 3.64 Favored 'General case' 0 N--CA 1.418 -2.056 0 O-C-N 123.721 0.638 . . . . 0.0 112.132 174.105 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 126' ' ' ILE . . . . . 0.579 HG23 HD12 ' A' ' 31' ' ' LEU . 1.7 mp -56.53 -47.63 81.61 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 CA-C-N 115.426 -0.806 . . . . 0.0 111.487 -176.282 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 127' ' ' LEU . . . . . 0.745 ' HG ' ' O ' ' B' ' 123' ' ' ILE . 2.2 pp -80.59 -19.59 45.2 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.306 -0.557 . . . . 0.0 112.103 -177.11 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 128' ' ' ASP . . . . . 0.516 ' HB2' ' O ' ' B' ' 124' ' ' LYS . 13.6 t70 -73.98 -31.16 62.86 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 179.367 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 129' ' ' SER . . . . . . . . . . . . . 84.1 p -52.63 -37.62 58.77 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.219 176.883 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 130' ' ' VAL . . . . . 0.559 HG23 HG13 ' B' ' 132' ' ' ILE . 7.5 m -103.95 5.85 10.35 Favored 'Isoleucine or valine' 0 C--O 1.232 0.137 0 CA-C-O 120.801 0.334 . . . . 0.0 111.536 179.324 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 131' ' ' GLY . . . . . . . . . . . . . . . 67.83 48.97 52.07 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 121.192 -0.528 . . . . 0.0 113.163 177.308 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 132' ' ' ILE . . . . . 0.565 ' HB ' ' HB2' ' B' ' 127' ' ' LEU . 8.7 mt -101.54 128.58 53.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-O 120.919 0.39 . . . . 0.0 110.963 178.229 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 133' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -67.47 136.45 54.65 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.187 -177.558 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 134' ' ' ALA . . . . . . . . . . . . . . . -152.57 143.61 23.07 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.182 -177.137 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 135' ' ' ASP . . . . . 0.733 ' HB2' ' HG3' ' B' ' 138' ' ' ARG . 34.1 m-20 -93.27 129.51 39.31 Favored 'General case' 0 C--O 1.251 1.149 0 CA-C-O 120.973 0.416 . . . . 0.0 110.12 174.772 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 136' ' ' ASP . . . . . 0.989 ' HA ' HD11 ' B' ' 139' ' ' LEU . 3.1 m-20 -71.22 -5.37 31.48 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-N 115.239 -0.892 . . . . 0.0 111.191 -169.949 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 137' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -100.53 -34.99 9.68 Favored 'General case' 0 N--CA 1.433 -1.282 0 C-N-CA 120.487 -0.485 . . . . 0.0 110.097 175.662 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 138' ' ' ARG . . . . . 0.733 ' HG3' ' HB2' ' B' ' 135' ' ' ASP . 43.7 mmt-85 -63.91 -46.23 85.74 Favored 'General case' 0 CA--C 1.503 -0.841 0 CA-C-O 122.118 0.961 . . . . 0.0 109.234 -176.323 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 139' ' ' LEU . . . . . 0.989 HD11 ' HA ' ' B' ' 136' ' ' ASP . 0.3 OUTLIER -74.16 -34.39 63.8 Favored 'General case' 0 C--O 1.209 -1.037 0 CA-C-N 114.529 -1.214 . . . . 0.0 111.6 -178.828 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 140' ' ' ASN . . . . . 0.628 ' H ' HD12 ' B' ' 139' ' ' LEU . 60.8 t30 -65.02 -27.98 69.18 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 122.331 1.062 . . . . 0.0 108.703 177.538 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 141' ' ' LYS . . . . . 0.607 ' O ' ' HG2' ' B' ' 145' ' ' GLU . 30.0 tttp -67.89 -56.0 10.72 Favored 'General case' 0 N--CA 1.44 -0.959 0 CA-C-N 114.141 -1.39 . . . . 0.0 108.882 175.918 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 142' ' ' VAL . . . . . 0.88 HG11 ' HB2' ' B' ' 103' ' ' TYR . 8.5 p -57.93 -31.57 41.22 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.236 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.449 178.827 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 143' ' ' ILE . . . . . 0.841 HG12 ' O ' ' B' ' 139' ' ' LEU . 28.1 mm -51.99 -67.41 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.513 -0.45 0 CA-C-O 121.151 0.501 . . . . 0.0 110.514 170.873 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 144' ' ' SER . . . . . . . . . . . . . 79.2 p -57.42 -25.42 59.58 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 114.96 -1.018 . . . . 0.0 111.89 -178.848 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 145' ' ' GLU . . . . . 0.607 ' HG2' ' O ' ' B' ' 141' ' ' LYS . 5.8 mm-40 -73.16 -46.47 50.6 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 120.898 0.38 . . . . 0.0 110.555 178.143 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 146' ' ' LEU . . . . . 0.722 ' HG ' ' O ' ' B' ' 142' ' ' VAL . 6.9 mt -82.63 -17.05 46.06 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.486 -0.324 . . . . 0.0 111.09 -176.593 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 147' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -56.54 111.84 1.11 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.207 0.527 . . . . 0.0 111.426 -175.817 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . 111.72 7.76 23.43 Favored Glycine 0 CA--C 1.519 0.33 0 CA-C-N 115.527 -0.76 . . . . 0.0 112.806 -179.285 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 149' ' ' LYS . . . . . 0.514 ' HE2' ' O ' ' B' ' 146' ' ' LEU . 0.8 OUTLIER -104.19 167.88 9.47 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.1 0.476 . . . . 0.0 111.038 -179.749 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 150' ' ' ASN . . . . . 0.511 ' O ' HG23 ' B' ' 154' ' ' VAL . 7.6 m-20 -103.93 91.01 3.79 Favored 'General case' 0 CA--C 1.511 -0.545 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 176.788 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 151' ' ' ILE . . . . . 0.831 HG13 HD12 ' B' ' 108' ' ' LEU . 1.8 mp -41.9 -62.87 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 O-C-N 124.376 1.048 . . . . 0.0 113.247 -168.936 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 152' ' ' GLU . . . . . 0.714 ' HG3' HD11 ' B' ' 112' ' ' LEU . 3.0 mp0 -57.42 -33.22 67.67 Favored 'General case' 0 C--O 1.219 -0.532 0 N-CA-C 111.839 0.311 . . . . 0.0 111.839 -174.487 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 153' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -78.52 -33.4 48.01 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.609 179.498 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 154' ' ' VAL . . . . . 0.783 ' HB ' HD12 ' B' ' 155' ' ' ILE . 58.2 t -54.84 -46.31 75.17 Favored 'Isoleucine or valine' 0 C--O 1.233 0.185 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 172.253 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 155' ' ' ILE . . . . . 0.783 HD12 ' HB ' ' B' ' 154' ' ' VAL . 2.3 mp -106.71 33.84 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 114.97 -1.014 . . . . 0.0 110.448 -179.314 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 156' ' ' ALA . . . . . 0.433 ' HB2' ' O ' ' B' ' 152' ' ' GLU . . . -101.75 2.99 39.1 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 167.526 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 157' ' ' GLN . . . . . . . . . . . . . 46.4 mt-30 -138.93 -1.42 1.79 Allowed 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 113.55 -1.659 . . . . 0.0 109.844 173.945 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 158' ' ' GLY . . . . . 0.406 ' O ' HG23 ' B' ' 155' ' ' ILE . . . -139.62 46.34 0.96 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.379 -0.915 . . . . 0.0 114.575 -167.274 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 159' ' ' ILE . . . . . 0.789 ' HB ' HG13 ' A' ' 60' ' ' ILE . 1.8 mp -61.59 -15.56 13.43 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 CA-C-O 122.039 0.923 . . . . 0.0 109.733 173.584 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 160' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.437 -1.29 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 178.509 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' SER . . . . . 0.745 ' HB2' ' HG3' ' A' ' 6' ' ' GLU . 6.2 m . . . . . 0 N--CA 1.439 -1.023 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.888 HG13 ' HG ' ' B' ' 112' ' ' LEU . 2.2 t -52.93 -28.22 13.64 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.78 0 CA-C-N 115.294 -0.866 . . . . 0.0 112.073 -179.573 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' SER . . . . . 0.746 ' HB3' ' HA ' ' A' ' 39' ' ' VAL . 71.7 m -68.45 -43.99 75.85 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.229 0.538 . . . . 0.0 109.784 175.723 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.745 ' HG3' ' HB2' ' A' ' 3' ' ' SER . 30.2 mt-10 -68.21 -49.04 63.44 Favored 'General case' 0 N--CA 1.444 -0.726 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 -178.209 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.877 ' HA ' HD12 ' A' ' 10' ' ' ILE . 2.9 tp -58.34 -35.01 71.27 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 114.443 -1.253 . . . . 0.0 111.949 175.396 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.579 ' HB2' HD23 ' B' ' 112' ' ' LEU . . . -68.37 -37.25 80.26 Favored 'General case' 0 CA--C 1.512 -0.484 0 CA-C-O 121.04 0.448 . . . . 0.0 110.786 179.054 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.528 ' HB2' HG11 ' A' ' 39' ' ' VAL . 4.6 t -67.35 -40.79 85.86 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 178.633 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.877 HD12 ' HA ' ' A' ' 7' ' ' LEU . 73.8 mt -48.92 -55.76 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.685 0 CA-C-N 113.896 -1.502 . . . . 0.0 110.051 171.896 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.852 ' HB2' HD13 ' B' ' 109' ' ' LEU . 23.9 m-85 -66.36 -41.46 89.46 Favored 'General case' 0 C--O 1.22 -0.455 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.557 -174.103 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.436 ' HA ' ' HG ' ' A' ' 31' ' ' LEU . 15.6 m -54.01 -42.09 68.7 Favored 'General case' 0 C--O 1.242 0.692 0 CA-C-O 121.489 0.661 . . . . 0.0 109.27 175.92 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -68.67 -28.94 67.32 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.39 176.154 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.693 HD22 HD11 ' A' ' 56' ' ' ILE . 0.2 OUTLIER -67.25 -55.58 13.41 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.49 179.34 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.404 HG12 ' O ' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -55.72 -43.84 74.99 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 176.889 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.597 HD12 HG13 ' A' ' 21' ' ' VAL . 3.8 tp -57.69 -44.27 85.73 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.501 177.75 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 25.1 t60 -75.73 -13.43 60.31 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.258 -0.883 . . . . 0.0 111.726 178.657 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 12.1 t0 -69.09 -42.31 76.34 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.247 0.546 . . . . 0.0 109.61 179.377 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.412 ' HB2' HG23 ' B' ' 132' ' ' ILE . 36.5 t70 -100.08 -7.04 25.4 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 122.032 0.92 . . . . 0.0 109.226 177.014 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 52.29 56.55 7.56 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-N 113.784 -1.553 . . . . 0.0 110.262 -175.286 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.597 HG13 HD12 ' A' ' 16' ' ' LEU . 6.1 p -106.21 159.45 6.18 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.679 0 CA-C-N 114.13 -1.396 . . . . 0.0 108.814 -178.825 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 82.2 p -49.8 139.1 13.74 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 114.193 1.183 . . . . 0.0 114.193 -169.48 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.604 HG12 ' HA ' ' A' ' 48' ' ' ALA . 63.1 t -103.77 111.86 35.06 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-N 114.216 -1.356 . . . . 0.0 110.986 -177.094 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.51 ' OG1' ' HE2' ' A' ' 27' ' ' LYS . 77.3 p -135.66 157.83 45.89 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 175.575 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -57.49 -41.23 80.29 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 120.71 -0.396 . . . . 0.0 110.094 -177.434 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -65.16 -29.92 70.8 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.08 178.344 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.51 ' HE2' ' OG1' ' A' ' 24' ' ' THR . 3.8 tppt? -66.53 -53.0 39.72 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 179.844 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 66.4 mt -60.41 -39.69 81.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 114.394 -1.275 . . . . 0.0 110.491 178.321 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 -61.97 -36.01 80.16 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.74 176.045 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.67 -45.59 92.1 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-N 116.552 -0.294 . . . . 0.0 110.484 177.732 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.562 ' HB3' HD21 ' B' ' 109' ' ' LEU . 1.3 mm? -58.35 -51.15 71.02 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 121.085 0.469 . . . . 0.0 110.13 173.838 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.561 HG23 ' O ' ' A' ' 37' ' ' VAL . 57.1 mt -48.28 -50.86 10.99 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 CA-C-N 114.873 -1.058 . . . . 0.0 111.646 178.686 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -69.82 -40.08 76.13 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.079 -0.51 . . . . 0.0 112.03 -176.748 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -64.2 -45.54 87.86 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-O 120.918 0.39 . . . . 0.0 111.093 -177.384 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.423 ' HB3' HG12 ' A' ' 37' ' ' VAL . . . -74.84 -34.82 62.36 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.429 178.669 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 96.96 18.48 29.36 Favored Glycine 0 N--CA 1.448 -0.554 0 CA-C-N 115.379 -0.828 . . . . 0.0 112.019 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.868 ' HB ' ' HA3' ' B' ' 113' ' ' GLY . 5.5 p -121.04 121.92 66.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 121.422 0.63 . . . . 0.0 111.059 -173.061 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 62.9 t30 -99.33 157.33 16.48 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.049 -0.978 . . . . 0.0 111.035 -169.308 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.746 ' HA ' ' HB3' ' A' ' 5' ' ' SER . 94.6 t -125.28 161.66 29.19 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.759 0 CA-C-N 115.056 -0.974 . . . . 0.0 110.937 -170.214 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.566 ' HB3' ' HD1' ' A' ' 43' ' ' TRP . 3.9 tp10 -67.65 105.41 0.9 Allowed Pre-proline 0 N--CA 1.441 -0.884 0 N-CA-C 107.756 -1.201 . . . . 0.0 107.756 169.972 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.522 ' C ' ' HD2' ' A' ' 44' ' ' PRO . 86.0 Cg_exo -49.54 -29.73 19.58 Favored 'Trans proline' 0 C--O 1.252 1.195 0 C-N-CA 123.602 2.868 . . . . 0.0 115.675 -163.767 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -60.76 -27.65 68.13 Favored 'General case' 0 C--N 1.333 -0.14 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 177.647 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' TRP . . . . . 0.566 ' HD1' ' HB3' ' A' ' 40' ' ' GLU . 9.6 m95 -65.08 -59.41 10.09 Favored Pre-proline 0 C--O 1.204 -1.337 0 CA-C-O 118.303 -0.856 . . . . 0.0 111.147 176.416 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.522 ' HD2' ' C ' ' A' ' 41' ' ' PRO . 83.3 Cg_exo -45.52 -44.46 17.0 Favored 'Trans proline' 0 C--N 1.359 1.086 0 C-N-CA 121.652 1.568 . . . . 0.0 111.913 174.622 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -60.4 -60.56 8.34 Favored Glycine 0 CA--C 1.525 0.68 0 C-N-CA 120.176 -1.012 . . . . 0.0 112.322 175.997 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 12.7 tp -65.79 -21.92 66.53 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.136 0.574 . . . . 0.0 112.11 -177.057 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.676 ' HD2' HD11 ' A' ' 51' ' ' LEU . 2.6 m-85 -74.72 -45.07 46.59 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 176.625 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.604 ' HA ' HG12 ' A' ' 23' ' ' VAL . . . -64.8 -30.23 71.22 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-O 121.821 0.82 . . . . 0.0 108.864 177.602 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 9.6 mmmt -66.27 -58.0 6.32 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 114.276 -1.329 . . . . 0.0 111.713 172.167 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.489 ' O ' HG22 ' A' ' 54' ' ' VAL . . . -76.03 -39.1 56.38 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 113.457 0.91 . . . . 0.0 113.457 -168.786 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.676 HD11 ' HD2' ' A' ' 47' ' ' PHE . 12.3 mt -68.85 -4.51 16.57 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 117.922 0.328 . . . . 0.0 111.7 -173.641 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -95.67 9.68 39.45 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.138 0.494 . . . . 0.0 110.296 174.726 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -143.62 -48.2 0.29 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.505 -178.697 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.489 HG22 ' O ' ' A' ' 50' ' ' ALA . 9.2 m -94.77 -169.55 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.282 179.851 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -121.59 -175.94 3.2 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.962 0.411 . . . . 0.0 111.3 178.199 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.693 HD11 HD22 ' A' ' 14' ' ' LEU . 3.0 tp -75.06 -28.46 20.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.356 -179.669 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -69.84 -15.5 71.49 Favored Glycine 0 N--CA 1.447 -0.571 0 N-CA-C 110.613 -0.995 . . . . 0.0 110.613 175.461 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 16.5 m -78.02 -19.61 54.05 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-O 121.174 0.511 . . . . 0.0 110.201 179.594 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.652 ' HB2' HG21 ' B' ' 159' ' ' ILE . 25.0 mt -64.16 -30.47 71.53 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.589 179.814 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.686 ' CD1' ' HB ' ' B' ' 159' ' ' ILE . 0.4 OUTLIER . . . . . 0 C--N 1.318 -0.783 0 CA-C-N 115.147 -0.933 . . . . 0.0 109.955 176.574 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 103' ' ' TYR . . . . . 0.663 ' HB2' HG11 ' B' ' 142' ' ' VAL . 47.6 m-85 . . . . . 0 N--CA 1.475 0.805 0 N-CA-C 112.087 0.403 . . . . 0.0 112.087 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 104' ' ' VAL . . . . . 0.522 ' O ' ' HB3' ' B' ' 107' ' ' TYR . 82.9 t -45.42 -44.34 3.76 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.256 0 CA-C-O 121.515 0.674 . . . . 0.0 110.404 175.777 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 105' ' ' ALA . . . . . 0.669 ' CB ' ' HB3' ' A' ' 14' ' ' LEU . . . -67.41 -38.78 85.16 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 114.925 -1.034 . . . . 0.0 111.559 -174.853 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 106' ' ' SER . . . . . 0.829 ' HB2' HG23 ' B' ' 123' ' ' ILE . 1.8 m -60.79 -38.44 85.34 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-O 121.784 0.802 . . . . 0.0 109.189 175.979 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 107' ' ' TYR . . . . . 0.759 ' O ' ' HG2' ' B' ' 118' ' ' PRO . 38.4 t80 -63.27 -49.33 74.52 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-N 114.016 -1.447 . . . . 0.0 108.706 178.814 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 108' ' ' LEU . . . . . 0.679 HD12 HG13 ' B' ' 151' ' ' ILE . 0.0 OUTLIER -56.4 -50.49 71.44 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.164 -0.926 . . . . 0.0 111.711 178.772 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 109' ' ' LEU . . . . . 0.852 HD13 ' HB2' ' A' ' 11' ' ' TYR . 7.8 tp -53.93 -54.91 32.25 Favored 'General case' 0 C--O 1.246 0.906 0 CA-C-O 121.4 0.619 . . . . 0.0 111.011 178.996 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -57.05 -39.14 74.3 Favored 'General case' 0 C--O 1.22 -0.458 0 CA-C-N 114.975 -1.011 . . . . 0.0 110.423 -178.259 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 111' ' ' ALA . . . . . 0.734 ' HA ' ' O ' ' B' ' 115' ' ' ASN . . . -77.83 -19.54 54.74 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.706 -178.915 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 112' ' ' LEU . . . . . 0.888 ' HG ' HG13 ' A' ' 4' ' ' VAL . 4.4 tp -77.19 -40.0 46.78 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.418 -179.047 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 113' ' ' GLY . . . . . 0.868 ' HA3' ' HB ' ' A' ' 37' ' ' VAL . . . -144.95 44.68 0.88 Allowed Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 118.819 -1.658 . . . . 0.0 114.354 -176.75 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 114' ' ' GLY . . . . . . . . . . . . . . . -166.25 -49.21 0.02 OUTLIER Glycine 0 N--CA 1.444 -0.792 0 C-N-CA 119.214 -1.47 . . . . 0.0 113.139 175.489 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 115' ' ' ASN . . . . . 0.734 ' O ' ' HA ' ' B' ' 111' ' ' ALA . 1.8 t-20 -155.47 113.63 3.43 Favored 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 109.227 -0.656 . . . . 0.0 109.227 -171.757 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 4.0 m -79.97 26.01 0.35 Allowed 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 122.152 0.977 . . . . 0.0 111.02 -168.33 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 117' ' ' SER . . . . . 0.494 ' N ' ' HD3' ' B' ' 118' ' ' PRO . 8.9 t -172.31 69.82 0.43 Allowed Pre-proline 0 C--N 1.312 -1.022 0 CA-C-N 113.789 -1.55 . . . . 0.0 108.346 178.668 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 118' ' ' PRO . . . . . 0.759 ' HG2' ' O ' ' B' ' 107' ' ' TYR . 33.3 Cg_exo -62.07 157.44 44.25 Favored 'Trans proline' 0 CA--C 1.511 -0.651 1 C-N-CA 125.605 4.203 . . . . 0.0 112.155 -173.934 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 119' ' ' SER . . . . . 0.55 ' O ' HG12 ' B' ' 123' ' ' ILE . 14.7 m -131.73 -174.98 3.57 Favored 'General case' 0 C--N 1.317 -0.828 0 C-N-CA 119.715 -0.794 . . . . 0.0 111.842 178.784 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 120' ' ' ALA . . . . . 0.745 ' HB1' HD13 ' B' ' 139' ' ' LEU . . . -63.27 -40.77 98.33 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.719 0.771 . . . . 0.0 109.611 -165.177 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 121' ' ' LYS . . . . . . . . . . . . . 1.8 mptm? -62.71 -36.83 84.22 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 114.078 -1.419 . . . . 0.0 110.86 177.304 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 122' ' ' ASP . . . . . . . . . . . . . 44.8 m-20 -70.42 -40.13 74.01 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 120.182 -0.607 . . . . 0.0 109.55 -178.999 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 123' ' ' ILE . . . . . 0.829 HG23 ' HB2' ' B' ' 106' ' ' SER . 23.3 mm -60.19 -42.94 92.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.52 175.581 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 124' ' ' LYS . . . . . 0.845 ' HD3' HD21 ' B' ' 139' ' ' LEU . 2.2 mmmp? -59.02 -39.73 82.84 Favored 'General case' 0 CA--C 1.504 -0.819 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 -178.875 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 125' ' ' LYS . . . . . . . . . . . . . 86.8 mttt -56.81 -61.69 2.26 Favored 'General case' 0 CA--C 1.489 -1.382 0 C-N-CA 119.274 -0.97 . . . . 0.0 110.841 173.653 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 126' ' ' ILE . . . . . 0.49 HG23 HD12 ' A' ' 31' ' ' LEU . 1.8 mp -57.44 -36.99 55.26 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.118 0 CA-C-N 114.282 -1.326 . . . . 0.0 110.951 -166.855 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 127' ' ' LEU . . . . . 0.75 ' HG ' ' O ' ' B' ' 123' ' ' ILE . 1.2 pp -80.68 -39.29 27.47 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.172 -0.611 . . . . 0.0 111.648 178.126 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 128' ' ' ASP . . . . . 0.459 ' N ' HD12 ' B' ' 127' ' ' LEU . 9.8 m-20 -70.0 -26.39 64.05 Favored 'General case' 0 N--CA 1.466 0.331 0 O-C-N 122.096 -0.377 . . . . 0.0 111.109 -179.438 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 129' ' ' SER . . . . . . . . . . . . . 84.4 p -60.11 -33.86 72.69 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.72 -177.169 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 130' ' ' VAL . . . . . . . . . . . . . 4.7 m -99.11 -34.16 4.3 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.398 175.679 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 131' ' ' GLY . . . . . . . . . . . . . . . 122.11 45.01 0.34 Allowed Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.233 179.664 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 132' ' ' ILE . . . . . 0.419 ' HB ' ' HB2' ' B' ' 127' ' ' LEU . 24.4 mt -112.17 136.32 48.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 179.424 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 133' ' ' GLU . . . . . . . . . . . . . 26.9 mm-40 -89.86 154.65 19.72 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.235 0.541 . . . . 0.0 111.743 -174.748 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 134' ' ' ALA . . . . . 0.543 ' HB2' HD22 ' B' ' 127' ' ' LEU . . . -153.21 145.26 23.74 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.078 -0.964 . . . . 0.0 112.049 -172.771 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 135' ' ' ASP . . . . . 0.682 ' HB2' ' CG ' ' B' ' 138' ' ' ARG . 53.9 m-20 -93.91 133.52 37.25 Favored 'General case' 0 C--O 1.251 1.161 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 170.728 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 136' ' ' ASP . . . . . 1.001 ' HA ' HD11 ' B' ' 139' ' ' LEU . 10.1 p-10 -72.03 -5.15 33.03 Favored 'General case' 0 CA--C 1.513 -0.464 0 CA-C-N 115.109 -0.951 . . . . 0.0 111.006 -169.654 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 137' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -101.04 -30.74 11.44 Favored 'General case' 0 N--CA 1.433 -1.293 0 C-N-CA 120.225 -0.59 . . . . 0.0 110.286 173.018 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 138' ' ' ARG . . . . . 0.682 ' CG ' ' HB2' ' B' ' 135' ' ' ASP . 36.3 mmt180 -66.22 -44.89 82.53 Favored 'General case' 0 CA--C 1.503 -0.855 0 CA-C-O 121.59 0.71 . . . . 0.0 109.86 -175.849 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 139' ' ' LEU . . . . . 1.001 HD11 ' HA ' ' B' ' 136' ' ' ASP . 0.3 OUTLIER -74.55 -33.79 62.81 Favored 'General case' 0 C--N 1.313 -0.981 0 C-N-CA 119.53 -0.868 . . . . 0.0 111.238 178.271 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 140' ' ' ASN . . . . . 0.482 ' H ' HD12 ' B' ' 139' ' ' LEU . 58.8 t30 -68.97 -27.61 65.88 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 -176.809 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 141' ' ' LYS . . . . . 0.669 ' HG3' ' O ' ' B' ' 138' ' ' ARG . 0.0 OUTLIER -86.2 -38.25 17.85 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.02 -0.991 . . . . 0.0 110.46 -177.944 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 142' ' ' VAL . . . . . 0.663 HG11 ' HB2' ' B' ' 103' ' ' TYR . 11.1 p -60.99 -44.8 98.95 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.636 0 N-CA-C 108.82 -0.808 . . . . 0.0 108.82 175.679 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 143' ' ' ILE . . . . . 0.754 HD11 ' CG1' ' B' ' 123' ' ' ILE . 16.1 mt -58.9 -45.61 91.71 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.88 0 C-N-CA 123.752 0.821 . . . . 0.0 112.36 171.219 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 144' ' ' SER . . . . . . . . . . . . . 30.9 t -52.82 -34.77 55.38 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.983 177.188 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 145' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -86.26 -40.49 15.48 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.369 177.729 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 146' ' ' LEU . . . . . 0.573 ' HB3' ' CZ ' ' B' ' 107' ' ' TYR . 2.6 mm? -61.72 -41.25 97.38 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 123.557 0.743 . . . . 0.0 112.388 177.878 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 147' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -45.84 124.3 5.16 Favored 'General case' 0 C--O 1.233 0.202 0 O-C-N 123.906 0.754 . . . . 0.0 111.788 -171.725 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . 86.96 59.2 1.8 Allowed Glycine 0 N--CA 1.447 -0.589 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.301 -175.544 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 149' ' ' LYS . . . . . 0.535 ' HB2' ' O ' ' B' ' 146' ' ' LEU . 3.3 tppt? -143.25 160.22 40.88 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 -177.538 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 150' ' ' ASN . . . . . 0.59 ' O ' HG23 ' B' ' 154' ' ' VAL . 17.5 m120 -105.33 88.72 2.92 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 176.901 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 151' ' ' ILE . . . . . 0.679 HG13 HD12 ' B' ' 108' ' ' LEU . 1.7 mp -42.92 -61.46 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 114.694 -1.139 . . . . 0.0 113.445 -168.59 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 152' ' ' GLU . . . . . 0.405 ' N ' HG22 ' B' ' 151' ' ' ILE . 30.9 mt-10 -54.6 -41.24 69.71 Favored 'General case' 0 C--O 1.216 -0.687 0 N-CA-C 112.271 0.471 . . . . 0.0 112.271 -174.038 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 153' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -74.78 -30.77 61.55 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.816 -0.354 . . . . 0.0 110.589 -177.921 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 154' ' ' VAL . . . . . 0.832 ' HB ' HD12 ' B' ' 155' ' ' ILE . 44.9 t -56.01 -48.58 78.59 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 CA-C-O 121.86 0.838 . . . . 0.0 109.141 171.077 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 155' ' ' ILE . . . . . 0.832 HD12 ' HB ' ' B' ' 154' ' ' VAL . 1.8 mp -109.15 44.1 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.096 -0.956 . . . . 0.0 110.961 -178.479 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . -112.65 3.02 16.39 Favored 'General case' 0 C--N 1.306 -1.283 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 167.428 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 157' ' ' GLN . . . . . . . . . . . . . 91.6 mt-30 -138.51 -5.02 1.6 Allowed 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 113.5 -1.682 . . . . 0.0 110.002 176.276 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 158' ' ' GLY . . . . . . . . . . . . . . . -137.85 44.9 1.09 Allowed Glycine 0 C--O 1.223 -0.539 0 C-N-CA 120.153 -1.023 . . . . 0.0 113.86 -172.503 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 159' ' ' ILE . . . . . 0.686 ' HB ' ' CD1' ' A' ' 60' ' ' ILE . 1.8 mp -57.62 -28.49 32.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 CA-C-O 121.015 0.436 . . . . 0.0 110.983 175.7 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 160' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.438 0 C-N-CA 120.524 -0.846 . . . . 0.0 112.944 -179.814 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' SER . . . . . 0.574 ' HB2' ' HG3' ' A' ' 6' ' ' GLU . 14.5 m . . . . . 0 N--CA 1.448 -0.572 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.853 HG13 ' HG ' ' B' ' 112' ' ' LEU . 2.4 t -58.04 -23.72 22.02 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 CA-C-N 115.005 -0.998 . . . . 0.0 111.693 -177.084 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' SER . . . . . 0.703 ' HB2' ' HA ' ' A' ' 39' ' ' VAL . 11.4 p -70.5 -53.92 14.27 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.855 0.836 . . . . 0.0 109.044 174.662 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.574 ' HG3' ' HB2' ' A' ' 3' ' ' SER . 32.1 mt-10 -56.29 -47.74 78.04 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 114.862 -1.063 . . . . 0.0 109.899 177.962 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.833 HD12 HD12 ' A' ' 10' ' ' ILE . 3.6 tp -61.22 -39.73 91.35 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.522 178.791 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -60.94 -37.72 83.32 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 121.162 0.506 . . . . 0.0 110.937 176.839 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.538 ' HB2' HG11 ' A' ' 39' ' ' VAL . 7.4 t -69.94 -43.09 72.31 Favored 'General case' 0 C--O 1.24 0.587 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.833 HD12 HD12 ' A' ' 7' ' ' LEU . 72.6 mt -46.2 -56.4 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 CA-C-N 113.993 -1.458 . . . . 0.0 109.715 171.703 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.632 ' OH ' ' HB ' ' B' ' 155' ' ' ILE . 23.5 m-85 -63.33 -40.03 96.17 Favored 'General case' 0 C--O 1.216 -0.689 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.448 -175.413 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.618 ' HB2' HG23 ' A' ' 28' ' ' ILE . 19.4 m -56.76 -41.49 77.71 Favored 'General case' 0 C--O 1.24 0.593 0 CA-C-O 121.482 0.658 . . . . 0.0 109.403 179.005 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -65.85 -34.32 77.87 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.124 174.595 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.804 HD22 HD11 ' A' ' 56' ' ' ILE . 0.3 OUTLIER -63.01 -53.37 54.94 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.437 179.719 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.832 HD11 HD12 ' B' ' 109' ' ' LEU . 0.0 OUTLIER -58.9 -37.6 68.04 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.542 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 178.146 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.575 HD21 ' HA ' ' A' ' 23' ' ' VAL . 1.6 tp -58.88 -35.04 72.35 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.429 175.805 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' HIS . . . . . 0.495 ' O ' ' HG2' ' A' ' 20' ' ' GLU . 80.4 m-70 -73.76 -16.5 61.17 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 112.776 0.658 . . . . 0.0 112.776 175.243 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -59.07 -46.96 86.94 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 121.063 0.459 . . . . 0.0 109.829 178.422 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.632 ' HB2' HG23 ' B' ' 132' ' ' ILE . 29.9 t70 -100.91 -13.06 18.49 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.597 0.713 . . . . 0.0 109.397 177.407 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.495 ' HG2' ' O ' ' A' ' 17' ' ' HIS . 5.3 mm-40 63.18 44.56 5.63 Favored 'General case' 0 CA--C 1.519 -0.245 0 CA-C-N 114.496 -1.229 . . . . 0.0 109.689 -175.925 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.681 HG22 ' H ' ' A' ' 22' ' ' THR . 14.8 p -99.92 177.96 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.134 0 CA-C-N 114.518 -1.219 . . . . 0.0 110.233 -168.873 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.681 ' H ' HG22 ' A' ' 21' ' ' VAL . 23.6 p -49.62 137.88 14.9 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 113.874 1.065 . . . . 0.0 113.874 -174.372 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.655 HG12 ' HA ' ' A' ' 48' ' ' ALA . 46.2 t -109.7 109.07 27.03 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.177 0 CA-C-N 113.961 -1.472 . . . . 0.0 110.193 -179.546 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.598 ' OG1' ' HB2' ' A' ' 27' ' ' LYS . 69.1 p -136.08 158.23 44.91 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.158 178.284 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -52.87 -46.57 67.94 Favored 'General case' 0 C--N 1.32 -0.7 0 O-C-N 123.508 0.505 . . . . 0.0 110.094 178.09 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -67.39 -26.3 66.38 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.582 -0.735 . . . . 0.0 111.364 -179.543 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.598 ' HB2' ' OG1' ' A' ' 24' ' ' THR . 3.7 tppt? -70.67 -54.43 11.91 Favored 'General case' 0 C--O 1.24 0.597 0 CA-C-O 121.856 0.836 . . . . 0.0 108.823 -179.1 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.618 HG23 ' HB2' ' A' ' 12' ' ' SER . 77.7 mt -59.04 -43.17 88.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 114.253 -1.339 . . . . 0.0 110.349 178.498 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.472 ' HA ' ' HB ' ' A' ' 32' ' ' ILE . 6.1 m-20 -68.61 -26.53 65.4 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.212 178.705 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.62 -47.73 80.19 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 174.144 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.557 ' HG ' HG13 ' A' ' 15' ' ' ILE . 1.5 mm? -58.48 -51.54 69.43 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 121.296 0.569 . . . . 0.0 110.093 174.204 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.67 HG23 ' O ' ' A' ' 37' ' ' VAL . 64.7 mt -48.42 -48.46 13.97 Favored 'Isoleucine or valine' 0 C--O 1.243 0.747 0 CA-C-N 114.652 -1.158 . . . . 0.0 112.111 179.099 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 53.0 tptt -75.34 -43.6 49.79 Favored 'General case' 0 N--CA 1.434 -1.231 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.781 -175.619 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -62.21 -37.26 84.67 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.619 0.247 . . . . 0.0 110.855 -178.252 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -80.04 -36.83 35.15 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.03 0.443 . . . . 0.0 110.951 177.984 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 103.11 16.03 22.16 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.599 176.462 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.805 ' HB ' ' HA2' ' B' ' 113' ' ' GLY . 2.7 p -118.24 118.27 57.52 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.546 0 CA-C-O 121.385 0.612 . . . . 0.0 110.455 -177.642 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 -95.87 158.85 15.26 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 114.85 -1.068 . . . . 0.0 110.832 -169.169 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.703 ' HA ' ' HB2' ' A' ' 5' ' ' SER . 96.0 t -129.63 164.95 30.86 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.781 0 CA-C-N 115.055 -0.975 . . . . 0.0 110.442 -168.836 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.56 ' HB2' ' CD1' ' A' ' 43' ' ' TRP . 21.9 mt-10 -65.85 111.88 7.48 Favored Pre-proline 0 CA--C 1.489 -1.367 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 167.481 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.456 ' HD3' ' HA ' ' A' ' 40' ' ' GLU . 69.9 Cg_exo -54.41 -29.64 59.71 Favored 'Trans proline' 0 C--N 1.311 -1.421 0 C-N-CA 123.244 2.629 . . . . 0.0 113.713 -167.776 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 1.7 p90 -61.36 -29.07 69.68 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 175.332 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' TRP . . . . . 0.56 ' CD1' ' HB2' ' A' ' 40' ' ' GLU . 8.2 m95 -62.72 -60.31 10.23 Favored Pre-proline 0 C--O 1.208 -1.119 0 CA-C-O 118.474 -0.774 . . . . 0.0 110.677 176.646 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.463 ' HD3' ' HB2' ' A' ' 43' ' ' TRP . 86.7 Cg_exo -47.15 -43.26 25.76 Favored 'Trans proline' 0 C--N 1.361 1.209 0 C-N-CA 121.894 1.73 . . . . 0.0 112.224 174.261 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -60.74 -59.18 10.64 Favored Glycine 0 CA--C 1.526 0.736 0 C-N-CA 120.124 -1.036 . . . . 0.0 112.444 176.804 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 4.5 tp -66.91 -26.57 66.93 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.467 0.707 . . . . 0.0 111.912 -176.846 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.728 ' HD2' HD11 ' A' ' 51' ' ' LEU . 2.9 m-85 -70.7 -46.67 62.69 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 175.615 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.655 ' HA ' HG12 ' A' ' 23' ' ' VAL . . . -62.66 -32.96 74.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.738 0.78 . . . . 0.0 109.115 179.198 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 9.2 mmmt -63.49 -62.77 1.45 Allowed 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 114.34 -1.3 . . . . 0.0 111.666 172.493 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -75.62 -31.68 59.99 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 113.709 1.003 . . . . 0.0 113.709 -167.986 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.728 HD11 ' HD2' ' A' ' 47' ' ' PHE . 13.1 mt -70.96 7.41 1.18 Allowed 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 112.843 0.683 . . . . 0.0 112.843 -174.136 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -101.88 5.26 40.88 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.49 0.662 . . . . 0.0 109.821 171.858 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 25.8 t30 -139.52 -52.8 0.54 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.421 -178.117 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 4.3 m -82.2 175.08 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.012 -179.702 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -113.69 165.31 12.66 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.253 176.511 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.804 HD11 HD22 ' A' ' 14' ' ' LEU . 3.9 tp -62.03 -25.18 36.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 120.838 0.352 . . . . 0.0 110.638 179.296 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -70.46 -14.95 72.53 Favored Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.816 -0.707 . . . . 0.0 111.548 177.048 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 20.4 t -78.04 -20.34 52.59 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-O 121.543 0.687 . . . . 0.0 109.549 179.701 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.692 ' HB2' HG21 ' B' ' 159' ' ' ILE . 19.8 mt -64.63 -29.63 70.64 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.434 179.515 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.766 HG13 ' HB ' ' B' ' 159' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--N 1.318 -0.768 0 CA-C-N 114.737 -1.12 . . . . 0.0 110.613 179.358 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 103' ' ' TYR . . . . . 0.663 ' HB2' HG11 ' B' ' 142' ' ' VAL . 51.7 m-85 . . . . . 0 C--O 1.239 0.501 0 CA-C-O 121.102 0.477 . . . . 0.0 110.275 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 104' ' ' VAL . . . . . 0.585 ' O ' HD22 ' B' ' 108' ' ' LEU . 61.2 t -46.61 -47.21 7.44 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.534 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.088 174.798 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 105' ' ' ALA . . . . . 0.608 ' CB ' ' HB3' ' A' ' 14' ' ' LEU . . . -67.0 -38.1 85.38 Favored 'General case' 0 N--CA 1.443 -0.81 0 CA-C-N 114.826 -1.079 . . . . 0.0 111.425 -173.776 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 106' ' ' SER . . . . . 0.833 ' HB2' HG23 ' B' ' 123' ' ' ILE . 1.3 m -60.48 -38.83 85.54 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 121.815 0.817 . . . . 0.0 109.251 176.167 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 107' ' ' TYR . . . . . 0.799 ' HD2' HG12 ' B' ' 143' ' ' ILE . 32.5 t80 -63.07 -49.11 75.81 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 114.272 -1.331 . . . . 0.0 108.945 179.097 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 108' ' ' LEU . . . . . 0.724 HD12 HG13 ' B' ' 151' ' ' ILE . 0.0 OUTLIER -58.92 -49.2 78.7 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 114.987 -1.006 . . . . 0.0 111.337 179.029 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 109' ' ' LEU . . . . . 0.832 HD12 HD11 ' A' ' 15' ' ' ILE . 0.3 OUTLIER -55.42 -43.16 75.05 Favored 'General case' 0 CA--C 1.506 -0.746 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.613 178.671 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.5 -43.45 90.09 Favored 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 120.496 -0.482 . . . . 0.0 110.819 -178.514 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 111' ' ' ALA . . . . . 0.664 ' HA ' ' O ' ' B' ' 115' ' ' ASN . . . -64.71 -26.23 68.28 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.607 179.174 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 112' ' ' LEU . . . . . 0.853 ' HG ' HG13 ' A' ' 4' ' ' VAL . 3.5 mp -80.39 -38.32 30.52 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.245 -0.889 . . . . 0.0 110.244 174.128 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 113' ' ' GLY . . . . . 0.805 ' HA2' ' HB ' ' A' ' 37' ' ' VAL . . . -68.5 -17.21 70.47 Favored Glycine 0 N--CA 1.449 -0.497 0 CA-C-N 115.263 -0.88 . . . . 0.0 112.348 -176.934 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 114' ' ' GLY . . . . . . . . . . . . . . . 133.33 3.4 3.45 Favored Glycine 0 N--CA 1.437 -1.299 0 C-N-CA 120.394 -0.908 . . . . 0.0 113.168 176.738 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 115' ' ' ASN . . . . . 0.664 ' O ' ' HA ' ' B' ' 111' ' ' ALA . 47.9 t30 -118.69 86.27 2.51 Favored 'General case' 0 N--CA 1.441 -0.884 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 178.224 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 7.4 m -80.23 31.09 0.27 Allowed 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 122.488 1.137 . . . . 0.0 110.748 -167.952 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 117' ' ' SER . . . . . 0.528 ' N ' ' HD3' ' B' ' 118' ' ' PRO . 15.6 t -171.0 67.64 0.47 Allowed Pre-proline 0 C--N 1.309 -1.172 0 CA-C-N 113.12 -1.855 . . . . 0.0 107.971 178.248 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 118' ' ' PRO . . . . . 0.607 ' HD2' ' CZ ' ' B' ' 107' ' ' TYR . 31.9 Cg_exo -66.08 166.67 20.17 Favored 'Trans proline' 0 CA--C 1.515 -0.431 0 C-N-CA 125.275 3.983 . . . . 0.0 111.58 -174.72 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 119' ' ' SER . . . . . 0.652 ' O ' HG12 ' B' ' 123' ' ' ILE . 16.4 m -145.59 -178.51 6.13 Favored 'General case' 0 C--N 1.317 -0.809 0 C-N-CA 120.225 -0.59 . . . . 0.0 111.592 178.622 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 120' ' ' ALA . . . . . 0.788 ' HB1' HD13 ' B' ' 139' ' ' LEU . . . -62.68 -45.8 91.12 Favored 'General case' 0 CA--C 1.508 -0.639 0 CA-C-O 122.036 0.922 . . . . 0.0 110.173 -163.888 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 121' ' ' LYS . . . . . 0.415 ' HD2' ' N ' ' B' ' 121' ' ' LYS . 12.9 mptt -66.72 -30.39 70.61 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 113.674 -1.603 . . . . 0.0 110.871 178.538 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 122' ' ' ASP . . . . . 0.437 ' O ' ' HB2' ' B' ' 125' ' ' LYS . 18.0 t0 -72.91 -39.09 66.61 Favored 'General case' 0 C--O 1.24 0.58 0 CA-C-O 122.004 0.907 . . . . 0.0 109.025 179.744 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 123' ' ' ILE . . . . . 0.833 HG23 ' HB2' ' B' ' 106' ' ' SER . 39.8 mm -59.93 -42.97 91.18 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.264 0 CA-C-N 114.549 -1.205 . . . . 0.0 109.657 173.236 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 124' ' ' LYS . . . . . 0.817 ' HD3' HD21 ' B' ' 139' ' ' LEU . 3.9 mmmp? -59.17 -42.52 90.97 Favored 'General case' 0 CA--C 1.504 -0.797 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.444 -178.784 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 125' ' ' LYS . . . . . 0.529 ' HD3' ' HA ' ' B' ' 125' ' ' LYS . 30.3 mmtt -50.38 -64.72 0.72 Allowed 'General case' 0 CA--C 1.502 -0.879 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 169.72 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 126' ' ' ILE . . . . . 0.48 HG23 HD12 ' A' ' 31' ' ' LEU . 1.7 mp -53.96 -44.41 61.58 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.857 0 CA-C-N 114.841 -1.072 . . . . 0.0 111.256 -170.217 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 127' ' ' LEU . . . . . 0.63 ' HG ' ' O ' ' B' ' 123' ' ' ILE . 3.6 pp -80.31 -24.74 39.74 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 -177.387 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 128' ' ' ASP . . . . . 0.434 ' N ' HD12 ' B' ' 127' ' ' LEU . 34.6 t70 -71.39 -27.51 63.37 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.584 -0.525 . . . . 0.0 109.584 178.831 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 129' ' ' SER . . . . . . . . . . . . . 17.4 t -60.92 -27.73 68.41 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.602 177.684 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 130' ' ' VAL . . . . . 0.46 HG23 HG13 ' B' ' 132' ' ' ILE . 3.7 m -107.38 -13.42 10.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 C-N-CA 120.813 -0.355 . . . . 0.0 111.483 177.521 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 131' ' ' GLY . . . . . . . . . . . . . . . 85.15 49.16 4.57 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 121.149 -0.548 . . . . 0.0 112.389 177.856 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 132' ' ' ILE . . . . . 0.632 HG23 ' HB2' ' A' ' 19' ' ' ASP . 11.5 mt -105.5 138.89 28.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-O 120.462 0.172 . . . . 0.0 111.078 -179.321 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 133' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -69.65 127.31 32.51 Favored 'General case' 0 CA--C 1.513 -0.456 0 CA-C-O 121.47 0.652 . . . . 0.0 111.478 -176.226 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 134' ' ' ALA . . . . . 0.513 ' HA ' ' OH ' ' B' ' 103' ' ' TYR . . . -136.21 141.04 43.96 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.15 -0.932 . . . . 0.0 111.473 -177.922 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 135' ' ' ASP . . . . . 0.815 ' HB2' ' HG3' ' B' ' 138' ' ' ARG . 49.3 m-20 -103.56 132.77 49.53 Favored 'General case' 0 C--O 1.25 1.094 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.024 172.892 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 136' ' ' ASP . . . . . 0.996 ' HA ' HD11 ' B' ' 139' ' ' LEU . 32.5 t70 -71.26 -7.92 50.2 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 115.095 -0.957 . . . . 0.0 111.236 -168.271 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 137' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -101.27 -30.16 11.67 Favored 'General case' 0 N--CA 1.438 -1.069 0 C-N-CA 120.017 -0.673 . . . . 0.0 110.653 174.555 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 138' ' ' ARG . . . . . 0.815 ' HG3' ' HB2' ' B' ' 135' ' ' ASP . 20.9 mmt180 -65.31 -45.92 82.43 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.793 0.806 . . . . 0.0 109.513 -176.976 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 139' ' ' LEU . . . . . 0.996 HD11 ' HA ' ' B' ' 136' ' ' ASP . 0.3 OUTLIER -74.2 -37.77 63.79 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 114.933 -1.03 . . . . 0.0 111.001 178.928 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 140' ' ' ASN . . . . . 0.665 ' H ' HD12 ' B' ' 139' ' ' LEU . 57.0 t30 -61.49 -31.25 71.23 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.687 0.756 . . . . 0.0 109.148 -179.773 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 141' ' ' LYS . . . . . 0.44 ' O ' ' HD3' ' B' ' 141' ' ' LYS . 4.3 tppt? -76.4 -50.06 15.14 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 114.585 -1.189 . . . . 0.0 110.43 179.279 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 142' ' ' VAL . . . . . 0.663 HG11 ' HB2' ' B' ' 103' ' ' TYR . 12.6 p -56.0 -44.48 78.51 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.581 0 C-N-CA 120.359 -0.537 . . . . 0.0 109.814 -179.716 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 143' ' ' ILE . . . . . 0.799 HG12 ' HD2' ' B' ' 107' ' ' TYR . 38.7 mt -58.55 -46.21 90.05 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 C-N-CA 124.163 0.985 . . . . 0.0 112.498 172.869 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 144' ' ' SER . . . . . . . . . . . . . 47.1 t -54.19 -33.68 58.73 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.927 176.744 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 145' ' ' GLU . . . . . 0.431 ' HG2' ' O ' ' B' ' 141' ' ' LYS . 6.9 mm-40 -83.98 -42.31 16.37 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 121.498 0.666 . . . . 0.0 110.63 178.029 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 146' ' ' LEU . . . . . 0.532 ' HB3' ' CZ ' ' B' ' 107' ' ' TYR . 2.2 mm? -62.7 -38.81 91.89 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 114.977 -1.01 . . . . 0.0 112.345 179.817 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 147' ' ' ASN . . . . . . . . . . . . . 64.1 t30 -54.16 120.03 5.91 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.124 -172.212 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . 99.4 40.33 3.24 Favored Glycine 0 N--CA 1.445 -0.703 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.549 -176.307 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 149' ' ' LYS . . . . . 0.482 ' HB2' ' O ' ' B' ' 146' ' ' LEU . 0.1 OUTLIER -134.79 168.56 18.83 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 -179.964 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 150' ' ' ASN . . . . . 0.588 ' O ' HG23 ' B' ' 154' ' ' VAL . 31.9 m-20 -106.82 90.57 3.36 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 107.702 -1.222 . . . . 0.0 107.702 179.068 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 151' ' ' ILE . . . . . 0.724 HG13 HD12 ' B' ' 108' ' ' LEU . 1.8 mp -41.69 -64.17 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 N-CA-C 113.571 0.952 . . . . 0.0 113.571 -168.089 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 152' ' ' GLU . . . . . 0.7 ' HG3' HD11 ' B' ' 112' ' ' LEU . 3.4 mp0 -57.31 -42.92 82.72 Favored 'General case' 0 C--O 1.209 -1.03 0 C-N-CA 120.93 -0.308 . . . . 0.0 111.365 -175.301 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 153' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -66.94 -29.57 69.47 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 120.548 0.214 . . . . 0.0 111.363 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 154' ' ' VAL . . . . . 0.818 ' HB ' HD12 ' B' ' 155' ' ' ILE . 61.8 t -61.15 -51.07 77.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 171.907 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 155' ' ' ILE . . . . . 0.818 HD12 ' HB ' ' B' ' 154' ' ' VAL . 1.6 mp -104.66 36.19 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-O 121.979 0.895 . . . . 0.0 110.368 -177.718 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . -100.96 0.42 38.24 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 107.246 -1.391 . . . . 0.0 107.246 169.168 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 157' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -137.36 -34.83 0.69 Allowed 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 113.043 -1.889 . . . . 0.0 109.357 173.346 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 158' ' ' GLY . . . . . . . . . . . . . . . -98.36 47.44 1.46 Allowed Glycine 0 CA--C 1.521 0.468 0 CA-C-N 115.548 -0.751 . . . . 0.0 114.357 -172.444 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 159' ' ' ILE . . . . . 0.766 ' HB ' HG13 ' A' ' 60' ' ' ILE . 1.8 mp -59.52 -18.0 13.76 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 CA-C-O 121.244 0.545 . . . . 0.0 111.045 176.213 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 160' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.584 0 N-CA-C 111.384 -0.686 . . . . 0.0 111.384 -178.664 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.7 p . . . . . 0 N--CA 1.446 -0.629 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.681 HG13 ' HG ' ' B' ' 112' ' ' LEU . 2.2 t -53.6 -27.2 14.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 115.191 -0.913 . . . . 0.0 112.238 -175.957 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' SER . . . . . 0.778 ' HB3' ' HA ' ' A' ' 39' ' ' VAL . 2.1 m -67.46 -52.68 36.52 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 122.204 1.002 . . . . 0.0 108.468 176.068 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.522 ' O ' HG13 ' A' ' 10' ' ' ILE . 33.9 tt0 -55.83 -52.84 62.61 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-N 113.985 -1.461 . . . . 0.0 110.171 177.205 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.89 HD12 HD12 ' A' ' 10' ' ' ILE . 4.4 tp -59.46 -34.97 73.2 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.091 -0.958 . . . . 0.0 111.758 179.178 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.647 ' HB2' HD23 ' B' ' 112' ' ' LEU . . . -69.85 -33.25 72.02 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-O 121.011 0.434 . . . . 0.0 110.847 179.252 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.594 ' HB2' HG11 ' A' ' 39' ' ' VAL . 7.5 t -70.88 -37.43 73.02 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 177.38 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.89 HD12 HD12 ' A' ' 7' ' ' LEU . 74.2 mt -51.67 -55.53 8.6 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.887 0 CA-C-N 114.168 -1.378 . . . . 0.0 109.824 170.682 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.729 ' HB2' HD13 ' B' ' 109' ' ' LEU . 23.4 m-85 -67.04 -41.0 87.29 Favored 'General case' 0 C--O 1.22 -0.479 0 CA-C-N 115.615 -0.721 . . . . 0.0 111.596 -173.741 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.453 ' O ' ' HB2' ' A' ' 16' ' ' LEU . 2.5 p -57.43 -41.45 80.47 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 176.612 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.04 -33.43 75.42 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.895 172.471 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.789 HD22 HD11 ' A' ' 56' ' ' ILE . 0.3 OUTLIER -64.87 -57.99 7.36 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.488 -179.612 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -54.82 -47.34 74.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 177.277 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.706 HD12 HG13 ' A' ' 21' ' ' VAL . 6.2 tp -53.19 -41.47 65.3 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.928 178.65 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 26.3 t60 -78.89 -13.68 59.66 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.178 -0.919 . . . . 0.0 112.065 -178.605 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -70.62 -47.99 57.32 Favored 'General case' 0 N--CA 1.467 0.389 0 O-C-N 121.895 -0.503 . . . . 0.0 110.051 176.558 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.772 ' HB2' HG23 ' B' ' 132' ' ' ILE . 28.7 t70 -91.31 -11.19 38.74 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.938 0.875 . . . . 0.0 109.575 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 55.61 52.43 11.06 Favored 'General case' 0 CA--C 1.509 -0.604 0 CA-C-N 113.641 -1.618 . . . . 0.0 110.125 -176.813 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.706 HG13 HD12 ' A' ' 16' ' ' LEU . 2.9 p -100.03 152.64 4.69 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.739 0 CA-C-N 113.581 -1.645 . . . . 0.0 109.073 -176.072 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.476 ' O ' ' HG2' ' A' ' 27' ' ' LYS . 30.6 p -34.96 127.97 0.5 Allowed 'General case' 0 C--N 1.317 -0.808 0 O-C-N 124.672 1.232 . . . . 0.0 114.077 -174.064 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.551 HG12 ' HA ' ' A' ' 48' ' ' ALA . 51.2 t -100.55 106.03 18.65 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.927 0 CA-C-N 114.376 -1.283 . . . . 0.0 110.473 -176.898 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.44 ' OG1' ' HB2' ' A' ' 27' ' ' LYS . 80.6 p -141.05 153.77 45.65 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.769 -179.169 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -51.42 -46.49 62.96 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.12 0.486 . . . . 0.0 110.773 179.633 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -58.26 -38.38 76.82 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.382 -0.826 . . . . 0.0 111.356 177.482 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.483 ' HG2' HD11 ' A' ' 16' ' ' LEU . 4.3 tppt? -64.48 -50.03 69.07 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-O 121.965 0.888 . . . . 0.0 109.285 -178.229 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 80.8 mt -61.7 -38.96 81.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 114.393 -1.276 . . . . 0.0 110.458 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.682 ' HA ' HD12 ' A' ' 32' ' ' ILE . 30.7 m-80 -68.41 -30.0 68.8 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.862 176.436 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -65.98 -38.91 89.73 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.562 -0.29 . . . . 0.0 110.397 176.21 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.617 ' HB3' HD21 ' B' ' 109' ' ' LEU . 1.2 mm? -65.17 -45.79 83.49 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 120.646 -0.422 . . . . 0.0 110.106 171.747 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.682 HD12 ' HA ' ' A' ' 29' ' ' ASN . 57.8 mt -49.23 -50.0 16.22 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 CA-C-N 115.294 -0.867 . . . . 0.0 111.361 177.917 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 23.0 tptp -71.89 -37.7 70.1 Favored 'General case' 0 N--CA 1.435 -1.177 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.624 -179.384 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.673 ' HB1' ' HA ' ' B' ' 126' ' ' ILE . . . -59.26 -41.97 90.08 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.001 0.429 . . . . 0.0 111.451 179.526 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.477 ' CB ' ' HG ' ' B' ' 109' ' ' LEU . . . -84.61 -33.19 23.38 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.254 179.756 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 96.29 19.23 28.67 Favored Glycine 0 N--CA 1.447 -0.569 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.765 -179.041 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.814 ' HB ' ' HA2' ' B' ' 113' ' ' GLY . 2.9 p -121.6 117.73 53.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 121.981 0.896 . . . . 0.0 111.204 -177.079 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.431 ' HA ' HG23 ' A' ' 32' ' ' ILE . 57.8 t30 -88.51 157.06 18.75 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 113.966 -1.47 . . . . 0.0 110.726 -172.051 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.778 ' HA ' ' HB3' ' A' ' 5' ' ' SER . 97.3 t -126.91 161.38 33.82 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.002 0 CA-C-N 114.878 -1.056 . . . . 0.0 110.381 -173.257 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.536 ' HB3' ' HD1' ' A' ' 43' ' ' TRP . 7.5 tp10 -68.54 106.45 1.38 Allowed Pre-proline 0 N--CA 1.439 -1.012 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 170.151 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.46 ' C ' ' HD2' ' A' ' 44' ' ' PRO . 83.0 Cg_exo -50.22 -31.06 27.78 Favored 'Trans proline' 0 C--O 1.252 1.179 0 C-N-CA 123.698 2.932 . . . . 0.0 115.478 -163.996 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.448 ' HD2' ' HG3' ' A' ' 40' ' ' GLU . 0.8 OUTLIER -59.93 -26.8 66.23 Favored 'General case' 0 C--N 1.334 -0.107 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 178.456 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 43' ' ' TRP . . . . . 0.536 ' HD1' ' HB3' ' A' ' 40' ' ' GLU . 11.2 m95 -65.02 -61.67 5.9 Favored Pre-proline 0 C--O 1.207 -1.138 0 CA-C-O 118.423 -0.799 . . . . 0.0 110.723 176.313 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.468 ' HD3' ' HB2' ' A' ' 43' ' ' TRP . 85.5 Cg_exo -43.92 -45.04 11.73 Favored 'Trans proline' 0 C--N 1.358 1.069 0 C-N-CA 121.837 1.691 . . . . 0.0 112.242 174.747 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -60.55 -60.36 8.65 Favored Glycine 0 CA--C 1.526 0.757 0 C-N-CA 120.088 -1.054 . . . . 0.0 112.315 176.598 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.401 ' O ' ' HB2' ' A' ' 49' ' ' LYS . 10.2 tp -64.29 -24.02 67.51 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 123.069 0.547 . . . . 0.0 111.988 -177.527 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.554 ' HD2' HD11 ' A' ' 51' ' ' LEU . 2.7 m-85 -73.66 -43.91 58.16 Favored 'General case' 0 C--N 1.315 -0.899 0 C-N-CA 122.296 0.238 . . . . 0.0 110.375 177.511 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.551 ' HA ' HG12 ' A' ' 23' ' ' VAL . . . -64.81 -32.13 73.68 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 176.997 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.401 ' HB2' ' O ' ' A' ' 46' ' ' LEU . 9.5 mmmt -65.29 -51.56 59.89 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 114.247 -1.342 . . . . 0.0 111.815 173.243 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.453 ' O ' HG22 ' A' ' 54' ' ' VAL . . . -80.03 -40.72 27.19 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 113.187 0.81 . . . . 0.0 113.187 -170.069 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.554 HD11 ' HD2' ' A' ' 47' ' ' PHE . 8.7 mt -66.9 0.77 2.25 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 -172.099 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -88.16 -17.92 29.88 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.883 0.373 . . . . 0.0 110.607 174.484 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 91.4 m-20 -130.69 -38.26 1.31 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.823 -175.225 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.453 HG22 ' O ' ' A' ' 50' ' ' ALA . 4.6 m -85.39 -176.62 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 121.022 0.439 . . . . 0.0 110.141 -179.833 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 23.1 t-20 -119.41 168.39 11.0 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.76 -0.654 . . . . 0.0 109.585 176.776 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.789 HD11 HD22 ' A' ' 14' ' ' LEU . 3.2 tp -66.29 -27.94 42.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-O 121.058 0.456 . . . . 0.0 109.934 178.406 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -72.25 -14.81 76.78 Favored Glycine 0 N--CA 1.446 -0.666 0 N-CA-C 111.05 -0.82 . . . . 0.0 111.05 175.982 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 20.3 m -78.68 -21.31 48.42 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-O 121.229 0.537 . . . . 0.0 109.849 179.07 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.599 ' HB2' HG21 ' B' ' 159' ' ' ILE . 30.0 mt -60.78 -36.41 78.91 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.617 -179.736 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.701 HG13 ' HB ' ' B' ' 159' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--N 1.322 -0.617 0 CA-C-N 115.041 -0.981 . . . . 0.0 110.829 179.131 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 103' ' ' TYR . . . . . 0.922 ' HB2' HG11 ' B' ' 142' ' ' VAL . 69.4 m-85 . . . . . 0 N--CA 1.468 0.441 0 CA-C-O 120.705 0.288 . . . . 0.0 111.688 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 104' ' ' VAL . . . . . 0.711 ' HA ' HD11 ' B' ' 146' ' ' LEU . 4.1 m -45.03 -45.43 2.97 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.221 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.161 171.765 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 105' ' ' ALA . . . . . 0.561 ' CB ' ' HB3' ' A' ' 14' ' ' LEU . . . -64.31 -30.25 71.31 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 115.291 -0.868 . . . . 0.0 111.289 -174.051 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 106' ' ' SER . . . . . 0.814 ' HB2' HG23 ' B' ' 123' ' ' ILE . 1.4 m -76.53 -36.39 57.74 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.796 0.808 . . . . 0.0 108.971 -178.529 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 107' ' ' TYR . . . . . 0.678 ' CG ' HD12 ' B' ' 146' ' ' LEU . 36.5 t80 -63.96 -46.02 86.51 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 114.139 -1.391 . . . . 0.0 108.336 176.883 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 108' ' ' LEU . . . . . 0.844 HD12 HG13 ' B' ' 151' ' ' ILE . 0.0 OUTLIER -58.62 -45.93 88.13 Favored 'General case' 0 N--CA 1.443 -0.801 0 CA-C-N 114.393 -1.276 . . . . 0.0 110.792 177.072 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 109' ' ' LEU . . . . . 0.729 HD13 ' HB2' ' A' ' 11' ' ' TYR . 8.6 tp -55.65 -50.96 68.83 Favored 'General case' 0 CA--C 1.514 -0.426 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.893 178.445 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 110' ' ' ALA . . . . . 0.469 ' HB3' ' HB3' ' B' ' 118' ' ' PRO . . . -63.18 -40.58 97.94 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.24 -176.135 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 111' ' ' ALA . . . . . 0.664 ' HA ' ' O ' ' B' ' 115' ' ' ASN . . . -64.61 -33.98 77.19 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.559 178.884 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 112' ' ' LEU . . . . . 0.757 HD11 ' HG3' ' B' ' 152' ' ' GLU . 5.5 mp -71.47 -38.23 71.27 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.053 173.964 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 113' ' ' GLY . . . . . 0.814 ' HA2' ' HB ' ' A' ' 37' ' ' VAL . . . -61.87 -23.53 63.56 Favored Glycine 0 N--CA 1.446 -0.643 0 CA-C-N 115.198 -0.91 . . . . 0.0 111.843 179.548 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 114' ' ' GLY . . . . . . . . . . . . . . . 133.48 4.66 3.11 Favored Glycine 0 N--CA 1.436 -1.344 0 C-N-CA 120.569 -0.824 . . . . 0.0 112.876 177.496 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 115' ' ' ASN . . . . . 0.664 ' O ' ' HA ' ' B' ' 111' ' ' ALA . 47.2 t30 -116.94 91.15 3.5 Favored 'General case' 0 N--CA 1.439 -0.988 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 -179.533 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -76.96 25.61 0.15 Allowed 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 122.211 1.005 . . . . 0.0 110.787 -167.815 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 117' ' ' SER . . . . . 0.538 ' N ' ' HD3' ' B' ' 118' ' ' PRO . 35.2 t -169.83 68.12 0.59 Allowed Pre-proline 0 C--N 1.311 -1.102 0 CA-C-N 113.648 -1.614 . . . . 0.0 108.809 -178.198 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 118' ' ' PRO . . . . . 0.661 ' HG2' ' O ' ' B' ' 107' ' ' TYR . 26.7 Cg_exo -67.71 154.15 74.03 Favored 'Trans proline' 0 C--N 1.327 -0.583 0 C-N-CA 125.066 3.844 . . . . 0.0 111.572 -176.946 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 119' ' ' SER . . . . . 0.596 ' O ' HG12 ' B' ' 123' ' ' ILE . 92.0 p -121.73 -178.58 3.86 Favored 'General case' 0 C--N 1.315 -0.892 0 C-N-CA 120.104 -0.639 . . . . 0.0 110.958 178.327 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 120' ' ' ALA . . . . . 0.807 ' HB1' HD13 ' B' ' 139' ' ' LEU . . . -64.95 -38.74 91.97 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-O 121.886 0.851 . . . . 0.0 109.366 -172.061 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 121' ' ' LYS . . . . . 0.493 ' HD2' ' N ' ' B' ' 121' ' ' LYS . 4.7 mptp? -64.83 -31.96 73.43 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 113.952 -1.476 . . . . 0.0 110.912 176.718 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 122' ' ' ASP . . . . . 0.811 ' HA ' ' HE3' ' B' ' 125' ' ' LYS . 19.2 m-20 -72.61 -43.6 63.09 Favored 'General case' 0 CA--C 1.515 -0.377 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 176.282 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 123' ' ' ILE . . . . . 0.814 HG23 ' HB2' ' B' ' 106' ' ' SER . 33.8 mm -55.38 -50.36 66.01 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.421 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 175.798 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 124' ' ' LYS . . . . . 0.5 ' HD3' HD11 ' B' ' 127' ' ' LEU . 4.0 tppp? -61.21 -35.92 78.51 Favored 'General case' 0 N--CA 1.443 -0.788 0 CA-C-N 114.38 -1.282 . . . . 0.0 109.486 -177.628 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 125' ' ' LYS . . . . . 0.811 ' HE3' ' HA ' ' B' ' 122' ' ' ASP . 0.0 OUTLIER -72.44 -44.14 62.81 Favored 'General case' 0 N--CA 1.432 -1.359 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.931 -177.328 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 126' ' ' ILE . . . . . 0.702 HD12 ' HD2' ' B' ' 125' ' ' LYS . 1.4 mp -54.93 -51.81 49.51 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 CA-C-N 116.539 -0.301 . . . . 0.0 110.726 173.745 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 127' ' ' LEU . . . . . 0.945 ' HB2' ' HB ' ' B' ' 132' ' ' ILE . 3.1 pp -77.14 -25.97 52.6 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.614 -0.435 . . . . 0.0 111.788 -175.704 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 128' ' ' ASP . . . . . 0.474 ' HB2' ' O ' ' B' ' 124' ' ' LYS . 19.5 t70 -67.18 -33.5 75.54 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 110.024 -0.362 . . . . 0.0 110.024 177.606 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 129' ' ' SER . . . . . 0.445 ' CB ' ' HB2' ' A' ' 34' ' ' ALA . 22.7 t -51.97 -43.06 63.37 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.351 176.619 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 130' ' ' VAL . . . . . 0.6 HG23 HG13 ' B' ' 132' ' ' ILE . 5.0 m -100.76 -6.34 9.13 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 N-CA-C 112.242 0.46 . . . . 0.0 112.242 -179.589 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 131' ' ' GLY . . . . . . . . . . . . . . . 83.22 46.55 6.12 Favored Glycine 0 CA--C 1.518 0.257 0 C-N-CA 120.941 -0.647 . . . . 0.0 113.112 177.856 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 132' ' ' ILE . . . . . 0.945 ' HB ' ' HB2' ' B' ' 127' ' ' LEU . 14.9 mt -95.35 134.53 32.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 120.671 0.272 . . . . 0.0 110.46 176.901 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 133' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -79.98 131.73 35.87 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.895 0.379 . . . . 0.0 111.114 -178.047 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 134' ' ' ALA . . . . . . . . . . . . . . . -145.29 154.14 42.03 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.493 -175.544 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 135' ' ' ASP . . . . . 0.747 ' HB2' ' CG ' ' B' ' 138' ' ' ARG . 18.1 m-20 -102.11 135.17 44.15 Favored 'General case' 0 C--O 1.252 1.19 0 CA-C-O 121.124 0.488 . . . . 0.0 109.736 172.241 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 136' ' ' ASP . . . . . 0.915 ' HA ' HD11 ' B' ' 139' ' ' LEU . 10.4 t70 -73.28 -11.61 60.56 Favored 'General case' 0 CA--C 1.514 -0.426 0 CA-C-N 115.14 -0.936 . . . . 0.0 110.995 -166.649 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 137' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -96.79 -30.06 13.39 Favored 'General case' 0 N--CA 1.438 -1.062 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.723 175.334 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 138' ' ' ARG . . . . . 0.747 ' CG ' ' HB2' ' B' ' 135' ' ' ASP . 17.5 mmt180 -66.81 -46.26 75.75 Favored 'General case' 0 CA--C 1.504 -0.79 0 CA-C-O 121.977 0.894 . . . . 0.0 109.224 -175.624 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 139' ' ' LEU . . . . . 0.915 HD11 ' HA ' ' B' ' 136' ' ' ASP . 0.3 OUTLIER -72.46 -36.68 68.55 Favored 'General case' 0 C--O 1.209 -1.072 0 CA-C-N 114.607 -1.179 . . . . 0.0 111.148 179.03 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 140' ' ' ASN . . . . . 0.597 ' O ' ' HB ' ' B' ' 143' ' ' ILE . 9.7 t30 -64.27 -26.92 68.71 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.925 0.869 . . . . 0.0 109.565 177.75 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 141' ' ' LYS . . . . . . . . . . . . . 44.4 tttt -69.93 -51.63 31.25 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 114.391 -1.277 . . . . 0.0 109.354 177.226 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 142' ' ' VAL . . . . . 0.922 HG11 ' HB2' ' B' ' 103' ' ' TYR . 8.6 p -62.55 -32.12 54.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.889 177.853 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 143' ' ' ILE . . . . . 0.86 HG12 ' O ' ' B' ' 139' ' ' LEU . 34.6 mm -50.47 -66.62 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.513 -0.455 0 CA-C-O 121.082 0.467 . . . . 0.0 110.439 170.388 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 144' ' ' SER . . . . . . . . . . . . . 70.6 p -54.41 -31.56 55.34 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.188 -0.915 . . . . 0.0 111.838 -178.669 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 145' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -74.97 -37.07 62.02 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 112.072 0.397 . . . . 0.0 112.072 179.254 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 146' ' ' LEU . . . . . 0.711 HD11 ' HA ' ' B' ' 104' ' ' VAL . 6.9 mt -86.98 -19.53 28.59 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.813 -0.355 . . . . 0.0 110.712 -178.325 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 147' ' ' ASN . . . . . 0.409 ' HA ' ' OH ' ' B' ' 107' ' ' TYR . 26.3 t-20 -54.31 117.96 3.71 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.041 -176.335 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . 96.9 36.25 5.07 Favored Glycine 0 N--CA 1.448 -0.52 0 CA-C-N 115.544 -0.753 . . . . 0.0 112.275 -178.297 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 149' ' ' LYS . . . . . 0.478 ' HB2' ' O ' ' B' ' 146' ' ' LEU . 0.3 OUTLIER -130.08 165.28 22.57 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.837 0.351 . . . . 0.0 110.601 179.842 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 150' ' ' ASN . . . . . 0.515 ' O ' HG23 ' B' ' 154' ' ' VAL . 85.3 m-20 -104.28 88.84 3.08 Favored 'General case' 0 CA--C 1.513 -0.468 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 177.893 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 151' ' ' ILE . . . . . 0.844 HG13 HD12 ' B' ' 108' ' ' LEU . 1.8 mp -39.26 -64.52 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 113.845 1.054 . . . . 0.0 113.845 -169.806 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 152' ' ' GLU . . . . . 0.757 ' HG3' HD11 ' B' ' 112' ' ' LEU . 3.1 mp0 -57.97 -35.38 71.09 Favored 'General case' 0 C--O 1.216 -0.66 0 O-C-N 122.355 -0.216 . . . . 0.0 111.263 -174.268 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 153' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -71.28 -37.98 71.84 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.855 177.784 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 154' ' ' VAL . . . . . 0.81 ' HB ' HD12 ' B' ' 155' ' ' ILE . 62.0 t -53.47 -47.97 58.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 121.49 0.662 . . . . 0.0 109.321 173.76 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 155' ' ' ILE . . . . . 0.81 HD12 ' HB ' ' B' ' 154' ' ' VAL . 1.6 mp -107.51 35.73 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-O 121.929 0.871 . . . . 0.0 110.804 -178.613 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 156' ' ' ALA . . . . . 0.454 ' HB2' ' O ' ' B' ' 152' ' ' GLU . . . -100.85 1.9 40.51 Favored 'General case' 0 C--N 1.311 -1.096 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 169.062 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 157' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -142.05 16.08 2.09 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 113.946 -1.479 . . . . 0.0 110.515 177.378 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 158' ' ' GLY . . . . . . . . . . . . . . . -159.5 45.54 0.44 Allowed Glycine 0 C--N 1.338 0.69 0 C-N-CA 119.507 -1.33 . . . . 0.0 115.204 -172.64 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 159' ' ' ILE . . . . . 0.701 ' HB ' HG13 ' A' ' 60' ' ' ILE . 1.8 mp -58.57 -25.88 29.48 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 C-N-CA 122.959 0.504 . . . . 0.0 111.736 176.638 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 160' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.51 0 C-N-CA 120.048 -1.072 . . . . 0.0 112.993 -178.321 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 11.4 m . . . . . 0 N--CA 1.441 -0.904 0 N-CA-C 107.783 -1.191 . . . . 0.0 107.783 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.867 HG13 ' HG ' ' B' ' 112' ' ' LEU . 2.1 t -51.85 -24.58 4.85 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-N 114.947 -1.024 . . . . 0.0 112.17 -178.63 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' SER . . . . . 0.723 ' HB3' ' HA ' ' A' ' 39' ' ' VAL . 8.5 m -69.65 -51.86 31.04 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 176.219 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.509 ' O ' HG13 ' A' ' 10' ' ' ILE . 30.6 mt-10 -58.85 -52.15 66.97 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 115.008 -0.996 . . . . 0.0 109.796 178.239 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.853 HD12 HD12 ' A' ' 10' ' ' ILE . 3.2 tp -57.83 -36.85 72.84 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 115.317 -0.856 . . . . 0.0 112.097 178.279 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.632 ' HB2' HD23 ' B' ' 112' ' ' LEU . . . -67.09 -35.47 79.88 Favored 'General case' 0 CA--C 1.516 -0.361 0 CA-C-O 120.957 0.408 . . . . 0.0 110.855 178.927 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.526 ' HB2' HG11 ' A' ' 39' ' ' VAL . 5.6 t -69.7 -41.09 75.85 Favored 'General case' 0 C--O 1.242 0.672 0 N-CA-C 108.188 -1.042 . . . . 0.0 108.188 178.467 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.853 HD12 HD12 ' A' ' 7' ' ' LEU . 68.0 mt -47.14 -54.1 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.671 0 CA-C-N 114.214 -1.357 . . . . 0.0 109.627 170.532 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.882 ' HB2' HD13 ' B' ' 109' ' ' LEU . 23.4 m-85 -66.32 -39.48 89.29 Favored 'General case' 0 C--O 1.219 -0.511 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.877 -174.961 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.563 ' HB2' HD23 ' A' ' 31' ' ' LEU . 79.4 p -56.78 -44.79 82.22 Favored 'General case' 0 C--O 1.243 0.739 0 CA-C-O 121.475 0.655 . . . . 0.0 109.383 179.148 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.532 ' HB1' ' HG ' ' A' ' 51' ' ' LEU . . . -63.2 -34.32 77.38 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 115.09 -0.959 . . . . 0.0 110.42 173.963 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.66 HD22 HD11 ' A' ' 56' ' ' ILE . 0.2 OUTLIER -61.36 -55.49 31.05 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.456 179.342 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.479 HG12 ' O ' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -55.27 -41.5 61.59 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 178.322 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.672 HD21 ' HA ' ' A' ' 23' ' ' VAL . 2.3 tp -55.46 -38.64 69.33 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.31 176.212 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' HIS . . . . . 0.468 ' CD2' ' HB ' ' A' ' 56' ' ' ILE . 93.8 m-70 -73.77 -14.28 61.09 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 176.228 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -68.96 -44.4 73.05 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.911 0.386 . . . . 0.0 110.281 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.736 ' HB2' HG23 ' B' ' 132' ' ' ILE . 37.7 t70 -97.92 -6.99 31.11 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.835 0.826 . . . . 0.0 109.178 177.639 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 53.32 52.57 13.27 Favored 'General case' 0 CA--C 1.516 -0.359 0 CA-C-N 113.803 -1.544 . . . . 0.0 109.976 -177.034 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.43 HG13 HD12 ' A' ' 16' ' ' LEU . 7.3 p -106.62 163.97 4.73 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 CA-C-N 114.319 -1.31 . . . . 0.0 109.365 -174.051 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 18.6 p -48.32 142.01 5.98 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 113.312 0.856 . . . . 0.0 113.312 -174.719 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.672 ' HA ' HD21 ' A' ' 16' ' ' LEU . 58.3 t -107.27 114.29 45.79 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 CA-C-N 114.305 -1.316 . . . . 0.0 110.769 -175.471 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.502 ' OG1' ' HD2' ' A' ' 27' ' ' LYS . 22.1 p -136.69 159.57 41.44 Favored 'General case' 0 C--O 1.245 0.848 0 CA-C-O 120.925 0.393 . . . . 0.0 110.511 176.346 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -56.57 -34.14 66.83 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.596 176.106 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -68.79 -31.95 71.33 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.17 177.938 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.606 ' HG2' HD11 ' A' ' 16' ' ' LEU . 0.3 OUTLIER -62.67 -58.1 8.69 Favored 'General case' 0 CA--C 1.512 -0.505 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 175.043 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.511 HG23 ' OG ' ' A' ' 12' ' ' SER . 37.0 mt -56.51 -40.95 71.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 114.184 -1.371 . . . . 0.0 110.999 -178.348 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 41.1 t-20 -59.37 -45.53 91.16 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.934 -0.575 . . . . 0.0 109.955 177.272 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -59.31 -47.79 84.06 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.405 179.842 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.722 ' HB3' HD21 ' B' ' 109' ' ' LEU . 0.9 OUTLIER -57.61 -50.43 73.17 Favored 'General case' 0 C--O 1.239 0.504 0 CA-C-O 121.006 0.431 . . . . 0.0 110.595 177.174 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.593 HG23 ' O ' ' A' ' 37' ' ' VAL . 67.1 mt -47.76 -51.48 7.95 Favored 'Isoleucine or valine' 0 C--O 1.242 0.698 0 CA-C-N 115.067 -0.97 . . . . 0.0 111.267 177.839 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 47.5 mmtm -74.2 -39.49 63.12 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.022 -0.99 . . . . 0.0 111.781 -174.036 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -63.24 -41.39 99.07 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-O 120.783 0.325 . . . . 0.0 110.97 -178.795 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.504 ' HA ' HD11 ' B' ' 126' ' ' ILE . . . -79.41 -31.8 42.77 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.079 179.784 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 97.38 16.16 35.58 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 121.021 -0.609 . . . . 0.0 111.91 178.316 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.881 ' HB ' ' HA2' ' B' ' 113' ' ' GLY . 2.5 p -119.57 119.99 62.14 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 CA-C-O 121.433 0.635 . . . . 0.0 110.458 -176.694 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.577 ' HA ' HG23 ' A' ' 32' ' ' ILE . 12.8 t30 -96.59 153.71 17.69 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 114.826 -1.079 . . . . 0.0 111.142 -167.673 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.723 ' HA ' ' HB3' ' A' ' 5' ' ' SER . 93.5 t -130.03 158.79 42.49 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.964 0 CA-C-N 114.982 -1.008 . . . . 0.0 109.923 -170.347 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.595 ' HB2' ' CD1' ' A' ' 43' ' ' TRP . 30.6 mt-10 -63.83 112.7 7.9 Favored Pre-proline 0 CA--C 1.487 -1.454 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 170.003 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.447 ' C ' ' HD2' ' A' ' 44' ' ' PRO . 54.4 Cg_exo -55.8 -27.75 63.73 Favored 'Trans proline' 0 C--N 1.312 -1.349 0 C-N-CA 123.042 2.495 . . . . 0.0 113.509 -167.943 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 1.6 p90 -62.0 -28.95 69.93 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.746 175.03 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' TRP . . . . . 0.595 ' CD1' ' HB2' ' A' ' 40' ' ' GLU . 9.8 m95 -62.47 -59.35 13.08 Favored Pre-proline 0 C--O 1.204 -1.338 0 CA-C-O 118.374 -0.822 . . . . 0.0 110.32 175.957 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.459 ' HD2' ' O ' ' A' ' 40' ' ' GLU . 84.8 Cg_exo -44.38 -45.28 12.72 Favored 'Trans proline' 0 C--N 1.36 1.165 0 C-N-CA 121.716 1.61 . . . . 0.0 112.527 172.483 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -60.26 -59.36 10.49 Favored Glycine 0 CA--C 1.529 0.962 0 C-N-CA 120.025 -1.084 . . . . 0.0 112.759 177.367 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 5.4 tp -65.41 -32.03 73.44 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 123.276 0.63 . . . . 0.0 111.791 -177.388 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.499 ' HE1' ' CE3' ' A' ' 43' ' ' TRP . 2.7 m-85 -65.32 -49.02 71.04 Favored 'General case' 0 C--N 1.317 -0.81 0 C-N-CA 122.685 0.394 . . . . 0.0 110.263 176.533 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.418 ' HA ' HG12 ' A' ' 23' ' ' VAL . . . -64.6 -31.11 72.18 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.505 0.669 . . . . 0.0 109.539 -179.757 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.549 ' HD2' ' O ' ' A' ' 49' ' ' LYS . 0.4 OUTLIER -66.82 -35.76 80.81 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 114.883 -1.053 . . . . 0.0 110.622 173.094 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.426 ' C ' HG22 ' A' ' 54' ' ' VAL . . . -85.03 -58.71 2.58 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.809 0.67 . . . . 0.0 112.809 -175.253 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.589 ' HB2' HG11 ' A' ' 23' ' ' VAL . 3.2 mm? -62.0 -11.71 14.95 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 112.746 0.647 . . . . 0.0 112.746 -170.437 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -74.34 -26.41 60.12 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.061 0.457 . . . . 0.0 110.426 175.787 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 84.1 m-20 -116.4 -39.13 3.41 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.048 -177.284 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.426 HG22 ' C ' ' A' ' 50' ' ' ALA . 4.1 m -98.43 -174.28 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.949 0.404 . . . . 0.0 110.789 -176.435 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 26.9 p-10 -111.71 178.71 4.23 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.334 179.364 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.66 HD11 HD22 ' A' ' 14' ' ' LEU . 4.7 tp -74.57 -25.1 18.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 120.971 0.415 . . . . 0.0 109.992 -179.183 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -70.32 -13.75 70.92 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.435 -0.888 . . . . 0.0 110.937 175.713 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 32.2 t -77.53 -21.75 52.17 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-O 121.27 0.557 . . . . 0.0 109.677 179.284 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.649 ' HB2' HG21 ' B' ' 159' ' ' ILE . 20.0 mt -64.98 -26.38 68.27 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.565 179.616 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.573 ' CD1' ' HB ' ' B' ' 159' ' ' ILE . 0.1 OUTLIER . . . . . 0 C--N 1.314 -0.936 0 CA-C-N 114.602 -1.181 . . . . 0.0 110.558 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 103' ' ' TYR . . . . . 0.664 ' HB3' HG21 ' B' ' 123' ' ' ILE . 41.5 m-85 . . . . . 0 C--O 1.237 0.425 0 CA-C-O 120.902 0.382 . . . . 0.0 111.234 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 104' ' ' VAL . . . . . 0.603 ' O ' HD22 ' B' ' 108' ' ' LEU . 63.4 t -44.15 -47.06 2.24 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.269 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.973 170.989 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 105' ' ' ALA . . . . . 0.623 ' CB ' ' HB3' ' A' ' 14' ' ' LEU . . . -65.95 -38.91 89.83 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.008 -0.996 . . . . 0.0 111.593 -173.879 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 106' ' ' SER . . . . . 0.881 ' HB2' HG23 ' B' ' 123' ' ' ILE . 1.4 m -63.75 -36.38 83.69 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-O 121.596 0.712 . . . . 0.0 109.683 177.427 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 107' ' ' TYR . . . . . 0.654 ' CZ ' ' HD2' ' B' ' 118' ' ' PRO . 31.8 t80 -62.93 -51.06 68.39 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 114.509 -1.223 . . . . 0.0 108.665 178.583 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 108' ' ' LEU . . . . . 0.907 HD12 HG13 ' B' ' 151' ' ' ILE . 0.0 OUTLIER -56.96 -45.36 82.92 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 114.652 -1.158 . . . . 0.0 110.971 178.341 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 109' ' ' LEU . . . . . 0.882 HD13 ' HB2' ' A' ' 11' ' ' TYR . 7.7 tp -56.41 -47.49 78.93 Favored 'General case' 0 CA--C 1.51 -0.574 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.033 179.099 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 110' ' ' ALA . . . . . 0.562 ' HB3' ' HB3' ' B' ' 118' ' ' PRO . . . -65.73 -38.98 90.63 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-O 120.998 0.428 . . . . 0.0 111.155 -177.358 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 111' ' ' ALA . . . . . 0.658 ' HA ' ' O ' ' B' ' 115' ' ' ASN . . . -69.01 -23.74 64.12 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.637 178.733 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 112' ' ' LEU . . . . . 0.867 ' HG ' HG13 ' A' ' 4' ' ' VAL . 1.4 mp -80.23 -37.54 32.87 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.058 172.831 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 113' ' ' GLY . . . . . 0.881 ' HA2' ' HB ' ' A' ' 37' ' ' VAL . . . -64.07 -20.99 65.43 Favored Glycine 0 N--CA 1.449 -0.499 0 CA-C-N 115.204 -0.907 . . . . 0.0 111.801 177.809 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 114' ' ' GLY . . . . . . . . . . . . . . . 130.01 9.64 3.02 Favored Glycine 0 N--CA 1.439 -1.16 0 C-N-CA 120.354 -0.927 . . . . 0.0 113.416 174.563 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 115' ' ' ASN . . . . . 0.658 ' O ' ' HA ' ' B' ' 111' ' ' ALA . 1.8 t-20 -115.11 95.31 5.14 Favored 'General case' 0 N--CA 1.44 -0.962 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 178.5 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 2.3 p -80.21 29.87 0.28 Allowed 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 114.895 -1.048 . . . . 0.0 110.75 -167.024 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 117' ' ' SER . . . . . 0.526 ' N ' ' HD3' ' B' ' 118' ' ' PRO . 41.9 t -175.78 67.96 0.25 Allowed Pre-proline 0 C--N 1.307 -1.252 0 CA-C-N 113.377 -1.738 . . . . 0.0 108.411 -179.05 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 118' ' ' PRO . . . . . 0.654 ' HD2' ' CZ ' ' B' ' 107' ' ' TYR . 32.1 Cg_exo -66.04 148.7 85.86 Favored 'Trans proline' 0 CA--C 1.513 -0.557 0 C-N-CA 125.115 3.877 . . . . 0.0 111.827 -175.268 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 119' ' ' SER . . . . . 0.648 ' O ' HG12 ' B' ' 123' ' ' ILE . 78.6 p -116.39 -178.42 3.41 Favored 'General case' 0 C--N 1.316 -0.858 0 C-N-CA 120.221 -0.591 . . . . 0.0 111.324 178.318 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 120' ' ' ALA . . . . . 0.838 ' HB1' HD13 ' B' ' 139' ' ' LEU . . . -66.81 -34.19 77.28 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 122.057 0.932 . . . . 0.0 109.77 -173.868 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 121' ' ' LYS . . . . . 0.603 ' HD2' ' N ' ' B' ' 121' ' ' LYS . 0.0 OUTLIER -69.74 -29.97 67.46 Favored 'General case' 0 N--CA 1.437 -1.084 0 CA-C-N 113.956 -1.475 . . . . 0.0 110.173 177.805 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 122' ' ' ASP . . . . . 0.428 ' O ' HD13 ' B' ' 126' ' ' ILE . 20.1 m-20 -70.41 -44.73 67.34 Favored 'General case' 0 CA--C 1.517 -0.306 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 174.517 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 123' ' ' ILE . . . . . 0.881 HG23 ' HB2' ' B' ' 106' ' ' SER . 25.1 mm -54.19 -49.57 61.57 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 CA-C-N 114.944 -1.026 . . . . 0.0 109.869 176.38 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 124' ' ' LYS . . . . . 0.984 ' HD2' HD11 ' B' ' 127' ' ' LEU . 1.7 mmmm -62.34 -41.59 98.7 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.23 -175.943 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 125' ' ' LYS . . . . . . . . . . . . . 44.3 mmtt -49.73 -60.95 2.41 Favored 'General case' 0 CA--C 1.496 -1.134 0 CA-C-O 121.931 0.872 . . . . 0.0 111.225 171.9 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 126' ' ' ILE . . . . . 0.635 HG23 HD12 ' A' ' 31' ' ' LEU . 1.6 mp -59.03 -41.89 84.68 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.667 0 CA-C-N 113.706 -1.588 . . . . 0.0 110.694 -169.885 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 127' ' ' LEU . . . . . 0.984 HD11 ' HD2' ' B' ' 124' ' ' LYS . 3.5 pp -78.94 -32.25 45.45 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 111.924 0.342 . . . . 0.0 111.924 -178.628 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 128' ' ' ASP . . . . . 0.484 ' N ' HD12 ' B' ' 127' ' ' LEU . 11.5 m-20 -70.33 -24.58 63.02 Favored 'General case' 0 CA--C 1.518 -0.281 0 O-C-N 122.232 -0.293 . . . . 0.0 111.03 -178.588 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 129' ' ' SER . . . . . . . . . . . . . 94.4 p -59.45 -42.83 92.87 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-O 120.715 0.293 . . . . 0.0 111.206 177.217 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 130' ' ' VAL . . . . . 0.566 HG23 HG13 ' B' ' 132' ' ' ILE . 13.1 m -93.41 -7.4 10.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.814 0.34 . . . . 0.0 111.776 -179.745 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 131' ' ' GLY . . . . . . . . . . . . . . . 85.62 39.75 8.08 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.478 177.474 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 132' ' ' ILE . . . . . 0.736 HG23 ' HB2' ' A' ' 19' ' ' ASP . 14.3 mt -94.7 126.94 47.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 110.195 -0.298 . . . . 0.0 110.195 176.617 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 133' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -80.53 127.04 31.98 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.227 0.536 . . . . 0.0 111.283 -176.171 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 134' ' ' ALA . . . . . 0.421 ' HB2' HD22 ' B' ' 127' ' ' LEU . . . -140.37 146.13 38.01 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.706 -173.253 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 135' ' ' ASP . . . . . 0.696 ' HB3' ' HG3' ' B' ' 138' ' ' ARG . 7.7 t70 -93.65 131.04 39.34 Favored 'General case' 0 C--O 1.253 1.253 0 CA-C-O 121.173 0.511 . . . . 0.0 110.447 175.352 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 136' ' ' ASP . . . . . 1.032 ' HA ' HD11 ' B' ' 139' ' ' LEU . 6.2 p-10 -77.42 5.21 9.23 Favored 'General case' 0 CA--C 1.517 -0.297 0 CA-C-N 115.029 -0.987 . . . . 0.0 111.627 -168.276 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 137' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -108.83 -30.94 7.89 Favored 'General case' 0 N--CA 1.434 -1.255 0 CA-C-O 121.059 0.457 . . . . 0.0 110.372 172.013 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 138' ' ' ARG . . . . . 0.73 ' HA ' ' HE2' ' B' ' 141' ' ' LYS . 9.3 mmt180 -67.4 -48.44 67.36 Favored 'General case' 0 CA--C 1.505 -0.76 0 CA-C-O 122.179 0.99 . . . . 0.0 109.155 -178.69 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 139' ' ' LEU . . . . . 1.032 HD11 ' HA ' ' B' ' 136' ' ' ASP . 0.3 OUTLIER -69.63 -26.09 64.25 Favored 'General case' 0 C--O 1.207 -1.147 0 CA-C-N 114.588 -1.187 . . . . 0.0 111.025 179.112 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 140' ' ' ASN . . . . . 0.608 ' O ' ' HB ' ' B' ' 143' ' ' ILE . 32.9 t30 -79.26 -26.44 42.42 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.875 0.845 . . . . 0.0 109.938 -178.39 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 141' ' ' LYS . . . . . 0.73 ' HE2' ' HA ' ' B' ' 138' ' ' ARG . 0.2 OUTLIER -80.69 -35.35 33.76 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 115.435 -0.802 . . . . 0.0 108.972 179.907 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 142' ' ' VAL . . . . . 0.624 HG12 ' O ' ' B' ' 139' ' ' LEU . 9.8 p -66.6 -39.12 83.09 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.444 0 C-N-CA 119.922 -0.711 . . . . 0.0 109.204 172.127 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 143' ' ' ILE . . . . . 0.903 HG12 ' O ' ' B' ' 139' ' ' LEU . 32.2 mm -45.51 -59.82 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.36 0 CA-C-O 121.778 0.799 . . . . 0.0 110.081 168.762 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 144' ' ' SER . . . . . . . . . . . . . 20.8 m -51.8 -42.61 62.6 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 113.97 -1.468 . . . . 0.0 112.298 -179.656 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 145' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -76.16 -23.63 54.77 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 120.948 0.404 . . . . 0.0 111.625 179.35 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 146' ' ' LEU . . . . . 0.575 ' HB3' ' CZ ' ' B' ' 107' ' ' TYR . 0.3 OUTLIER -86.0 -36.96 19.44 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.569 -177.416 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 147' ' ' ASN . . . . . . . . . . . . . 16.0 t-20 -43.6 113.04 0.45 Allowed 'General case' 0 C--N 1.331 -0.203 0 O-C-N 124.157 0.911 . . . . 0.0 112.424 -173.168 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . 97.23 61.22 0.94 Allowed Glycine 0 N--CA 1.448 -0.56 0 CA-C-N 115.277 -0.874 . . . . 0.0 111.807 -178.14 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 149' ' ' LYS . . . . . . . . . . . . . 2.5 tppt? -144.49 162.54 36.29 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 -178.168 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 150' ' ' ASN . . . . . 0.619 ' O ' HG23 ' B' ' 154' ' ' VAL . 42.2 m-80 -106.08 90.26 3.32 Favored 'General case' 0 CA--C 1.514 -0.427 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 178.079 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 151' ' ' ILE . . . . . 0.907 HG13 HD12 ' B' ' 108' ' ' LEU . 1.8 mp -43.45 -66.01 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 O-C-N 124.528 1.142 . . . . 0.0 113.744 -169.028 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 152' ' ' GLU . . . . . 0.579 ' OE1' HD22 ' A' ' 7' ' ' LEU . 2.4 mt-10 -48.94 -52.61 23.7 Favored 'General case' 0 C--O 1.207 -1.149 0 CA-C-N 118.249 0.477 . . . . 0.0 111.981 -177.775 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 153' ' ' ASP . . . . . . . . . . . . . 26.5 m-20 -64.76 -27.77 69.12 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 119.983 -0.687 . . . . 0.0 111.103 -176.014 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 154' ' ' VAL . . . . . 0.855 ' HB ' HD12 ' B' ' 155' ' ' ILE . 49.6 t -57.6 -52.97 50.7 Favored 'Isoleucine or valine' 0 C--O 1.233 0.189 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 170.374 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 155' ' ' ILE . . . . . 0.855 HD12 ' HB ' ' B' ' 154' ' ' VAL . 1.8 mp -105.25 34.4 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.706 -176.613 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . -105.03 0.59 27.79 Favored 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 171.405 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 157' ' ' GLN . . . . . . . . . . . . . 49.9 mt-30 -141.69 1.85 1.55 Allowed 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 113.353 -1.749 . . . . 0.0 109.908 175.837 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 158' ' ' GLY . . . . . . . . . . . . . . . -142.34 46.26 0.88 Allowed Glycine 0 C--N 1.334 0.456 0 C-N-CA 120.695 -0.764 . . . . 0.0 113.588 -170.747 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 159' ' ' ILE . . . . . 0.649 HG21 ' HB2' ' A' ' 59' ' ' LEU . 1.8 mp -60.41 -15.81 11.3 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.775 0 C-N-CA 123.127 0.571 . . . . 0.0 111.721 178.859 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 160' ' ' GLY . . . . . 0.402 ' HA2' HG23 ' A' ' 56' ' ' ILE . . . . . . . . 0 N--CA 1.446 -0.676 0 C-N-CA 120.59 -0.814 . . . . 0.0 112.204 -174.591 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' SER . . . . . 0.498 ' HB2' ' HG3' ' A' ' 6' ' ' GLU . 5.8 m . . . . . 0 N--CA 1.448 -0.538 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.539 HG13 ' HG ' ' B' ' 112' ' ' LEU . 2.1 t -52.57 -26.59 10.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.053 -0.976 . . . . 0.0 112.496 -178.301 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' SER . . . . . 0.424 ' HB2' ' HA ' ' A' ' 39' ' ' VAL . 10.9 p -68.71 -53.26 23.21 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 177.471 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.552 ' O ' HG13 ' A' ' 10' ' ' ILE . 31.3 mt-10 -56.95 -50.27 73.13 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 114.816 -1.083 . . . . 0.0 109.614 176.966 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.868 HD12 HD12 ' A' ' 10' ' ' ILE . 4.4 tp -61.61 -36.6 81.19 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 115.12 -0.945 . . . . 0.0 111.841 -179.404 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.685 ' HB2' HD23 ' B' ' 112' ' ' LEU . . . -69.21 -35.11 75.85 Favored 'General case' 0 CA--C 1.513 -0.456 0 CA-C-O 121.023 0.439 . . . . 0.0 110.719 179.11 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.46 ' HB2' HG11 ' A' ' 39' ' ' VAL . 5.0 t -67.63 -41.11 84.44 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 178.337 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.868 HD12 HD12 ' A' ' 7' ' ' LEU . 68.5 mt -47.92 -56.57 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 CA-C-N 113.859 -1.518 . . . . 0.0 109.905 170.976 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.873 ' HB2' HD13 ' B' ' 109' ' ' LEU . 22.9 m-85 -65.13 -39.64 93.32 Favored 'General case' 0 C--O 1.218 -0.586 0 CA-C-N 115.685 -0.688 . . . . 0.0 111.413 -174.194 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.467 ' HB2' HG23 ' A' ' 28' ' ' ILE . 16.0 m -57.34 -40.84 78.87 Favored 'General case' 0 C--O 1.24 0.588 0 CA-C-O 121.463 0.649 . . . . 0.0 109.315 177.197 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.438 ' CB ' HD11 ' A' ' 51' ' ' LEU . . . -67.13 -30.93 71.07 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 115.186 -0.915 . . . . 0.0 110.212 175.067 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.704 HD22 HD11 ' A' ' 56' ' ' ILE . 0.3 OUTLIER -66.98 -53.63 29.68 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.591 179.684 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.455 HG12 ' H ' ' A' ' 15' ' ' ILE . 0.0 OUTLIER -57.77 -41.66 80.13 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 CA-C-O 120.961 0.41 . . . . 0.0 109.955 176.8 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.574 HD11 ' HG2' ' A' ' 27' ' ' LYS . 2.6 tp -60.08 -41.94 93.54 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.821 176.816 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 47.4 t60 -80.47 -8.31 59.5 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.316 179.594 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -73.8 -43.34 59.15 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 178.761 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -97.71 -14.55 20.81 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-O 121.991 0.901 . . . . 0.0 109.045 177.916 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 61.0 52.69 3.97 Favored 'General case' 0 CA--C 1.51 -0.566 0 CA-C-N 113.753 -1.567 . . . . 0.0 109.979 -174.735 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.511 HG13 HD12 ' A' ' 16' ' ' LEU . 7.3 p -102.08 171.64 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.426 -1.643 0 CA-C-N 114.445 -1.252 . . . . 0.0 108.506 -178.216 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.503 ' H ' HG22 ' A' ' 21' ' ' VAL . 41.2 p -54.19 138.65 37.87 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 113.365 0.876 . . . . 0.0 113.365 -170.595 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.587 HG12 ' HA ' ' A' ' 48' ' ' ALA . 59.4 t -107.19 108.7 25.85 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.995 0 CA-C-N 114.371 -1.286 . . . . 0.0 110.54 -176.649 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.508 ' OG1' ' HE2' ' A' ' 27' ' ' LYS . 68.5 p -140.24 155.14 47.0 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.61 179.029 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -54.83 -43.36 72.92 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.228 0.537 . . . . 0.0 109.788 178.901 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 -60.5 -34.55 74.24 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.168 -0.923 . . . . 0.0 110.76 178.985 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.574 ' HG2' HD11 ' A' ' 16' ' ' LEU . 3.9 tppt? -67.53 -54.12 22.74 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-O 121.881 0.848 . . . . 0.0 109.233 -178.66 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.467 HG23 ' HB2' ' A' ' 12' ' ' SER . 88.1 mt -58.76 -39.35 76.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 114.459 -1.246 . . . . 0.0 110.287 178.262 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 42.8 t-20 -58.14 -42.85 86.76 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.109 176.538 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -60.42 -46.85 88.53 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.243 177.636 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.512 ' HB3' HD21 ' B' ' 109' ' ' LEU . 1.1 mm? -55.54 -51.46 66.98 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 121.221 0.534 . . . . 0.0 110.216 175.348 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.621 HG23 ' O ' ' A' ' 37' ' ' VAL . 67.8 mt -47.71 -49.46 10.24 Favored 'Isoleucine or valine' 0 C--O 1.242 0.665 0 CA-C-N 114.655 -1.157 . . . . 0.0 111.936 179.199 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.431 ' HA ' ' HD2' ' A' ' 33' ' ' LYS . 3.0 mmmp? -78.45 -31.26 47.93 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.528 0.566 . . . . 0.0 112.528 -173.669 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.521 ' HB2' ' HB3' ' B' ' 129' ' ' SER . . . -68.83 -38.15 79.66 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 120.641 -0.423 . . . . 0.0 110.463 177.719 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.549 ' CB ' ' HG ' ' B' ' 109' ' ' LEU . . . -77.6 -36.3 51.96 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.412 177.02 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 97.62 13.25 44.83 Favored Glycine 0 N--CA 1.445 -0.715 0 CA-C-N 115.427 -0.806 . . . . 0.0 111.959 178.6 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.953 ' HB ' ' HA2' ' B' ' 113' ' ' GLY . 2.6 p -116.13 116.96 53.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-O 121.818 0.818 . . . . 0.0 110.969 -175.126 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -90.12 152.82 20.95 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 114.268 -1.333 . . . . 0.0 110.551 -171.684 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.504 HG12 ' N ' ' A' ' 40' ' ' GLU . 96.3 t -120.51 166.13 15.26 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.07 0 CA-C-N 114.555 -1.202 . . . . 0.0 109.935 -173.056 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.635 ' HB3' ' HD1' ' A' ' 43' ' ' TRP . 28.3 tp10 -72.62 106.35 2.11 Favored Pre-proline 0 N--CA 1.439 -1.023 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 168.872 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.529 ' C ' ' HD2' ' A' ' 44' ' ' PRO . 86.8 Cg_exo -50.09 -30.71 25.81 Favored 'Trans proline' 0 C--O 1.253 1.243 0 C-N-CA 123.709 2.94 . . . . 0.0 115.65 -163.9 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.402 ' HD2' ' HG3' ' A' ' 40' ' ' GLU . 0.5 OUTLIER -59.43 -28.4 66.91 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 177.246 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 43' ' ' TRP . . . . . 0.635 ' HD1' ' HB3' ' A' ' 40' ' ' GLU . 17.4 m95 -64.2 -60.44 8.72 Favored Pre-proline 0 C--O 1.206 -1.214 0 CA-C-O 118.369 -0.824 . . . . 0.0 111.153 176.083 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.529 ' HD2' ' C ' ' A' ' 41' ' ' PRO . 93.1 Cg_exo -44.99 -44.89 14.61 Favored 'Trans proline' 0 C--N 1.36 1.155 0 C-N-CA 121.849 1.699 . . . . 0.0 112.167 175.094 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -61.55 -55.77 26.95 Favored Glycine 0 CA--C 1.525 0.68 0 C-N-CA 120.035 -1.079 . . . . 0.0 112.525 177.17 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 8.9 tp -67.42 -27.92 67.47 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 122.849 0.459 . . . . 0.0 112.025 -177.366 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.513 ' HE1' ' CE3' ' A' ' 43' ' ' TRP . 2.8 m-85 -69.89 -46.8 64.66 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 177.112 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.587 ' HA ' HG12 ' A' ' 23' ' ' VAL . . . -62.84 -34.34 77.13 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.81 0.814 . . . . 0.0 109.592 178.26 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.471 ' HD2' ' C ' ' A' ' 49' ' ' LYS . 0.3 OUTLIER -70.85 -42.26 70.36 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 114.291 -1.322 . . . . 0.0 111.484 177.085 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.415 ' O ' HG22 ' A' ' 54' ' ' VAL . . . -82.23 -44.96 15.68 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 112.687 0.625 . . . . 0.0 112.687 -173.569 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.537 ' HB2' HG11 ' A' ' 23' ' ' VAL . 11.1 mt -63.71 -13.15 40.65 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 112.87 0.693 . . . . 0.0 112.87 -171.835 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -83.1 -10.25 58.78 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.135 0.493 . . . . 0.0 110.579 176.623 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 33.9 m-80 -122.6 -47.6 2.08 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.261 -176.55 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.415 HG22 ' O ' ' A' ' 50' ' ' ALA . 13.7 m -99.55 -169.93 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 176.601 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -130.59 -173.1 2.98 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 120.484 -0.486 . . . . 0.0 111.338 178.149 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.704 HD11 HD22 ' A' ' 14' ' ' LEU . 3.4 tp -66.03 -26.99 39.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-O 121.006 0.431 . . . . 0.0 111.08 -174.262 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -71.15 -14.99 74.26 Favored Glycine 0 N--CA 1.442 -0.904 0 C-N-CA 120.459 -0.877 . . . . 0.0 111.21 179.798 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 14.8 t -79.99 -21.27 43.85 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-O 121.157 0.504 . . . . 0.0 110.054 179.631 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.545 ' HB2' HG21 ' B' ' 159' ' ' ILE . 26.0 mt -62.67 -33.05 74.28 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.518 -0.764 . . . . 0.0 110.848 -178.298 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.648 ' CD1' ' HB ' ' B' ' 159' ' ' ILE . 0.1 OUTLIER . . . . . 0 C--N 1.319 -0.752 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.914 -179.299 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 103' ' ' TYR . . . . . 0.827 ' HB2' HG11 ' B' ' 142' ' ' VAL . 52.2 m-85 . . . . . 0 N--CA 1.477 0.886 0 CA-C-O 120.778 0.323 . . . . 0.0 111.807 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 104' ' ' VAL . . . . . 0.526 ' O ' HD22 ' B' ' 108' ' ' LEU . 50.1 t -43.17 -50.28 1.24 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.371 0 CA-C-O 121.736 0.779 . . . . 0.0 110.255 174.069 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 105' ' ' ALA . . . . . 0.655 ' CB ' ' HB3' ' A' ' 14' ' ' LEU . . . -64.67 -37.85 88.98 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-N 114.519 -1.219 . . . . 0.0 111.669 -174.306 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 106' ' ' SER . . . . . 0.703 ' HB2' HG23 ' B' ' 123' ' ' ILE . 1.4 m -62.82 -37.78 88.11 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.533 0.682 . . . . 0.0 109.391 178.533 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 107' ' ' TYR . . . . . 0.683 ' CG ' HD12 ' B' ' 146' ' ' LEU . 34.2 t80 -63.99 -47.58 79.81 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 114.727 -1.124 . . . . 0.0 108.689 178.285 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 108' ' ' LEU . . . . . 0.836 HD12 HG13 ' B' ' 151' ' ' ILE . 0.0 OUTLIER -58.21 -47.54 83.17 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.103 -0.953 . . . . 0.0 110.943 177.522 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 109' ' ' LEU . . . . . 0.873 HD13 ' HB2' ' A' ' 11' ' ' TYR . 8.1 tp -54.19 -48.76 70.61 Favored 'General case' 0 CA--C 1.511 -0.541 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.193 179.11 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 110' ' ' ALA . . . . . 0.43 ' HB3' ' HB3' ' B' ' 118' ' ' PRO . . . -64.65 -41.13 96.33 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.975 0.417 . . . . 0.0 111.044 -177.442 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 111' ' ' ALA . . . . . 0.665 ' HA ' ' O ' ' B' ' 115' ' ' ASN . . . -68.65 -20.17 64.44 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.275 0.56 . . . . 0.0 110.802 179.318 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 112' ' ' LEU . . . . . 0.685 HD23 ' HB2' ' A' ' 8' ' ' ALA . 1.4 mp -85.14 -37.11 20.59 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.966 173.723 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 113' ' ' GLY . . . . . 0.953 ' HA2' ' HB ' ' A' ' 37' ' ' VAL . . . -62.81 -39.23 97.73 Favored Glycine 0 N--CA 1.445 -0.705 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.769 -179.123 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 114' ' ' GLY . . . . . . . . . . . . . . . 155.09 6.21 0.08 OUTLIER Glycine 0 N--CA 1.44 -1.09 0 C-N-CA 120.217 -0.992 . . . . 0.0 112.928 177.216 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 115' ' ' ASN . . . . . 0.665 ' O ' ' HA ' ' B' ' 111' ' ' ALA . 37.4 t30 -119.63 92.62 3.83 Favored 'General case' 0 N--CA 1.444 -0.77 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 -179.454 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 5.2 p -80.59 27.53 0.36 Allowed 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 122.325 1.059 . . . . 0.0 111.038 -166.049 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 117' ' ' SER . . . . . 0.521 ' N ' ' HD3' ' B' ' 118' ' ' PRO . 33.0 t -172.14 68.29 0.42 Allowed Pre-proline 0 C--N 1.31 -1.137 0 CA-C-N 113.419 -1.719 . . . . 0.0 108.098 178.55 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 118' ' ' PRO . . . . . 0.679 ' HG2' ' O ' ' B' ' 107' ' ' TYR . 37.1 Cg_exo -64.09 156.25 60.07 Favored 'Trans proline' 0 CA--C 1.512 -0.611 0 C-N-CA 125.028 3.818 . . . . 0.0 111.718 -174.291 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 119' ' ' SER . . . . . 0.67 ' O ' HG12 ' B' ' 123' ' ' ILE . 90.2 p -123.75 179.78 4.67 Favored 'General case' 0 C--N 1.314 -0.961 0 C-N-CA 120.079 -0.648 . . . . 0.0 110.831 177.837 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 120' ' ' ALA . . . . . 0.834 ' HB1' HD13 ' B' ' 139' ' ' LEU . . . -65.9 -39.2 90.39 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-O 121.75 0.786 . . . . 0.0 109.617 -172.577 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 121' ' ' LYS . . . . . . . . . . . . . 13.9 mptt -60.33 -37.91 82.12 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 114.076 -1.42 . . . . 0.0 110.538 175.169 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 122' ' ' ASP . . . . . 0.628 ' O ' ' HB2' ' B' ' 125' ' ' LYS . 2.6 t0 -74.44 -35.06 63.33 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 121.665 0.745 . . . . 0.0 109.105 -178.644 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 123' ' ' ILE . . . . . 0.746 ' O ' ' HG ' ' B' ' 127' ' ' LEU . 42.7 mm -60.01 -44.3 94.43 Favored 'Isoleucine or valine' 0 C--O 1.235 0.301 0 CA-C-N 115.43 -0.805 . . . . 0.0 109.511 172.762 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 124' ' ' LYS . . . . . 0.687 ' HD3' HD21 ' B' ' 139' ' ' LEU . 5.2 mmmp? -58.66 -44.59 90.18 Favored 'General case' 0 CA--C 1.503 -0.864 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 -179.27 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 125' ' ' LYS . . . . . 0.628 ' HB2' ' O ' ' B' ' 122' ' ' ASP . 17.6 mmtp -45.03 -66.76 0.36 Allowed 'General case' 0 C--O 1.248 0.975 0 CA-C-O 121.609 0.719 . . . . 0.0 112.54 169.724 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 126' ' ' ILE . . . . . 0.453 HD11 ' HA ' ' A' ' 35' ' ' ALA . 1.7 mp -54.65 -43.23 64.76 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.13 0 CA-C-N 113.801 -1.545 . . . . 0.0 111.112 -168.701 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 127' ' ' LEU . . . . . 0.746 ' HG ' ' O ' ' B' ' 123' ' ' ILE . 1.5 pp -84.27 -23.46 30.35 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.505 0.557 . . . . 0.0 112.505 -178.299 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 128' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -70.44 -27.88 64.6 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 120.784 0.326 . . . . 0.0 110.22 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 129' ' ' SER . . . . . 0.521 ' HB3' ' HB2' ' A' ' 34' ' ' ALA . 89.2 p -55.87 -45.86 78.43 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.292 177.556 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 130' ' ' VAL . . . . . 0.499 HG23 HG13 ' B' ' 132' ' ' ILE . 10.9 m -88.88 -17.93 8.11 Favored 'Isoleucine or valine' 0 C--O 1.231 0.083 0 CA-C-O 120.727 0.299 . . . . 0.0 111.563 179.369 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 131' ' ' GLY . . . . . . . . . . . . . . . 100.74 18.76 19.65 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.661 -0.78 . . . . 0.0 112.686 177.321 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 132' ' ' ILE . . . . . 0.539 ' O ' HD13 ' B' ' 127' ' ' LEU . 27.5 mt -78.16 114.93 19.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.788 0.327 . . . . 0.0 110.271 178.334 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 133' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -79.02 138.47 38.03 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.386 -175.263 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 134' ' ' ALA . . . . . . . . . . . . . . . -139.79 143.69 37.0 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.774 -0.648 . . . . 0.0 112.103 -169.442 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 135' ' ' ASP . . . . . 0.783 ' HB2' ' HG3' ' B' ' 138' ' ' ARG . 6.3 m-20 -84.05 128.17 34.38 Favored 'General case' 0 C--O 1.252 1.201 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 175.104 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 136' ' ' ASP . . . . . 1.031 ' HA ' HD11 ' B' ' 139' ' ' LEU . 1.3 p-10 -77.14 -0.34 24.55 Favored 'General case' 0 CA--C 1.518 -0.261 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.26 -166.438 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 137' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -103.22 -31.74 9.96 Favored 'General case' 0 N--CA 1.439 -1.01 0 CA-C-O 121.186 0.517 . . . . 0.0 110.14 172.44 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 138' ' ' ARG . . . . . 0.783 ' HG3' ' HB2' ' B' ' 135' ' ' ASP . 44.9 mmt-85 -63.26 -54.37 38.28 Favored 'General case' 0 CA--C 1.504 -0.803 0 CA-C-O 122.108 0.956 . . . . 0.0 109.177 -177.93 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 139' ' ' LEU . . . . . 1.031 HD11 ' HA ' ' B' ' 136' ' ' ASP . 0.3 OUTLIER -66.88 -28.02 67.99 Favored 'General case' 0 C--O 1.211 -0.96 0 CA-C-N 114.383 -1.28 . . . . 0.0 110.996 -179.942 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 140' ' ' ASN . . . . . 0.721 ' O ' ' HB ' ' B' ' 143' ' ' ILE . 11.1 t30 -75.98 -25.77 56.13 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.712 0.768 . . . . 0.0 110.029 -177.461 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 141' ' ' LYS . . . . . 0.522 ' HG2' ' O ' ' B' ' 138' ' ' ARG . 10.5 ptmt -84.34 -31.39 24.84 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.364 -0.835 . . . . 0.0 109.649 -179.477 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 142' ' ' VAL . . . . . 0.827 HG11 ' HB2' ' B' ' 103' ' ' TYR . 9.6 p -70.22 -33.68 55.58 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.119 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 170.583 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 143' ' ' ILE . . . . . 0.88 HG12 ' O ' ' B' ' 139' ' ' LEU . 29.5 mm -47.84 -61.87 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.376 0 CA-C-O 121.463 0.649 . . . . 0.0 109.375 166.514 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 144' ' ' SER . . . . . . . . . . . . . 25.4 m -49.27 -44.38 43.86 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 114.545 -1.207 . . . . 0.0 112.355 177.953 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 145' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -70.88 -30.36 66.71 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 112.368 0.507 . . . . 0.0 112.368 -177.606 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 146' ' ' LEU . . . . . 0.683 HD12 ' CG ' ' B' ' 107' ' ' TYR . 5.3 mt -93.55 -17.88 22.86 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.346 -0.541 . . . . 0.0 111.023 -177.763 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 147' ' ' ASN . . . . . . . . . . . . . 39.3 t30 -57.79 115.46 2.84 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.08 -177.702 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . 104.27 15.93 20.0 Favored Glycine 0 N--CA 1.448 -0.536 0 CA-C-N 115.745 -0.662 . . . . 0.0 112.518 -179.248 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 149' ' ' LYS . . . . . 0.428 ' HB2' ' O ' ' B' ' 146' ' ' LEU . 0.6 OUTLIER -112.6 158.59 19.78 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.599 0.238 . . . . 0.0 110.659 179.11 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 150' ' ' ASN . . . . . 0.536 ' O ' HG23 ' B' ' 154' ' ' VAL . 25.9 t-20 -97.7 95.87 7.87 Favored 'General case' 0 CA--C 1.511 -0.529 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 175.523 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 151' ' ' ILE . . . . . 0.836 HG13 HD12 ' B' ' 108' ' ' LEU . 1.8 mp -43.61 -60.79 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 O-C-N 124.621 1.2 . . . . 0.0 113.148 -169.4 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 152' ' ' GLU . . . . . 0.409 ' N ' HG22 ' B' ' 151' ' ' ILE . 47.0 mt-10 -56.2 -39.93 73.19 Favored 'General case' 0 C--O 1.212 -0.87 0 N-CA-C 111.708 0.262 . . . . 0.0 111.708 -174.426 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 153' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -74.56 -26.4 59.93 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 120.707 -0.397 . . . . 0.0 110.96 -179.051 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 154' ' ' VAL . . . . . 0.816 ' HB ' HD12 ' B' ' 155' ' ' ILE . 53.9 t -59.56 -50.06 81.36 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 170.172 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 155' ' ' ILE . . . . . 0.816 HD12 ' HB ' ' B' ' 154' ' ' VAL . 3.0 mp -107.47 34.29 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.19 -177.05 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . -95.77 -4.29 44.21 Favored 'General case' 0 C--N 1.309 -1.157 0 N-CA-C 107.505 -1.294 . . . . 0.0 107.505 169.51 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 157' ' ' GLN . . . . . . . . . . . . . 70.0 mm-40 -135.63 -27.83 1.14 Allowed 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 113.289 -1.778 . . . . 0.0 110.682 175.415 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 158' ' ' GLY . . . . . . . . . . . . . . . -105.85 46.56 1.16 Allowed Glycine 0 C--O 1.222 -0.595 0 CA-C-O 119.581 -0.566 . . . . 0.0 114.511 -171.377 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 159' ' ' ILE . . . . . 0.648 ' HB ' ' CD1' ' A' ' 60' ' ' ILE . 1.8 mp -56.5 -24.0 18.01 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.094 0 CA-C-N 117.385 0.593 . . . . 0.0 110.876 176.043 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 160' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.694 0 C-N-CA 120.835 -0.698 . . . . 0.0 111.805 179.382 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' SER . . . . . 0.538 ' HB2' ' OE1' ' A' ' 6' ' ' GLU . 0.7 OUTLIER . . . . . 0 N--CA 1.448 -0.556 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 . . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.548 HG13 ' HG ' ' B' ' 112' ' ' LEU . 2.1 t -51.77 -22.86 2.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-N 114.189 -1.368 . . . . 0.0 112.825 -177.215 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' SER . . . . . 0.523 ' HB3' ' HA ' ' A' ' 39' ' ' VAL . 16.8 m -71.32 -58.22 3.74 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 179.162 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.542 ' O ' HG13 ' A' ' 10' ' ' ILE . 2.3 mp0 -54.69 -52.45 62.36 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.657 176.004 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.875 ' HA ' HD12 ' A' ' 10' ' ' ILE . 3.6 tp -56.42 -37.14 69.79 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 115.344 -0.843 . . . . 0.0 112.503 179.782 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.64 ' HB2' HD23 ' B' ' 112' ' ' LEU . . . -70.04 -33.38 71.9 Favored 'General case' 0 N--CA 1.468 0.447 0 O-C-N 122.007 -0.433 . . . . 0.0 110.849 179.059 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.605 ' HB2' HG11 ' A' ' 39' ' ' VAL . 8.2 t -70.32 -38.7 74.97 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 177.686 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.875 HD12 ' HA ' ' A' ' 7' ' ' LEU . 67.4 mt -49.22 -55.88 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.74 0 CA-C-N 114.071 -1.422 . . . . 0.0 109.661 170.679 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.672 ' OH ' ' HB ' ' B' ' 155' ' ' ILE . 23.1 m-85 -67.59 -44.18 78.76 Favored 'General case' 0 C--O 1.22 -0.458 0 CA-C-N 115.771 -0.65 . . . . 0.0 112.164 -173.043 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.0 p -54.56 -46.06 73.58 Favored 'General case' 0 C--O 1.243 0.754 0 CA-C-O 121.447 0.642 . . . . 0.0 109.802 177.305 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.04 -36.94 78.39 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.57 172.92 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.646 HD22 HD11 ' A' ' 56' ' ' ILE . 0.2 OUTLIER -60.84 -55.85 28.2 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.264 -179.537 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.465 HG12 ' O ' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -52.85 -44.81 49.54 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.54 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 177.612 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.543 HD21 ' HA ' ' A' ' 23' ' ' VAL . 3.4 tp -54.7 -35.6 63.8 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.282 178.135 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' HIS . . . . . 0.483 ' NE2' HD22 ' A' ' 51' ' ' LEU . 30.5 m-70 -83.48 -14.71 51.84 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 177.574 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -76.4 -33.69 58.85 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.314 0.578 . . . . 0.0 109.593 -178.676 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.818 ' HB2' HG23 ' B' ' 132' ' ' ILE . 15.1 t70 -96.07 -12.34 25.0 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 174.625 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 55.24 50.05 15.91 Favored 'General case' 0 CA--C 1.518 -0.274 0 CA-C-N 113.861 -1.518 . . . . 0.0 109.979 -175.191 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.624 HG22 ' H ' ' A' ' 22' ' ' THR . 7.9 p -108.08 175.08 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.321 0 CA-C-N 114.589 -1.187 . . . . 0.0 109.286 -174.204 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.624 ' H ' HG22 ' A' ' 21' ' ' VAL . 63.2 p -54.53 137.61 42.66 Favored 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 113.606 0.965 . . . . 0.0 113.606 -170.929 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.572 HG12 ' HA ' ' A' ' 48' ' ' ALA . 54.0 t -104.91 109.01 26.28 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.758 0 CA-C-N 114.182 -1.372 . . . . 0.0 110.469 -177.484 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.591 ' OG1' ' HB2' ' A' ' 27' ' ' LYS . 82.4 p -144.77 155.8 43.72 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.719 -179.429 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 49.7 tt0 -57.2 -41.7 79.87 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.429 -0.351 . . . . 0.0 110.748 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -66.7 -27.42 67.63 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-O 120.962 0.41 . . . . 0.0 110.449 179.547 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.591 ' HB2' ' OG1' ' A' ' 24' ' ' THR . 3.3 tppt? -71.12 -52.17 20.88 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 -179.195 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 45.9 mt -58.98 -38.65 74.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 114.547 -1.206 . . . . 0.0 110.401 176.685 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 7.8 m-20 -58.02 -43.5 86.77 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.868 173.826 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -58.02 -46.61 85.01 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.675 178.015 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.592 ' HB3' HD21 ' B' ' 109' ' ' LEU . 1.3 mm? -59.03 -51.99 67.7 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 121.045 0.45 . . . . 0.0 110.65 175.495 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.617 HG23 ' O ' ' A' ' 37' ' ' VAL . 56.0 mt -49.91 -51.19 17.15 Favored 'Isoleucine or valine' 0 C--O 1.239 0.543 0 CA-C-N 115.155 -0.929 . . . . 0.0 111.916 -178.842 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.606 ' HD2' HG22 ' A' ' 32' ' ' ILE . 14.0 mptt -77.16 -28.14 54.02 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.66 -0.7 . . . . 0.0 112.103 -175.598 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -68.45 -41.43 80.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.902 0.382 . . . . 0.0 110.525 177.464 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -79.26 -38.65 34.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.255 0.55 . . . . 0.0 110.858 178.231 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 101.15 16.94 23.98 Favored Glycine 0 N--CA 1.447 -0.614 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.848 -179.313 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.906 ' HB ' ' HA2' ' B' ' 113' ' ' GLY . 3.0 p -121.11 121.17 64.24 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.423 0 CA-C-O 121.241 0.543 . . . . 0.0 110.827 -177.264 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.528 ' HA ' HG23 ' A' ' 32' ' ' ILE . 8.0 t-20 -100.59 167.65 10.21 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.153 -0.931 . . . . 0.0 110.869 -171.356 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.605 HG11 ' HB2' ' A' ' 9' ' ' CYS . 94.7 t -132.79 165.07 33.47 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 CA-C-N 115.01 -0.996 . . . . 0.0 110.477 -170.585 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.549 ' HB3' ' HD1' ' A' ' 43' ' ' TRP . 4.7 tp10 -68.44 108.07 2.53 Favored Pre-proline 0 N--CA 1.444 -0.726 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 168.353 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.489 ' C ' ' HD2' ' A' ' 44' ' ' PRO . 81.1 Cg_exo -51.77 -28.77 31.55 Favored 'Trans proline' 0 C--O 1.251 1.145 0 C-N-CA 123.582 2.855 . . . . 0.0 115.855 -164.243 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -61.41 -27.77 68.78 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 120.39 -0.524 . . . . 0.0 109.627 177.562 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' TRP . . . . . 0.568 ' CE3' ' HE1' ' A' ' 47' ' ' PHE . 14.1 m95 -64.46 -60.63 8.08 Favored Pre-proline 0 C--O 1.206 -1.222 0 CA-C-O 118.467 -0.778 . . . . 0.0 110.914 176.566 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.517 ' HD3' ' HB2' ' A' ' 43' ' ' TRP . 96.8 Cg_exo -46.13 -44.37 19.55 Favored 'Trans proline' 0 C--N 1.359 1.13 0 C-N-CA 121.811 1.674 . . . . 0.0 111.88 175.176 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -58.7 -62.24 6.47 Favored Glycine 0 CA--C 1.525 0.684 0 C-N-CA 120.187 -1.006 . . . . 0.0 112.631 176.428 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.411 ' O ' ' HB2' ' A' ' 49' ' ' LYS . 4.2 tp -64.44 -32.31 73.89 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 123.081 0.552 . . . . 0.0 111.99 -176.789 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.568 ' HE1' ' CE3' ' A' ' 43' ' ' TRP . 3.2 m-85 -61.81 -50.69 71.31 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 120.826 0.346 . . . . 0.0 110.089 175.483 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.572 ' HA ' HG12 ' A' ' 23' ' ' VAL . . . -66.37 -28.58 68.76 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.572 0.701 . . . . 0.0 109.891 -178.645 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.411 ' HB2' ' O ' ' A' ' 46' ' ' LEU . 9.4 mmmt -65.66 -51.08 62.25 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 114.546 -1.206 . . . . 0.0 112.08 174.538 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.41 ' O ' HG22 ' A' ' 54' ' ' VAL . . . -88.36 -36.69 16.45 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 113.215 0.821 . . . . 0.0 113.215 -169.471 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.511 ' HB2' HG11 ' A' ' 23' ' ' VAL . 24.0 mt -68.65 -0.7 5.53 Favored 'General case' 0 N--CA 1.464 0.227 0 N-CA-C 112.456 0.539 . . . . 0.0 112.456 -172.963 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -84.96 -1.75 57.08 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.818 0.342 . . . . 0.0 110.307 173.758 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 9.6 t30 -143.97 -39.66 0.29 Allowed 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.228 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.41 HG22 ' O ' ' A' ' 50' ' ' ALA . 6.4 m -82.27 -171.49 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 178.309 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 18.3 m120 -121.32 175.93 5.9 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.044 0.45 . . . . 0.0 110.758 177.58 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.646 HD11 HD22 ' A' ' 14' ' ' LEU . 4.3 tp -75.78 -26.22 17.78 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 177.69 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -72.64 -9.52 74.44 Favored Glycine 0 N--CA 1.445 -0.713 0 N-CA-C 111.058 -0.817 . . . . 0.0 111.058 175.167 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 21.2 m -80.48 -24.56 39.37 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-O 121.346 0.593 . . . . 0.0 109.523 177.045 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.47 HD11 HD12 ' A' ' 56' ' ' ILE . 24.9 mt -60.79 -32.83 72.16 Favored 'General case' 0 CA--C 1.517 -0.304 0 CA-C-N 115.443 -0.798 . . . . 0.0 110.957 -178.848 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.613 ' CD1' ' HB ' ' B' ' 159' ' ' ILE . 0.1 OUTLIER . . . . . 0 C--N 1.316 -0.878 0 CA-C-N 114.786 -1.097 . . . . 0.0 111.18 -177.999 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 103' ' ' TYR . . . . . 0.614 ' HB2' HG11 ' B' ' 142' ' ' VAL . 39.6 m-85 . . . . . 0 N--CA 1.478 0.944 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 104' ' ' VAL . . . . . 0.478 HG12 ' CD2' ' B' ' 108' ' ' LEU . 96.1 t -44.42 -46.45 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 CA-C-O 121.864 0.84 . . . . 0.0 109.391 174.153 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 105' ' ' ALA . . . . . 0.638 ' CB ' ' HB3' ' A' ' 14' ' ' LEU . . . -66.8 -38.47 86.57 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-N 114.288 -1.324 . . . . 0.0 112.226 -173.984 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 106' ' ' SER . . . . . 0.737 ' HB2' HG23 ' B' ' 123' ' ' ILE . 3.2 m -63.82 -37.86 88.96 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-O 121.625 0.726 . . . . 0.0 109.611 178.536 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 107' ' ' TYR . . . . . 0.736 ' O ' ' HG2' ' B' ' 118' ' ' PRO . 33.1 t80 -62.28 -49.57 75.14 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 114.684 -1.144 . . . . 0.0 108.316 177.549 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 108' ' ' LEU . . . . . 0.855 HD12 HG13 ' B' ' 151' ' ' ILE . 0.0 OUTLIER -56.28 -47.49 78.5 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 114.542 -1.208 . . . . 0.0 111.313 177.866 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 109' ' ' LEU . . . . . 0.62 HD13 ' HB2' ' A' ' 11' ' ' TYR . 8.9 tp -56.6 -47.75 78.93 Favored 'General case' 0 CA--C 1.515 -0.398 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.908 179.759 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 110' ' ' ALA . . . . . 0.421 ' HB3' ' HB3' ' B' ' 118' ' ' PRO . . . -64.26 -39.76 94.62 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.583 -0.447 . . . . 0.0 110.985 -177.149 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 111' ' ' ALA . . . . . 0.68 ' HA ' ' O ' ' B' ' 115' ' ' ASN . . . -66.66 -28.89 68.83 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.53 179.862 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 112' ' ' LEU . . . . . 0.64 HD23 ' HB2' ' A' ' 8' ' ' ALA . 1.8 mp -80.37 -34.85 36.13 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.35 175.558 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 113' ' ' GLY . . . . . 0.906 ' HA2' ' HB ' ' A' ' 37' ' ' VAL . . . -64.15 -25.05 69.32 Favored Glycine 0 CA--C 1.504 -0.619 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.814 179.363 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 114' ' ' GLY . . . . . . . . . . . . . . . 144.17 -4.73 1.6 Allowed Glycine 0 N--CA 1.436 -1.326 0 C-N-CA 120.25 -0.976 . . . . 0.0 112.993 176.604 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 115' ' ' ASN . . . . . 0.68 ' O ' ' HA ' ' B' ' 111' ' ' ALA . 19.0 t-20 -117.06 90.83 3.42 Favored 'General case' 0 CA--C 1.507 -0.688 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 -176.236 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 7.5 p -77.44 23.64 0.21 Allowed 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.062 -0.972 . . . . 0.0 111.836 -164.853 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 117' ' ' SER . . . . . 0.546 ' N ' ' HD3' ' B' ' 118' ' ' PRO . 8.5 t -164.92 66.93 1.25 Allowed Pre-proline 0 C--N 1.311 -1.092 0 CA-C-N 114.293 -1.321 . . . . 0.0 108.664 179.648 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 118' ' ' PRO . . . . . 0.736 ' HG2' ' O ' ' B' ' 107' ' ' TYR . 33.9 Cg_exo -64.56 157.8 53.32 Favored 'Trans proline' 0 C--N 1.328 -0.517 1 C-N-CA 125.444 4.096 . . . . 0.0 112.351 -174.091 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 119' ' ' SER . . . . . 0.63 ' O ' HG12 ' B' ' 123' ' ' ILE . 27.2 m -126.02 -175.56 3.39 Favored 'General case' 0 C--N 1.316 -0.856 0 C-N-CA 120.597 -0.441 . . . . 0.0 110.943 177.076 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 120' ' ' ALA . . . . . 0.863 ' HB1' HD13 ' B' ' 139' ' ' LEU . . . -67.84 -35.24 78.24 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 122.214 1.007 . . . . 0.0 110.014 -166.532 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 121' ' ' LYS . . . . . 0.473 ' HD2' ' N ' ' B' ' 121' ' ' LYS . 4.4 mptp? -74.24 -26.76 60.42 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 113.681 -1.6 . . . . 0.0 109.756 -179.07 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 122' ' ' ASP . . . . . . . . . . . . . 25.8 m-20 -72.57 -41.31 65.85 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 174.767 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 123' ' ' ILE . . . . . 0.737 HG23 ' HB2' ' B' ' 106' ' ' SER . 36.8 mm -54.11 -48.05 65.78 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.368 0 CA-C-N 114.988 -1.005 . . . . 0.0 109.489 173.655 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 124' ' ' LYS . . . . . 0.867 ' HD2' HD11 ' B' ' 127' ' ' LEU . 2.7 mmmt -62.58 -40.71 97.75 Favored 'General case' 0 N--CA 1.439 -1.011 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.785 -176.545 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 125' ' ' LYS . . . . . . . . . . . . . 42.0 mmtt -50.65 -62.68 1.45 Allowed 'General case' 0 CA--C 1.498 -1.023 0 CA-C-O 121.776 0.798 . . . . 0.0 111.367 170.421 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 126' ' ' ILE . . . . . . . . . . . . . 1.7 mp -56.77 -41.48 75.35 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 CA-C-N 113.756 -1.565 . . . . 0.0 110.758 -169.733 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 127' ' ' LEU . . . . . 0.867 HD11 ' HD2' ' B' ' 124' ' ' LYS . 3.9 pp -79.08 -32.73 44.79 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 -178.548 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 128' ' ' ASP . . . . . 0.513 ' HB2' ' O ' ' B' ' 124' ' ' LYS . 0.6 OUTLIER -70.24 -24.78 63.14 Favored 'General case' 0 CA--C 1.517 -0.323 0 C-N-CA 121.326 -0.15 . . . . 0.0 111.261 -177.587 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 129' ' ' SER . . . . . . . . . . . . . 93.7 p -56.72 -37.19 70.6 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-O 120.928 0.394 . . . . 0.0 111.2 176.722 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 130' ' ' VAL . . . . . 0.784 HG23 HG13 ' B' ' 132' ' ' ILE . 13.0 m -104.69 -2.9 9.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.391 179.471 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 131' ' ' GLY . . . . . . . . . . . . . . . 81.01 36.04 22.76 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 121.029 -0.605 . . . . 0.0 112.882 177.328 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 132' ' ' ILE . . . . . 0.818 HG23 ' HB2' ' A' ' 19' ' ' ASP . 18.6 mt -78.86 131.94 33.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 110.443 -0.206 . . . . 0.0 110.443 177.402 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 133' ' ' GLU . . . . . . . . . . . . . 87.5 mt-10 -77.0 125.24 29.0 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.361 0.6 . . . . 0.0 110.663 -176.197 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 134' ' ' ALA . . . . . 0.491 ' HA ' ' OH ' ' B' ' 103' ' ' TYR . . . -134.99 143.7 46.97 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.381 -0.827 . . . . 0.0 112.135 -173.202 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 135' ' ' ASP . . . . . 0.774 ' HB2' ' HG3' ' B' ' 138' ' ' ARG . 16.2 m-20 -103.11 132.43 49.37 Favored 'General case' 0 C--O 1.252 1.223 0 CA-C-N 115.65 -0.704 . . . . 0.0 109.358 170.515 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 136' ' ' ASP . . . . . 0.987 ' HA ' HD11 ' B' ' 139' ' ' LEU . 17.4 t70 -73.8 -8.61 56.69 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.061 -166.965 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 137' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -96.11 -29.77 13.9 Favored 'General case' 0 N--CA 1.44 -0.953 0 C-N-CA 120.17 -0.612 . . . . 0.0 110.54 174.374 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 138' ' ' ARG . . . . . 0.774 ' HG3' ' HB2' ' B' ' 135' ' ' ASP . 12.8 mmt180 -68.26 -52.12 37.41 Favored 'General case' 0 CA--C 1.503 -0.86 0 CA-C-O 122.176 0.988 . . . . 0.0 108.665 -175.595 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 139' ' ' LEU . . . . . 0.987 HD11 ' HA ' ' B' ' 136' ' ' ASP . 0.4 OUTLIER -67.47 -30.3 69.97 Favored 'General case' 0 C--O 1.209 -1.038 0 CA-C-N 114.024 -1.444 . . . . 0.0 110.878 -179.528 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 140' ' ' ASN . . . . . 0.624 ' O ' ' HB ' ' B' ' 143' ' ' ILE . 12.1 t30 -75.94 -25.41 55.92 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.591 0.71 . . . . 0.0 109.805 -177.929 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 141' ' ' LYS . . . . . 0.524 ' HG2' ' O ' ' B' ' 138' ' ' ARG . 2.6 ptmm? -77.94 -38.55 45.13 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 179.056 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 142' ' ' VAL . . . . . 0.628 HG12 ' O ' ' B' ' 139' ' ' LEU . 7.2 p -69.38 -32.98 55.38 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.401 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 175.05 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 143' ' ' ILE . . . . . 0.878 HG12 ' O ' ' B' ' 139' ' ' LEU . 23.5 mm -49.14 -62.56 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.512 -0.486 0 CA-C-O 121.41 0.624 . . . . 0.0 110.001 166.98 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 144' ' ' SER . . . . . . . . . . . . . 47.4 t -54.08 -34.2 59.52 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 114.608 -1.178 . . . . 0.0 111.695 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 145' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -79.52 -30.79 42.02 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.426 0.528 . . . . 0.0 112.426 -178.767 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 146' ' ' LEU . . . . . 0.72 HD12 ' CG ' ' B' ' 107' ' ' TYR . 6.6 mt -89.55 -31.79 17.44 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.63 -0.428 . . . . 0.0 110.99 179.021 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 147' ' ' ASN . . . . . 0.489 ' HA ' ' OH ' ' B' ' 107' ' ' TYR . 8.3 t30 -40.52 120.34 1.23 Allowed 'General case' 0 N--CA 1.471 0.587 0 O-C-N 124.079 0.862 . . . . 0.0 112.838 -169.941 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . 90.89 36.36 6.79 Favored Glycine 0 N--CA 1.447 -0.57 0 CA-C-N 115.342 -0.844 . . . . 0.0 111.905 -177.7 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 149' ' ' LYS . . . . . 0.684 ' HB2' ' O ' ' B' ' 146' ' ' LEU . 5.2 tppt? -116.92 159.29 22.66 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 110.231 -0.285 . . . . 0.0 110.231 -177.45 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 150' ' ' ASN . . . . . 0.573 ' O ' HG23 ' B' ' 154' ' ' VAL . 92.5 m-20 -106.19 89.95 3.21 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 177.056 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 151' ' ' ILE . . . . . 0.855 HG13 HD12 ' B' ' 108' ' ' LEU . 1.8 mp -46.69 -61.87 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 114.223 -1.353 . . . . 0.0 113.604 -166.797 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 152' ' ' GLU . . . . . 0.454 ' O ' ' HB2' ' B' ' 156' ' ' ALA . 22.5 mt-10 -53.96 -34.1 58.75 Favored 'General case' 0 C--O 1.216 -0.672 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 -173.281 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 153' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -81.36 -32.94 32.69 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 120.744 -0.382 . . . . 0.0 110.794 -179.575 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 154' ' ' VAL . . . . . 0.885 ' HB ' HD12 ' B' ' 155' ' ' ILE . 40.0 t -53.26 -48.83 54.73 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 169.828 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 155' ' ' ILE . . . . . 0.885 HD12 ' HB ' ' B' ' 154' ' ' VAL . 1.5 mp -108.5 38.6 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.005 -0.998 . . . . 0.0 110.893 -178.069 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 156' ' ' ALA . . . . . 0.454 ' HB2' ' O ' ' B' ' 152' ' ' GLU . . . -99.25 7.14 45.97 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 107.115 -1.439 . . . . 0.0 107.115 166.179 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 157' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -143.05 -43.83 0.3 Allowed 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 112.844 -1.98 . . . . 0.0 109.459 175.748 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 158' ' ' GLY . . . . . . . . . . . . . . . -86.57 47.2 3.69 Favored Glycine 0 CA--C 1.521 0.46 0 CA-C-N 115.439 -0.801 . . . . 0.0 114.217 -173.577 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 159' ' ' ILE . . . . . 0.613 ' HB ' ' CD1' ' A' ' 60' ' ' ILE . 1.8 mp -63.63 -14.6 15.04 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 CA-C-O 121.8 0.81 . . . . 0.0 110.104 176.395 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 160' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.441 -0.994 0 N-CA-C 110.349 -1.1 . . . . 0.0 110.349 179.648 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 12.0 m . . . . . 0 N--CA 1.449 -0.477 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.777 HG13 ' HG ' ' B' ' 112' ' ' LEU . 2.0 t -47.05 -28.61 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.254 -0.884 . . . . 0.0 113.38 -177.027 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' SER . . . . . 0.905 ' HB3' ' HA ' ' A' ' 39' ' ' VAL . 69.1 m -70.64 -50.93 31.59 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.864 0.84 . . . . 0.0 109.001 176.278 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.481 ' O ' HG13 ' A' ' 10' ' ' ILE . 40.4 tt0 -57.31 -51.18 70.41 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 114.598 -1.183 . . . . 0.0 109.81 176.454 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.95 HD12 HD12 ' A' ' 10' ' ' ILE . 5.7 tp -58.9 -36.28 74.44 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.547 177.568 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.586 ' HB2' HD23 ' B' ' 112' ' ' LEU . . . -66.65 -35.99 81.49 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 121.199 0.523 . . . . 0.0 110.889 178.532 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.541 ' HB2' HG11 ' A' ' 39' ' ' VAL . 7.4 t -68.0 -42.97 79.9 Favored 'General case' 0 C--O 1.242 0.687 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 179.027 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.95 HD12 HD12 ' A' ' 7' ' ' LEU . 72.0 mt -46.34 -56.77 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.605 0 CA-C-N 113.669 -1.605 . . . . 0.0 109.982 170.984 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.871 ' HB2' HD13 ' B' ' 109' ' ' LEU . 23.9 m-85 -64.3 -36.76 85.15 Favored 'General case' 0 CA--C 1.512 -0.484 0 CA-C-N 115.441 -0.799 . . . . 0.0 111.271 -174.983 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.465 ' HA ' ' HG ' ' A' ' 31' ' ' LEU . 18.9 m -56.97 -42.93 81.05 Favored 'General case' 0 C--O 1.243 0.712 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 177.574 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.418 ' HB2' HD11 ' A' ' 51' ' ' LEU . . . -67.17 -31.97 72.74 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.195 175.846 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.734 HD22 HD11 ' A' ' 56' ' ' ILE . 0.3 OUTLIER -63.58 -54.3 38.2 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.316 179.689 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.542 HG12 ' O ' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -60.23 -35.85 64.65 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.412 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 178.868 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.507 ' HA ' HD12 ' A' ' 16' ' ' LEU . 2.3 tp -59.85 -36.06 76.06 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.904 175.616 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' HIS . . . . . 0.524 ' CD2' ' HB ' ' A' ' 56' ' ' ILE . 70.2 m-70 -73.12 -18.7 61.26 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 116.145 -0.48 . . . . 0.0 112.254 176.479 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -59.37 -38.48 80.56 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 121.074 0.464 . . . . 0.0 110.171 179.818 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.441 ' CB ' HG12 ' B' ' 132' ' ' ILE . 32.0 t70 -111.25 -4.75 14.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.822 0.82 . . . . 0.0 109.827 176.92 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.462 ' HG2' ' O ' ' A' ' 17' ' ' HIS . 5.5 mm-40 53.1 48.38 22.39 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-N 114.446 -1.252 . . . . 0.0 110.266 -175.398 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.755 HG22 ' H ' ' A' ' 22' ' ' THR . 13.8 p -100.84 -179.55 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.156 0 CA-C-N 114.903 -1.044 . . . . 0.0 109.966 -170.327 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.755 ' H ' HG22 ' A' ' 21' ' ' VAL . 32.6 p -50.2 141.8 10.82 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 113.608 0.966 . . . . 0.0 113.608 -173.456 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.642 HG12 ' HA ' ' A' ' 48' ' ' ALA . 58.3 t -118.86 111.01 31.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 114.343 -1.298 . . . . 0.0 110.332 -175.2 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.542 ' OG1' ' HE2' ' A' ' 27' ' ' LYS . 77.0 p -143.54 156.67 44.67 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.002 177.84 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -56.64 -40.23 75.06 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.954 0.407 . . . . 0.0 110.259 177.309 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -56.95 -39.26 74.21 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.294 173.314 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.542 ' HE2' ' OG1' ' A' ' 24' ' ' THR . 1.6 tppt? -63.31 -52.04 63.53 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-O 121.94 0.876 . . . . 0.0 109.093 -179.178 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 27.8 mt -61.0 -38.96 80.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 114.628 -1.169 . . . . 0.0 110.72 179.144 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 11.3 m-80 -61.27 -35.49 77.43 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.782 175.782 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.91 -47.92 78.67 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.513 176.972 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.766 ' HB3' HD21 ' B' ' 109' ' ' LEU . 1.2 mm? -58.01 -50.13 74.46 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 121.113 0.482 . . . . 0.0 110.418 174.945 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.626 HG23 ' O ' ' A' ' 37' ' ' VAL . 57.7 mt -48.34 -48.18 13.77 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 CA-C-N 115.039 -0.982 . . . . 0.0 111.925 178.387 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 22.8 tptm -75.95 -38.82 57.15 Favored 'General case' 0 N--CA 1.433 -1.306 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.799 -174.343 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -67.39 -33.59 75.52 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.964 0.411 . . . . 0.0 110.787 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.529 ' CB ' ' HG ' ' B' ' 109' ' ' LEU . . . -82.44 -36.57 26.49 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.856 177.625 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 97.29 18.15 29.57 Favored Glycine 0 N--CA 1.447 -0.591 0 CA-C-N 115.733 -0.667 . . . . 0.0 112.017 179.483 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.891 ' HB ' ' HA2' ' B' ' 113' ' ' GLY . 2.7 p -121.91 120.84 62.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 121.583 0.706 . . . . 0.0 111.104 -176.216 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -93.69 155.22 17.37 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 114.504 -1.226 . . . . 0.0 110.891 -170.599 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.905 ' HA ' ' HB3' ' A' ' 5' ' ' SER . 97.8 t -127.22 161.3 34.72 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-N 115.102 -0.954 . . . . 0.0 110.593 -170.987 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.511 ' HB3' ' HD1' ' A' ' 43' ' ' TRP . 3.8 tp10 -67.55 105.49 0.92 Allowed Pre-proline 0 N--CA 1.444 -0.731 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 170.882 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.49 ' C ' ' HD2' ' A' ' 44' ' ' PRO . 76.9 Cg_exo -50.93 -30.5 30.69 Favored 'Trans proline' 0 C--O 1.252 1.175 0 C-N-CA 123.599 2.866 . . . . 0.0 115.6 -163.657 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.402 ' CE2' ' HG2' ' A' ' 40' ' ' GLU . 0.8 OUTLIER -60.04 -28.3 67.65 Favored 'General case' 0 C--N 1.334 -0.097 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 178.167 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 43' ' ' TRP . . . . . 0.511 ' HD1' ' HB3' ' A' ' 40' ' ' GLU . 7.9 m95 -62.82 -61.66 7.09 Favored Pre-proline 0 C--O 1.205 -1.24 0 CA-C-O 118.27 -0.871 . . . . 0.0 110.725 176.56 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.49 ' HD2' ' C ' ' A' ' 41' ' ' PRO . 99.3 Cg_exo -44.98 -46.24 13.27 Favored 'Trans proline' 0 C--N 1.36 1.145 0 C-N-CA 121.811 1.674 . . . . 0.0 111.981 175.346 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -59.12 -61.58 7.18 Favored Glycine 0 CA--C 1.525 0.68 0 C-N-CA 120.172 -1.013 . . . . 0.0 112.491 177.771 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 4.5 tp -67.08 -22.61 65.83 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 122.887 0.475 . . . . 0.0 111.714 -176.75 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.461 ' HD2' HD11 ' A' ' 51' ' ' LEU . 2.0 m-85 -69.76 -46.41 65.88 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 175.895 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.642 ' HA ' HG12 ' A' ' 23' ' ' VAL . . . -65.05 -32.22 73.83 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.805 0.812 . . . . 0.0 109.237 178.216 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 11.1 mmmt -66.72 -49.44 66.03 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 114.303 -1.317 . . . . 0.0 111.938 174.773 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -84.74 -34.75 22.81 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 113.3 0.852 . . . . 0.0 113.3 -169.915 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.503 ' HB2' HG11 ' A' ' 23' ' ' VAL . 9.7 mt -67.07 -0.8 3.51 Favored 'General case' 0 N--CA 1.462 0.165 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 -175.281 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -85.89 -14.99 43.18 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.974 0.416 . . . . 0.0 110.353 174.852 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 91.8 m-20 -123.05 -49.89 1.94 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.717 -179.745 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 3.8 m -88.28 166.97 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.584 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.399 -179.242 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 -113.95 179.38 3.97 Favored 'General case' 0 C--N 1.312 -1.023 0 C-N-CA 120.475 -0.49 . . . . 0.0 109.783 176.948 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.734 HD11 HD22 ' A' ' 14' ' ' LEU . 4.6 tp -64.16 -25.35 37.86 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 CA-C-O 120.868 0.366 . . . . 0.0 111.025 -176.345 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -70.47 -15.26 72.79 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.631 -0.795 . . . . 0.0 111.151 178.132 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 33.3 t -78.64 -20.98 49.08 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-O 120.911 0.386 . . . . 0.0 110.184 179.544 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.733 ' HB2' HG21 ' B' ' 159' ' ' ILE . 20.9 mt -65.98 -26.96 67.8 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.859 0.838 . . . . 0.0 110.482 -178.976 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.706 HG13 ' HB ' ' B' ' 159' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--N 1.317 -0.819 0 CA-C-N 114.418 -1.264 . . . . 0.0 110.509 178.685 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 103' ' ' TYR . . . . . 0.887 ' HB2' HG11 ' B' ' 142' ' ' VAL . 58.1 m-85 . . . . . 0 C--O 1.242 0.662 0 CA-C-O 121.023 0.439 . . . . 0.0 110.616 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 104' ' ' VAL . . . . . 0.729 ' HA ' HD11 ' B' ' 146' ' ' LEU . 90.2 t -45.0 -49.08 2.72 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.353 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.31 172.201 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 105' ' ' ALA . . . . . 0.67 ' HA ' HD22 ' B' ' 108' ' ' LEU . . . -62.86 -41.1 99.24 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.271 -1.331 . . . . 0.0 112.088 -174.323 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 106' ' ' SER . . . . . 0.872 ' HB2' HG23 ' B' ' 123' ' ' ILE . 1.0 OUTLIER -62.73 -38.92 92.42 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.58 0.705 . . . . 0.0 109.538 179.296 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 107' ' ' TYR . . . . . 0.696 ' CG ' HD12 ' B' ' 146' ' ' LEU . 39.5 t80 -62.04 -46.71 87.94 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 114.443 -1.253 . . . . 0.0 108.748 178.48 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 108' ' ' LEU . . . . . 0.832 HD12 HG13 ' B' ' 151' ' ' ILE . 0.0 OUTLIER -58.66 -46.92 86.12 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 114.409 -1.268 . . . . 0.0 111.088 177.882 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 109' ' ' LEU . . . . . 0.871 HD13 ' HB2' ' A' ' 11' ' ' TYR . 7.2 tp -55.43 -49.33 72.7 Favored 'General case' 0 CA--C 1.513 -0.474 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.793 179.672 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -62.76 -42.63 99.77 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.809 -177.625 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 111' ' ' ALA . . . . . 0.606 ' HA ' ' O ' ' B' ' 115' ' ' ASN . . . -65.64 -27.66 68.55 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.874 179.659 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 112' ' ' LEU . . . . . 0.777 ' HG ' HG13 ' A' ' 4' ' ' VAL . 2.3 mp -78.5 -37.79 42.35 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.007 175.351 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 113' ' ' GLY . . . . . 0.891 ' HA2' ' HB ' ' A' ' 37' ' ' VAL . . . -63.5 -38.88 97.01 Favored Glycine 0 CA--C 1.503 -0.657 0 CA-C-N 115.125 -0.943 . . . . 0.0 111.972 -179.038 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 114' ' ' GLY . . . . . . . . . . . . . . . 159.78 -4.08 0.1 Allowed Glycine 0 N--CA 1.44 -1.072 0 C-N-CA 120.144 -1.027 . . . . 0.0 113.029 177.456 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 115' ' ' ASN . . . . . 0.606 ' O ' ' HA ' ' B' ' 111' ' ' ALA . 45.0 t30 -116.18 86.04 2.41 Favored 'General case' 0 N--CA 1.44 -0.956 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 -176.571 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 116' ' ' SER . . . . . 0.482 ' HA ' ' CB ' ' B' ' 111' ' ' ALA . 3.3 m -78.56 28.46 0.2 Allowed 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 122.239 1.019 . . . . 0.0 110.763 -169.181 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 117' ' ' SER . . . . . 0.536 ' N ' ' HD3' ' B' ' 118' ' ' PRO . 22.7 t -166.19 67.3 1.05 Allowed Pre-proline 0 C--N 1.308 -1.222 0 CA-C-N 113.495 -1.684 . . . . 0.0 107.92 178.211 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 118' ' ' PRO . . . . . 0.635 ' HD2' ' CZ ' ' B' ' 107' ' ' TYR . 26.9 Cg_exo -67.36 165.35 27.24 Favored 'Trans proline' 0 C--O 1.235 0.36 1 C-N-CA 125.44 4.093 . . . . 0.0 112.257 -173.36 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 119' ' ' SER . . . . . 0.664 ' O ' HG12 ' B' ' 123' ' ' ILE . 96.9 p -130.82 -178.5 4.83 Favored 'General case' 0 C--N 1.319 -0.753 0 C-N-CA 120.464 -0.494 . . . . 0.0 110.784 176.258 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 120' ' ' ALA . . . . . 0.813 ' HB1' HD13 ' B' ' 139' ' ' LEU . . . -67.7 -37.75 82.72 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 122.117 0.96 . . . . 0.0 109.387 -172.886 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 121' ' ' LYS . . . . . 0.439 ' HD2' ' N ' ' B' ' 121' ' ' LYS . 0.5 OUTLIER -61.51 -36.26 80.03 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 113.588 -1.642 . . . . 0.0 109.944 176.046 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 122' ' ' ASP . . . . . 0.424 ' O ' ' HB2' ' B' ' 125' ' ' LYS . 16.8 t0 -71.94 -39.01 69.72 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 115.529 -0.76 . . . . 0.0 109.18 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 123' ' ' ILE . . . . . 0.872 HG23 ' HB2' ' B' ' 106' ' ' SER . 27.9 mm -59.93 -45.66 94.9 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 CA-C-N 115.43 -0.805 . . . . 0.0 109.847 175.243 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 124' ' ' LYS . . . . . 0.71 ' HD3' HD21 ' B' ' 139' ' ' LEU . 5.5 mmmp? -59.21 -41.62 89.03 Favored 'General case' 0 CA--C 1.501 -0.927 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.559 -178.771 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 125' ' ' LYS . . . . . 0.424 ' HB2' ' O ' ' B' ' 122' ' ' ASP . 43.5 mmtt -52.45 -63.49 1.13 Allowed 'General case' 0 CA--C 1.496 -1.111 0 CA-C-O 121.668 0.747 . . . . 0.0 111.502 172.793 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 126' ' ' ILE . . . . . . . . . . . . . 1.7 mp -55.3 -42.73 68.01 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.416 0 CA-C-N 113.963 -1.471 . . . . 0.0 111.368 -168.955 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 127' ' ' LEU . . . . . 0.713 ' HG ' ' O ' ' B' ' 123' ' ' ILE . 2.6 pp -82.04 -26.17 33.98 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.619 -0.433 . . . . 0.0 112.117 -177.901 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 128' ' ' ASP . . . . . 0.42 ' N ' HD12 ' B' ' 127' ' ' LEU . 20.4 t70 -71.83 -30.11 65.12 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 120.982 -0.287 . . . . 0.0 110.478 -179.283 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 129' ' ' SER . . . . . . . . . . . . . 90.2 p -52.81 -44.26 66.52 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.382 179.144 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 130' ' ' VAL . . . . . 0.417 ' CG2' HD12 ' B' ' 132' ' ' ILE . 12.7 m -88.03 -24.58 6.16 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 116.539 -0.301 . . . . 0.0 111.447 178.851 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 131' ' ' GLY . . . . . . . . . . . . . . . 109.74 25.06 5.58 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.306 -0.95 . . . . 0.0 113.175 176.04 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 132' ' ' ILE . . . . . 0.441 HG12 ' CB ' ' A' ' 19' ' ' ASP . 3.2 mt -85.26 132.82 30.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 116.943 0.371 . . . . 0.0 110.092 176.334 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 133' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -91.03 137.11 32.61 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.192 0.52 . . . . 0.0 110.457 -177.614 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 134' ' ' ALA . . . . . . . . . . . . . . . -143.14 143.83 31.97 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.608 -172.397 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 135' ' ' ASP . . . . . 0.759 ' HB2' ' CG ' ' B' ' 138' ' ' ARG . 4.1 m-20 -80.53 125.6 30.18 Favored 'General case' 0 C--O 1.258 1.523 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 172.998 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 136' ' ' ASP . . . . . 1.021 ' HA ' HD11 ' B' ' 139' ' ' LEU . 5.4 p-10 -72.11 2.06 6.43 Favored 'General case' 0 CA--C 1.514 -0.406 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.524 -173.261 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 137' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -102.93 -36.49 8.19 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.398 174.729 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 138' ' ' ARG . . . . . 0.759 ' CG ' ' HB2' ' B' ' 135' ' ' ASP . 24.9 mmt180 -67.23 -43.5 81.85 Favored 'General case' 0 CA--C 1.505 -0.766 0 CA-C-O 122.317 1.056 . . . . 0.0 108.626 -174.544 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 139' ' ' LEU . . . . . 1.021 HD11 ' HA ' ' B' ' 136' ' ' ASP . 0.4 OUTLIER -72.96 -32.29 65.13 Favored 'General case' 0 C--O 1.209 -1.053 0 CA-C-N 114.423 -1.262 . . . . 0.0 111.034 179.183 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 140' ' ' ASN . . . . . 0.581 ' O ' ' HB ' ' B' ' 143' ' ' ILE . 67.1 t30 -66.36 -25.53 66.85 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 122.29 1.043 . . . . 0.0 108.871 177.41 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 141' ' ' LYS . . . . . 0.513 ' HB3' ' O ' ' B' ' 138' ' ' ARG . 11.8 tppt? -70.4 -52.24 23.79 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 114.199 -1.364 . . . . 0.0 109.707 176.027 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 142' ' ' VAL . . . . . 0.887 HG11 ' HB2' ' B' ' 103' ' ' TYR . 7.9 p -61.82 -33.07 56.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.181 -0.463 . . . . 0.0 109.92 177.422 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 143' ' ' ILE . . . . . 0.87 HG12 ' O ' ' B' ' 139' ' ' LEU . 29.9 mm -50.24 -61.75 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.374 0 CA-C-O 121.426 0.632 . . . . 0.0 110.052 169.532 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 144' ' ' SER . . . . . . . . . . . . . 45.3 t -54.88 -32.26 60.68 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 114.331 -1.304 . . . . 0.0 111.716 -179.759 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 145' ' ' GLU . . . . . . . . . . . . . 68.4 mm-40 -80.01 -34.69 38.25 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.378 0.51 . . . . 0.0 112.378 -179.281 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 146' ' ' LEU . . . . . 0.729 HD11 ' HA ' ' B' ' 104' ' ' VAL . 7.2 mt -87.63 -19.99 26.97 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 121.021 -0.272 . . . . 0.0 110.832 -178.568 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 147' ' ' ASN . . . . . . . . . . . . . 37.7 t30 -53.97 108.79 0.39 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.13 -177.255 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . 108.99 18.99 8.84 Favored Glycine 0 N--CA 1.449 -0.436 0 CA-C-N 115.356 -0.838 . . . . 0.0 112.454 -179.283 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 149' ' ' LYS . . . . . 0.458 ' HB2' ' O ' ' B' ' 146' ' ' LEU . 0.2 OUTLIER -109.09 171.54 7.37 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.87 0.367 . . . . 0.0 110.646 -178.937 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 150' ' ' ASN . . . . . 0.591 ' O ' HG23 ' B' ' 154' ' ' VAL . 10.6 m-80 -110.24 89.12 2.93 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 178.423 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 151' ' ' ILE . . . . . 0.832 HG13 HD12 ' B' ' 108' ' ' LEU . 1.8 mp -41.87 -63.74 0.17 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.357 0 N-CA-C 113.775 1.028 . . . . 0.0 113.775 -166.447 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 152' ' ' GLU . . . . . 0.702 ' HG3' HD11 ' B' ' 112' ' ' LEU . 3.3 mp0 -59.85 -36.4 76.77 Favored 'General case' 0 C--O 1.209 -1.046 0 C-N-CA 120.508 -0.477 . . . . 0.0 111.105 -174.698 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 153' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -73.51 -27.72 61.51 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 120.73 0.3 . . . . 0.0 110.815 -179.329 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 154' ' ' VAL . . . . . 0.834 ' HB ' HD12 ' B' ' 155' ' ' ILE . 46.4 t -60.3 -48.78 86.84 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 171.15 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 155' ' ' ILE . . . . . 0.834 HD12 ' HB ' ' B' ' 154' ' ' VAL . 3.3 mp -106.65 33.94 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 122.11 0.957 . . . . 0.0 110.973 -177.887 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 156' ' ' ALA . . . . . 0.413 ' HB2' ' O ' ' B' ' 152' ' ' GLU . . . -99.37 -1.34 39.01 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 169.531 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 157' ' ' GLN . . . . . . . . . . . . . 72.8 mt-30 -139.55 -2.76 1.55 Allowed 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 113.333 -1.758 . . . . 0.0 109.678 175.141 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 158' ' ' GLY . . . . . . . . . . . . . . . -134.48 45.79 1.09 Allowed Glycine 0 C--O 1.225 -0.411 0 C-N-CA 120.603 -0.808 . . . . 0.0 114.077 -168.383 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 159' ' ' ILE . . . . . 0.733 HG21 ' HB2' ' A' ' 59' ' ' LEU . 1.8 mp -59.26 -25.76 31.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 CA-C-O 121.011 0.434 . . . . 0.0 110.854 176.757 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 160' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.517 0 C-N-CA 120.562 -0.828 . . . . 0.0 112.653 179.279 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 92.9 p . . . . . 0 N--CA 1.443 -0.803 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.678 HG13 ' HG ' ' B' ' 112' ' ' LEU . 1.9 t -50.85 -22.47 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 CA-C-N 114.373 -1.285 . . . . 0.0 112.442 -179.773 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' SER . . . . . 0.83 ' HB3' ' HA ' ' A' ' 39' ' ' VAL . 63.0 m -73.17 -52.25 14.86 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.209 0.528 . . . . 0.0 109.598 175.773 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.624 ' HG2' ' NE1' ' A' ' 43' ' ' TRP . 36.7 mt-10 -57.86 -51.22 70.52 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.67 177.805 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.792 HD12 HD12 ' A' ' 10' ' ' ILE . 3.6 tp -58.2 -37.28 74.47 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.178 -0.919 . . . . 0.0 111.746 177.741 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.6 ' HB2' HD23 ' B' ' 112' ' ' LEU . . . -67.43 -34.0 76.33 Favored 'General case' 0 N--CA 1.468 0.428 0 O-C-N 121.958 -0.464 . . . . 0.0 111.115 178.903 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.523 ' HB2' HG11 ' A' ' 39' ' ' VAL . 6.8 t -71.29 -37.2 71.85 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 178.877 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.792 HD12 HD12 ' A' ' 7' ' ' LEU . 66.9 mt -50.53 -55.57 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.809 0 CA-C-N 114.29 -1.323 . . . . 0.0 109.684 170.202 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.72 ' HB2' HD13 ' B' ' 109' ' ' LEU . 23.5 m-85 -67.04 -43.7 82.09 Favored 'General case' 0 C--O 1.219 -0.514 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.964 -173.454 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.7 p -55.08 -41.82 72.03 Favored 'General case' 0 C--O 1.239 0.526 0 CA-C-O 121.15 0.5 . . . . 0.0 109.947 176.409 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.416 ' CB ' HD11 ' A' ' 51' ' ' LEU . . . -62.64 -35.33 79.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.913 172.681 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.778 HD22 HD11 ' A' ' 56' ' ' ILE . 0.4 OUTLIER -62.73 -54.48 38.5 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.868 179.573 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.432 HG12 ' H ' ' A' ' 15' ' ' ILE . 0.0 OUTLIER -57.39 -45.65 85.48 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 CA-C-O 121.048 0.451 . . . . 0.0 110.048 177.302 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.511 HD11 ' HG2' ' A' ' 27' ' ' LYS . 5.7 tp -55.85 -40.54 73.03 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.577 0.703 . . . . 0.0 110.845 177.589 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 15.0 t60 -75.68 -11.28 59.97 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 114.722 -1.126 . . . . 0.0 111.999 -179.294 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -74.93 -45.83 39.82 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 121.871 -0.518 . . . . 0.0 110.437 178.178 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.501 ' OD2' ' HB ' ' A' ' 21' ' ' VAL . 29.3 t70 -88.89 -11.49 44.45 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.732 0.777 . . . . 0.0 109.085 177.713 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 56.18 48.98 16.3 Favored 'General case' 0 CA--C 1.516 -0.348 0 CA-C-N 113.975 -1.466 . . . . 0.0 109.626 -175.927 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.501 ' HB ' ' OD2' ' A' ' 19' ' ' ASP . 7.6 p -101.75 168.41 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.479 0 CA-C-N 114.519 -1.219 . . . . 0.0 109.586 -170.596 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.445 ' N ' HG22 ' A' ' 21' ' ' VAL . 45.5 p -43.97 129.52 5.89 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-O 121.77 0.795 . . . . 0.0 113.105 -175.147 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.699 HG12 ' HA ' ' A' ' 48' ' ' ALA . 60.0 t -103.97 108.63 25.06 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.041 0 CA-C-N 114.299 -1.319 . . . . 0.0 110.182 -176.058 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.534 ' OG1' ' HB2' ' A' ' 27' ' ' LYS . 70.4 p -140.61 151.98 45.09 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.02 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -51.78 -45.56 63.84 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.082 0.467 . . . . 0.0 110.258 177.812 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -62.54 -31.13 71.87 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.736 179.163 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.534 ' HB2' ' OG1' ' A' ' 24' ' ' THR . 4.0 tppt? -67.48 -49.42 63.59 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-O 122.032 0.92 . . . . 0.0 108.573 178.075 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 86.3 mt -60.75 -40.54 85.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 114.296 -1.32 . . . . 0.0 110.445 177.549 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -61.15 -35.41 77.01 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.567 175.886 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.82 -45.69 91.44 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.724 175.972 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.672 ' HB3' HD21 ' B' ' 109' ' ' LEU . 1.4 mm? -61.99 -46.31 89.8 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 121.017 0.437 . . . . 0.0 110.438 174.985 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.579 HG23 ' O ' ' A' ' 37' ' ' VAL . 44.2 mt -50.07 -48.18 23.63 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 CA-C-N 115.273 -0.876 . . . . 0.0 111.412 177.799 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 22.7 tptp -72.78 -39.68 66.55 Favored 'General case' 0 N--CA 1.438 -1.055 0 CA-C-N 115.707 -0.678 . . . . 0.0 111.45 -178.773 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.655 ' HB1' ' HA ' ' B' ' 126' ' ' ILE . . . -56.89 -48.75 77.45 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.195 0.521 . . . . 0.0 110.845 179.842 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.442 ' CB ' ' HG ' ' B' ' 109' ' ' LEU . . . -76.83 -37.41 55.71 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.066 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 99.06 20.74 17.44 Favored Glycine 0 N--CA 1.449 -0.438 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.767 -178.816 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.839 ' HB ' ' HA2' ' B' ' 113' ' ' GLY . 3.0 p -122.57 121.87 64.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 121.443 0.639 . . . . 0.0 110.646 -176.742 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.462 ' HA ' HG23 ' A' ' 32' ' ' ILE . 61.5 t30 -96.41 156.54 16.3 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 114.773 -1.103 . . . . 0.0 111.0 -170.012 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.83 ' HA ' ' HB3' ' A' ' 5' ' ' SER . 93.3 t -126.82 159.95 35.85 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.075 0 CA-C-N 115.01 -0.995 . . . . 0.0 110.356 -172.561 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.511 ' HB3' ' HD1' ' A' ' 43' ' ' TRP . 3.5 tp10 -67.44 107.23 1.61 Allowed Pre-proline 0 N--CA 1.44 -0.932 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 169.6 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.477 ' C ' ' HD2' ' A' ' 44' ' ' PRO . 73.7 Cg_exo -51.35 -28.07 25.84 Favored 'Trans proline' 0 C--O 1.249 1.034 0 C-N-CA 123.598 2.866 . . . . 0.0 115.304 -164.828 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.43 ' HD2' ' CG ' ' A' ' 40' ' ' GLU . 0.5 OUTLIER -60.19 -27.01 66.79 Favored 'General case' 0 C--N 1.333 -0.15 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 177.645 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 43' ' ' TRP . . . . . 0.624 ' NE1' ' HG2' ' A' ' 6' ' ' GLU . 22.5 m95 -65.36 -60.12 8.33 Favored Pre-proline 0 C--O 1.204 -1.331 0 CA-C-O 118.373 -0.822 . . . . 0.0 110.743 175.923 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.477 ' HD2' ' C ' ' A' ' 41' ' ' PRO . 74.7 Cg_exo -44.1 -44.66 12.37 Favored 'Trans proline' 0 C--N 1.357 1.004 0 C-N-CA 121.671 1.58 . . . . 0.0 112.203 173.654 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -62.0 -56.49 22.13 Favored Glycine 0 CA--C 1.525 0.712 0 C-N-CA 120.238 -0.982 . . . . 0.0 112.952 176.801 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.461 ' O ' ' HB2' ' A' ' 49' ' ' LYS . 9.4 tp -69.78 -23.01 63.28 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 122.91 0.484 . . . . 0.0 111.821 -176.861 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.519 ' HE1' ' CE3' ' A' ' 43' ' ' TRP . 3.1 m-85 -73.48 -43.78 59.4 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 109.962 -0.384 . . . . 0.0 109.962 175.605 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.699 ' HA ' HG12 ' A' ' 23' ' ' VAL . . . -63.67 -33.14 74.97 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 177.074 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.461 ' HB2' ' O ' ' A' ' 46' ' ' LEU . 9.6 mmmt -62.68 -62.26 1.85 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 114.569 -1.196 . . . . 0.0 111.701 171.187 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.473 ' O ' HG22 ' A' ' 54' ' ' VAL . . . -69.77 -41.26 75.4 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 113.114 0.783 . . . . 0.0 113.114 -169.408 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.542 ' HB2' HG11 ' A' ' 23' ' ' VAL . 12.4 mt -65.64 -10.98 40.78 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.75 0.309 . . . . 0.0 111.792 -174.37 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -84.59 0.22 50.86 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.303 177.217 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -141.22 -47.03 0.39 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.234 -179.119 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.473 HG22 ' O ' ' A' ' 50' ' ' ALA . 5.8 m -91.08 -175.19 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.847 0.356 . . . . 0.0 110.33 -177.473 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 16.4 m120 -116.03 169.47 9.23 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.734 178.16 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.778 HD11 HD22 ' A' ' 14' ' ' LEU . 3.2 tp -61.35 -25.09 35.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.551 178.603 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -70.83 -11.94 70.18 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.691 -0.766 . . . . 0.0 111.36 179.277 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 22.9 t -81.34 -23.71 37.59 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-O 121.323 0.582 . . . . 0.0 109.817 179.433 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.743 ' HB2' HG21 ' B' ' 159' ' ' ILE . 26.3 mt -62.32 -31.19 71.78 Favored 'General case' 0 CA--C 1.517 -0.314 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.751 -178.876 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.887 HG13 ' HB ' ' B' ' 159' ' ' ILE . 0.1 OUTLIER . . . . . 0 C--N 1.321 -0.653 0 CA-C-N 114.904 -1.044 . . . . 0.0 110.888 -179.647 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 103' ' ' TYR . . . . . 0.565 ' HB2' HG11 ' B' ' 142' ' ' VAL . 47.3 m-85 . . . . . 0 CA--C 1.521 -0.135 0 CA-C-O 121.354 0.597 . . . . 0.0 109.766 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 104' ' ' VAL . . . . . 0.555 HG12 ' CD2' ' B' ' 108' ' ' LEU . 48.2 t -46.45 -45.95 6.78 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.519 0 CA-C-N 114.71 -1.132 . . . . 0.0 110.13 173.806 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 105' ' ' ALA . . . . . 0.613 ' CB ' ' HB3' ' A' ' 14' ' ' LEU . . . -66.22 -39.37 89.54 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 114.822 -1.081 . . . . 0.0 111.656 -174.703 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 106' ' ' SER . . . . . 0.713 ' HB2' HG23 ' B' ' 123' ' ' ILE . 1.0 OUTLIER -62.87 -35.39 79.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.666 0.746 . . . . 0.0 109.066 176.567 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 107' ' ' TYR . . . . . 0.779 ' HD2' HG12 ' B' ' 143' ' ' ILE . 32.7 t80 -65.23 -51.61 59.86 Favored 'General case' 0 N--CA 1.445 -0.722 0 CA-C-N 114.483 -1.235 . . . . 0.0 108.625 179.093 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 108' ' ' LEU . . . . . 0.868 HD12 HG13 ' B' ' 151' ' ' ILE . 0.0 OUTLIER -56.62 -46.83 80.71 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-N 114.99 -1.004 . . . . 0.0 110.769 177.227 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 109' ' ' LEU . . . . . 0.72 HD13 ' HB2' ' A' ' 11' ' ' TYR . 9.4 tp -52.98 -49.06 66.9 Favored 'General case' 0 CA--C 1.512 -0.494 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.665 178.434 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 110' ' ' ALA . . . . . 0.583 ' HB3' ' HB3' ' B' ' 118' ' ' PRO . . . -66.45 -36.43 82.75 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.134 -176.719 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 111' ' ' ALA . . . . . 0.816 ' HA ' ' O ' ' B' ' 115' ' ' ASN . . . -70.63 -19.99 62.77 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.354 0.597 . . . . 0.0 111.023 179.101 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 112' ' ' LEU . . . . . 0.751 ' HB3' HG21 ' A' ' 37' ' ' VAL . 5.6 mp -86.53 -37.24 18.39 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.084 171.284 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 113' ' ' GLY . . . . . 0.839 ' HA2' ' HB ' ' A' ' 37' ' ' VAL . . . -66.26 -39.35 94.36 Favored Glycine 0 N--CA 1.444 -0.798 0 CA-C-N 115.054 -0.975 . . . . 0.0 113.117 -176.389 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 114' ' ' GLY . . . . . . . . . . . . . . . 164.17 6.97 0.04 OUTLIER Glycine 0 N--CA 1.442 -0.901 0 C-N-CA 119.514 -1.327 . . . . 0.0 114.051 178.457 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 115' ' ' ASN . . . . . 0.816 ' O ' ' HA ' ' B' ' 111' ' ' ALA . 95.7 m-20 -130.92 98.0 4.48 Favored 'General case' 0 CA--C 1.494 -1.183 0 CA-C-N 118.061 0.93 . . . . 0.0 108.827 178.165 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 2.5 p -76.02 29.08 0.11 Allowed 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 122.533 1.158 . . . . 0.0 109.818 -178.352 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 117' ' ' SER . . . . . 0.614 ' H ' ' C ' ' B' ' 115' ' ' ASN . 23.2 t -169.95 71.18 0.63 Allowed Pre-proline 0 N--CA 1.447 -0.61 0 CA-C-N 113.261 -1.79 . . . . 0.0 107.93 179.694 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 118' ' ' PRO . . . . . 0.616 ' HD2' ' CZ ' ' B' ' 107' ' ' TYR . 21.0 Cg_exo -71.81 152.39 58.23 Favored 'Trans proline' 0 C--N 1.33 -0.42 1 C-N-CA 125.352 4.034 . . . . 0.0 111.722 -177.102 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 119' ' ' SER . . . . . 0.536 ' O ' HG12 ' B' ' 123' ' ' ILE . 78.9 p -123.09 -175.47 3.19 Favored 'General case' 0 C--N 1.317 -0.824 0 C-N-CA 119.998 -0.681 . . . . 0.0 111.606 178.003 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 120' ' ' ALA . . . . . 0.78 ' HB1' HD13 ' B' ' 139' ' ' LEU . . . -66.58 -39.98 88.72 Favored 'General case' 0 CA--C 1.507 -0.682 0 CA-C-O 121.785 0.802 . . . . 0.0 109.315 -170.347 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 121' ' ' LYS . . . . . 0.406 ' HD2' ' N ' ' B' ' 121' ' ' LYS . 13.8 mptt -58.99 -37.38 76.71 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 113.932 -1.485 . . . . 0.0 111.108 174.642 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 122' ' ' ASP . . . . . 0.401 ' O ' ' HD2' ' B' ' 125' ' ' LYS . 21.1 m-20 -69.56 -40.04 77.02 Favored 'General case' 0 CA--C 1.517 -0.299 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.33 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 123' ' ' ILE . . . . . 0.75 ' CG1' HD11 ' B' ' 143' ' ' ILE . 33.2 mm -59.29 -50.84 78.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.959 176.236 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 124' ' ' LYS . . . . . 0.85 ' HD3' HD21 ' B' ' 139' ' ' LEU . 3.7 mmmp? -59.91 -31.66 70.03 Favored 'General case' 0 C--O 1.216 -0.686 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.789 -178.802 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 125' ' ' LYS . . . . . 0.735 ' HD2' HD12 ' B' ' 126' ' ' ILE . 0.0 OUTLIER -71.92 -48.08 47.94 Favored 'General case' 0 N--CA 1.431 -1.384 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.935 -179.773 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 126' ' ' ILE . . . . . 0.735 HD12 ' HD2' ' B' ' 125' ' ' LYS . 1.1 mp -55.56 -51.01 62.54 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 CA-C-O 120.604 0.24 . . . . 0.0 110.941 176.031 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 127' ' ' LEU . . . . . 0.689 ' HG ' ' O ' ' B' ' 123' ' ' ILE . 1.8 pp -76.82 -24.09 52.76 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.605 -0.438 . . . . 0.0 111.629 -175.852 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 128' ' ' ASP . . . . . 0.533 ' HB2' ' O ' ' B' ' 124' ' ' LYS . 24.9 t70 -65.53 -32.86 74.69 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 175.589 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 129' ' ' SER . . . . . 0.508 ' HB2' ' HB2' ' A' ' 34' ' ' ALA . 7.1 t -56.5 -33.12 65.71 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-N 115.714 -0.676 . . . . 0.0 111.827 176.835 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 130' ' ' VAL . . . . . 0.443 HG23 HG13 ' B' ' 132' ' ' ILE . 2.5 m -108.63 -8.48 11.12 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 O-C-N 122.098 -0.376 . . . . 0.0 111.904 178.89 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 131' ' ' GLY . . . . . . . . . . . . . . . 87.26 27.11 28.86 Favored Glycine 0 CA--C 1.519 0.342 0 C-N-CA 121.036 -0.602 . . . . 0.0 113.18 175.744 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 132' ' ' ILE . . . . . 0.525 ' O ' HD13 ' B' ' 127' ' ' LEU . 17.9 mt -85.09 128.3 39.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.669 0.234 . . . . 0.0 110.854 -179.059 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 133' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -76.53 133.16 39.81 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.124 0.487 . . . . 0.0 111.385 -176.185 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 134' ' ' ALA . . . . . 0.493 ' HB2' HD22 ' B' ' 127' ' ' LEU . . . -139.9 143.94 36.92 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.769 -174.677 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 135' ' ' ASP . . . . . 0.808 ' HB2' ' HG3' ' B' ' 138' ' ' ARG . 5.5 m-20 -88.88 127.97 35.65 Favored 'General case' 0 C--O 1.256 1.416 0 CA-C-O 121.261 0.553 . . . . 0.0 109.712 176.234 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 136' ' ' ASP . . . . . 0.993 ' HA ' HD11 ' B' ' 139' ' ' LEU . 9.0 p-10 -78.07 2.08 18.99 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-N 115.127 -0.942 . . . . 0.0 111.587 -166.593 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 137' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -105.57 -32.76 8.34 Favored 'General case' 0 N--CA 1.44 -0.932 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.189 170.65 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 138' ' ' ARG . . . . . 0.808 ' HG3' ' HB2' ' B' ' 135' ' ' ASP . 11.8 mmt85 -63.32 -47.6 81.53 Favored 'General case' 0 CA--C 1.504 -0.803 0 CA-C-O 121.781 0.8 . . . . 0.0 109.425 -175.948 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 139' ' ' LEU . . . . . 0.993 HD11 ' HA ' ' B' ' 136' ' ' ASP . 0.3 OUTLIER -71.81 -39.43 69.84 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 114.653 -1.158 . . . . 0.0 111.356 -179.151 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 140' ' ' ASN . . . . . 0.682 ' H ' HD12 ' B' ' 139' ' ' LEU . 11.0 t30 -62.98 -29.38 70.77 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-O 121.571 0.701 . . . . 0.0 109.11 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 141' ' ' LYS . . . . . . . . . . . . . 18.4 tttm -72.09 -52.42 16.86 Favored 'General case' 0 C--O 1.242 0.699 0 CA-C-N 114.672 -1.149 . . . . 0.0 110.358 178.271 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 142' ' ' VAL . . . . . 0.62 HG12 ' O ' ' B' ' 139' ' ' LEU . 11.7 p -56.93 -42.34 78.48 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.743 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.721 -179.013 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 143' ' ' ILE . . . . . 0.779 HG12 ' HD2' ' B' ' 107' ' ' TYR . 34.6 mt -59.39 -49.73 82.45 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 C-N-CA 123.554 0.742 . . . . 0.0 112.792 174.845 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 144' ' ' SER . . . . . . . . . . . . . 66.3 m -53.26 -33.93 55.14 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 115.668 -0.697 . . . . 0.0 111.294 178.191 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 145' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -87.5 -33.63 18.92 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 120.981 0.419 . . . . 0.0 111.606 176.942 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 146' ' ' LEU . . . . . 0.529 HD11 HG13 ' B' ' 104' ' ' VAL . 0.3 OUTLIER -70.83 -31.92 68.8 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 123.374 0.67 . . . . 0.0 111.511 -179.01 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 147' ' ' ASN . . . . . . . . . . . . . 23.3 t-20 -56.04 124.86 19.19 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.973 -177.502 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . 101.86 28.37 6.62 Favored Glycine 0 N--CA 1.449 -0.495 0 CA-C-N 115.636 -0.711 . . . . 0.0 112.563 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 149' ' ' LYS . . . . . 0.505 ' HE2' ' O ' ' B' ' 146' ' ' LEU . 1.0 OUTLIER -127.79 175.01 8.66 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 110.21 -0.292 . . . . 0.0 110.21 177.13 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 150' ' ' ASN . . . . . 0.553 ' O ' HG23 ' B' ' 154' ' ' VAL . 44.0 m-80 -111.7 93.15 4.32 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 108.582 -0.895 . . . . 0.0 108.582 179.48 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 151' ' ' ILE . . . . . 0.868 HG13 HD12 ' B' ' 108' ' ' LEU . 1.8 mp -41.74 -65.03 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 O-C-N 124.366 1.041 . . . . 0.0 113.662 -169.167 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 152' ' ' GLU . . . . . 0.524 ' HG3' HD11 ' B' ' 112' ' ' LEU . 1.7 mp0 -55.14 -42.83 73.54 Favored 'General case' 0 C--O 1.219 -0.535 0 CA-C-N 117.879 0.309 . . . . 0.0 111.52 -174.26 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 153' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -69.05 -28.61 66.7 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.523 179.696 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 154' ' ' VAL . . . . . 0.837 ' HB ' HD12 ' B' ' 155' ' ' ILE . 61.1 t -61.29 -51.36 73.88 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 CA-C-O 121.691 0.757 . . . . 0.0 109.071 171.208 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 155' ' ' ILE . . . . . 0.837 HD12 ' HB ' ' B' ' 154' ' ' VAL . 1.9 mp -101.15 33.29 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.496 -177.223 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . -98.69 -4.97 32.47 Favored 'General case' 0 C--N 1.308 -1.228 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 168.714 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 157' ' ' GLN . . . . . . . . . . . . . 67.5 mm-40 -142.85 14.72 1.92 Allowed 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 113.563 -1.653 . . . . 0.0 110.047 174.648 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 158' ' ' GLY . . . . . . . . . . . . . . . -146.83 46.34 0.74 Allowed Glycine 0 C--N 1.336 0.567 0 C-N-CA 120.707 -0.758 . . . . 0.0 113.727 -170.933 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 159' ' ' ILE . . . . . 0.887 ' HB ' HG13 ' A' ' 60' ' ' ILE . 1.8 mp -66.79 -14.76 18.44 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 CA-C-O 121.244 0.545 . . . . 0.0 110.889 178.29 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 160' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.616 0 C-N-CA 120.848 -0.691 . . . . 0.0 111.908 -176.122 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.481 1.082 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.663 ' HB3' HD13 ' A' ' 7' ' ' LEU . . . -115.83 -167.59 1.28 Allowed 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 175.792 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.62 ' HB2' ' HG3' ' A' ' 6' ' ' GLU . 4.0 m -89.91 125.06 35.22 Favored 'General case' 0 N--CA 1.438 -1.041 0 N-CA-C 107.254 -1.388 . . . . 0.0 107.254 165.186 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.767 HG13 ' HG ' ' B' ' 112' ' ' LEU . 2.0 t -52.29 -23.49 4.42 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.704 -179.382 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.739 ' HB2' ' HA ' ' A' ' 39' ' ' VAL . 15.8 p -68.08 -53.89 22.21 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.633 0.73 . . . . 0.0 109.328 175.212 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.62 ' HG3' ' HB2' ' A' ' 3' ' ' SER . 31.0 mt-10 -57.74 -52.06 66.99 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 115.009 -0.996 . . . . 0.0 109.661 178.931 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.821 ' HA ' HD12 ' A' ' 10' ' ' ILE . 2.0 tp -57.79 -35.88 71.42 Favored 'General case' 0 N--CA 1.447 -0.575 0 CA-C-N 115.085 -0.961 . . . . 0.0 111.789 177.762 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -66.33 -40.26 89.75 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-O 121.245 0.545 . . . . 0.0 110.938 178.52 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.575 ' HB2' HG11 ' A' ' 39' ' ' VAL . 8.4 t -65.88 -40.89 92.01 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 179.856 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.821 HD12 ' HA ' ' A' ' 7' ' ' LEU . 57.6 mt -47.9 -57.25 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.851 0 CA-C-N 113.646 -1.616 . . . . 0.0 109.927 172.85 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.903 ' HB2' HD13 ' B' ' 109' ' ' LEU . 21.2 m-85 -65.95 -40.83 91.66 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.604 -173.696 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.513 ' HB2' HG23 ' A' ' 28' ' ' ILE . 14.9 m -53.78 -43.27 69.12 Favored 'General case' 0 C--O 1.243 0.738 0 CA-C-O 121.709 0.766 . . . . 0.0 109.49 176.259 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -67.53 -32.52 73.35 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-N 115.192 -0.913 . . . . 0.0 110.166 176.907 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.645 ' HB3' ' CB ' ' B' ' 105' ' ' ALA . 0.3 OUTLIER -62.51 -56.87 13.93 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.113 179.467 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.466 HG12 ' H ' ' A' ' 15' ' ' ILE . 0.0 OUTLIER -54.36 -42.19 56.75 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 N-CA-C 109.897 -0.408 . . . . 0.0 109.897 177.421 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.483 ' HA ' HD12 ' A' ' 16' ' ' LEU . 3.9 tp -56.64 -37.81 71.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.26 176.832 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' HIS . . . . . 0.448 ' CD2' ' HB ' ' A' ' 56' ' ' ILE . 72.0 m-70 -77.78 -9.64 59.13 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 112.493 0.553 . . . . 0.0 112.493 178.957 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.521 ' HA ' ' N ' ' B' ' 100' ' ' ALA . 5.4 t70 -78.61 -29.14 45.87 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 119.513 -0.875 . . . . 0.0 109.807 -177.511 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -107.32 -8.15 16.45 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 173.666 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.416 ' HG2' ' O ' ' A' ' 17' ' ' HIS . 5.2 mm-40 51.89 50.14 19.25 Favored 'General case' 0 CA--C 1.511 -0.545 0 CA-C-N 113.925 -1.489 . . . . 0.0 110.633 -174.93 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.442 HG22 ' H ' ' A' ' 22' ' ' THR . 7.3 p -99.13 168.76 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.424 -1.743 0 CA-C-N 114.678 -1.147 . . . . 0.0 108.624 -174.439 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.442 ' H ' HG22 ' A' ' 21' ' ' VAL . 48.5 p -52.45 139.73 24.23 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-O 121.958 0.885 . . . . 0.0 113.377 -169.677 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.609 HG12 ' HA ' ' A' ' 48' ' ' ALA . 58.7 t -109.32 106.39 20.61 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.012 0 CA-C-N 114.339 -1.301 . . . . 0.0 110.536 -174.638 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.556 ' OG1' ' HB2' ' A' ' 27' ' ' LYS . 70.8 p -131.23 156.04 46.06 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.979 178.465 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -54.35 -43.57 71.39 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.226 0.536 . . . . 0.0 109.856 178.806 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -68.49 -25.58 65.04 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.295 -0.866 . . . . 0.0 111.458 -179.794 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.556 ' HB2' ' OG1' ' A' ' 24' ' ' THR . 3.7 tppt? -70.34 -52.24 24.13 Favored 'General case' 0 C--O 1.239 0.53 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 178.894 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.513 HG23 ' HB2' ' A' ' 12' ' ' SER . 70.9 mt -61.08 -40.68 86.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 114.547 -1.206 . . . . 0.0 110.315 177.9 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.592 ' HA ' HD12 ' A' ' 32' ' ' ILE . 44.7 t-20 -60.19 -39.45 86.59 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.936 176.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -60.98 -44.6 97.14 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.016 177.549 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.579 HD12 HG23 ' B' ' 126' ' ' ILE . 1.4 mm? -59.79 -49.39 77.9 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 121.01 0.434 . . . . 0.0 110.315 173.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.602 HG23 ' O ' ' A' ' 37' ' ' VAL . 75.5 mt -46.98 -52.53 4.04 Favored 'Isoleucine or valine' 0 C--O 1.239 0.538 0 CA-C-N 115.184 -0.916 . . . . 0.0 111.366 178.037 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 46.5 mmtm -72.37 -33.41 67.23 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.542 -0.753 . . . . 0.0 111.543 -176.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -62.85 -44.34 96.39 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.062 -179.089 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.5 ' HB3' HG12 ' A' ' 37' ' ' VAL . . . -82.01 -30.61 31.44 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.918 178.743 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 95.3 15.64 43.51 Favored Glycine 0 N--CA 1.447 -0.62 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.75 -178.792 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.987 ' HB ' ' HA3' ' B' ' 113' ' ' GLY . 5.1 p -115.8 118.85 60.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.758 0.79 . . . . 0.0 110.708 -174.778 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.449 ' HA ' HG23 ' A' ' 32' ' ' ILE . 64.3 t30 -96.52 158.59 15.36 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 114.581 -1.19 . . . . 0.0 111.256 -167.486 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.739 ' HA ' ' HB2' ' A' ' 5' ' ' SER . 67.9 t -127.75 163.42 31.38 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.972 0 CA-C-N 114.966 -1.015 . . . . 0.0 110.551 -172.07 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.561 ' HB3' ' HD1' ' A' ' 43' ' ' TRP . 8.2 tp10 -71.24 106.46 1.89 Allowed Pre-proline 0 N--CA 1.44 -0.928 0 N-CA-C 107.429 -1.323 . . . . 0.0 107.429 167.721 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.529 ' C ' ' HD2' ' A' ' 44' ' ' PRO . 77.6 Cg_exo -51.26 -27.69 23.98 Favored 'Trans proline' 0 C--O 1.25 1.112 0 C-N-CA 123.883 3.055 . . . . 0.0 115.532 -164.221 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.432 ' HD2' ' HG3' ' A' ' 40' ' ' GLU . 0.5 OUTLIER -61.38 -28.17 69.05 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 177.471 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 43' ' ' TRP . . . . . 0.611 ' CE3' ' HE1' ' A' ' 47' ' ' PHE . 18.8 m95 -64.56 -59.65 10.16 Favored Pre-proline 0 C--O 1.205 -1.26 0 CA-C-O 118.383 -0.817 . . . . 0.0 110.949 176.068 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.529 ' HD2' ' C ' ' A' ' 41' ' ' PRO . 97.6 Cg_exo -45.81 -42.84 19.67 Favored 'Trans proline' 0 C--N 1.359 1.119 0 C-N-CA 121.766 1.644 . . . . 0.0 111.871 174.532 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -60.4 -61.0 7.56 Favored Glycine 0 CA--C 1.525 0.701 0 C-N-CA 120.231 -0.985 . . . . 0.0 112.516 175.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.567 ' O ' ' HB2' ' A' ' 49' ' ' LYS . 8.7 tp -63.26 -32.1 73.42 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.196 0.599 . . . . 0.0 111.973 -177.417 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.611 ' HE1' ' CE3' ' A' ' 43' ' ' TRP . 3.6 m-85 -64.14 -48.13 77.24 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.192 176.237 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.609 ' HA ' HG12 ' A' ' 23' ' ' VAL . . . -65.25 -31.44 72.59 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.56 0.695 . . . . 0.0 109.396 -179.516 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.567 ' HB2' ' O ' ' A' ' 46' ' ' LEU . 9.3 mmmt -59.28 -54.92 41.27 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 114.589 -1.187 . . . . 0.0 111.748 172.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -86.61 -43.49 12.62 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 113.802 1.038 . . . . 0.0 113.802 -168.811 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.587 HD11 ' CD2' ' A' ' 47' ' ' PHE . 21.5 mt -65.87 -7.23 15.26 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 113.721 1.008 . . . . 0.0 113.721 -168.556 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -81.01 -2.2 46.97 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.892 0.377 . . . . 0.0 110.425 176.374 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 10.5 t30 -143.01 -41.71 0.31 Allowed 'General case' 0 C--O 1.235 0.294 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.251 -179.568 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 4.3 m -83.01 -179.6 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 121.429 0.633 . . . . 0.0 110.61 -178.542 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 95.6 m-20 -112.15 155.98 23.03 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 115.505 -0.771 . . . . 0.0 111.135 177.788 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.632 HD11 HD22 ' A' ' 14' ' ' LEU . 3.5 tp -60.01 -21.3 21.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 114.773 -1.103 . . . . 0.0 110.83 179.732 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -69.67 -15.4 71.0 Favored Glycine 0 N--CA 1.444 -0.821 0 C-N-CA 120.779 -0.724 . . . . 0.0 111.392 177.789 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 35.1 t -75.99 -22.77 55.49 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-O 121.477 0.656 . . . . 0.0 109.76 178.782 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.828 ' HB2' HG21 ' B' ' 159' ' ' ILE . 19.7 mt -65.12 -25.67 67.87 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.958 -178.423 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.854 HG13 ' HB ' ' B' ' 159' ' ' ILE . 0.2 OUTLIER -67.85 -19.72 25.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 114.935 -1.03 . . . . 0.0 110.595 178.539 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 41.3 t -98.67 -37.73 9.39 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.063 -0.972 . . . . 0.0 110.395 178.545 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 5.3 p30 35.25 59.81 0.74 Allowed 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.107 0.879 . . . . 0.0 113.0 -176.287 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.422 HG22 ' O ' ' A' ' 63' ' ' VAL . 11.5 p 34.19 43.7 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.795 0 CA-C-N 113.725 -1.579 . . . . 0.0 113.243 179.857 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -161.57 -54.72 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.021 178.375 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . 52.03 50.91 17.51 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.172 0.51 . . . . 0.0 111.673 179.423 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -97.2 152.76 20.11 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.057 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -114.74 -80.63 0.92 Allowed Glycine 0 N--CA 1.448 -0.526 0 N-CA-C 111.224 -0.75 . . . . 0.0 111.224 177.532 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_endo -81.81 -169.46 0.77 Allowed 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 122.698 2.265 . . . . 0.0 111.276 174.0 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.002 0 CA-C-O 118.762 -0.637 . . . . 0.0 110.183 178.122 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 100' ' ' ALA . . . . . 0.521 ' N ' ' HA ' ' A' ' 18' ' ' ASP . . . . . . . . 0 N--CA 1.481 1.076 0 CA-C-O 120.693 0.282 . . . . 0.0 111.221 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 101' ' ' MET . . . . . 0.535 ' CE ' HD12 ' A' ' 14' ' ' LEU . 0.0 OUTLIER -131.12 -3.39 3.95 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.092 0.472 . . . . 0.0 109.877 -178.447 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 102' ' ' ARG . . . . . 0.429 ' HB2' ' O ' ' B' ' 101' ' ' MET . 59.4 mtm180 79.36 -162.84 0.03 OUTLIER 'General case' 0 C--O 1.232 0.176 0 CA-C-N 114.961 -1.018 . . . . 0.0 111.928 174.53 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 103' ' ' TYR . . . . . 0.999 ' HB2' HG11 ' B' ' 142' ' ' VAL . 43.2 m-85 -73.67 6.41 3.17 Favored 'General case' 0 C--O 1.242 0.671 0 CA-C-N 114.698 -1.137 . . . . 0.0 113.119 -163.787 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 104' ' ' VAL . . . . . 0.605 HG21 ' HB3' ' B' ' 163' ' ' ALA . 44.9 t -50.51 -49.99 23.09 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.448 0 CA-C-O 121.639 0.733 . . . . 0.0 110.034 177.316 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 105' ' ' ALA . . . . . 0.645 ' CB ' ' HB3' ' A' ' 14' ' ' LEU . . . -64.68 -39.36 93.54 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 114.683 -1.144 . . . . 0.0 111.798 -173.249 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 106' ' ' SER . . . . . 0.609 ' HB2' HG23 ' B' ' 123' ' ' ILE . 0.7 OUTLIER -61.06 -38.92 87.91 Favored 'General case' 0 C--O 1.24 0.582 0 CA-C-O 121.786 0.803 . . . . 0.0 109.123 177.905 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 107' ' ' TYR . . . . . 0.756 ' HD2' HG12 ' B' ' 143' ' ' ILE . 41.5 t80 -61.88 -48.7 79.32 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-N 114.08 -1.418 . . . . 0.0 109.067 179.037 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 108' ' ' LEU . . . . . 0.835 HD12 HG13 ' B' ' 151' ' ' ILE . 0.0 OUTLIER -58.14 -46.18 86.08 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-N 115.327 -0.852 . . . . 0.0 111.417 179.553 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 109' ' ' LEU . . . . . 0.903 HD13 ' HB2' ' A' ' 11' ' ' TYR . 8.5 tp -54.19 -56.07 21.77 Favored 'General case' 0 C--O 1.247 0.929 0 CA-C-O 121.393 0.616 . . . . 0.0 110.777 178.54 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 110' ' ' ALA . . . . . 0.427 ' HB3' ' HB3' ' B' ' 118' ' ' PRO . . . -56.05 -41.38 74.94 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 114.991 -1.004 . . . . 0.0 110.372 -177.96 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 111' ' ' ALA . . . . . 0.78 ' HA ' ' O ' ' B' ' 115' ' ' ASN . . . -75.03 -22.25 58.56 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.881 -177.917 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 112' ' ' LEU . . . . . 0.767 ' HG ' HG13 ' A' ' 4' ' ' VAL . 4.3 tp -77.66 -39.51 44.8 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.415 -177.661 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 113' ' ' GLY . . . . . 0.987 ' HA3' ' HB ' ' A' ' 37' ' ' VAL . . . -140.01 33.09 2.14 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 118.652 -1.737 . . . . 0.0 115.155 -174.652 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 114' ' ' GLY . . . . . . . . . . . . . . . -159.45 -47.1 0.01 OUTLIER Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 119.299 -1.429 . . . . 0.0 112.969 176.804 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 115' ' ' ASN . . . . . 0.78 ' O ' ' HA ' ' B' ' 111' ' ' ALA . 8.0 t30 -158.33 112.34 2.49 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 -173.055 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 5.9 m -80.77 28.36 0.35 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 122.083 0.944 . . . . 0.0 111.019 -169.051 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 117' ' ' SER . . . . . 0.478 ' N ' ' HD3' ' B' ' 118' ' ' PRO . 28.3 t -168.01 68.88 0.83 Allowed Pre-proline 0 C--N 1.312 -1.044 0 CA-C-N 113.857 -1.52 . . . . 0.0 108.045 177.65 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 118' ' ' PRO . . . . . 0.679 ' HD2' ' CZ ' ' B' ' 107' ' ' TYR . 34.5 Cg_exo -65.7 155.43 69.15 Favored 'Trans proline' 0 CA--C 1.514 -0.512 0 C-N-CA 125.281 3.988 . . . . 0.0 112.389 -172.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 119' ' ' SER . . . . . 0.534 ' C ' HD13 ' B' ' 143' ' ' ILE . 89.8 p -126.57 -176.14 3.59 Favored 'General case' 0 N--CA 1.443 -0.821 0 C-N-CA 120.18 -0.608 . . . . 0.0 111.525 177.74 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 120' ' ' ALA . . . . . 0.821 ' HB1' HD13 ' B' ' 139' ' ' LEU . . . -63.21 -36.5 83.85 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 122.222 1.011 . . . . 0.0 109.409 -169.617 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 121' ' ' LYS . . . . . 0.477 ' HD2' ' N ' ' B' ' 121' ' ' LYS . 0.9 OUTLIER -68.14 -32.91 73.51 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 113.489 -1.687 . . . . 0.0 110.898 178.91 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 122' ' ' ASP . . . . . 0.511 ' O ' ' HB3' ' B' ' 125' ' ' LYS . 10.6 m-20 -71.66 -36.75 70.76 Favored 'General case' 0 CA--C 1.515 -0.372 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 178.412 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 123' ' ' ILE . . . . . 0.779 ' CG1' HD11 ' B' ' 143' ' ' ILE . 36.9 mm -62.9 -48.38 88.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.108 176.591 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 124' ' ' LYS . . . . . 0.838 ' HD3' HD21 ' B' ' 139' ' ' LEU . 2.9 mmmp? -57.59 -45.21 85.55 Favored 'General case' 0 C--O 1.21 -0.996 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 -179.357 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 125' ' ' LYS . . . . . 0.511 ' HB3' ' O ' ' B' ' 122' ' ' ASP . 0.1 OUTLIER -47.18 -63.99 0.9 Allowed 'General case' 0 N--CA 1.416 -2.149 0 N-CA-C 112.777 0.658 . . . . 0.0 112.777 172.743 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 126' ' ' ILE . . . . . 0.579 HG23 HD12 ' A' ' 31' ' ' LEU . 1.7 mp -56.69 -46.01 82.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.298 -0.865 . . . . 0.0 111.367 -174.859 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 127' ' ' LEU . . . . . 0.757 ' HG ' ' O ' ' B' ' 123' ' ' ILE . 2.2 pp -78.47 -24.82 45.77 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 120.284 -0.567 . . . . 0.0 111.909 -177.822 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 128' ' ' ASP . . . . . 0.509 ' HB2' ' O ' ' B' ' 124' ' ' LYS . 17.0 t70 -67.1 -35.92 80.82 Favored 'General case' 0 CA--C 1.514 -0.407 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 179.861 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 129' ' ' SER . . . . . . . . . . . . . 83.3 p -58.71 -30.14 67.21 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 115.75 -0.659 . . . . 0.0 112.32 -179.23 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 130' ' ' VAL . . . . . . . . . . . . . 3.1 m -108.41 6.02 9.45 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 CA-C-O 120.856 0.36 . . . . 0.0 111.506 177.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 131' ' ' GLY . . . . . . . . . . . . . . . 74.32 30.42 60.62 Favored Glycine 0 CA--C 1.52 0.357 0 C-N-CA 121.075 -0.583 . . . . 0.0 113.722 175.531 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 132' ' ' ILE . . . . . 0.52 ' O ' HD13 ' B' ' 127' ' ' LEU . 18.6 mt -90.08 130.11 39.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.955 0.377 . . . . 0.0 110.026 176.691 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 133' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -81.15 146.73 30.39 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-O 120.922 0.392 . . . . 0.0 110.937 -174.536 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 134' ' ' ALA . . . . . 0.434 ' HB2' HD22 ' B' ' 127' ' ' LEU . . . -146.23 144.07 29.64 Favored 'General case' 0 N--CA 1.442 -0.849 0 CA-C-N 115.795 -0.638 . . . . 0.0 111.639 -176.033 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 135' ' ' ASP . . . . . 0.746 ' HB2' ' HG3' ' B' ' 138' ' ' ARG . 16.3 m-20 -94.03 132.91 38.04 Favored 'General case' 0 C--O 1.251 1.146 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 174.114 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 136' ' ' ASP . . . . . 0.952 ' HA ' HD11 ' B' ' 139' ' ' LEU . 5.5 m-20 -71.53 -11.45 60.87 Favored 'General case' 0 CA--C 1.511 -0.525 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.547 -167.042 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 137' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -97.32 -31.06 12.6 Favored 'General case' 0 N--CA 1.434 -1.228 0 C-N-CA 120.103 -0.639 . . . . 0.0 110.444 174.441 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 138' ' ' ARG . . . . . 0.746 ' HG3' ' HB2' ' B' ' 135' ' ' ASP . 52.4 mmt-85 -66.02 -43.96 86.12 Favored 'General case' 0 CA--C 1.506 -0.725 0 CA-C-O 121.553 0.692 . . . . 0.0 109.565 -174.956 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 139' ' ' LEU . . . . . 0.952 HD11 ' HA ' ' B' ' 136' ' ' ASP . 0.3 OUTLIER -75.91 -36.71 59.34 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.152 -0.931 . . . . 0.0 111.417 179.688 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 140' ' ' ASN . . . . . 0.615 ' H ' HD12 ' B' ' 139' ' ' LEU . 61.6 t30 -63.19 -25.95 68.58 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 177.699 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 141' ' ' LYS . . . . . . . . . . . . . 35.9 tptt -76.26 -49.09 17.96 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.632 -1.167 . . . . 0.0 110.838 177.639 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 142' ' ' VAL . . . . . 0.999 HG11 ' HB2' ' B' ' 103' ' ' TYR . 13.7 p -57.92 -45.95 87.61 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.367 0 CA-C-O 121.212 0.53 . . . . 0.0 109.716 179.561 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 143' ' ' ILE . . . . . 0.779 HD11 ' CG1' ' B' ' 123' ' ' ILE . 34.7 mt -58.56 -46.25 90.05 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.802 0 C-N-CA 124.124 0.97 . . . . 0.0 112.198 173.581 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 144' ' ' SER . . . . . . . . . . . . . 46.5 t -51.59 -39.23 57.52 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.917 176.225 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 145' ' ' GLU . . . . . . . . . . . . . 15.6 mm-40 -73.86 -50.86 18.3 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 121.765 0.793 . . . . 0.0 110.431 175.505 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 146' ' ' LEU . . . . . 0.57 ' O ' ' HE2' ' B' ' 149' ' ' LYS . 2.2 mm? -61.28 -32.7 72.53 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 114.56 -1.2 . . . . 0.0 112.973 -175.879 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 147' ' ' ASN . . . . . . . . . . . . . 50.6 t30 -54.69 116.99 3.0 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.74 -172.823 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 148' ' ' GLY . . . . . 0.44 ' O ' ' HD3' ' B' ' 149' ' ' LYS . . . 98.97 36.15 4.57 Favored Glycine 0 N--CA 1.448 -0.533 0 CA-C-N 115.52 -0.764 . . . . 0.0 112.446 -179.577 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 149' ' ' LYS . . . . . 0.57 ' HE2' ' O ' ' B' ' 146' ' ' LEU . 0.5 OUTLIER -130.48 164.02 25.71 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 110.04 -0.355 . . . . 0.0 110.04 177.898 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 150' ' ' ASN . . . . . 0.507 ' O ' HG23 ' B' ' 154' ' ' VAL . 4.8 m-20 -102.14 90.13 3.83 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 -178.437 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 151' ' ' ILE . . . . . 0.835 HG13 HD12 ' B' ' 108' ' ' LEU . 1.8 mp -34.58 -68.52 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 O-C-N 124.734 1.271 . . . . 0.0 113.251 -172.898 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 152' ' ' GLU . . . . . 0.49 ' N ' HG22 ' B' ' 151' ' ' ILE . 1.5 mm-40 -46.14 -56.68 5.32 Favored 'General case' 0 C--O 1.213 -0.84 0 N-CA-C 112.549 0.574 . . . . 0.0 112.549 -179.482 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 153' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -57.3 -35.67 70.13 Favored 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 120.85 -0.34 . . . . 0.0 111.673 -178.683 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 154' ' ' VAL . . . . . 0.738 ' HB ' HD12 ' B' ' 155' ' ' ILE . 64.4 t -57.87 -53.94 38.52 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 CA-C-O 121.273 0.558 . . . . 0.0 110.1 177.37 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 155' ' ' ILE . . . . . 0.738 HD12 ' HB ' ' B' ' 154' ' ' VAL . 3.6 mp -87.76 -19.78 7.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.56 -0.746 . . . . 0.0 111.729 -173.542 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . -57.21 -16.67 8.72 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.022 0.439 . . . . 0.0 110.919 179.585 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 157' ' ' GLN . . . . . . . . . . . . . 49.8 mt-30 -130.89 26.77 4.95 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.921 170.231 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 158' ' ' GLY . . . . . . . . . . . . . . . -160.04 46.85 0.41 Allowed Glycine 0 CA--C 1.526 0.76 0 CA-C-N 115.989 -0.551 . . . . 0.0 113.943 -172.297 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 159' ' ' ILE . . . . . 0.854 ' HB ' HG13 ' A' ' 60' ' ' ILE . 1.9 mp -61.16 -12.17 5.53 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 CA-C-O 121.875 0.845 . . . . 0.0 110.162 171.748 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 160' ' ' GLY . . . . . . . . . . . . . . . -134.24 162.2 24.51 Favored Glycine 0 N--CA 1.439 -1.143 0 N-CA-C 109.977 -1.249 . . . . 0.0 109.977 -178.806 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 161' ' ' LYS . . . . . 0.539 ' HB3' HG22 ' B' ' 165' ' ' VAL . 3.7 mppt? 52.07 29.41 6.31 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.589 0.589 . . . . 0.0 112.589 -174.184 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 162' ' ' LEU . . . . . 0.473 ' HB3' HG11 ' B' ' 104' ' ' VAL . 9.1 mp -38.08 116.82 0.55 Allowed 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 113.037 0.754 . . . . 0.0 113.037 175.183 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 163' ' ' ALA . . . . . 0.605 ' HB3' HG21 ' B' ' 104' ' ' VAL . . . 46.39 -78.29 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 114.588 1.329 . . . . 0.0 114.588 179.586 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 164' ' ' SER . . . . . . . . . . . . . 5.4 m -89.43 109.3 20.23 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 121.018 0.437 . . . . 0.0 110.955 -179.179 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 165' ' ' VAL . . . . . 0.539 HG22 ' HB3' ' B' ' 161' ' ' LYS . 27.9 t -79.21 125.06 84.09 Favored Pre-proline 0 C--N 1.325 -0.479 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.074 179.068 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 166' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_exo -16.99 115.74 0.01 OUTLIER 'Trans proline' 0 N--CA 1.438 -1.751 1 C-N-CA 127.438 5.425 . . . . 0.0 115.545 179.235 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 167' ' ' ALA . . . . . . . . . . . . . . . -84.18 115.66 22.54 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.826 -176.345 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 168' ' ' GLY . . . . . . . . . . . . . . . -109.33 103.55 1.79 Allowed Glycine 0 N--CA 1.446 -0.7 0 CA-C-N 115.899 -0.591 . . . . 0.0 112.212 -178.251 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 169' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.106 0 CA-C-O 118.819 -0.99 . . . . 0.0 112.076 178.536 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 49.3 ttm . . . . . 0 N--CA 1.483 1.2 0 CA-C-O 121.021 0.438 . . . . 0.0 110.577 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.816 ' HB3' HD13 ' A' ' 7' ' ' LEU . . . -76.61 158.33 31.21 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.1 179.51 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.503 ' HB2' ' HG3' ' A' ' 6' ' ' GLU . 1.5 m -70.87 135.43 48.03 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 171.86 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.974 HG13 ' HG ' ' B' ' 112' ' ' LEU . 2.1 t -54.33 -24.86 12.82 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-N 115.128 -0.942 . . . . 0.0 112.348 -177.446 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.849 ' HB3' ' HA ' ' A' ' 39' ' ' VAL . 49.7 m -71.27 -48.55 50.21 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.446 0.641 . . . . 0.0 109.304 175.996 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.57 ' HG2' ' HE1' ' A' ' 43' ' ' TRP . 28.4 mt-10 -61.57 -49.42 76.72 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.322 -0.853 . . . . 0.0 109.274 179.18 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.856 HD12 HD12 ' A' ' 10' ' ' ILE . 4.7 tp -60.24 -35.12 74.76 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 114.831 -1.077 . . . . 0.0 111.47 177.136 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.686 ' HB2' HD23 ' B' ' 112' ' ' LEU . . . -67.87 -37.15 81.45 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 120.933 0.397 . . . . 0.0 110.871 179.029 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.508 ' HB2' HG11 ' A' ' 39' ' ' VAL . 8.4 t -67.81 -39.58 83.95 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 178.955 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.856 HD12 HD12 ' A' ' 7' ' ' LEU . 68.9 mt -48.48 -55.56 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.694 0 CA-C-N 114.264 -1.335 . . . . 0.0 109.726 170.03 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.858 ' HB2' HD13 ' B' ' 109' ' ' LEU . 23.0 m-85 -67.11 -39.03 86.63 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.698 -173.978 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.477 ' OG ' HG23 ' A' ' 28' ' ' ILE . 73.1 p -57.1 -40.42 76.97 Favored 'General case' 0 C--O 1.237 0.395 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 177.209 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -65.94 -33.02 74.87 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 115.195 -0.911 . . . . 0.0 110.574 173.834 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.899 HD22 HD11 ' A' ' 56' ' ' ILE . 0.4 OUTLIER -66.12 -50.52 63.73 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.967 -179.774 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.494 HG12 ' O ' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -63.11 -42.43 96.56 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 177.497 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.618 HD21 ' HA ' ' A' ' 23' ' ' VAL . 6.1 tp -56.12 -38.16 70.4 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.37 0.605 . . . . 0.0 110.388 173.859 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 45.9 t60 -78.78 -7.61 57.98 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.018 -0.992 . . . . 0.0 111.598 178.728 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -66.62 -52.74 41.84 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 175.188 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -93.1 -10.84 34.56 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 122.098 0.952 . . . . 0.0 108.896 178.512 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 55.79 53.45 9.4 Favored 'General case' 0 CA--C 1.51 -0.576 0 CA-C-N 113.871 -1.513 . . . . 0.0 109.597 -175.026 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.404 HG13 HD12 ' A' ' 16' ' ' LEU . 7.6 p -99.87 160.07 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.723 0 CA-C-N 113.971 -1.468 . . . . 0.0 108.667 -176.96 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.509 ' O ' ' HG3' ' A' ' 27' ' ' LYS . 50.8 p -43.37 131.28 4.84 Favored 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 113.525 0.935 . . . . 0.0 113.525 -171.661 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.618 ' HA ' HD21 ' A' ' 16' ' ' LEU . 57.7 t -96.82 109.31 22.83 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.04 0 CA-C-N 114.283 -1.326 . . . . 0.0 110.863 -177.071 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.747 ' OG1' ' HG2' ' A' ' 27' ' ' LYS . 21.3 p -133.31 157.13 46.24 Favored 'General case' 0 C--O 1.245 0.855 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.186 179.457 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -53.27 -44.71 68.42 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.601 177.313 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -68.76 -24.97 64.5 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.282 179.589 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.747 ' HG2' ' OG1' ' A' ' 24' ' ' THR . 2.8 mmtm -61.44 -56.43 20.24 Favored 'General case' 0 CA--C 1.514 -0.407 0 N-CA-C 107.937 -1.135 . . . . 0.0 107.937 173.644 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.477 HG23 ' OG ' ' A' ' 12' ' ' SER . 83.5 mt -55.73 -43.3 73.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 113.728 -1.578 . . . . 0.0 110.818 -178.894 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.418 ' HA ' HD12 ' A' ' 32' ' ' ILE . 29.4 m-80 -65.52 -33.17 75.3 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.065 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.23 -48.88 76.41 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.333 176.072 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.674 ' HB3' HD21 ' B' ' 109' ' ' LEU . 1.9 mm? -59.53 -47.6 84.92 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-O 120.917 0.389 . . . . 0.0 110.617 175.939 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.564 HG23 ' O ' ' A' ' 37' ' ' VAL . 44.0 mt -48.58 -48.98 14.47 Favored 'Isoleucine or valine' 0 C--O 1.241 0.647 0 CA-C-N 115.227 -0.897 . . . . 0.0 111.277 178.166 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 42.5 tptt -72.57 -42.46 64.6 Favored 'General case' 0 N--CA 1.431 -1.399 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.607 -176.461 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -60.74 -40.4 92.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.948 0.404 . . . . 0.0 111.217 -177.848 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.467 ' HA ' HD11 ' B' ' 126' ' ' ILE . . . -79.96 -34.79 38.44 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.178 0.513 . . . . 0.0 111.105 178.967 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 97.75 17.66 29.93 Favored Glycine 0 N--CA 1.448 -0.548 0 CA-C-N 115.672 -0.695 . . . . 0.0 112.003 -179.567 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.909 ' HB ' ' HA2' ' B' ' 113' ' ' GLY . 2.9 p -119.69 119.32 60.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-O 121.599 0.714 . . . . 0.0 110.618 -176.567 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.457 ' HA ' HG23 ' A' ' 32' ' ' ILE . 13.6 t-20 -97.57 150.99 20.52 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 114.816 -1.084 . . . . 0.0 110.342 -170.345 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.849 ' HA ' ' HB3' ' A' ' 5' ' ' SER . 99.0 t -121.56 162.55 20.59 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.028 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.381 -169.497 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.48 ' HB3' ' HD1' ' A' ' 43' ' ' TRP . 5.1 tp10 -70.69 106.58 1.84 Allowed Pre-proline 0 N--CA 1.438 -1.04 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 169.665 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.502 ' C ' ' HD2' ' A' ' 44' ' ' PRO . 77.7 Cg_exo -51.71 -26.36 23.09 Favored 'Trans proline' 0 C--O 1.247 0.925 0 C-N-CA 123.818 3.012 . . . . 0.0 115.503 -164.199 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.418 ' HD2' ' HG3' ' A' ' 40' ' ' GLU . 0.6 OUTLIER -61.91 -27.32 68.73 Favored 'General case' 0 CA--C 1.526 0.048 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 177.898 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 43' ' ' TRP . . . . . 0.57 ' HE1' ' HG2' ' A' ' 6' ' ' GLU . 20.8 m95 -64.31 -59.63 10.48 Favored Pre-proline 0 C--O 1.208 -1.107 0 CA-C-O 118.626 -0.702 . . . . 0.0 110.977 176.04 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.502 ' HD2' ' C ' ' A' ' 41' ' ' PRO . 90.7 Cg_exo -45.26 -43.97 16.29 Favored 'Trans proline' 0 C--N 1.358 1.035 0 C-N-CA 121.733 1.622 . . . . 0.0 112.031 173.474 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -60.21 -59.11 10.95 Favored Glycine 0 CA--C 1.525 0.671 0 C-N-CA 120.36 -0.924 . . . . 0.0 112.581 176.649 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.439 ' O ' ' HB2' ' A' ' 49' ' ' LYS . 5.9 tp -67.46 -26.9 66.61 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 122.909 0.483 . . . . 0.0 112.108 -176.785 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.545 ' HE1' ' CE3' ' A' ' 43' ' ' TRP . 3.0 m-85 -69.05 -46.78 67.01 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 110.19 -0.3 . . . . 0.0 110.19 176.317 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.436 ' HA ' HG12 ' A' ' 23' ' ' VAL . . . -65.47 -32.02 73.42 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.322 -0.622 . . . . 0.0 109.322 178.229 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.439 ' HB2' ' O ' ' A' ' 46' ' ' LEU . 8.0 mmmt -60.44 -55.33 34.83 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 114.832 -1.077 . . . . 0.0 111.707 171.289 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.605 ' O ' HG22 ' A' ' 54' ' ' VAL . . . -76.4 -41.09 49.01 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 -170.211 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.568 ' HB2' HG11 ' A' ' 23' ' ' VAL . 12.7 mt -74.21 45.47 0.22 Allowed 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 121.473 0.654 . . . . 0.0 111.925 -173.279 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -134.68 -24.58 1.52 Allowed 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.05 -0.977 . . . . 0.0 109.026 172.837 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -121.39 -25.28 5.23 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 115.56 -0.746 . . . . 0.0 111.13 178.826 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.605 HG22 ' O ' ' A' ' 50' ' ' ALA . 10.4 m -99.64 -170.37 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 174.853 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 34.9 p30 -129.67 -178.39 4.67 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.794 175.59 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.899 HD11 HD22 ' A' ' 14' ' ' LEU . 3.1 tp -68.32 -28.69 41.58 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-O 120.642 0.258 . . . . 0.0 110.94 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -72.14 -11.05 74.74 Favored Glycine 0 N--CA 1.448 -0.5 0 C-N-CA 120.447 -0.882 . . . . 0.0 111.016 177.326 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 14.8 t -82.46 -19.21 39.34 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-O 121.598 0.713 . . . . 0.0 109.356 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.703 ' HB2' HG21 ' B' ' 159' ' ' ILE . 22.0 mt -64.0 -31.65 72.92 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.208 -0.906 . . . . 0.0 110.258 177.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.789 HG13 ' HB ' ' B' ' 159' ' ' ILE . 0.2 OUTLIER -63.22 -16.22 17.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 114.898 -1.047 . . . . 0.0 110.483 177.798 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 7.1 t -96.73 16.19 19.77 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 115.117 -0.947 . . . . 0.0 110.834 -178.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -56.86 -23.79 46.84 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.802 0.334 . . . . 0.0 111.451 -176.921 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 23.2 m -80.23 32.67 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 121.452 0.644 . . . . 0.0 111.475 178.834 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 179.59 -67.64 0.07 OUTLIER Glycine 0 N--CA 1.444 -0.768 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.879 -178.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . 53.47 30.66 10.88 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 123.02 0.528 . . . . 0.0 111.672 -178.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 138.12 -95.57 0.22 Allowed Glycine 0 N--CA 1.445 -0.712 0 N-CA-C 111.225 -0.75 . . . . 0.0 111.225 -176.151 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 170.47 115.67 0.35 Allowed Glycine 0 N--CA 1.446 -0.665 0 C-N-CA 120.714 -0.755 . . . . 0.0 111.852 178.494 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -61.24 109.26 0.69 Allowed 'Trans proline' 0 C--O 1.235 0.342 0 C-N-CA 122.591 2.194 . . . . 0.0 111.917 179.501 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.993 0 CA-C-O 118.732 -0.651 . . . . 0.0 110.082 -179.404 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 100' ' ' ALA . . . . . 0.59 ' N ' ' HG ' ' B' ' 164' ' ' SER . . . . . . . . 0 N--CA 1.479 0.976 0 CA-C-O 120.704 0.288 . . . . 0.0 110.658 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 101' ' ' MET . . . . . 0.54 ' HE3' HD12 ' A' ' 14' ' ' LEU . 1.2 tmt? -127.02 128.19 45.94 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.54 177.947 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 102' ' ' ARG . . . . . . . . . . . . . 74.3 mtt180 -152.99 -92.15 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 O-C-N 123.759 0.662 . . . . 0.0 110.31 172.636 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 103' ' ' TYR . . . . . 0.88 ' HB2' HG11 ' B' ' 142' ' ' VAL . 39.8 m-85 -79.1 -10.06 59.72 Favored 'General case' 0 C--O 1.24 0.556 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.076 -174.847 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 104' ' ' VAL . . . . . 0.707 HG11 ' HB3' ' B' ' 162' ' ' LEU . 97.8 t -43.64 -49.31 1.66 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.242 0 CA-C-O 121.701 0.763 . . . . 0.0 109.099 172.399 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 105' ' ' ALA . . . . . 0.652 ' CB ' ' HB3' ' A' ' 14' ' ' LEU . . . -64.17 -42.34 96.76 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 114.273 -1.331 . . . . 0.0 112.175 -173.919 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 106' ' ' SER . . . . . 0.773 ' HB2' HG23 ' B' ' 123' ' ' ILE . 0.8 OUTLIER -62.59 -37.68 87.17 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.687 0.756 . . . . 0.0 109.666 -179.747 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 107' ' ' TYR . . . . . 0.685 ' O ' ' HG2' ' B' ' 118' ' ' PRO . 43.6 t80 -63.41 -47.44 81.97 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 114.652 -1.158 . . . . 0.0 108.662 178.235 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 108' ' ' LEU . . . . . 0.831 HD12 HG13 ' B' ' 151' ' ' ILE . 0.0 OUTLIER -57.87 -46.44 84.85 Favored 'General case' 0 N--CA 1.442 -0.842 0 CA-C-N 114.766 -1.106 . . . . 0.0 110.866 177.194 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 109' ' ' LEU . . . . . 0.858 HD13 ' HB2' ' A' ' 11' ' ' TYR . 8.4 tp -54.85 -47.32 74.33 Favored 'General case' 0 CA--C 1.511 -0.543 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.916 179.047 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 110' ' ' ALA . . . . . 0.48 ' HB3' ' HB3' ' B' ' 118' ' ' PRO . . . -68.01 -36.61 80.27 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.59 -0.444 . . . . 0.0 111.334 -176.772 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 111' ' ' ALA . . . . . 0.788 ' HA ' ' O ' ' B' ' 115' ' ' ASN . . . -70.91 -20.0 62.53 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.411 0.624 . . . . 0.0 110.703 178.51 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 112' ' ' LEU . . . . . 0.974 ' HG ' HG13 ' A' ' 4' ' ' VAL . 2.8 mp -84.5 -40.18 17.97 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 114.962 -1.017 . . . . 0.0 109.762 172.191 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 113' ' ' GLY . . . . . 0.909 ' HA2' ' HB ' ' A' ' 37' ' ' VAL . . . -61.54 -53.65 42.22 Favored Glycine 0 N--CA 1.442 -0.904 0 CA-C-N 114.928 -1.033 . . . . 0.0 112.155 -177.942 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 114' ' ' GLY . . . . . . . . . . . . . . . 177.33 4.03 0.02 OUTLIER Glycine 0 N--CA 1.441 -1.01 0 C-N-CA 119.55 -1.31 . . . . 0.0 113.909 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 115' ' ' ASN . . . . . 0.788 ' O ' ' HA ' ' B' ' 111' ' ' ALA . 38.2 m-20 -126.78 98.89 5.54 Favored 'General case' 0 CA--C 1.497 -1.076 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 14.1 m -77.04 26.8 0.14 Allowed 'General case' 0 C--N 1.315 -0.9 0 CA-C-O 122.107 0.956 . . . . 0.0 109.763 -175.562 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 117' ' ' SER . . . . . 0.579 ' H ' ' C ' ' B' ' 115' ' ' ASN . 34.8 t -168.8 70.39 0.75 Allowed Pre-proline 0 C--N 1.321 -0.633 0 CA-C-N 113.738 -1.573 . . . . 0.0 108.385 178.924 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 118' ' ' PRO . . . . . 0.685 ' HG2' ' O ' ' B' ' 107' ' ' TYR . 34.1 Cg_exo -66.82 158.77 54.73 Favored 'Trans proline' 0 C--N 1.328 -0.547 0 C-N-CA 125.167 3.911 . . . . 0.0 111.675 -176.916 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 119' ' ' SER . . . . . 0.58 ' O ' HG12 ' B' ' 123' ' ' ILE . 8.6 m -122.31 -179.39 4.17 Favored 'General case' 0 C--N 1.316 -0.882 0 C-N-CA 120.555 -0.458 . . . . 0.0 110.875 176.175 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 120' ' ' ALA . . . . . 0.904 ' HB1' HD13 ' B' ' 139' ' ' LEU . . . -65.99 -36.46 83.36 Favored 'General case' 0 CA--C 1.504 -0.812 0 CA-C-O 122.219 1.009 . . . . 0.0 109.236 -173.347 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 121' ' ' LYS . . . . . 0.447 ' HD2' ' N ' ' B' ' 121' ' ' LYS . 0.4 OUTLIER -63.61 -34.86 78.77 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 113.332 -1.758 . . . . 0.0 110.101 176.782 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 122' ' ' ASP . . . . . 0.475 ' O ' HD13 ' B' ' 126' ' ' ILE . 18.5 m-20 -71.1 -37.6 72.38 Favored 'General case' 0 CA--C 1.517 -0.314 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 176.486 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 123' ' ' ILE . . . . . 0.773 HG23 ' HB2' ' B' ' 106' ' ' SER . 34.1 mm -61.83 -49.9 82.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.132 177.453 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 124' ' ' LYS . . . . . 0.818 ' HD3' HD21 ' B' ' 139' ' ' LEU . 4.2 mmmp? -58.91 -43.61 91.12 Favored 'General case' 0 C--O 1.213 -0.839 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.228 -178.862 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 125' ' ' LYS . . . . . 0.523 ' HA ' ' HD3' ' B' ' 125' ' ' LYS . 10.0 tppt? -50.51 -59.82 3.64 Favored 'General case' 0 N--CA 1.418 -2.056 0 O-C-N 123.721 0.638 . . . . 0.0 112.132 174.105 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 126' ' ' ILE . . . . . 0.579 HG23 HD12 ' A' ' 31' ' ' LEU . 1.7 mp -56.53 -47.63 81.61 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 CA-C-N 115.426 -0.806 . . . . 0.0 111.487 -176.282 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 127' ' ' LEU . . . . . 0.745 ' HG ' ' O ' ' B' ' 123' ' ' ILE . 2.2 pp -80.59 -19.59 45.2 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.306 -0.557 . . . . 0.0 112.103 -177.11 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 128' ' ' ASP . . . . . 0.516 ' HB2' ' O ' ' B' ' 124' ' ' LYS . 13.6 t70 -73.98 -31.16 62.86 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 179.367 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 129' ' ' SER . . . . . . . . . . . . . 84.1 p -52.63 -37.62 58.77 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.219 176.883 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 130' ' ' VAL . . . . . 0.559 HG23 HG13 ' B' ' 132' ' ' ILE . 7.5 m -103.95 5.85 10.35 Favored 'Isoleucine or valine' 0 C--O 1.232 0.137 0 CA-C-O 120.801 0.334 . . . . 0.0 111.536 179.324 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 131' ' ' GLY . . . . . . . . . . . . . . . 67.83 48.97 52.07 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 121.192 -0.528 . . . . 0.0 113.163 177.308 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 132' ' ' ILE . . . . . 0.565 ' HB ' ' HB2' ' B' ' 127' ' ' LEU . 8.7 mt -101.54 128.58 53.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-O 120.919 0.39 . . . . 0.0 110.963 178.229 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 133' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -67.47 136.45 54.65 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.187 -177.558 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 134' ' ' ALA . . . . . . . . . . . . . . . -152.57 143.61 23.07 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.182 -177.137 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 135' ' ' ASP . . . . . 0.733 ' HB2' ' HG3' ' B' ' 138' ' ' ARG . 34.1 m-20 -93.27 129.51 39.31 Favored 'General case' 0 C--O 1.251 1.149 0 CA-C-O 120.973 0.416 . . . . 0.0 110.12 174.772 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 136' ' ' ASP . . . . . 0.989 ' HA ' HD11 ' B' ' 139' ' ' LEU . 3.1 m-20 -71.22 -5.37 31.48 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-N 115.239 -0.892 . . . . 0.0 111.191 -169.949 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 137' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -100.53 -34.99 9.68 Favored 'General case' 0 N--CA 1.433 -1.282 0 C-N-CA 120.487 -0.485 . . . . 0.0 110.097 175.662 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 138' ' ' ARG . . . . . 0.733 ' HG3' ' HB2' ' B' ' 135' ' ' ASP . 43.7 mmt-85 -63.91 -46.23 85.74 Favored 'General case' 0 CA--C 1.503 -0.841 0 CA-C-O 122.118 0.961 . . . . 0.0 109.234 -176.323 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 139' ' ' LEU . . . . . 0.989 HD11 ' HA ' ' B' ' 136' ' ' ASP . 0.3 OUTLIER -74.16 -34.39 63.8 Favored 'General case' 0 C--O 1.209 -1.037 0 CA-C-N 114.529 -1.214 . . . . 0.0 111.6 -178.828 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 140' ' ' ASN . . . . . 0.628 ' H ' HD12 ' B' ' 139' ' ' LEU . 60.8 t30 -65.02 -27.98 69.18 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 122.331 1.062 . . . . 0.0 108.703 177.538 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 141' ' ' LYS . . . . . 0.607 ' O ' ' HG2' ' B' ' 145' ' ' GLU . 30.0 tttp -67.89 -56.0 10.72 Favored 'General case' 0 N--CA 1.44 -0.959 0 CA-C-N 114.141 -1.39 . . . . 0.0 108.882 175.918 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 142' ' ' VAL . . . . . 0.88 HG11 ' HB2' ' B' ' 103' ' ' TYR . 8.5 p -57.93 -31.57 41.22 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.236 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.449 178.827 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 143' ' ' ILE . . . . . 0.841 HG12 ' O ' ' B' ' 139' ' ' LEU . 28.1 mm -51.99 -67.41 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.513 -0.45 0 CA-C-O 121.151 0.501 . . . . 0.0 110.514 170.873 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 144' ' ' SER . . . . . . . . . . . . . 79.2 p -57.42 -25.42 59.58 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 114.96 -1.018 . . . . 0.0 111.89 -178.848 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 145' ' ' GLU . . . . . 0.607 ' HG2' ' O ' ' B' ' 141' ' ' LYS . 5.8 mm-40 -73.16 -46.47 50.6 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 120.898 0.38 . . . . 0.0 110.555 178.143 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 146' ' ' LEU . . . . . 0.722 ' HG ' ' O ' ' B' ' 142' ' ' VAL . 6.9 mt -82.63 -17.05 46.06 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.486 -0.324 . . . . 0.0 111.09 -176.593 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 147' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -56.54 111.84 1.11 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.207 0.527 . . . . 0.0 111.426 -175.817 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . 111.72 7.76 23.43 Favored Glycine 0 CA--C 1.519 0.33 0 CA-C-N 115.527 -0.76 . . . . 0.0 112.806 -179.285 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 149' ' ' LYS . . . . . 0.514 ' HE2' ' O ' ' B' ' 146' ' ' LEU . 0.8 OUTLIER -104.19 167.88 9.47 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.1 0.476 . . . . 0.0 111.038 -179.749 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 150' ' ' ASN . . . . . 0.511 ' O ' HG23 ' B' ' 154' ' ' VAL . 7.6 m-20 -103.93 91.01 3.79 Favored 'General case' 0 CA--C 1.511 -0.545 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 176.788 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 151' ' ' ILE . . . . . 0.831 HG13 HD12 ' B' ' 108' ' ' LEU . 1.8 mp -41.9 -62.87 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 O-C-N 124.376 1.048 . . . . 0.0 113.247 -168.936 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 152' ' ' GLU . . . . . 0.714 ' HG3' HD11 ' B' ' 112' ' ' LEU . 3.0 mp0 -57.42 -33.22 67.67 Favored 'General case' 0 C--O 1.219 -0.532 0 N-CA-C 111.839 0.311 . . . . 0.0 111.839 -174.487 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 153' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -78.52 -33.4 48.01 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.609 179.498 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 154' ' ' VAL . . . . . 0.783 ' HB ' HD12 ' B' ' 155' ' ' ILE . 58.2 t -54.84 -46.31 75.17 Favored 'Isoleucine or valine' 0 C--O 1.233 0.185 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 172.253 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 155' ' ' ILE . . . . . 0.783 HD12 ' HB ' ' B' ' 154' ' ' VAL . 2.3 mp -106.71 33.84 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 114.97 -1.014 . . . . 0.0 110.448 -179.314 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 156' ' ' ALA . . . . . 0.433 ' HB2' ' O ' ' B' ' 152' ' ' GLU . . . -101.75 2.99 39.1 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 167.526 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 157' ' ' GLN . . . . . . . . . . . . . 46.4 mt-30 -138.93 -1.42 1.79 Allowed 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 113.55 -1.659 . . . . 0.0 109.844 173.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 158' ' ' GLY . . . . . 0.406 ' O ' HG23 ' B' ' 155' ' ' ILE . . . -139.62 46.34 0.96 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.379 -0.915 . . . . 0.0 114.575 -167.274 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 159' ' ' ILE . . . . . 0.789 ' HB ' HG13 ' A' ' 60' ' ' ILE . 1.8 mp -61.59 -15.56 13.43 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 CA-C-O 122.039 0.923 . . . . 0.0 109.733 173.584 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 160' ' ' GLY . . . . . . . . . . . . . . . -129.49 144.57 15.62 Favored Glycine 0 N--CA 1.437 -1.29 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 178.509 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 161' ' ' LYS . . . . . 0.64 ' HG2' ' HD2' ' B' ' 166' ' ' PRO . 0.1 OUTLIER 51.8 41.83 29.53 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.777 0.289 . . . . 0.0 111.395 -168.343 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 162' ' ' LEU . . . . . 0.707 ' HB3' HG11 ' B' ' 104' ' ' VAL . 9.8 mp -29.12 123.39 0.13 Allowed 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 113.2 0.815 . . . . 0.0 113.2 172.302 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 163' ' ' ALA . . . . . . . . . . . . . . . 61.05 -68.58 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 O-C-N 124.383 1.052 . . . . 0.0 113.491 -178.542 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 164' ' ' SER . . . . . 0.59 ' HG ' ' N ' ' B' ' 100' ' ' ALA . 7.1 t -103.5 132.22 49.95 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-O 121.554 0.693 . . . . 0.0 112.173 -174.623 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 165' ' ' VAL . . . . . . . . . . . . . 23.0 t -114.37 132.48 22.78 Favored Pre-proline 0 C--N 1.317 -0.818 0 CA-C-N 114.763 -1.108 . . . . 0.0 109.217 178.654 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 166' ' ' PRO . . . . . 0.64 ' HD2' ' HG2' ' B' ' 161' ' ' LYS . 19.6 Cg_exo -12.51 116.44 0.01 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.369 1 C-N-CA 127.155 5.237 . . . . 0.0 117.009 -175.772 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 167' ' ' ALA . . . . . . . . . . . . . . . -130.96 66.41 1.53 Allowed 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 114.862 -1.063 . . . . 0.0 110.13 -179.239 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 168' ' ' GLY . . . . . . . . . . . . . . . 119.79 57.2 0.25 Allowed Glycine 0 N--CA 1.446 -0.654 0 CA-C-N 115.674 -0.693 . . . . 0.0 111.626 -176.29 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 169' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.984 0 CA-C-O 118.537 -1.146 . . . . 0.0 111.763 -179.049 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.4 ' HA ' ' CE ' ' A' ' 1' ' ' MET . 0.8 OUTLIER . . . . . 0 N--CA 1.481 1.116 0 N-CA-C 110.108 -0.33 . . . . 0.0 110.108 . . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.506 ' HB1' HD13 ' A' ' 7' ' ' LEU . . . 176.35 149.38 0.12 Allowed 'General case' 0 CA--C 1.508 -0.64 0 CA-C-N 115.45 -0.795 . . . . 0.0 109.21 178.618 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.745 ' HB2' ' HG3' ' A' ' 6' ' ' GLU . 6.2 m -83.27 119.16 24.24 Favored 'General case' 0 N--CA 1.439 -1.023 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 167.673 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.888 HG13 ' HG ' ' B' ' 112' ' ' LEU . 2.2 t -52.93 -28.22 13.64 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.78 0 CA-C-N 115.294 -0.866 . . . . 0.0 112.073 -179.573 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.746 ' HB3' ' HA ' ' A' ' 39' ' ' VAL . 71.7 m -68.45 -43.99 75.85 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.229 0.538 . . . . 0.0 109.784 175.723 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.745 ' HG3' ' HB2' ' A' ' 3' ' ' SER . 30.2 mt-10 -68.21 -49.04 63.44 Favored 'General case' 0 N--CA 1.444 -0.726 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 -178.209 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.877 ' HA ' HD12 ' A' ' 10' ' ' ILE . 2.9 tp -58.34 -35.01 71.27 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 114.443 -1.253 . . . . 0.0 111.949 175.396 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.579 ' HB2' HD23 ' B' ' 112' ' ' LEU . . . -68.37 -37.25 80.26 Favored 'General case' 0 CA--C 1.512 -0.484 0 CA-C-O 121.04 0.448 . . . . 0.0 110.786 179.054 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.528 ' HB2' HG11 ' A' ' 39' ' ' VAL . 4.6 t -67.35 -40.79 85.86 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 178.633 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.877 HD12 ' HA ' ' A' ' 7' ' ' LEU . 73.8 mt -48.92 -55.76 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.685 0 CA-C-N 113.896 -1.502 . . . . 0.0 110.051 171.896 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.852 ' HB2' HD13 ' B' ' 109' ' ' LEU . 23.9 m-85 -66.36 -41.46 89.46 Favored 'General case' 0 C--O 1.22 -0.455 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.557 -174.103 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.436 ' HA ' ' HG ' ' A' ' 31' ' ' LEU . 15.6 m -54.01 -42.09 68.7 Favored 'General case' 0 C--O 1.242 0.692 0 CA-C-O 121.489 0.661 . . . . 0.0 109.27 175.92 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -68.67 -28.94 67.32 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.39 176.154 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.693 HD22 HD11 ' A' ' 56' ' ' ILE . 0.2 OUTLIER -67.25 -55.58 13.41 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.49 179.34 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.404 HG12 ' O ' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -55.72 -43.84 74.99 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 176.889 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.597 HD12 HG13 ' A' ' 21' ' ' VAL . 3.8 tp -57.69 -44.27 85.73 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.501 177.75 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 25.1 t60 -75.73 -13.43 60.31 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.258 -0.883 . . . . 0.0 111.726 178.657 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.534 ' OD2' ' HA ' ' B' ' 102' ' ' ARG . 12.1 t0 -69.09 -42.31 76.34 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.247 0.546 . . . . 0.0 109.61 179.377 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.412 ' HB2' HG23 ' B' ' 132' ' ' ILE . 36.5 t70 -100.08 -7.04 25.4 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 122.032 0.92 . . . . 0.0 109.226 177.014 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 52.29 56.55 7.56 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-N 113.784 -1.553 . . . . 0.0 110.262 -175.286 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.597 HG13 HD12 ' A' ' 16' ' ' LEU . 6.1 p -106.21 159.45 6.18 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.679 0 CA-C-N 114.13 -1.396 . . . . 0.0 108.814 -178.825 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 82.2 p -49.8 139.1 13.74 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 114.193 1.183 . . . . 0.0 114.193 -169.48 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.604 HG12 ' HA ' ' A' ' 48' ' ' ALA . 63.1 t -103.77 111.86 35.06 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-N 114.216 -1.356 . . . . 0.0 110.986 -177.094 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.51 ' OG1' ' HE2' ' A' ' 27' ' ' LYS . 77.3 p -135.66 157.83 45.89 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 175.575 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -57.49 -41.23 80.29 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 120.71 -0.396 . . . . 0.0 110.094 -177.434 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -65.16 -29.92 70.8 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.08 178.344 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.51 ' HE2' ' OG1' ' A' ' 24' ' ' THR . 3.8 tppt? -66.53 -53.0 39.72 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 179.844 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 66.4 mt -60.41 -39.69 81.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 114.394 -1.275 . . . . 0.0 110.491 178.321 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 -61.97 -36.01 80.16 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.74 176.045 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.67 -45.59 92.1 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-N 116.552 -0.294 . . . . 0.0 110.484 177.732 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.562 ' HB3' HD21 ' B' ' 109' ' ' LEU . 1.3 mm? -58.35 -51.15 71.02 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 121.085 0.469 . . . . 0.0 110.13 173.838 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.561 HG23 ' O ' ' A' ' 37' ' ' VAL . 57.1 mt -48.28 -50.86 10.99 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 CA-C-N 114.873 -1.058 . . . . 0.0 111.646 178.686 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -69.82 -40.08 76.13 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.079 -0.51 . . . . 0.0 112.03 -176.748 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -64.2 -45.54 87.86 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-O 120.918 0.39 . . . . 0.0 111.093 -177.384 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.423 ' HB3' HG12 ' A' ' 37' ' ' VAL . . . -74.84 -34.82 62.36 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.429 178.669 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 96.96 18.48 29.36 Favored Glycine 0 N--CA 1.448 -0.554 0 CA-C-N 115.379 -0.828 . . . . 0.0 112.019 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.868 ' HB ' ' HA3' ' B' ' 113' ' ' GLY . 5.5 p -121.04 121.92 66.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 121.422 0.63 . . . . 0.0 111.059 -173.061 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 62.9 t30 -99.33 157.33 16.48 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.049 -0.978 . . . . 0.0 111.035 -169.308 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.746 ' HA ' ' HB3' ' A' ' 5' ' ' SER . 94.6 t -125.28 161.66 29.19 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.759 0 CA-C-N 115.056 -0.974 . . . . 0.0 110.937 -170.214 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.566 ' HB3' ' HD1' ' A' ' 43' ' ' TRP . 3.9 tp10 -67.65 105.41 0.9 Allowed Pre-proline 0 N--CA 1.441 -0.884 0 N-CA-C 107.756 -1.201 . . . . 0.0 107.756 169.972 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.522 ' C ' ' HD2' ' A' ' 44' ' ' PRO . 86.0 Cg_exo -49.54 -29.73 19.58 Favored 'Trans proline' 0 C--O 1.252 1.195 0 C-N-CA 123.602 2.868 . . . . 0.0 115.675 -163.767 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -60.76 -27.65 68.13 Favored 'General case' 0 C--N 1.333 -0.14 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 177.647 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' TRP . . . . . 0.566 ' HD1' ' HB3' ' A' ' 40' ' ' GLU . 9.6 m95 -65.08 -59.41 10.09 Favored Pre-proline 0 C--O 1.204 -1.337 0 CA-C-O 118.303 -0.856 . . . . 0.0 111.147 176.416 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.522 ' HD2' ' C ' ' A' ' 41' ' ' PRO . 83.3 Cg_exo -45.52 -44.46 17.0 Favored 'Trans proline' 0 C--N 1.359 1.086 0 C-N-CA 121.652 1.568 . . . . 0.0 111.913 174.622 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -60.4 -60.56 8.34 Favored Glycine 0 CA--C 1.525 0.68 0 C-N-CA 120.176 -1.012 . . . . 0.0 112.322 175.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 12.7 tp -65.79 -21.92 66.53 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.136 0.574 . . . . 0.0 112.11 -177.057 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.676 ' HD2' HD11 ' A' ' 51' ' ' LEU . 2.6 m-85 -74.72 -45.07 46.59 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 176.625 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.604 ' HA ' HG12 ' A' ' 23' ' ' VAL . . . -64.8 -30.23 71.22 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-O 121.821 0.82 . . . . 0.0 108.864 177.602 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 9.6 mmmt -66.27 -58.0 6.32 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 114.276 -1.329 . . . . 0.0 111.713 172.167 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.489 ' O ' HG22 ' A' ' 54' ' ' VAL . . . -76.03 -39.1 56.38 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 113.457 0.91 . . . . 0.0 113.457 -168.786 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.676 HD11 ' HD2' ' A' ' 47' ' ' PHE . 12.3 mt -68.85 -4.51 16.57 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 117.922 0.328 . . . . 0.0 111.7 -173.641 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -95.67 9.68 39.45 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.138 0.494 . . . . 0.0 110.296 174.726 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -143.62 -48.2 0.29 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.505 -178.697 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.489 HG22 ' O ' ' A' ' 50' ' ' ALA . 9.2 m -94.77 -169.55 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.282 179.851 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -121.59 -175.94 3.2 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.962 0.411 . . . . 0.0 111.3 178.199 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.693 HD11 HD22 ' A' ' 14' ' ' LEU . 3.0 tp -75.06 -28.46 20.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.356 -179.669 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -69.84 -15.5 71.49 Favored Glycine 0 N--CA 1.447 -0.571 0 N-CA-C 110.613 -0.995 . . . . 0.0 110.613 175.461 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 16.5 m -78.02 -19.61 54.05 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-O 121.174 0.511 . . . . 0.0 110.201 179.594 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.652 ' HB2' HG21 ' B' ' 159' ' ' ILE . 25.0 mt -64.16 -30.47 71.53 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.589 179.814 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.686 ' CD1' ' HB ' ' B' ' 159' ' ' ILE . 0.4 OUTLIER -67.11 -26.65 37.02 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-N 115.147 -0.933 . . . . 0.0 109.955 176.574 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 0.426 ' C ' ' H ' ' A' ' 63' ' ' VAL . 23.8 t -82.07 -45.12 15.66 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-N 115.168 -0.924 . . . . 0.0 110.065 178.746 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 10.1 p30 54.53 -13.83 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 116.247 1.944 . . . . 0.0 116.247 173.675 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.426 ' H ' ' C ' ' A' ' 61' ' ' CYS . 31.0 m -82.6 34.62 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-O 121.27 0.557 . . . . 0.0 111.597 179.369 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 57.94 62.94 5.73 Favored Glycine 0 N--CA 1.451 -0.301 0 CA-C-N 115.474 -0.785 . . . . 0.0 112.787 178.781 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -84.24 52.65 2.39 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.169 0.509 . . . . 0.0 110.846 -178.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -161.78 32.69 0.34 Allowed Glycine 0 N--CA 1.447 -0.602 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.802 -179.062 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -176.96 73.75 0.08 OUTLIER Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 120.684 -0.77 . . . . 0.0 111.975 -179.679 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -60.41 -52.26 4.21 Favored 'Trans proline' 0 C--O 1.233 0.271 0 C-N-CA 122.793 2.329 . . . . 0.0 112.267 -179.821 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.905 0 CA-C-O 118.658 -0.687 . . . . 0.0 110.411 179.211 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.971 0 CA-C-O 120.637 0.256 . . . . 0.0 110.493 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 101' ' ' MET . . . . . 0.603 ' HE1' HD12 ' A' ' 14' ' ' LEU . 4.3 ttt -137.57 129.22 28.45 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 111.884 0.327 . . . . 0.0 111.884 179.579 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 102' ' ' ARG . . . . . 0.534 ' HA ' ' OD2' ' A' ' 18' ' ' ASP . 4.7 ptp180 -170.02 125.9 0.81 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.303 166.713 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 103' ' ' TYR . . . . . 0.663 ' HB2' HG11 ' B' ' 142' ' ' VAL . 47.6 m-85 71.66 -25.66 0.17 Allowed 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.97 0.908 . . . . 0.0 112.087 177.762 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 104' ' ' VAL . . . . . 0.6 HG11 ' H ' ' B' ' 163' ' ' ALA . 82.9 t -45.42 -44.34 3.76 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.256 0 CA-C-O 121.515 0.674 . . . . 0.0 110.404 175.777 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 105' ' ' ALA . . . . . 0.669 ' CB ' ' HB3' ' A' ' 14' ' ' LEU . . . -67.41 -38.78 85.16 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 114.925 -1.034 . . . . 0.0 111.559 -174.853 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 106' ' ' SER . . . . . 0.829 ' HB2' HG23 ' B' ' 123' ' ' ILE . 1.8 m -60.79 -38.44 85.34 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-O 121.784 0.802 . . . . 0.0 109.189 175.979 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 107' ' ' TYR . . . . . 0.759 ' O ' ' HG2' ' B' ' 118' ' ' PRO . 38.4 t80 -63.27 -49.33 74.52 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-N 114.016 -1.447 . . . . 0.0 108.706 178.814 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 108' ' ' LEU . . . . . 0.679 HD12 HG13 ' B' ' 151' ' ' ILE . 0.0 OUTLIER -56.4 -50.49 71.44 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.164 -0.926 . . . . 0.0 111.711 178.772 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 109' ' ' LEU . . . . . 0.852 HD13 ' HB2' ' A' ' 11' ' ' TYR . 7.8 tp -53.93 -54.91 32.25 Favored 'General case' 0 C--O 1.246 0.906 0 CA-C-O 121.4 0.619 . . . . 0.0 111.011 178.996 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -57.05 -39.14 74.3 Favored 'General case' 0 C--O 1.22 -0.458 0 CA-C-N 114.975 -1.011 . . . . 0.0 110.423 -178.259 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 111' ' ' ALA . . . . . 0.734 ' HA ' ' O ' ' B' ' 115' ' ' ASN . . . -77.83 -19.54 54.74 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.706 -178.915 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 112' ' ' LEU . . . . . 0.888 ' HG ' HG13 ' A' ' 4' ' ' VAL . 4.4 tp -77.19 -40.0 46.78 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.418 -179.047 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 113' ' ' GLY . . . . . 0.868 ' HA3' ' HB ' ' A' ' 37' ' ' VAL . . . -144.95 44.68 0.88 Allowed Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 118.819 -1.658 . . . . 0.0 114.354 -176.75 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 114' ' ' GLY . . . . . . . . . . . . . . . -166.25 -49.21 0.02 OUTLIER Glycine 0 N--CA 1.444 -0.792 0 C-N-CA 119.214 -1.47 . . . . 0.0 113.139 175.489 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 115' ' ' ASN . . . . . 0.734 ' O ' ' HA ' ' B' ' 111' ' ' ALA . 1.8 t-20 -155.47 113.63 3.43 Favored 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 109.227 -0.656 . . . . 0.0 109.227 -171.757 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 4.0 m -79.97 26.01 0.35 Allowed 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 122.152 0.977 . . . . 0.0 111.02 -168.33 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 117' ' ' SER . . . . . 0.494 ' N ' ' HD3' ' B' ' 118' ' ' PRO . 8.9 t -172.31 69.82 0.43 Allowed Pre-proline 0 C--N 1.312 -1.022 0 CA-C-N 113.789 -1.55 . . . . 0.0 108.346 178.668 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 118' ' ' PRO . . . . . 0.759 ' HG2' ' O ' ' B' ' 107' ' ' TYR . 33.3 Cg_exo -62.07 157.44 44.25 Favored 'Trans proline' 0 CA--C 1.511 -0.651 1 C-N-CA 125.605 4.203 . . . . 0.0 112.155 -173.934 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 119' ' ' SER . . . . . 0.55 ' O ' HG12 ' B' ' 123' ' ' ILE . 14.7 m -131.73 -174.98 3.57 Favored 'General case' 0 C--N 1.317 -0.828 0 C-N-CA 119.715 -0.794 . . . . 0.0 111.842 178.784 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 120' ' ' ALA . . . . . 0.745 ' HB1' HD13 ' B' ' 139' ' ' LEU . . . -63.27 -40.77 98.33 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.719 0.771 . . . . 0.0 109.611 -165.177 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 121' ' ' LYS . . . . . . . . . . . . . 1.8 mptm? -62.71 -36.83 84.22 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 114.078 -1.419 . . . . 0.0 110.86 177.304 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 122' ' ' ASP . . . . . . . . . . . . . 44.8 m-20 -70.42 -40.13 74.01 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 120.182 -0.607 . . . . 0.0 109.55 -178.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 123' ' ' ILE . . . . . 0.829 HG23 ' HB2' ' B' ' 106' ' ' SER . 23.3 mm -60.19 -42.94 92.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.52 175.581 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 124' ' ' LYS . . . . . 0.845 ' HD3' HD21 ' B' ' 139' ' ' LEU . 2.2 mmmp? -59.02 -39.73 82.84 Favored 'General case' 0 CA--C 1.504 -0.819 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 -178.875 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 125' ' ' LYS . . . . . . . . . . . . . 86.8 mttt -56.81 -61.69 2.26 Favored 'General case' 0 CA--C 1.489 -1.382 0 C-N-CA 119.274 -0.97 . . . . 0.0 110.841 173.653 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 126' ' ' ILE . . . . . 0.49 HG23 HD12 ' A' ' 31' ' ' LEU . 1.8 mp -57.44 -36.99 55.26 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.118 0 CA-C-N 114.282 -1.326 . . . . 0.0 110.951 -166.855 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 127' ' ' LEU . . . . . 0.75 ' HG ' ' O ' ' B' ' 123' ' ' ILE . 1.2 pp -80.68 -39.29 27.47 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.172 -0.611 . . . . 0.0 111.648 178.126 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 128' ' ' ASP . . . . . 0.459 ' N ' HD12 ' B' ' 127' ' ' LEU . 9.8 m-20 -70.0 -26.39 64.05 Favored 'General case' 0 N--CA 1.466 0.331 0 O-C-N 122.096 -0.377 . . . . 0.0 111.109 -179.438 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 129' ' ' SER . . . . . . . . . . . . . 84.4 p -60.11 -33.86 72.69 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.72 -177.169 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 130' ' ' VAL . . . . . . . . . . . . . 4.7 m -99.11 -34.16 4.3 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.398 175.679 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 131' ' ' GLY . . . . . . . . . . . . . . . 122.11 45.01 0.34 Allowed Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.233 179.664 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 132' ' ' ILE . . . . . 0.419 ' HB ' ' HB2' ' B' ' 127' ' ' LEU . 24.4 mt -112.17 136.32 48.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 179.424 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 133' ' ' GLU . . . . . . . . . . . . . 26.9 mm-40 -89.86 154.65 19.72 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.235 0.541 . . . . 0.0 111.743 -174.748 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 134' ' ' ALA . . . . . 0.543 ' HB2' HD22 ' B' ' 127' ' ' LEU . . . -153.21 145.26 23.74 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.078 -0.964 . . . . 0.0 112.049 -172.771 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 135' ' ' ASP . . . . . 0.682 ' HB2' ' CG ' ' B' ' 138' ' ' ARG . 53.9 m-20 -93.91 133.52 37.25 Favored 'General case' 0 C--O 1.251 1.161 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 170.728 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 136' ' ' ASP . . . . . 1.001 ' HA ' HD11 ' B' ' 139' ' ' LEU . 10.1 p-10 -72.03 -5.15 33.03 Favored 'General case' 0 CA--C 1.513 -0.464 0 CA-C-N 115.109 -0.951 . . . . 0.0 111.006 -169.654 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 137' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -101.04 -30.74 11.44 Favored 'General case' 0 N--CA 1.433 -1.293 0 C-N-CA 120.225 -0.59 . . . . 0.0 110.286 173.018 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 138' ' ' ARG . . . . . 0.682 ' CG ' ' HB2' ' B' ' 135' ' ' ASP . 36.3 mmt180 -66.22 -44.89 82.53 Favored 'General case' 0 CA--C 1.503 -0.855 0 CA-C-O 121.59 0.71 . . . . 0.0 109.86 -175.849 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 139' ' ' LEU . . . . . 1.001 HD11 ' HA ' ' B' ' 136' ' ' ASP . 0.3 OUTLIER -74.55 -33.79 62.81 Favored 'General case' 0 C--N 1.313 -0.981 0 C-N-CA 119.53 -0.868 . . . . 0.0 111.238 178.271 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 140' ' ' ASN . . . . . 0.482 ' H ' HD12 ' B' ' 139' ' ' LEU . 58.8 t30 -68.97 -27.61 65.88 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 -176.809 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 141' ' ' LYS . . . . . 0.669 ' HG3' ' O ' ' B' ' 138' ' ' ARG . 0.0 OUTLIER -86.2 -38.25 17.85 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.02 -0.991 . . . . 0.0 110.46 -177.944 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 142' ' ' VAL . . . . . 0.663 HG11 ' HB2' ' B' ' 103' ' ' TYR . 11.1 p -60.99 -44.8 98.95 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.636 0 N-CA-C 108.82 -0.808 . . . . 0.0 108.82 175.679 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 143' ' ' ILE . . . . . 0.754 HD11 ' CG1' ' B' ' 123' ' ' ILE . 16.1 mt -58.9 -45.61 91.71 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.88 0 C-N-CA 123.752 0.821 . . . . 0.0 112.36 171.219 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 144' ' ' SER . . . . . . . . . . . . . 30.9 t -52.82 -34.77 55.38 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.983 177.188 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 145' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -86.26 -40.49 15.48 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.369 177.729 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 146' ' ' LEU . . . . . 0.573 ' HB3' ' CZ ' ' B' ' 107' ' ' TYR . 2.6 mm? -61.72 -41.25 97.38 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 123.557 0.743 . . . . 0.0 112.388 177.878 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 147' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -45.84 124.3 5.16 Favored 'General case' 0 C--O 1.233 0.202 0 O-C-N 123.906 0.754 . . . . 0.0 111.788 -171.725 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . 86.96 59.2 1.8 Allowed Glycine 0 N--CA 1.447 -0.589 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.301 -175.544 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 149' ' ' LYS . . . . . 0.535 ' HB2' ' O ' ' B' ' 146' ' ' LEU . 3.3 tppt? -143.25 160.22 40.88 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 -177.538 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 150' ' ' ASN . . . . . 0.59 ' O ' HG23 ' B' ' 154' ' ' VAL . 17.5 m120 -105.33 88.72 2.92 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 176.901 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 151' ' ' ILE . . . . . 0.679 HG13 HD12 ' B' ' 108' ' ' LEU . 1.7 mp -42.92 -61.46 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 114.694 -1.139 . . . . 0.0 113.445 -168.59 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 152' ' ' GLU . . . . . 0.405 ' N ' HG22 ' B' ' 151' ' ' ILE . 30.9 mt-10 -54.6 -41.24 69.71 Favored 'General case' 0 C--O 1.216 -0.687 0 N-CA-C 112.271 0.471 . . . . 0.0 112.271 -174.038 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 153' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -74.78 -30.77 61.55 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.816 -0.354 . . . . 0.0 110.589 -177.921 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 154' ' ' VAL . . . . . 0.832 ' HB ' HD12 ' B' ' 155' ' ' ILE . 44.9 t -56.01 -48.58 78.59 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 CA-C-O 121.86 0.838 . . . . 0.0 109.141 171.077 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 155' ' ' ILE . . . . . 0.832 HD12 ' HB ' ' B' ' 154' ' ' VAL . 1.8 mp -109.15 44.1 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.096 -0.956 . . . . 0.0 110.961 -178.479 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . -112.65 3.02 16.39 Favored 'General case' 0 C--N 1.306 -1.283 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 167.428 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 157' ' ' GLN . . . . . . . . . . . . . 91.6 mt-30 -138.51 -5.02 1.6 Allowed 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 113.5 -1.682 . . . . 0.0 110.002 176.276 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 158' ' ' GLY . . . . . 0.55 ' O ' HD12 ' B' ' 162' ' ' LEU . . . -137.85 44.9 1.09 Allowed Glycine 0 C--O 1.223 -0.539 0 C-N-CA 120.153 -1.023 . . . . 0.0 113.86 -172.503 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 159' ' ' ILE . . . . . 0.686 ' HB ' ' CD1' ' A' ' 60' ' ' ILE . 1.8 mp -57.62 -28.49 32.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 CA-C-O 121.015 0.436 . . . . 0.0 110.983 175.7 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 160' ' ' GLY . . . . . . . . . . . . . . . -96.92 -54.78 1.26 Allowed Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.524 -0.846 . . . . 0.0 112.944 -179.814 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 161' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.75 -34.47 78.26 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 113.905 1.076 . . . . 0.0 113.905 -177.652 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 162' ' ' LEU . . . . . 0.55 HD12 ' O ' ' B' ' 158' ' ' GLY . 5.3 mp 45.03 -162.7 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 113.914 1.079 . . . . 0.0 113.914 -171.295 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 163' ' ' ALA . . . . . 0.6 ' H ' HG11 ' B' ' 104' ' ' VAL . . . 50.56 -90.85 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.168 0 C-N-CA 124.191 0.996 . . . . 0.0 113.257 -179.776 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 164' ' ' SER . . . . . . . . . . . . . 7.3 p -144.39 111.82 6.04 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.202 0.525 . . . . 0.0 110.748 179.317 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 165' ' ' VAL . . . . . 0.454 ' HA ' ' HD2' ' B' ' 166' ' ' PRO . 2.2 t -106.34 123.67 38.17 Favored Pre-proline 0 C--N 1.322 -0.62 0 CA-C-N 115.692 -0.686 . . . . 0.0 109.265 178.002 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 166' ' ' PRO . . . . . 0.454 ' HD2' ' HA ' ' B' ' 165' ' ' VAL . 45.0 Cg_exo -17.1 110.65 0.01 OUTLIER 'Trans proline' 0 N--CA 1.44 -1.671 1 C-N-CA 126.964 5.11 . . . . 0.0 115.727 -178.328 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 167' ' ' ALA . . . . . . . . . . . . . . . -115.42 -24.33 8.43 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.509 -176.789 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 168' ' ' GLY . . . . . . . . . . . . . . . -129.75 -40.78 0.26 Allowed Glycine 0 N--CA 1.446 -0.653 0 N-CA-C 111.169 -0.772 . . . . 0.0 111.169 175.574 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 169' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.934 0 CA-C-O 118.635 -1.092 . . . . 0.0 111.363 176.269 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.644 ' HA ' ' HB1' ' B' ' 156' ' ' ALA . 23.6 ttt . . . . . 0 N--CA 1.479 1.011 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.866 ' HB3' HD13 ' A' ' 7' ' ' LEU . . . -130.75 157.49 42.68 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.087 -177.831 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.574 ' HB2' ' HG3' ' A' ' 6' ' ' GLU . 14.5 m -69.57 139.33 53.71 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 170.134 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.853 HG13 ' HG ' ' B' ' 112' ' ' LEU . 2.4 t -58.04 -23.72 22.02 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 CA-C-N 115.005 -0.998 . . . . 0.0 111.693 -177.084 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.703 ' HB2' ' HA ' ' A' ' 39' ' ' VAL . 11.4 p -70.5 -53.92 14.27 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.855 0.836 . . . . 0.0 109.044 174.662 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.574 ' HG3' ' HB2' ' A' ' 3' ' ' SER . 32.1 mt-10 -56.29 -47.74 78.04 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 114.862 -1.063 . . . . 0.0 109.899 177.962 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.866 HD13 ' HB3' ' A' ' 2' ' ' ALA . 3.6 tp -61.22 -39.73 91.35 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.522 178.791 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -60.94 -37.72 83.32 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 121.162 0.506 . . . . 0.0 110.937 176.839 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.538 ' HB2' HG11 ' A' ' 39' ' ' VAL . 7.4 t -69.94 -43.09 72.31 Favored 'General case' 0 C--O 1.24 0.587 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.833 HD12 HD12 ' A' ' 7' ' ' LEU . 72.6 mt -46.2 -56.4 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 CA-C-N 113.993 -1.458 . . . . 0.0 109.715 171.703 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.632 ' OH ' ' HB ' ' B' ' 155' ' ' ILE . 23.5 m-85 -63.33 -40.03 96.17 Favored 'General case' 0 C--O 1.216 -0.689 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.448 -175.413 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.618 ' HB2' HG23 ' A' ' 28' ' ' ILE . 19.4 m -56.76 -41.49 77.71 Favored 'General case' 0 C--O 1.24 0.593 0 CA-C-O 121.482 0.658 . . . . 0.0 109.403 179.005 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -65.85 -34.32 77.87 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.124 174.595 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.804 HD22 HD11 ' A' ' 56' ' ' ILE . 0.3 OUTLIER -63.01 -53.37 54.94 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.437 179.719 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.832 HD11 HD12 ' B' ' 109' ' ' LEU . 0.0 OUTLIER -58.9 -37.6 68.04 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.542 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 178.146 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.575 HD21 ' HA ' ' A' ' 23' ' ' VAL . 1.6 tp -58.88 -35.04 72.35 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.429 175.805 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' HIS . . . . . 0.495 ' O ' ' HG2' ' A' ' 20' ' ' GLU . 80.4 m-70 -73.76 -16.5 61.17 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 112.776 0.658 . . . . 0.0 112.776 175.243 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.467 ' OD2' ' HG2' ' B' ' 102' ' ' ARG . 6.8 t70 -59.07 -46.96 86.94 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 121.063 0.459 . . . . 0.0 109.829 178.422 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.632 ' HB2' HG23 ' B' ' 132' ' ' ILE . 29.9 t70 -100.91 -13.06 18.49 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.597 0.713 . . . . 0.0 109.397 177.407 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.495 ' HG2' ' O ' ' A' ' 17' ' ' HIS . 5.3 mm-40 63.18 44.56 5.63 Favored 'General case' 0 CA--C 1.519 -0.245 0 CA-C-N 114.496 -1.229 . . . . 0.0 109.689 -175.925 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.681 HG22 ' H ' ' A' ' 22' ' ' THR . 14.8 p -99.92 177.96 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.134 0 CA-C-N 114.518 -1.219 . . . . 0.0 110.233 -168.873 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.681 ' H ' HG22 ' A' ' 21' ' ' VAL . 23.6 p -49.62 137.88 14.9 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 113.874 1.065 . . . . 0.0 113.874 -174.372 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.655 HG12 ' HA ' ' A' ' 48' ' ' ALA . 46.2 t -109.7 109.07 27.03 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.177 0 CA-C-N 113.961 -1.472 . . . . 0.0 110.193 -179.546 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.598 ' OG1' ' HB2' ' A' ' 27' ' ' LYS . 69.1 p -136.08 158.23 44.91 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.158 178.284 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -52.87 -46.57 67.94 Favored 'General case' 0 C--N 1.32 -0.7 0 O-C-N 123.508 0.505 . . . . 0.0 110.094 178.09 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -67.39 -26.3 66.38 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.582 -0.735 . . . . 0.0 111.364 -179.543 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.598 ' HB2' ' OG1' ' A' ' 24' ' ' THR . 3.7 tppt? -70.67 -54.43 11.91 Favored 'General case' 0 C--O 1.24 0.597 0 CA-C-O 121.856 0.836 . . . . 0.0 108.823 -179.1 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.618 HG23 ' HB2' ' A' ' 12' ' ' SER . 77.7 mt -59.04 -43.17 88.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 114.253 -1.339 . . . . 0.0 110.349 178.498 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.472 ' HA ' ' HB ' ' A' ' 32' ' ' ILE . 6.1 m-20 -68.61 -26.53 65.4 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.212 178.705 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.62 -47.73 80.19 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 174.144 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.557 ' HG ' HG13 ' A' ' 15' ' ' ILE . 1.5 mm? -58.48 -51.54 69.43 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 121.296 0.569 . . . . 0.0 110.093 174.204 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.67 HG23 ' O ' ' A' ' 37' ' ' VAL . 64.7 mt -48.42 -48.46 13.97 Favored 'Isoleucine or valine' 0 C--O 1.243 0.747 0 CA-C-N 114.652 -1.158 . . . . 0.0 112.111 179.099 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 53.0 tptt -75.34 -43.6 49.79 Favored 'General case' 0 N--CA 1.434 -1.231 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.781 -175.619 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -62.21 -37.26 84.67 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.619 0.247 . . . . 0.0 110.855 -178.252 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -80.04 -36.83 35.15 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.03 0.443 . . . . 0.0 110.951 177.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 103.11 16.03 22.16 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.599 176.462 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.805 ' HB ' ' HA2' ' B' ' 113' ' ' GLY . 2.7 p -118.24 118.27 57.52 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.546 0 CA-C-O 121.385 0.612 . . . . 0.0 110.455 -177.642 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 -95.87 158.85 15.26 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 114.85 -1.068 . . . . 0.0 110.832 -169.169 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.703 ' HA ' ' HB2' ' A' ' 5' ' ' SER . 96.0 t -129.63 164.95 30.86 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.781 0 CA-C-N 115.055 -0.975 . . . . 0.0 110.442 -168.836 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.56 ' HB2' ' CD1' ' A' ' 43' ' ' TRP . 21.9 mt-10 -65.85 111.88 7.48 Favored Pre-proline 0 CA--C 1.489 -1.367 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 167.481 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.456 ' HD3' ' HA ' ' A' ' 40' ' ' GLU . 69.9 Cg_exo -54.41 -29.64 59.71 Favored 'Trans proline' 0 C--N 1.311 -1.421 0 C-N-CA 123.244 2.629 . . . . 0.0 113.713 -167.776 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 1.7 p90 -61.36 -29.07 69.68 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 175.332 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' TRP . . . . . 0.56 ' CD1' ' HB2' ' A' ' 40' ' ' GLU . 8.2 m95 -62.72 -60.31 10.23 Favored Pre-proline 0 C--O 1.208 -1.119 0 CA-C-O 118.474 -0.774 . . . . 0.0 110.677 176.646 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.463 ' HD3' ' HB2' ' A' ' 43' ' ' TRP . 86.7 Cg_exo -47.15 -43.26 25.76 Favored 'Trans proline' 0 C--N 1.361 1.209 0 C-N-CA 121.894 1.73 . . . . 0.0 112.224 174.261 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -60.74 -59.18 10.64 Favored Glycine 0 CA--C 1.526 0.736 0 C-N-CA 120.124 -1.036 . . . . 0.0 112.444 176.804 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 4.5 tp -66.91 -26.57 66.93 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.467 0.707 . . . . 0.0 111.912 -176.846 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.728 ' HD2' HD11 ' A' ' 51' ' ' LEU . 2.9 m-85 -70.7 -46.67 62.69 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 175.615 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.655 ' HA ' HG12 ' A' ' 23' ' ' VAL . . . -62.66 -32.96 74.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.738 0.78 . . . . 0.0 109.115 179.198 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 9.2 mmmt -63.49 -62.77 1.45 Allowed 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 114.34 -1.3 . . . . 0.0 111.666 172.493 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -75.62 -31.68 59.99 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 113.709 1.003 . . . . 0.0 113.709 -167.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.728 HD11 ' HD2' ' A' ' 47' ' ' PHE . 13.1 mt -70.96 7.41 1.18 Allowed 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 112.843 0.683 . . . . 0.0 112.843 -174.136 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -101.88 5.26 40.88 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.49 0.662 . . . . 0.0 109.821 171.858 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 25.8 t30 -139.52 -52.8 0.54 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.421 -178.117 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 4.3 m -82.2 175.08 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.012 -179.702 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -113.69 165.31 12.66 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.253 176.511 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.804 HD11 HD22 ' A' ' 14' ' ' LEU . 3.9 tp -62.03 -25.18 36.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 120.838 0.352 . . . . 0.0 110.638 179.296 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -70.46 -14.95 72.53 Favored Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.816 -0.707 . . . . 0.0 111.548 177.048 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 20.4 t -78.04 -20.34 52.59 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-O 121.543 0.687 . . . . 0.0 109.549 179.701 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.692 ' HB2' HG21 ' B' ' 159' ' ' ILE . 19.8 mt -64.63 -29.63 70.64 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.434 179.515 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.766 HG13 ' HB ' ' B' ' 159' ' ' ILE . 0.2 OUTLIER -65.99 -16.28 20.34 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-N 114.737 -1.12 . . . . 0.0 110.613 179.358 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 14.4 t -95.68 -5.54 42.02 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.646 -178.116 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 77.1 m-20 -65.05 -19.09 65.82 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-O 121.076 0.465 . . . . 0.0 111.188 -175.626 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.407 ' O ' HG13 ' A' ' 63' ' ' VAL . 9.0 p -82.89 60.87 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 122.894 1.331 . . . . 0.0 109.351 173.727 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 154.15 -41.99 0.63 Allowed Glycine 0 N--CA 1.447 -0.571 0 CA-C-N 114.146 -1.388 . . . . 0.0 111.398 -177.75 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -96.6 64.15 2.12 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.339 0.59 . . . . 0.0 109.937 177.682 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 173.82 43.02 0.05 OUTLIER Glycine 0 N--CA 1.448 -0.537 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.966 178.882 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.446 ' HA3' ' HD3' ' A' ' 68' ' ' PRO . . . -116.32 -98.82 2.11 Favored Glycine 0 N--CA 1.446 -0.633 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.143 -179.389 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.446 ' HD3' ' HA3' ' A' ' 67' ' ' GLY . 10.4 Cg_exo -71.47 77.46 1.72 Allowed 'Trans proline' 0 C--O 1.235 0.336 0 C-N-CA 123.362 2.708 . . . . 0.0 112.745 -177.801 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.921 0 CA-C-O 118.41 -0.805 . . . . 0.0 109.747 175.981 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 100' ' ' ALA . . . . . 0.507 ' O ' HG21 ' B' ' 104' ' ' VAL . . . . . . . . 0 N--CA 1.478 0.943 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 101' ' ' MET . . . . . 0.642 ' HG2' HD22 ' B' ' 162' ' ' LEU . 1.4 tmt? -119.61 130.86 55.31 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 120.761 -0.375 . . . . 0.0 111.381 -177.12 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 102' ' ' ARG . . . . . 0.467 ' HG2' ' OD2' ' A' ' 18' ' ' ASP . 1.0 OUTLIER -172.52 -91.12 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.236 -0.893 . . . . 0.0 109.189 171.039 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 103' ' ' TYR . . . . . 0.663 ' HB2' HG11 ' B' ' 142' ' ' VAL . 51.7 m-85 -81.01 -10.08 59.75 Favored 'General case' 0 C--O 1.239 0.501 0 CA-C-O 121.102 0.477 . . . . 0.0 110.275 179.024 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 104' ' ' VAL . . . . . 0.594 HG11 ' HB3' ' B' ' 162' ' ' LEU . 61.2 t -46.61 -47.21 7.44 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.534 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.088 174.798 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 105' ' ' ALA . . . . . 0.608 ' CB ' ' HB3' ' A' ' 14' ' ' LEU . . . -67.0 -38.1 85.38 Favored 'General case' 0 N--CA 1.443 -0.81 0 CA-C-N 114.826 -1.079 . . . . 0.0 111.425 -173.776 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 106' ' ' SER . . . . . 0.833 ' HB2' HG23 ' B' ' 123' ' ' ILE . 1.3 m -60.48 -38.83 85.54 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 121.815 0.817 . . . . 0.0 109.251 176.167 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 107' ' ' TYR . . . . . 0.799 ' HD2' HG12 ' B' ' 143' ' ' ILE . 32.5 t80 -63.07 -49.11 75.81 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 114.272 -1.331 . . . . 0.0 108.945 179.097 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 108' ' ' LEU . . . . . 0.724 HD12 HG13 ' B' ' 151' ' ' ILE . 0.0 OUTLIER -58.92 -49.2 78.7 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 114.987 -1.006 . . . . 0.0 111.337 179.029 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 109' ' ' LEU . . . . . 0.832 HD12 HD11 ' A' ' 15' ' ' ILE . 0.3 OUTLIER -55.42 -43.16 75.05 Favored 'General case' 0 CA--C 1.506 -0.746 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.613 178.671 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.5 -43.45 90.09 Favored 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 120.496 -0.482 . . . . 0.0 110.819 -178.514 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 111' ' ' ALA . . . . . 0.664 ' HA ' ' O ' ' B' ' 115' ' ' ASN . . . -64.71 -26.23 68.28 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.607 179.174 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 112' ' ' LEU . . . . . 0.853 ' HG ' HG13 ' A' ' 4' ' ' VAL . 3.5 mp -80.39 -38.32 30.52 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.245 -0.889 . . . . 0.0 110.244 174.128 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 113' ' ' GLY . . . . . 0.805 ' HA2' ' HB ' ' A' ' 37' ' ' VAL . . . -68.5 -17.21 70.47 Favored Glycine 0 N--CA 1.449 -0.497 0 CA-C-N 115.263 -0.88 . . . . 0.0 112.348 -176.934 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 114' ' ' GLY . . . . . . . . . . . . . . . 133.33 3.4 3.45 Favored Glycine 0 N--CA 1.437 -1.299 0 C-N-CA 120.394 -0.908 . . . . 0.0 113.168 176.738 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 115' ' ' ASN . . . . . 0.664 ' O ' ' HA ' ' B' ' 111' ' ' ALA . 47.9 t30 -118.69 86.27 2.51 Favored 'General case' 0 N--CA 1.441 -0.884 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 178.224 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 7.4 m -80.23 31.09 0.27 Allowed 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 122.488 1.137 . . . . 0.0 110.748 -167.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 117' ' ' SER . . . . . 0.528 ' N ' ' HD3' ' B' ' 118' ' ' PRO . 15.6 t -171.0 67.64 0.47 Allowed Pre-proline 0 C--N 1.309 -1.172 0 CA-C-N 113.12 -1.855 . . . . 0.0 107.971 178.248 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 118' ' ' PRO . . . . . 0.607 ' HD2' ' CZ ' ' B' ' 107' ' ' TYR . 31.9 Cg_exo -66.08 166.67 20.17 Favored 'Trans proline' 0 CA--C 1.515 -0.431 0 C-N-CA 125.275 3.983 . . . . 0.0 111.58 -174.72 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 119' ' ' SER . . . . . 0.652 ' O ' HG12 ' B' ' 123' ' ' ILE . 16.4 m -145.59 -178.51 6.13 Favored 'General case' 0 C--N 1.317 -0.809 0 C-N-CA 120.225 -0.59 . . . . 0.0 111.592 178.622 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 120' ' ' ALA . . . . . 0.788 ' HB1' HD13 ' B' ' 139' ' ' LEU . . . -62.68 -45.8 91.12 Favored 'General case' 0 CA--C 1.508 -0.639 0 CA-C-O 122.036 0.922 . . . . 0.0 110.173 -163.888 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 121' ' ' LYS . . . . . 0.415 ' HD2' ' N ' ' B' ' 121' ' ' LYS . 12.9 mptt -66.72 -30.39 70.61 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 113.674 -1.603 . . . . 0.0 110.871 178.538 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 122' ' ' ASP . . . . . 0.437 ' O ' ' HB2' ' B' ' 125' ' ' LYS . 18.0 t0 -72.91 -39.09 66.61 Favored 'General case' 0 C--O 1.24 0.58 0 CA-C-O 122.004 0.907 . . . . 0.0 109.025 179.744 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 123' ' ' ILE . . . . . 0.833 HG23 ' HB2' ' B' ' 106' ' ' SER . 39.8 mm -59.93 -42.97 91.18 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.264 0 CA-C-N 114.549 -1.205 . . . . 0.0 109.657 173.236 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 124' ' ' LYS . . . . . 0.817 ' HD3' HD21 ' B' ' 139' ' ' LEU . 3.9 mmmp? -59.17 -42.52 90.97 Favored 'General case' 0 CA--C 1.504 -0.797 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.444 -178.784 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 125' ' ' LYS . . . . . 0.529 ' HD3' ' HA ' ' B' ' 125' ' ' LYS . 30.3 mmtt -50.38 -64.72 0.72 Allowed 'General case' 0 CA--C 1.502 -0.879 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 169.72 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 126' ' ' ILE . . . . . 0.48 HG23 HD12 ' A' ' 31' ' ' LEU . 1.7 mp -53.96 -44.41 61.58 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.857 0 CA-C-N 114.841 -1.072 . . . . 0.0 111.256 -170.217 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 127' ' ' LEU . . . . . 0.63 ' HG ' ' O ' ' B' ' 123' ' ' ILE . 3.6 pp -80.31 -24.74 39.74 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 -177.387 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 128' ' ' ASP . . . . . 0.434 ' N ' HD12 ' B' ' 127' ' ' LEU . 34.6 t70 -71.39 -27.51 63.37 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.584 -0.525 . . . . 0.0 109.584 178.831 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 129' ' ' SER . . . . . . . . . . . . . 17.4 t -60.92 -27.73 68.41 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.602 177.684 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 130' ' ' VAL . . . . . 0.46 HG23 HG13 ' B' ' 132' ' ' ILE . 3.7 m -107.38 -13.42 10.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 C-N-CA 120.813 -0.355 . . . . 0.0 111.483 177.521 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 131' ' ' GLY . . . . . . . . . . . . . . . 85.15 49.16 4.57 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 121.149 -0.548 . . . . 0.0 112.389 177.856 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 132' ' ' ILE . . . . . 0.632 HG23 ' HB2' ' A' ' 19' ' ' ASP . 11.5 mt -105.5 138.89 28.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-O 120.462 0.172 . . . . 0.0 111.078 -179.321 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 133' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -69.65 127.31 32.51 Favored 'General case' 0 CA--C 1.513 -0.456 0 CA-C-O 121.47 0.652 . . . . 0.0 111.478 -176.226 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 134' ' ' ALA . . . . . 0.513 ' HA ' ' OH ' ' B' ' 103' ' ' TYR . . . -136.21 141.04 43.96 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.15 -0.932 . . . . 0.0 111.473 -177.922 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 135' ' ' ASP . . . . . 0.815 ' HB2' ' HG3' ' B' ' 138' ' ' ARG . 49.3 m-20 -103.56 132.77 49.53 Favored 'General case' 0 C--O 1.25 1.094 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.024 172.892 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 136' ' ' ASP . . . . . 0.996 ' HA ' HD11 ' B' ' 139' ' ' LEU . 32.5 t70 -71.26 -7.92 50.2 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 115.095 -0.957 . . . . 0.0 111.236 -168.271 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 137' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -101.27 -30.16 11.67 Favored 'General case' 0 N--CA 1.438 -1.069 0 C-N-CA 120.017 -0.673 . . . . 0.0 110.653 174.555 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 138' ' ' ARG . . . . . 0.815 ' HG3' ' HB2' ' B' ' 135' ' ' ASP . 20.9 mmt180 -65.31 -45.92 82.43 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.793 0.806 . . . . 0.0 109.513 -176.976 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 139' ' ' LEU . . . . . 0.996 HD11 ' HA ' ' B' ' 136' ' ' ASP . 0.3 OUTLIER -74.2 -37.77 63.79 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 114.933 -1.03 . . . . 0.0 111.001 178.928 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 140' ' ' ASN . . . . . 0.665 ' H ' HD12 ' B' ' 139' ' ' LEU . 57.0 t30 -61.49 -31.25 71.23 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.687 0.756 . . . . 0.0 109.148 -179.773 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 141' ' ' LYS . . . . . 0.44 ' O ' ' HD3' ' B' ' 141' ' ' LYS . 4.3 tppt? -76.4 -50.06 15.14 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 114.585 -1.189 . . . . 0.0 110.43 179.279 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 142' ' ' VAL . . . . . 0.663 HG11 ' HB2' ' B' ' 103' ' ' TYR . 12.6 p -56.0 -44.48 78.51 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.581 0 C-N-CA 120.359 -0.537 . . . . 0.0 109.814 -179.716 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 143' ' ' ILE . . . . . 0.799 HG12 ' HD2' ' B' ' 107' ' ' TYR . 38.7 mt -58.55 -46.21 90.05 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 C-N-CA 124.163 0.985 . . . . 0.0 112.498 172.869 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 144' ' ' SER . . . . . . . . . . . . . 47.1 t -54.19 -33.68 58.73 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.927 176.744 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 145' ' ' GLU . . . . . 0.431 ' HG2' ' O ' ' B' ' 141' ' ' LYS . 6.9 mm-40 -83.98 -42.31 16.37 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 121.498 0.666 . . . . 0.0 110.63 178.029 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 146' ' ' LEU . . . . . 0.532 ' HB3' ' CZ ' ' B' ' 107' ' ' TYR . 2.2 mm? -62.7 -38.81 91.89 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 114.977 -1.01 . . . . 0.0 112.345 179.817 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 147' ' ' ASN . . . . . . . . . . . . . 64.1 t30 -54.16 120.03 5.91 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.124 -172.212 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . 99.4 40.33 3.24 Favored Glycine 0 N--CA 1.445 -0.703 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.549 -176.307 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 149' ' ' LYS . . . . . 0.482 ' HB2' ' O ' ' B' ' 146' ' ' LEU . 0.1 OUTLIER -134.79 168.56 18.83 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 -179.964 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 150' ' ' ASN . . . . . 0.588 ' O ' HG23 ' B' ' 154' ' ' VAL . 31.9 m-20 -106.82 90.57 3.36 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 107.702 -1.222 . . . . 0.0 107.702 179.068 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 151' ' ' ILE . . . . . 0.724 HG13 HD12 ' B' ' 108' ' ' LEU . 1.8 mp -41.69 -64.17 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 N-CA-C 113.571 0.952 . . . . 0.0 113.571 -168.089 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 152' ' ' GLU . . . . . 0.7 ' HG3' HD11 ' B' ' 112' ' ' LEU . 3.4 mp0 -57.31 -42.92 82.72 Favored 'General case' 0 C--O 1.209 -1.03 0 C-N-CA 120.93 -0.308 . . . . 0.0 111.365 -175.301 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 153' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -66.94 -29.57 69.47 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 120.548 0.214 . . . . 0.0 111.363 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 154' ' ' VAL . . . . . 0.818 ' HB ' HD12 ' B' ' 155' ' ' ILE . 61.8 t -61.15 -51.07 77.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 171.907 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 155' ' ' ILE . . . . . 0.818 HD12 ' HB ' ' B' ' 154' ' ' VAL . 1.6 mp -104.66 36.19 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-O 121.979 0.895 . . . . 0.0 110.368 -177.718 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 156' ' ' ALA . . . . . 0.644 ' HB1' ' HA ' ' A' ' 1' ' ' MET . . . -100.96 0.42 38.24 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 107.246 -1.391 . . . . 0.0 107.246 169.168 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 157' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -137.36 -34.83 0.69 Allowed 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 113.043 -1.889 . . . . 0.0 109.357 173.346 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 158' ' ' GLY . . . . . 0.487 ' O ' HD12 ' B' ' 162' ' ' LEU . . . -98.36 47.44 1.46 Allowed Glycine 0 CA--C 1.521 0.468 0 CA-C-N 115.548 -0.751 . . . . 0.0 114.357 -172.444 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 159' ' ' ILE . . . . . 0.766 ' HB ' HG13 ' A' ' 60' ' ' ILE . 1.8 mp -59.52 -18.0 13.76 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 CA-C-O 121.244 0.545 . . . . 0.0 111.045 176.213 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 160' ' ' GLY . . . . . . . . . . . . . . . -111.16 -65.05 0.51 Allowed Glycine 0 N--CA 1.447 -0.584 0 N-CA-C 111.384 -0.686 . . . . 0.0 111.384 -178.664 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 161' ' ' LYS . . . . . 0.481 ' HD3' ' N ' ' B' ' 161' ' ' LYS . 2.8 mppt? -78.14 61.74 2.73 Favored 'General case' 0 N--CA 1.441 -0.879 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 175.965 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 162' ' ' LEU . . . . . 0.642 HD22 ' HG2' ' B' ' 101' ' ' MET . 10.9 mp -46.8 146.32 1.65 Allowed 'General case' 0 C--O 1.236 0.345 0 CA-C-N 115.69 -0.687 . . . . 0.0 111.751 170.55 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 163' ' ' ALA . . . . . . . . . . . . . . . 50.55 51.82 16.1 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 115.505 -0.771 . . . . 0.0 112.75 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 164' ' ' SER . . . . . . . . . . . . . 90.2 p 62.43 159.13 0.07 Allowed 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.267 1.027 . . . . 0.0 113.32 173.521 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 165' ' ' VAL . . . . . 0.446 ' HA ' ' HD2' ' B' ' 166' ' ' PRO . 4.0 t -91.41 132.09 34.61 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 115.41 -0.813 . . . . 0.0 109.546 178.267 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 166' ' ' PRO . . . . . 0.446 ' HD2' ' HA ' ' B' ' 165' ' ' VAL . 21.1 Cg_exo -13.7 121.13 0.01 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.371 1 C-N-CA 127.237 5.292 . . . . 0.0 116.104 -179.165 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 167' ' ' ALA . . . . . . . . . . . . . . . -91.76 -54.81 3.72 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.772 -177.202 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 168' ' ' GLY . . . . . . . . . . . . . . . -119.51 -2.36 13.25 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.106 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 169' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.121 0 CA-C-O 118.234 -1.315 . . . . 0.0 111.243 -179.111 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 47.9 ttm . . . . . 0 N--CA 1.478 0.972 0 CA-C-O 120.848 0.356 . . . . 0.0 110.131 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.875 ' HB3' HD13 ' A' ' 7' ' ' LEU . . . -86.29 166.87 15.31 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.257 -179.164 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.7 p -78.72 131.82 36.74 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 171.777 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.681 HG13 ' HG ' ' B' ' 112' ' ' LEU . 2.2 t -53.6 -27.2 14.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 115.191 -0.913 . . . . 0.0 112.238 -175.957 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.778 ' HB3' ' HA ' ' A' ' 39' ' ' VAL . 2.1 m -67.46 -52.68 36.52 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 122.204 1.002 . . . . 0.0 108.468 176.068 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.522 ' O ' HG13 ' A' ' 10' ' ' ILE . 33.9 tt0 -55.83 -52.84 62.61 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-N 113.985 -1.461 . . . . 0.0 110.171 177.205 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.89 HD12 HD12 ' A' ' 10' ' ' ILE . 4.4 tp -59.46 -34.97 73.2 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.091 -0.958 . . . . 0.0 111.758 179.178 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.647 ' HB2' HD23 ' B' ' 112' ' ' LEU . . . -69.85 -33.25 72.02 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-O 121.011 0.434 . . . . 0.0 110.847 179.252 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.594 ' HB2' HG11 ' A' ' 39' ' ' VAL . 7.5 t -70.88 -37.43 73.02 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 177.38 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.89 HD12 HD12 ' A' ' 7' ' ' LEU . 74.2 mt -51.67 -55.53 8.6 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.887 0 CA-C-N 114.168 -1.378 . . . . 0.0 109.824 170.682 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.729 ' HB2' HD13 ' B' ' 109' ' ' LEU . 23.4 m-85 -67.04 -41.0 87.29 Favored 'General case' 0 C--O 1.22 -0.479 0 CA-C-N 115.615 -0.721 . . . . 0.0 111.596 -173.741 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.453 ' O ' ' HB2' ' A' ' 16' ' ' LEU . 2.5 p -57.43 -41.45 80.47 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 176.612 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.04 -33.43 75.42 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.895 172.471 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.789 HD22 HD11 ' A' ' 56' ' ' ILE . 0.3 OUTLIER -64.87 -57.99 7.36 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.488 -179.612 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -54.82 -47.34 74.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 177.277 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.706 HD12 HG13 ' A' ' 21' ' ' VAL . 6.2 tp -53.19 -41.47 65.3 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.928 178.65 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 26.3 t60 -78.89 -13.68 59.66 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.178 -0.919 . . . . 0.0 112.065 -178.605 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -70.62 -47.99 57.32 Favored 'General case' 0 N--CA 1.467 0.389 0 O-C-N 121.895 -0.503 . . . . 0.0 110.051 176.558 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.772 ' HB2' HG23 ' B' ' 132' ' ' ILE . 28.7 t70 -91.31 -11.19 38.74 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.938 0.875 . . . . 0.0 109.575 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 55.61 52.43 11.06 Favored 'General case' 0 CA--C 1.509 -0.604 0 CA-C-N 113.641 -1.618 . . . . 0.0 110.125 -176.813 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.706 HG13 HD12 ' A' ' 16' ' ' LEU . 2.9 p -100.03 152.64 4.69 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.739 0 CA-C-N 113.581 -1.645 . . . . 0.0 109.073 -176.072 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.476 ' O ' ' HG2' ' A' ' 27' ' ' LYS . 30.6 p -34.96 127.97 0.5 Allowed 'General case' 0 C--N 1.317 -0.808 0 O-C-N 124.672 1.232 . . . . 0.0 114.077 -174.064 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.551 HG12 ' HA ' ' A' ' 48' ' ' ALA . 51.2 t -100.55 106.03 18.65 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.927 0 CA-C-N 114.376 -1.283 . . . . 0.0 110.473 -176.898 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.44 ' OG1' ' HB2' ' A' ' 27' ' ' LYS . 80.6 p -141.05 153.77 45.65 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.769 -179.169 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -51.42 -46.49 62.96 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.12 0.486 . . . . 0.0 110.773 179.633 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -58.26 -38.38 76.82 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.382 -0.826 . . . . 0.0 111.356 177.482 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.483 ' HG2' HD11 ' A' ' 16' ' ' LEU . 4.3 tppt? -64.48 -50.03 69.07 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-O 121.965 0.888 . . . . 0.0 109.285 -178.229 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 80.8 mt -61.7 -38.96 81.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 114.393 -1.276 . . . . 0.0 110.458 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.682 ' HA ' HD12 ' A' ' 32' ' ' ILE . 30.7 m-80 -68.41 -30.0 68.8 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.862 176.436 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -65.98 -38.91 89.73 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.562 -0.29 . . . . 0.0 110.397 176.21 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.617 ' HB3' HD21 ' B' ' 109' ' ' LEU . 1.2 mm? -65.17 -45.79 83.49 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 120.646 -0.422 . . . . 0.0 110.106 171.747 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.682 HD12 ' HA ' ' A' ' 29' ' ' ASN . 57.8 mt -49.23 -50.0 16.22 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 CA-C-N 115.294 -0.867 . . . . 0.0 111.361 177.917 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 23.0 tptp -71.89 -37.7 70.1 Favored 'General case' 0 N--CA 1.435 -1.177 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.624 -179.384 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.673 ' HB1' ' HA ' ' B' ' 126' ' ' ILE . . . -59.26 -41.97 90.08 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.001 0.429 . . . . 0.0 111.451 179.526 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.477 ' CB ' ' HG ' ' B' ' 109' ' ' LEU . . . -84.61 -33.19 23.38 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.254 179.756 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 96.29 19.23 28.67 Favored Glycine 0 N--CA 1.447 -0.569 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.765 -179.041 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.814 ' HB ' ' HA2' ' B' ' 113' ' ' GLY . 2.9 p -121.6 117.73 53.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 121.981 0.896 . . . . 0.0 111.204 -177.079 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.431 ' HA ' HG23 ' A' ' 32' ' ' ILE . 57.8 t30 -88.51 157.06 18.75 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 113.966 -1.47 . . . . 0.0 110.726 -172.051 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.778 ' HA ' ' HB3' ' A' ' 5' ' ' SER . 97.3 t -126.91 161.38 33.82 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.002 0 CA-C-N 114.878 -1.056 . . . . 0.0 110.381 -173.257 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.536 ' HB3' ' HD1' ' A' ' 43' ' ' TRP . 7.5 tp10 -68.54 106.45 1.38 Allowed Pre-proline 0 N--CA 1.439 -1.012 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 170.151 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.46 ' C ' ' HD2' ' A' ' 44' ' ' PRO . 83.0 Cg_exo -50.22 -31.06 27.78 Favored 'Trans proline' 0 C--O 1.252 1.179 0 C-N-CA 123.698 2.932 . . . . 0.0 115.478 -163.996 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.448 ' HD2' ' HG3' ' A' ' 40' ' ' GLU . 0.8 OUTLIER -59.93 -26.8 66.23 Favored 'General case' 0 C--N 1.334 -0.107 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 178.456 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 43' ' ' TRP . . . . . 0.536 ' HD1' ' HB3' ' A' ' 40' ' ' GLU . 11.2 m95 -65.02 -61.67 5.9 Favored Pre-proline 0 C--O 1.207 -1.138 0 CA-C-O 118.423 -0.799 . . . . 0.0 110.723 176.313 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.468 ' HD3' ' HB2' ' A' ' 43' ' ' TRP . 85.5 Cg_exo -43.92 -45.04 11.73 Favored 'Trans proline' 0 C--N 1.358 1.069 0 C-N-CA 121.837 1.691 . . . . 0.0 112.242 174.747 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -60.55 -60.36 8.65 Favored Glycine 0 CA--C 1.526 0.757 0 C-N-CA 120.088 -1.054 . . . . 0.0 112.315 176.598 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.401 ' O ' ' HB2' ' A' ' 49' ' ' LYS . 10.2 tp -64.29 -24.02 67.51 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 123.069 0.547 . . . . 0.0 111.988 -177.527 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.554 ' HD2' HD11 ' A' ' 51' ' ' LEU . 2.7 m-85 -73.66 -43.91 58.16 Favored 'General case' 0 C--N 1.315 -0.899 0 C-N-CA 122.296 0.238 . . . . 0.0 110.375 177.511 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.551 ' HA ' HG12 ' A' ' 23' ' ' VAL . . . -64.81 -32.13 73.68 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 176.997 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.401 ' HB2' ' O ' ' A' ' 46' ' ' LEU . 9.5 mmmt -65.29 -51.56 59.89 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 114.247 -1.342 . . . . 0.0 111.815 173.243 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.453 ' O ' HG22 ' A' ' 54' ' ' VAL . . . -80.03 -40.72 27.19 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 113.187 0.81 . . . . 0.0 113.187 -170.069 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.554 HD11 ' HD2' ' A' ' 47' ' ' PHE . 8.7 mt -66.9 0.77 2.25 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 -172.099 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -88.16 -17.92 29.88 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.883 0.373 . . . . 0.0 110.607 174.484 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 91.4 m-20 -130.69 -38.26 1.31 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.823 -175.225 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.453 HG22 ' O ' ' A' ' 50' ' ' ALA . 4.6 m -85.39 -176.62 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 121.022 0.439 . . . . 0.0 110.141 -179.833 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 23.1 t-20 -119.41 168.39 11.0 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.76 -0.654 . . . . 0.0 109.585 176.776 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.789 HD11 HD22 ' A' ' 14' ' ' LEU . 3.2 tp -66.29 -27.94 42.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-O 121.058 0.456 . . . . 0.0 109.934 178.406 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -72.25 -14.81 76.78 Favored Glycine 0 N--CA 1.446 -0.666 0 N-CA-C 111.05 -0.82 . . . . 0.0 111.05 175.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 20.3 m -78.68 -21.31 48.42 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-O 121.229 0.537 . . . . 0.0 109.849 179.07 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.599 ' HB2' HG21 ' B' ' 159' ' ' ILE . 30.0 mt -60.78 -36.41 78.91 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.617 -179.736 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.701 HG13 ' HB ' ' B' ' 159' ' ' ILE . 0.2 OUTLIER -60.11 -20.89 20.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 115.041 -0.981 . . . . 0.0 110.829 179.131 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 5.6 t -95.76 13.79 25.37 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.417 -0.811 . . . . 0.0 111.285 -175.759 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.498 ' OD1' HG13 ' A' ' 63' ' ' VAL . 9.0 p30 -57.9 -35.15 70.64 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.961 -0.296 . . . . 0.0 111.456 -175.841 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.498 HG13 ' OD1' ' A' ' 62' ' ' ASN . 14.9 m -101.5 19.26 3.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.609 0.719 . . . . 0.0 110.994 176.792 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -121.75 0.93 11.07 Favored Glycine 0 C--N 1.312 -0.753 0 CA-C-N 114.946 -1.025 . . . . 0.0 111.522 179.735 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -87.31 -6.54 58.47 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.226 0.536 . . . . 0.0 110.275 178.225 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -105.11 116.85 5.4 Favored Glycine 0 N--CA 1.445 -0.756 0 N-CA-C 111.104 -0.799 . . . . 0.0 111.104 175.679 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 150.74 -79.39 0.21 Allowed Glycine 0 N--CA 1.447 -0.63 0 N-CA-C 111.617 -0.593 . . . . 0.0 111.617 -176.226 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -86.55 38.63 0.58 Allowed 'Trans proline' 0 N--CA 1.459 -0.506 0 C-N-CA 122.959 2.44 . . . . 0.0 112.458 178.34 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.909 0 CA-C-O 118.387 -0.816 . . . . 0.0 110.513 -179.584 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.061 0 CA-C-O 121.162 0.506 . . . . 0.0 110.572 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 101' ' ' MET . . . . . 0.697 ' HG2' HD22 ' B' ' 162' ' ' LEU . 1.3 tmt? -90.61 135.78 33.49 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.057 -178.358 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 102' ' ' ARG . . . . . 0.502 HH12 ' HE2' ' B' ' 141' ' ' LYS . 29.1 ptt180 -170.24 -147.26 0.05 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.834 -175.198 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 103' ' ' TYR . . . . . 0.922 ' HB2' HG11 ' B' ' 142' ' ' VAL . 69.4 m-85 -61.89 -8.19 4.7 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 120.705 0.288 . . . . 0.0 111.688 179.276 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 104' ' ' VAL . . . . . 0.746 HG23 HD23 ' B' ' 162' ' ' LEU . 4.1 m -45.03 -45.43 2.97 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.221 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.161 171.765 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 105' ' ' ALA . . . . . 0.561 ' CB ' ' HB3' ' A' ' 14' ' ' LEU . . . -64.31 -30.25 71.31 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 115.291 -0.868 . . . . 0.0 111.289 -174.051 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 106' ' ' SER . . . . . 0.814 ' HB2' HG23 ' B' ' 123' ' ' ILE . 1.4 m -76.53 -36.39 57.74 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.796 0.808 . . . . 0.0 108.971 -178.529 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 107' ' ' TYR . . . . . 0.678 ' CG ' HD12 ' B' ' 146' ' ' LEU . 36.5 t80 -63.96 -46.02 86.51 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 114.139 -1.391 . . . . 0.0 108.336 176.883 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 108' ' ' LEU . . . . . 0.844 HD12 HG13 ' B' ' 151' ' ' ILE . 0.0 OUTLIER -58.62 -45.93 88.13 Favored 'General case' 0 N--CA 1.443 -0.801 0 CA-C-N 114.393 -1.276 . . . . 0.0 110.792 177.072 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 109' ' ' LEU . . . . . 0.729 HD13 ' HB2' ' A' ' 11' ' ' TYR . 8.6 tp -55.65 -50.96 68.83 Favored 'General case' 0 CA--C 1.514 -0.426 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.893 178.445 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 110' ' ' ALA . . . . . 0.469 ' HB3' ' HB3' ' B' ' 118' ' ' PRO . . . -63.18 -40.58 97.94 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.24 -176.135 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 111' ' ' ALA . . . . . 0.664 ' HA ' ' O ' ' B' ' 115' ' ' ASN . . . -64.61 -33.98 77.19 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.559 178.884 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 112' ' ' LEU . . . . . 0.757 HD11 ' HG3' ' B' ' 152' ' ' GLU . 5.5 mp -71.47 -38.23 71.27 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.053 173.964 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 113' ' ' GLY . . . . . 0.814 ' HA2' ' HB ' ' A' ' 37' ' ' VAL . . . -61.87 -23.53 63.56 Favored Glycine 0 N--CA 1.446 -0.643 0 CA-C-N 115.198 -0.91 . . . . 0.0 111.843 179.548 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 114' ' ' GLY . . . . . . . . . . . . . . . 133.48 4.66 3.11 Favored Glycine 0 N--CA 1.436 -1.344 0 C-N-CA 120.569 -0.824 . . . . 0.0 112.876 177.496 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 115' ' ' ASN . . . . . 0.664 ' O ' ' HA ' ' B' ' 111' ' ' ALA . 47.2 t30 -116.94 91.15 3.5 Favored 'General case' 0 N--CA 1.439 -0.988 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 -179.533 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -76.96 25.61 0.15 Allowed 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 122.211 1.005 . . . . 0.0 110.787 -167.815 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 117' ' ' SER . . . . . 0.538 ' N ' ' HD3' ' B' ' 118' ' ' PRO . 35.2 t -169.83 68.12 0.59 Allowed Pre-proline 0 C--N 1.311 -1.102 0 CA-C-N 113.648 -1.614 . . . . 0.0 108.809 -178.198 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 118' ' ' PRO . . . . . 0.661 ' HG2' ' O ' ' B' ' 107' ' ' TYR . 26.7 Cg_exo -67.71 154.15 74.03 Favored 'Trans proline' 0 C--N 1.327 -0.583 0 C-N-CA 125.066 3.844 . . . . 0.0 111.572 -176.946 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 119' ' ' SER . . . . . 0.596 ' O ' HG12 ' B' ' 123' ' ' ILE . 92.0 p -121.73 -178.58 3.86 Favored 'General case' 0 C--N 1.315 -0.892 0 C-N-CA 120.104 -0.639 . . . . 0.0 110.958 178.327 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 120' ' ' ALA . . . . . 0.807 ' HB1' HD13 ' B' ' 139' ' ' LEU . . . -64.95 -38.74 91.97 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-O 121.886 0.851 . . . . 0.0 109.366 -172.061 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 121' ' ' LYS . . . . . 0.493 ' HD2' ' N ' ' B' ' 121' ' ' LYS . 4.7 mptp? -64.83 -31.96 73.43 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 113.952 -1.476 . . . . 0.0 110.912 176.718 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 122' ' ' ASP . . . . . 0.811 ' HA ' ' HE3' ' B' ' 125' ' ' LYS . 19.2 m-20 -72.61 -43.6 63.09 Favored 'General case' 0 CA--C 1.515 -0.377 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 176.282 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 123' ' ' ILE . . . . . 0.814 HG23 ' HB2' ' B' ' 106' ' ' SER . 33.8 mm -55.38 -50.36 66.01 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.421 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 175.798 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 124' ' ' LYS . . . . . 0.5 ' HD3' HD11 ' B' ' 127' ' ' LEU . 4.0 tppp? -61.21 -35.92 78.51 Favored 'General case' 0 N--CA 1.443 -0.788 0 CA-C-N 114.38 -1.282 . . . . 0.0 109.486 -177.628 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 125' ' ' LYS . . . . . 0.811 ' HE3' ' HA ' ' B' ' 122' ' ' ASP . 0.0 OUTLIER -72.44 -44.14 62.81 Favored 'General case' 0 N--CA 1.432 -1.359 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.931 -177.328 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 126' ' ' ILE . . . . . 0.702 HD12 ' HD2' ' B' ' 125' ' ' LYS . 1.4 mp -54.93 -51.81 49.51 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 CA-C-N 116.539 -0.301 . . . . 0.0 110.726 173.745 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 127' ' ' LEU . . . . . 0.945 ' HB2' ' HB ' ' B' ' 132' ' ' ILE . 3.1 pp -77.14 -25.97 52.6 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.614 -0.435 . . . . 0.0 111.788 -175.704 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 128' ' ' ASP . . . . . 0.474 ' HB2' ' O ' ' B' ' 124' ' ' LYS . 19.5 t70 -67.18 -33.5 75.54 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 110.024 -0.362 . . . . 0.0 110.024 177.606 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 129' ' ' SER . . . . . 0.445 ' CB ' ' HB2' ' A' ' 34' ' ' ALA . 22.7 t -51.97 -43.06 63.37 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.351 176.619 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 130' ' ' VAL . . . . . 0.6 HG23 HG13 ' B' ' 132' ' ' ILE . 5.0 m -100.76 -6.34 9.13 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 N-CA-C 112.242 0.46 . . . . 0.0 112.242 -179.589 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 131' ' ' GLY . . . . . . . . . . . . . . . 83.22 46.55 6.12 Favored Glycine 0 CA--C 1.518 0.257 0 C-N-CA 120.941 -0.647 . . . . 0.0 113.112 177.856 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 132' ' ' ILE . . . . . 0.945 ' HB ' ' HB2' ' B' ' 127' ' ' LEU . 14.9 mt -95.35 134.53 32.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 120.671 0.272 . . . . 0.0 110.46 176.901 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 133' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -79.98 131.73 35.87 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.895 0.379 . . . . 0.0 111.114 -178.047 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 134' ' ' ALA . . . . . . . . . . . . . . . -145.29 154.14 42.03 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.493 -175.544 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 135' ' ' ASP . . . . . 0.747 ' HB2' ' CG ' ' B' ' 138' ' ' ARG . 18.1 m-20 -102.11 135.17 44.15 Favored 'General case' 0 C--O 1.252 1.19 0 CA-C-O 121.124 0.488 . . . . 0.0 109.736 172.241 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 136' ' ' ASP . . . . . 0.915 ' HA ' HD11 ' B' ' 139' ' ' LEU . 10.4 t70 -73.28 -11.61 60.56 Favored 'General case' 0 CA--C 1.514 -0.426 0 CA-C-N 115.14 -0.936 . . . . 0.0 110.995 -166.649 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 137' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -96.79 -30.06 13.39 Favored 'General case' 0 N--CA 1.438 -1.062 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.723 175.334 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 138' ' ' ARG . . . . . 0.747 ' CG ' ' HB2' ' B' ' 135' ' ' ASP . 17.5 mmt180 -66.81 -46.26 75.75 Favored 'General case' 0 CA--C 1.504 -0.79 0 CA-C-O 121.977 0.894 . . . . 0.0 109.224 -175.624 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 139' ' ' LEU . . . . . 0.915 HD11 ' HA ' ' B' ' 136' ' ' ASP . 0.3 OUTLIER -72.46 -36.68 68.55 Favored 'General case' 0 C--O 1.209 -1.072 0 CA-C-N 114.607 -1.179 . . . . 0.0 111.148 179.03 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 140' ' ' ASN . . . . . 0.597 ' O ' ' HB ' ' B' ' 143' ' ' ILE . 9.7 t30 -64.27 -26.92 68.71 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.925 0.869 . . . . 0.0 109.565 177.75 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 141' ' ' LYS . . . . . 0.502 ' HE2' HH12 ' B' ' 102' ' ' ARG . 44.4 tttt -69.93 -51.63 31.25 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 114.391 -1.277 . . . . 0.0 109.354 177.226 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 142' ' ' VAL . . . . . 0.922 HG11 ' HB2' ' B' ' 103' ' ' TYR . 8.6 p -62.55 -32.12 54.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.889 177.853 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 143' ' ' ILE . . . . . 0.86 HG12 ' O ' ' B' ' 139' ' ' LEU . 34.6 mm -50.47 -66.62 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.513 -0.455 0 CA-C-O 121.082 0.467 . . . . 0.0 110.439 170.388 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 144' ' ' SER . . . . . . . . . . . . . 70.6 p -54.41 -31.56 55.34 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.188 -0.915 . . . . 0.0 111.838 -178.669 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 145' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -74.97 -37.07 62.02 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 112.072 0.397 . . . . 0.0 112.072 179.254 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 146' ' ' LEU . . . . . 0.711 HD11 ' HA ' ' B' ' 104' ' ' VAL . 6.9 mt -86.98 -19.53 28.59 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.813 -0.355 . . . . 0.0 110.712 -178.325 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 147' ' ' ASN . . . . . 0.409 ' HA ' ' OH ' ' B' ' 107' ' ' TYR . 26.3 t-20 -54.31 117.96 3.71 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.041 -176.335 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . 96.9 36.25 5.07 Favored Glycine 0 N--CA 1.448 -0.52 0 CA-C-N 115.544 -0.753 . . . . 0.0 112.275 -178.297 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 149' ' ' LYS . . . . . 0.478 ' HB2' ' O ' ' B' ' 146' ' ' LEU . 0.3 OUTLIER -130.08 165.28 22.57 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.837 0.351 . . . . 0.0 110.601 179.842 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 150' ' ' ASN . . . . . 0.515 ' O ' HG23 ' B' ' 154' ' ' VAL . 85.3 m-20 -104.28 88.84 3.08 Favored 'General case' 0 CA--C 1.513 -0.468 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 177.893 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 151' ' ' ILE . . . . . 0.844 HG13 HD12 ' B' ' 108' ' ' LEU . 1.8 mp -39.26 -64.52 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 113.845 1.054 . . . . 0.0 113.845 -169.806 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 152' ' ' GLU . . . . . 0.757 ' HG3' HD11 ' B' ' 112' ' ' LEU . 3.1 mp0 -57.97 -35.38 71.09 Favored 'General case' 0 C--O 1.216 -0.66 0 O-C-N 122.355 -0.216 . . . . 0.0 111.263 -174.268 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 153' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -71.28 -37.98 71.84 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.855 177.784 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 154' ' ' VAL . . . . . 0.81 ' HB ' HD12 ' B' ' 155' ' ' ILE . 62.0 t -53.47 -47.97 58.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 121.49 0.662 . . . . 0.0 109.321 173.76 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 155' ' ' ILE . . . . . 0.81 HD12 ' HB ' ' B' ' 154' ' ' VAL . 1.6 mp -107.51 35.73 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-O 121.929 0.871 . . . . 0.0 110.804 -178.613 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 156' ' ' ALA . . . . . 0.454 ' HB2' ' O ' ' B' ' 152' ' ' GLU . . . -100.85 1.9 40.51 Favored 'General case' 0 C--N 1.311 -1.096 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 169.062 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 157' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -142.05 16.08 2.09 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 113.946 -1.479 . . . . 0.0 110.515 177.378 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 158' ' ' GLY . . . . . 0.787 ' HA3' HG21 ' B' ' 165' ' ' VAL . . . -159.5 45.54 0.44 Allowed Glycine 0 C--N 1.338 0.69 0 C-N-CA 119.507 -1.33 . . . . 0.0 115.204 -172.64 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 159' ' ' ILE . . . . . 0.701 ' HB ' HG13 ' A' ' 60' ' ' ILE . 1.8 mp -58.57 -25.88 29.48 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 C-N-CA 122.959 0.504 . . . . 0.0 111.736 176.638 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 160' ' ' GLY . . . . . . . . . . . . . . . -91.71 -67.21 1.14 Allowed Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.048 -1.072 . . . . 0.0 112.993 -178.321 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 161' ' ' LYS . . . . . 0.668 ' HB2' HG22 ' B' ' 165' ' ' VAL . 31.3 mmmt -65.11 -30.02 70.93 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 113.469 0.915 . . . . 0.0 113.469 -174.709 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 162' ' ' LEU . . . . . 0.746 HD23 HG23 ' B' ' 104' ' ' VAL . 7.4 mp 48.27 175.88 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 114.504 1.298 . . . . 0.0 114.504 -171.013 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 163' ' ' ALA . . . . . 0.473 ' HB2' HG11 ' B' ' 104' ' ' VAL . . . 55.13 -88.57 0.02 OUTLIER 'General case' 0 C--N 1.339 0.147 0 CA-C-N 115.092 -0.958 . . . . 0.0 112.748 -175.401 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 164' ' ' SER . . . . . . . . . . . . . 6.7 m -117.95 116.2 26.45 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 120.877 0.37 . . . . 0.0 110.156 178.025 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 165' ' ' VAL . . . . . 0.787 HG21 ' HA3' ' B' ' 158' ' ' GLY . 5.2 t -128.77 120.25 20.47 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.546 -176.439 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 166' ' ' PRO . . . . . 0.44 ' HD2' ' HA ' ' B' ' 165' ' ' VAL . 50.1 Cg_exo -19.63 114.85 0.02 OUTLIER 'Trans proline' 0 N--CA 1.437 -1.831 1 C-N-CA 127.154 5.236 . . . . 0.0 116.003 177.516 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 167' ' ' ALA . . . . . . . . . . . . . . . -105.85 -24.84 12.37 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.832 179.171 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 168' ' ' GLY . . . . . . . . . . . . . . . -141.87 100.4 0.26 Allowed Glycine 0 N--CA 1.445 -0.702 0 CA-C-N 115.152 -0.931 . . . . 0.0 111.422 175.863 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 169' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.927 0 CA-C-O 119.047 -0.863 . . . . 0.0 111.776 -179.99 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.557 ' HG2' ' H ' ' A' ' 2' ' ' ALA . 17.3 ttt . . . . . 0 N--CA 1.481 1.091 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.615 ' HB3' HD13 ' A' ' 7' ' ' LEU . . . -116.09 167.92 10.56 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 120.936 0.398 . . . . 0.0 111.07 -176.727 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 11.4 m -90.15 136.66 32.91 Favored 'General case' 0 N--CA 1.441 -0.904 0 N-CA-C 107.783 -1.191 . . . . 0.0 107.783 164.861 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.867 HG13 ' HG ' ' B' ' 112' ' ' LEU . 2.1 t -51.85 -24.58 4.85 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-N 114.947 -1.024 . . . . 0.0 112.17 -178.63 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.723 ' HB3' ' HA ' ' A' ' 39' ' ' VAL . 8.5 m -69.65 -51.86 31.04 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 176.219 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.509 ' O ' HG13 ' A' ' 10' ' ' ILE . 30.6 mt-10 -58.85 -52.15 66.97 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 115.008 -0.996 . . . . 0.0 109.796 178.239 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.853 HD12 HD12 ' A' ' 10' ' ' ILE . 3.2 tp -57.83 -36.85 72.84 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 115.317 -0.856 . . . . 0.0 112.097 178.279 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.632 ' HB2' HD23 ' B' ' 112' ' ' LEU . . . -67.09 -35.47 79.88 Favored 'General case' 0 CA--C 1.516 -0.361 0 CA-C-O 120.957 0.408 . . . . 0.0 110.855 178.927 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.526 ' HB2' HG11 ' A' ' 39' ' ' VAL . 5.6 t -69.7 -41.09 75.85 Favored 'General case' 0 C--O 1.242 0.672 0 N-CA-C 108.188 -1.042 . . . . 0.0 108.188 178.467 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.853 HD12 HD12 ' A' ' 7' ' ' LEU . 68.0 mt -47.14 -54.1 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.671 0 CA-C-N 114.214 -1.357 . . . . 0.0 109.627 170.532 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.882 ' HB2' HD13 ' B' ' 109' ' ' LEU . 23.4 m-85 -66.32 -39.48 89.29 Favored 'General case' 0 C--O 1.219 -0.511 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.877 -174.961 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.563 ' HB2' HD23 ' A' ' 31' ' ' LEU . 79.4 p -56.78 -44.79 82.22 Favored 'General case' 0 C--O 1.243 0.739 0 CA-C-O 121.475 0.655 . . . . 0.0 109.383 179.148 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.532 ' HB1' ' HG ' ' A' ' 51' ' ' LEU . . . -63.2 -34.32 77.38 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 115.09 -0.959 . . . . 0.0 110.42 173.963 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.66 HD22 HD11 ' A' ' 56' ' ' ILE . 0.2 OUTLIER -61.36 -55.49 31.05 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.456 179.342 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.479 HG12 ' O ' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -55.27 -41.5 61.59 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 178.322 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.672 HD21 ' HA ' ' A' ' 23' ' ' VAL . 2.3 tp -55.46 -38.64 69.33 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.31 176.212 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' HIS . . . . . 0.468 ' CD2' ' HB ' ' A' ' 56' ' ' ILE . 93.8 m-70 -73.77 -14.28 61.09 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 176.228 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -68.96 -44.4 73.05 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.911 0.386 . . . . 0.0 110.281 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.736 ' HB2' HG23 ' B' ' 132' ' ' ILE . 37.7 t70 -97.92 -6.99 31.11 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.835 0.826 . . . . 0.0 109.178 177.639 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 53.32 52.57 13.27 Favored 'General case' 0 CA--C 1.516 -0.359 0 CA-C-N 113.803 -1.544 . . . . 0.0 109.976 -177.034 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.43 HG13 HD12 ' A' ' 16' ' ' LEU . 7.3 p -106.62 163.97 4.73 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 CA-C-N 114.319 -1.31 . . . . 0.0 109.365 -174.051 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 18.6 p -48.32 142.01 5.98 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 113.312 0.856 . . . . 0.0 113.312 -174.719 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.672 ' HA ' HD21 ' A' ' 16' ' ' LEU . 58.3 t -107.27 114.29 45.79 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 CA-C-N 114.305 -1.316 . . . . 0.0 110.769 -175.471 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.502 ' OG1' ' HD2' ' A' ' 27' ' ' LYS . 22.1 p -136.69 159.57 41.44 Favored 'General case' 0 C--O 1.245 0.848 0 CA-C-O 120.925 0.393 . . . . 0.0 110.511 176.346 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -56.57 -34.14 66.83 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.596 176.106 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -68.79 -31.95 71.33 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.17 177.938 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.606 ' HG2' HD11 ' A' ' 16' ' ' LEU . 0.3 OUTLIER -62.67 -58.1 8.69 Favored 'General case' 0 CA--C 1.512 -0.505 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 175.043 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.511 HG23 ' OG ' ' A' ' 12' ' ' SER . 37.0 mt -56.51 -40.95 71.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 114.184 -1.371 . . . . 0.0 110.999 -178.348 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 41.1 t-20 -59.37 -45.53 91.16 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.934 -0.575 . . . . 0.0 109.955 177.272 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -59.31 -47.79 84.06 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.405 179.842 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.722 ' HB3' HD21 ' B' ' 109' ' ' LEU . 0.9 OUTLIER -57.61 -50.43 73.17 Favored 'General case' 0 C--O 1.239 0.504 0 CA-C-O 121.006 0.431 . . . . 0.0 110.595 177.174 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.593 HG23 ' O ' ' A' ' 37' ' ' VAL . 67.1 mt -47.76 -51.48 7.95 Favored 'Isoleucine or valine' 0 C--O 1.242 0.698 0 CA-C-N 115.067 -0.97 . . . . 0.0 111.267 177.839 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 47.5 mmtm -74.2 -39.49 63.12 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.022 -0.99 . . . . 0.0 111.781 -174.036 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -63.24 -41.39 99.07 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-O 120.783 0.325 . . . . 0.0 110.97 -178.795 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.504 ' HA ' HD11 ' B' ' 126' ' ' ILE . . . -79.41 -31.8 42.77 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.079 179.784 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 97.38 16.16 35.58 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 121.021 -0.609 . . . . 0.0 111.91 178.316 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.881 ' HB ' ' HA2' ' B' ' 113' ' ' GLY . 2.5 p -119.57 119.99 62.14 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 CA-C-O 121.433 0.635 . . . . 0.0 110.458 -176.694 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.577 ' HA ' HG23 ' A' ' 32' ' ' ILE . 12.8 t30 -96.59 153.71 17.69 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 114.826 -1.079 . . . . 0.0 111.142 -167.673 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.723 ' HA ' ' HB3' ' A' ' 5' ' ' SER . 93.5 t -130.03 158.79 42.49 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.964 0 CA-C-N 114.982 -1.008 . . . . 0.0 109.923 -170.347 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.595 ' HB2' ' CD1' ' A' ' 43' ' ' TRP . 30.6 mt-10 -63.83 112.7 7.9 Favored Pre-proline 0 CA--C 1.487 -1.454 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 170.003 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.447 ' C ' ' HD2' ' A' ' 44' ' ' PRO . 54.4 Cg_exo -55.8 -27.75 63.73 Favored 'Trans proline' 0 C--N 1.312 -1.349 0 C-N-CA 123.042 2.495 . . . . 0.0 113.509 -167.943 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 1.6 p90 -62.0 -28.95 69.93 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.746 175.03 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' TRP . . . . . 0.595 ' CD1' ' HB2' ' A' ' 40' ' ' GLU . 9.8 m95 -62.47 -59.35 13.08 Favored Pre-proline 0 C--O 1.204 -1.338 0 CA-C-O 118.374 -0.822 . . . . 0.0 110.32 175.957 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.459 ' HD2' ' O ' ' A' ' 40' ' ' GLU . 84.8 Cg_exo -44.38 -45.28 12.72 Favored 'Trans proline' 0 C--N 1.36 1.165 0 C-N-CA 121.716 1.61 . . . . 0.0 112.527 172.483 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -60.26 -59.36 10.49 Favored Glycine 0 CA--C 1.529 0.962 0 C-N-CA 120.025 -1.084 . . . . 0.0 112.759 177.367 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 5.4 tp -65.41 -32.03 73.44 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 123.276 0.63 . . . . 0.0 111.791 -177.388 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.499 ' HE1' ' CE3' ' A' ' 43' ' ' TRP . 2.7 m-85 -65.32 -49.02 71.04 Favored 'General case' 0 C--N 1.317 -0.81 0 C-N-CA 122.685 0.394 . . . . 0.0 110.263 176.533 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.418 ' HA ' HG12 ' A' ' 23' ' ' VAL . . . -64.6 -31.11 72.18 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.505 0.669 . . . . 0.0 109.539 -179.757 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.549 ' HD2' ' O ' ' A' ' 49' ' ' LYS . 0.4 OUTLIER -66.82 -35.76 80.81 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 114.883 -1.053 . . . . 0.0 110.622 173.094 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.426 ' C ' HG22 ' A' ' 54' ' ' VAL . . . -85.03 -58.71 2.58 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.809 0.67 . . . . 0.0 112.809 -175.253 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.589 ' HB2' HG11 ' A' ' 23' ' ' VAL . 3.2 mm? -62.0 -11.71 14.95 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 112.746 0.647 . . . . 0.0 112.746 -170.437 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -74.34 -26.41 60.12 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.061 0.457 . . . . 0.0 110.426 175.787 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 84.1 m-20 -116.4 -39.13 3.41 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.048 -177.284 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.426 HG22 ' C ' ' A' ' 50' ' ' ALA . 4.1 m -98.43 -174.28 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.949 0.404 . . . . 0.0 110.789 -176.435 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 26.9 p-10 -111.71 178.71 4.23 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.334 179.364 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.66 HD11 HD22 ' A' ' 14' ' ' LEU . 4.7 tp -74.57 -25.1 18.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 120.971 0.415 . . . . 0.0 109.992 -179.183 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -70.32 -13.75 70.92 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.435 -0.888 . . . . 0.0 110.937 175.713 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 32.2 t -77.53 -21.75 52.17 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-O 121.27 0.557 . . . . 0.0 109.677 179.284 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.649 ' HB2' HG21 ' B' ' 159' ' ' ILE . 20.0 mt -64.98 -26.38 68.27 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.565 179.616 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.573 ' CD1' ' HB ' ' B' ' 159' ' ' ILE . 0.1 OUTLIER -66.01 -12.37 14.11 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 CA-C-N 114.602 -1.181 . . . . 0.0 110.558 179.867 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 0.575 ' HA ' ' HB3' ' A' ' 65' ' ' ALA . 16.4 t -93.41 -5.91 48.29 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.036 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 91.0 m-20 -78.0 -7.13 56.45 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.655 -177.175 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 18.8 m -122.98 29.49 2.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.284 0.564 . . . . 0.0 110.691 177.61 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 131.52 -120.06 2.76 Favored Glycine 0 N--CA 1.451 -0.331 0 CA-C-N 115.544 -0.753 . . . . 0.0 112.518 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.575 ' HB3' ' HA ' ' A' ' 61' ' ' CYS . . . 52.03 48.8 22.01 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 123.015 0.526 . . . . 0.0 111.781 -179.263 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -122.85 -43.94 0.35 Allowed Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.847 -0.692 . . . . 0.0 111.952 179.14 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 127.89 -142.48 13.56 Favored Glycine 0 N--CA 1.445 -0.75 0 C-N-CA 120.866 -0.683 . . . . 0.0 111.752 -178.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -63.81 -45.39 10.91 Favored 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 122.754 2.303 . . . . 0.0 111.505 178.026 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.025 0 CA-C-O 118.246 -0.883 . . . . 0.0 109.914 178.308 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.126 0 CA-C-O 120.796 0.332 . . . . 0.0 110.977 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 101' ' ' MET . . . . . 0.54 ' HE3' HD12 ' A' ' 14' ' ' LEU . 1.3 tmt? -79.83 124.56 28.74 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.15 -0.477 . . . . 0.0 109.883 178.3 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 102' ' ' ARG . . . . . . . . . . . . . 29.8 ptt180 -162.74 -122.74 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.707 -0.678 . . . . 0.0 109.766 176.414 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 103' ' ' TYR . . . . . 0.664 ' HB3' HG21 ' B' ' 123' ' ' ILE . 41.5 m-85 -61.51 -10.17 7.31 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-O 120.902 0.382 . . . . 0.0 111.234 179.581 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 104' ' ' VAL . . . . . 0.603 ' O ' HD22 ' B' ' 108' ' ' LEU . 63.4 t -44.15 -47.06 2.24 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.269 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.973 170.989 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 105' ' ' ALA . . . . . 0.623 ' CB ' ' HB3' ' A' ' 14' ' ' LEU . . . -65.95 -38.91 89.83 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.008 -0.996 . . . . 0.0 111.593 -173.879 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 106' ' ' SER . . . . . 0.881 ' HB2' HG23 ' B' ' 123' ' ' ILE . 1.4 m -63.75 -36.38 83.69 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-O 121.596 0.712 . . . . 0.0 109.683 177.427 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 107' ' ' TYR . . . . . 0.654 ' CZ ' ' HD2' ' B' ' 118' ' ' PRO . 31.8 t80 -62.93 -51.06 68.39 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 114.509 -1.223 . . . . 0.0 108.665 178.583 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 108' ' ' LEU . . . . . 0.907 HD12 HG13 ' B' ' 151' ' ' ILE . 0.0 OUTLIER -56.96 -45.36 82.92 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 114.652 -1.158 . . . . 0.0 110.971 178.341 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 109' ' ' LEU . . . . . 0.882 HD13 ' HB2' ' A' ' 11' ' ' TYR . 7.7 tp -56.41 -47.49 78.93 Favored 'General case' 0 CA--C 1.51 -0.574 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.033 179.099 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 110' ' ' ALA . . . . . 0.562 ' HB3' ' HB3' ' B' ' 118' ' ' PRO . . . -65.73 -38.98 90.63 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-O 120.998 0.428 . . . . 0.0 111.155 -177.358 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 111' ' ' ALA . . . . . 0.658 ' HA ' ' O ' ' B' ' 115' ' ' ASN . . . -69.01 -23.74 64.12 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.637 178.733 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 112' ' ' LEU . . . . . 0.867 ' HG ' HG13 ' A' ' 4' ' ' VAL . 1.4 mp -80.23 -37.54 32.87 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.058 172.831 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 113' ' ' GLY . . . . . 0.881 ' HA2' ' HB ' ' A' ' 37' ' ' VAL . . . -64.07 -20.99 65.43 Favored Glycine 0 N--CA 1.449 -0.499 0 CA-C-N 115.204 -0.907 . . . . 0.0 111.801 177.809 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 114' ' ' GLY . . . . . . . . . . . . . . . 130.01 9.64 3.02 Favored Glycine 0 N--CA 1.439 -1.16 0 C-N-CA 120.354 -0.927 . . . . 0.0 113.416 174.563 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 115' ' ' ASN . . . . . 0.658 ' O ' ' HA ' ' B' ' 111' ' ' ALA . 1.8 t-20 -115.11 95.31 5.14 Favored 'General case' 0 N--CA 1.44 -0.962 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 178.5 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 2.3 p -80.21 29.87 0.28 Allowed 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 114.895 -1.048 . . . . 0.0 110.75 -167.024 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 117' ' ' SER . . . . . 0.526 ' N ' ' HD3' ' B' ' 118' ' ' PRO . 41.9 t -175.78 67.96 0.25 Allowed Pre-proline 0 C--N 1.307 -1.252 0 CA-C-N 113.377 -1.738 . . . . 0.0 108.411 -179.05 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 118' ' ' PRO . . . . . 0.654 ' HD2' ' CZ ' ' B' ' 107' ' ' TYR . 32.1 Cg_exo -66.04 148.7 85.86 Favored 'Trans proline' 0 CA--C 1.513 -0.557 0 C-N-CA 125.115 3.877 . . . . 0.0 111.827 -175.268 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 119' ' ' SER . . . . . 0.648 ' O ' HG12 ' B' ' 123' ' ' ILE . 78.6 p -116.39 -178.42 3.41 Favored 'General case' 0 C--N 1.316 -0.858 0 C-N-CA 120.221 -0.591 . . . . 0.0 111.324 178.318 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 120' ' ' ALA . . . . . 0.838 ' HB1' HD13 ' B' ' 139' ' ' LEU . . . -66.81 -34.19 77.28 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 122.057 0.932 . . . . 0.0 109.77 -173.868 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 121' ' ' LYS . . . . . 0.603 ' HD2' ' N ' ' B' ' 121' ' ' LYS . 0.0 OUTLIER -69.74 -29.97 67.46 Favored 'General case' 0 N--CA 1.437 -1.084 0 CA-C-N 113.956 -1.475 . . . . 0.0 110.173 177.805 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 122' ' ' ASP . . . . . 0.428 ' O ' HD13 ' B' ' 126' ' ' ILE . 20.1 m-20 -70.41 -44.73 67.34 Favored 'General case' 0 CA--C 1.517 -0.306 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 174.517 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 123' ' ' ILE . . . . . 0.881 HG23 ' HB2' ' B' ' 106' ' ' SER . 25.1 mm -54.19 -49.57 61.57 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 CA-C-N 114.944 -1.026 . . . . 0.0 109.869 176.38 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 124' ' ' LYS . . . . . 0.984 ' HD2' HD11 ' B' ' 127' ' ' LEU . 1.7 mmmm -62.34 -41.59 98.7 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.23 -175.943 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 125' ' ' LYS . . . . . . . . . . . . . 44.3 mmtt -49.73 -60.95 2.41 Favored 'General case' 0 CA--C 1.496 -1.134 0 CA-C-O 121.931 0.872 . . . . 0.0 111.225 171.9 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 126' ' ' ILE . . . . . 0.635 HG23 HD12 ' A' ' 31' ' ' LEU . 1.6 mp -59.03 -41.89 84.68 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.667 0 CA-C-N 113.706 -1.588 . . . . 0.0 110.694 -169.885 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 127' ' ' LEU . . . . . 0.984 HD11 ' HD2' ' B' ' 124' ' ' LYS . 3.5 pp -78.94 -32.25 45.45 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 111.924 0.342 . . . . 0.0 111.924 -178.628 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 128' ' ' ASP . . . . . 0.484 ' N ' HD12 ' B' ' 127' ' ' LEU . 11.5 m-20 -70.33 -24.58 63.02 Favored 'General case' 0 CA--C 1.518 -0.281 0 O-C-N 122.232 -0.293 . . . . 0.0 111.03 -178.588 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 129' ' ' SER . . . . . . . . . . . . . 94.4 p -59.45 -42.83 92.87 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-O 120.715 0.293 . . . . 0.0 111.206 177.217 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 130' ' ' VAL . . . . . 0.566 HG23 HG13 ' B' ' 132' ' ' ILE . 13.1 m -93.41 -7.4 10.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.814 0.34 . . . . 0.0 111.776 -179.745 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 131' ' ' GLY . . . . . . . . . . . . . . . 85.62 39.75 8.08 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.478 177.474 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 132' ' ' ILE . . . . . 0.736 HG23 ' HB2' ' A' ' 19' ' ' ASP . 14.3 mt -94.7 126.94 47.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 110.195 -0.298 . . . . 0.0 110.195 176.617 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 133' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -80.53 127.04 31.98 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.227 0.536 . . . . 0.0 111.283 -176.171 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 134' ' ' ALA . . . . . 0.421 ' HB2' HD22 ' B' ' 127' ' ' LEU . . . -140.37 146.13 38.01 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.706 -173.253 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 135' ' ' ASP . . . . . 0.696 ' HB3' ' HG3' ' B' ' 138' ' ' ARG . 7.7 t70 -93.65 131.04 39.34 Favored 'General case' 0 C--O 1.253 1.253 0 CA-C-O 121.173 0.511 . . . . 0.0 110.447 175.352 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 136' ' ' ASP . . . . . 1.032 ' HA ' HD11 ' B' ' 139' ' ' LEU . 6.2 p-10 -77.42 5.21 9.23 Favored 'General case' 0 CA--C 1.517 -0.297 0 CA-C-N 115.029 -0.987 . . . . 0.0 111.627 -168.276 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 137' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -108.83 -30.94 7.89 Favored 'General case' 0 N--CA 1.434 -1.255 0 CA-C-O 121.059 0.457 . . . . 0.0 110.372 172.013 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 138' ' ' ARG . . . . . 0.73 ' HA ' ' HE2' ' B' ' 141' ' ' LYS . 9.3 mmt180 -67.4 -48.44 67.36 Favored 'General case' 0 CA--C 1.505 -0.76 0 CA-C-O 122.179 0.99 . . . . 0.0 109.155 -178.69 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 139' ' ' LEU . . . . . 1.032 HD11 ' HA ' ' B' ' 136' ' ' ASP . 0.3 OUTLIER -69.63 -26.09 64.25 Favored 'General case' 0 C--O 1.207 -1.147 0 CA-C-N 114.588 -1.187 . . . . 0.0 111.025 179.112 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 140' ' ' ASN . . . . . 0.608 ' O ' ' HB ' ' B' ' 143' ' ' ILE . 32.9 t30 -79.26 -26.44 42.42 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.875 0.845 . . . . 0.0 109.938 -178.39 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 141' ' ' LYS . . . . . 0.73 ' HE2' ' HA ' ' B' ' 138' ' ' ARG . 0.2 OUTLIER -80.69 -35.35 33.76 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 115.435 -0.802 . . . . 0.0 108.972 179.907 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 142' ' ' VAL . . . . . 0.624 HG12 ' O ' ' B' ' 139' ' ' LEU . 9.8 p -66.6 -39.12 83.09 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.444 0 C-N-CA 119.922 -0.711 . . . . 0.0 109.204 172.127 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 143' ' ' ILE . . . . . 0.903 HG12 ' O ' ' B' ' 139' ' ' LEU . 32.2 mm -45.51 -59.82 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.36 0 CA-C-O 121.778 0.799 . . . . 0.0 110.081 168.762 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 144' ' ' SER . . . . . . . . . . . . . 20.8 m -51.8 -42.61 62.6 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 113.97 -1.468 . . . . 0.0 112.298 -179.656 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 145' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -76.16 -23.63 54.77 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 120.948 0.404 . . . . 0.0 111.625 179.35 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 146' ' ' LEU . . . . . 0.575 ' HB3' ' CZ ' ' B' ' 107' ' ' TYR . 0.3 OUTLIER -86.0 -36.96 19.44 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.569 -177.416 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 147' ' ' ASN . . . . . . . . . . . . . 16.0 t-20 -43.6 113.04 0.45 Allowed 'General case' 0 C--N 1.331 -0.203 0 O-C-N 124.157 0.911 . . . . 0.0 112.424 -173.168 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . 97.23 61.22 0.94 Allowed Glycine 0 N--CA 1.448 -0.56 0 CA-C-N 115.277 -0.874 . . . . 0.0 111.807 -178.14 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 149' ' ' LYS . . . . . . . . . . . . . 2.5 tppt? -144.49 162.54 36.29 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 -178.168 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 150' ' ' ASN . . . . . 0.619 ' O ' HG23 ' B' ' 154' ' ' VAL . 42.2 m-80 -106.08 90.26 3.32 Favored 'General case' 0 CA--C 1.514 -0.427 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 178.079 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 151' ' ' ILE . . . . . 0.907 HG13 HD12 ' B' ' 108' ' ' LEU . 1.8 mp -43.45 -66.01 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 O-C-N 124.528 1.142 . . . . 0.0 113.744 -169.028 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 152' ' ' GLU . . . . . 0.579 ' OE1' HD22 ' A' ' 7' ' ' LEU . 2.4 mt-10 -48.94 -52.61 23.7 Favored 'General case' 0 C--O 1.207 -1.149 0 CA-C-N 118.249 0.477 . . . . 0.0 111.981 -177.775 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 153' ' ' ASP . . . . . . . . . . . . . 26.5 m-20 -64.76 -27.77 69.12 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 119.983 -0.687 . . . . 0.0 111.103 -176.014 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 154' ' ' VAL . . . . . 0.855 ' HB ' HD12 ' B' ' 155' ' ' ILE . 49.6 t -57.6 -52.97 50.7 Favored 'Isoleucine or valine' 0 C--O 1.233 0.189 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 170.374 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 155' ' ' ILE . . . . . 0.855 HD12 ' HB ' ' B' ' 154' ' ' VAL . 1.8 mp -105.25 34.4 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.706 -176.613 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . -105.03 0.59 27.79 Favored 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 171.405 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 157' ' ' GLN . . . . . . . . . . . . . 49.9 mt-30 -141.69 1.85 1.55 Allowed 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 113.353 -1.749 . . . . 0.0 109.908 175.837 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 158' ' ' GLY . . . . . . . . . . . . . . . -142.34 46.26 0.88 Allowed Glycine 0 C--N 1.334 0.456 0 C-N-CA 120.695 -0.764 . . . . 0.0 113.588 -170.747 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 159' ' ' ILE . . . . . 0.649 HG21 ' HB2' ' A' ' 59' ' ' LEU . 1.8 mp -60.41 -15.81 11.3 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.775 0 C-N-CA 123.127 0.571 . . . . 0.0 111.721 178.859 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 160' ' ' GLY . . . . . 0.402 ' HA2' HG23 ' A' ' 56' ' ' ILE . . . -105.56 -80.35 1.35 Allowed Glycine 0 N--CA 1.446 -0.676 0 C-N-CA 120.59 -0.814 . . . . 0.0 112.204 -174.591 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 161' ' ' LYS . . . . . 0.41 ' HA ' ' HD2' ' B' ' 161' ' ' LYS . 31.0 mmmt -77.18 61.4 2.08 Favored 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 113.178 0.807 . . . . 0.0 113.178 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 162' ' ' LEU . . . . . 0.463 ' HB2' ' HG2' ' B' ' 101' ' ' MET . 9.9 mp -41.3 136.7 1.61 Allowed 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.828 168.801 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 163' ' ' ALA . . . . . . . . . . . . . . . 55.82 44.44 26.02 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 115.716 -0.675 . . . . 0.0 112.789 179.839 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 164' ' ' SER . . . . . . . . . . . . . 80.1 p 56.9 169.49 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 113.968 1.099 . . . . 0.0 113.968 173.685 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 165' ' ' VAL . . . . . 0.402 ' HA ' ' HD2' ' B' ' 166' ' ' PRO . 11.0 t -102.17 129.96 25.22 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-N 114.831 -1.077 . . . . 0.0 108.968 175.155 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 166' ' ' PRO . . . . . 0.402 ' HD2' ' HA ' ' B' ' 165' ' ' VAL . 39.6 Cg_exo -13.52 112.96 0.01 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.421 1 C-N-CA 127.112 5.208 . . . . 0.0 116.149 -174.693 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 167' ' ' ALA . . . . . . . . . . . . . . . -103.88 46.43 0.92 Allowed 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.968 -175.283 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 168' ' ' GLY . . . . . . . . . . . . . . . 128.01 -41.86 1.52 Allowed Glycine 0 N--CA 1.448 -0.525 0 N-CA-C 111.071 -0.812 . . . . 0.0 111.071 -176.554 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 169' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.192 -1.338 . . . . 0.0 111.223 178.183 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.493 ' HA ' ' HB1' ' B' ' 156' ' ' ALA . 26.6 ttm . . . . . 0 N--CA 1.479 1.02 0 N-CA-C 110.249 -0.278 . . . . 0.0 110.249 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.863 ' HB3' HD13 ' A' ' 7' ' ' LEU . . . -84.4 166.96 16.91 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.379 -178.247 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.498 ' HB2' ' HG3' ' A' ' 6' ' ' GLU . 5.8 m -74.53 130.0 38.78 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 173.285 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.539 HG13 ' HG ' ' B' ' 112' ' ' LEU . 2.1 t -52.57 -26.59 10.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.053 -0.976 . . . . 0.0 112.496 -178.301 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.424 ' HB2' ' HA ' ' A' ' 39' ' ' VAL . 10.9 p -68.71 -53.26 23.21 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 177.471 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.552 ' O ' HG13 ' A' ' 10' ' ' ILE . 31.3 mt-10 -56.95 -50.27 73.13 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 114.816 -1.083 . . . . 0.0 109.614 176.966 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.868 HD12 HD12 ' A' ' 10' ' ' ILE . 4.4 tp -61.61 -36.6 81.19 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 115.12 -0.945 . . . . 0.0 111.841 -179.404 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.685 ' HB2' HD23 ' B' ' 112' ' ' LEU . . . -69.21 -35.11 75.85 Favored 'General case' 0 CA--C 1.513 -0.456 0 CA-C-O 121.023 0.439 . . . . 0.0 110.719 179.11 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.46 ' HB2' HG11 ' A' ' 39' ' ' VAL . 5.0 t -67.63 -41.11 84.44 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 178.337 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.868 HD12 HD12 ' A' ' 7' ' ' LEU . 68.5 mt -47.92 -56.57 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 CA-C-N 113.859 -1.518 . . . . 0.0 109.905 170.976 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.873 ' HB2' HD13 ' B' ' 109' ' ' LEU . 22.9 m-85 -65.13 -39.64 93.32 Favored 'General case' 0 C--O 1.218 -0.586 0 CA-C-N 115.685 -0.688 . . . . 0.0 111.413 -174.194 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.467 ' HB2' HG23 ' A' ' 28' ' ' ILE . 16.0 m -57.34 -40.84 78.87 Favored 'General case' 0 C--O 1.24 0.588 0 CA-C-O 121.463 0.649 . . . . 0.0 109.315 177.197 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.438 ' CB ' HD11 ' A' ' 51' ' ' LEU . . . -67.13 -30.93 71.07 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 115.186 -0.915 . . . . 0.0 110.212 175.067 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.704 HD22 HD11 ' A' ' 56' ' ' ILE . 0.3 OUTLIER -66.98 -53.63 29.68 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.591 179.684 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.455 HG12 ' H ' ' A' ' 15' ' ' ILE . 0.0 OUTLIER -57.77 -41.66 80.13 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 CA-C-O 120.961 0.41 . . . . 0.0 109.955 176.8 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.574 HD11 ' HG2' ' A' ' 27' ' ' LYS . 2.6 tp -60.08 -41.94 93.54 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.821 176.816 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 47.4 t60 -80.47 -8.31 59.5 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.316 179.594 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -73.8 -43.34 59.15 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 178.761 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -97.71 -14.55 20.81 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-O 121.991 0.901 . . . . 0.0 109.045 177.916 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 61.0 52.69 3.97 Favored 'General case' 0 CA--C 1.51 -0.566 0 CA-C-N 113.753 -1.567 . . . . 0.0 109.979 -174.735 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.511 HG13 HD12 ' A' ' 16' ' ' LEU . 7.3 p -102.08 171.64 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.426 -1.643 0 CA-C-N 114.445 -1.252 . . . . 0.0 108.506 -178.216 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.503 ' H ' HG22 ' A' ' 21' ' ' VAL . 41.2 p -54.19 138.65 37.87 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 113.365 0.876 . . . . 0.0 113.365 -170.595 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.587 HG12 ' HA ' ' A' ' 48' ' ' ALA . 59.4 t -107.19 108.7 25.85 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.995 0 CA-C-N 114.371 -1.286 . . . . 0.0 110.54 -176.649 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.508 ' OG1' ' HE2' ' A' ' 27' ' ' LYS . 68.5 p -140.24 155.14 47.0 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.61 179.029 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -54.83 -43.36 72.92 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.228 0.537 . . . . 0.0 109.788 178.901 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 -60.5 -34.55 74.24 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.168 -0.923 . . . . 0.0 110.76 178.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.574 ' HG2' HD11 ' A' ' 16' ' ' LEU . 3.9 tppt? -67.53 -54.12 22.74 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-O 121.881 0.848 . . . . 0.0 109.233 -178.66 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.467 HG23 ' HB2' ' A' ' 12' ' ' SER . 88.1 mt -58.76 -39.35 76.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 114.459 -1.246 . . . . 0.0 110.287 178.262 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 42.8 t-20 -58.14 -42.85 86.76 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.109 176.538 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -60.42 -46.85 88.53 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.243 177.636 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.512 ' HB3' HD21 ' B' ' 109' ' ' LEU . 1.1 mm? -55.54 -51.46 66.98 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 121.221 0.534 . . . . 0.0 110.216 175.348 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.621 HG23 ' O ' ' A' ' 37' ' ' VAL . 67.8 mt -47.71 -49.46 10.24 Favored 'Isoleucine or valine' 0 C--O 1.242 0.665 0 CA-C-N 114.655 -1.157 . . . . 0.0 111.936 179.199 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.431 ' HA ' ' HD2' ' A' ' 33' ' ' LYS . 3.0 mmmp? -78.45 -31.26 47.93 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.528 0.566 . . . . 0.0 112.528 -173.669 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.521 ' HB2' ' HB3' ' B' ' 129' ' ' SER . . . -68.83 -38.15 79.66 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 120.641 -0.423 . . . . 0.0 110.463 177.719 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.549 ' CB ' ' HG ' ' B' ' 109' ' ' LEU . . . -77.6 -36.3 51.96 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.412 177.02 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 97.62 13.25 44.83 Favored Glycine 0 N--CA 1.445 -0.715 0 CA-C-N 115.427 -0.806 . . . . 0.0 111.959 178.6 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.953 ' HB ' ' HA2' ' B' ' 113' ' ' GLY . 2.6 p -116.13 116.96 53.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-O 121.818 0.818 . . . . 0.0 110.969 -175.126 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -90.12 152.82 20.95 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 114.268 -1.333 . . . . 0.0 110.551 -171.684 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.504 HG12 ' N ' ' A' ' 40' ' ' GLU . 96.3 t -120.51 166.13 15.26 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.07 0 CA-C-N 114.555 -1.202 . . . . 0.0 109.935 -173.056 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.635 ' HB3' ' HD1' ' A' ' 43' ' ' TRP . 28.3 tp10 -72.62 106.35 2.11 Favored Pre-proline 0 N--CA 1.439 -1.023 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 168.872 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.529 ' C ' ' HD2' ' A' ' 44' ' ' PRO . 86.8 Cg_exo -50.09 -30.71 25.81 Favored 'Trans proline' 0 C--O 1.253 1.243 0 C-N-CA 123.709 2.94 . . . . 0.0 115.65 -163.9 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.402 ' HD2' ' HG3' ' A' ' 40' ' ' GLU . 0.5 OUTLIER -59.43 -28.4 66.91 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 177.246 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 43' ' ' TRP . . . . . 0.635 ' HD1' ' HB3' ' A' ' 40' ' ' GLU . 17.4 m95 -64.2 -60.44 8.72 Favored Pre-proline 0 C--O 1.206 -1.214 0 CA-C-O 118.369 -0.824 . . . . 0.0 111.153 176.083 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.529 ' HD2' ' C ' ' A' ' 41' ' ' PRO . 93.1 Cg_exo -44.99 -44.89 14.61 Favored 'Trans proline' 0 C--N 1.36 1.155 0 C-N-CA 121.849 1.699 . . . . 0.0 112.167 175.094 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -61.55 -55.77 26.95 Favored Glycine 0 CA--C 1.525 0.68 0 C-N-CA 120.035 -1.079 . . . . 0.0 112.525 177.17 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 8.9 tp -67.42 -27.92 67.47 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 122.849 0.459 . . . . 0.0 112.025 -177.366 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.513 ' HE1' ' CE3' ' A' ' 43' ' ' TRP . 2.8 m-85 -69.89 -46.8 64.66 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 177.112 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.587 ' HA ' HG12 ' A' ' 23' ' ' VAL . . . -62.84 -34.34 77.13 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.81 0.814 . . . . 0.0 109.592 178.26 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.471 ' HD2' ' C ' ' A' ' 49' ' ' LYS . 0.3 OUTLIER -70.85 -42.26 70.36 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 114.291 -1.322 . . . . 0.0 111.484 177.085 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.415 ' O ' HG22 ' A' ' 54' ' ' VAL . . . -82.23 -44.96 15.68 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 112.687 0.625 . . . . 0.0 112.687 -173.569 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.537 ' HB2' HG11 ' A' ' 23' ' ' VAL . 11.1 mt -63.71 -13.15 40.65 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 112.87 0.693 . . . . 0.0 112.87 -171.835 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -83.1 -10.25 58.78 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.135 0.493 . . . . 0.0 110.579 176.623 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 33.9 m-80 -122.6 -47.6 2.08 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.261 -176.55 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.415 HG22 ' O ' ' A' ' 50' ' ' ALA . 13.7 m -99.55 -169.93 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 176.601 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -130.59 -173.1 2.98 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 120.484 -0.486 . . . . 0.0 111.338 178.149 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.704 HD11 HD22 ' A' ' 14' ' ' LEU . 3.4 tp -66.03 -26.99 39.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-O 121.006 0.431 . . . . 0.0 111.08 -174.262 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -71.15 -14.99 74.26 Favored Glycine 0 N--CA 1.442 -0.904 0 C-N-CA 120.459 -0.877 . . . . 0.0 111.21 179.798 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 14.8 t -79.99 -21.27 43.85 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-O 121.157 0.504 . . . . 0.0 110.054 179.631 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.545 ' HB2' HG21 ' B' ' 159' ' ' ILE . 26.0 mt -62.67 -33.05 74.28 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.518 -0.764 . . . . 0.0 110.848 -178.298 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.648 ' CD1' ' HB ' ' B' ' 159' ' ' ILE . 0.1 OUTLIER -65.64 -15.36 18.55 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.914 -179.299 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 25.8 t -96.45 -7.9 33.64 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.69 -178.237 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.482 ' HB3' ' HH2' ' A' ' 43' ' ' TRP . 9.4 m120 -63.24 -30.92 71.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.914 0.387 . . . . 0.0 111.228 -175.06 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 18.2 m -100.91 29.93 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 121.415 0.626 . . . . 0.0 111.095 -179.661 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -175.15 55.1 0.12 Allowed Glycine 0 N--CA 1.447 -0.598 0 CA-C-N 115.427 -0.806 . . . . 0.0 111.561 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -116.02 20.12 14.61 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.935 0.398 . . . . 0.0 110.769 -177.199 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -91.67 53.24 3.02 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.951 -0.642 . . . . 0.0 111.634 178.597 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.417 ' HA2' ' HD3' ' A' ' 68' ' ' PRO . . . 132.26 124.92 2.6 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.911 -0.662 . . . . 0.0 111.986 -178.372 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.417 ' HD3' ' HA2' ' A' ' 67' ' ' GLY . 13.7 Cg_exo -69.64 170.37 16.6 Favored 'Trans proline' 0 C--O 1.237 0.43 0 C-N-CA 122.912 2.408 . . . . 0.0 112.533 -179.496 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.039 0 CA-C-O 118.509 -0.757 . . . . 0.0 110.068 179.795 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.067 0 CA-C-O 120.968 0.413 . . . . 0.0 110.732 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 101' ' ' MET . . . . . 0.529 ' CE ' HD12 ' A' ' 14' ' ' LEU . 0.6 OUTLIER -97.12 99.73 11.22 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 120.878 -0.329 . . . . 0.0 111.287 -178.868 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 102' ' ' ARG . . . . . 0.414 ' C ' ' H ' ' B' ' 104' ' ' VAL . 14.9 mmt180 -143.67 112.28 6.49 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 170.042 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 103' ' ' TYR . . . . . 0.827 ' HB2' HG11 ' B' ' 142' ' ' VAL . 52.2 m-85 72.91 -15.16 0.53 Allowed 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.478 0.711 . . . . 0.0 111.807 178.765 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 104' ' ' VAL . . . . . 0.526 ' O ' HD22 ' B' ' 108' ' ' LEU . 50.1 t -43.17 -50.28 1.24 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.371 0 CA-C-O 121.736 0.779 . . . . 0.0 110.255 174.069 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 105' ' ' ALA . . . . . 0.655 ' CB ' ' HB3' ' A' ' 14' ' ' LEU . . . -64.67 -37.85 88.98 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-N 114.519 -1.219 . . . . 0.0 111.669 -174.306 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 106' ' ' SER . . . . . 0.703 ' HB2' HG23 ' B' ' 123' ' ' ILE . 1.4 m -62.82 -37.78 88.11 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.533 0.682 . . . . 0.0 109.391 178.533 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 107' ' ' TYR . . . . . 0.683 ' CG ' HD12 ' B' ' 146' ' ' LEU . 34.2 t80 -63.99 -47.58 79.81 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 114.727 -1.124 . . . . 0.0 108.689 178.285 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 108' ' ' LEU . . . . . 0.836 HD12 HG13 ' B' ' 151' ' ' ILE . 0.0 OUTLIER -58.21 -47.54 83.17 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.103 -0.953 . . . . 0.0 110.943 177.522 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 109' ' ' LEU . . . . . 0.873 HD13 ' HB2' ' A' ' 11' ' ' TYR . 8.1 tp -54.19 -48.76 70.61 Favored 'General case' 0 CA--C 1.511 -0.541 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.193 179.11 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 110' ' ' ALA . . . . . 0.43 ' HB3' ' HB3' ' B' ' 118' ' ' PRO . . . -64.65 -41.13 96.33 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.975 0.417 . . . . 0.0 111.044 -177.442 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 111' ' ' ALA . . . . . 0.665 ' HA ' ' O ' ' B' ' 115' ' ' ASN . . . -68.65 -20.17 64.44 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.275 0.56 . . . . 0.0 110.802 179.318 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 112' ' ' LEU . . . . . 0.685 HD23 ' HB2' ' A' ' 8' ' ' ALA . 1.4 mp -85.14 -37.11 20.59 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.966 173.723 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 113' ' ' GLY . . . . . 0.953 ' HA2' ' HB ' ' A' ' 37' ' ' VAL . . . -62.81 -39.23 97.73 Favored Glycine 0 N--CA 1.445 -0.705 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.769 -179.123 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 114' ' ' GLY . . . . . . . . . . . . . . . 155.09 6.21 0.08 OUTLIER Glycine 0 N--CA 1.44 -1.09 0 C-N-CA 120.217 -0.992 . . . . 0.0 112.928 177.216 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 115' ' ' ASN . . . . . 0.665 ' O ' ' HA ' ' B' ' 111' ' ' ALA . 37.4 t30 -119.63 92.62 3.83 Favored 'General case' 0 N--CA 1.444 -0.77 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 -179.454 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 5.2 p -80.59 27.53 0.36 Allowed 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 122.325 1.059 . . . . 0.0 111.038 -166.049 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 117' ' ' SER . . . . . 0.521 ' N ' ' HD3' ' B' ' 118' ' ' PRO . 33.0 t -172.14 68.29 0.42 Allowed Pre-proline 0 C--N 1.31 -1.137 0 CA-C-N 113.419 -1.719 . . . . 0.0 108.098 178.55 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 118' ' ' PRO . . . . . 0.679 ' HG2' ' O ' ' B' ' 107' ' ' TYR . 37.1 Cg_exo -64.09 156.25 60.07 Favored 'Trans proline' 0 CA--C 1.512 -0.611 0 C-N-CA 125.028 3.818 . . . . 0.0 111.718 -174.291 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 119' ' ' SER . . . . . 0.67 ' O ' HG12 ' B' ' 123' ' ' ILE . 90.2 p -123.75 179.78 4.67 Favored 'General case' 0 C--N 1.314 -0.961 0 C-N-CA 120.079 -0.648 . . . . 0.0 110.831 177.837 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 120' ' ' ALA . . . . . 0.834 ' HB1' HD13 ' B' ' 139' ' ' LEU . . . -65.9 -39.2 90.39 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-O 121.75 0.786 . . . . 0.0 109.617 -172.577 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 121' ' ' LYS . . . . . . . . . . . . . 13.9 mptt -60.33 -37.91 82.12 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 114.076 -1.42 . . . . 0.0 110.538 175.169 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 122' ' ' ASP . . . . . 0.628 ' O ' ' HB2' ' B' ' 125' ' ' LYS . 2.6 t0 -74.44 -35.06 63.33 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 121.665 0.745 . . . . 0.0 109.105 -178.644 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 123' ' ' ILE . . . . . 0.746 ' O ' ' HG ' ' B' ' 127' ' ' LEU . 42.7 mm -60.01 -44.3 94.43 Favored 'Isoleucine or valine' 0 C--O 1.235 0.301 0 CA-C-N 115.43 -0.805 . . . . 0.0 109.511 172.762 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 124' ' ' LYS . . . . . 0.687 ' HD3' HD21 ' B' ' 139' ' ' LEU . 5.2 mmmp? -58.66 -44.59 90.18 Favored 'General case' 0 CA--C 1.503 -0.864 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 -179.27 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 125' ' ' LYS . . . . . 0.628 ' HB2' ' O ' ' B' ' 122' ' ' ASP . 17.6 mmtp -45.03 -66.76 0.36 Allowed 'General case' 0 C--O 1.248 0.975 0 CA-C-O 121.609 0.719 . . . . 0.0 112.54 169.724 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 126' ' ' ILE . . . . . 0.453 HD11 ' HA ' ' A' ' 35' ' ' ALA . 1.7 mp -54.65 -43.23 64.76 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.13 0 CA-C-N 113.801 -1.545 . . . . 0.0 111.112 -168.701 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 127' ' ' LEU . . . . . 0.746 ' HG ' ' O ' ' B' ' 123' ' ' ILE . 1.5 pp -84.27 -23.46 30.35 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.505 0.557 . . . . 0.0 112.505 -178.299 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 128' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -70.44 -27.88 64.6 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 120.784 0.326 . . . . 0.0 110.22 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 129' ' ' SER . . . . . 0.521 ' HB3' ' HB2' ' A' ' 34' ' ' ALA . 89.2 p -55.87 -45.86 78.43 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.292 177.556 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 130' ' ' VAL . . . . . 0.499 HG23 HG13 ' B' ' 132' ' ' ILE . 10.9 m -88.88 -17.93 8.11 Favored 'Isoleucine or valine' 0 C--O 1.231 0.083 0 CA-C-O 120.727 0.299 . . . . 0.0 111.563 179.369 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 131' ' ' GLY . . . . . . . . . . . . . . . 100.74 18.76 19.65 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.661 -0.78 . . . . 0.0 112.686 177.321 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 132' ' ' ILE . . . . . 0.539 ' O ' HD13 ' B' ' 127' ' ' LEU . 27.5 mt -78.16 114.93 19.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.788 0.327 . . . . 0.0 110.271 178.334 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 133' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -79.02 138.47 38.03 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.386 -175.263 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 134' ' ' ALA . . . . . . . . . . . . . . . -139.79 143.69 37.0 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.774 -0.648 . . . . 0.0 112.103 -169.442 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 135' ' ' ASP . . . . . 0.783 ' HB2' ' HG3' ' B' ' 138' ' ' ARG . 6.3 m-20 -84.05 128.17 34.38 Favored 'General case' 0 C--O 1.252 1.201 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 175.104 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 136' ' ' ASP . . . . . 1.031 ' HA ' HD11 ' B' ' 139' ' ' LEU . 1.3 p-10 -77.14 -0.34 24.55 Favored 'General case' 0 CA--C 1.518 -0.261 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.26 -166.438 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 137' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -103.22 -31.74 9.96 Favored 'General case' 0 N--CA 1.439 -1.01 0 CA-C-O 121.186 0.517 . . . . 0.0 110.14 172.44 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 138' ' ' ARG . . . . . 0.783 ' HG3' ' HB2' ' B' ' 135' ' ' ASP . 44.9 mmt-85 -63.26 -54.37 38.28 Favored 'General case' 0 CA--C 1.504 -0.803 0 CA-C-O 122.108 0.956 . . . . 0.0 109.177 -177.93 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 139' ' ' LEU . . . . . 1.031 HD11 ' HA ' ' B' ' 136' ' ' ASP . 0.3 OUTLIER -66.88 -28.02 67.99 Favored 'General case' 0 C--O 1.211 -0.96 0 CA-C-N 114.383 -1.28 . . . . 0.0 110.996 -179.942 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 140' ' ' ASN . . . . . 0.721 ' O ' ' HB ' ' B' ' 143' ' ' ILE . 11.1 t30 -75.98 -25.77 56.13 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.712 0.768 . . . . 0.0 110.029 -177.461 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 141' ' ' LYS . . . . . 0.522 ' HG2' ' O ' ' B' ' 138' ' ' ARG . 10.5 ptmt -84.34 -31.39 24.84 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.364 -0.835 . . . . 0.0 109.649 -179.477 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 142' ' ' VAL . . . . . 0.827 HG11 ' HB2' ' B' ' 103' ' ' TYR . 9.6 p -70.22 -33.68 55.58 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.119 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 170.583 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 143' ' ' ILE . . . . . 0.88 HG12 ' O ' ' B' ' 139' ' ' LEU . 29.5 mm -47.84 -61.87 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.376 0 CA-C-O 121.463 0.649 . . . . 0.0 109.375 166.514 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 144' ' ' SER . . . . . . . . . . . . . 25.4 m -49.27 -44.38 43.86 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 114.545 -1.207 . . . . 0.0 112.355 177.953 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 145' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -70.88 -30.36 66.71 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 112.368 0.507 . . . . 0.0 112.368 -177.606 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 146' ' ' LEU . . . . . 0.683 HD12 ' CG ' ' B' ' 107' ' ' TYR . 5.3 mt -93.55 -17.88 22.86 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.346 -0.541 . . . . 0.0 111.023 -177.763 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 147' ' ' ASN . . . . . . . . . . . . . 39.3 t30 -57.79 115.46 2.84 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.08 -177.702 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . 104.27 15.93 20.0 Favored Glycine 0 N--CA 1.448 -0.536 0 CA-C-N 115.745 -0.662 . . . . 0.0 112.518 -179.248 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 149' ' ' LYS . . . . . 0.428 ' HB2' ' O ' ' B' ' 146' ' ' LEU . 0.6 OUTLIER -112.6 158.59 19.78 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.599 0.238 . . . . 0.0 110.659 179.11 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 150' ' ' ASN . . . . . 0.536 ' O ' HG23 ' B' ' 154' ' ' VAL . 25.9 t-20 -97.7 95.87 7.87 Favored 'General case' 0 CA--C 1.511 -0.529 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 175.523 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 151' ' ' ILE . . . . . 0.836 HG13 HD12 ' B' ' 108' ' ' LEU . 1.8 mp -43.61 -60.79 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 O-C-N 124.621 1.2 . . . . 0.0 113.148 -169.4 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 152' ' ' GLU . . . . . 0.409 ' N ' HG22 ' B' ' 151' ' ' ILE . 47.0 mt-10 -56.2 -39.93 73.19 Favored 'General case' 0 C--O 1.212 -0.87 0 N-CA-C 111.708 0.262 . . . . 0.0 111.708 -174.426 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 153' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -74.56 -26.4 59.93 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 120.707 -0.397 . . . . 0.0 110.96 -179.051 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 154' ' ' VAL . . . . . 0.816 ' HB ' HD12 ' B' ' 155' ' ' ILE . 53.9 t -59.56 -50.06 81.36 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 170.172 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 155' ' ' ILE . . . . . 0.816 HD12 ' HB ' ' B' ' 154' ' ' VAL . 3.0 mp -107.47 34.29 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.19 -177.05 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 156' ' ' ALA . . . . . 0.493 ' HB1' ' HA ' ' A' ' 1' ' ' MET . . . -95.77 -4.29 44.21 Favored 'General case' 0 C--N 1.309 -1.157 0 N-CA-C 107.505 -1.294 . . . . 0.0 107.505 169.51 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 157' ' ' GLN . . . . . . . . . . . . . 70.0 mm-40 -135.63 -27.83 1.14 Allowed 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 113.289 -1.778 . . . . 0.0 110.682 175.415 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 158' ' ' GLY . . . . . 0.539 ' O ' HD12 ' B' ' 162' ' ' LEU . . . -105.85 46.56 1.16 Allowed Glycine 0 C--O 1.222 -0.595 0 CA-C-O 119.581 -0.566 . . . . 0.0 114.511 -171.377 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 159' ' ' ILE . . . . . 0.648 ' HB ' ' CD1' ' A' ' 60' ' ' ILE . 1.8 mp -56.5 -24.0 18.01 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.094 0 CA-C-N 117.385 0.593 . . . . 0.0 110.876 176.043 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 160' ' ' GLY . . . . . . . . . . . . . . . -113.88 -42.11 0.88 Allowed Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 120.835 -0.698 . . . . 0.0 111.805 179.382 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 161' ' ' LYS . . . . . 0.477 ' HD3' ' N ' ' B' ' 161' ' ' LYS . 3.3 mppt? -76.48 39.5 0.21 Allowed 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 112.813 0.671 . . . . 0.0 112.813 -179.736 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 162' ' ' LEU . . . . . 0.539 HD12 ' O ' ' B' ' 158' ' ' GLY . 11.2 mp -48.88 129.73 17.4 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 176.425 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 163' ' ' ALA . . . . . . . . . . . . . . . 47.99 54.75 9.6 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 115.24 -0.891 . . . . 0.0 112.877 178.776 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 164' ' ' SER . . . . . . . . . . . . . 55.3 p 59.2 113.57 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 113.924 1.083 . . . . 0.0 113.924 171.585 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 165' ' ' VAL . . . . . 0.404 HG23 ' HD2' ' B' ' 166' ' ' PRO . 7.8 p -69.2 132.09 90.16 Favored Pre-proline 0 C--N 1.326 -0.446 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 170.781 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 166' ' ' PRO . . . . . 0.404 ' HD2' HG23 ' B' ' 165' ' ' VAL . 10.2 Cg_exo -5.12 109.6 0.0 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.162 1 C-N-CA 127.03 5.153 . . . . 0.0 116.663 -165.364 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 167' ' ' ALA . . . . . . . . . . . . . . . -82.91 94.69 7.77 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 114.349 -1.296 . . . . 0.0 111.477 -171.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 168' ' ' GLY . . . . . . . . . . . . . . . 176.03 -152.55 13.07 Favored Glycine 0 N--CA 1.438 -1.216 0 C-N-CA 120.787 -0.72 . . . . 0.0 111.978 178.04 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 169' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.933 0 CA-C-O 118.781 -1.011 . . . . 0.0 111.618 -175.538 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 52.8 ttm . . . . . 0 N--CA 1.48 1.05 0 CA-C-O 121.026 0.441 . . . . 0.0 110.646 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.884 ' HB3' HD13 ' A' ' 7' ' ' LEU . . . -66.05 148.05 52.4 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.8 -0.637 . . . . 0.0 111.182 175.512 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.538 ' HB2' ' OE1' ' A' ' 6' ' ' GLU . 0.7 OUTLIER -70.2 143.65 52.16 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 173.165 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.548 HG13 ' HG ' ' B' ' 112' ' ' LEU . 2.1 t -51.77 -22.86 2.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-N 114.189 -1.368 . . . . 0.0 112.825 -177.215 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.523 ' HB3' ' HA ' ' A' ' 39' ' ' VAL . 16.8 m -71.32 -58.22 3.74 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 179.162 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.542 ' O ' HG13 ' A' ' 10' ' ' ILE . 2.3 mp0 -54.69 -52.45 62.36 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.657 176.004 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.884 HD13 ' HB3' ' A' ' 2' ' ' ALA . 3.6 tp -56.42 -37.14 69.79 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 115.344 -0.843 . . . . 0.0 112.503 179.782 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.64 ' HB2' HD23 ' B' ' 112' ' ' LEU . . . -70.04 -33.38 71.9 Favored 'General case' 0 N--CA 1.468 0.447 0 O-C-N 122.007 -0.433 . . . . 0.0 110.849 179.059 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.605 ' HB2' HG11 ' A' ' 39' ' ' VAL . 8.2 t -70.32 -38.7 74.97 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 177.686 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.875 HD12 ' HA ' ' A' ' 7' ' ' LEU . 67.4 mt -49.22 -55.88 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.74 0 CA-C-N 114.071 -1.422 . . . . 0.0 109.661 170.679 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.672 ' OH ' ' HB ' ' B' ' 155' ' ' ILE . 23.1 m-85 -67.59 -44.18 78.76 Favored 'General case' 0 C--O 1.22 -0.458 0 CA-C-N 115.771 -0.65 . . . . 0.0 112.164 -173.043 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.0 p -54.56 -46.06 73.58 Favored 'General case' 0 C--O 1.243 0.754 0 CA-C-O 121.447 0.642 . . . . 0.0 109.802 177.305 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.04 -36.94 78.39 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.57 172.92 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.705 ' HG ' HD21 ' B' ' 162' ' ' LEU . 0.2 OUTLIER -60.84 -55.85 28.2 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.264 -179.537 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.465 HG12 ' O ' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -52.85 -44.81 49.54 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.54 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 177.612 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.543 HD21 ' HA ' ' A' ' 23' ' ' VAL . 3.4 tp -54.7 -35.6 63.8 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.282 178.135 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' HIS . . . . . 0.483 ' NE2' HD22 ' A' ' 51' ' ' LEU . 30.5 m-70 -83.48 -14.71 51.84 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 177.574 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 1.005 ' HA ' ' HA ' ' B' ' 100' ' ' ALA . 6.1 t0 -76.4 -33.69 58.85 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.314 0.578 . . . . 0.0 109.593 -178.676 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.818 ' HB2' HG23 ' B' ' 132' ' ' ILE . 15.1 t70 -96.07 -12.34 25.0 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 174.625 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 55.24 50.05 15.91 Favored 'General case' 0 CA--C 1.518 -0.274 0 CA-C-N 113.861 -1.518 . . . . 0.0 109.979 -175.191 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.624 HG22 ' H ' ' A' ' 22' ' ' THR . 7.9 p -108.08 175.08 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.321 0 CA-C-N 114.589 -1.187 . . . . 0.0 109.286 -174.204 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.624 ' H ' HG22 ' A' ' 21' ' ' VAL . 63.2 p -54.53 137.61 42.66 Favored 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 113.606 0.965 . . . . 0.0 113.606 -170.929 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.572 HG12 ' HA ' ' A' ' 48' ' ' ALA . 54.0 t -104.91 109.01 26.28 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.758 0 CA-C-N 114.182 -1.372 . . . . 0.0 110.469 -177.484 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.591 ' OG1' ' HB2' ' A' ' 27' ' ' LYS . 82.4 p -144.77 155.8 43.72 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.719 -179.429 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 49.7 tt0 -57.2 -41.7 79.87 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.429 -0.351 . . . . 0.0 110.748 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -66.7 -27.42 67.63 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-O 120.962 0.41 . . . . 0.0 110.449 179.547 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.591 ' HB2' ' OG1' ' A' ' 24' ' ' THR . 3.3 tppt? -71.12 -52.17 20.88 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 -179.195 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 45.9 mt -58.98 -38.65 74.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 114.547 -1.206 . . . . 0.0 110.401 176.685 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 7.8 m-20 -58.02 -43.5 86.77 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.868 173.826 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -58.02 -46.61 85.01 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.675 178.015 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.592 ' HB3' HD21 ' B' ' 109' ' ' LEU . 1.3 mm? -59.03 -51.99 67.7 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 121.045 0.45 . . . . 0.0 110.65 175.495 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.617 HG23 ' O ' ' A' ' 37' ' ' VAL . 56.0 mt -49.91 -51.19 17.15 Favored 'Isoleucine or valine' 0 C--O 1.239 0.543 0 CA-C-N 115.155 -0.929 . . . . 0.0 111.916 -178.842 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.606 ' HD2' HG22 ' A' ' 32' ' ' ILE . 14.0 mptt -77.16 -28.14 54.02 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.66 -0.7 . . . . 0.0 112.103 -175.598 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -68.45 -41.43 80.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.902 0.382 . . . . 0.0 110.525 177.464 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -79.26 -38.65 34.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.255 0.55 . . . . 0.0 110.858 178.231 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 101.15 16.94 23.98 Favored Glycine 0 N--CA 1.447 -0.614 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.848 -179.313 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.906 ' HB ' ' HA2' ' B' ' 113' ' ' GLY . 3.0 p -121.11 121.17 64.24 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.423 0 CA-C-O 121.241 0.543 . . . . 0.0 110.827 -177.264 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.528 ' HA ' HG23 ' A' ' 32' ' ' ILE . 8.0 t-20 -100.59 167.65 10.21 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.153 -0.931 . . . . 0.0 110.869 -171.356 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.605 HG11 ' HB2' ' A' ' 9' ' ' CYS . 94.7 t -132.79 165.07 33.47 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 CA-C-N 115.01 -0.996 . . . . 0.0 110.477 -170.585 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.549 ' HB3' ' HD1' ' A' ' 43' ' ' TRP . 4.7 tp10 -68.44 108.07 2.53 Favored Pre-proline 0 N--CA 1.444 -0.726 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 168.353 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.489 ' C ' ' HD2' ' A' ' 44' ' ' PRO . 81.1 Cg_exo -51.77 -28.77 31.55 Favored 'Trans proline' 0 C--O 1.251 1.145 0 C-N-CA 123.582 2.855 . . . . 0.0 115.855 -164.243 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -61.41 -27.77 68.78 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 120.39 -0.524 . . . . 0.0 109.627 177.562 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' TRP . . . . . 0.568 ' CE3' ' HE1' ' A' ' 47' ' ' PHE . 14.1 m95 -64.46 -60.63 8.08 Favored Pre-proline 0 C--O 1.206 -1.222 0 CA-C-O 118.467 -0.778 . . . . 0.0 110.914 176.566 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.517 ' HD3' ' HB2' ' A' ' 43' ' ' TRP . 96.8 Cg_exo -46.13 -44.37 19.55 Favored 'Trans proline' 0 C--N 1.359 1.13 0 C-N-CA 121.811 1.674 . . . . 0.0 111.88 175.176 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -58.7 -62.24 6.47 Favored Glycine 0 CA--C 1.525 0.684 0 C-N-CA 120.187 -1.006 . . . . 0.0 112.631 176.428 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.411 ' O ' ' HB2' ' A' ' 49' ' ' LYS . 4.2 tp -64.44 -32.31 73.89 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 123.081 0.552 . . . . 0.0 111.99 -176.789 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.568 ' HE1' ' CE3' ' A' ' 43' ' ' TRP . 3.2 m-85 -61.81 -50.69 71.31 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 120.826 0.346 . . . . 0.0 110.089 175.483 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.572 ' HA ' HG12 ' A' ' 23' ' ' VAL . . . -66.37 -28.58 68.76 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.572 0.701 . . . . 0.0 109.891 -178.645 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.411 ' HB2' ' O ' ' A' ' 46' ' ' LEU . 9.4 mmmt -65.66 -51.08 62.25 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 114.546 -1.206 . . . . 0.0 112.08 174.538 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.41 ' O ' HG22 ' A' ' 54' ' ' VAL . . . -88.36 -36.69 16.45 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 113.215 0.821 . . . . 0.0 113.215 -169.471 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.511 ' HB2' HG11 ' A' ' 23' ' ' VAL . 24.0 mt -68.65 -0.7 5.53 Favored 'General case' 0 N--CA 1.464 0.227 0 N-CA-C 112.456 0.539 . . . . 0.0 112.456 -172.963 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -84.96 -1.75 57.08 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.818 0.342 . . . . 0.0 110.307 173.758 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 9.6 t30 -143.97 -39.66 0.29 Allowed 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.228 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.41 HG22 ' O ' ' A' ' 50' ' ' ALA . 6.4 m -82.27 -171.49 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 178.309 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 18.3 m120 -121.32 175.93 5.9 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.044 0.45 . . . . 0.0 110.758 177.58 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.646 HD11 HD22 ' A' ' 14' ' ' LEU . 4.3 tp -75.78 -26.22 17.78 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 177.69 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -72.64 -9.52 74.44 Favored Glycine 0 N--CA 1.445 -0.713 0 N-CA-C 111.058 -0.817 . . . . 0.0 111.058 175.167 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 21.2 m -80.48 -24.56 39.37 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-O 121.346 0.593 . . . . 0.0 109.523 177.045 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.47 HD11 HD12 ' A' ' 56' ' ' ILE . 24.9 mt -60.79 -32.83 72.16 Favored 'General case' 0 CA--C 1.517 -0.304 0 CA-C-N 115.443 -0.798 . . . . 0.0 110.957 -178.848 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.613 ' CD1' ' HB ' ' B' ' 159' ' ' ILE . 0.1 OUTLIER -63.46 -14.72 15.02 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 CA-C-N 114.786 -1.097 . . . . 0.0 111.18 -177.999 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 25.3 t -88.37 -3.15 58.89 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.844 -176.494 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -58.6 -28.47 65.62 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.388 -173.531 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 16.5 m -87.99 29.66 0.12 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.201 0 CA-C-O 121.283 0.563 . . . . 0.0 111.639 -177.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 101.27 -94.1 1.21 Allowed Glycine 0 N--CA 1.446 -0.647 0 CA-C-N 115.564 -0.744 . . . . 0.0 112.438 177.869 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . 60.37 13.88 4.34 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 113.027 0.751 . . . . 0.0 113.027 179.11 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 59.07 56.21 26.59 Favored Glycine 0 C--N 1.332 0.339 0 CA-C-N 116.012 -0.54 . . . . 0.0 112.908 179.259 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.453 ' HA2' ' HD3' ' A' ' 68' ' ' PRO . . . -58.43 134.63 52.36 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.979 -0.629 . . . . 0.0 112.837 -177.614 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.453 ' HD3' ' HA2' ' A' ' 67' ' ' GLY . 26.0 Cg_exo -62.9 -58.51 0.31 Allowed 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.975 2.45 . . . . 0.0 111.876 179.593 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.097 0 CA-C-O 118.579 -0.724 . . . . 0.0 110.331 179.639 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 100' ' ' ALA . . . . . 1.005 ' HA ' ' HA ' ' A' ' 18' ' ' ASP . . . . . . . . 0 N--CA 1.478 0.958 0 CA-C-O 120.782 0.325 . . . . 0.0 110.532 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 101' ' ' MET . . . . . 0.63 ' CE ' HD12 ' A' ' 14' ' ' LEU . 0.0 OUTLIER -132.37 -81.19 0.5 Allowed 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.758 176.427 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 102' ' ' ARG . . . . . 0.589 ' HB2' ' O ' ' B' ' 101' ' ' MET . 54.3 ttp180 168.1 60.06 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.412 0 O-C-N 123.785 0.678 . . . . 0.0 111.568 176.582 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 103' ' ' TYR . . . . . 0.614 ' HB2' HG11 ' B' ' 142' ' ' VAL . 39.6 m-85 66.62 -4.2 0.78 Allowed 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 168.372 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 104' ' ' VAL . . . . . 0.689 HG11 ' HB3' ' B' ' 162' ' ' LEU . 96.1 t -44.42 -46.45 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 CA-C-O 121.864 0.84 . . . . 0.0 109.391 174.153 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 105' ' ' ALA . . . . . 0.638 ' CB ' ' HB3' ' A' ' 14' ' ' LEU . . . -66.8 -38.47 86.57 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-N 114.288 -1.324 . . . . 0.0 112.226 -173.984 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 106' ' ' SER . . . . . 0.737 ' HB2' HG23 ' B' ' 123' ' ' ILE . 3.2 m -63.82 -37.86 88.96 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-O 121.625 0.726 . . . . 0.0 109.611 178.536 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 107' ' ' TYR . . . . . 0.736 ' O ' ' HG2' ' B' ' 118' ' ' PRO . 33.1 t80 -62.28 -49.57 75.14 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 114.684 -1.144 . . . . 0.0 108.316 177.549 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 108' ' ' LEU . . . . . 0.855 HD12 HG13 ' B' ' 151' ' ' ILE . 0.0 OUTLIER -56.28 -47.49 78.5 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 114.542 -1.208 . . . . 0.0 111.313 177.866 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 109' ' ' LEU . . . . . 0.62 HD13 ' HB2' ' A' ' 11' ' ' TYR . 8.9 tp -56.6 -47.75 78.93 Favored 'General case' 0 CA--C 1.515 -0.398 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.908 179.759 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 110' ' ' ALA . . . . . 0.421 ' HB3' ' HB3' ' B' ' 118' ' ' PRO . . . -64.26 -39.76 94.62 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.583 -0.447 . . . . 0.0 110.985 -177.149 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 111' ' ' ALA . . . . . 0.68 ' HA ' ' O ' ' B' ' 115' ' ' ASN . . . -66.66 -28.89 68.83 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.53 179.862 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 112' ' ' LEU . . . . . 0.64 HD23 ' HB2' ' A' ' 8' ' ' ALA . 1.8 mp -80.37 -34.85 36.13 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.35 175.558 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 113' ' ' GLY . . . . . 0.906 ' HA2' ' HB ' ' A' ' 37' ' ' VAL . . . -64.15 -25.05 69.32 Favored Glycine 0 CA--C 1.504 -0.619 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.814 179.363 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 114' ' ' GLY . . . . . . . . . . . . . . . 144.17 -4.73 1.6 Allowed Glycine 0 N--CA 1.436 -1.326 0 C-N-CA 120.25 -0.976 . . . . 0.0 112.993 176.604 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 115' ' ' ASN . . . . . 0.68 ' O ' ' HA ' ' B' ' 111' ' ' ALA . 19.0 t-20 -117.06 90.83 3.42 Favored 'General case' 0 CA--C 1.507 -0.688 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 -176.236 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 7.5 p -77.44 23.64 0.21 Allowed 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.062 -0.972 . . . . 0.0 111.836 -164.853 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 117' ' ' SER . . . . . 0.546 ' N ' ' HD3' ' B' ' 118' ' ' PRO . 8.5 t -164.92 66.93 1.25 Allowed Pre-proline 0 C--N 1.311 -1.092 0 CA-C-N 114.293 -1.321 . . . . 0.0 108.664 179.648 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 118' ' ' PRO . . . . . 0.736 ' HG2' ' O ' ' B' ' 107' ' ' TYR . 33.9 Cg_exo -64.56 157.8 53.32 Favored 'Trans proline' 0 C--N 1.328 -0.517 1 C-N-CA 125.444 4.096 . . . . 0.0 112.351 -174.091 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 119' ' ' SER . . . . . 0.63 ' O ' HG12 ' B' ' 123' ' ' ILE . 27.2 m -126.02 -175.56 3.39 Favored 'General case' 0 C--N 1.316 -0.856 0 C-N-CA 120.597 -0.441 . . . . 0.0 110.943 177.076 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 120' ' ' ALA . . . . . 0.863 ' HB1' HD13 ' B' ' 139' ' ' LEU . . . -67.84 -35.24 78.24 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 122.214 1.007 . . . . 0.0 110.014 -166.532 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 121' ' ' LYS . . . . . 0.473 ' HD2' ' N ' ' B' ' 121' ' ' LYS . 4.4 mptp? -74.24 -26.76 60.42 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 113.681 -1.6 . . . . 0.0 109.756 -179.07 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 122' ' ' ASP . . . . . . . . . . . . . 25.8 m-20 -72.57 -41.31 65.85 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 174.767 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 123' ' ' ILE . . . . . 0.737 HG23 ' HB2' ' B' ' 106' ' ' SER . 36.8 mm -54.11 -48.05 65.78 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.368 0 CA-C-N 114.988 -1.005 . . . . 0.0 109.489 173.655 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 124' ' ' LYS . . . . . 0.867 ' HD2' HD11 ' B' ' 127' ' ' LEU . 2.7 mmmt -62.58 -40.71 97.75 Favored 'General case' 0 N--CA 1.439 -1.011 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.785 -176.545 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 125' ' ' LYS . . . . . . . . . . . . . 42.0 mmtt -50.65 -62.68 1.45 Allowed 'General case' 0 CA--C 1.498 -1.023 0 CA-C-O 121.776 0.798 . . . . 0.0 111.367 170.421 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 126' ' ' ILE . . . . . . . . . . . . . 1.7 mp -56.77 -41.48 75.35 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 CA-C-N 113.756 -1.565 . . . . 0.0 110.758 -169.733 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 127' ' ' LEU . . . . . 0.867 HD11 ' HD2' ' B' ' 124' ' ' LYS . 3.9 pp -79.08 -32.73 44.79 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 -178.548 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 128' ' ' ASP . . . . . 0.513 ' HB2' ' O ' ' B' ' 124' ' ' LYS . 0.6 OUTLIER -70.24 -24.78 63.14 Favored 'General case' 0 CA--C 1.517 -0.323 0 C-N-CA 121.326 -0.15 . . . . 0.0 111.261 -177.587 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 129' ' ' SER . . . . . . . . . . . . . 93.7 p -56.72 -37.19 70.6 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-O 120.928 0.394 . . . . 0.0 111.2 176.722 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 130' ' ' VAL . . . . . 0.784 HG23 HG13 ' B' ' 132' ' ' ILE . 13.0 m -104.69 -2.9 9.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.391 179.471 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 131' ' ' GLY . . . . . . . . . . . . . . . 81.01 36.04 22.76 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 121.029 -0.605 . . . . 0.0 112.882 177.328 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 132' ' ' ILE . . . . . 0.818 HG23 ' HB2' ' A' ' 19' ' ' ASP . 18.6 mt -78.86 131.94 33.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 110.443 -0.206 . . . . 0.0 110.443 177.402 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 133' ' ' GLU . . . . . . . . . . . . . 87.5 mt-10 -77.0 125.24 29.0 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.361 0.6 . . . . 0.0 110.663 -176.197 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 134' ' ' ALA . . . . . 0.491 ' HA ' ' OH ' ' B' ' 103' ' ' TYR . . . -134.99 143.7 46.97 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.381 -0.827 . . . . 0.0 112.135 -173.202 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 135' ' ' ASP . . . . . 0.774 ' HB2' ' HG3' ' B' ' 138' ' ' ARG . 16.2 m-20 -103.11 132.43 49.37 Favored 'General case' 0 C--O 1.252 1.223 0 CA-C-N 115.65 -0.704 . . . . 0.0 109.358 170.515 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 136' ' ' ASP . . . . . 0.987 ' HA ' HD11 ' B' ' 139' ' ' LEU . 17.4 t70 -73.8 -8.61 56.69 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.061 -166.965 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 137' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -96.11 -29.77 13.9 Favored 'General case' 0 N--CA 1.44 -0.953 0 C-N-CA 120.17 -0.612 . . . . 0.0 110.54 174.374 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 138' ' ' ARG . . . . . 0.774 ' HG3' ' HB2' ' B' ' 135' ' ' ASP . 12.8 mmt180 -68.26 -52.12 37.41 Favored 'General case' 0 CA--C 1.503 -0.86 0 CA-C-O 122.176 0.988 . . . . 0.0 108.665 -175.595 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 139' ' ' LEU . . . . . 0.987 HD11 ' HA ' ' B' ' 136' ' ' ASP . 0.4 OUTLIER -67.47 -30.3 69.97 Favored 'General case' 0 C--O 1.209 -1.038 0 CA-C-N 114.024 -1.444 . . . . 0.0 110.878 -179.528 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 140' ' ' ASN . . . . . 0.624 ' O ' ' HB ' ' B' ' 143' ' ' ILE . 12.1 t30 -75.94 -25.41 55.92 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.591 0.71 . . . . 0.0 109.805 -177.929 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 141' ' ' LYS . . . . . 0.524 ' HG2' ' O ' ' B' ' 138' ' ' ARG . 2.6 ptmm? -77.94 -38.55 45.13 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 179.056 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 142' ' ' VAL . . . . . 0.628 HG12 ' O ' ' B' ' 139' ' ' LEU . 7.2 p -69.38 -32.98 55.38 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.401 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 175.05 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 143' ' ' ILE . . . . . 0.878 HG12 ' O ' ' B' ' 139' ' ' LEU . 23.5 mm -49.14 -62.56 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.512 -0.486 0 CA-C-O 121.41 0.624 . . . . 0.0 110.001 166.98 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 144' ' ' SER . . . . . . . . . . . . . 47.4 t -54.08 -34.2 59.52 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 114.608 -1.178 . . . . 0.0 111.695 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 145' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -79.52 -30.79 42.02 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.426 0.528 . . . . 0.0 112.426 -178.767 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 146' ' ' LEU . . . . . 0.72 HD12 ' CG ' ' B' ' 107' ' ' TYR . 6.6 mt -89.55 -31.79 17.44 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.63 -0.428 . . . . 0.0 110.99 179.021 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 147' ' ' ASN . . . . . 0.489 ' HA ' ' OH ' ' B' ' 107' ' ' TYR . 8.3 t30 -40.52 120.34 1.23 Allowed 'General case' 0 N--CA 1.471 0.587 0 O-C-N 124.079 0.862 . . . . 0.0 112.838 -169.941 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . 90.89 36.36 6.79 Favored Glycine 0 N--CA 1.447 -0.57 0 CA-C-N 115.342 -0.844 . . . . 0.0 111.905 -177.7 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 149' ' ' LYS . . . . . 0.684 ' HB2' ' O ' ' B' ' 146' ' ' LEU . 5.2 tppt? -116.92 159.29 22.66 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 110.231 -0.285 . . . . 0.0 110.231 -177.45 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 150' ' ' ASN . . . . . 0.573 ' O ' HG23 ' B' ' 154' ' ' VAL . 92.5 m-20 -106.19 89.95 3.21 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 177.056 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 151' ' ' ILE . . . . . 0.855 HG13 HD12 ' B' ' 108' ' ' LEU . 1.8 mp -46.69 -61.87 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 114.223 -1.353 . . . . 0.0 113.604 -166.797 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 152' ' ' GLU . . . . . 0.454 ' O ' ' HB2' ' B' ' 156' ' ' ALA . 22.5 mt-10 -53.96 -34.1 58.75 Favored 'General case' 0 C--O 1.216 -0.672 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 -173.281 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 153' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -81.36 -32.94 32.69 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 120.744 -0.382 . . . . 0.0 110.794 -179.575 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 154' ' ' VAL . . . . . 0.885 ' HB ' HD12 ' B' ' 155' ' ' ILE . 40.0 t -53.26 -48.83 54.73 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 169.828 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 155' ' ' ILE . . . . . 0.885 HD12 ' HB ' ' B' ' 154' ' ' VAL . 1.5 mp -108.5 38.6 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.005 -0.998 . . . . 0.0 110.893 -178.069 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 156' ' ' ALA . . . . . 0.454 ' HB2' ' O ' ' B' ' 152' ' ' GLU . . . -99.25 7.14 45.97 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 107.115 -1.439 . . . . 0.0 107.115 166.179 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 157' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -143.05 -43.83 0.3 Allowed 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 112.844 -1.98 . . . . 0.0 109.459 175.748 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 158' ' ' GLY . . . . . . . . . . . . . . . -86.57 47.2 3.69 Favored Glycine 0 CA--C 1.521 0.46 0 CA-C-N 115.439 -0.801 . . . . 0.0 114.217 -173.577 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 159' ' ' ILE . . . . . 0.613 ' HB ' ' CD1' ' A' ' 60' ' ' ILE . 1.8 mp -63.63 -14.6 15.04 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 CA-C-O 121.8 0.81 . . . . 0.0 110.104 176.395 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 160' ' ' GLY . . . . . . . . . . . . . . . -130.8 139.51 11.0 Favored Glycine 0 N--CA 1.441 -0.994 0 N-CA-C 110.349 -1.1 . . . . 0.0 110.349 179.648 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 161' ' ' LYS . . . . . 0.596 ' HZ2' ' HB2' ' B' ' 161' ' ' LYS . 0.1 OUTLIER 55.14 40.31 31.75 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.931 0.396 . . . . 0.0 111.201 -172.355 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 162' ' ' LEU . . . . . 0.705 HD21 ' HG ' ' A' ' 14' ' ' LEU . 6.8 mp -28.29 119.23 0.11 Allowed 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 114.437 -1.256 . . . . 0.0 114.042 173.931 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 163' ' ' ALA . . . . . . . . . . . . . . . 46.1 -90.2 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 O-C-N 124.648 1.217 . . . . 0.0 113.646 177.394 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 164' ' ' SER . . . . . . . . . . . . . 13.7 p -79.55 104.27 10.03 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.176 0.512 . . . . 0.0 111.165 -178.722 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 165' ' ' VAL . . . . . 0.422 ' HA ' ' HD2' ' B' ' 166' ' ' PRO . 34.9 t -75.5 131.19 77.87 Favored Pre-proline 0 C--N 1.32 -0.703 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.869 -179.369 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 166' ' ' PRO . . . . . 0.422 ' HD2' ' HA ' ' B' ' 165' ' ' VAL . 40.3 Cg_exo -17.54 118.76 0.01 OUTLIER 'Trans proline' 0 N--CA 1.443 -1.47 1 C-N-CA 127.131 5.22 . . . . 0.0 115.545 177.976 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 167' ' ' ALA . . . . . . . . . . . . . . . 50.61 56.4 8.02 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.804 -176.413 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 168' ' ' GLY . . . . . . . . . . . . . . . -87.08 64.77 3.81 Favored Glycine 0 N--CA 1.447 -0.61 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.905 -178.788 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 169' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.919 0 CA-C-O 118.667 -1.074 . . . . 0.0 111.291 178.942 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.2 ttt . . . . . 0 N--CA 1.478 0.96 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.828 ' HB3' HD13 ' A' ' 7' ' ' LEU . . . -63.29 150.07 44.12 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.784 178.93 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 12.0 m -80.06 131.19 35.72 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 173.88 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.777 HG13 ' HG ' ' B' ' 112' ' ' LEU . 2.0 t -47.05 -28.61 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.254 -0.884 . . . . 0.0 113.38 -177.027 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.905 ' HB3' ' HA ' ' A' ' 39' ' ' VAL . 69.1 m -70.64 -50.93 31.59 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.864 0.84 . . . . 0.0 109.001 176.278 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.481 ' O ' HG13 ' A' ' 10' ' ' ILE . 40.4 tt0 -57.31 -51.18 70.41 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 114.598 -1.183 . . . . 0.0 109.81 176.454 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.95 HD12 HD12 ' A' ' 10' ' ' ILE . 5.7 tp -58.9 -36.28 74.44 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.547 177.568 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.586 ' HB2' HD23 ' B' ' 112' ' ' LEU . . . -66.65 -35.99 81.49 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 121.199 0.523 . . . . 0.0 110.889 178.532 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.541 ' HB2' HG11 ' A' ' 39' ' ' VAL . 7.4 t -68.0 -42.97 79.9 Favored 'General case' 0 C--O 1.242 0.687 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 179.027 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.95 HD12 HD12 ' A' ' 7' ' ' LEU . 72.0 mt -46.34 -56.77 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.605 0 CA-C-N 113.669 -1.605 . . . . 0.0 109.982 170.984 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.871 ' HB2' HD13 ' B' ' 109' ' ' LEU . 23.9 m-85 -64.3 -36.76 85.15 Favored 'General case' 0 CA--C 1.512 -0.484 0 CA-C-N 115.441 -0.799 . . . . 0.0 111.271 -174.983 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.465 ' HA ' ' HG ' ' A' ' 31' ' ' LEU . 18.9 m -56.97 -42.93 81.05 Favored 'General case' 0 C--O 1.243 0.712 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 177.574 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.418 ' HB2' HD11 ' A' ' 51' ' ' LEU . . . -67.17 -31.97 72.74 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.195 175.846 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.734 HD22 HD11 ' A' ' 56' ' ' ILE . 0.3 OUTLIER -63.58 -54.3 38.2 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.316 179.689 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.542 HG12 ' O ' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -60.23 -35.85 64.65 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.412 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 178.868 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.507 ' HA ' HD12 ' A' ' 16' ' ' LEU . 2.3 tp -59.85 -36.06 76.06 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.904 175.616 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' HIS . . . . . 0.524 ' CD2' ' HB ' ' A' ' 56' ' ' ILE . 70.2 m-70 -73.12 -18.7 61.26 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 116.145 -0.48 . . . . 0.0 112.254 176.479 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -59.37 -38.48 80.56 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 121.074 0.464 . . . . 0.0 110.171 179.818 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.441 ' CB ' HG12 ' B' ' 132' ' ' ILE . 32.0 t70 -111.25 -4.75 14.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.822 0.82 . . . . 0.0 109.827 176.92 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.462 ' HG2' ' O ' ' A' ' 17' ' ' HIS . 5.5 mm-40 53.1 48.38 22.39 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-N 114.446 -1.252 . . . . 0.0 110.266 -175.398 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.755 HG22 ' H ' ' A' ' 22' ' ' THR . 13.8 p -100.84 -179.55 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.156 0 CA-C-N 114.903 -1.044 . . . . 0.0 109.966 -170.327 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.755 ' H ' HG22 ' A' ' 21' ' ' VAL . 32.6 p -50.2 141.8 10.82 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 113.608 0.966 . . . . 0.0 113.608 -173.456 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.642 HG12 ' HA ' ' A' ' 48' ' ' ALA . 58.3 t -118.86 111.01 31.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 114.343 -1.298 . . . . 0.0 110.332 -175.2 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.542 ' OG1' ' HE2' ' A' ' 27' ' ' LYS . 77.0 p -143.54 156.67 44.67 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.002 177.84 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -56.64 -40.23 75.06 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.954 0.407 . . . . 0.0 110.259 177.309 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -56.95 -39.26 74.21 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.294 173.314 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.542 ' HE2' ' OG1' ' A' ' 24' ' ' THR . 1.6 tppt? -63.31 -52.04 63.53 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-O 121.94 0.876 . . . . 0.0 109.093 -179.178 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 27.8 mt -61.0 -38.96 80.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 114.628 -1.169 . . . . 0.0 110.72 179.144 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 11.3 m-80 -61.27 -35.49 77.43 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.782 175.782 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.91 -47.92 78.67 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.513 176.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.766 ' HB3' HD21 ' B' ' 109' ' ' LEU . 1.2 mm? -58.01 -50.13 74.46 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 121.113 0.482 . . . . 0.0 110.418 174.945 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.626 HG23 ' O ' ' A' ' 37' ' ' VAL . 57.7 mt -48.34 -48.18 13.77 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 CA-C-N 115.039 -0.982 . . . . 0.0 111.925 178.387 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 22.8 tptm -75.95 -38.82 57.15 Favored 'General case' 0 N--CA 1.433 -1.306 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.799 -174.343 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -67.39 -33.59 75.52 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.964 0.411 . . . . 0.0 110.787 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.529 ' CB ' ' HG ' ' B' ' 109' ' ' LEU . . . -82.44 -36.57 26.49 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.856 177.625 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 97.29 18.15 29.57 Favored Glycine 0 N--CA 1.447 -0.591 0 CA-C-N 115.733 -0.667 . . . . 0.0 112.017 179.483 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.891 ' HB ' ' HA2' ' B' ' 113' ' ' GLY . 2.7 p -121.91 120.84 62.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 121.583 0.706 . . . . 0.0 111.104 -176.216 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -93.69 155.22 17.37 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 114.504 -1.226 . . . . 0.0 110.891 -170.599 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.905 ' HA ' ' HB3' ' A' ' 5' ' ' SER . 97.8 t -127.22 161.3 34.72 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-N 115.102 -0.954 . . . . 0.0 110.593 -170.987 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.511 ' HB3' ' HD1' ' A' ' 43' ' ' TRP . 3.8 tp10 -67.55 105.49 0.92 Allowed Pre-proline 0 N--CA 1.444 -0.731 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 170.882 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.49 ' C ' ' HD2' ' A' ' 44' ' ' PRO . 76.9 Cg_exo -50.93 -30.5 30.69 Favored 'Trans proline' 0 C--O 1.252 1.175 0 C-N-CA 123.599 2.866 . . . . 0.0 115.6 -163.657 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.402 ' CE2' ' HG2' ' A' ' 40' ' ' GLU . 0.8 OUTLIER -60.04 -28.3 67.65 Favored 'General case' 0 C--N 1.334 -0.097 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 178.167 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 43' ' ' TRP . . . . . 0.511 ' HD1' ' HB3' ' A' ' 40' ' ' GLU . 7.9 m95 -62.82 -61.66 7.09 Favored Pre-proline 0 C--O 1.205 -1.24 0 CA-C-O 118.27 -0.871 . . . . 0.0 110.725 176.56 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.49 ' HD2' ' C ' ' A' ' 41' ' ' PRO . 99.3 Cg_exo -44.98 -46.24 13.27 Favored 'Trans proline' 0 C--N 1.36 1.145 0 C-N-CA 121.811 1.674 . . . . 0.0 111.981 175.346 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -59.12 -61.58 7.18 Favored Glycine 0 CA--C 1.525 0.68 0 C-N-CA 120.172 -1.013 . . . . 0.0 112.491 177.771 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 4.5 tp -67.08 -22.61 65.83 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 122.887 0.475 . . . . 0.0 111.714 -176.75 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.461 ' HD2' HD11 ' A' ' 51' ' ' LEU . 2.0 m-85 -69.76 -46.41 65.88 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 175.895 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.642 ' HA ' HG12 ' A' ' 23' ' ' VAL . . . -65.05 -32.22 73.83 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.805 0.812 . . . . 0.0 109.237 178.216 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 11.1 mmmt -66.72 -49.44 66.03 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 114.303 -1.317 . . . . 0.0 111.938 174.773 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -84.74 -34.75 22.81 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 113.3 0.852 . . . . 0.0 113.3 -169.915 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.503 ' HB2' HG11 ' A' ' 23' ' ' VAL . 9.7 mt -67.07 -0.8 3.51 Favored 'General case' 0 N--CA 1.462 0.165 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 -175.281 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -85.89 -14.99 43.18 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.974 0.416 . . . . 0.0 110.353 174.852 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 91.8 m-20 -123.05 -49.89 1.94 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.717 -179.745 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 3.8 m -88.28 166.97 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.584 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.399 -179.242 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 -113.95 179.38 3.97 Favored 'General case' 0 C--N 1.312 -1.023 0 C-N-CA 120.475 -0.49 . . . . 0.0 109.783 176.948 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.734 HD11 HD22 ' A' ' 14' ' ' LEU . 4.6 tp -64.16 -25.35 37.86 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 CA-C-O 120.868 0.366 . . . . 0.0 111.025 -176.345 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -70.47 -15.26 72.79 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.631 -0.795 . . . . 0.0 111.151 178.132 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 33.3 t -78.64 -20.98 49.08 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-O 120.911 0.386 . . . . 0.0 110.184 179.544 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.733 ' HB2' HG21 ' B' ' 159' ' ' ILE . 20.9 mt -65.98 -26.96 67.8 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.859 0.838 . . . . 0.0 110.482 -178.976 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.706 HG13 ' HB ' ' B' ' 159' ' ' ILE . 0.2 OUTLIER -67.27 -13.28 16.46 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-N 114.418 -1.264 . . . . 0.0 110.509 178.685 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 33.9 t -94.63 -15.41 24.03 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.782 179.723 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -75.82 -51.03 13.47 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.996 -175.851 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.4 HG22 ' O ' ' A' ' 63' ' ' VAL . 9.1 p -88.19 33.01 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 122.239 1.019 . . . . 0.0 110.662 -177.931 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 97.39 111.31 2.88 Favored Glycine 0 N--CA 1.446 -0.657 0 CA-C-N 115.193 -0.912 . . . . 0.0 111.666 -177.734 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -77.08 51.09 0.79 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.247 0.546 . . . . 0.0 111.622 -176.68 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 175.63 153.64 10.57 Favored Glycine 0 N--CA 1.445 -0.736 0 N-CA-C 111.271 -0.732 . . . . 0.0 111.271 179.607 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -128.45 112.62 1.45 Allowed Glycine 0 N--CA 1.446 -0.676 0 C-N-CA 120.463 -0.875 . . . . 0.0 112.196 -178.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -71.04 148.48 56.92 Favored 'Trans proline' 0 C--O 1.235 0.35 0 C-N-CA 122.568 2.179 . . . . 0.0 111.932 178.07 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.932 0 CA-C-O 118.574 -0.727 . . . . 0.0 110.401 179.536 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 100' ' ' ALA . . . . . 0.71 ' N ' ' HG ' ' B' ' 164' ' ' SER . . . . . . . . 0 N--CA 1.48 1.047 0 CA-C-O 121.198 0.523 . . . . 0.0 110.518 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 101' ' ' MET . . . . . 0.863 ' HG2' HD22 ' B' ' 162' ' ' LEU . 1.1 tmt? -81.86 124.18 29.47 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.167 179.849 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 102' ' ' ARG . . . . . 0.411 ' HG3' ' O ' ' B' ' 101' ' ' MET . 8.7 mtp180 -164.51 -99.41 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 O-C-N 123.792 0.682 . . . . 0.0 109.792 173.486 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 103' ' ' TYR . . . . . 0.887 ' HB2' HG11 ' B' ' 142' ' ' VAL . 58.1 m-85 -81.22 -8.79 59.82 Favored 'General case' 0 C--O 1.242 0.662 0 CA-C-O 121.023 0.439 . . . . 0.0 110.616 -178.388 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 104' ' ' VAL . . . . . 0.729 ' HA ' HD11 ' B' ' 146' ' ' LEU . 90.2 t -45.0 -49.08 2.72 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.353 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.31 172.201 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 105' ' ' ALA . . . . . 0.67 ' HA ' HD22 ' B' ' 108' ' ' LEU . . . -62.86 -41.1 99.24 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.271 -1.331 . . . . 0.0 112.088 -174.323 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 106' ' ' SER . . . . . 0.872 ' HB2' HG23 ' B' ' 123' ' ' ILE . 1.0 OUTLIER -62.73 -38.92 92.42 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.58 0.705 . . . . 0.0 109.538 179.296 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 107' ' ' TYR . . . . . 0.696 ' CG ' HD12 ' B' ' 146' ' ' LEU . 39.5 t80 -62.04 -46.71 87.94 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 114.443 -1.253 . . . . 0.0 108.748 178.48 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 108' ' ' LEU . . . . . 0.832 HD12 HG13 ' B' ' 151' ' ' ILE . 0.0 OUTLIER -58.66 -46.92 86.12 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 114.409 -1.268 . . . . 0.0 111.088 177.882 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 109' ' ' LEU . . . . . 0.871 HD13 ' HB2' ' A' ' 11' ' ' TYR . 7.2 tp -55.43 -49.33 72.7 Favored 'General case' 0 CA--C 1.513 -0.474 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.793 179.672 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -62.76 -42.63 99.77 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.809 -177.625 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 111' ' ' ALA . . . . . 0.606 ' HA ' ' O ' ' B' ' 115' ' ' ASN . . . -65.64 -27.66 68.55 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.874 179.659 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 112' ' ' LEU . . . . . 0.777 ' HG ' HG13 ' A' ' 4' ' ' VAL . 2.3 mp -78.5 -37.79 42.35 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.007 175.351 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 113' ' ' GLY . . . . . 0.891 ' HA2' ' HB ' ' A' ' 37' ' ' VAL . . . -63.5 -38.88 97.01 Favored Glycine 0 CA--C 1.503 -0.657 0 CA-C-N 115.125 -0.943 . . . . 0.0 111.972 -179.038 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 114' ' ' GLY . . . . . . . . . . . . . . . 159.78 -4.08 0.1 Allowed Glycine 0 N--CA 1.44 -1.072 0 C-N-CA 120.144 -1.027 . . . . 0.0 113.029 177.456 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 115' ' ' ASN . . . . . 0.606 ' O ' ' HA ' ' B' ' 111' ' ' ALA . 45.0 t30 -116.18 86.04 2.41 Favored 'General case' 0 N--CA 1.44 -0.956 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 -176.571 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 116' ' ' SER . . . . . 0.482 ' HA ' ' CB ' ' B' ' 111' ' ' ALA . 3.3 m -78.56 28.46 0.2 Allowed 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 122.239 1.019 . . . . 0.0 110.763 -169.181 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 117' ' ' SER . . . . . 0.536 ' N ' ' HD3' ' B' ' 118' ' ' PRO . 22.7 t -166.19 67.3 1.05 Allowed Pre-proline 0 C--N 1.308 -1.222 0 CA-C-N 113.495 -1.684 . . . . 0.0 107.92 178.211 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 118' ' ' PRO . . . . . 0.635 ' HD2' ' CZ ' ' B' ' 107' ' ' TYR . 26.9 Cg_exo -67.36 165.35 27.24 Favored 'Trans proline' 0 C--O 1.235 0.36 1 C-N-CA 125.44 4.093 . . . . 0.0 112.257 -173.36 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 119' ' ' SER . . . . . 0.664 ' O ' HG12 ' B' ' 123' ' ' ILE . 96.9 p -130.82 -178.5 4.83 Favored 'General case' 0 C--N 1.319 -0.753 0 C-N-CA 120.464 -0.494 . . . . 0.0 110.784 176.258 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 120' ' ' ALA . . . . . 0.813 ' HB1' HD13 ' B' ' 139' ' ' LEU . . . -67.7 -37.75 82.72 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 122.117 0.96 . . . . 0.0 109.387 -172.886 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 121' ' ' LYS . . . . . 0.439 ' HD2' ' N ' ' B' ' 121' ' ' LYS . 0.5 OUTLIER -61.51 -36.26 80.03 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 113.588 -1.642 . . . . 0.0 109.944 176.046 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 122' ' ' ASP . . . . . 0.424 ' O ' ' HB2' ' B' ' 125' ' ' LYS . 16.8 t0 -71.94 -39.01 69.72 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 115.529 -0.76 . . . . 0.0 109.18 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 123' ' ' ILE . . . . . 0.872 HG23 ' HB2' ' B' ' 106' ' ' SER . 27.9 mm -59.93 -45.66 94.9 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 CA-C-N 115.43 -0.805 . . . . 0.0 109.847 175.243 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 124' ' ' LYS . . . . . 0.71 ' HD3' HD21 ' B' ' 139' ' ' LEU . 5.5 mmmp? -59.21 -41.62 89.03 Favored 'General case' 0 CA--C 1.501 -0.927 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.559 -178.771 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 125' ' ' LYS . . . . . 0.424 ' HB2' ' O ' ' B' ' 122' ' ' ASP . 43.5 mmtt -52.45 -63.49 1.13 Allowed 'General case' 0 CA--C 1.496 -1.111 0 CA-C-O 121.668 0.747 . . . . 0.0 111.502 172.793 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 126' ' ' ILE . . . . . . . . . . . . . 1.7 mp -55.3 -42.73 68.01 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.416 0 CA-C-N 113.963 -1.471 . . . . 0.0 111.368 -168.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 127' ' ' LEU . . . . . 0.713 ' HG ' ' O ' ' B' ' 123' ' ' ILE . 2.6 pp -82.04 -26.17 33.98 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.619 -0.433 . . . . 0.0 112.117 -177.901 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 128' ' ' ASP . . . . . 0.42 ' N ' HD12 ' B' ' 127' ' ' LEU . 20.4 t70 -71.83 -30.11 65.12 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 120.982 -0.287 . . . . 0.0 110.478 -179.283 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 129' ' ' SER . . . . . . . . . . . . . 90.2 p -52.81 -44.26 66.52 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.382 179.144 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 130' ' ' VAL . . . . . 0.417 ' CG2' HD12 ' B' ' 132' ' ' ILE . 12.7 m -88.03 -24.58 6.16 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 116.539 -0.301 . . . . 0.0 111.447 178.851 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 131' ' ' GLY . . . . . . . . . . . . . . . 109.74 25.06 5.58 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.306 -0.95 . . . . 0.0 113.175 176.04 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 132' ' ' ILE . . . . . 0.441 HG12 ' CB ' ' A' ' 19' ' ' ASP . 3.2 mt -85.26 132.82 30.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 116.943 0.371 . . . . 0.0 110.092 176.334 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 133' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -91.03 137.11 32.61 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.192 0.52 . . . . 0.0 110.457 -177.614 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 134' ' ' ALA . . . . . . . . . . . . . . . -143.14 143.83 31.97 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.608 -172.397 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 135' ' ' ASP . . . . . 0.759 ' HB2' ' CG ' ' B' ' 138' ' ' ARG . 4.1 m-20 -80.53 125.6 30.18 Favored 'General case' 0 C--O 1.258 1.523 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 172.998 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 136' ' ' ASP . . . . . 1.021 ' HA ' HD11 ' B' ' 139' ' ' LEU . 5.4 p-10 -72.11 2.06 6.43 Favored 'General case' 0 CA--C 1.514 -0.406 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.524 -173.261 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 137' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -102.93 -36.49 8.19 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.398 174.729 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 138' ' ' ARG . . . . . 0.759 ' CG ' ' HB2' ' B' ' 135' ' ' ASP . 24.9 mmt180 -67.23 -43.5 81.85 Favored 'General case' 0 CA--C 1.505 -0.766 0 CA-C-O 122.317 1.056 . . . . 0.0 108.626 -174.544 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 139' ' ' LEU . . . . . 1.021 HD11 ' HA ' ' B' ' 136' ' ' ASP . 0.4 OUTLIER -72.96 -32.29 65.13 Favored 'General case' 0 C--O 1.209 -1.053 0 CA-C-N 114.423 -1.262 . . . . 0.0 111.034 179.183 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 140' ' ' ASN . . . . . 0.581 ' O ' ' HB ' ' B' ' 143' ' ' ILE . 67.1 t30 -66.36 -25.53 66.85 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 122.29 1.043 . . . . 0.0 108.871 177.41 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 141' ' ' LYS . . . . . 0.513 ' HB3' ' O ' ' B' ' 138' ' ' ARG . 11.8 tppt? -70.4 -52.24 23.79 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 114.199 -1.364 . . . . 0.0 109.707 176.027 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 142' ' ' VAL . . . . . 0.887 HG11 ' HB2' ' B' ' 103' ' ' TYR . 7.9 p -61.82 -33.07 56.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.181 -0.463 . . . . 0.0 109.92 177.422 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 143' ' ' ILE . . . . . 0.87 HG12 ' O ' ' B' ' 139' ' ' LEU . 29.9 mm -50.24 -61.75 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.374 0 CA-C-O 121.426 0.632 . . . . 0.0 110.052 169.532 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 144' ' ' SER . . . . . . . . . . . . . 45.3 t -54.88 -32.26 60.68 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 114.331 -1.304 . . . . 0.0 111.716 -179.759 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 145' ' ' GLU . . . . . . . . . . . . . 68.4 mm-40 -80.01 -34.69 38.25 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.378 0.51 . . . . 0.0 112.378 -179.281 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 146' ' ' LEU . . . . . 0.729 HD11 ' HA ' ' B' ' 104' ' ' VAL . 7.2 mt -87.63 -19.99 26.97 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 121.021 -0.272 . . . . 0.0 110.832 -178.568 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 147' ' ' ASN . . . . . . . . . . . . . 37.7 t30 -53.97 108.79 0.39 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.13 -177.255 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . 108.99 18.99 8.84 Favored Glycine 0 N--CA 1.449 -0.436 0 CA-C-N 115.356 -0.838 . . . . 0.0 112.454 -179.283 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 149' ' ' LYS . . . . . 0.458 ' HB2' ' O ' ' B' ' 146' ' ' LEU . 0.2 OUTLIER -109.09 171.54 7.37 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.87 0.367 . . . . 0.0 110.646 -178.937 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 150' ' ' ASN . . . . . 0.591 ' O ' HG23 ' B' ' 154' ' ' VAL . 10.6 m-80 -110.24 89.12 2.93 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 178.423 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 151' ' ' ILE . . . . . 0.832 HG13 HD12 ' B' ' 108' ' ' LEU . 1.8 mp -41.87 -63.74 0.17 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.357 0 N-CA-C 113.775 1.028 . . . . 0.0 113.775 -166.447 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 152' ' ' GLU . . . . . 0.702 ' HG3' HD11 ' B' ' 112' ' ' LEU . 3.3 mp0 -59.85 -36.4 76.77 Favored 'General case' 0 C--O 1.209 -1.046 0 C-N-CA 120.508 -0.477 . . . . 0.0 111.105 -174.698 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 153' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -73.51 -27.72 61.51 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 120.73 0.3 . . . . 0.0 110.815 -179.329 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 154' ' ' VAL . . . . . 0.834 ' HB ' HD12 ' B' ' 155' ' ' ILE . 46.4 t -60.3 -48.78 86.84 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 171.15 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 155' ' ' ILE . . . . . 0.834 HD12 ' HB ' ' B' ' 154' ' ' VAL . 3.3 mp -106.65 33.94 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 122.11 0.957 . . . . 0.0 110.973 -177.887 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 156' ' ' ALA . . . . . 0.413 ' HB2' ' O ' ' B' ' 152' ' ' GLU . . . -99.37 -1.34 39.01 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 169.531 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 157' ' ' GLN . . . . . . . . . . . . . 72.8 mt-30 -139.55 -2.76 1.55 Allowed 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 113.333 -1.758 . . . . 0.0 109.678 175.141 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 158' ' ' GLY . . . . . . . . . . . . . . . -134.48 45.79 1.09 Allowed Glycine 0 C--O 1.225 -0.411 0 C-N-CA 120.603 -0.808 . . . . 0.0 114.077 -168.383 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 159' ' ' ILE . . . . . 0.733 HG21 ' HB2' ' A' ' 59' ' ' LEU . 1.8 mp -59.26 -25.76 31.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 CA-C-O 121.011 0.434 . . . . 0.0 110.854 176.757 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 160' ' ' GLY . . . . . . . . . . . . . . . -104.67 -45.24 1.44 Allowed Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.562 -0.828 . . . . 0.0 112.653 179.279 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 161' ' ' LYS . . . . . 0.446 ' HD2' ' HA ' ' B' ' 161' ' ' LYS . 30.5 mmmt -81.51 -15.05 56.11 Favored 'General case' 0 N--CA 1.444 -0.741 0 N-CA-C 113.486 0.921 . . . . 0.0 113.486 -176.257 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 162' ' ' LEU . . . . . 0.863 HD22 ' HG2' ' B' ' 101' ' ' MET . 8.9 mp 42.28 -144.27 0.07 Allowed 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 123.346 0.658 . . . . 0.0 112.579 -173.911 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 163' ' ' ALA . . . . . 0.562 ' H ' HG11 ' B' ' 104' ' ' VAL . . . -73.19 60.38 0.58 Allowed 'General case' 0 N--CA 1.442 -0.831 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 -178.77 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 164' ' ' SER . . . . . 0.71 ' HG ' ' N ' ' B' ' 100' ' ' ALA . 20.5 p -170.88 155.5 4.64 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.696 176.084 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 165' ' ' VAL . . . . . 0.494 ' HA ' ' HD2' ' B' ' 166' ' ' PRO . 3.8 t 61.61 121.51 0.02 OUTLIER Pre-proline 0 CA--C 1.538 0.502 0 N-CA-C 113.814 1.042 . . . . 0.0 113.814 -178.14 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 166' ' ' PRO . . . . . 0.494 ' HD2' ' HA ' ' B' ' 165' ' ' VAL . 53.2 Cg_exo -20.05 118.93 0.02 OUTLIER 'Trans proline' 0 N--CA 1.44 -1.636 1 C-N-CA 128.07 5.846 . . . . 0.0 116.395 179.869 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 167' ' ' ALA . . . . . . . . . . . . . . . -89.7 69.26 7.7 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.493 178.161 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 168' ' ' GLY . . . . . . . . . . . . . . . 138.95 150.63 5.6 Favored Glycine 0 N--CA 1.443 -0.838 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.153 -179.874 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 169' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.231 -1.316 . . . . 0.0 111.534 177.526 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.2 ttt . . . . . 0 N--CA 1.479 1.013 0 N-CA-C 109.503 -0.555 . . . . 0.0 109.503 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.695 ' HB3' HD13 ' A' ' 7' ' ' LEU . . . -63.4 138.59 58.58 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.679 0.276 . . . . 0.0 110.883 179.691 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 92.9 p -71.78 142.29 49.71 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 173.038 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.678 HG13 ' HG ' ' B' ' 112' ' ' LEU . 1.9 t -50.85 -22.47 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 CA-C-N 114.373 -1.285 . . . . 0.0 112.442 -179.773 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.83 ' HB3' ' HA ' ' A' ' 39' ' ' VAL . 63.0 m -73.17 -52.25 14.86 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.209 0.528 . . . . 0.0 109.598 175.773 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.624 ' HG2' ' NE1' ' A' ' 43' ' ' TRP . 36.7 mt-10 -57.86 -51.22 70.52 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.67 177.805 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.792 HD12 HD12 ' A' ' 10' ' ' ILE . 3.6 tp -58.2 -37.28 74.47 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.178 -0.919 . . . . 0.0 111.746 177.741 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.6 ' HB2' HD23 ' B' ' 112' ' ' LEU . . . -67.43 -34.0 76.33 Favored 'General case' 0 N--CA 1.468 0.428 0 O-C-N 121.958 -0.464 . . . . 0.0 111.115 178.903 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.523 ' HB2' HG11 ' A' ' 39' ' ' VAL . 6.8 t -71.29 -37.2 71.85 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 178.877 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.792 HD12 HD12 ' A' ' 7' ' ' LEU . 66.9 mt -50.53 -55.57 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.809 0 CA-C-N 114.29 -1.323 . . . . 0.0 109.684 170.202 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.72 ' HB2' HD13 ' B' ' 109' ' ' LEU . 23.5 m-85 -67.04 -43.7 82.09 Favored 'General case' 0 C--O 1.219 -0.514 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.964 -173.454 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.7 p -55.08 -41.82 72.03 Favored 'General case' 0 C--O 1.239 0.526 0 CA-C-O 121.15 0.5 . . . . 0.0 109.947 176.409 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.416 ' CB ' HD11 ' A' ' 51' ' ' LEU . . . -62.64 -35.33 79.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.913 172.681 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.778 HD22 HD11 ' A' ' 56' ' ' ILE . 0.4 OUTLIER -62.73 -54.48 38.5 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.868 179.573 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.432 HG12 ' H ' ' A' ' 15' ' ' ILE . 0.0 OUTLIER -57.39 -45.65 85.48 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 CA-C-O 121.048 0.451 . . . . 0.0 110.048 177.302 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.511 HD11 ' HG2' ' A' ' 27' ' ' LYS . 5.7 tp -55.85 -40.54 73.03 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.577 0.703 . . . . 0.0 110.845 177.589 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 15.0 t60 -75.68 -11.28 59.97 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 114.722 -1.126 . . . . 0.0 111.999 -179.294 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.422 ' CG ' ' HG3' ' B' ' 102' ' ' ARG . 37.4 t70 -74.93 -45.83 39.82 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 121.871 -0.518 . . . . 0.0 110.437 178.178 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.501 ' OD2' ' HB ' ' A' ' 21' ' ' VAL . 29.3 t70 -88.89 -11.49 44.45 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.732 0.777 . . . . 0.0 109.085 177.713 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 56.18 48.98 16.3 Favored 'General case' 0 CA--C 1.516 -0.348 0 CA-C-N 113.975 -1.466 . . . . 0.0 109.626 -175.927 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.501 ' HB ' ' OD2' ' A' ' 19' ' ' ASP . 7.6 p -101.75 168.41 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.479 0 CA-C-N 114.519 -1.219 . . . . 0.0 109.586 -170.596 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.445 ' N ' HG22 ' A' ' 21' ' ' VAL . 45.5 p -43.97 129.52 5.89 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-O 121.77 0.795 . . . . 0.0 113.105 -175.147 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.699 HG12 ' HA ' ' A' ' 48' ' ' ALA . 60.0 t -103.97 108.63 25.06 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.041 0 CA-C-N 114.299 -1.319 . . . . 0.0 110.182 -176.058 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.534 ' OG1' ' HB2' ' A' ' 27' ' ' LYS . 70.4 p -140.61 151.98 45.09 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.02 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -51.78 -45.56 63.84 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.082 0.467 . . . . 0.0 110.258 177.812 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -62.54 -31.13 71.87 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.736 179.163 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.534 ' HB2' ' OG1' ' A' ' 24' ' ' THR . 4.0 tppt? -67.48 -49.42 63.59 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-O 122.032 0.92 . . . . 0.0 108.573 178.075 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 86.3 mt -60.75 -40.54 85.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 114.296 -1.32 . . . . 0.0 110.445 177.549 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -61.15 -35.41 77.01 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.567 175.886 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.82 -45.69 91.44 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.724 175.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.672 ' HB3' HD21 ' B' ' 109' ' ' LEU . 1.4 mm? -61.99 -46.31 89.8 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 121.017 0.437 . . . . 0.0 110.438 174.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.579 HG23 ' O ' ' A' ' 37' ' ' VAL . 44.2 mt -50.07 -48.18 23.63 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 CA-C-N 115.273 -0.876 . . . . 0.0 111.412 177.799 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 22.7 tptp -72.78 -39.68 66.55 Favored 'General case' 0 N--CA 1.438 -1.055 0 CA-C-N 115.707 -0.678 . . . . 0.0 111.45 -178.773 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.655 ' HB1' ' HA ' ' B' ' 126' ' ' ILE . . . -56.89 -48.75 77.45 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.195 0.521 . . . . 0.0 110.845 179.842 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.442 ' CB ' ' HG ' ' B' ' 109' ' ' LEU . . . -76.83 -37.41 55.71 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.066 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 99.06 20.74 17.44 Favored Glycine 0 N--CA 1.449 -0.438 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.767 -178.816 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.839 ' HB ' ' HA2' ' B' ' 113' ' ' GLY . 3.0 p -122.57 121.87 64.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 121.443 0.639 . . . . 0.0 110.646 -176.742 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.462 ' HA ' HG23 ' A' ' 32' ' ' ILE . 61.5 t30 -96.41 156.54 16.3 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 114.773 -1.103 . . . . 0.0 111.0 -170.012 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.83 ' HA ' ' HB3' ' A' ' 5' ' ' SER . 93.3 t -126.82 159.95 35.85 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.075 0 CA-C-N 115.01 -0.995 . . . . 0.0 110.356 -172.561 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.511 ' HB3' ' HD1' ' A' ' 43' ' ' TRP . 3.5 tp10 -67.44 107.23 1.61 Allowed Pre-proline 0 N--CA 1.44 -0.932 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 169.6 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.477 ' C ' ' HD2' ' A' ' 44' ' ' PRO . 73.7 Cg_exo -51.35 -28.07 25.84 Favored 'Trans proline' 0 C--O 1.249 1.034 0 C-N-CA 123.598 2.866 . . . . 0.0 115.304 -164.828 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.43 ' HD2' ' CG ' ' A' ' 40' ' ' GLU . 0.5 OUTLIER -60.19 -27.01 66.79 Favored 'General case' 0 C--N 1.333 -0.15 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 177.645 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 43' ' ' TRP . . . . . 0.624 ' NE1' ' HG2' ' A' ' 6' ' ' GLU . 22.5 m95 -65.36 -60.12 8.33 Favored Pre-proline 0 C--O 1.204 -1.331 0 CA-C-O 118.373 -0.822 . . . . 0.0 110.743 175.923 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.477 ' HD2' ' C ' ' A' ' 41' ' ' PRO . 74.7 Cg_exo -44.1 -44.66 12.37 Favored 'Trans proline' 0 C--N 1.357 1.004 0 C-N-CA 121.671 1.58 . . . . 0.0 112.203 173.654 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -62.0 -56.49 22.13 Favored Glycine 0 CA--C 1.525 0.712 0 C-N-CA 120.238 -0.982 . . . . 0.0 112.952 176.801 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.461 ' O ' ' HB2' ' A' ' 49' ' ' LYS . 9.4 tp -69.78 -23.01 63.28 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 122.91 0.484 . . . . 0.0 111.821 -176.861 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.519 ' HE1' ' CE3' ' A' ' 43' ' ' TRP . 3.1 m-85 -73.48 -43.78 59.4 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 109.962 -0.384 . . . . 0.0 109.962 175.605 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.699 ' HA ' HG12 ' A' ' 23' ' ' VAL . . . -63.67 -33.14 74.97 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 177.074 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.461 ' HB2' ' O ' ' A' ' 46' ' ' LEU . 9.6 mmmt -62.68 -62.26 1.85 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 114.569 -1.196 . . . . 0.0 111.701 171.187 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.473 ' O ' HG22 ' A' ' 54' ' ' VAL . . . -69.77 -41.26 75.4 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 113.114 0.783 . . . . 0.0 113.114 -169.408 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.542 ' HB2' HG11 ' A' ' 23' ' ' VAL . 12.4 mt -65.64 -10.98 40.78 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.75 0.309 . . . . 0.0 111.792 -174.37 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -84.59 0.22 50.86 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.303 177.217 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -141.22 -47.03 0.39 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.234 -179.119 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.473 HG22 ' O ' ' A' ' 50' ' ' ALA . 5.8 m -91.08 -175.19 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.847 0.356 . . . . 0.0 110.33 -177.473 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 16.4 m120 -116.03 169.47 9.23 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.734 178.16 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.778 HD11 HD22 ' A' ' 14' ' ' LEU . 3.2 tp -61.35 -25.09 35.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.551 178.603 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -70.83 -11.94 70.18 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.691 -0.766 . . . . 0.0 111.36 179.277 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 22.9 t -81.34 -23.71 37.59 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-O 121.323 0.582 . . . . 0.0 109.817 179.433 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.743 ' HB2' HG21 ' B' ' 159' ' ' ILE . 26.3 mt -62.32 -31.19 71.78 Favored 'General case' 0 CA--C 1.517 -0.314 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.751 -178.876 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.887 HG13 ' HB ' ' B' ' 159' ' ' ILE . 0.1 OUTLIER -62.3 -18.64 20.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 114.904 -1.044 . . . . 0.0 110.888 -179.647 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 0.434 ' O ' ' HB2' ' A' ' 65' ' ' ALA . 5.4 t -96.18 -10.02 29.14 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.315 -176.1 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.4 HD22 ' HA ' ' A' ' 62' ' ' ASN . 12.0 m120 -69.76 -26.36 64.26 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.909 0.385 . . . . 0.0 110.943 -177.096 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 16.5 m -93.97 36.63 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.053 179.321 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 141.1 96.83 0.29 Allowed Glycine 0 N--CA 1.447 -0.625 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.919 177.148 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.434 ' HB2' ' O ' ' A' ' 61' ' ' CYS . . . -142.84 -65.5 0.39 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.026 0.441 . . . . 0.0 111.549 -177.746 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 114.96 -135.01 12.0 Favored Glycine 0 N--CA 1.448 -0.541 0 N-CA-C 110.92 -0.872 . . . . 0.0 110.92 -174.615 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.459 ' HA2' ' HD3' ' A' ' 68' ' ' PRO . . . 166.88 140.9 3.0 Favored Glycine 0 N--CA 1.449 -0.433 0 C-N-CA 120.222 -0.99 . . . . 0.0 112.69 178.402 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.459 ' HD3' ' HA2' ' A' ' 67' ' ' GLY . 15.4 Cg_exo -68.65 99.76 0.65 Allowed 'Trans proline' 0 C--O 1.234 0.302 0 C-N-CA 123.024 2.483 . . . . 0.0 112.058 178.167 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.896 0 CA-C-O 118.445 -0.788 . . . . 0.0 110.1 178.453 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.122 0 CA-C-O 120.609 0.243 . . . . 0.0 110.349 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 101' ' ' MET . . . . . 0.67 ' HG2' HD22 ' B' ' 162' ' ' LEU . 1.3 tmt? -91.87 126.02 36.8 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.985 0.422 . . . . 0.0 111.445 -177.366 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 102' ' ' ARG . . . . . 0.422 ' HG3' ' CG ' ' A' ' 18' ' ' ASP . 18.9 ttt180 -164.67 -94.87 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.221 168.192 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 103' ' ' TYR . . . . . 0.565 ' HB2' HG11 ' B' ' 142' ' ' VAL . 47.3 m-85 -77.21 -11.29 59.8 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.354 0.597 . . . . 0.0 109.766 -177.888 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 104' ' ' VAL . . . . . 0.555 HG12 ' CD2' ' B' ' 108' ' ' LEU . 48.2 t -46.45 -45.95 6.78 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.519 0 CA-C-N 114.71 -1.132 . . . . 0.0 110.13 173.806 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 105' ' ' ALA . . . . . 0.613 ' CB ' ' HB3' ' A' ' 14' ' ' LEU . . . -66.22 -39.37 89.54 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 114.822 -1.081 . . . . 0.0 111.656 -174.703 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 106' ' ' SER . . . . . 0.713 ' HB2' HG23 ' B' ' 123' ' ' ILE . 1.0 OUTLIER -62.87 -35.39 79.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.666 0.746 . . . . 0.0 109.066 176.567 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 107' ' ' TYR . . . . . 0.779 ' HD2' HG12 ' B' ' 143' ' ' ILE . 32.7 t80 -65.23 -51.61 59.86 Favored 'General case' 0 N--CA 1.445 -0.722 0 CA-C-N 114.483 -1.235 . . . . 0.0 108.625 179.093 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 108' ' ' LEU . . . . . 0.868 HD12 HG13 ' B' ' 151' ' ' ILE . 0.0 OUTLIER -56.62 -46.83 80.71 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-N 114.99 -1.004 . . . . 0.0 110.769 177.227 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 109' ' ' LEU . . . . . 0.72 HD13 ' HB2' ' A' ' 11' ' ' TYR . 9.4 tp -52.98 -49.06 66.9 Favored 'General case' 0 CA--C 1.512 -0.494 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.665 178.434 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 110' ' ' ALA . . . . . 0.583 ' HB3' ' HB3' ' B' ' 118' ' ' PRO . . . -66.45 -36.43 82.75 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.134 -176.719 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 111' ' ' ALA . . . . . 0.816 ' HA ' ' O ' ' B' ' 115' ' ' ASN . . . -70.63 -19.99 62.77 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.354 0.597 . . . . 0.0 111.023 179.101 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 112' ' ' LEU . . . . . 0.751 ' HB3' HG21 ' A' ' 37' ' ' VAL . 5.6 mp -86.53 -37.24 18.39 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.084 171.284 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 113' ' ' GLY . . . . . 0.839 ' HA2' ' HB ' ' A' ' 37' ' ' VAL . . . -66.26 -39.35 94.36 Favored Glycine 0 N--CA 1.444 -0.798 0 CA-C-N 115.054 -0.975 . . . . 0.0 113.117 -176.389 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 114' ' ' GLY . . . . . . . . . . . . . . . 164.17 6.97 0.04 OUTLIER Glycine 0 N--CA 1.442 -0.901 0 C-N-CA 119.514 -1.327 . . . . 0.0 114.051 178.457 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 115' ' ' ASN . . . . . 0.816 ' O ' ' HA ' ' B' ' 111' ' ' ALA . 95.7 m-20 -130.92 98.0 4.48 Favored 'General case' 0 CA--C 1.494 -1.183 0 CA-C-N 118.061 0.93 . . . . 0.0 108.827 178.165 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 2.5 p -76.02 29.08 0.11 Allowed 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 122.533 1.158 . . . . 0.0 109.818 -178.352 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 117' ' ' SER . . . . . 0.614 ' H ' ' C ' ' B' ' 115' ' ' ASN . 23.2 t -169.95 71.18 0.63 Allowed Pre-proline 0 N--CA 1.447 -0.61 0 CA-C-N 113.261 -1.79 . . . . 0.0 107.93 179.694 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 118' ' ' PRO . . . . . 0.616 ' HD2' ' CZ ' ' B' ' 107' ' ' TYR . 21.0 Cg_exo -71.81 152.39 58.23 Favored 'Trans proline' 0 C--N 1.33 -0.42 1 C-N-CA 125.352 4.034 . . . . 0.0 111.722 -177.102 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 119' ' ' SER . . . . . 0.536 ' O ' HG12 ' B' ' 123' ' ' ILE . 78.9 p -123.09 -175.47 3.19 Favored 'General case' 0 C--N 1.317 -0.824 0 C-N-CA 119.998 -0.681 . . . . 0.0 111.606 178.003 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 120' ' ' ALA . . . . . 0.78 ' HB1' HD13 ' B' ' 139' ' ' LEU . . . -66.58 -39.98 88.72 Favored 'General case' 0 CA--C 1.507 -0.682 0 CA-C-O 121.785 0.802 . . . . 0.0 109.315 -170.347 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 121' ' ' LYS . . . . . 0.406 ' HD2' ' N ' ' B' ' 121' ' ' LYS . 13.8 mptt -58.99 -37.38 76.71 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 113.932 -1.485 . . . . 0.0 111.108 174.642 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 122' ' ' ASP . . . . . 0.401 ' O ' ' HD2' ' B' ' 125' ' ' LYS . 21.1 m-20 -69.56 -40.04 77.02 Favored 'General case' 0 CA--C 1.517 -0.299 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.33 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 123' ' ' ILE . . . . . 0.75 ' CG1' HD11 ' B' ' 143' ' ' ILE . 33.2 mm -59.29 -50.84 78.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.959 176.236 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 124' ' ' LYS . . . . . 0.85 ' HD3' HD21 ' B' ' 139' ' ' LEU . 3.7 mmmp? -59.91 -31.66 70.03 Favored 'General case' 0 C--O 1.216 -0.686 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.789 -178.802 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 125' ' ' LYS . . . . . 0.735 ' HD2' HD12 ' B' ' 126' ' ' ILE . 0.0 OUTLIER -71.92 -48.08 47.94 Favored 'General case' 0 N--CA 1.431 -1.384 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.935 -179.773 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 126' ' ' ILE . . . . . 0.735 HD12 ' HD2' ' B' ' 125' ' ' LYS . 1.1 mp -55.56 -51.01 62.54 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 CA-C-O 120.604 0.24 . . . . 0.0 110.941 176.031 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 127' ' ' LEU . . . . . 0.689 ' HG ' ' O ' ' B' ' 123' ' ' ILE . 1.8 pp -76.82 -24.09 52.76 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.605 -0.438 . . . . 0.0 111.629 -175.852 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 128' ' ' ASP . . . . . 0.533 ' HB2' ' O ' ' B' ' 124' ' ' LYS . 24.9 t70 -65.53 -32.86 74.69 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 175.589 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 129' ' ' SER . . . . . 0.508 ' HB2' ' HB2' ' A' ' 34' ' ' ALA . 7.1 t -56.5 -33.12 65.71 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-N 115.714 -0.676 . . . . 0.0 111.827 176.835 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 130' ' ' VAL . . . . . 0.443 HG23 HG13 ' B' ' 132' ' ' ILE . 2.5 m -108.63 -8.48 11.12 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 O-C-N 122.098 -0.376 . . . . 0.0 111.904 178.89 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 131' ' ' GLY . . . . . . . . . . . . . . . 87.26 27.11 28.86 Favored Glycine 0 CA--C 1.519 0.342 0 C-N-CA 121.036 -0.602 . . . . 0.0 113.18 175.744 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 132' ' ' ILE . . . . . 0.525 ' O ' HD13 ' B' ' 127' ' ' LEU . 17.9 mt -85.09 128.3 39.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.669 0.234 . . . . 0.0 110.854 -179.059 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 133' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -76.53 133.16 39.81 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.124 0.487 . . . . 0.0 111.385 -176.185 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 134' ' ' ALA . . . . . 0.493 ' HB2' HD22 ' B' ' 127' ' ' LEU . . . -139.9 143.94 36.92 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.769 -174.677 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 135' ' ' ASP . . . . . 0.808 ' HB2' ' HG3' ' B' ' 138' ' ' ARG . 5.5 m-20 -88.88 127.97 35.65 Favored 'General case' 0 C--O 1.256 1.416 0 CA-C-O 121.261 0.553 . . . . 0.0 109.712 176.234 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 136' ' ' ASP . . . . . 0.993 ' HA ' HD11 ' B' ' 139' ' ' LEU . 9.0 p-10 -78.07 2.08 18.99 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-N 115.127 -0.942 . . . . 0.0 111.587 -166.593 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 137' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -105.57 -32.76 8.34 Favored 'General case' 0 N--CA 1.44 -0.932 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.189 170.65 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 138' ' ' ARG . . . . . 0.808 ' HG3' ' HB2' ' B' ' 135' ' ' ASP . 11.8 mmt85 -63.32 -47.6 81.53 Favored 'General case' 0 CA--C 1.504 -0.803 0 CA-C-O 121.781 0.8 . . . . 0.0 109.425 -175.948 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 139' ' ' LEU . . . . . 0.993 HD11 ' HA ' ' B' ' 136' ' ' ASP . 0.3 OUTLIER -71.81 -39.43 69.84 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 114.653 -1.158 . . . . 0.0 111.356 -179.151 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 140' ' ' ASN . . . . . 0.682 ' H ' HD12 ' B' ' 139' ' ' LEU . 11.0 t30 -62.98 -29.38 70.77 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-O 121.571 0.701 . . . . 0.0 109.11 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 141' ' ' LYS . . . . . . . . . . . . . 18.4 tttm -72.09 -52.42 16.86 Favored 'General case' 0 C--O 1.242 0.699 0 CA-C-N 114.672 -1.149 . . . . 0.0 110.358 178.271 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 142' ' ' VAL . . . . . 0.62 HG12 ' O ' ' B' ' 139' ' ' LEU . 11.7 p -56.93 -42.34 78.48 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.743 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.721 -179.013 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 143' ' ' ILE . . . . . 0.779 HG12 ' HD2' ' B' ' 107' ' ' TYR . 34.6 mt -59.39 -49.73 82.45 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 C-N-CA 123.554 0.742 . . . . 0.0 112.792 174.845 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 144' ' ' SER . . . . . . . . . . . . . 66.3 m -53.26 -33.93 55.14 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 115.668 -0.697 . . . . 0.0 111.294 178.191 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 145' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -87.5 -33.63 18.92 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 120.981 0.419 . . . . 0.0 111.606 176.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 146' ' ' LEU . . . . . 0.529 HD11 HG13 ' B' ' 104' ' ' VAL . 0.3 OUTLIER -70.83 -31.92 68.8 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 123.374 0.67 . . . . 0.0 111.511 -179.01 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 147' ' ' ASN . . . . . . . . . . . . . 23.3 t-20 -56.04 124.86 19.19 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.973 -177.502 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . 101.86 28.37 6.62 Favored Glycine 0 N--CA 1.449 -0.495 0 CA-C-N 115.636 -0.711 . . . . 0.0 112.563 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 149' ' ' LYS . . . . . 0.505 ' HE2' ' O ' ' B' ' 146' ' ' LEU . 1.0 OUTLIER -127.79 175.01 8.66 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 110.21 -0.292 . . . . 0.0 110.21 177.13 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 150' ' ' ASN . . . . . 0.553 ' O ' HG23 ' B' ' 154' ' ' VAL . 44.0 m-80 -111.7 93.15 4.32 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 108.582 -0.895 . . . . 0.0 108.582 179.48 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 151' ' ' ILE . . . . . 0.868 HG13 HD12 ' B' ' 108' ' ' LEU . 1.8 mp -41.74 -65.03 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 O-C-N 124.366 1.041 . . . . 0.0 113.662 -169.167 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 152' ' ' GLU . . . . . 0.524 ' HG3' HD11 ' B' ' 112' ' ' LEU . 1.7 mp0 -55.14 -42.83 73.54 Favored 'General case' 0 C--O 1.219 -0.535 0 CA-C-N 117.879 0.309 . . . . 0.0 111.52 -174.26 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 153' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -69.05 -28.61 66.7 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.523 179.696 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 154' ' ' VAL . . . . . 0.837 ' HB ' HD12 ' B' ' 155' ' ' ILE . 61.1 t -61.29 -51.36 73.88 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 CA-C-O 121.691 0.757 . . . . 0.0 109.071 171.208 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 155' ' ' ILE . . . . . 0.837 HD12 ' HB ' ' B' ' 154' ' ' VAL . 1.9 mp -101.15 33.29 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.496 -177.223 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . -98.69 -4.97 32.47 Favored 'General case' 0 C--N 1.308 -1.228 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 168.714 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 157' ' ' GLN . . . . . . . . . . . . . 67.5 mm-40 -142.85 14.72 1.92 Allowed 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 113.563 -1.653 . . . . 0.0 110.047 174.648 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 158' ' ' GLY . . . . . . . . . . . . . . . -146.83 46.34 0.74 Allowed Glycine 0 C--N 1.336 0.567 0 C-N-CA 120.707 -0.758 . . . . 0.0 113.727 -170.933 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 159' ' ' ILE . . . . . 0.887 ' HB ' HG13 ' A' ' 60' ' ' ILE . 1.8 mp -66.79 -14.76 18.44 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 CA-C-O 121.244 0.545 . . . . 0.0 110.889 178.29 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 160' ' ' GLY . . . . . . . . . . . . . . . -114.86 -62.81 0.39 Allowed Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 120.848 -0.691 . . . . 0.0 111.908 -176.122 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 161' ' ' LYS . . . . . 0.513 ' HD3' ' N ' ' B' ' 161' ' ' LYS . 3.2 mppt? -78.66 57.45 2.04 Favored 'General case' 0 N--CA 1.442 -0.837 0 N-CA-C 111.822 0.304 . . . . 0.0 111.822 178.018 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 162' ' ' LEU . . . . . 0.67 HD22 ' HG2' ' B' ' 101' ' ' MET . 10.8 mp -49.72 142.24 8.81 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.165 -0.47 . . . . 0.0 112.022 173.932 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 163' ' ' ALA . . . . . . . . . . . . . . . 51.91 55.91 8.57 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.62 -0.718 . . . . 0.0 112.858 179.109 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 164' ' ' SER . . . . . . . . . . . . . 79.9 p 66.63 154.71 0.09 Allowed 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.308 1.043 . . . . 0.0 113.274 171.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 165' ' ' VAL . . . . . . . . . . . . . 12.8 t -86.32 135.83 36.26 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 114.766 -1.106 . . . . 0.0 109.974 -179.741 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 166' ' ' PRO . . . . . . . . . . . . . 17.5 Cg_exo -13.72 118.91 0.01 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.272 1 C-N-CA 127.355 5.37 . . . . 0.0 116.124 179.563 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 167' ' ' ALA . . . . . . . . . . . . . . . -72.24 95.6 1.71 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.337 -0.847 . . . . 0.0 111.753 -174.748 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 168' ' ' GLY . . . . . . . . . . . . . . . 86.67 -10.87 65.8 Favored Glycine 0 N--CA 1.452 -0.27 0 CA-C-N 115.788 -0.642 . . . . 0.0 112.292 177.944 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 169' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.855 0 CA-C-O 118.667 -1.074 . . . . 0.0 111.433 -178.156 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . 0.62 ' HB2' ' HG3' ' A' ' 6' ' ' GLU . 4.0 m . . . . . 0 N--CA 1.438 -1.041 0 N-CA-C 107.254 -1.388 . . . . 0.0 107.254 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.767 HG13 ' HG ' ' B' ' 112' ' ' LEU . 2.0 t -52.29 -23.49 4.42 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.704 -179.382 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . 0.739 ' HB2' ' HA ' ' A' ' 39' ' ' VAL . 15.8 p -68.08 -53.89 22.21 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.633 0.73 . . . . 0.0 109.328 175.212 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.62 ' HG3' ' HB2' ' A' ' 3' ' ' SER . 31.0 mt-10 -57.74 -52.06 66.99 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 115.009 -0.996 . . . . 0.0 109.661 178.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.821 ' HA ' HD12 ' A' ' 10' ' ' ILE . 2.0 tp -57.79 -35.88 71.42 Favored 'General case' 0 N--CA 1.447 -0.575 0 CA-C-N 115.085 -0.961 . . . . 0.0 111.789 177.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -66.33 -40.26 89.75 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-O 121.245 0.545 . . . . 0.0 110.938 178.52 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.575 ' HB2' HG11 ' A' ' 39' ' ' VAL . 8.4 t -65.88 -40.89 92.01 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 179.856 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.821 HD12 ' HA ' ' A' ' 7' ' ' LEU . 57.6 mt -47.9 -57.25 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.851 0 CA-C-N 113.646 -1.616 . . . . 0.0 109.927 172.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.903 ' HB2' HD13 ' B' ' 109' ' ' LEU . 21.2 m-85 -65.95 -40.83 91.66 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.604 -173.696 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.513 ' HB2' HG23 ' A' ' 28' ' ' ILE . 14.9 m -53.78 -43.27 69.12 Favored 'General case' 0 C--O 1.243 0.738 0 CA-C-O 121.709 0.766 . . . . 0.0 109.49 176.259 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -67.53 -32.52 73.35 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-N 115.192 -0.913 . . . . 0.0 110.166 176.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.645 ' HB3' ' CB ' ' B' ' 105' ' ' ALA . 0.3 OUTLIER -62.51 -56.87 13.93 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.113 179.467 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.466 HG12 ' H ' ' A' ' 15' ' ' ILE . 0.0 OUTLIER -54.36 -42.19 56.75 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 N-CA-C 109.897 -0.408 . . . . 0.0 109.897 177.421 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.483 ' HA ' HD12 ' A' ' 16' ' ' LEU . 3.9 tp -56.64 -37.81 71.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.26 176.832 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . 0.448 ' CD2' ' HB ' ' A' ' 56' ' ' ILE . 72.0 m-70 -77.78 -9.64 59.13 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 112.493 0.553 . . . . 0.0 112.493 178.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -78.61 -29.14 45.87 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 119.513 -0.875 . . . . 0.0 109.807 -177.511 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -107.32 -8.15 16.45 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 173.666 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.416 ' HG2' ' O ' ' A' ' 17' ' ' HIS . 5.2 mm-40 51.89 50.14 19.25 Favored 'General case' 0 CA--C 1.511 -0.545 0 CA-C-N 113.925 -1.489 . . . . 0.0 110.633 -174.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.442 HG22 ' H ' ' A' ' 22' ' ' THR . 7.3 p -99.13 168.76 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.424 -1.743 0 CA-C-N 114.678 -1.147 . . . . 0.0 108.624 -174.439 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.442 ' H ' HG22 ' A' ' 21' ' ' VAL . 48.5 p -52.45 139.73 24.23 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-O 121.958 0.885 . . . . 0.0 113.377 -169.677 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.609 HG12 ' HA ' ' A' ' 48' ' ' ALA . 58.7 t -109.32 106.39 20.61 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.012 0 CA-C-N 114.339 -1.301 . . . . 0.0 110.536 -174.638 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.556 ' OG1' ' HB2' ' A' ' 27' ' ' LYS . 70.8 p -131.23 156.04 46.06 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.979 178.465 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -54.35 -43.57 71.39 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.226 0.536 . . . . 0.0 109.856 178.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -68.49 -25.58 65.04 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.295 -0.866 . . . . 0.0 111.458 -179.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.556 ' HB2' ' OG1' ' A' ' 24' ' ' THR . 3.7 tppt? -70.34 -52.24 24.13 Favored 'General case' 0 C--O 1.239 0.53 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 178.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.513 HG23 ' HB2' ' A' ' 12' ' ' SER . 70.9 mt -61.08 -40.68 86.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 114.547 -1.206 . . . . 0.0 110.315 177.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.592 ' HA ' HD12 ' A' ' 32' ' ' ILE . 44.7 t-20 -60.19 -39.45 86.59 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.936 176.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -60.98 -44.6 97.14 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.016 177.549 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.579 HD12 HG23 ' B' ' 126' ' ' ILE . 1.4 mm? -59.79 -49.39 77.9 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 121.01 0.434 . . . . 0.0 110.315 173.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.602 HG23 ' O ' ' A' ' 37' ' ' VAL . 75.5 mt -46.98 -52.53 4.04 Favored 'Isoleucine or valine' 0 C--O 1.239 0.538 0 CA-C-N 115.184 -0.916 . . . . 0.0 111.366 178.037 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 46.5 mmtm -72.37 -33.41 67.23 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.542 -0.753 . . . . 0.0 111.543 -176.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -62.85 -44.34 96.39 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.062 -179.089 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.5 ' HB3' HG12 ' A' ' 37' ' ' VAL . . . -82.01 -30.61 31.44 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.918 178.743 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 95.3 15.64 43.51 Favored Glycine 0 N--CA 1.447 -0.62 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.75 -178.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.987 ' HB ' ' HA3' ' B' ' 113' ' ' GLY . 5.1 p -115.8 118.85 60.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.758 0.79 . . . . 0.0 110.708 -174.778 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.449 ' HA ' HG23 ' A' ' 32' ' ' ILE . 64.3 t30 -96.52 158.59 15.36 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 114.581 -1.19 . . . . 0.0 111.256 -167.486 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.739 ' HA ' ' HB2' ' A' ' 5' ' ' SER . 67.9 t -127.75 163.42 31.38 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.972 0 CA-C-N 114.966 -1.015 . . . . 0.0 110.551 -172.07 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.561 ' HB3' ' HD1' ' A' ' 43' ' ' TRP . 8.2 tp10 -71.24 106.46 1.89 Allowed Pre-proline 0 N--CA 1.44 -0.928 0 N-CA-C 107.429 -1.323 . . . . 0.0 107.429 167.721 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.529 ' C ' ' HD2' ' A' ' 44' ' ' PRO . 77.6 Cg_exo -51.26 -27.69 23.98 Favored 'Trans proline' 0 C--O 1.25 1.112 0 C-N-CA 123.883 3.055 . . . . 0.0 115.532 -164.221 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.432 ' HD2' ' HG3' ' A' ' 40' ' ' GLU . 0.5 OUTLIER -61.38 -28.17 69.05 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 177.471 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . 0.611 ' CE3' ' HE1' ' A' ' 47' ' ' PHE . 18.8 m95 -64.56 -59.65 10.16 Favored Pre-proline 0 C--O 1.205 -1.26 0 CA-C-O 118.383 -0.817 . . . . 0.0 110.949 176.068 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.529 ' HD2' ' C ' ' A' ' 41' ' ' PRO . 97.6 Cg_exo -45.81 -42.84 19.67 Favored 'Trans proline' 0 C--N 1.359 1.119 0 C-N-CA 121.766 1.644 . . . . 0.0 111.871 174.532 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -60.4 -61.0 7.56 Favored Glycine 0 CA--C 1.525 0.701 0 C-N-CA 120.231 -0.985 . . . . 0.0 112.516 175.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.567 ' O ' ' HB2' ' A' ' 49' ' ' LYS . 8.7 tp -63.26 -32.1 73.42 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.196 0.599 . . . . 0.0 111.973 -177.417 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.611 ' HE1' ' CE3' ' A' ' 43' ' ' TRP . 3.6 m-85 -64.14 -48.13 77.24 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.192 176.237 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.609 ' HA ' HG12 ' A' ' 23' ' ' VAL . . . -65.25 -31.44 72.59 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.56 0.695 . . . . 0.0 109.396 -179.516 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.567 ' HB2' ' O ' ' A' ' 46' ' ' LEU . 9.3 mmmt -59.28 -54.92 41.27 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 114.589 -1.187 . . . . 0.0 111.748 172.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -86.61 -43.49 12.62 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 113.802 1.038 . . . . 0.0 113.802 -168.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.587 HD11 ' CD2' ' A' ' 47' ' ' PHE . 21.5 mt -65.87 -7.23 15.26 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 113.721 1.008 . . . . 0.0 113.721 -168.556 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -81.01 -2.2 46.97 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.892 0.377 . . . . 0.0 110.425 176.374 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 10.5 t30 -143.01 -41.71 0.31 Allowed 'General case' 0 C--O 1.235 0.294 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.251 -179.568 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 4.3 m -83.01 -179.6 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 121.429 0.633 . . . . 0.0 110.61 -178.542 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 11.5 m120 -112.15 155.98 23.03 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 115.505 -0.771 . . . . 0.0 111.135 177.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.632 HD11 HD22 ' A' ' 14' ' ' LEU . 3.5 tp -60.01 -21.3 21.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 114.773 -1.103 . . . . 0.0 110.83 179.732 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -69.67 -15.4 71.0 Favored Glycine 0 N--CA 1.444 -0.821 0 C-N-CA 120.779 -0.724 . . . . 0.0 111.392 177.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 35.1 t -75.99 -22.77 55.49 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-O 121.477 0.656 . . . . 0.0 109.76 178.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.828 ' HB2' HG21 ' B' ' 159' ' ' ILE . 19.7 mt -65.12 -25.67 67.87 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.958 -178.423 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.854 HG13 ' HB ' ' B' ' 159' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--N 1.323 -0.586 0 CA-C-N 114.935 -1.03 . . . . 0.0 110.595 178.539 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 103' ' ' TYR . . . . . 0.999 ' HB2' HG11 ' B' ' 142' ' ' VAL . 43.2 m-85 . . . . . 0 C--O 1.242 0.671 0 N-CA-C 113.119 0.785 . . . . 0.0 113.119 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 104' ' ' VAL . . . . . 0.596 ' O ' HD22 ' B' ' 108' ' ' LEU . 44.9 t -50.51 -49.99 23.09 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.448 0 CA-C-O 121.639 0.733 . . . . 0.0 110.034 177.316 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 105' ' ' ALA . . . . . 0.645 ' CB ' ' HB3' ' A' ' 14' ' ' LEU . . . -64.68 -39.36 93.54 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 114.683 -1.144 . . . . 0.0 111.798 -173.249 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 106' ' ' SER . . . . . 0.609 ' HB2' HG23 ' B' ' 123' ' ' ILE . 0.7 OUTLIER -61.06 -38.92 87.91 Favored 'General case' 0 C--O 1.24 0.582 0 CA-C-O 121.786 0.803 . . . . 0.0 109.123 177.905 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 107' ' ' TYR . . . . . 0.756 ' HD2' HG12 ' B' ' 143' ' ' ILE . 41.5 t80 -61.88 -48.7 79.32 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-N 114.08 -1.418 . . . . 0.0 109.067 179.037 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 108' ' ' LEU . . . . . 0.835 HD12 HG13 ' B' ' 151' ' ' ILE . 0.0 OUTLIER -58.14 -46.18 86.08 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-N 115.327 -0.852 . . . . 0.0 111.417 179.553 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 109' ' ' LEU . . . . . 0.903 HD13 ' HB2' ' A' ' 11' ' ' TYR . 8.5 tp -54.19 -56.07 21.77 Favored 'General case' 0 C--O 1.247 0.929 0 CA-C-O 121.393 0.616 . . . . 0.0 110.777 178.54 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 110' ' ' ALA . . . . . 0.427 ' HB3' ' HB3' ' B' ' 118' ' ' PRO . . . -56.05 -41.38 74.94 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 114.991 -1.004 . . . . 0.0 110.372 -177.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 111' ' ' ALA . . . . . 0.78 ' HA ' ' O ' ' B' ' 115' ' ' ASN . . . -75.03 -22.25 58.56 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.881 -177.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 112' ' ' LEU . . . . . 0.767 ' HG ' HG13 ' A' ' 4' ' ' VAL . 4.3 tp -77.66 -39.51 44.8 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.415 -177.661 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 113' ' ' GLY . . . . . 0.987 ' HA3' ' HB ' ' A' ' 37' ' ' VAL . . . -140.01 33.09 2.14 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 118.652 -1.737 . . . . 0.0 115.155 -174.652 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 114' ' ' GLY . . . . . . . . . . . . . . . -159.45 -47.1 0.01 OUTLIER Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 119.299 -1.429 . . . . 0.0 112.969 176.804 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 115' ' ' ASN . . . . . 0.78 ' O ' ' HA ' ' B' ' 111' ' ' ALA . 8.0 t30 -158.33 112.34 2.49 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 -173.055 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 5.9 m -80.77 28.36 0.35 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 122.083 0.944 . . . . 0.0 111.019 -169.051 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 117' ' ' SER . . . . . 0.478 ' N ' ' HD3' ' B' ' 118' ' ' PRO . 28.3 t -168.01 68.88 0.83 Allowed Pre-proline 0 C--N 1.312 -1.044 0 CA-C-N 113.857 -1.52 . . . . 0.0 108.045 177.65 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 118' ' ' PRO . . . . . 0.679 ' HD2' ' CZ ' ' B' ' 107' ' ' TYR . 34.5 Cg_exo -65.7 155.43 69.15 Favored 'Trans proline' 0 CA--C 1.514 -0.512 0 C-N-CA 125.281 3.988 . . . . 0.0 112.389 -172.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 119' ' ' SER . . . . . 0.534 ' C ' HD13 ' B' ' 143' ' ' ILE . 89.8 p -126.57 -176.14 3.59 Favored 'General case' 0 N--CA 1.443 -0.821 0 C-N-CA 120.18 -0.608 . . . . 0.0 111.525 177.74 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 120' ' ' ALA . . . . . 0.821 ' HB1' HD13 ' B' ' 139' ' ' LEU . . . -63.21 -36.5 83.85 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 122.222 1.011 . . . . 0.0 109.409 -169.617 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 121' ' ' LYS . . . . . 0.477 ' HD2' ' N ' ' B' ' 121' ' ' LYS . 0.9 OUTLIER -68.14 -32.91 73.51 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 113.489 -1.687 . . . . 0.0 110.898 178.91 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 122' ' ' ASP . . . . . 0.511 ' O ' ' HB3' ' B' ' 125' ' ' LYS . 10.6 m-20 -71.66 -36.75 70.76 Favored 'General case' 0 CA--C 1.515 -0.372 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 178.412 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 123' ' ' ILE . . . . . 0.779 ' CG1' HD11 ' B' ' 143' ' ' ILE . 36.9 mm -62.9 -48.38 88.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.108 176.591 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 124' ' ' LYS . . . . . 0.838 ' HD3' HD21 ' B' ' 139' ' ' LEU . 2.9 mmmp? -57.59 -45.21 85.55 Favored 'General case' 0 C--O 1.21 -0.996 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 -179.357 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 125' ' ' LYS . . . . . 0.511 ' HB3' ' O ' ' B' ' 122' ' ' ASP . 0.1 OUTLIER -47.18 -63.99 0.9 Allowed 'General case' 0 N--CA 1.416 -2.149 0 N-CA-C 112.777 0.658 . . . . 0.0 112.777 172.743 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 126' ' ' ILE . . . . . 0.579 HG23 HD12 ' A' ' 31' ' ' LEU . 1.7 mp -56.69 -46.01 82.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.298 -0.865 . . . . 0.0 111.367 -174.859 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 127' ' ' LEU . . . . . 0.757 ' HG ' ' O ' ' B' ' 123' ' ' ILE . 2.2 pp -78.47 -24.82 45.77 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 120.284 -0.567 . . . . 0.0 111.909 -177.822 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 128' ' ' ASP . . . . . 0.509 ' HB2' ' O ' ' B' ' 124' ' ' LYS . 17.0 t70 -67.1 -35.92 80.82 Favored 'General case' 0 CA--C 1.514 -0.407 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 179.861 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 129' ' ' SER . . . . . . . . . . . . . 83.3 p -58.71 -30.14 67.21 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 115.75 -0.659 . . . . 0.0 112.32 -179.23 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 130' ' ' VAL . . . . . . . . . . . . . 3.1 m -108.41 6.02 9.45 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 CA-C-O 120.856 0.36 . . . . 0.0 111.506 177.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 131' ' ' GLY . . . . . . . . . . . . . . . 74.32 30.42 60.62 Favored Glycine 0 CA--C 1.52 0.357 0 C-N-CA 121.075 -0.583 . . . . 0.0 113.722 175.531 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 132' ' ' ILE . . . . . 0.52 ' O ' HD13 ' B' ' 127' ' ' LEU . 18.6 mt -90.08 130.11 39.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.955 0.377 . . . . 0.0 110.026 176.691 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 133' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -81.15 146.73 30.39 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-O 120.922 0.392 . . . . 0.0 110.937 -174.536 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 134' ' ' ALA . . . . . 0.434 ' HB2' HD22 ' B' ' 127' ' ' LEU . . . -146.23 144.07 29.64 Favored 'General case' 0 N--CA 1.442 -0.849 0 CA-C-N 115.795 -0.638 . . . . 0.0 111.639 -176.033 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 135' ' ' ASP . . . . . 0.746 ' HB2' ' HG3' ' B' ' 138' ' ' ARG . 16.3 m-20 -94.03 132.91 38.04 Favored 'General case' 0 C--O 1.251 1.146 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 174.114 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 136' ' ' ASP . . . . . 0.952 ' HA ' HD11 ' B' ' 139' ' ' LEU . 5.5 m-20 -71.53 -11.45 60.87 Favored 'General case' 0 CA--C 1.511 -0.525 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.547 -167.042 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 137' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -97.32 -31.06 12.6 Favored 'General case' 0 N--CA 1.434 -1.228 0 C-N-CA 120.103 -0.639 . . . . 0.0 110.444 174.441 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 138' ' ' ARG . . . . . 0.746 ' HG3' ' HB2' ' B' ' 135' ' ' ASP . 52.4 mmt-85 -66.02 -43.96 86.12 Favored 'General case' 0 CA--C 1.506 -0.725 0 CA-C-O 121.553 0.692 . . . . 0.0 109.565 -174.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 139' ' ' LEU . . . . . 0.952 HD11 ' HA ' ' B' ' 136' ' ' ASP . 0.3 OUTLIER -75.91 -36.71 59.34 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.152 -0.931 . . . . 0.0 111.417 179.688 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 140' ' ' ASN . . . . . 0.615 ' H ' HD12 ' B' ' 139' ' ' LEU . 61.6 t30 -63.19 -25.95 68.58 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 177.699 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 141' ' ' LYS . . . . . . . . . . . . . 35.9 tptt -76.26 -49.09 17.96 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.632 -1.167 . . . . 0.0 110.838 177.639 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 142' ' ' VAL . . . . . 0.999 HG11 ' HB2' ' B' ' 103' ' ' TYR . 13.7 p -57.92 -45.95 87.61 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.367 0 CA-C-O 121.212 0.53 . . . . 0.0 109.716 179.561 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 143' ' ' ILE . . . . . 0.779 HD11 ' CG1' ' B' ' 123' ' ' ILE . 34.7 mt -58.56 -46.25 90.05 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.802 0 C-N-CA 124.124 0.97 . . . . 0.0 112.198 173.581 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 144' ' ' SER . . . . . . . . . . . . . 46.5 t -51.59 -39.23 57.52 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.917 176.225 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 145' ' ' GLU . . . . . . . . . . . . . 15.6 mm-40 -73.86 -50.86 18.3 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 121.765 0.793 . . . . 0.0 110.431 175.505 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 146' ' ' LEU . . . . . 0.57 ' O ' ' HE2' ' B' ' 149' ' ' LYS . 2.2 mm? -61.28 -32.7 72.53 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 114.56 -1.2 . . . . 0.0 112.973 -175.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 147' ' ' ASN . . . . . . . . . . . . . 50.6 t30 -54.69 116.99 3.0 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.74 -172.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 148' ' ' GLY . . . . . 0.44 ' O ' ' HD3' ' B' ' 149' ' ' LYS . . . 98.97 36.15 4.57 Favored Glycine 0 N--CA 1.448 -0.533 0 CA-C-N 115.52 -0.764 . . . . 0.0 112.446 -179.577 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 149' ' ' LYS . . . . . 0.57 ' HE2' ' O ' ' B' ' 146' ' ' LEU . 0.5 OUTLIER -130.48 164.02 25.71 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 110.04 -0.355 . . . . 0.0 110.04 177.898 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 150' ' ' ASN . . . . . 0.507 ' O ' HG23 ' B' ' 154' ' ' VAL . 4.8 m-20 -102.14 90.13 3.83 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 -178.437 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 151' ' ' ILE . . . . . 0.835 HG13 HD12 ' B' ' 108' ' ' LEU . 1.8 mp -34.58 -68.52 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 O-C-N 124.734 1.271 . . . . 0.0 113.251 -172.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 152' ' ' GLU . . . . . 0.49 ' N ' HG22 ' B' ' 151' ' ' ILE . 1.5 mm-40 -46.14 -56.68 5.32 Favored 'General case' 0 C--O 1.213 -0.84 0 N-CA-C 112.549 0.574 . . . . 0.0 112.549 -179.482 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 153' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -57.3 -35.67 70.13 Favored 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 120.85 -0.34 . . . . 0.0 111.673 -178.683 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 154' ' ' VAL . . . . . 0.738 ' HB ' HD12 ' B' ' 155' ' ' ILE . 64.4 t -57.87 -53.94 38.52 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 CA-C-O 121.273 0.558 . . . . 0.0 110.1 177.37 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 155' ' ' ILE . . . . . 0.738 HD12 ' HB ' ' B' ' 154' ' ' VAL . 3.6 mp -87.76 -19.78 7.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.56 -0.746 . . . . 0.0 111.729 -173.542 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . -57.21 -16.67 8.72 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.022 0.439 . . . . 0.0 110.919 179.585 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 157' ' ' GLN . . . . . . . . . . . . . 49.8 mt-30 -130.89 26.77 4.95 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.921 170.231 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 158' ' ' GLY . . . . . . . . . . . . . . . -160.04 46.85 0.41 Allowed Glycine 0 CA--C 1.526 0.76 0 CA-C-N 115.989 -0.551 . . . . 0.0 113.943 -172.297 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 159' ' ' ILE . . . . . 0.854 ' HB ' HG13 ' A' ' 60' ' ' ILE . 1.9 mp -61.16 -12.17 5.53 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 CA-C-O 121.875 0.845 . . . . 0.0 110.162 171.748 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 160' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.439 -1.143 0 N-CA-C 109.977 -1.249 . . . . 0.0 109.977 -178.806 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . 0.503 ' HB2' ' HG3' ' A' ' 6' ' ' GLU . 1.5 m . . . . . 0 N--CA 1.449 -0.525 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.974 HG13 ' HG ' ' B' ' 112' ' ' LEU . 2.1 t -54.33 -24.86 12.82 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-N 115.128 -0.942 . . . . 0.0 112.348 -177.446 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . 0.849 ' HB3' ' HA ' ' A' ' 39' ' ' VAL . 49.7 m -71.27 -48.55 50.21 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.446 0.641 . . . . 0.0 109.304 175.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.57 ' HG2' ' HE1' ' A' ' 43' ' ' TRP . 28.4 mt-10 -61.57 -49.42 76.72 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.322 -0.853 . . . . 0.0 109.274 179.18 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.856 HD12 HD12 ' A' ' 10' ' ' ILE . 4.7 tp -60.24 -35.12 74.76 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 114.831 -1.077 . . . . 0.0 111.47 177.136 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.686 ' HB2' HD23 ' B' ' 112' ' ' LEU . . . -67.87 -37.15 81.45 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 120.933 0.397 . . . . 0.0 110.871 179.029 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.508 ' HB2' HG11 ' A' ' 39' ' ' VAL . 8.4 t -67.81 -39.58 83.95 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 178.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.856 HD12 HD12 ' A' ' 7' ' ' LEU . 68.9 mt -48.48 -55.56 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.694 0 CA-C-N 114.264 -1.335 . . . . 0.0 109.726 170.03 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.858 ' HB2' HD13 ' B' ' 109' ' ' LEU . 23.0 m-85 -67.11 -39.03 86.63 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.698 -173.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.477 ' OG ' HG23 ' A' ' 28' ' ' ILE . 73.1 p -57.1 -40.42 76.97 Favored 'General case' 0 C--O 1.237 0.395 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 177.209 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -65.94 -33.02 74.87 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 115.195 -0.911 . . . . 0.0 110.574 173.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.899 HD22 HD11 ' A' ' 56' ' ' ILE . 0.4 OUTLIER -66.12 -50.52 63.73 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.967 -179.774 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.494 HG12 ' O ' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -63.11 -42.43 96.56 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 177.497 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.618 HD21 ' HA ' ' A' ' 23' ' ' VAL . 6.1 tp -56.12 -38.16 70.4 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.37 0.605 . . . . 0.0 110.388 173.859 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 45.9 t60 -78.78 -7.61 57.98 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.018 -0.992 . . . . 0.0 111.598 178.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -66.62 -52.74 41.84 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 175.188 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -93.1 -10.84 34.56 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 122.098 0.952 . . . . 0.0 108.896 178.512 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 55.79 53.45 9.4 Favored 'General case' 0 CA--C 1.51 -0.576 0 CA-C-N 113.871 -1.513 . . . . 0.0 109.597 -175.026 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.404 HG13 HD12 ' A' ' 16' ' ' LEU . 7.6 p -99.87 160.07 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.723 0 CA-C-N 113.971 -1.468 . . . . 0.0 108.667 -176.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.509 ' O ' ' HG3' ' A' ' 27' ' ' LYS . 50.8 p -43.37 131.28 4.84 Favored 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 113.525 0.935 . . . . 0.0 113.525 -171.661 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.618 ' HA ' HD21 ' A' ' 16' ' ' LEU . 57.7 t -96.82 109.31 22.83 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.04 0 CA-C-N 114.283 -1.326 . . . . 0.0 110.863 -177.071 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.747 ' OG1' ' HG2' ' A' ' 27' ' ' LYS . 21.3 p -133.31 157.13 46.24 Favored 'General case' 0 C--O 1.245 0.855 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.186 179.457 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -53.27 -44.71 68.42 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.601 177.313 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -68.76 -24.97 64.5 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.282 179.589 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.747 ' HG2' ' OG1' ' A' ' 24' ' ' THR . 2.8 mmtm -61.44 -56.43 20.24 Favored 'General case' 0 CA--C 1.514 -0.407 0 N-CA-C 107.937 -1.135 . . . . 0.0 107.937 173.644 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.477 HG23 ' OG ' ' A' ' 12' ' ' SER . 83.5 mt -55.73 -43.3 73.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 113.728 -1.578 . . . . 0.0 110.818 -178.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.418 ' HA ' HD12 ' A' ' 32' ' ' ILE . 29.4 m-80 -65.52 -33.17 75.3 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.065 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.23 -48.88 76.41 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.333 176.072 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.674 ' HB3' HD21 ' B' ' 109' ' ' LEU . 1.9 mm? -59.53 -47.6 84.92 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-O 120.917 0.389 . . . . 0.0 110.617 175.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.564 HG23 ' O ' ' A' ' 37' ' ' VAL . 44.0 mt -48.58 -48.98 14.47 Favored 'Isoleucine or valine' 0 C--O 1.241 0.647 0 CA-C-N 115.227 -0.897 . . . . 0.0 111.277 178.166 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 42.5 tptt -72.57 -42.46 64.6 Favored 'General case' 0 N--CA 1.431 -1.399 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.607 -176.461 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -60.74 -40.4 92.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.948 0.404 . . . . 0.0 111.217 -177.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.467 ' HA ' HD11 ' B' ' 126' ' ' ILE . . . -79.96 -34.79 38.44 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.178 0.513 . . . . 0.0 111.105 178.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 97.75 17.66 29.93 Favored Glycine 0 N--CA 1.448 -0.548 0 CA-C-N 115.672 -0.695 . . . . 0.0 112.003 -179.567 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.909 ' HB ' ' HA2' ' B' ' 113' ' ' GLY . 2.9 p -119.69 119.32 60.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-O 121.599 0.714 . . . . 0.0 110.618 -176.567 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.457 ' HA ' HG23 ' A' ' 32' ' ' ILE . 13.6 t-20 -97.57 150.99 20.52 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 114.816 -1.084 . . . . 0.0 110.342 -170.345 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.849 ' HA ' ' HB3' ' A' ' 5' ' ' SER . 99.0 t -121.56 162.55 20.59 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.028 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.381 -169.497 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.48 ' HB3' ' HD1' ' A' ' 43' ' ' TRP . 5.1 tp10 -70.69 106.58 1.84 Allowed Pre-proline 0 N--CA 1.438 -1.04 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 169.665 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.502 ' C ' ' HD2' ' A' ' 44' ' ' PRO . 77.7 Cg_exo -51.71 -26.36 23.09 Favored 'Trans proline' 0 C--O 1.247 0.925 0 C-N-CA 123.818 3.012 . . . . 0.0 115.503 -164.199 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.418 ' HD2' ' HG3' ' A' ' 40' ' ' GLU . 0.6 OUTLIER -61.91 -27.32 68.73 Favored 'General case' 0 CA--C 1.526 0.048 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 177.898 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . 0.57 ' HE1' ' HG2' ' A' ' 6' ' ' GLU . 20.8 m95 -64.31 -59.63 10.48 Favored Pre-proline 0 C--O 1.208 -1.107 0 CA-C-O 118.626 -0.702 . . . . 0.0 110.977 176.04 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.502 ' HD2' ' C ' ' A' ' 41' ' ' PRO . 90.7 Cg_exo -45.26 -43.97 16.29 Favored 'Trans proline' 0 C--N 1.358 1.035 0 C-N-CA 121.733 1.622 . . . . 0.0 112.031 173.474 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -60.21 -59.11 10.95 Favored Glycine 0 CA--C 1.525 0.671 0 C-N-CA 120.36 -0.924 . . . . 0.0 112.581 176.649 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.439 ' O ' ' HB2' ' A' ' 49' ' ' LYS . 5.9 tp -67.46 -26.9 66.61 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 122.909 0.483 . . . . 0.0 112.108 -176.785 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.545 ' HE1' ' CE3' ' A' ' 43' ' ' TRP . 3.0 m-85 -69.05 -46.78 67.01 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 110.19 -0.3 . . . . 0.0 110.19 176.317 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.436 ' HA ' HG12 ' A' ' 23' ' ' VAL . . . -65.47 -32.02 73.42 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.322 -0.622 . . . . 0.0 109.322 178.229 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.439 ' HB2' ' O ' ' A' ' 46' ' ' LEU . 8.0 mmmt -60.44 -55.33 34.83 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 114.832 -1.077 . . . . 0.0 111.707 171.289 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.605 ' O ' HG22 ' A' ' 54' ' ' VAL . . . -76.4 -41.09 49.01 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 -170.211 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.568 ' HB2' HG11 ' A' ' 23' ' ' VAL . 12.7 mt -74.21 45.47 0.22 Allowed 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 121.473 0.654 . . . . 0.0 111.925 -173.279 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -134.68 -24.58 1.52 Allowed 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.05 -0.977 . . . . 0.0 109.026 172.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -121.39 -25.28 5.23 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 115.56 -0.746 . . . . 0.0 111.13 178.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.605 HG22 ' O ' ' A' ' 50' ' ' ALA . 10.4 m -99.64 -170.37 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 174.853 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 34.9 p30 -129.67 -178.39 4.67 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.794 175.59 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.899 HD11 HD22 ' A' ' 14' ' ' LEU . 3.1 tp -68.32 -28.69 41.58 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-O 120.642 0.258 . . . . 0.0 110.94 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -72.14 -11.05 74.74 Favored Glycine 0 N--CA 1.448 -0.5 0 C-N-CA 120.447 -0.882 . . . . 0.0 111.016 177.326 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 14.8 t -82.46 -19.21 39.34 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-O 121.598 0.713 . . . . 0.0 109.356 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.703 ' HB2' HG21 ' B' ' 159' ' ' ILE . 22.0 mt -64.0 -31.65 72.92 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.208 -0.906 . . . . 0.0 110.258 177.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.789 HG13 ' HB ' ' B' ' 159' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--N 1.323 -0.574 0 CA-C-N 114.898 -1.047 . . . . 0.0 110.483 177.798 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 103' ' ' TYR . . . . . 0.88 ' HB2' HG11 ' B' ' 142' ' ' VAL . 39.8 m-85 . . . . . 0 C--O 1.24 0.556 0 CA-C-O 120.722 0.296 . . . . 0.0 111.076 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 104' ' ' VAL . . . . . 0.562 ' HA ' HD11 ' B' ' 146' ' ' LEU . 97.8 t -43.64 -49.31 1.66 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.242 0 CA-C-O 121.701 0.763 . . . . 0.0 109.099 172.399 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 105' ' ' ALA . . . . . 0.652 ' CB ' ' HB3' ' A' ' 14' ' ' LEU . . . -64.17 -42.34 96.76 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 114.273 -1.331 . . . . 0.0 112.175 -173.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 106' ' ' SER . . . . . 0.773 ' HB2' HG23 ' B' ' 123' ' ' ILE . 0.8 OUTLIER -62.59 -37.68 87.17 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.687 0.756 . . . . 0.0 109.666 -179.747 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 107' ' ' TYR . . . . . 0.685 ' O ' ' HG2' ' B' ' 118' ' ' PRO . 43.6 t80 -63.41 -47.44 81.97 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 114.652 -1.158 . . . . 0.0 108.662 178.235 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 108' ' ' LEU . . . . . 0.831 HD12 HG13 ' B' ' 151' ' ' ILE . 0.0 OUTLIER -57.87 -46.44 84.85 Favored 'General case' 0 N--CA 1.442 -0.842 0 CA-C-N 114.766 -1.106 . . . . 0.0 110.866 177.194 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 109' ' ' LEU . . . . . 0.858 HD13 ' HB2' ' A' ' 11' ' ' TYR . 8.4 tp -54.85 -47.32 74.33 Favored 'General case' 0 CA--C 1.511 -0.543 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.916 179.047 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 110' ' ' ALA . . . . . 0.48 ' HB3' ' HB3' ' B' ' 118' ' ' PRO . . . -68.01 -36.61 80.27 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.59 -0.444 . . . . 0.0 111.334 -176.772 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 111' ' ' ALA . . . . . 0.788 ' HA ' ' O ' ' B' ' 115' ' ' ASN . . . -70.91 -20.0 62.53 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.411 0.624 . . . . 0.0 110.703 178.51 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 112' ' ' LEU . . . . . 0.974 ' HG ' HG13 ' A' ' 4' ' ' VAL . 2.8 mp -84.5 -40.18 17.97 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 114.962 -1.017 . . . . 0.0 109.762 172.191 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 113' ' ' GLY . . . . . 0.909 ' HA2' ' HB ' ' A' ' 37' ' ' VAL . . . -61.54 -53.65 42.22 Favored Glycine 0 N--CA 1.442 -0.904 0 CA-C-N 114.928 -1.033 . . . . 0.0 112.155 -177.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 114' ' ' GLY . . . . . . . . . . . . . . . 177.33 4.03 0.02 OUTLIER Glycine 0 N--CA 1.441 -1.01 0 C-N-CA 119.55 -1.31 . . . . 0.0 113.909 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 115' ' ' ASN . . . . . 0.788 ' O ' ' HA ' ' B' ' 111' ' ' ALA . 38.2 m-20 -126.78 98.89 5.54 Favored 'General case' 0 CA--C 1.497 -1.076 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 14.1 m -77.04 26.8 0.14 Allowed 'General case' 0 C--N 1.315 -0.9 0 CA-C-O 122.107 0.956 . . . . 0.0 109.763 -175.562 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 117' ' ' SER . . . . . 0.579 ' H ' ' C ' ' B' ' 115' ' ' ASN . 34.8 t -168.8 70.39 0.75 Allowed Pre-proline 0 C--N 1.321 -0.633 0 CA-C-N 113.738 -1.573 . . . . 0.0 108.385 178.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 118' ' ' PRO . . . . . 0.685 ' HG2' ' O ' ' B' ' 107' ' ' TYR . 34.1 Cg_exo -66.82 158.77 54.73 Favored 'Trans proline' 0 C--N 1.328 -0.547 0 C-N-CA 125.167 3.911 . . . . 0.0 111.675 -176.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 119' ' ' SER . . . . . 0.58 ' O ' HG12 ' B' ' 123' ' ' ILE . 8.6 m -122.31 -179.39 4.17 Favored 'General case' 0 C--N 1.316 -0.882 0 C-N-CA 120.555 -0.458 . . . . 0.0 110.875 176.175 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 120' ' ' ALA . . . . . 0.904 ' HB1' HD13 ' B' ' 139' ' ' LEU . . . -65.99 -36.46 83.36 Favored 'General case' 0 CA--C 1.504 -0.812 0 CA-C-O 122.219 1.009 . . . . 0.0 109.236 -173.347 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 121' ' ' LYS . . . . . 0.447 ' HD2' ' N ' ' B' ' 121' ' ' LYS . 0.4 OUTLIER -63.61 -34.86 78.77 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 113.332 -1.758 . . . . 0.0 110.101 176.782 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 122' ' ' ASP . . . . . 0.475 ' O ' HD13 ' B' ' 126' ' ' ILE . 18.5 m-20 -71.1 -37.6 72.38 Favored 'General case' 0 CA--C 1.517 -0.314 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 176.486 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 123' ' ' ILE . . . . . 0.773 HG23 ' HB2' ' B' ' 106' ' ' SER . 34.1 mm -61.83 -49.9 82.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.132 177.453 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 124' ' ' LYS . . . . . 0.818 ' HD3' HD21 ' B' ' 139' ' ' LEU . 4.2 mmmp? -58.91 -43.61 91.12 Favored 'General case' 0 C--O 1.213 -0.839 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.228 -178.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 125' ' ' LYS . . . . . 0.523 ' HA ' ' HD3' ' B' ' 125' ' ' LYS . 10.0 tppt? -50.51 -59.82 3.64 Favored 'General case' 0 N--CA 1.418 -2.056 0 O-C-N 123.721 0.638 . . . . 0.0 112.132 174.105 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 126' ' ' ILE . . . . . 0.579 HG23 HD12 ' A' ' 31' ' ' LEU . 1.7 mp -56.53 -47.63 81.61 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 CA-C-N 115.426 -0.806 . . . . 0.0 111.487 -176.282 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 127' ' ' LEU . . . . . 0.745 ' HG ' ' O ' ' B' ' 123' ' ' ILE . 2.2 pp -80.59 -19.59 45.2 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.306 -0.557 . . . . 0.0 112.103 -177.11 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 128' ' ' ASP . . . . . 0.516 ' HB2' ' O ' ' B' ' 124' ' ' LYS . 13.6 t70 -73.98 -31.16 62.86 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 179.367 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 129' ' ' SER . . . . . . . . . . . . . 84.1 p -52.63 -37.62 58.77 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.219 176.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 130' ' ' VAL . . . . . 0.559 HG23 HG13 ' B' ' 132' ' ' ILE . 7.5 m -103.95 5.85 10.35 Favored 'Isoleucine or valine' 0 C--O 1.232 0.137 0 CA-C-O 120.801 0.334 . . . . 0.0 111.536 179.324 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 131' ' ' GLY . . . . . . . . . . . . . . . 67.83 48.97 52.07 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 121.192 -0.528 . . . . 0.0 113.163 177.308 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 132' ' ' ILE . . . . . 0.565 ' HB ' ' HB2' ' B' ' 127' ' ' LEU . 8.7 mt -101.54 128.58 53.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-O 120.919 0.39 . . . . 0.0 110.963 178.229 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 133' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -67.47 136.45 54.65 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.187 -177.558 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 134' ' ' ALA . . . . . . . . . . . . . . . -152.57 143.61 23.07 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.182 -177.137 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 135' ' ' ASP . . . . . 0.733 ' HB2' ' HG3' ' B' ' 138' ' ' ARG . 34.1 m-20 -93.27 129.51 39.31 Favored 'General case' 0 C--O 1.251 1.149 0 CA-C-O 120.973 0.416 . . . . 0.0 110.12 174.772 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 136' ' ' ASP . . . . . 0.989 ' HA ' HD11 ' B' ' 139' ' ' LEU . 3.1 m-20 -71.22 -5.37 31.48 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-N 115.239 -0.892 . . . . 0.0 111.191 -169.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 137' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -100.53 -34.99 9.68 Favored 'General case' 0 N--CA 1.433 -1.282 0 C-N-CA 120.487 -0.485 . . . . 0.0 110.097 175.662 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 138' ' ' ARG . . . . . 0.733 ' HG3' ' HB2' ' B' ' 135' ' ' ASP . 43.7 mmt-85 -63.91 -46.23 85.74 Favored 'General case' 0 CA--C 1.503 -0.841 0 CA-C-O 122.118 0.961 . . . . 0.0 109.234 -176.323 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 139' ' ' LEU . . . . . 0.989 HD11 ' HA ' ' B' ' 136' ' ' ASP . 0.3 OUTLIER -74.16 -34.39 63.8 Favored 'General case' 0 C--O 1.209 -1.037 0 CA-C-N 114.529 -1.214 . . . . 0.0 111.6 -178.828 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 140' ' ' ASN . . . . . 0.628 ' H ' HD12 ' B' ' 139' ' ' LEU . 60.8 t30 -65.02 -27.98 69.18 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 122.331 1.062 . . . . 0.0 108.703 177.538 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 141' ' ' LYS . . . . . 0.607 ' O ' ' HG2' ' B' ' 145' ' ' GLU . 30.0 tttp -67.89 -56.0 10.72 Favored 'General case' 0 N--CA 1.44 -0.959 0 CA-C-N 114.141 -1.39 . . . . 0.0 108.882 175.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 142' ' ' VAL . . . . . 0.88 HG11 ' HB2' ' B' ' 103' ' ' TYR . 8.5 p -57.93 -31.57 41.22 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.236 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.449 178.827 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 143' ' ' ILE . . . . . 0.841 HG12 ' O ' ' B' ' 139' ' ' LEU . 28.1 mm -51.99 -67.41 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.513 -0.45 0 CA-C-O 121.151 0.501 . . . . 0.0 110.514 170.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 144' ' ' SER . . . . . . . . . . . . . 79.2 p -57.42 -25.42 59.58 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 114.96 -1.018 . . . . 0.0 111.89 -178.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 145' ' ' GLU . . . . . 0.607 ' HG2' ' O ' ' B' ' 141' ' ' LYS . 5.8 mm-40 -73.16 -46.47 50.6 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 120.898 0.38 . . . . 0.0 110.555 178.143 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 146' ' ' LEU . . . . . 0.722 ' HG ' ' O ' ' B' ' 142' ' ' VAL . 6.9 mt -82.63 -17.05 46.06 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.486 -0.324 . . . . 0.0 111.09 -176.593 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 147' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -56.54 111.84 1.11 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.207 0.527 . . . . 0.0 111.426 -175.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . 111.72 7.76 23.43 Favored Glycine 0 CA--C 1.519 0.33 0 CA-C-N 115.527 -0.76 . . . . 0.0 112.806 -179.285 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 149' ' ' LYS . . . . . 0.514 ' HE2' ' O ' ' B' ' 146' ' ' LEU . 0.8 OUTLIER -104.19 167.88 9.47 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.1 0.476 . . . . 0.0 111.038 -179.749 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 150' ' ' ASN . . . . . 0.511 ' O ' HG23 ' B' ' 154' ' ' VAL . 0.9 OUTLIER -103.93 91.01 3.79 Favored 'General case' 0 CA--C 1.511 -0.545 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 176.788 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 151' ' ' ILE . . . . . 0.831 HG13 HD12 ' B' ' 108' ' ' LEU . 1.8 mp -41.9 -62.87 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 O-C-N 124.376 1.048 . . . . 0.0 113.247 -168.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 152' ' ' GLU . . . . . 0.714 ' HG3' HD11 ' B' ' 112' ' ' LEU . 3.0 mp0 -57.42 -33.22 67.67 Favored 'General case' 0 C--O 1.219 -0.532 0 N-CA-C 111.839 0.311 . . . . 0.0 111.839 -174.487 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 153' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -78.52 -33.4 48.01 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.609 179.498 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 154' ' ' VAL . . . . . 0.783 ' HB ' HD12 ' B' ' 155' ' ' ILE . 58.2 t -54.84 -46.31 75.17 Favored 'Isoleucine or valine' 0 C--O 1.233 0.185 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 172.253 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 155' ' ' ILE . . . . . 0.783 HD12 ' HB ' ' B' ' 154' ' ' VAL . 2.3 mp -106.71 33.84 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 114.97 -1.014 . . . . 0.0 110.448 -179.314 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 156' ' ' ALA . . . . . 0.433 ' HB2' ' O ' ' B' ' 152' ' ' GLU . . . -101.75 2.99 39.1 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 167.526 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 157' ' ' GLN . . . . . . . . . . . . . 46.4 mt-30 -138.93 -1.42 1.79 Allowed 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 113.55 -1.659 . . . . 0.0 109.844 173.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 158' ' ' GLY . . . . . 0.406 ' O ' HG23 ' B' ' 155' ' ' ILE . . . -139.62 46.34 0.96 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.379 -0.915 . . . . 0.0 114.575 -167.274 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 159' ' ' ILE . . . . . 0.789 ' HB ' HG13 ' A' ' 60' ' ' ILE . 1.8 mp -61.59 -15.56 13.43 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 CA-C-O 122.039 0.923 . . . . 0.0 109.733 173.584 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 160' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.437 -1.29 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 178.509 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . 0.745 ' HB2' ' HG3' ' A' ' 6' ' ' GLU . 6.2 m . . . . . 0 N--CA 1.439 -1.023 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.888 HG13 ' HG ' ' B' ' 112' ' ' LEU . 2.2 t -52.93 -28.22 13.64 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.78 0 CA-C-N 115.294 -0.866 . . . . 0.0 112.073 -179.573 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . 0.746 ' HB3' ' HA ' ' A' ' 39' ' ' VAL . 71.7 m -68.45 -43.99 75.85 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.229 0.538 . . . . 0.0 109.784 175.723 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.745 ' HG3' ' HB2' ' A' ' 3' ' ' SER . 30.2 mt-10 -68.21 -49.04 63.44 Favored 'General case' 0 N--CA 1.444 -0.726 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 -178.209 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.877 ' HA ' HD12 ' A' ' 10' ' ' ILE . 2.9 tp -58.34 -35.01 71.27 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 114.443 -1.253 . . . . 0.0 111.949 175.396 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.579 ' HB2' HD23 ' B' ' 112' ' ' LEU . . . -68.37 -37.25 80.26 Favored 'General case' 0 CA--C 1.512 -0.484 0 CA-C-O 121.04 0.448 . . . . 0.0 110.786 179.054 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.528 ' HB2' HG11 ' A' ' 39' ' ' VAL . 4.6 t -67.35 -40.79 85.86 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 178.633 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.877 HD12 ' HA ' ' A' ' 7' ' ' LEU . 73.8 mt -48.92 -55.76 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.685 0 CA-C-N 113.896 -1.502 . . . . 0.0 110.051 171.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.852 ' HB2' HD13 ' B' ' 109' ' ' LEU . 23.9 m-85 -66.36 -41.46 89.46 Favored 'General case' 0 C--O 1.22 -0.455 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.557 -174.103 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.436 ' HA ' ' HG ' ' A' ' 31' ' ' LEU . 15.6 m -54.01 -42.09 68.7 Favored 'General case' 0 C--O 1.242 0.692 0 CA-C-O 121.489 0.661 . . . . 0.0 109.27 175.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -68.67 -28.94 67.32 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.39 176.154 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.693 HD22 HD11 ' A' ' 56' ' ' ILE . 0.2 OUTLIER -67.25 -55.58 13.41 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.49 179.34 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.404 HG12 ' O ' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -55.72 -43.84 74.99 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 176.889 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.597 HD12 HG13 ' A' ' 21' ' ' VAL . 3.8 tp -57.69 -44.27 85.73 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.501 177.75 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 25.1 t60 -75.73 -13.43 60.31 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.258 -0.883 . . . . 0.0 111.726 178.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 12.1 t0 -69.09 -42.31 76.34 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.247 0.546 . . . . 0.0 109.61 179.377 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.412 ' HB2' HG23 ' B' ' 132' ' ' ILE . 36.5 t70 -100.08 -7.04 25.4 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 122.032 0.92 . . . . 0.0 109.226 177.014 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 52.29 56.55 7.56 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-N 113.784 -1.553 . . . . 0.0 110.262 -175.286 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.597 HG13 HD12 ' A' ' 16' ' ' LEU . 6.1 p -106.21 159.45 6.18 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.679 0 CA-C-N 114.13 -1.396 . . . . 0.0 108.814 -178.825 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 82.2 p -49.8 139.1 13.74 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 114.193 1.183 . . . . 0.0 114.193 -169.48 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.604 HG12 ' HA ' ' A' ' 48' ' ' ALA . 63.1 t -103.77 111.86 35.06 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-N 114.216 -1.356 . . . . 0.0 110.986 -177.094 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.51 ' OG1' ' HE2' ' A' ' 27' ' ' LYS . 77.3 p -135.66 157.83 45.89 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 175.575 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -57.49 -41.23 80.29 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 120.71 -0.396 . . . . 0.0 110.094 -177.434 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -65.16 -29.92 70.8 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.08 178.344 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.51 ' HE2' ' OG1' ' A' ' 24' ' ' THR . 3.8 tppt? -66.53 -53.0 39.72 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 179.844 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 66.4 mt -60.41 -39.69 81.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 114.394 -1.275 . . . . 0.0 110.491 178.321 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 -61.97 -36.01 80.16 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.74 176.045 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.67 -45.59 92.1 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-N 116.552 -0.294 . . . . 0.0 110.484 177.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.562 ' HB3' HD21 ' B' ' 109' ' ' LEU . 1.3 mm? -58.35 -51.15 71.02 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 121.085 0.469 . . . . 0.0 110.13 173.838 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.561 HG23 ' O ' ' A' ' 37' ' ' VAL . 57.1 mt -48.28 -50.86 10.99 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 CA-C-N 114.873 -1.058 . . . . 0.0 111.646 178.686 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -69.82 -40.08 76.13 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.079 -0.51 . . . . 0.0 112.03 -176.748 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -64.2 -45.54 87.86 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-O 120.918 0.39 . . . . 0.0 111.093 -177.384 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.423 ' HB3' HG12 ' A' ' 37' ' ' VAL . . . -74.84 -34.82 62.36 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.429 178.669 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 96.96 18.48 29.36 Favored Glycine 0 N--CA 1.448 -0.554 0 CA-C-N 115.379 -0.828 . . . . 0.0 112.019 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.868 ' HB ' ' HA3' ' B' ' 113' ' ' GLY . 5.5 p -121.04 121.92 66.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 121.422 0.63 . . . . 0.0 111.059 -173.061 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 62.9 t30 -99.33 157.33 16.48 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.049 -0.978 . . . . 0.0 111.035 -169.308 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.746 ' HA ' ' HB3' ' A' ' 5' ' ' SER . 94.6 t -125.28 161.66 29.19 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.759 0 CA-C-N 115.056 -0.974 . . . . 0.0 110.937 -170.214 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.566 ' HB3' ' HD1' ' A' ' 43' ' ' TRP . 3.9 tp10 -67.65 105.41 0.9 Allowed Pre-proline 0 N--CA 1.441 -0.884 0 N-CA-C 107.756 -1.201 . . . . 0.0 107.756 169.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.522 ' C ' ' HD2' ' A' ' 44' ' ' PRO . 86.0 Cg_exo -49.54 -29.73 19.58 Favored 'Trans proline' 0 C--O 1.252 1.195 0 C-N-CA 123.602 2.868 . . . . 0.0 115.675 -163.767 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -60.76 -27.65 68.13 Favored 'General case' 0 C--N 1.333 -0.14 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 177.647 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . 0.566 ' HD1' ' HB3' ' A' ' 40' ' ' GLU . 9.6 m95 -65.08 -59.41 10.09 Favored Pre-proline 0 C--O 1.204 -1.337 0 CA-C-O 118.303 -0.856 . . . . 0.0 111.147 176.416 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.522 ' HD2' ' C ' ' A' ' 41' ' ' PRO . 83.3 Cg_exo -45.52 -44.46 17.0 Favored 'Trans proline' 0 C--N 1.359 1.086 0 C-N-CA 121.652 1.568 . . . . 0.0 111.913 174.622 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -60.4 -60.56 8.34 Favored Glycine 0 CA--C 1.525 0.68 0 C-N-CA 120.176 -1.012 . . . . 0.0 112.322 175.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 12.7 tp -65.79 -21.92 66.53 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.136 0.574 . . . . 0.0 112.11 -177.057 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.676 ' HD2' HD11 ' A' ' 51' ' ' LEU . 2.6 m-85 -74.72 -45.07 46.59 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 176.625 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.604 ' HA ' HG12 ' A' ' 23' ' ' VAL . . . -64.8 -30.23 71.22 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-O 121.821 0.82 . . . . 0.0 108.864 177.602 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 9.6 mmmt -66.27 -58.0 6.32 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 114.276 -1.329 . . . . 0.0 111.713 172.167 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.489 ' O ' HG22 ' A' ' 54' ' ' VAL . . . -76.03 -39.1 56.38 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 113.457 0.91 . . . . 0.0 113.457 -168.786 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.676 HD11 ' HD2' ' A' ' 47' ' ' PHE . 12.3 mt -68.85 -4.51 16.57 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 117.922 0.328 . . . . 0.0 111.7 -173.641 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -95.67 9.68 39.45 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.138 0.494 . . . . 0.0 110.296 174.726 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -143.62 -48.2 0.29 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.505 -178.697 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.489 HG22 ' O ' ' A' ' 50' ' ' ALA . 9.2 m -94.77 -169.55 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.282 179.851 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 11.3 m120 -121.59 -175.94 3.2 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.962 0.411 . . . . 0.0 111.3 178.199 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.693 HD11 HD22 ' A' ' 14' ' ' LEU . 3.0 tp -75.06 -28.46 20.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.356 -179.669 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -69.84 -15.5 71.49 Favored Glycine 0 N--CA 1.447 -0.571 0 N-CA-C 110.613 -0.995 . . . . 0.0 110.613 175.461 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 16.5 m -78.02 -19.61 54.05 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-O 121.174 0.511 . . . . 0.0 110.201 179.594 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.652 ' HB2' HG21 ' B' ' 159' ' ' ILE . 25.0 mt -64.16 -30.47 71.53 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.589 179.814 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.686 ' CD1' ' HB ' ' B' ' 159' ' ' ILE . 0.4 OUTLIER . . . . . 0 C--N 1.318 -0.783 0 CA-C-N 115.147 -0.933 . . . . 0.0 109.955 176.574 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 103' ' ' TYR . . . . . 0.663 ' HB2' HG11 ' B' ' 142' ' ' VAL . 47.6 m-85 . . . . . 0 N--CA 1.475 0.805 0 N-CA-C 112.087 0.403 . . . . 0.0 112.087 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 104' ' ' VAL . . . . . 0.522 ' O ' ' HB3' ' B' ' 107' ' ' TYR . 82.9 t -45.42 -44.34 3.76 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.256 0 CA-C-O 121.515 0.674 . . . . 0.0 110.404 175.777 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 105' ' ' ALA . . . . . 0.669 ' CB ' ' HB3' ' A' ' 14' ' ' LEU . . . -67.41 -38.78 85.16 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 114.925 -1.034 . . . . 0.0 111.559 -174.853 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 106' ' ' SER . . . . . 0.829 ' HB2' HG23 ' B' ' 123' ' ' ILE . 1.8 m -60.79 -38.44 85.34 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-O 121.784 0.802 . . . . 0.0 109.189 175.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 107' ' ' TYR . . . . . 0.759 ' O ' ' HG2' ' B' ' 118' ' ' PRO . 38.4 t80 -63.27 -49.33 74.52 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-N 114.016 -1.447 . . . . 0.0 108.706 178.814 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 108' ' ' LEU . . . . . 0.679 HD12 HG13 ' B' ' 151' ' ' ILE . 0.0 OUTLIER -56.4 -50.49 71.44 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.164 -0.926 . . . . 0.0 111.711 178.772 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 109' ' ' LEU . . . . . 0.852 HD13 ' HB2' ' A' ' 11' ' ' TYR . 7.8 tp -53.93 -54.91 32.25 Favored 'General case' 0 C--O 1.246 0.906 0 CA-C-O 121.4 0.619 . . . . 0.0 111.011 178.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -57.05 -39.14 74.3 Favored 'General case' 0 C--O 1.22 -0.458 0 CA-C-N 114.975 -1.011 . . . . 0.0 110.423 -178.259 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 111' ' ' ALA . . . . . 0.734 ' HA ' ' O ' ' B' ' 115' ' ' ASN . . . -77.83 -19.54 54.74 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.706 -178.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 112' ' ' LEU . . . . . 0.888 ' HG ' HG13 ' A' ' 4' ' ' VAL . 4.4 tp -77.19 -40.0 46.78 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.418 -179.047 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 113' ' ' GLY . . . . . 0.868 ' HA3' ' HB ' ' A' ' 37' ' ' VAL . . . -144.95 44.68 0.88 Allowed Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 118.819 -1.658 . . . . 0.0 114.354 -176.75 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 114' ' ' GLY . . . . . . . . . . . . . . . -166.25 -49.21 0.02 OUTLIER Glycine 0 N--CA 1.444 -0.792 0 C-N-CA 119.214 -1.47 . . . . 0.0 113.139 175.489 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 115' ' ' ASN . . . . . 0.734 ' O ' ' HA ' ' B' ' 111' ' ' ALA . 10.0 t30 -155.47 113.63 3.43 Favored 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 109.227 -0.656 . . . . 0.0 109.227 -171.757 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 4.0 m -79.97 26.01 0.35 Allowed 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 122.152 0.977 . . . . 0.0 111.02 -168.33 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 117' ' ' SER . . . . . 0.494 ' N ' ' HD3' ' B' ' 118' ' ' PRO . 8.9 t -172.31 69.82 0.43 Allowed Pre-proline 0 C--N 1.312 -1.022 0 CA-C-N 113.789 -1.55 . . . . 0.0 108.346 178.668 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 118' ' ' PRO . . . . . 0.759 ' HG2' ' O ' ' B' ' 107' ' ' TYR . 33.3 Cg_exo -62.07 157.44 44.25 Favored 'Trans proline' 0 CA--C 1.511 -0.651 1 C-N-CA 125.605 4.203 . . . . 0.0 112.155 -173.934 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 119' ' ' SER . . . . . 0.55 ' O ' HG12 ' B' ' 123' ' ' ILE . 14.7 m -131.73 -174.98 3.57 Favored 'General case' 0 C--N 1.317 -0.828 0 C-N-CA 119.715 -0.794 . . . . 0.0 111.842 178.784 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 120' ' ' ALA . . . . . 0.745 ' HB1' HD13 ' B' ' 139' ' ' LEU . . . -63.27 -40.77 98.33 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.719 0.771 . . . . 0.0 109.611 -165.177 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 121' ' ' LYS . . . . . . . . . . . . . 1.8 mptm? -62.71 -36.83 84.22 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 114.078 -1.419 . . . . 0.0 110.86 177.304 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 122' ' ' ASP . . . . . . . . . . . . . 44.8 m-20 -70.42 -40.13 74.01 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 120.182 -0.607 . . . . 0.0 109.55 -178.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 123' ' ' ILE . . . . . 0.829 HG23 ' HB2' ' B' ' 106' ' ' SER . 23.3 mm -60.19 -42.94 92.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.52 175.581 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 124' ' ' LYS . . . . . 0.845 ' HD3' HD21 ' B' ' 139' ' ' LEU . 2.2 mmmp? -59.02 -39.73 82.84 Favored 'General case' 0 CA--C 1.504 -0.819 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 -178.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 125' ' ' LYS . . . . . . . . . . . . . 86.8 mttt -56.81 -61.69 2.26 Favored 'General case' 0 CA--C 1.489 -1.382 0 C-N-CA 119.274 -0.97 . . . . 0.0 110.841 173.653 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 126' ' ' ILE . . . . . 0.49 HG23 HD12 ' A' ' 31' ' ' LEU . 1.8 mp -57.44 -36.99 55.26 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.118 0 CA-C-N 114.282 -1.326 . . . . 0.0 110.951 -166.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 127' ' ' LEU . . . . . 0.75 ' HG ' ' O ' ' B' ' 123' ' ' ILE . 1.2 pp -80.68 -39.29 27.47 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.172 -0.611 . . . . 0.0 111.648 178.126 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 128' ' ' ASP . . . . . 0.459 ' N ' HD12 ' B' ' 127' ' ' LEU . 9.8 m-20 -70.0 -26.39 64.05 Favored 'General case' 0 N--CA 1.466 0.331 0 O-C-N 122.096 -0.377 . . . . 0.0 111.109 -179.438 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 129' ' ' SER . . . . . . . . . . . . . 84.4 p -60.11 -33.86 72.69 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.72 -177.169 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 130' ' ' VAL . . . . . . . . . . . . . 4.7 m -99.11 -34.16 4.3 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.398 175.679 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 131' ' ' GLY . . . . . . . . . . . . . . . 122.11 45.01 0.34 Allowed Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.233 179.664 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 132' ' ' ILE . . . . . 0.419 ' HB ' ' HB2' ' B' ' 127' ' ' LEU . 24.4 mt -112.17 136.32 48.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 179.424 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 133' ' ' GLU . . . . . . . . . . . . . 26.9 mm-40 -89.86 154.65 19.72 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.235 0.541 . . . . 0.0 111.743 -174.748 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 134' ' ' ALA . . . . . 0.543 ' HB2' HD22 ' B' ' 127' ' ' LEU . . . -153.21 145.26 23.74 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.078 -0.964 . . . . 0.0 112.049 -172.771 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 135' ' ' ASP . . . . . 0.682 ' HB2' ' CG ' ' B' ' 138' ' ' ARG . 53.9 m-20 -93.91 133.52 37.25 Favored 'General case' 0 C--O 1.251 1.161 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 170.728 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 136' ' ' ASP . . . . . 1.001 ' HA ' HD11 ' B' ' 139' ' ' LEU . 10.1 p-10 -72.03 -5.15 33.03 Favored 'General case' 0 CA--C 1.513 -0.464 0 CA-C-N 115.109 -0.951 . . . . 0.0 111.006 -169.654 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 137' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -101.04 -30.74 11.44 Favored 'General case' 0 N--CA 1.433 -1.293 0 C-N-CA 120.225 -0.59 . . . . 0.0 110.286 173.018 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 138' ' ' ARG . . . . . 0.682 ' CG ' ' HB2' ' B' ' 135' ' ' ASP . 36.3 mmt180 -66.22 -44.89 82.53 Favored 'General case' 0 CA--C 1.503 -0.855 0 CA-C-O 121.59 0.71 . . . . 0.0 109.86 -175.849 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 139' ' ' LEU . . . . . 1.001 HD11 ' HA ' ' B' ' 136' ' ' ASP . 0.3 OUTLIER -74.55 -33.79 62.81 Favored 'General case' 0 C--N 1.313 -0.981 0 C-N-CA 119.53 -0.868 . . . . 0.0 111.238 178.271 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 140' ' ' ASN . . . . . 0.482 ' H ' HD12 ' B' ' 139' ' ' LEU . 58.8 t30 -68.97 -27.61 65.88 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 -176.809 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 141' ' ' LYS . . . . . 0.669 ' HG3' ' O ' ' B' ' 138' ' ' ARG . 0.0 OUTLIER -86.2 -38.25 17.85 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.02 -0.991 . . . . 0.0 110.46 -177.944 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 142' ' ' VAL . . . . . 0.663 HG11 ' HB2' ' B' ' 103' ' ' TYR . 11.1 p -60.99 -44.8 98.95 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.636 0 N-CA-C 108.82 -0.808 . . . . 0.0 108.82 175.679 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 143' ' ' ILE . . . . . 0.754 HD11 ' CG1' ' B' ' 123' ' ' ILE . 16.1 mt -58.9 -45.61 91.71 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.88 0 C-N-CA 123.752 0.821 . . . . 0.0 112.36 171.219 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 144' ' ' SER . . . . . . . . . . . . . 30.9 t -52.82 -34.77 55.38 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.983 177.188 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 145' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -86.26 -40.49 15.48 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.369 177.729 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 146' ' ' LEU . . . . . 0.573 ' HB3' ' CZ ' ' B' ' 107' ' ' TYR . 2.6 mm? -61.72 -41.25 97.38 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 123.557 0.743 . . . . 0.0 112.388 177.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 147' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -45.84 124.3 5.16 Favored 'General case' 0 C--O 1.233 0.202 0 O-C-N 123.906 0.754 . . . . 0.0 111.788 -171.725 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . 86.96 59.2 1.8 Allowed Glycine 0 N--CA 1.447 -0.589 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.301 -175.544 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 149' ' ' LYS . . . . . 0.535 ' HB2' ' O ' ' B' ' 146' ' ' LEU . 3.3 tppt? -143.25 160.22 40.88 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 -177.538 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 150' ' ' ASN . . . . . 0.59 ' O ' HG23 ' B' ' 154' ' ' VAL . 17.5 m120 -105.33 88.72 2.92 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 176.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 151' ' ' ILE . . . . . 0.679 HG13 HD12 ' B' ' 108' ' ' LEU . 1.7 mp -42.92 -61.46 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 114.694 -1.139 . . . . 0.0 113.445 -168.59 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 152' ' ' GLU . . . . . 0.405 ' N ' HG22 ' B' ' 151' ' ' ILE . 30.9 mt-10 -54.6 -41.24 69.71 Favored 'General case' 0 C--O 1.216 -0.687 0 N-CA-C 112.271 0.471 . . . . 0.0 112.271 -174.038 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 153' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -74.78 -30.77 61.55 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.816 -0.354 . . . . 0.0 110.589 -177.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 154' ' ' VAL . . . . . 0.832 ' HB ' HD12 ' B' ' 155' ' ' ILE . 44.9 t -56.01 -48.58 78.59 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 CA-C-O 121.86 0.838 . . . . 0.0 109.141 171.077 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 155' ' ' ILE . . . . . 0.832 HD12 ' HB ' ' B' ' 154' ' ' VAL . 1.8 mp -109.15 44.1 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.096 -0.956 . . . . 0.0 110.961 -178.479 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . -112.65 3.02 16.39 Favored 'General case' 0 C--N 1.306 -1.283 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 167.428 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 157' ' ' GLN . . . . . . . . . . . . . 24.3 mt-30 -138.51 -5.02 1.6 Allowed 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 113.5 -1.682 . . . . 0.0 110.002 176.276 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 158' ' ' GLY . . . . . . . . . . . . . . . -137.85 44.9 1.09 Allowed Glycine 0 C--O 1.223 -0.539 0 C-N-CA 120.153 -1.023 . . . . 0.0 113.86 -172.503 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 159' ' ' ILE . . . . . 0.686 ' HB ' ' CD1' ' A' ' 60' ' ' ILE . 1.8 mp -57.62 -28.49 32.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 CA-C-O 121.015 0.436 . . . . 0.0 110.983 175.7 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 160' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.438 0 C-N-CA 120.524 -0.846 . . . . 0.0 112.944 -179.814 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . 0.574 ' HB2' ' HG3' ' A' ' 6' ' ' GLU . 14.5 m . . . . . 0 N--CA 1.448 -0.572 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.853 HG13 ' HG ' ' B' ' 112' ' ' LEU . 2.4 t -58.04 -23.72 22.02 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 CA-C-N 115.005 -0.998 . . . . 0.0 111.693 -177.084 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . 0.703 ' HB2' ' HA ' ' A' ' 39' ' ' VAL . 11.4 p -70.5 -53.92 14.27 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.855 0.836 . . . . 0.0 109.044 174.662 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.574 ' HG3' ' HB2' ' A' ' 3' ' ' SER . 32.1 mt-10 -56.29 -47.74 78.04 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 114.862 -1.063 . . . . 0.0 109.899 177.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.833 HD12 HD12 ' A' ' 10' ' ' ILE . 3.6 tp -61.22 -39.73 91.35 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.522 178.791 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -60.94 -37.72 83.32 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 121.162 0.506 . . . . 0.0 110.937 176.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.538 ' HB2' HG11 ' A' ' 39' ' ' VAL . 7.4 t -69.94 -43.09 72.31 Favored 'General case' 0 C--O 1.24 0.587 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.833 HD12 HD12 ' A' ' 7' ' ' LEU . 72.6 mt -46.2 -56.4 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 CA-C-N 113.993 -1.458 . . . . 0.0 109.715 171.703 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.632 ' OH ' ' HB ' ' B' ' 155' ' ' ILE . 23.5 m-85 -63.33 -40.03 96.17 Favored 'General case' 0 C--O 1.216 -0.689 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.448 -175.413 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.618 ' HB2' HG23 ' A' ' 28' ' ' ILE . 19.4 m -56.76 -41.49 77.71 Favored 'General case' 0 C--O 1.24 0.593 0 CA-C-O 121.482 0.658 . . . . 0.0 109.403 179.005 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -65.85 -34.32 77.87 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.124 174.595 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.804 HD22 HD11 ' A' ' 56' ' ' ILE . 0.3 OUTLIER -63.01 -53.37 54.94 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.437 179.719 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.832 HD11 HD12 ' B' ' 109' ' ' LEU . 0.0 OUTLIER -58.9 -37.6 68.04 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.542 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 178.146 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.575 HD21 ' HA ' ' A' ' 23' ' ' VAL . 1.6 tp -58.88 -35.04 72.35 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.429 175.805 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . 0.495 ' O ' ' HG2' ' A' ' 20' ' ' GLU . 80.4 m-70 -73.76 -16.5 61.17 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 112.776 0.658 . . . . 0.0 112.776 175.243 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -59.07 -46.96 86.94 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 121.063 0.459 . . . . 0.0 109.829 178.422 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.632 ' HB2' HG23 ' B' ' 132' ' ' ILE . 29.9 t70 -100.91 -13.06 18.49 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.597 0.713 . . . . 0.0 109.397 177.407 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.495 ' HG2' ' O ' ' A' ' 17' ' ' HIS . 5.3 mm-40 63.18 44.56 5.63 Favored 'General case' 0 CA--C 1.519 -0.245 0 CA-C-N 114.496 -1.229 . . . . 0.0 109.689 -175.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.681 HG22 ' H ' ' A' ' 22' ' ' THR . 14.8 p -99.92 177.96 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.134 0 CA-C-N 114.518 -1.219 . . . . 0.0 110.233 -168.873 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.681 ' H ' HG22 ' A' ' 21' ' ' VAL . 23.6 p -49.62 137.88 14.9 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 113.874 1.065 . . . . 0.0 113.874 -174.372 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.655 HG12 ' HA ' ' A' ' 48' ' ' ALA . 46.2 t -109.7 109.07 27.03 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.177 0 CA-C-N 113.961 -1.472 . . . . 0.0 110.193 -179.546 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.598 ' OG1' ' HB2' ' A' ' 27' ' ' LYS . 69.1 p -136.08 158.23 44.91 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.158 178.284 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -52.87 -46.57 67.94 Favored 'General case' 0 C--N 1.32 -0.7 0 O-C-N 123.508 0.505 . . . . 0.0 110.094 178.09 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -67.39 -26.3 66.38 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.582 -0.735 . . . . 0.0 111.364 -179.543 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.598 ' HB2' ' OG1' ' A' ' 24' ' ' THR . 3.7 tppt? -70.67 -54.43 11.91 Favored 'General case' 0 C--O 1.24 0.597 0 CA-C-O 121.856 0.836 . . . . 0.0 108.823 -179.1 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.618 HG23 ' HB2' ' A' ' 12' ' ' SER . 77.7 mt -59.04 -43.17 88.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 114.253 -1.339 . . . . 0.0 110.349 178.498 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.472 ' HA ' ' HB ' ' A' ' 32' ' ' ILE . 6.1 m-20 -68.61 -26.53 65.4 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.212 178.705 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.62 -47.73 80.19 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 174.144 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.557 ' HG ' HG13 ' A' ' 15' ' ' ILE . 1.5 mm? -58.48 -51.54 69.43 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 121.296 0.569 . . . . 0.0 110.093 174.204 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.67 HG23 ' O ' ' A' ' 37' ' ' VAL . 64.7 mt -48.42 -48.46 13.97 Favored 'Isoleucine or valine' 0 C--O 1.243 0.747 0 CA-C-N 114.652 -1.158 . . . . 0.0 112.111 179.099 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 53.0 tptt -75.34 -43.6 49.79 Favored 'General case' 0 N--CA 1.434 -1.231 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.781 -175.619 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -62.21 -37.26 84.67 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.619 0.247 . . . . 0.0 110.855 -178.252 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -80.04 -36.83 35.15 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.03 0.443 . . . . 0.0 110.951 177.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 103.11 16.03 22.16 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.599 176.462 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.805 ' HB ' ' HA2' ' B' ' 113' ' ' GLY . 2.7 p -118.24 118.27 57.52 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.546 0 CA-C-O 121.385 0.612 . . . . 0.0 110.455 -177.642 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 -95.87 158.85 15.26 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 114.85 -1.068 . . . . 0.0 110.832 -169.169 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.703 ' HA ' ' HB2' ' A' ' 5' ' ' SER . 96.0 t -129.63 164.95 30.86 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.781 0 CA-C-N 115.055 -0.975 . . . . 0.0 110.442 -168.836 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.56 ' HB2' ' CD1' ' A' ' 43' ' ' TRP . 21.9 mt-10 -65.85 111.88 7.48 Favored Pre-proline 0 CA--C 1.489 -1.367 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 167.481 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.456 ' HD3' ' HA ' ' A' ' 40' ' ' GLU . 69.9 Cg_exo -54.41 -29.64 59.71 Favored 'Trans proline' 0 C--N 1.311 -1.421 0 C-N-CA 123.244 2.629 . . . . 0.0 113.713 -167.776 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 1.7 p90 -61.36 -29.07 69.68 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 175.332 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . 0.56 ' CD1' ' HB2' ' A' ' 40' ' ' GLU . 8.2 m95 -62.72 -60.31 10.23 Favored Pre-proline 0 C--O 1.208 -1.119 0 CA-C-O 118.474 -0.774 . . . . 0.0 110.677 176.646 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.463 ' HD3' ' HB2' ' A' ' 43' ' ' TRP . 86.7 Cg_exo -47.15 -43.26 25.76 Favored 'Trans proline' 0 C--N 1.361 1.209 0 C-N-CA 121.894 1.73 . . . . 0.0 112.224 174.261 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -60.74 -59.18 10.64 Favored Glycine 0 CA--C 1.526 0.736 0 C-N-CA 120.124 -1.036 . . . . 0.0 112.444 176.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 4.5 tp -66.91 -26.57 66.93 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.467 0.707 . . . . 0.0 111.912 -176.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.728 ' HD2' HD11 ' A' ' 51' ' ' LEU . 2.9 m-85 -70.7 -46.67 62.69 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 175.615 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.655 ' HA ' HG12 ' A' ' 23' ' ' VAL . . . -62.66 -32.96 74.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.738 0.78 . . . . 0.0 109.115 179.198 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 9.2 mmmt -63.49 -62.77 1.45 Allowed 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 114.34 -1.3 . . . . 0.0 111.666 172.493 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -75.62 -31.68 59.99 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 113.709 1.003 . . . . 0.0 113.709 -167.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.728 HD11 ' HD2' ' A' ' 47' ' ' PHE . 13.1 mt -70.96 7.41 1.18 Allowed 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 112.843 0.683 . . . . 0.0 112.843 -174.136 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -101.88 5.26 40.88 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.49 0.662 . . . . 0.0 109.821 171.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 25.8 t30 -139.52 -52.8 0.54 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.421 -178.117 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 4.3 m -82.2 175.08 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.012 -179.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -113.69 165.31 12.66 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.253 176.511 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.804 HD11 HD22 ' A' ' 14' ' ' LEU . 3.9 tp -62.03 -25.18 36.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 120.838 0.352 . . . . 0.0 110.638 179.296 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -70.46 -14.95 72.53 Favored Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.816 -0.707 . . . . 0.0 111.548 177.048 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 20.4 t -78.04 -20.34 52.59 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-O 121.543 0.687 . . . . 0.0 109.549 179.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.692 ' HB2' HG21 ' B' ' 159' ' ' ILE . 19.8 mt -64.63 -29.63 70.64 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.434 179.515 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.766 HG13 ' HB ' ' B' ' 159' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--N 1.318 -0.768 0 CA-C-N 114.737 -1.12 . . . . 0.0 110.613 179.358 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 103' ' ' TYR . . . . . 0.663 ' HB2' HG11 ' B' ' 142' ' ' VAL . 51.7 m-85 . . . . . 0 C--O 1.239 0.501 0 CA-C-O 121.102 0.477 . . . . 0.0 110.275 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 104' ' ' VAL . . . . . 0.585 ' O ' HD22 ' B' ' 108' ' ' LEU . 61.2 t -46.61 -47.21 7.44 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.534 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.088 174.798 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 105' ' ' ALA . . . . . 0.608 ' CB ' ' HB3' ' A' ' 14' ' ' LEU . . . -67.0 -38.1 85.38 Favored 'General case' 0 N--CA 1.443 -0.81 0 CA-C-N 114.826 -1.079 . . . . 0.0 111.425 -173.776 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 106' ' ' SER . . . . . 0.833 ' HB2' HG23 ' B' ' 123' ' ' ILE . 1.3 m -60.48 -38.83 85.54 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 121.815 0.817 . . . . 0.0 109.251 176.167 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 107' ' ' TYR . . . . . 0.799 ' HD2' HG12 ' B' ' 143' ' ' ILE . 32.5 t80 -63.07 -49.11 75.81 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 114.272 -1.331 . . . . 0.0 108.945 179.097 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 108' ' ' LEU . . . . . 0.724 HD12 HG13 ' B' ' 151' ' ' ILE . 0.0 OUTLIER -58.92 -49.2 78.7 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 114.987 -1.006 . . . . 0.0 111.337 179.029 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 109' ' ' LEU . . . . . 0.832 HD12 HD11 ' A' ' 15' ' ' ILE . 0.3 OUTLIER -55.42 -43.16 75.05 Favored 'General case' 0 CA--C 1.506 -0.746 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.613 178.671 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.5 -43.45 90.09 Favored 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 120.496 -0.482 . . . . 0.0 110.819 -178.514 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 111' ' ' ALA . . . . . 0.664 ' HA ' ' O ' ' B' ' 115' ' ' ASN . . . -64.71 -26.23 68.28 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.607 179.174 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 112' ' ' LEU . . . . . 0.853 ' HG ' HG13 ' A' ' 4' ' ' VAL . 3.5 mp -80.39 -38.32 30.52 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.245 -0.889 . . . . 0.0 110.244 174.128 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 113' ' ' GLY . . . . . 0.805 ' HA2' ' HB ' ' A' ' 37' ' ' VAL . . . -68.5 -17.21 70.47 Favored Glycine 0 N--CA 1.449 -0.497 0 CA-C-N 115.263 -0.88 . . . . 0.0 112.348 -176.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 114' ' ' GLY . . . . . . . . . . . . . . . 133.33 3.4 3.45 Favored Glycine 0 N--CA 1.437 -1.299 0 C-N-CA 120.394 -0.908 . . . . 0.0 113.168 176.738 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 115' ' ' ASN . . . . . 0.664 ' O ' ' HA ' ' B' ' 111' ' ' ALA . 47.9 t30 -118.69 86.27 2.51 Favored 'General case' 0 N--CA 1.441 -0.884 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 178.224 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 7.4 m -80.23 31.09 0.27 Allowed 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 122.488 1.137 . . . . 0.0 110.748 -167.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 117' ' ' SER . . . . . 0.528 ' N ' ' HD3' ' B' ' 118' ' ' PRO . 15.6 t -171.0 67.64 0.47 Allowed Pre-proline 0 C--N 1.309 -1.172 0 CA-C-N 113.12 -1.855 . . . . 0.0 107.971 178.248 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 118' ' ' PRO . . . . . 0.607 ' HD2' ' CZ ' ' B' ' 107' ' ' TYR . 31.9 Cg_exo -66.08 166.67 20.17 Favored 'Trans proline' 0 CA--C 1.515 -0.431 0 C-N-CA 125.275 3.983 . . . . 0.0 111.58 -174.72 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 119' ' ' SER . . . . . 0.652 ' O ' HG12 ' B' ' 123' ' ' ILE . 16.4 m -145.59 -178.51 6.13 Favored 'General case' 0 C--N 1.317 -0.809 0 C-N-CA 120.225 -0.59 . . . . 0.0 111.592 178.622 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 120' ' ' ALA . . . . . 0.788 ' HB1' HD13 ' B' ' 139' ' ' LEU . . . -62.68 -45.8 91.12 Favored 'General case' 0 CA--C 1.508 -0.639 0 CA-C-O 122.036 0.922 . . . . 0.0 110.173 -163.888 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 121' ' ' LYS . . . . . 0.415 ' HD2' ' N ' ' B' ' 121' ' ' LYS . 12.9 mptt -66.72 -30.39 70.61 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 113.674 -1.603 . . . . 0.0 110.871 178.538 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 122' ' ' ASP . . . . . 0.437 ' O ' ' HB2' ' B' ' 125' ' ' LYS . 18.0 t0 -72.91 -39.09 66.61 Favored 'General case' 0 C--O 1.24 0.58 0 CA-C-O 122.004 0.907 . . . . 0.0 109.025 179.744 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 123' ' ' ILE . . . . . 0.833 HG23 ' HB2' ' B' ' 106' ' ' SER . 39.8 mm -59.93 -42.97 91.18 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.264 0 CA-C-N 114.549 -1.205 . . . . 0.0 109.657 173.236 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 124' ' ' LYS . . . . . 0.817 ' HD3' HD21 ' B' ' 139' ' ' LEU . 3.9 mmmp? -59.17 -42.52 90.97 Favored 'General case' 0 CA--C 1.504 -0.797 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.444 -178.784 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 125' ' ' LYS . . . . . 0.529 ' HD3' ' HA ' ' B' ' 125' ' ' LYS . 30.3 mmtt -50.38 -64.72 0.72 Allowed 'General case' 0 CA--C 1.502 -0.879 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 169.72 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 126' ' ' ILE . . . . . 0.48 HG23 HD12 ' A' ' 31' ' ' LEU . 1.7 mp -53.96 -44.41 61.58 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.857 0 CA-C-N 114.841 -1.072 . . . . 0.0 111.256 -170.217 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 127' ' ' LEU . . . . . 0.63 ' HG ' ' O ' ' B' ' 123' ' ' ILE . 3.6 pp -80.31 -24.74 39.74 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 -177.387 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 128' ' ' ASP . . . . . 0.434 ' N ' HD12 ' B' ' 127' ' ' LEU . 34.6 t70 -71.39 -27.51 63.37 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.584 -0.525 . . . . 0.0 109.584 178.831 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 129' ' ' SER . . . . . . . . . . . . . 17.4 t -60.92 -27.73 68.41 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.602 177.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 130' ' ' VAL . . . . . 0.46 HG23 HG13 ' B' ' 132' ' ' ILE . 3.7 m -107.38 -13.42 10.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 C-N-CA 120.813 -0.355 . . . . 0.0 111.483 177.521 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 131' ' ' GLY . . . . . . . . . . . . . . . 85.15 49.16 4.57 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 121.149 -0.548 . . . . 0.0 112.389 177.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 132' ' ' ILE . . . . . 0.632 HG23 ' HB2' ' A' ' 19' ' ' ASP . 11.5 mt -105.5 138.89 28.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-O 120.462 0.172 . . . . 0.0 111.078 -179.321 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 133' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -69.65 127.31 32.51 Favored 'General case' 0 CA--C 1.513 -0.456 0 CA-C-O 121.47 0.652 . . . . 0.0 111.478 -176.226 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 134' ' ' ALA . . . . . 0.513 ' HA ' ' OH ' ' B' ' 103' ' ' TYR . . . -136.21 141.04 43.96 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.15 -0.932 . . . . 0.0 111.473 -177.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 135' ' ' ASP . . . . . 0.815 ' HB2' ' HG3' ' B' ' 138' ' ' ARG . 49.3 m-20 -103.56 132.77 49.53 Favored 'General case' 0 C--O 1.25 1.094 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.024 172.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 136' ' ' ASP . . . . . 0.996 ' HA ' HD11 ' B' ' 139' ' ' LEU . 32.5 t70 -71.26 -7.92 50.2 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 115.095 -0.957 . . . . 0.0 111.236 -168.271 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 137' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -101.27 -30.16 11.67 Favored 'General case' 0 N--CA 1.438 -1.069 0 C-N-CA 120.017 -0.673 . . . . 0.0 110.653 174.555 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 138' ' ' ARG . . . . . 0.815 ' HG3' ' HB2' ' B' ' 135' ' ' ASP . 20.9 mmt180 -65.31 -45.92 82.43 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.793 0.806 . . . . 0.0 109.513 -176.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 139' ' ' LEU . . . . . 0.996 HD11 ' HA ' ' B' ' 136' ' ' ASP . 0.3 OUTLIER -74.2 -37.77 63.79 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 114.933 -1.03 . . . . 0.0 111.001 178.928 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 140' ' ' ASN . . . . . 0.665 ' H ' HD12 ' B' ' 139' ' ' LEU . 57.0 t30 -61.49 -31.25 71.23 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.687 0.756 . . . . 0.0 109.148 -179.773 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 141' ' ' LYS . . . . . 0.44 ' O ' ' HD3' ' B' ' 141' ' ' LYS . 4.3 tppt? -76.4 -50.06 15.14 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 114.585 -1.189 . . . . 0.0 110.43 179.279 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 142' ' ' VAL . . . . . 0.663 HG11 ' HB2' ' B' ' 103' ' ' TYR . 12.6 p -56.0 -44.48 78.51 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.581 0 C-N-CA 120.359 -0.537 . . . . 0.0 109.814 -179.716 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 143' ' ' ILE . . . . . 0.799 HG12 ' HD2' ' B' ' 107' ' ' TYR . 38.7 mt -58.55 -46.21 90.05 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 C-N-CA 124.163 0.985 . . . . 0.0 112.498 172.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 144' ' ' SER . . . . . . . . . . . . . 47.1 t -54.19 -33.68 58.73 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.927 176.744 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 145' ' ' GLU . . . . . 0.431 ' HG2' ' O ' ' B' ' 141' ' ' LYS . 6.9 mm-40 -83.98 -42.31 16.37 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 121.498 0.666 . . . . 0.0 110.63 178.029 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 146' ' ' LEU . . . . . 0.532 ' HB3' ' CZ ' ' B' ' 107' ' ' TYR . 2.2 mm? -62.7 -38.81 91.89 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 114.977 -1.01 . . . . 0.0 112.345 179.817 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 147' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -54.16 120.03 5.91 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.124 -172.212 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . 99.4 40.33 3.24 Favored Glycine 0 N--CA 1.445 -0.703 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.549 -176.307 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 149' ' ' LYS . . . . . 0.482 ' HB2' ' O ' ' B' ' 146' ' ' LEU . 0.1 OUTLIER -134.79 168.56 18.83 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 -179.964 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 150' ' ' ASN . . . . . 0.588 ' O ' HG23 ' B' ' 154' ' ' VAL . 31.9 m-20 -106.82 90.57 3.36 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 107.702 -1.222 . . . . 0.0 107.702 179.068 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 151' ' ' ILE . . . . . 0.724 HG13 HD12 ' B' ' 108' ' ' LEU . 1.8 mp -41.69 -64.17 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 N-CA-C 113.571 0.952 . . . . 0.0 113.571 -168.089 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 152' ' ' GLU . . . . . 0.7 ' HG3' HD11 ' B' ' 112' ' ' LEU . 3.4 mp0 -57.31 -42.92 82.72 Favored 'General case' 0 C--O 1.209 -1.03 0 C-N-CA 120.93 -0.308 . . . . 0.0 111.365 -175.301 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 153' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -66.94 -29.57 69.47 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 120.548 0.214 . . . . 0.0 111.363 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 154' ' ' VAL . . . . . 0.818 ' HB ' HD12 ' B' ' 155' ' ' ILE . 61.8 t -61.15 -51.07 77.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 171.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 155' ' ' ILE . . . . . 0.818 HD12 ' HB ' ' B' ' 154' ' ' VAL . 1.6 mp -104.66 36.19 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-O 121.979 0.895 . . . . 0.0 110.368 -177.718 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . -100.96 0.42 38.24 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 107.246 -1.391 . . . . 0.0 107.246 169.168 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 157' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -137.36 -34.83 0.69 Allowed 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 113.043 -1.889 . . . . 0.0 109.357 173.346 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 158' ' ' GLY . . . . . . . . . . . . . . . -98.36 47.44 1.46 Allowed Glycine 0 CA--C 1.521 0.468 0 CA-C-N 115.548 -0.751 . . . . 0.0 114.357 -172.444 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 159' ' ' ILE . . . . . 0.766 ' HB ' HG13 ' A' ' 60' ' ' ILE . 1.8 mp -59.52 -18.0 13.76 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 CA-C-O 121.244 0.545 . . . . 0.0 111.045 176.213 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 160' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.584 0 N-CA-C 111.384 -0.686 . . . . 0.0 111.384 -178.664 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.7 p . . . . . 0 N--CA 1.446 -0.629 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.681 HG13 ' HG ' ' B' ' 112' ' ' LEU . 2.2 t -53.6 -27.2 14.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 115.191 -0.913 . . . . 0.0 112.238 -175.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . 0.778 ' HB3' ' HA ' ' A' ' 39' ' ' VAL . 2.1 m -67.46 -52.68 36.52 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 122.204 1.002 . . . . 0.0 108.468 176.068 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.522 ' O ' HG13 ' A' ' 10' ' ' ILE . 33.9 tt0 -55.83 -52.84 62.61 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-N 113.985 -1.461 . . . . 0.0 110.171 177.205 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.89 HD12 HD12 ' A' ' 10' ' ' ILE . 4.4 tp -59.46 -34.97 73.2 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.091 -0.958 . . . . 0.0 111.758 179.178 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.647 ' HB2' HD23 ' B' ' 112' ' ' LEU . . . -69.85 -33.25 72.02 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-O 121.011 0.434 . . . . 0.0 110.847 179.252 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.594 ' HB2' HG11 ' A' ' 39' ' ' VAL . 7.5 t -70.88 -37.43 73.02 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 177.38 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.89 HD12 HD12 ' A' ' 7' ' ' LEU . 74.2 mt -51.67 -55.53 8.6 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.887 0 CA-C-N 114.168 -1.378 . . . . 0.0 109.824 170.682 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.729 ' HB2' HD13 ' B' ' 109' ' ' LEU . 23.4 m-85 -67.04 -41.0 87.29 Favored 'General case' 0 C--O 1.22 -0.479 0 CA-C-N 115.615 -0.721 . . . . 0.0 111.596 -173.741 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.453 ' O ' ' HB2' ' A' ' 16' ' ' LEU . 2.5 p -57.43 -41.45 80.47 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 176.612 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.04 -33.43 75.42 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.895 172.471 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.789 HD22 HD11 ' A' ' 56' ' ' ILE . 0.3 OUTLIER -64.87 -57.99 7.36 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.488 -179.612 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -54.82 -47.34 74.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 177.277 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.706 HD12 HG13 ' A' ' 21' ' ' VAL . 6.2 tp -53.19 -41.47 65.3 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.928 178.65 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 26.3 t60 -78.89 -13.68 59.66 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.178 -0.919 . . . . 0.0 112.065 -178.605 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -70.62 -47.99 57.32 Favored 'General case' 0 N--CA 1.467 0.389 0 O-C-N 121.895 -0.503 . . . . 0.0 110.051 176.558 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.772 ' HB2' HG23 ' B' ' 132' ' ' ILE . 28.7 t70 -91.31 -11.19 38.74 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.938 0.875 . . . . 0.0 109.575 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 55.61 52.43 11.06 Favored 'General case' 0 CA--C 1.509 -0.604 0 CA-C-N 113.641 -1.618 . . . . 0.0 110.125 -176.813 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.706 HG13 HD12 ' A' ' 16' ' ' LEU . 2.9 p -100.03 152.64 4.69 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.739 0 CA-C-N 113.581 -1.645 . . . . 0.0 109.073 -176.072 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.476 ' O ' ' HG2' ' A' ' 27' ' ' LYS . 30.6 p -34.96 127.97 0.5 Allowed 'General case' 0 C--N 1.317 -0.808 0 O-C-N 124.672 1.232 . . . . 0.0 114.077 -174.064 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.551 HG12 ' HA ' ' A' ' 48' ' ' ALA . 51.2 t -100.55 106.03 18.65 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.927 0 CA-C-N 114.376 -1.283 . . . . 0.0 110.473 -176.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.44 ' OG1' ' HB2' ' A' ' 27' ' ' LYS . 80.6 p -141.05 153.77 45.65 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.769 -179.169 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -51.42 -46.49 62.96 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.12 0.486 . . . . 0.0 110.773 179.633 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -58.26 -38.38 76.82 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.382 -0.826 . . . . 0.0 111.356 177.482 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.483 ' HG2' HD11 ' A' ' 16' ' ' LEU . 4.3 tppt? -64.48 -50.03 69.07 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-O 121.965 0.888 . . . . 0.0 109.285 -178.229 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 80.8 mt -61.7 -38.96 81.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 114.393 -1.276 . . . . 0.0 110.458 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.682 ' HA ' HD12 ' A' ' 32' ' ' ILE . 30.7 m-80 -68.41 -30.0 68.8 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.862 176.436 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -65.98 -38.91 89.73 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.562 -0.29 . . . . 0.0 110.397 176.21 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.617 ' HB3' HD21 ' B' ' 109' ' ' LEU . 1.2 mm? -65.17 -45.79 83.49 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 120.646 -0.422 . . . . 0.0 110.106 171.747 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.682 HD12 ' HA ' ' A' ' 29' ' ' ASN . 57.8 mt -49.23 -50.0 16.22 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 CA-C-N 115.294 -0.867 . . . . 0.0 111.361 177.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 23.0 tptp -71.89 -37.7 70.1 Favored 'General case' 0 N--CA 1.435 -1.177 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.624 -179.384 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.673 ' HB1' ' HA ' ' B' ' 126' ' ' ILE . . . -59.26 -41.97 90.08 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.001 0.429 . . . . 0.0 111.451 179.526 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.477 ' CB ' ' HG ' ' B' ' 109' ' ' LEU . . . -84.61 -33.19 23.38 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.254 179.756 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 96.29 19.23 28.67 Favored Glycine 0 N--CA 1.447 -0.569 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.765 -179.041 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.814 ' HB ' ' HA2' ' B' ' 113' ' ' GLY . 2.9 p -121.6 117.73 53.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 121.981 0.896 . . . . 0.0 111.204 -177.079 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.431 ' HA ' HG23 ' A' ' 32' ' ' ILE . 57.8 t30 -88.51 157.06 18.75 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 113.966 -1.47 . . . . 0.0 110.726 -172.051 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.778 ' HA ' ' HB3' ' A' ' 5' ' ' SER . 97.3 t -126.91 161.38 33.82 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.002 0 CA-C-N 114.878 -1.056 . . . . 0.0 110.381 -173.257 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.536 ' HB3' ' HD1' ' A' ' 43' ' ' TRP . 7.5 tp10 -68.54 106.45 1.38 Allowed Pre-proline 0 N--CA 1.439 -1.012 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 170.151 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.46 ' C ' ' HD2' ' A' ' 44' ' ' PRO . 83.0 Cg_exo -50.22 -31.06 27.78 Favored 'Trans proline' 0 C--O 1.252 1.179 0 C-N-CA 123.698 2.932 . . . . 0.0 115.478 -163.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.448 ' HD2' ' HG3' ' A' ' 40' ' ' GLU . 0.8 OUTLIER -59.93 -26.8 66.23 Favored 'General case' 0 C--N 1.334 -0.107 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 178.456 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . 0.536 ' HD1' ' HB3' ' A' ' 40' ' ' GLU . 11.2 m95 -65.02 -61.67 5.9 Favored Pre-proline 0 C--O 1.207 -1.138 0 CA-C-O 118.423 -0.799 . . . . 0.0 110.723 176.313 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.468 ' HD3' ' HB2' ' A' ' 43' ' ' TRP . 85.5 Cg_exo -43.92 -45.04 11.73 Favored 'Trans proline' 0 C--N 1.358 1.069 0 C-N-CA 121.837 1.691 . . . . 0.0 112.242 174.747 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -60.55 -60.36 8.65 Favored Glycine 0 CA--C 1.526 0.757 0 C-N-CA 120.088 -1.054 . . . . 0.0 112.315 176.598 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.401 ' O ' ' HB2' ' A' ' 49' ' ' LYS . 10.2 tp -64.29 -24.02 67.51 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 123.069 0.547 . . . . 0.0 111.988 -177.527 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.554 ' HD2' HD11 ' A' ' 51' ' ' LEU . 2.7 m-85 -73.66 -43.91 58.16 Favored 'General case' 0 C--N 1.315 -0.899 0 C-N-CA 122.296 0.238 . . . . 0.0 110.375 177.511 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.551 ' HA ' HG12 ' A' ' 23' ' ' VAL . . . -64.81 -32.13 73.68 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 176.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.401 ' HB2' ' O ' ' A' ' 46' ' ' LEU . 9.5 mmmt -65.29 -51.56 59.89 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 114.247 -1.342 . . . . 0.0 111.815 173.243 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.453 ' O ' HG22 ' A' ' 54' ' ' VAL . . . -80.03 -40.72 27.19 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 113.187 0.81 . . . . 0.0 113.187 -170.069 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.554 HD11 ' HD2' ' A' ' 47' ' ' PHE . 8.7 mt -66.9 0.77 2.25 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 -172.099 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -88.16 -17.92 29.88 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.883 0.373 . . . . 0.0 110.607 174.484 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 91.4 m-20 -130.69 -38.26 1.31 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.823 -175.225 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.453 HG22 ' O ' ' A' ' 50' ' ' ALA . 4.6 m -85.39 -176.62 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 121.022 0.439 . . . . 0.0 110.141 -179.833 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 23.1 t-20 -119.41 168.39 11.0 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.76 -0.654 . . . . 0.0 109.585 176.776 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.789 HD11 HD22 ' A' ' 14' ' ' LEU . 3.2 tp -66.29 -27.94 42.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-O 121.058 0.456 . . . . 0.0 109.934 178.406 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -72.25 -14.81 76.78 Favored Glycine 0 N--CA 1.446 -0.666 0 N-CA-C 111.05 -0.82 . . . . 0.0 111.05 175.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 20.3 m -78.68 -21.31 48.42 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-O 121.229 0.537 . . . . 0.0 109.849 179.07 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.599 ' HB2' HG21 ' B' ' 159' ' ' ILE . 30.0 mt -60.78 -36.41 78.91 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.617 -179.736 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.701 HG13 ' HB ' ' B' ' 159' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--N 1.322 -0.617 0 CA-C-N 115.041 -0.981 . . . . 0.0 110.829 179.131 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 103' ' ' TYR . . . . . 0.922 ' HB2' HG11 ' B' ' 142' ' ' VAL . 69.4 m-85 . . . . . 0 N--CA 1.468 0.441 0 CA-C-O 120.705 0.288 . . . . 0.0 111.688 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 104' ' ' VAL . . . . . 0.711 ' HA ' HD11 ' B' ' 146' ' ' LEU . 4.1 m -45.03 -45.43 2.97 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.221 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.161 171.765 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 105' ' ' ALA . . . . . 0.561 ' CB ' ' HB3' ' A' ' 14' ' ' LEU . . . -64.31 -30.25 71.31 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 115.291 -0.868 . . . . 0.0 111.289 -174.051 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 106' ' ' SER . . . . . 0.814 ' HB2' HG23 ' B' ' 123' ' ' ILE . 1.4 m -76.53 -36.39 57.74 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.796 0.808 . . . . 0.0 108.971 -178.529 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 107' ' ' TYR . . . . . 0.678 ' CG ' HD12 ' B' ' 146' ' ' LEU . 36.5 t80 -63.96 -46.02 86.51 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 114.139 -1.391 . . . . 0.0 108.336 176.883 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 108' ' ' LEU . . . . . 0.844 HD12 HG13 ' B' ' 151' ' ' ILE . 0.0 OUTLIER -58.62 -45.93 88.13 Favored 'General case' 0 N--CA 1.443 -0.801 0 CA-C-N 114.393 -1.276 . . . . 0.0 110.792 177.072 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 109' ' ' LEU . . . . . 0.729 HD13 ' HB2' ' A' ' 11' ' ' TYR . 8.6 tp -55.65 -50.96 68.83 Favored 'General case' 0 CA--C 1.514 -0.426 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.893 178.445 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 110' ' ' ALA . . . . . 0.469 ' HB3' ' HB3' ' B' ' 118' ' ' PRO . . . -63.18 -40.58 97.94 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.24 -176.135 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 111' ' ' ALA . . . . . 0.664 ' HA ' ' O ' ' B' ' 115' ' ' ASN . . . -64.61 -33.98 77.19 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.559 178.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 112' ' ' LEU . . . . . 0.757 HD11 ' HG3' ' B' ' 152' ' ' GLU . 5.5 mp -71.47 -38.23 71.27 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.053 173.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 113' ' ' GLY . . . . . 0.814 ' HA2' ' HB ' ' A' ' 37' ' ' VAL . . . -61.87 -23.53 63.56 Favored Glycine 0 N--CA 1.446 -0.643 0 CA-C-N 115.198 -0.91 . . . . 0.0 111.843 179.548 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 114' ' ' GLY . . . . . . . . . . . . . . . 133.48 4.66 3.11 Favored Glycine 0 N--CA 1.436 -1.344 0 C-N-CA 120.569 -0.824 . . . . 0.0 112.876 177.496 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 115' ' ' ASN . . . . . 0.664 ' O ' ' HA ' ' B' ' 111' ' ' ALA . 47.2 t30 -116.94 91.15 3.5 Favored 'General case' 0 N--CA 1.439 -0.988 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 -179.533 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -76.96 25.61 0.15 Allowed 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 122.211 1.005 . . . . 0.0 110.787 -167.815 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 117' ' ' SER . . . . . 0.538 ' N ' ' HD3' ' B' ' 118' ' ' PRO . 35.2 t -169.83 68.12 0.59 Allowed Pre-proline 0 C--N 1.311 -1.102 0 CA-C-N 113.648 -1.614 . . . . 0.0 108.809 -178.198 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 118' ' ' PRO . . . . . 0.661 ' HG2' ' O ' ' B' ' 107' ' ' TYR . 26.7 Cg_exo -67.71 154.15 74.03 Favored 'Trans proline' 0 C--N 1.327 -0.583 0 C-N-CA 125.066 3.844 . . . . 0.0 111.572 -176.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 119' ' ' SER . . . . . 0.596 ' O ' HG12 ' B' ' 123' ' ' ILE . 92.0 p -121.73 -178.58 3.86 Favored 'General case' 0 C--N 1.315 -0.892 0 C-N-CA 120.104 -0.639 . . . . 0.0 110.958 178.327 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 120' ' ' ALA . . . . . 0.807 ' HB1' HD13 ' B' ' 139' ' ' LEU . . . -64.95 -38.74 91.97 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-O 121.886 0.851 . . . . 0.0 109.366 -172.061 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 121' ' ' LYS . . . . . 0.493 ' HD2' ' N ' ' B' ' 121' ' ' LYS . 4.7 mptp? -64.83 -31.96 73.43 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 113.952 -1.476 . . . . 0.0 110.912 176.718 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 122' ' ' ASP . . . . . 0.811 ' HA ' ' HE3' ' B' ' 125' ' ' LYS . 19.2 m-20 -72.61 -43.6 63.09 Favored 'General case' 0 CA--C 1.515 -0.377 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 176.282 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 123' ' ' ILE . . . . . 0.814 HG23 ' HB2' ' B' ' 106' ' ' SER . 33.8 mm -55.38 -50.36 66.01 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.421 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 175.798 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 124' ' ' LYS . . . . . 0.5 ' HD3' HD11 ' B' ' 127' ' ' LEU . 4.0 tppp? -61.21 -35.92 78.51 Favored 'General case' 0 N--CA 1.443 -0.788 0 CA-C-N 114.38 -1.282 . . . . 0.0 109.486 -177.628 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 125' ' ' LYS . . . . . 0.811 ' HE3' ' HA ' ' B' ' 122' ' ' ASP . 0.0 OUTLIER -72.44 -44.14 62.81 Favored 'General case' 0 N--CA 1.432 -1.359 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.931 -177.328 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 126' ' ' ILE . . . . . 0.702 HD12 ' HD2' ' B' ' 125' ' ' LYS . 1.4 mp -54.93 -51.81 49.51 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 CA-C-N 116.539 -0.301 . . . . 0.0 110.726 173.745 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 127' ' ' LEU . . . . . 0.945 ' HB2' ' HB ' ' B' ' 132' ' ' ILE . 3.1 pp -77.14 -25.97 52.6 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.614 -0.435 . . . . 0.0 111.788 -175.704 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 128' ' ' ASP . . . . . 0.474 ' HB2' ' O ' ' B' ' 124' ' ' LYS . 19.5 t70 -67.18 -33.5 75.54 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 110.024 -0.362 . . . . 0.0 110.024 177.606 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 129' ' ' SER . . . . . 0.445 ' CB ' ' HB2' ' A' ' 34' ' ' ALA . 22.7 t -51.97 -43.06 63.37 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.351 176.619 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 130' ' ' VAL . . . . . 0.6 HG23 HG13 ' B' ' 132' ' ' ILE . 5.0 m -100.76 -6.34 9.13 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 N-CA-C 112.242 0.46 . . . . 0.0 112.242 -179.589 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 131' ' ' GLY . . . . . . . . . . . . . . . 83.22 46.55 6.12 Favored Glycine 0 CA--C 1.518 0.257 0 C-N-CA 120.941 -0.647 . . . . 0.0 113.112 177.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 132' ' ' ILE . . . . . 0.945 ' HB ' ' HB2' ' B' ' 127' ' ' LEU . 14.9 mt -95.35 134.53 32.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 120.671 0.272 . . . . 0.0 110.46 176.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 133' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -79.98 131.73 35.87 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.895 0.379 . . . . 0.0 111.114 -178.047 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 134' ' ' ALA . . . . . . . . . . . . . . . -145.29 154.14 42.03 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.493 -175.544 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 135' ' ' ASP . . . . . 0.747 ' HB2' ' CG ' ' B' ' 138' ' ' ARG . 18.1 m-20 -102.11 135.17 44.15 Favored 'General case' 0 C--O 1.252 1.19 0 CA-C-O 121.124 0.488 . . . . 0.0 109.736 172.241 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 136' ' ' ASP . . . . . 0.915 ' HA ' HD11 ' B' ' 139' ' ' LEU . 10.4 t70 -73.28 -11.61 60.56 Favored 'General case' 0 CA--C 1.514 -0.426 0 CA-C-N 115.14 -0.936 . . . . 0.0 110.995 -166.649 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 137' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -96.79 -30.06 13.39 Favored 'General case' 0 N--CA 1.438 -1.062 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.723 175.334 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 138' ' ' ARG . . . . . 0.747 ' CG ' ' HB2' ' B' ' 135' ' ' ASP . 17.5 mmt180 -66.81 -46.26 75.75 Favored 'General case' 0 CA--C 1.504 -0.79 0 CA-C-O 121.977 0.894 . . . . 0.0 109.224 -175.624 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 139' ' ' LEU . . . . . 0.915 HD11 ' HA ' ' B' ' 136' ' ' ASP . 0.3 OUTLIER -72.46 -36.68 68.55 Favored 'General case' 0 C--O 1.209 -1.072 0 CA-C-N 114.607 -1.179 . . . . 0.0 111.148 179.03 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 140' ' ' ASN . . . . . 0.597 ' O ' ' HB ' ' B' ' 143' ' ' ILE . 9.7 t30 -64.27 -26.92 68.71 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.925 0.869 . . . . 0.0 109.565 177.75 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 141' ' ' LYS . . . . . . . . . . . . . 44.4 tttt -69.93 -51.63 31.25 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 114.391 -1.277 . . . . 0.0 109.354 177.226 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 142' ' ' VAL . . . . . 0.922 HG11 ' HB2' ' B' ' 103' ' ' TYR . 8.6 p -62.55 -32.12 54.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.889 177.853 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 143' ' ' ILE . . . . . 0.86 HG12 ' O ' ' B' ' 139' ' ' LEU . 34.6 mm -50.47 -66.62 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.513 -0.455 0 CA-C-O 121.082 0.467 . . . . 0.0 110.439 170.388 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 144' ' ' SER . . . . . . . . . . . . . 70.6 p -54.41 -31.56 55.34 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.188 -0.915 . . . . 0.0 111.838 -178.669 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 145' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -74.97 -37.07 62.02 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 112.072 0.397 . . . . 0.0 112.072 179.254 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 146' ' ' LEU . . . . . 0.711 HD11 ' HA ' ' B' ' 104' ' ' VAL . 6.9 mt -86.98 -19.53 28.59 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.813 -0.355 . . . . 0.0 110.712 -178.325 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 147' ' ' ASN . . . . . 0.409 ' HA ' ' OH ' ' B' ' 107' ' ' TYR . 26.3 t-20 -54.31 117.96 3.71 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.041 -176.335 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . 96.9 36.25 5.07 Favored Glycine 0 N--CA 1.448 -0.52 0 CA-C-N 115.544 -0.753 . . . . 0.0 112.275 -178.297 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 149' ' ' LYS . . . . . 0.478 ' HB2' ' O ' ' B' ' 146' ' ' LEU . 0.3 OUTLIER -130.08 165.28 22.57 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.837 0.351 . . . . 0.0 110.601 179.842 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 150' ' ' ASN . . . . . 0.515 ' O ' HG23 ' B' ' 154' ' ' VAL . 85.3 m-20 -104.28 88.84 3.08 Favored 'General case' 0 CA--C 1.513 -0.468 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 177.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 151' ' ' ILE . . . . . 0.844 HG13 HD12 ' B' ' 108' ' ' LEU . 1.8 mp -39.26 -64.52 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 113.845 1.054 . . . . 0.0 113.845 -169.806 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 152' ' ' GLU . . . . . 0.757 ' HG3' HD11 ' B' ' 112' ' ' LEU . 3.1 mp0 -57.97 -35.38 71.09 Favored 'General case' 0 C--O 1.216 -0.66 0 O-C-N 122.355 -0.216 . . . . 0.0 111.263 -174.268 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 153' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -71.28 -37.98 71.84 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.855 177.784 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 154' ' ' VAL . . . . . 0.81 ' HB ' HD12 ' B' ' 155' ' ' ILE . 62.0 t -53.47 -47.97 58.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 121.49 0.662 . . . . 0.0 109.321 173.76 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 155' ' ' ILE . . . . . 0.81 HD12 ' HB ' ' B' ' 154' ' ' VAL . 1.6 mp -107.51 35.73 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-O 121.929 0.871 . . . . 0.0 110.804 -178.613 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 156' ' ' ALA . . . . . 0.454 ' HB2' ' O ' ' B' ' 152' ' ' GLU . . . -100.85 1.9 40.51 Favored 'General case' 0 C--N 1.311 -1.096 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 169.062 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 157' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 -142.05 16.08 2.09 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 113.946 -1.479 . . . . 0.0 110.515 177.378 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 158' ' ' GLY . . . . . . . . . . . . . . . -159.5 45.54 0.44 Allowed Glycine 0 C--N 1.338 0.69 0 C-N-CA 119.507 -1.33 . . . . 0.0 115.204 -172.64 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 159' ' ' ILE . . . . . 0.701 ' HB ' HG13 ' A' ' 60' ' ' ILE . 1.8 mp -58.57 -25.88 29.48 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 C-N-CA 122.959 0.504 . . . . 0.0 111.736 176.638 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 160' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.51 0 C-N-CA 120.048 -1.072 . . . . 0.0 112.993 -178.321 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 11.4 m . . . . . 0 N--CA 1.441 -0.904 0 N-CA-C 107.783 -1.191 . . . . 0.0 107.783 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.867 HG13 ' HG ' ' B' ' 112' ' ' LEU . 2.1 t -51.85 -24.58 4.85 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-N 114.947 -1.024 . . . . 0.0 112.17 -178.63 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . 0.723 ' HB3' ' HA ' ' A' ' 39' ' ' VAL . 8.5 m -69.65 -51.86 31.04 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 176.219 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.509 ' O ' HG13 ' A' ' 10' ' ' ILE . 30.6 mt-10 -58.85 -52.15 66.97 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 115.008 -0.996 . . . . 0.0 109.796 178.239 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.853 HD12 HD12 ' A' ' 10' ' ' ILE . 3.2 tp -57.83 -36.85 72.84 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 115.317 -0.856 . . . . 0.0 112.097 178.279 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.632 ' HB2' HD23 ' B' ' 112' ' ' LEU . . . -67.09 -35.47 79.88 Favored 'General case' 0 CA--C 1.516 -0.361 0 CA-C-O 120.957 0.408 . . . . 0.0 110.855 178.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.526 ' HB2' HG11 ' A' ' 39' ' ' VAL . 5.6 t -69.7 -41.09 75.85 Favored 'General case' 0 C--O 1.242 0.672 0 N-CA-C 108.188 -1.042 . . . . 0.0 108.188 178.467 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.853 HD12 HD12 ' A' ' 7' ' ' LEU . 68.0 mt -47.14 -54.1 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.671 0 CA-C-N 114.214 -1.357 . . . . 0.0 109.627 170.532 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.882 ' HB2' HD13 ' B' ' 109' ' ' LEU . 23.4 m-85 -66.32 -39.48 89.29 Favored 'General case' 0 C--O 1.219 -0.511 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.877 -174.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.563 ' HB2' HD23 ' A' ' 31' ' ' LEU . 79.4 p -56.78 -44.79 82.22 Favored 'General case' 0 C--O 1.243 0.739 0 CA-C-O 121.475 0.655 . . . . 0.0 109.383 179.148 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.532 ' HB1' ' HG ' ' A' ' 51' ' ' LEU . . . -63.2 -34.32 77.38 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 115.09 -0.959 . . . . 0.0 110.42 173.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.66 HD22 HD11 ' A' ' 56' ' ' ILE . 0.2 OUTLIER -61.36 -55.49 31.05 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.456 179.342 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.479 HG12 ' O ' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -55.27 -41.5 61.59 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 178.322 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.672 HD21 ' HA ' ' A' ' 23' ' ' VAL . 2.3 tp -55.46 -38.64 69.33 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.31 176.212 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . 0.468 ' CD2' ' HB ' ' A' ' 56' ' ' ILE . 93.8 m-70 -73.77 -14.28 61.09 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 176.228 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -68.96 -44.4 73.05 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.911 0.386 . . . . 0.0 110.281 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.736 ' HB2' HG23 ' B' ' 132' ' ' ILE . 37.7 t70 -97.92 -6.99 31.11 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.835 0.826 . . . . 0.0 109.178 177.639 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 53.32 52.57 13.27 Favored 'General case' 0 CA--C 1.516 -0.359 0 CA-C-N 113.803 -1.544 . . . . 0.0 109.976 -177.034 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.43 HG13 HD12 ' A' ' 16' ' ' LEU . 7.3 p -106.62 163.97 4.73 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 CA-C-N 114.319 -1.31 . . . . 0.0 109.365 -174.051 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 18.6 p -48.32 142.01 5.98 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 113.312 0.856 . . . . 0.0 113.312 -174.719 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.672 ' HA ' HD21 ' A' ' 16' ' ' LEU . 58.3 t -107.27 114.29 45.79 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 CA-C-N 114.305 -1.316 . . . . 0.0 110.769 -175.471 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.502 ' OG1' ' HD2' ' A' ' 27' ' ' LYS . 22.1 p -136.69 159.57 41.44 Favored 'General case' 0 C--O 1.245 0.848 0 CA-C-O 120.925 0.393 . . . . 0.0 110.511 176.346 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -56.57 -34.14 66.83 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.596 176.106 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -68.79 -31.95 71.33 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.17 177.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.606 ' HG2' HD11 ' A' ' 16' ' ' LEU . 0.3 OUTLIER -62.67 -58.1 8.69 Favored 'General case' 0 CA--C 1.512 -0.505 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 175.043 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.511 HG23 ' OG ' ' A' ' 12' ' ' SER . 37.0 mt -56.51 -40.95 71.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 114.184 -1.371 . . . . 0.0 110.999 -178.348 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 41.1 t-20 -59.37 -45.53 91.16 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.934 -0.575 . . . . 0.0 109.955 177.272 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -59.31 -47.79 84.06 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.405 179.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.722 ' HB3' HD21 ' B' ' 109' ' ' LEU . 0.9 OUTLIER -57.61 -50.43 73.17 Favored 'General case' 0 C--O 1.239 0.504 0 CA-C-O 121.006 0.431 . . . . 0.0 110.595 177.174 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.593 HG23 ' O ' ' A' ' 37' ' ' VAL . 67.1 mt -47.76 -51.48 7.95 Favored 'Isoleucine or valine' 0 C--O 1.242 0.698 0 CA-C-N 115.067 -0.97 . . . . 0.0 111.267 177.839 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 47.5 mmtm -74.2 -39.49 63.12 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.022 -0.99 . . . . 0.0 111.781 -174.036 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -63.24 -41.39 99.07 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-O 120.783 0.325 . . . . 0.0 110.97 -178.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.504 ' HA ' HD11 ' B' ' 126' ' ' ILE . . . -79.41 -31.8 42.77 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.079 179.784 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 97.38 16.16 35.58 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 121.021 -0.609 . . . . 0.0 111.91 178.316 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.881 ' HB ' ' HA2' ' B' ' 113' ' ' GLY . 2.5 p -119.57 119.99 62.14 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 CA-C-O 121.433 0.635 . . . . 0.0 110.458 -176.694 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.577 ' HA ' HG23 ' A' ' 32' ' ' ILE . 12.8 t30 -96.59 153.71 17.69 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 114.826 -1.079 . . . . 0.0 111.142 -167.673 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.723 ' HA ' ' HB3' ' A' ' 5' ' ' SER . 93.5 t -130.03 158.79 42.49 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.964 0 CA-C-N 114.982 -1.008 . . . . 0.0 109.923 -170.347 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.595 ' HB2' ' CD1' ' A' ' 43' ' ' TRP . 30.6 mt-10 -63.83 112.7 7.9 Favored Pre-proline 0 CA--C 1.487 -1.454 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 170.003 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.447 ' C ' ' HD2' ' A' ' 44' ' ' PRO . 54.4 Cg_exo -55.8 -27.75 63.73 Favored 'Trans proline' 0 C--N 1.312 -1.349 0 C-N-CA 123.042 2.495 . . . . 0.0 113.509 -167.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 1.6 p90 -62.0 -28.95 69.93 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.746 175.03 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . 0.595 ' CD1' ' HB2' ' A' ' 40' ' ' GLU . 9.8 m95 -62.47 -59.35 13.08 Favored Pre-proline 0 C--O 1.204 -1.338 0 CA-C-O 118.374 -0.822 . . . . 0.0 110.32 175.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.459 ' HD2' ' O ' ' A' ' 40' ' ' GLU . 84.8 Cg_exo -44.38 -45.28 12.72 Favored 'Trans proline' 0 C--N 1.36 1.165 0 C-N-CA 121.716 1.61 . . . . 0.0 112.527 172.483 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -60.26 -59.36 10.49 Favored Glycine 0 CA--C 1.529 0.962 0 C-N-CA 120.025 -1.084 . . . . 0.0 112.759 177.367 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 5.4 tp -65.41 -32.03 73.44 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 123.276 0.63 . . . . 0.0 111.791 -177.388 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.499 ' HE1' ' CE3' ' A' ' 43' ' ' TRP . 2.7 m-85 -65.32 -49.02 71.04 Favored 'General case' 0 C--N 1.317 -0.81 0 C-N-CA 122.685 0.394 . . . . 0.0 110.263 176.533 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.418 ' HA ' HG12 ' A' ' 23' ' ' VAL . . . -64.6 -31.11 72.18 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.505 0.669 . . . . 0.0 109.539 -179.757 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.549 ' HD2' ' O ' ' A' ' 49' ' ' LYS . 0.4 OUTLIER -66.82 -35.76 80.81 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 114.883 -1.053 . . . . 0.0 110.622 173.094 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.426 ' C ' HG22 ' A' ' 54' ' ' VAL . . . -85.03 -58.71 2.58 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.809 0.67 . . . . 0.0 112.809 -175.253 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.589 ' HB2' HG11 ' A' ' 23' ' ' VAL . 3.2 mm? -62.0 -11.71 14.95 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 112.746 0.647 . . . . 0.0 112.746 -170.437 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -74.34 -26.41 60.12 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.061 0.457 . . . . 0.0 110.426 175.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 84.1 m-20 -116.4 -39.13 3.41 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.048 -177.284 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.426 HG22 ' C ' ' A' ' 50' ' ' ALA . 4.1 m -98.43 -174.28 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.949 0.404 . . . . 0.0 110.789 -176.435 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 26.9 p-10 -111.71 178.71 4.23 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.334 179.364 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.66 HD11 HD22 ' A' ' 14' ' ' LEU . 4.7 tp -74.57 -25.1 18.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 120.971 0.415 . . . . 0.0 109.992 -179.183 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -70.32 -13.75 70.92 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.435 -0.888 . . . . 0.0 110.937 175.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 32.2 t -77.53 -21.75 52.17 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-O 121.27 0.557 . . . . 0.0 109.677 179.284 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.649 ' HB2' HG21 ' B' ' 159' ' ' ILE . 20.0 mt -64.98 -26.38 68.27 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.565 179.616 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.573 ' CD1' ' HB ' ' B' ' 159' ' ' ILE . 0.1 OUTLIER . . . . . 0 C--N 1.314 -0.936 0 CA-C-N 114.602 -1.181 . . . . 0.0 110.558 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 103' ' ' TYR . . . . . 0.664 ' HB3' HG21 ' B' ' 123' ' ' ILE . 41.5 m-85 . . . . . 0 C--O 1.237 0.425 0 CA-C-O 120.902 0.382 . . . . 0.0 111.234 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 104' ' ' VAL . . . . . 0.603 ' O ' HD22 ' B' ' 108' ' ' LEU . 63.4 t -44.15 -47.06 2.24 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.269 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.973 170.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 105' ' ' ALA . . . . . 0.623 ' CB ' ' HB3' ' A' ' 14' ' ' LEU . . . -65.95 -38.91 89.83 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.008 -0.996 . . . . 0.0 111.593 -173.879 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 106' ' ' SER . . . . . 0.881 ' HB2' HG23 ' B' ' 123' ' ' ILE . 1.4 m -63.75 -36.38 83.69 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-O 121.596 0.712 . . . . 0.0 109.683 177.427 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 107' ' ' TYR . . . . . 0.654 ' CZ ' ' HD2' ' B' ' 118' ' ' PRO . 31.8 t80 -62.93 -51.06 68.39 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 114.509 -1.223 . . . . 0.0 108.665 178.583 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 108' ' ' LEU . . . . . 0.907 HD12 HG13 ' B' ' 151' ' ' ILE . 0.0 OUTLIER -56.96 -45.36 82.92 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 114.652 -1.158 . . . . 0.0 110.971 178.341 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 109' ' ' LEU . . . . . 0.882 HD13 ' HB2' ' A' ' 11' ' ' TYR . 7.7 tp -56.41 -47.49 78.93 Favored 'General case' 0 CA--C 1.51 -0.574 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.033 179.099 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 110' ' ' ALA . . . . . 0.562 ' HB3' ' HB3' ' B' ' 118' ' ' PRO . . . -65.73 -38.98 90.63 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-O 120.998 0.428 . . . . 0.0 111.155 -177.358 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 111' ' ' ALA . . . . . 0.658 ' HA ' ' O ' ' B' ' 115' ' ' ASN . . . -69.01 -23.74 64.12 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.637 178.733 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 112' ' ' LEU . . . . . 0.867 ' HG ' HG13 ' A' ' 4' ' ' VAL . 1.4 mp -80.23 -37.54 32.87 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.058 172.831 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 113' ' ' GLY . . . . . 0.881 ' HA2' ' HB ' ' A' ' 37' ' ' VAL . . . -64.07 -20.99 65.43 Favored Glycine 0 N--CA 1.449 -0.499 0 CA-C-N 115.204 -0.907 . . . . 0.0 111.801 177.809 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 114' ' ' GLY . . . . . . . . . . . . . . . 130.01 9.64 3.02 Favored Glycine 0 N--CA 1.439 -1.16 0 C-N-CA 120.354 -0.927 . . . . 0.0 113.416 174.563 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 115' ' ' ASN . . . . . 0.658 ' O ' ' HA ' ' B' ' 111' ' ' ALA . 33.7 t30 -115.11 95.31 5.14 Favored 'General case' 0 N--CA 1.44 -0.962 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 178.5 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 2.3 p -80.21 29.87 0.28 Allowed 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 114.895 -1.048 . . . . 0.0 110.75 -167.024 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 117' ' ' SER . . . . . 0.526 ' N ' ' HD3' ' B' ' 118' ' ' PRO . 41.9 t -175.78 67.96 0.25 Allowed Pre-proline 0 C--N 1.307 -1.252 0 CA-C-N 113.377 -1.738 . . . . 0.0 108.411 -179.05 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 118' ' ' PRO . . . . . 0.654 ' HD2' ' CZ ' ' B' ' 107' ' ' TYR . 32.1 Cg_exo -66.04 148.7 85.86 Favored 'Trans proline' 0 CA--C 1.513 -0.557 0 C-N-CA 125.115 3.877 . . . . 0.0 111.827 -175.268 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 119' ' ' SER . . . . . 0.648 ' O ' HG12 ' B' ' 123' ' ' ILE . 78.6 p -116.39 -178.42 3.41 Favored 'General case' 0 C--N 1.316 -0.858 0 C-N-CA 120.221 -0.591 . . . . 0.0 111.324 178.318 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 120' ' ' ALA . . . . . 0.838 ' HB1' HD13 ' B' ' 139' ' ' LEU . . . -66.81 -34.19 77.28 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 122.057 0.932 . . . . 0.0 109.77 -173.868 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 121' ' ' LYS . . . . . 0.603 ' HD2' ' N ' ' B' ' 121' ' ' LYS . 0.0 OUTLIER -69.74 -29.97 67.46 Favored 'General case' 0 N--CA 1.437 -1.084 0 CA-C-N 113.956 -1.475 . . . . 0.0 110.173 177.805 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 122' ' ' ASP . . . . . 0.428 ' O ' HD13 ' B' ' 126' ' ' ILE . 20.1 m-20 -70.41 -44.73 67.34 Favored 'General case' 0 CA--C 1.517 -0.306 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 174.517 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 123' ' ' ILE . . . . . 0.881 HG23 ' HB2' ' B' ' 106' ' ' SER . 25.1 mm -54.19 -49.57 61.57 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 CA-C-N 114.944 -1.026 . . . . 0.0 109.869 176.38 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 124' ' ' LYS . . . . . 0.984 ' HD2' HD11 ' B' ' 127' ' ' LEU . 1.7 mmmm -62.34 -41.59 98.7 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.23 -175.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 125' ' ' LYS . . . . . . . . . . . . . 44.3 mmtt -49.73 -60.95 2.41 Favored 'General case' 0 CA--C 1.496 -1.134 0 CA-C-O 121.931 0.872 . . . . 0.0 111.225 171.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 126' ' ' ILE . . . . . 0.635 HG23 HD12 ' A' ' 31' ' ' LEU . 1.6 mp -59.03 -41.89 84.68 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.667 0 CA-C-N 113.706 -1.588 . . . . 0.0 110.694 -169.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 127' ' ' LEU . . . . . 0.984 HD11 ' HD2' ' B' ' 124' ' ' LYS . 3.5 pp -78.94 -32.25 45.45 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 111.924 0.342 . . . . 0.0 111.924 -178.628 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 128' ' ' ASP . . . . . 0.484 ' N ' HD12 ' B' ' 127' ' ' LEU . 11.5 m-20 -70.33 -24.58 63.02 Favored 'General case' 0 CA--C 1.518 -0.281 0 O-C-N 122.232 -0.293 . . . . 0.0 111.03 -178.588 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 129' ' ' SER . . . . . . . . . . . . . 94.4 p -59.45 -42.83 92.87 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-O 120.715 0.293 . . . . 0.0 111.206 177.217 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 130' ' ' VAL . . . . . 0.566 HG23 HG13 ' B' ' 132' ' ' ILE . 13.1 m -93.41 -7.4 10.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.814 0.34 . . . . 0.0 111.776 -179.745 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 131' ' ' GLY . . . . . . . . . . . . . . . 85.62 39.75 8.08 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.478 177.474 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 132' ' ' ILE . . . . . 0.736 HG23 ' HB2' ' A' ' 19' ' ' ASP . 14.3 mt -94.7 126.94 47.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 110.195 -0.298 . . . . 0.0 110.195 176.617 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 133' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -80.53 127.04 31.98 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.227 0.536 . . . . 0.0 111.283 -176.171 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 134' ' ' ALA . . . . . 0.421 ' HB2' HD22 ' B' ' 127' ' ' LEU . . . -140.37 146.13 38.01 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.706 -173.253 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 135' ' ' ASP . . . . . 0.696 ' HB3' ' HG3' ' B' ' 138' ' ' ARG . 7.7 t70 -93.65 131.04 39.34 Favored 'General case' 0 C--O 1.253 1.253 0 CA-C-O 121.173 0.511 . . . . 0.0 110.447 175.352 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 136' ' ' ASP . . . . . 1.032 ' HA ' HD11 ' B' ' 139' ' ' LEU . 6.2 p-10 -77.42 5.21 9.23 Favored 'General case' 0 CA--C 1.517 -0.297 0 CA-C-N 115.029 -0.987 . . . . 0.0 111.627 -168.276 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 137' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -108.83 -30.94 7.89 Favored 'General case' 0 N--CA 1.434 -1.255 0 CA-C-O 121.059 0.457 . . . . 0.0 110.372 172.013 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 138' ' ' ARG . . . . . 0.73 ' HA ' ' HE2' ' B' ' 141' ' ' LYS . 9.3 mmt180 -67.4 -48.44 67.36 Favored 'General case' 0 CA--C 1.505 -0.76 0 CA-C-O 122.179 0.99 . . . . 0.0 109.155 -178.69 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 139' ' ' LEU . . . . . 1.032 HD11 ' HA ' ' B' ' 136' ' ' ASP . 0.3 OUTLIER -69.63 -26.09 64.25 Favored 'General case' 0 C--O 1.207 -1.147 0 CA-C-N 114.588 -1.187 . . . . 0.0 111.025 179.112 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 140' ' ' ASN . . . . . 0.608 ' O ' ' HB ' ' B' ' 143' ' ' ILE . 32.9 t30 -79.26 -26.44 42.42 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.875 0.845 . . . . 0.0 109.938 -178.39 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 141' ' ' LYS . . . . . 0.73 ' HE2' ' HA ' ' B' ' 138' ' ' ARG . 0.2 OUTLIER -80.69 -35.35 33.76 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 115.435 -0.802 . . . . 0.0 108.972 179.907 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 142' ' ' VAL . . . . . 0.624 HG12 ' O ' ' B' ' 139' ' ' LEU . 9.8 p -66.6 -39.12 83.09 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.444 0 C-N-CA 119.922 -0.711 . . . . 0.0 109.204 172.127 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 143' ' ' ILE . . . . . 0.903 HG12 ' O ' ' B' ' 139' ' ' LEU . 32.2 mm -45.51 -59.82 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.36 0 CA-C-O 121.778 0.799 . . . . 0.0 110.081 168.762 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 144' ' ' SER . . . . . . . . . . . . . 20.8 m -51.8 -42.61 62.6 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 113.97 -1.468 . . . . 0.0 112.298 -179.656 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 145' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -76.16 -23.63 54.77 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 120.948 0.404 . . . . 0.0 111.625 179.35 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 146' ' ' LEU . . . . . 0.575 ' HB3' ' CZ ' ' B' ' 107' ' ' TYR . 0.3 OUTLIER -86.0 -36.96 19.44 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.569 -177.416 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 147' ' ' ASN . . . . . . . . . . . . . 16.0 t-20 -43.6 113.04 0.45 Allowed 'General case' 0 C--N 1.331 -0.203 0 O-C-N 124.157 0.911 . . . . 0.0 112.424 -173.168 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . 97.23 61.22 0.94 Allowed Glycine 0 N--CA 1.448 -0.56 0 CA-C-N 115.277 -0.874 . . . . 0.0 111.807 -178.14 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 149' ' ' LYS . . . . . . . . . . . . . 2.5 tppt? -144.49 162.54 36.29 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 -178.168 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 150' ' ' ASN . . . . . 0.619 ' O ' HG23 ' B' ' 154' ' ' VAL . 42.2 m-80 -106.08 90.26 3.32 Favored 'General case' 0 CA--C 1.514 -0.427 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 178.079 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 151' ' ' ILE . . . . . 0.907 HG13 HD12 ' B' ' 108' ' ' LEU . 1.8 mp -43.45 -66.01 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 O-C-N 124.528 1.142 . . . . 0.0 113.744 -169.028 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 152' ' ' GLU . . . . . 0.579 ' OE1' HD22 ' A' ' 7' ' ' LEU . 2.4 mt-10 -48.94 -52.61 23.7 Favored 'General case' 0 C--O 1.207 -1.149 0 CA-C-N 118.249 0.477 . . . . 0.0 111.981 -177.775 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 153' ' ' ASP . . . . . . . . . . . . . 26.5 m-20 -64.76 -27.77 69.12 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 119.983 -0.687 . . . . 0.0 111.103 -176.014 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 154' ' ' VAL . . . . . 0.855 ' HB ' HD12 ' B' ' 155' ' ' ILE . 49.6 t -57.6 -52.97 50.7 Favored 'Isoleucine or valine' 0 C--O 1.233 0.189 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 170.374 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 155' ' ' ILE . . . . . 0.855 HD12 ' HB ' ' B' ' 154' ' ' VAL . 1.8 mp -105.25 34.4 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.706 -176.613 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . -105.03 0.59 27.79 Favored 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 171.405 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 157' ' ' GLN . . . . . . . . . . . . . 49.9 mt-30 -141.69 1.85 1.55 Allowed 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 113.353 -1.749 . . . . 0.0 109.908 175.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 158' ' ' GLY . . . . . . . . . . . . . . . -142.34 46.26 0.88 Allowed Glycine 0 C--N 1.334 0.456 0 C-N-CA 120.695 -0.764 . . . . 0.0 113.588 -170.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 159' ' ' ILE . . . . . 0.649 HG21 ' HB2' ' A' ' 59' ' ' LEU . 1.8 mp -60.41 -15.81 11.3 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.775 0 C-N-CA 123.127 0.571 . . . . 0.0 111.721 178.859 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 160' ' ' GLY . . . . . 0.402 ' HA2' HG23 ' A' ' 56' ' ' ILE . . . . . . . . 0 N--CA 1.446 -0.676 0 C-N-CA 120.59 -0.814 . . . . 0.0 112.204 -174.591 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . 0.498 ' HB2' ' HG3' ' A' ' 6' ' ' GLU . 5.8 m . . . . . 0 N--CA 1.448 -0.538 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.539 HG13 ' HG ' ' B' ' 112' ' ' LEU . 2.1 t -52.57 -26.59 10.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.053 -0.976 . . . . 0.0 112.496 -178.301 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . 0.424 ' HB2' ' HA ' ' A' ' 39' ' ' VAL . 10.9 p -68.71 -53.26 23.21 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 177.471 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.552 ' O ' HG13 ' A' ' 10' ' ' ILE . 31.3 mt-10 -56.95 -50.27 73.13 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 114.816 -1.083 . . . . 0.0 109.614 176.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.868 HD12 HD12 ' A' ' 10' ' ' ILE . 4.4 tp -61.61 -36.6 81.19 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 115.12 -0.945 . . . . 0.0 111.841 -179.404 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.685 ' HB2' HD23 ' B' ' 112' ' ' LEU . . . -69.21 -35.11 75.85 Favored 'General case' 0 CA--C 1.513 -0.456 0 CA-C-O 121.023 0.439 . . . . 0.0 110.719 179.11 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.46 ' HB2' HG11 ' A' ' 39' ' ' VAL . 5.0 t -67.63 -41.11 84.44 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 178.337 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.868 HD12 HD12 ' A' ' 7' ' ' LEU . 68.5 mt -47.92 -56.57 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 CA-C-N 113.859 -1.518 . . . . 0.0 109.905 170.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.873 ' HB2' HD13 ' B' ' 109' ' ' LEU . 22.9 m-85 -65.13 -39.64 93.32 Favored 'General case' 0 C--O 1.218 -0.586 0 CA-C-N 115.685 -0.688 . . . . 0.0 111.413 -174.194 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.467 ' HB2' HG23 ' A' ' 28' ' ' ILE . 16.0 m -57.34 -40.84 78.87 Favored 'General case' 0 C--O 1.24 0.588 0 CA-C-O 121.463 0.649 . . . . 0.0 109.315 177.197 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.438 ' CB ' HD11 ' A' ' 51' ' ' LEU . . . -67.13 -30.93 71.07 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 115.186 -0.915 . . . . 0.0 110.212 175.067 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.704 HD22 HD11 ' A' ' 56' ' ' ILE . 0.3 OUTLIER -66.98 -53.63 29.68 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.591 179.684 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.455 HG12 ' H ' ' A' ' 15' ' ' ILE . 0.0 OUTLIER -57.77 -41.66 80.13 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 CA-C-O 120.961 0.41 . . . . 0.0 109.955 176.8 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.574 HD11 ' HG2' ' A' ' 27' ' ' LYS . 2.6 tp -60.08 -41.94 93.54 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.821 176.816 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 47.4 t60 -80.47 -8.31 59.5 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.316 179.594 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -73.8 -43.34 59.15 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 178.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -97.71 -14.55 20.81 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-O 121.991 0.901 . . . . 0.0 109.045 177.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 61.0 52.69 3.97 Favored 'General case' 0 CA--C 1.51 -0.566 0 CA-C-N 113.753 -1.567 . . . . 0.0 109.979 -174.735 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.511 HG13 HD12 ' A' ' 16' ' ' LEU . 7.3 p -102.08 171.64 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.426 -1.643 0 CA-C-N 114.445 -1.252 . . . . 0.0 108.506 -178.216 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.503 ' H ' HG22 ' A' ' 21' ' ' VAL . 41.2 p -54.19 138.65 37.87 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 113.365 0.876 . . . . 0.0 113.365 -170.595 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.587 HG12 ' HA ' ' A' ' 48' ' ' ALA . 59.4 t -107.19 108.7 25.85 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.995 0 CA-C-N 114.371 -1.286 . . . . 0.0 110.54 -176.649 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.508 ' OG1' ' HE2' ' A' ' 27' ' ' LYS . 68.5 p -140.24 155.14 47.0 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.61 179.029 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -54.83 -43.36 72.92 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.228 0.537 . . . . 0.0 109.788 178.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 -60.5 -34.55 74.24 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.168 -0.923 . . . . 0.0 110.76 178.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.574 ' HG2' HD11 ' A' ' 16' ' ' LEU . 3.9 tppt? -67.53 -54.12 22.74 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-O 121.881 0.848 . . . . 0.0 109.233 -178.66 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.467 HG23 ' HB2' ' A' ' 12' ' ' SER . 88.1 mt -58.76 -39.35 76.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 114.459 -1.246 . . . . 0.0 110.287 178.262 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 42.8 t-20 -58.14 -42.85 86.76 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.109 176.538 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -60.42 -46.85 88.53 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.243 177.636 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.512 ' HB3' HD21 ' B' ' 109' ' ' LEU . 1.1 mm? -55.54 -51.46 66.98 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 121.221 0.534 . . . . 0.0 110.216 175.348 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.621 HG23 ' O ' ' A' ' 37' ' ' VAL . 67.8 mt -47.71 -49.46 10.24 Favored 'Isoleucine or valine' 0 C--O 1.242 0.665 0 CA-C-N 114.655 -1.157 . . . . 0.0 111.936 179.199 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.431 ' HA ' ' HD2' ' A' ' 33' ' ' LYS . 3.0 mmmp? -78.45 -31.26 47.93 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.528 0.566 . . . . 0.0 112.528 -173.669 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.521 ' HB2' ' HB3' ' B' ' 129' ' ' SER . . . -68.83 -38.15 79.66 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 120.641 -0.423 . . . . 0.0 110.463 177.719 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.549 ' CB ' ' HG ' ' B' ' 109' ' ' LEU . . . -77.6 -36.3 51.96 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.412 177.02 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 97.62 13.25 44.83 Favored Glycine 0 N--CA 1.445 -0.715 0 CA-C-N 115.427 -0.806 . . . . 0.0 111.959 178.6 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.953 ' HB ' ' HA2' ' B' ' 113' ' ' GLY . 2.6 p -116.13 116.96 53.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-O 121.818 0.818 . . . . 0.0 110.969 -175.126 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -90.12 152.82 20.95 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 114.268 -1.333 . . . . 0.0 110.551 -171.684 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.504 HG12 ' N ' ' A' ' 40' ' ' GLU . 96.3 t -120.51 166.13 15.26 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.07 0 CA-C-N 114.555 -1.202 . . . . 0.0 109.935 -173.056 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.635 ' HB3' ' HD1' ' A' ' 43' ' ' TRP . 28.3 tp10 -72.62 106.35 2.11 Favored Pre-proline 0 N--CA 1.439 -1.023 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 168.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.529 ' C ' ' HD2' ' A' ' 44' ' ' PRO . 86.8 Cg_exo -50.09 -30.71 25.81 Favored 'Trans proline' 0 C--O 1.253 1.243 0 C-N-CA 123.709 2.94 . . . . 0.0 115.65 -163.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.402 ' HD2' ' HG3' ' A' ' 40' ' ' GLU . 0.5 OUTLIER -59.43 -28.4 66.91 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 177.246 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . 0.635 ' HD1' ' HB3' ' A' ' 40' ' ' GLU . 17.4 m95 -64.2 -60.44 8.72 Favored Pre-proline 0 C--O 1.206 -1.214 0 CA-C-O 118.369 -0.824 . . . . 0.0 111.153 176.083 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.529 ' HD2' ' C ' ' A' ' 41' ' ' PRO . 93.1 Cg_exo -44.99 -44.89 14.61 Favored 'Trans proline' 0 C--N 1.36 1.155 0 C-N-CA 121.849 1.699 . . . . 0.0 112.167 175.094 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -61.55 -55.77 26.95 Favored Glycine 0 CA--C 1.525 0.68 0 C-N-CA 120.035 -1.079 . . . . 0.0 112.525 177.17 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 8.9 tp -67.42 -27.92 67.47 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 122.849 0.459 . . . . 0.0 112.025 -177.366 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.513 ' HE1' ' CE3' ' A' ' 43' ' ' TRP . 2.8 m-85 -69.89 -46.8 64.66 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 177.112 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.587 ' HA ' HG12 ' A' ' 23' ' ' VAL . . . -62.84 -34.34 77.13 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.81 0.814 . . . . 0.0 109.592 178.26 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.471 ' HD2' ' C ' ' A' ' 49' ' ' LYS . 0.3 OUTLIER -70.85 -42.26 70.36 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 114.291 -1.322 . . . . 0.0 111.484 177.085 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.415 ' O ' HG22 ' A' ' 54' ' ' VAL . . . -82.23 -44.96 15.68 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 112.687 0.625 . . . . 0.0 112.687 -173.569 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.537 ' HB2' HG11 ' A' ' 23' ' ' VAL . 11.1 mt -63.71 -13.15 40.65 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 112.87 0.693 . . . . 0.0 112.87 -171.835 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -83.1 -10.25 58.78 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.135 0.493 . . . . 0.0 110.579 176.623 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 33.9 m-80 -122.6 -47.6 2.08 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.261 -176.55 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.415 HG22 ' O ' ' A' ' 50' ' ' ALA . 13.7 m -99.55 -169.93 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 176.601 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -130.59 -173.1 2.98 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 120.484 -0.486 . . . . 0.0 111.338 178.149 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.704 HD11 HD22 ' A' ' 14' ' ' LEU . 3.4 tp -66.03 -26.99 39.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-O 121.006 0.431 . . . . 0.0 111.08 -174.262 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -71.15 -14.99 74.26 Favored Glycine 0 N--CA 1.442 -0.904 0 C-N-CA 120.459 -0.877 . . . . 0.0 111.21 179.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 14.8 t -79.99 -21.27 43.85 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-O 121.157 0.504 . . . . 0.0 110.054 179.631 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.545 ' HB2' HG21 ' B' ' 159' ' ' ILE . 26.0 mt -62.67 -33.05 74.28 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.518 -0.764 . . . . 0.0 110.848 -178.298 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.648 ' CD1' ' HB ' ' B' ' 159' ' ' ILE . 0.1 OUTLIER . . . . . 0 C--N 1.319 -0.752 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.914 -179.299 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 103' ' ' TYR . . . . . 0.827 ' HB2' HG11 ' B' ' 142' ' ' VAL . 52.2 m-85 . . . . . 0 N--CA 1.477 0.886 0 CA-C-O 120.778 0.323 . . . . 0.0 111.807 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 104' ' ' VAL . . . . . 0.526 ' O ' HD22 ' B' ' 108' ' ' LEU . 50.1 t -43.17 -50.28 1.24 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.371 0 CA-C-O 121.736 0.779 . . . . 0.0 110.255 174.069 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 105' ' ' ALA . . . . . 0.655 ' CB ' ' HB3' ' A' ' 14' ' ' LEU . . . -64.67 -37.85 88.98 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-N 114.519 -1.219 . . . . 0.0 111.669 -174.306 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 106' ' ' SER . . . . . 0.703 ' HB2' HG23 ' B' ' 123' ' ' ILE . 1.4 m -62.82 -37.78 88.11 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.533 0.682 . . . . 0.0 109.391 178.533 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 107' ' ' TYR . . . . . 0.683 ' CG ' HD12 ' B' ' 146' ' ' LEU . 34.2 t80 -63.99 -47.58 79.81 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 114.727 -1.124 . . . . 0.0 108.689 178.285 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 108' ' ' LEU . . . . . 0.836 HD12 HG13 ' B' ' 151' ' ' ILE . 0.0 OUTLIER -58.21 -47.54 83.17 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.103 -0.953 . . . . 0.0 110.943 177.522 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 109' ' ' LEU . . . . . 0.873 HD13 ' HB2' ' A' ' 11' ' ' TYR . 8.1 tp -54.19 -48.76 70.61 Favored 'General case' 0 CA--C 1.511 -0.541 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.193 179.11 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 110' ' ' ALA . . . . . 0.43 ' HB3' ' HB3' ' B' ' 118' ' ' PRO . . . -64.65 -41.13 96.33 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.975 0.417 . . . . 0.0 111.044 -177.442 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 111' ' ' ALA . . . . . 0.665 ' HA ' ' O ' ' B' ' 115' ' ' ASN . . . -68.65 -20.17 64.44 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.275 0.56 . . . . 0.0 110.802 179.318 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 112' ' ' LEU . . . . . 0.685 HD23 ' HB2' ' A' ' 8' ' ' ALA . 1.4 mp -85.14 -37.11 20.59 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.966 173.723 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 113' ' ' GLY . . . . . 0.953 ' HA2' ' HB ' ' A' ' 37' ' ' VAL . . . -62.81 -39.23 97.73 Favored Glycine 0 N--CA 1.445 -0.705 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.769 -179.123 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 114' ' ' GLY . . . . . . . . . . . . . . . 155.09 6.21 0.08 OUTLIER Glycine 0 N--CA 1.44 -1.09 0 C-N-CA 120.217 -0.992 . . . . 0.0 112.928 177.216 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 115' ' ' ASN . . . . . 0.665 ' O ' ' HA ' ' B' ' 111' ' ' ALA . 37.4 t30 -119.63 92.62 3.83 Favored 'General case' 0 N--CA 1.444 -0.77 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 -179.454 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 5.2 p -80.59 27.53 0.36 Allowed 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 122.325 1.059 . . . . 0.0 111.038 -166.049 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 117' ' ' SER . . . . . 0.521 ' N ' ' HD3' ' B' ' 118' ' ' PRO . 33.0 t -172.14 68.29 0.42 Allowed Pre-proline 0 C--N 1.31 -1.137 0 CA-C-N 113.419 -1.719 . . . . 0.0 108.098 178.55 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 118' ' ' PRO . . . . . 0.679 ' HG2' ' O ' ' B' ' 107' ' ' TYR . 37.1 Cg_exo -64.09 156.25 60.07 Favored 'Trans proline' 0 CA--C 1.512 -0.611 0 C-N-CA 125.028 3.818 . . . . 0.0 111.718 -174.291 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 119' ' ' SER . . . . . 0.67 ' O ' HG12 ' B' ' 123' ' ' ILE . 90.2 p -123.75 179.78 4.67 Favored 'General case' 0 C--N 1.314 -0.961 0 C-N-CA 120.079 -0.648 . . . . 0.0 110.831 177.837 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 120' ' ' ALA . . . . . 0.834 ' HB1' HD13 ' B' ' 139' ' ' LEU . . . -65.9 -39.2 90.39 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-O 121.75 0.786 . . . . 0.0 109.617 -172.577 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 121' ' ' LYS . . . . . . . . . . . . . 13.9 mptt -60.33 -37.91 82.12 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 114.076 -1.42 . . . . 0.0 110.538 175.169 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 122' ' ' ASP . . . . . 0.628 ' O ' ' HB2' ' B' ' 125' ' ' LYS . 2.6 t0 -74.44 -35.06 63.33 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 121.665 0.745 . . . . 0.0 109.105 -178.644 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 123' ' ' ILE . . . . . 0.746 ' O ' ' HG ' ' B' ' 127' ' ' LEU . 42.7 mm -60.01 -44.3 94.43 Favored 'Isoleucine or valine' 0 C--O 1.235 0.301 0 CA-C-N 115.43 -0.805 . . . . 0.0 109.511 172.762 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 124' ' ' LYS . . . . . 0.687 ' HD3' HD21 ' B' ' 139' ' ' LEU . 5.2 mmmp? -58.66 -44.59 90.18 Favored 'General case' 0 CA--C 1.503 -0.864 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 -179.27 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 125' ' ' LYS . . . . . 0.628 ' HB2' ' O ' ' B' ' 122' ' ' ASP . 17.6 mmtp -45.03 -66.76 0.36 Allowed 'General case' 0 C--O 1.248 0.975 0 CA-C-O 121.609 0.719 . . . . 0.0 112.54 169.724 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 126' ' ' ILE . . . . . 0.453 HD11 ' HA ' ' A' ' 35' ' ' ALA . 1.7 mp -54.65 -43.23 64.76 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.13 0 CA-C-N 113.801 -1.545 . . . . 0.0 111.112 -168.701 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 127' ' ' LEU . . . . . 0.746 ' HG ' ' O ' ' B' ' 123' ' ' ILE . 1.5 pp -84.27 -23.46 30.35 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.505 0.557 . . . . 0.0 112.505 -178.299 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 128' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -70.44 -27.88 64.6 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 120.784 0.326 . . . . 0.0 110.22 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 129' ' ' SER . . . . . 0.521 ' HB3' ' HB2' ' A' ' 34' ' ' ALA . 89.2 p -55.87 -45.86 78.43 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.292 177.556 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 130' ' ' VAL . . . . . 0.499 HG23 HG13 ' B' ' 132' ' ' ILE . 10.9 m -88.88 -17.93 8.11 Favored 'Isoleucine or valine' 0 C--O 1.231 0.083 0 CA-C-O 120.727 0.299 . . . . 0.0 111.563 179.369 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 131' ' ' GLY . . . . . . . . . . . . . . . 100.74 18.76 19.65 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.661 -0.78 . . . . 0.0 112.686 177.321 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 132' ' ' ILE . . . . . 0.539 ' O ' HD13 ' B' ' 127' ' ' LEU . 27.5 mt -78.16 114.93 19.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.788 0.327 . . . . 0.0 110.271 178.334 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 133' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -79.02 138.47 38.03 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.386 -175.263 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 134' ' ' ALA . . . . . . . . . . . . . . . -139.79 143.69 37.0 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.774 -0.648 . . . . 0.0 112.103 -169.442 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 135' ' ' ASP . . . . . 0.783 ' HB2' ' HG3' ' B' ' 138' ' ' ARG . 6.3 m-20 -84.05 128.17 34.38 Favored 'General case' 0 C--O 1.252 1.201 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 175.104 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 136' ' ' ASP . . . . . 1.031 ' HA ' HD11 ' B' ' 139' ' ' LEU . 1.3 p-10 -77.14 -0.34 24.55 Favored 'General case' 0 CA--C 1.518 -0.261 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.26 -166.438 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 137' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -103.22 -31.74 9.96 Favored 'General case' 0 N--CA 1.439 -1.01 0 CA-C-O 121.186 0.517 . . . . 0.0 110.14 172.44 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 138' ' ' ARG . . . . . 0.783 ' HG3' ' HB2' ' B' ' 135' ' ' ASP . 44.9 mmt-85 -63.26 -54.37 38.28 Favored 'General case' 0 CA--C 1.504 -0.803 0 CA-C-O 122.108 0.956 . . . . 0.0 109.177 -177.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 139' ' ' LEU . . . . . 1.031 HD11 ' HA ' ' B' ' 136' ' ' ASP . 0.3 OUTLIER -66.88 -28.02 67.99 Favored 'General case' 0 C--O 1.211 -0.96 0 CA-C-N 114.383 -1.28 . . . . 0.0 110.996 -179.942 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 140' ' ' ASN . . . . . 0.721 ' O ' ' HB ' ' B' ' 143' ' ' ILE . 11.1 t30 -75.98 -25.77 56.13 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.712 0.768 . . . . 0.0 110.029 -177.461 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 141' ' ' LYS . . . . . 0.522 ' HG2' ' O ' ' B' ' 138' ' ' ARG . 10.5 ptmt -84.34 -31.39 24.84 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.364 -0.835 . . . . 0.0 109.649 -179.477 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 142' ' ' VAL . . . . . 0.827 HG11 ' HB2' ' B' ' 103' ' ' TYR . 9.6 p -70.22 -33.68 55.58 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.119 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 170.583 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 143' ' ' ILE . . . . . 0.88 HG12 ' O ' ' B' ' 139' ' ' LEU . 29.5 mm -47.84 -61.87 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.376 0 CA-C-O 121.463 0.649 . . . . 0.0 109.375 166.514 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 144' ' ' SER . . . . . . . . . . . . . 25.4 m -49.27 -44.38 43.86 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 114.545 -1.207 . . . . 0.0 112.355 177.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 145' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -70.88 -30.36 66.71 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 112.368 0.507 . . . . 0.0 112.368 -177.606 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 146' ' ' LEU . . . . . 0.683 HD12 ' CG ' ' B' ' 107' ' ' TYR . 5.3 mt -93.55 -17.88 22.86 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.346 -0.541 . . . . 0.0 111.023 -177.763 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 147' ' ' ASN . . . . . . . . . . . . . 39.3 t30 -57.79 115.46 2.84 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.08 -177.702 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . 104.27 15.93 20.0 Favored Glycine 0 N--CA 1.448 -0.536 0 CA-C-N 115.745 -0.662 . . . . 0.0 112.518 -179.248 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 149' ' ' LYS . . . . . 0.428 ' HB2' ' O ' ' B' ' 146' ' ' LEU . 0.6 OUTLIER -112.6 158.59 19.78 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.599 0.238 . . . . 0.0 110.659 179.11 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 150' ' ' ASN . . . . . 0.536 ' O ' HG23 ' B' ' 154' ' ' VAL . 25.9 t-20 -97.7 95.87 7.87 Favored 'General case' 0 CA--C 1.511 -0.529 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 175.523 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 151' ' ' ILE . . . . . 0.836 HG13 HD12 ' B' ' 108' ' ' LEU . 1.8 mp -43.61 -60.79 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 O-C-N 124.621 1.2 . . . . 0.0 113.148 -169.4 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 152' ' ' GLU . . . . . 0.409 ' N ' HG22 ' B' ' 151' ' ' ILE . 47.0 mt-10 -56.2 -39.93 73.19 Favored 'General case' 0 C--O 1.212 -0.87 0 N-CA-C 111.708 0.262 . . . . 0.0 111.708 -174.426 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 153' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -74.56 -26.4 59.93 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 120.707 -0.397 . . . . 0.0 110.96 -179.051 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 154' ' ' VAL . . . . . 0.816 ' HB ' HD12 ' B' ' 155' ' ' ILE . 53.9 t -59.56 -50.06 81.36 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 170.172 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 155' ' ' ILE . . . . . 0.816 HD12 ' HB ' ' B' ' 154' ' ' VAL . 3.0 mp -107.47 34.29 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.19 -177.05 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . -95.77 -4.29 44.21 Favored 'General case' 0 C--N 1.309 -1.157 0 N-CA-C 107.505 -1.294 . . . . 0.0 107.505 169.51 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 157' ' ' GLN . . . . . . . . . . . . . 70.0 mm-40 -135.63 -27.83 1.14 Allowed 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 113.289 -1.778 . . . . 0.0 110.682 175.415 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 158' ' ' GLY . . . . . . . . . . . . . . . -105.85 46.56 1.16 Allowed Glycine 0 C--O 1.222 -0.595 0 CA-C-O 119.581 -0.566 . . . . 0.0 114.511 -171.377 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 159' ' ' ILE . . . . . 0.648 ' HB ' ' CD1' ' A' ' 60' ' ' ILE . 1.8 mp -56.5 -24.0 18.01 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.094 0 CA-C-N 117.385 0.593 . . . . 0.0 110.876 176.043 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 160' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.694 0 C-N-CA 120.835 -0.698 . . . . 0.0 111.805 179.382 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . 0.538 ' HB2' ' OE1' ' A' ' 6' ' ' GLU . 0.7 OUTLIER . . . . . 0 N--CA 1.448 -0.556 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.548 HG13 ' HG ' ' B' ' 112' ' ' LEU . 2.1 t -51.77 -22.86 2.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-N 114.189 -1.368 . . . . 0.0 112.825 -177.215 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . 0.523 ' HB3' ' HA ' ' A' ' 39' ' ' VAL . 16.8 m -71.32 -58.22 3.74 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 179.162 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.542 ' O ' HG13 ' A' ' 10' ' ' ILE . 2.3 mp0 -54.69 -52.45 62.36 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.657 176.004 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.875 ' HA ' HD12 ' A' ' 10' ' ' ILE . 3.6 tp -56.42 -37.14 69.79 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 115.344 -0.843 . . . . 0.0 112.503 179.782 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.64 ' HB2' HD23 ' B' ' 112' ' ' LEU . . . -70.04 -33.38 71.9 Favored 'General case' 0 N--CA 1.468 0.447 0 O-C-N 122.007 -0.433 . . . . 0.0 110.849 179.059 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.605 ' HB2' HG11 ' A' ' 39' ' ' VAL . 8.2 t -70.32 -38.7 74.97 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 177.686 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.875 HD12 ' HA ' ' A' ' 7' ' ' LEU . 67.4 mt -49.22 -55.88 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.74 0 CA-C-N 114.071 -1.422 . . . . 0.0 109.661 170.679 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.672 ' OH ' ' HB ' ' B' ' 155' ' ' ILE . 23.1 m-85 -67.59 -44.18 78.76 Favored 'General case' 0 C--O 1.22 -0.458 0 CA-C-N 115.771 -0.65 . . . . 0.0 112.164 -173.043 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.0 p -54.56 -46.06 73.58 Favored 'General case' 0 C--O 1.243 0.754 0 CA-C-O 121.447 0.642 . . . . 0.0 109.802 177.305 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.04 -36.94 78.39 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.57 172.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.646 HD22 HD11 ' A' ' 56' ' ' ILE . 0.2 OUTLIER -60.84 -55.85 28.2 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.264 -179.537 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.465 HG12 ' O ' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -52.85 -44.81 49.54 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.54 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 177.612 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.543 HD21 ' HA ' ' A' ' 23' ' ' VAL . 3.4 tp -54.7 -35.6 63.8 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.282 178.135 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . 0.483 ' NE2' HD22 ' A' ' 51' ' ' LEU . 30.5 m-70 -83.48 -14.71 51.84 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 177.574 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -76.4 -33.69 58.85 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.314 0.578 . . . . 0.0 109.593 -178.676 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.818 ' HB2' HG23 ' B' ' 132' ' ' ILE . 15.1 t70 -96.07 -12.34 25.0 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 174.625 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 55.24 50.05 15.91 Favored 'General case' 0 CA--C 1.518 -0.274 0 CA-C-N 113.861 -1.518 . . . . 0.0 109.979 -175.191 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.624 HG22 ' H ' ' A' ' 22' ' ' THR . 7.9 p -108.08 175.08 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.321 0 CA-C-N 114.589 -1.187 . . . . 0.0 109.286 -174.204 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.624 ' H ' HG22 ' A' ' 21' ' ' VAL . 63.2 p -54.53 137.61 42.66 Favored 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 113.606 0.965 . . . . 0.0 113.606 -170.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.572 HG12 ' HA ' ' A' ' 48' ' ' ALA . 54.0 t -104.91 109.01 26.28 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.758 0 CA-C-N 114.182 -1.372 . . . . 0.0 110.469 -177.484 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.591 ' OG1' ' HB2' ' A' ' 27' ' ' LYS . 82.4 p -144.77 155.8 43.72 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.719 -179.429 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 49.7 tt0 -57.2 -41.7 79.87 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.429 -0.351 . . . . 0.0 110.748 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -66.7 -27.42 67.63 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-O 120.962 0.41 . . . . 0.0 110.449 179.547 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.591 ' HB2' ' OG1' ' A' ' 24' ' ' THR . 3.3 tppt? -71.12 -52.17 20.88 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 -179.195 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 45.9 mt -58.98 -38.65 74.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 114.547 -1.206 . . . . 0.0 110.401 176.685 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 7.8 m-20 -58.02 -43.5 86.77 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.868 173.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -58.02 -46.61 85.01 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.675 178.015 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.592 ' HB3' HD21 ' B' ' 109' ' ' LEU . 1.3 mm? -59.03 -51.99 67.7 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 121.045 0.45 . . . . 0.0 110.65 175.495 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.617 HG23 ' O ' ' A' ' 37' ' ' VAL . 56.0 mt -49.91 -51.19 17.15 Favored 'Isoleucine or valine' 0 C--O 1.239 0.543 0 CA-C-N 115.155 -0.929 . . . . 0.0 111.916 -178.842 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.606 ' HD2' HG22 ' A' ' 32' ' ' ILE . 14.0 mptt -77.16 -28.14 54.02 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.66 -0.7 . . . . 0.0 112.103 -175.598 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -68.45 -41.43 80.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.902 0.382 . . . . 0.0 110.525 177.464 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -79.26 -38.65 34.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.255 0.55 . . . . 0.0 110.858 178.231 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 101.15 16.94 23.98 Favored Glycine 0 N--CA 1.447 -0.614 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.848 -179.313 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.906 ' HB ' ' HA2' ' B' ' 113' ' ' GLY . 3.0 p -121.11 121.17 64.24 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.423 0 CA-C-O 121.241 0.543 . . . . 0.0 110.827 -177.264 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.528 ' HA ' HG23 ' A' ' 32' ' ' ILE . 8.0 t-20 -100.59 167.65 10.21 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.153 -0.931 . . . . 0.0 110.869 -171.356 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.605 HG11 ' HB2' ' A' ' 9' ' ' CYS . 94.7 t -132.79 165.07 33.47 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 CA-C-N 115.01 -0.996 . . . . 0.0 110.477 -170.585 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.549 ' HB3' ' HD1' ' A' ' 43' ' ' TRP . 4.7 tp10 -68.44 108.07 2.53 Favored Pre-proline 0 N--CA 1.444 -0.726 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 168.353 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.489 ' C ' ' HD2' ' A' ' 44' ' ' PRO . 81.1 Cg_exo -51.77 -28.77 31.55 Favored 'Trans proline' 0 C--O 1.251 1.145 0 C-N-CA 123.582 2.855 . . . . 0.0 115.855 -164.243 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -61.41 -27.77 68.78 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 120.39 -0.524 . . . . 0.0 109.627 177.562 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . 0.568 ' CE3' ' HE1' ' A' ' 47' ' ' PHE . 14.1 m95 -64.46 -60.63 8.08 Favored Pre-proline 0 C--O 1.206 -1.222 0 CA-C-O 118.467 -0.778 . . . . 0.0 110.914 176.566 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.517 ' HD3' ' HB2' ' A' ' 43' ' ' TRP . 96.8 Cg_exo -46.13 -44.37 19.55 Favored 'Trans proline' 0 C--N 1.359 1.13 0 C-N-CA 121.811 1.674 . . . . 0.0 111.88 175.176 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -58.7 -62.24 6.47 Favored Glycine 0 CA--C 1.525 0.684 0 C-N-CA 120.187 -1.006 . . . . 0.0 112.631 176.428 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.411 ' O ' ' HB2' ' A' ' 49' ' ' LYS . 4.2 tp -64.44 -32.31 73.89 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 123.081 0.552 . . . . 0.0 111.99 -176.789 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.568 ' HE1' ' CE3' ' A' ' 43' ' ' TRP . 3.2 m-85 -61.81 -50.69 71.31 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 120.826 0.346 . . . . 0.0 110.089 175.483 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.572 ' HA ' HG12 ' A' ' 23' ' ' VAL . . . -66.37 -28.58 68.76 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.572 0.701 . . . . 0.0 109.891 -178.645 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.411 ' HB2' ' O ' ' A' ' 46' ' ' LEU . 9.4 mmmt -65.66 -51.08 62.25 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 114.546 -1.206 . . . . 0.0 112.08 174.538 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.41 ' O ' HG22 ' A' ' 54' ' ' VAL . . . -88.36 -36.69 16.45 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 113.215 0.821 . . . . 0.0 113.215 -169.471 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.511 ' HB2' HG11 ' A' ' 23' ' ' VAL . 24.0 mt -68.65 -0.7 5.53 Favored 'General case' 0 N--CA 1.464 0.227 0 N-CA-C 112.456 0.539 . . . . 0.0 112.456 -172.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -84.96 -1.75 57.08 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.818 0.342 . . . . 0.0 110.307 173.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 9.6 t30 -143.97 -39.66 0.29 Allowed 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.228 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.41 HG22 ' O ' ' A' ' 50' ' ' ALA . 6.4 m -82.27 -171.49 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 178.309 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 18.3 m120 -121.32 175.93 5.9 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.044 0.45 . . . . 0.0 110.758 177.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.646 HD11 HD22 ' A' ' 14' ' ' LEU . 4.3 tp -75.78 -26.22 17.78 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 177.69 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -72.64 -9.52 74.44 Favored Glycine 0 N--CA 1.445 -0.713 0 N-CA-C 111.058 -0.817 . . . . 0.0 111.058 175.167 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 21.2 m -80.48 -24.56 39.37 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-O 121.346 0.593 . . . . 0.0 109.523 177.045 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.47 HD11 HD12 ' A' ' 56' ' ' ILE . 24.9 mt -60.79 -32.83 72.16 Favored 'General case' 0 CA--C 1.517 -0.304 0 CA-C-N 115.443 -0.798 . . . . 0.0 110.957 -178.848 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.613 ' CD1' ' HB ' ' B' ' 159' ' ' ILE . 0.1 OUTLIER . . . . . 0 C--N 1.316 -0.878 0 CA-C-N 114.786 -1.097 . . . . 0.0 111.18 -177.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 103' ' ' TYR . . . . . 0.614 ' HB2' HG11 ' B' ' 142' ' ' VAL . 39.6 m-85 . . . . . 0 N--CA 1.478 0.944 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 104' ' ' VAL . . . . . 0.478 HG12 ' CD2' ' B' ' 108' ' ' LEU . 96.1 t -44.42 -46.45 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 CA-C-O 121.864 0.84 . . . . 0.0 109.391 174.153 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 105' ' ' ALA . . . . . 0.638 ' CB ' ' HB3' ' A' ' 14' ' ' LEU . . . -66.8 -38.47 86.57 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-N 114.288 -1.324 . . . . 0.0 112.226 -173.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 106' ' ' SER . . . . . 0.737 ' HB2' HG23 ' B' ' 123' ' ' ILE . 3.2 m -63.82 -37.86 88.96 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-O 121.625 0.726 . . . . 0.0 109.611 178.536 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 107' ' ' TYR . . . . . 0.736 ' O ' ' HG2' ' B' ' 118' ' ' PRO . 33.1 t80 -62.28 -49.57 75.14 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 114.684 -1.144 . . . . 0.0 108.316 177.549 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 108' ' ' LEU . . . . . 0.855 HD12 HG13 ' B' ' 151' ' ' ILE . 0.0 OUTLIER -56.28 -47.49 78.5 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 114.542 -1.208 . . . . 0.0 111.313 177.866 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 109' ' ' LEU . . . . . 0.62 HD13 ' HB2' ' A' ' 11' ' ' TYR . 8.9 tp -56.6 -47.75 78.93 Favored 'General case' 0 CA--C 1.515 -0.398 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.908 179.759 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 110' ' ' ALA . . . . . 0.421 ' HB3' ' HB3' ' B' ' 118' ' ' PRO . . . -64.26 -39.76 94.62 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.583 -0.447 . . . . 0.0 110.985 -177.149 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 111' ' ' ALA . . . . . 0.68 ' HA ' ' O ' ' B' ' 115' ' ' ASN . . . -66.66 -28.89 68.83 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.53 179.862 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 112' ' ' LEU . . . . . 0.64 HD23 ' HB2' ' A' ' 8' ' ' ALA . 1.8 mp -80.37 -34.85 36.13 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.35 175.558 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 113' ' ' GLY . . . . . 0.906 ' HA2' ' HB ' ' A' ' 37' ' ' VAL . . . -64.15 -25.05 69.32 Favored Glycine 0 CA--C 1.504 -0.619 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.814 179.363 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 114' ' ' GLY . . . . . . . . . . . . . . . 144.17 -4.73 1.6 Allowed Glycine 0 N--CA 1.436 -1.326 0 C-N-CA 120.25 -0.976 . . . . 0.0 112.993 176.604 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 115' ' ' ASN . . . . . 0.68 ' O ' ' HA ' ' B' ' 111' ' ' ALA . 8.9 t30 -117.06 90.83 3.42 Favored 'General case' 0 CA--C 1.507 -0.688 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 -176.236 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 7.5 p -77.44 23.64 0.21 Allowed 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.062 -0.972 . . . . 0.0 111.836 -164.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 117' ' ' SER . . . . . 0.546 ' N ' ' HD3' ' B' ' 118' ' ' PRO . 8.5 t -164.92 66.93 1.25 Allowed Pre-proline 0 C--N 1.311 -1.092 0 CA-C-N 114.293 -1.321 . . . . 0.0 108.664 179.648 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 118' ' ' PRO . . . . . 0.736 ' HG2' ' O ' ' B' ' 107' ' ' TYR . 33.9 Cg_exo -64.56 157.8 53.32 Favored 'Trans proline' 0 C--N 1.328 -0.517 1 C-N-CA 125.444 4.096 . . . . 0.0 112.351 -174.091 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 119' ' ' SER . . . . . 0.63 ' O ' HG12 ' B' ' 123' ' ' ILE . 27.2 m -126.02 -175.56 3.39 Favored 'General case' 0 C--N 1.316 -0.856 0 C-N-CA 120.597 -0.441 . . . . 0.0 110.943 177.076 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 120' ' ' ALA . . . . . 0.863 ' HB1' HD13 ' B' ' 139' ' ' LEU . . . -67.84 -35.24 78.24 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 122.214 1.007 . . . . 0.0 110.014 -166.532 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 121' ' ' LYS . . . . . 0.473 ' HD2' ' N ' ' B' ' 121' ' ' LYS . 4.4 mptp? -74.24 -26.76 60.42 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 113.681 -1.6 . . . . 0.0 109.756 -179.07 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 122' ' ' ASP . . . . . . . . . . . . . 25.8 m-20 -72.57 -41.31 65.85 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 174.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 123' ' ' ILE . . . . . 0.737 HG23 ' HB2' ' B' ' 106' ' ' SER . 36.8 mm -54.11 -48.05 65.78 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.368 0 CA-C-N 114.988 -1.005 . . . . 0.0 109.489 173.655 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 124' ' ' LYS . . . . . 0.867 ' HD2' HD11 ' B' ' 127' ' ' LEU . 2.7 mmmt -62.58 -40.71 97.75 Favored 'General case' 0 N--CA 1.439 -1.011 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.785 -176.545 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 125' ' ' LYS . . . . . . . . . . . . . 42.0 mmtt -50.65 -62.68 1.45 Allowed 'General case' 0 CA--C 1.498 -1.023 0 CA-C-O 121.776 0.798 . . . . 0.0 111.367 170.421 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 126' ' ' ILE . . . . . . . . . . . . . 1.7 mp -56.77 -41.48 75.35 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 CA-C-N 113.756 -1.565 . . . . 0.0 110.758 -169.733 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 127' ' ' LEU . . . . . 0.867 HD11 ' HD2' ' B' ' 124' ' ' LYS . 3.9 pp -79.08 -32.73 44.79 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 -178.548 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 128' ' ' ASP . . . . . 0.513 ' HB2' ' O ' ' B' ' 124' ' ' LYS . 0.6 OUTLIER -70.24 -24.78 63.14 Favored 'General case' 0 CA--C 1.517 -0.323 0 C-N-CA 121.326 -0.15 . . . . 0.0 111.261 -177.587 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 129' ' ' SER . . . . . . . . . . . . . 93.7 p -56.72 -37.19 70.6 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-O 120.928 0.394 . . . . 0.0 111.2 176.722 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 130' ' ' VAL . . . . . 0.784 HG23 HG13 ' B' ' 132' ' ' ILE . 13.0 m -104.69 -2.9 9.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.391 179.471 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 131' ' ' GLY . . . . . . . . . . . . . . . 81.01 36.04 22.76 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 121.029 -0.605 . . . . 0.0 112.882 177.328 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 132' ' ' ILE . . . . . 0.818 HG23 ' HB2' ' A' ' 19' ' ' ASP . 18.6 mt -78.86 131.94 33.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 110.443 -0.206 . . . . 0.0 110.443 177.402 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 133' ' ' GLU . . . . . . . . . . . . . 87.5 mt-10 -77.0 125.24 29.0 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.361 0.6 . . . . 0.0 110.663 -176.197 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 134' ' ' ALA . . . . . 0.491 ' HA ' ' OH ' ' B' ' 103' ' ' TYR . . . -134.99 143.7 46.97 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.381 -0.827 . . . . 0.0 112.135 -173.202 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 135' ' ' ASP . . . . . 0.774 ' HB2' ' HG3' ' B' ' 138' ' ' ARG . 16.2 m-20 -103.11 132.43 49.37 Favored 'General case' 0 C--O 1.252 1.223 0 CA-C-N 115.65 -0.704 . . . . 0.0 109.358 170.515 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 136' ' ' ASP . . . . . 0.987 ' HA ' HD11 ' B' ' 139' ' ' LEU . 17.4 t70 -73.8 -8.61 56.69 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.061 -166.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 137' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -96.11 -29.77 13.9 Favored 'General case' 0 N--CA 1.44 -0.953 0 C-N-CA 120.17 -0.612 . . . . 0.0 110.54 174.374 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 138' ' ' ARG . . . . . 0.774 ' HG3' ' HB2' ' B' ' 135' ' ' ASP . 12.8 mmt180 -68.26 -52.12 37.41 Favored 'General case' 0 CA--C 1.503 -0.86 0 CA-C-O 122.176 0.988 . . . . 0.0 108.665 -175.595 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 139' ' ' LEU . . . . . 0.987 HD11 ' HA ' ' B' ' 136' ' ' ASP . 0.4 OUTLIER -67.47 -30.3 69.97 Favored 'General case' 0 C--O 1.209 -1.038 0 CA-C-N 114.024 -1.444 . . . . 0.0 110.878 -179.528 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 140' ' ' ASN . . . . . 0.624 ' O ' ' HB ' ' B' ' 143' ' ' ILE . 12.1 t30 -75.94 -25.41 55.92 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.591 0.71 . . . . 0.0 109.805 -177.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 141' ' ' LYS . . . . . 0.524 ' HG2' ' O ' ' B' ' 138' ' ' ARG . 2.6 ptmm? -77.94 -38.55 45.13 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 179.056 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 142' ' ' VAL . . . . . 0.628 HG12 ' O ' ' B' ' 139' ' ' LEU . 7.2 p -69.38 -32.98 55.38 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.401 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 175.05 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 143' ' ' ILE . . . . . 0.878 HG12 ' O ' ' B' ' 139' ' ' LEU . 23.5 mm -49.14 -62.56 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.512 -0.486 0 CA-C-O 121.41 0.624 . . . . 0.0 110.001 166.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 144' ' ' SER . . . . . . . . . . . . . 47.4 t -54.08 -34.2 59.52 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 114.608 -1.178 . . . . 0.0 111.695 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 145' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -79.52 -30.79 42.02 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.426 0.528 . . . . 0.0 112.426 -178.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 146' ' ' LEU . . . . . 0.72 HD12 ' CG ' ' B' ' 107' ' ' TYR . 6.6 mt -89.55 -31.79 17.44 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.63 -0.428 . . . . 0.0 110.99 179.021 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 147' ' ' ASN . . . . . 0.489 ' HA ' ' OH ' ' B' ' 107' ' ' TYR . 8.3 t30 -40.52 120.34 1.23 Allowed 'General case' 0 N--CA 1.471 0.587 0 O-C-N 124.079 0.862 . . . . 0.0 112.838 -169.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . 90.89 36.36 6.79 Favored Glycine 0 N--CA 1.447 -0.57 0 CA-C-N 115.342 -0.844 . . . . 0.0 111.905 -177.7 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 149' ' ' LYS . . . . . 0.684 ' HB2' ' O ' ' B' ' 146' ' ' LEU . 5.2 tppt? -116.92 159.29 22.66 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 110.231 -0.285 . . . . 0.0 110.231 -177.45 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 150' ' ' ASN . . . . . 0.573 ' O ' HG23 ' B' ' 154' ' ' VAL . 92.5 m-20 -106.19 89.95 3.21 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 177.056 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 151' ' ' ILE . . . . . 0.855 HG13 HD12 ' B' ' 108' ' ' LEU . 1.8 mp -46.69 -61.87 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 114.223 -1.353 . . . . 0.0 113.604 -166.797 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 152' ' ' GLU . . . . . 0.454 ' O ' ' HB2' ' B' ' 156' ' ' ALA . 22.5 mt-10 -53.96 -34.1 58.75 Favored 'General case' 0 C--O 1.216 -0.672 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 -173.281 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 153' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -81.36 -32.94 32.69 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 120.744 -0.382 . . . . 0.0 110.794 -179.575 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 154' ' ' VAL . . . . . 0.885 ' HB ' HD12 ' B' ' 155' ' ' ILE . 40.0 t -53.26 -48.83 54.73 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 169.828 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 155' ' ' ILE . . . . . 0.885 HD12 ' HB ' ' B' ' 154' ' ' VAL . 1.5 mp -108.5 38.6 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.005 -0.998 . . . . 0.0 110.893 -178.069 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 156' ' ' ALA . . . . . 0.454 ' HB2' ' O ' ' B' ' 152' ' ' GLU . . . -99.25 7.14 45.97 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 107.115 -1.439 . . . . 0.0 107.115 166.179 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 157' ' ' GLN . . . . . . . . . . . . . 25.5 mt-30 -143.05 -43.83 0.3 Allowed 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 112.844 -1.98 . . . . 0.0 109.459 175.748 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 158' ' ' GLY . . . . . . . . . . . . . . . -86.57 47.2 3.69 Favored Glycine 0 CA--C 1.521 0.46 0 CA-C-N 115.439 -0.801 . . . . 0.0 114.217 -173.577 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 159' ' ' ILE . . . . . 0.613 ' HB ' ' CD1' ' A' ' 60' ' ' ILE . 1.8 mp -63.63 -14.6 15.04 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 CA-C-O 121.8 0.81 . . . . 0.0 110.104 176.395 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 160' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.441 -0.994 0 N-CA-C 110.349 -1.1 . . . . 0.0 110.349 179.648 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 12.0 m . . . . . 0 N--CA 1.449 -0.477 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.777 HG13 ' HG ' ' B' ' 112' ' ' LEU . 2.0 t -47.05 -28.61 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.254 -0.884 . . . . 0.0 113.38 -177.027 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . 0.905 ' HB3' ' HA ' ' A' ' 39' ' ' VAL . 69.1 m -70.64 -50.93 31.59 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.864 0.84 . . . . 0.0 109.001 176.278 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.481 ' O ' HG13 ' A' ' 10' ' ' ILE . 40.4 tt0 -57.31 -51.18 70.41 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 114.598 -1.183 . . . . 0.0 109.81 176.454 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.95 HD12 HD12 ' A' ' 10' ' ' ILE . 5.7 tp -58.9 -36.28 74.44 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.547 177.568 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.586 ' HB2' HD23 ' B' ' 112' ' ' LEU . . . -66.65 -35.99 81.49 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 121.199 0.523 . . . . 0.0 110.889 178.532 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.541 ' HB2' HG11 ' A' ' 39' ' ' VAL . 7.4 t -68.0 -42.97 79.9 Favored 'General case' 0 C--O 1.242 0.687 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 179.027 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.95 HD12 HD12 ' A' ' 7' ' ' LEU . 72.0 mt -46.34 -56.77 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.605 0 CA-C-N 113.669 -1.605 . . . . 0.0 109.982 170.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.871 ' HB2' HD13 ' B' ' 109' ' ' LEU . 23.9 m-85 -64.3 -36.76 85.15 Favored 'General case' 0 CA--C 1.512 -0.484 0 CA-C-N 115.441 -0.799 . . . . 0.0 111.271 -174.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.465 ' HA ' ' HG ' ' A' ' 31' ' ' LEU . 18.9 m -56.97 -42.93 81.05 Favored 'General case' 0 C--O 1.243 0.712 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 177.574 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.418 ' HB2' HD11 ' A' ' 51' ' ' LEU . . . -67.17 -31.97 72.74 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.195 175.846 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.734 HD22 HD11 ' A' ' 56' ' ' ILE . 0.3 OUTLIER -63.58 -54.3 38.2 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.316 179.689 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.542 HG12 ' O ' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -60.23 -35.85 64.65 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.412 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 178.868 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.507 ' HA ' HD12 ' A' ' 16' ' ' LEU . 2.3 tp -59.85 -36.06 76.06 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.904 175.616 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . 0.524 ' CD2' ' HB ' ' A' ' 56' ' ' ILE . 70.2 m-70 -73.12 -18.7 61.26 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 116.145 -0.48 . . . . 0.0 112.254 176.479 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -59.37 -38.48 80.56 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 121.074 0.464 . . . . 0.0 110.171 179.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.441 ' CB ' HG12 ' B' ' 132' ' ' ILE . 32.0 t70 -111.25 -4.75 14.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.822 0.82 . . . . 0.0 109.827 176.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.462 ' HG2' ' O ' ' A' ' 17' ' ' HIS . 5.5 mm-40 53.1 48.38 22.39 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-N 114.446 -1.252 . . . . 0.0 110.266 -175.398 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.755 HG22 ' H ' ' A' ' 22' ' ' THR . 13.8 p -100.84 -179.55 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.156 0 CA-C-N 114.903 -1.044 . . . . 0.0 109.966 -170.327 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.755 ' H ' HG22 ' A' ' 21' ' ' VAL . 32.6 p -50.2 141.8 10.82 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 113.608 0.966 . . . . 0.0 113.608 -173.456 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.642 HG12 ' HA ' ' A' ' 48' ' ' ALA . 58.3 t -118.86 111.01 31.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 114.343 -1.298 . . . . 0.0 110.332 -175.2 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.542 ' OG1' ' HE2' ' A' ' 27' ' ' LYS . 77.0 p -143.54 156.67 44.67 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.002 177.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -56.64 -40.23 75.06 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.954 0.407 . . . . 0.0 110.259 177.309 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -56.95 -39.26 74.21 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.294 173.314 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.542 ' HE2' ' OG1' ' A' ' 24' ' ' THR . 1.6 tppt? -63.31 -52.04 63.53 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-O 121.94 0.876 . . . . 0.0 109.093 -179.178 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 27.8 mt -61.0 -38.96 80.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 114.628 -1.169 . . . . 0.0 110.72 179.144 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 11.3 m-80 -61.27 -35.49 77.43 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.782 175.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.91 -47.92 78.67 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.513 176.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.766 ' HB3' HD21 ' B' ' 109' ' ' LEU . 1.2 mm? -58.01 -50.13 74.46 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 121.113 0.482 . . . . 0.0 110.418 174.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.626 HG23 ' O ' ' A' ' 37' ' ' VAL . 57.7 mt -48.34 -48.18 13.77 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 CA-C-N 115.039 -0.982 . . . . 0.0 111.925 178.387 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 22.8 tptm -75.95 -38.82 57.15 Favored 'General case' 0 N--CA 1.433 -1.306 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.799 -174.343 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -67.39 -33.59 75.52 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.964 0.411 . . . . 0.0 110.787 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.529 ' CB ' ' HG ' ' B' ' 109' ' ' LEU . . . -82.44 -36.57 26.49 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.856 177.625 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 97.29 18.15 29.57 Favored Glycine 0 N--CA 1.447 -0.591 0 CA-C-N 115.733 -0.667 . . . . 0.0 112.017 179.483 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.891 ' HB ' ' HA2' ' B' ' 113' ' ' GLY . 2.7 p -121.91 120.84 62.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 121.583 0.706 . . . . 0.0 111.104 -176.216 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -93.69 155.22 17.37 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 114.504 -1.226 . . . . 0.0 110.891 -170.599 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.905 ' HA ' ' HB3' ' A' ' 5' ' ' SER . 97.8 t -127.22 161.3 34.72 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-N 115.102 -0.954 . . . . 0.0 110.593 -170.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.511 ' HB3' ' HD1' ' A' ' 43' ' ' TRP . 3.8 tp10 -67.55 105.49 0.92 Allowed Pre-proline 0 N--CA 1.444 -0.731 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 170.882 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.49 ' C ' ' HD2' ' A' ' 44' ' ' PRO . 76.9 Cg_exo -50.93 -30.5 30.69 Favored 'Trans proline' 0 C--O 1.252 1.175 0 C-N-CA 123.599 2.866 . . . . 0.0 115.6 -163.657 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.402 ' CE2' ' HG2' ' A' ' 40' ' ' GLU . 0.8 OUTLIER -60.04 -28.3 67.65 Favored 'General case' 0 C--N 1.334 -0.097 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 178.167 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . 0.511 ' HD1' ' HB3' ' A' ' 40' ' ' GLU . 7.9 m95 -62.82 -61.66 7.09 Favored Pre-proline 0 C--O 1.205 -1.24 0 CA-C-O 118.27 -0.871 . . . . 0.0 110.725 176.56 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.49 ' HD2' ' C ' ' A' ' 41' ' ' PRO . 99.3 Cg_exo -44.98 -46.24 13.27 Favored 'Trans proline' 0 C--N 1.36 1.145 0 C-N-CA 121.811 1.674 . . . . 0.0 111.981 175.346 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -59.12 -61.58 7.18 Favored Glycine 0 CA--C 1.525 0.68 0 C-N-CA 120.172 -1.013 . . . . 0.0 112.491 177.771 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 4.5 tp -67.08 -22.61 65.83 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 122.887 0.475 . . . . 0.0 111.714 -176.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.461 ' HD2' HD11 ' A' ' 51' ' ' LEU . 2.0 m-85 -69.76 -46.41 65.88 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 175.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.642 ' HA ' HG12 ' A' ' 23' ' ' VAL . . . -65.05 -32.22 73.83 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.805 0.812 . . . . 0.0 109.237 178.216 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 11.1 mmmt -66.72 -49.44 66.03 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 114.303 -1.317 . . . . 0.0 111.938 174.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -84.74 -34.75 22.81 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 113.3 0.852 . . . . 0.0 113.3 -169.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.503 ' HB2' HG11 ' A' ' 23' ' ' VAL . 9.7 mt -67.07 -0.8 3.51 Favored 'General case' 0 N--CA 1.462 0.165 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 -175.281 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -85.89 -14.99 43.18 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.974 0.416 . . . . 0.0 110.353 174.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 91.8 m-20 -123.05 -49.89 1.94 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.717 -179.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 3.8 m -88.28 166.97 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.584 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.399 -179.242 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 -113.95 179.38 3.97 Favored 'General case' 0 C--N 1.312 -1.023 0 C-N-CA 120.475 -0.49 . . . . 0.0 109.783 176.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.734 HD11 HD22 ' A' ' 14' ' ' LEU . 4.6 tp -64.16 -25.35 37.86 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 CA-C-O 120.868 0.366 . . . . 0.0 111.025 -176.345 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -70.47 -15.26 72.79 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.631 -0.795 . . . . 0.0 111.151 178.132 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 33.3 t -78.64 -20.98 49.08 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-O 120.911 0.386 . . . . 0.0 110.184 179.544 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.733 ' HB2' HG21 ' B' ' 159' ' ' ILE . 20.9 mt -65.98 -26.96 67.8 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.859 0.838 . . . . 0.0 110.482 -178.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.706 HG13 ' HB ' ' B' ' 159' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--N 1.317 -0.819 0 CA-C-N 114.418 -1.264 . . . . 0.0 110.509 178.685 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 103' ' ' TYR . . . . . 0.887 ' HB2' HG11 ' B' ' 142' ' ' VAL . 58.1 m-85 . . . . . 0 C--O 1.242 0.662 0 CA-C-O 121.023 0.439 . . . . 0.0 110.616 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 104' ' ' VAL . . . . . 0.729 ' HA ' HD11 ' B' ' 146' ' ' LEU . 90.2 t -45.0 -49.08 2.72 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.353 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.31 172.201 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 105' ' ' ALA . . . . . 0.67 ' HA ' HD22 ' B' ' 108' ' ' LEU . . . -62.86 -41.1 99.24 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.271 -1.331 . . . . 0.0 112.088 -174.323 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 106' ' ' SER . . . . . 0.872 ' HB2' HG23 ' B' ' 123' ' ' ILE . 1.0 OUTLIER -62.73 -38.92 92.42 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.58 0.705 . . . . 0.0 109.538 179.296 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 107' ' ' TYR . . . . . 0.696 ' CG ' HD12 ' B' ' 146' ' ' LEU . 39.5 t80 -62.04 -46.71 87.94 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 114.443 -1.253 . . . . 0.0 108.748 178.48 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 108' ' ' LEU . . . . . 0.832 HD12 HG13 ' B' ' 151' ' ' ILE . 0.0 OUTLIER -58.66 -46.92 86.12 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 114.409 -1.268 . . . . 0.0 111.088 177.882 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 109' ' ' LEU . . . . . 0.871 HD13 ' HB2' ' A' ' 11' ' ' TYR . 7.2 tp -55.43 -49.33 72.7 Favored 'General case' 0 CA--C 1.513 -0.474 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.793 179.672 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -62.76 -42.63 99.77 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.809 -177.625 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 111' ' ' ALA . . . . . 0.606 ' HA ' ' O ' ' B' ' 115' ' ' ASN . . . -65.64 -27.66 68.55 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.874 179.659 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 112' ' ' LEU . . . . . 0.777 ' HG ' HG13 ' A' ' 4' ' ' VAL . 2.3 mp -78.5 -37.79 42.35 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.007 175.351 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 113' ' ' GLY . . . . . 0.891 ' HA2' ' HB ' ' A' ' 37' ' ' VAL . . . -63.5 -38.88 97.01 Favored Glycine 0 CA--C 1.503 -0.657 0 CA-C-N 115.125 -0.943 . . . . 0.0 111.972 -179.038 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 114' ' ' GLY . . . . . . . . . . . . . . . 159.78 -4.08 0.1 Allowed Glycine 0 N--CA 1.44 -1.072 0 C-N-CA 120.144 -1.027 . . . . 0.0 113.029 177.456 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 115' ' ' ASN . . . . . 0.606 ' O ' ' HA ' ' B' ' 111' ' ' ALA . 45.0 t30 -116.18 86.04 2.41 Favored 'General case' 0 N--CA 1.44 -0.956 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 -176.571 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 116' ' ' SER . . . . . 0.482 ' HA ' ' CB ' ' B' ' 111' ' ' ALA . 3.3 m -78.56 28.46 0.2 Allowed 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 122.239 1.019 . . . . 0.0 110.763 -169.181 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 117' ' ' SER . . . . . 0.536 ' N ' ' HD3' ' B' ' 118' ' ' PRO . 22.7 t -166.19 67.3 1.05 Allowed Pre-proline 0 C--N 1.308 -1.222 0 CA-C-N 113.495 -1.684 . . . . 0.0 107.92 178.211 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 118' ' ' PRO . . . . . 0.635 ' HD2' ' CZ ' ' B' ' 107' ' ' TYR . 26.9 Cg_exo -67.36 165.35 27.24 Favored 'Trans proline' 0 C--O 1.235 0.36 1 C-N-CA 125.44 4.093 . . . . 0.0 112.257 -173.36 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 119' ' ' SER . . . . . 0.664 ' O ' HG12 ' B' ' 123' ' ' ILE . 96.9 p -130.82 -178.5 4.83 Favored 'General case' 0 C--N 1.319 -0.753 0 C-N-CA 120.464 -0.494 . . . . 0.0 110.784 176.258 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 120' ' ' ALA . . . . . 0.813 ' HB1' HD13 ' B' ' 139' ' ' LEU . . . -67.7 -37.75 82.72 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 122.117 0.96 . . . . 0.0 109.387 -172.886 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 121' ' ' LYS . . . . . 0.439 ' HD2' ' N ' ' B' ' 121' ' ' LYS . 0.5 OUTLIER -61.51 -36.26 80.03 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 113.588 -1.642 . . . . 0.0 109.944 176.046 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 122' ' ' ASP . . . . . 0.424 ' O ' ' HB2' ' B' ' 125' ' ' LYS . 16.8 t0 -71.94 -39.01 69.72 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 115.529 -0.76 . . . . 0.0 109.18 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 123' ' ' ILE . . . . . 0.872 HG23 ' HB2' ' B' ' 106' ' ' SER . 27.9 mm -59.93 -45.66 94.9 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 CA-C-N 115.43 -0.805 . . . . 0.0 109.847 175.243 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 124' ' ' LYS . . . . . 0.71 ' HD3' HD21 ' B' ' 139' ' ' LEU . 5.5 mmmp? -59.21 -41.62 89.03 Favored 'General case' 0 CA--C 1.501 -0.927 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.559 -178.771 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 125' ' ' LYS . . . . . 0.424 ' HB2' ' O ' ' B' ' 122' ' ' ASP . 43.5 mmtt -52.45 -63.49 1.13 Allowed 'General case' 0 CA--C 1.496 -1.111 0 CA-C-O 121.668 0.747 . . . . 0.0 111.502 172.793 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 126' ' ' ILE . . . . . . . . . . . . . 1.7 mp -55.3 -42.73 68.01 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.416 0 CA-C-N 113.963 -1.471 . . . . 0.0 111.368 -168.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 127' ' ' LEU . . . . . 0.713 ' HG ' ' O ' ' B' ' 123' ' ' ILE . 2.6 pp -82.04 -26.17 33.98 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.619 -0.433 . . . . 0.0 112.117 -177.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 128' ' ' ASP . . . . . 0.42 ' N ' HD12 ' B' ' 127' ' ' LEU . 20.4 t70 -71.83 -30.11 65.12 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 120.982 -0.287 . . . . 0.0 110.478 -179.283 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 129' ' ' SER . . . . . . . . . . . . . 90.2 p -52.81 -44.26 66.52 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.382 179.144 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 130' ' ' VAL . . . . . 0.417 ' CG2' HD12 ' B' ' 132' ' ' ILE . 12.7 m -88.03 -24.58 6.16 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 116.539 -0.301 . . . . 0.0 111.447 178.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 131' ' ' GLY . . . . . . . . . . . . . . . 109.74 25.06 5.58 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.306 -0.95 . . . . 0.0 113.175 176.04 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 132' ' ' ILE . . . . . 0.441 HG12 ' CB ' ' A' ' 19' ' ' ASP . 3.2 mt -85.26 132.82 30.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 116.943 0.371 . . . . 0.0 110.092 176.334 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 133' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -91.03 137.11 32.61 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.192 0.52 . . . . 0.0 110.457 -177.614 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 134' ' ' ALA . . . . . . . . . . . . . . . -143.14 143.83 31.97 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.608 -172.397 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 135' ' ' ASP . . . . . 0.759 ' HB2' ' CG ' ' B' ' 138' ' ' ARG . 4.1 m-20 -80.53 125.6 30.18 Favored 'General case' 0 C--O 1.258 1.523 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 172.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 136' ' ' ASP . . . . . 1.021 ' HA ' HD11 ' B' ' 139' ' ' LEU . 5.4 p-10 -72.11 2.06 6.43 Favored 'General case' 0 CA--C 1.514 -0.406 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.524 -173.261 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 137' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -102.93 -36.49 8.19 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.398 174.729 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 138' ' ' ARG . . . . . 0.759 ' CG ' ' HB2' ' B' ' 135' ' ' ASP . 24.9 mmt180 -67.23 -43.5 81.85 Favored 'General case' 0 CA--C 1.505 -0.766 0 CA-C-O 122.317 1.056 . . . . 0.0 108.626 -174.544 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 139' ' ' LEU . . . . . 1.021 HD11 ' HA ' ' B' ' 136' ' ' ASP . 0.4 OUTLIER -72.96 -32.29 65.13 Favored 'General case' 0 C--O 1.209 -1.053 0 CA-C-N 114.423 -1.262 . . . . 0.0 111.034 179.183 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 140' ' ' ASN . . . . . 0.581 ' O ' ' HB ' ' B' ' 143' ' ' ILE . 67.1 t30 -66.36 -25.53 66.85 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 122.29 1.043 . . . . 0.0 108.871 177.41 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 141' ' ' LYS . . . . . 0.513 ' HB3' ' O ' ' B' ' 138' ' ' ARG . 11.8 tppt? -70.4 -52.24 23.79 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 114.199 -1.364 . . . . 0.0 109.707 176.027 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 142' ' ' VAL . . . . . 0.887 HG11 ' HB2' ' B' ' 103' ' ' TYR . 7.9 p -61.82 -33.07 56.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.181 -0.463 . . . . 0.0 109.92 177.422 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 143' ' ' ILE . . . . . 0.87 HG12 ' O ' ' B' ' 139' ' ' LEU . 29.9 mm -50.24 -61.75 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.374 0 CA-C-O 121.426 0.632 . . . . 0.0 110.052 169.532 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 144' ' ' SER . . . . . . . . . . . . . 45.3 t -54.88 -32.26 60.68 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 114.331 -1.304 . . . . 0.0 111.716 -179.759 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 145' ' ' GLU . . . . . . . . . . . . . 68.4 mm-40 -80.01 -34.69 38.25 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.378 0.51 . . . . 0.0 112.378 -179.281 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 146' ' ' LEU . . . . . 0.729 HD11 ' HA ' ' B' ' 104' ' ' VAL . 7.2 mt -87.63 -19.99 26.97 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 121.021 -0.272 . . . . 0.0 110.832 -178.568 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 147' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -53.97 108.79 0.39 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.13 -177.255 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . 108.99 18.99 8.84 Favored Glycine 0 N--CA 1.449 -0.436 0 CA-C-N 115.356 -0.838 . . . . 0.0 112.454 -179.283 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 149' ' ' LYS . . . . . 0.458 ' HB2' ' O ' ' B' ' 146' ' ' LEU . 0.2 OUTLIER -109.09 171.54 7.37 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.87 0.367 . . . . 0.0 110.646 -178.937 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 150' ' ' ASN . . . . . 0.591 ' O ' HG23 ' B' ' 154' ' ' VAL . 10.6 m-80 -110.24 89.12 2.93 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 178.423 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 151' ' ' ILE . . . . . 0.832 HG13 HD12 ' B' ' 108' ' ' LEU . 1.8 mp -41.87 -63.74 0.17 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.357 0 N-CA-C 113.775 1.028 . . . . 0.0 113.775 -166.447 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 152' ' ' GLU . . . . . 0.702 ' HG3' HD11 ' B' ' 112' ' ' LEU . 3.3 mp0 -59.85 -36.4 76.77 Favored 'General case' 0 C--O 1.209 -1.046 0 C-N-CA 120.508 -0.477 . . . . 0.0 111.105 -174.698 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 153' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -73.51 -27.72 61.51 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 120.73 0.3 . . . . 0.0 110.815 -179.329 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 154' ' ' VAL . . . . . 0.834 ' HB ' HD12 ' B' ' 155' ' ' ILE . 46.4 t -60.3 -48.78 86.84 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 171.15 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 155' ' ' ILE . . . . . 0.834 HD12 ' HB ' ' B' ' 154' ' ' VAL . 3.3 mp -106.65 33.94 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 122.11 0.957 . . . . 0.0 110.973 -177.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 156' ' ' ALA . . . . . 0.413 ' HB2' ' O ' ' B' ' 152' ' ' GLU . . . -99.37 -1.34 39.01 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 169.531 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 157' ' ' GLN . . . . . . . . . . . . . 23.2 mt-30 -139.55 -2.76 1.55 Allowed 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 113.333 -1.758 . . . . 0.0 109.678 175.141 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 158' ' ' GLY . . . . . . . . . . . . . . . -134.48 45.79 1.09 Allowed Glycine 0 C--O 1.225 -0.411 0 C-N-CA 120.603 -0.808 . . . . 0.0 114.077 -168.383 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 159' ' ' ILE . . . . . 0.733 HG21 ' HB2' ' A' ' 59' ' ' LEU . 1.8 mp -59.26 -25.76 31.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 CA-C-O 121.011 0.434 . . . . 0.0 110.854 176.757 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 160' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.517 0 C-N-CA 120.562 -0.828 . . . . 0.0 112.653 179.279 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 92.9 p . . . . . 0 N--CA 1.443 -0.803 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.678 HG13 ' HG ' ' B' ' 112' ' ' LEU . 1.9 t -50.85 -22.47 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 CA-C-N 114.373 -1.285 . . . . 0.0 112.442 -179.773 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . 0.83 ' HB3' ' HA ' ' A' ' 39' ' ' VAL . 63.0 m -73.17 -52.25 14.86 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.209 0.528 . . . . 0.0 109.598 175.773 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.624 ' HG2' ' NE1' ' A' ' 43' ' ' TRP . 36.7 mt-10 -57.86 -51.22 70.52 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.67 177.805 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.792 HD12 HD12 ' A' ' 10' ' ' ILE . 3.6 tp -58.2 -37.28 74.47 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.178 -0.919 . . . . 0.0 111.746 177.741 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.6 ' HB2' HD23 ' B' ' 112' ' ' LEU . . . -67.43 -34.0 76.33 Favored 'General case' 0 N--CA 1.468 0.428 0 O-C-N 121.958 -0.464 . . . . 0.0 111.115 178.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.523 ' HB2' HG11 ' A' ' 39' ' ' VAL . 6.8 t -71.29 -37.2 71.85 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 178.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.792 HD12 HD12 ' A' ' 7' ' ' LEU . 66.9 mt -50.53 -55.57 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.809 0 CA-C-N 114.29 -1.323 . . . . 0.0 109.684 170.202 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.72 ' HB2' HD13 ' B' ' 109' ' ' LEU . 23.5 m-85 -67.04 -43.7 82.09 Favored 'General case' 0 C--O 1.219 -0.514 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.964 -173.454 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.7 p -55.08 -41.82 72.03 Favored 'General case' 0 C--O 1.239 0.526 0 CA-C-O 121.15 0.5 . . . . 0.0 109.947 176.409 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.416 ' CB ' HD11 ' A' ' 51' ' ' LEU . . . -62.64 -35.33 79.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.913 172.681 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.778 HD22 HD11 ' A' ' 56' ' ' ILE . 0.4 OUTLIER -62.73 -54.48 38.5 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.868 179.573 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.432 HG12 ' H ' ' A' ' 15' ' ' ILE . 0.0 OUTLIER -57.39 -45.65 85.48 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 CA-C-O 121.048 0.451 . . . . 0.0 110.048 177.302 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.511 HD11 ' HG2' ' A' ' 27' ' ' LYS . 5.7 tp -55.85 -40.54 73.03 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.577 0.703 . . . . 0.0 110.845 177.589 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 15.0 t60 -75.68 -11.28 59.97 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 114.722 -1.126 . . . . 0.0 111.999 -179.294 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -74.93 -45.83 39.82 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 121.871 -0.518 . . . . 0.0 110.437 178.178 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.501 ' OD2' ' HB ' ' A' ' 21' ' ' VAL . 29.3 t70 -88.89 -11.49 44.45 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.732 0.777 . . . . 0.0 109.085 177.713 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 56.18 48.98 16.3 Favored 'General case' 0 CA--C 1.516 -0.348 0 CA-C-N 113.975 -1.466 . . . . 0.0 109.626 -175.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.501 ' HB ' ' OD2' ' A' ' 19' ' ' ASP . 7.6 p -101.75 168.41 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.479 0 CA-C-N 114.519 -1.219 . . . . 0.0 109.586 -170.596 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.445 ' N ' HG22 ' A' ' 21' ' ' VAL . 45.5 p -43.97 129.52 5.89 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-O 121.77 0.795 . . . . 0.0 113.105 -175.147 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.699 HG12 ' HA ' ' A' ' 48' ' ' ALA . 60.0 t -103.97 108.63 25.06 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.041 0 CA-C-N 114.299 -1.319 . . . . 0.0 110.182 -176.058 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.534 ' OG1' ' HB2' ' A' ' 27' ' ' LYS . 70.4 p -140.61 151.98 45.09 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.02 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -51.78 -45.56 63.84 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.082 0.467 . . . . 0.0 110.258 177.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -62.54 -31.13 71.87 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.736 179.163 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.534 ' HB2' ' OG1' ' A' ' 24' ' ' THR . 4.0 tppt? -67.48 -49.42 63.59 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-O 122.032 0.92 . . . . 0.0 108.573 178.075 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 86.3 mt -60.75 -40.54 85.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 114.296 -1.32 . . . . 0.0 110.445 177.549 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -61.15 -35.41 77.01 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.567 175.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.82 -45.69 91.44 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.724 175.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.672 ' HB3' HD21 ' B' ' 109' ' ' LEU . 1.4 mm? -61.99 -46.31 89.8 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 121.017 0.437 . . . . 0.0 110.438 174.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.579 HG23 ' O ' ' A' ' 37' ' ' VAL . 44.2 mt -50.07 -48.18 23.63 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 CA-C-N 115.273 -0.876 . . . . 0.0 111.412 177.799 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 22.7 tptp -72.78 -39.68 66.55 Favored 'General case' 0 N--CA 1.438 -1.055 0 CA-C-N 115.707 -0.678 . . . . 0.0 111.45 -178.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.655 ' HB1' ' HA ' ' B' ' 126' ' ' ILE . . . -56.89 -48.75 77.45 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.195 0.521 . . . . 0.0 110.845 179.842 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.442 ' CB ' ' HG ' ' B' ' 109' ' ' LEU . . . -76.83 -37.41 55.71 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.066 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 99.06 20.74 17.44 Favored Glycine 0 N--CA 1.449 -0.438 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.767 -178.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.839 ' HB ' ' HA2' ' B' ' 113' ' ' GLY . 3.0 p -122.57 121.87 64.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 121.443 0.639 . . . . 0.0 110.646 -176.742 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.462 ' HA ' HG23 ' A' ' 32' ' ' ILE . 61.5 t30 -96.41 156.54 16.3 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 114.773 -1.103 . . . . 0.0 111.0 -170.012 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.83 ' HA ' ' HB3' ' A' ' 5' ' ' SER . 93.3 t -126.82 159.95 35.85 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.075 0 CA-C-N 115.01 -0.995 . . . . 0.0 110.356 -172.561 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.511 ' HB3' ' HD1' ' A' ' 43' ' ' TRP . 3.5 tp10 -67.44 107.23 1.61 Allowed Pre-proline 0 N--CA 1.44 -0.932 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 169.6 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.477 ' C ' ' HD2' ' A' ' 44' ' ' PRO . 73.7 Cg_exo -51.35 -28.07 25.84 Favored 'Trans proline' 0 C--O 1.249 1.034 0 C-N-CA 123.598 2.866 . . . . 0.0 115.304 -164.828 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.43 ' HD2' ' CG ' ' A' ' 40' ' ' GLU . 0.5 OUTLIER -60.19 -27.01 66.79 Favored 'General case' 0 C--N 1.333 -0.15 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 177.645 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . 0.624 ' NE1' ' HG2' ' A' ' 6' ' ' GLU . 22.5 m95 -65.36 -60.12 8.33 Favored Pre-proline 0 C--O 1.204 -1.331 0 CA-C-O 118.373 -0.822 . . . . 0.0 110.743 175.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.477 ' HD2' ' C ' ' A' ' 41' ' ' PRO . 74.7 Cg_exo -44.1 -44.66 12.37 Favored 'Trans proline' 0 C--N 1.357 1.004 0 C-N-CA 121.671 1.58 . . . . 0.0 112.203 173.654 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -62.0 -56.49 22.13 Favored Glycine 0 CA--C 1.525 0.712 0 C-N-CA 120.238 -0.982 . . . . 0.0 112.952 176.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.461 ' O ' ' HB2' ' A' ' 49' ' ' LYS . 9.4 tp -69.78 -23.01 63.28 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 122.91 0.484 . . . . 0.0 111.821 -176.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.519 ' HE1' ' CE3' ' A' ' 43' ' ' TRP . 3.1 m-85 -73.48 -43.78 59.4 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 109.962 -0.384 . . . . 0.0 109.962 175.605 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.699 ' HA ' HG12 ' A' ' 23' ' ' VAL . . . -63.67 -33.14 74.97 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 177.074 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.461 ' HB2' ' O ' ' A' ' 46' ' ' LEU . 9.6 mmmt -62.68 -62.26 1.85 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 114.569 -1.196 . . . . 0.0 111.701 171.187 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.473 ' O ' HG22 ' A' ' 54' ' ' VAL . . . -69.77 -41.26 75.4 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 113.114 0.783 . . . . 0.0 113.114 -169.408 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.542 ' HB2' HG11 ' A' ' 23' ' ' VAL . 12.4 mt -65.64 -10.98 40.78 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.75 0.309 . . . . 0.0 111.792 -174.37 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -84.59 0.22 50.86 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.303 177.217 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -141.22 -47.03 0.39 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.234 -179.119 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.473 HG22 ' O ' ' A' ' 50' ' ' ALA . 5.8 m -91.08 -175.19 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.847 0.356 . . . . 0.0 110.33 -177.473 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 16.4 m120 -116.03 169.47 9.23 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.734 178.16 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.778 HD11 HD22 ' A' ' 14' ' ' LEU . 3.2 tp -61.35 -25.09 35.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.551 178.603 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -70.83 -11.94 70.18 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.691 -0.766 . . . . 0.0 111.36 179.277 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 22.9 t -81.34 -23.71 37.59 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-O 121.323 0.582 . . . . 0.0 109.817 179.433 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.743 ' HB2' HG21 ' B' ' 159' ' ' ILE . 26.3 mt -62.32 -31.19 71.78 Favored 'General case' 0 CA--C 1.517 -0.314 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.751 -178.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.887 HG13 ' HB ' ' B' ' 159' ' ' ILE . 0.1 OUTLIER . . . . . 0 C--N 1.321 -0.653 0 CA-C-N 114.904 -1.044 . . . . 0.0 110.888 -179.647 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 103' ' ' TYR . . . . . 0.565 ' HB2' HG11 ' B' ' 142' ' ' VAL . 47.3 m-85 . . . . . 0 CA--C 1.521 -0.135 0 CA-C-O 121.354 0.597 . . . . 0.0 109.766 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 104' ' ' VAL . . . . . 0.555 HG12 ' CD2' ' B' ' 108' ' ' LEU . 48.2 t -46.45 -45.95 6.78 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.519 0 CA-C-N 114.71 -1.132 . . . . 0.0 110.13 173.806 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 105' ' ' ALA . . . . . 0.613 ' CB ' ' HB3' ' A' ' 14' ' ' LEU . . . -66.22 -39.37 89.54 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 114.822 -1.081 . . . . 0.0 111.656 -174.703 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 106' ' ' SER . . . . . 0.713 ' HB2' HG23 ' B' ' 123' ' ' ILE . 1.0 OUTLIER -62.87 -35.39 79.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.666 0.746 . . . . 0.0 109.066 176.567 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 107' ' ' TYR . . . . . 0.779 ' HD2' HG12 ' B' ' 143' ' ' ILE . 32.7 t80 -65.23 -51.61 59.86 Favored 'General case' 0 N--CA 1.445 -0.722 0 CA-C-N 114.483 -1.235 . . . . 0.0 108.625 179.093 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 108' ' ' LEU . . . . . 0.868 HD12 HG13 ' B' ' 151' ' ' ILE . 0.0 OUTLIER -56.62 -46.83 80.71 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-N 114.99 -1.004 . . . . 0.0 110.769 177.227 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 109' ' ' LEU . . . . . 0.72 HD13 ' HB2' ' A' ' 11' ' ' TYR . 9.4 tp -52.98 -49.06 66.9 Favored 'General case' 0 CA--C 1.512 -0.494 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.665 178.434 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 110' ' ' ALA . . . . . 0.583 ' HB3' ' HB3' ' B' ' 118' ' ' PRO . . . -66.45 -36.43 82.75 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.134 -176.719 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 111' ' ' ALA . . . . . 0.816 ' HA ' ' O ' ' B' ' 115' ' ' ASN . . . -70.63 -19.99 62.77 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.354 0.597 . . . . 0.0 111.023 179.101 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 112' ' ' LEU . . . . . 0.751 ' HB3' HG21 ' A' ' 37' ' ' VAL . 5.6 mp -86.53 -37.24 18.39 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.084 171.284 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 113' ' ' GLY . . . . . 0.839 ' HA2' ' HB ' ' A' ' 37' ' ' VAL . . . -66.26 -39.35 94.36 Favored Glycine 0 N--CA 1.444 -0.798 0 CA-C-N 115.054 -0.975 . . . . 0.0 113.117 -176.389 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 114' ' ' GLY . . . . . . . . . . . . . . . 164.17 6.97 0.04 OUTLIER Glycine 0 N--CA 1.442 -0.901 0 C-N-CA 119.514 -1.327 . . . . 0.0 114.051 178.457 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 115' ' ' ASN . . . . . 0.816 ' O ' ' HA ' ' B' ' 111' ' ' ALA . 95.7 m-20 -130.92 98.0 4.48 Favored 'General case' 0 CA--C 1.494 -1.183 0 CA-C-N 118.061 0.93 . . . . 0.0 108.827 178.165 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 2.5 p -76.02 29.08 0.11 Allowed 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 122.533 1.158 . . . . 0.0 109.818 -178.352 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 117' ' ' SER . . . . . 0.614 ' H ' ' C ' ' B' ' 115' ' ' ASN . 23.2 t -169.95 71.18 0.63 Allowed Pre-proline 0 N--CA 1.447 -0.61 0 CA-C-N 113.261 -1.79 . . . . 0.0 107.93 179.694 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 118' ' ' PRO . . . . . 0.616 ' HD2' ' CZ ' ' B' ' 107' ' ' TYR . 21.0 Cg_exo -71.81 152.39 58.23 Favored 'Trans proline' 0 C--N 1.33 -0.42 1 C-N-CA 125.352 4.034 . . . . 0.0 111.722 -177.102 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 119' ' ' SER . . . . . 0.536 ' O ' HG12 ' B' ' 123' ' ' ILE . 78.9 p -123.09 -175.47 3.19 Favored 'General case' 0 C--N 1.317 -0.824 0 C-N-CA 119.998 -0.681 . . . . 0.0 111.606 178.003 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 120' ' ' ALA . . . . . 0.78 ' HB1' HD13 ' B' ' 139' ' ' LEU . . . -66.58 -39.98 88.72 Favored 'General case' 0 CA--C 1.507 -0.682 0 CA-C-O 121.785 0.802 . . . . 0.0 109.315 -170.347 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 121' ' ' LYS . . . . . 0.406 ' HD2' ' N ' ' B' ' 121' ' ' LYS . 13.8 mptt -58.99 -37.38 76.71 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 113.932 -1.485 . . . . 0.0 111.108 174.642 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 122' ' ' ASP . . . . . 0.401 ' O ' ' HD2' ' B' ' 125' ' ' LYS . 21.1 m-20 -69.56 -40.04 77.02 Favored 'General case' 0 CA--C 1.517 -0.299 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.33 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 123' ' ' ILE . . . . . 0.75 ' CG1' HD11 ' B' ' 143' ' ' ILE . 33.2 mm -59.29 -50.84 78.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.959 176.236 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 124' ' ' LYS . . . . . 0.85 ' HD3' HD21 ' B' ' 139' ' ' LEU . 3.7 mmmp? -59.91 -31.66 70.03 Favored 'General case' 0 C--O 1.216 -0.686 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.789 -178.802 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 125' ' ' LYS . . . . . 0.735 ' HD2' HD12 ' B' ' 126' ' ' ILE . 0.0 OUTLIER -71.92 -48.08 47.94 Favored 'General case' 0 N--CA 1.431 -1.384 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.935 -179.773 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 126' ' ' ILE . . . . . 0.735 HD12 ' HD2' ' B' ' 125' ' ' LYS . 1.1 mp -55.56 -51.01 62.54 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 CA-C-O 120.604 0.24 . . . . 0.0 110.941 176.031 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 127' ' ' LEU . . . . . 0.689 ' HG ' ' O ' ' B' ' 123' ' ' ILE . 1.8 pp -76.82 -24.09 52.76 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.605 -0.438 . . . . 0.0 111.629 -175.852 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 128' ' ' ASP . . . . . 0.533 ' HB2' ' O ' ' B' ' 124' ' ' LYS . 24.9 t70 -65.53 -32.86 74.69 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 175.589 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 129' ' ' SER . . . . . 0.508 ' HB2' ' HB2' ' A' ' 34' ' ' ALA . 7.1 t -56.5 -33.12 65.71 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-N 115.714 -0.676 . . . . 0.0 111.827 176.835 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 130' ' ' VAL . . . . . 0.443 HG23 HG13 ' B' ' 132' ' ' ILE . 2.5 m -108.63 -8.48 11.12 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 O-C-N 122.098 -0.376 . . . . 0.0 111.904 178.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 131' ' ' GLY . . . . . . . . . . . . . . . 87.26 27.11 28.86 Favored Glycine 0 CA--C 1.519 0.342 0 C-N-CA 121.036 -0.602 . . . . 0.0 113.18 175.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 132' ' ' ILE . . . . . 0.525 ' O ' HD13 ' B' ' 127' ' ' LEU . 17.9 mt -85.09 128.3 39.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.669 0.234 . . . . 0.0 110.854 -179.059 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 133' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -76.53 133.16 39.81 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.124 0.487 . . . . 0.0 111.385 -176.185 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 134' ' ' ALA . . . . . 0.493 ' HB2' HD22 ' B' ' 127' ' ' LEU . . . -139.9 143.94 36.92 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.769 -174.677 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 135' ' ' ASP . . . . . 0.808 ' HB2' ' HG3' ' B' ' 138' ' ' ARG . 5.5 m-20 -88.88 127.97 35.65 Favored 'General case' 0 C--O 1.256 1.416 0 CA-C-O 121.261 0.553 . . . . 0.0 109.712 176.234 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 136' ' ' ASP . . . . . 0.993 ' HA ' HD11 ' B' ' 139' ' ' LEU . 9.0 p-10 -78.07 2.08 18.99 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-N 115.127 -0.942 . . . . 0.0 111.587 -166.593 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 137' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -105.57 -32.76 8.34 Favored 'General case' 0 N--CA 1.44 -0.932 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.189 170.65 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 138' ' ' ARG . . . . . 0.808 ' HG3' ' HB2' ' B' ' 135' ' ' ASP . 11.8 mmt85 -63.32 -47.6 81.53 Favored 'General case' 0 CA--C 1.504 -0.803 0 CA-C-O 121.781 0.8 . . . . 0.0 109.425 -175.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 139' ' ' LEU . . . . . 0.993 HD11 ' HA ' ' B' ' 136' ' ' ASP . 0.3 OUTLIER -71.81 -39.43 69.84 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 114.653 -1.158 . . . . 0.0 111.356 -179.151 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 140' ' ' ASN . . . . . 0.682 ' H ' HD12 ' B' ' 139' ' ' LEU . 11.0 t30 -62.98 -29.38 70.77 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-O 121.571 0.701 . . . . 0.0 109.11 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 141' ' ' LYS . . . . . . . . . . . . . 18.4 tttm -72.09 -52.42 16.86 Favored 'General case' 0 C--O 1.242 0.699 0 CA-C-N 114.672 -1.149 . . . . 0.0 110.358 178.271 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 142' ' ' VAL . . . . . 0.62 HG12 ' O ' ' B' ' 139' ' ' LEU . 11.7 p -56.93 -42.34 78.48 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.743 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.721 -179.013 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 143' ' ' ILE . . . . . 0.779 HG12 ' HD2' ' B' ' 107' ' ' TYR . 34.6 mt -59.39 -49.73 82.45 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 C-N-CA 123.554 0.742 . . . . 0.0 112.792 174.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 144' ' ' SER . . . . . . . . . . . . . 66.3 m -53.26 -33.93 55.14 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 115.668 -0.697 . . . . 0.0 111.294 178.191 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 145' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -87.5 -33.63 18.92 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 120.981 0.419 . . . . 0.0 111.606 176.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 146' ' ' LEU . . . . . 0.529 HD11 HG13 ' B' ' 104' ' ' VAL . 0.3 OUTLIER -70.83 -31.92 68.8 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 123.374 0.67 . . . . 0.0 111.511 -179.01 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 147' ' ' ASN . . . . . . . . . . . . . 23.3 t-20 -56.04 124.86 19.19 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.973 -177.502 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . 101.86 28.37 6.62 Favored Glycine 0 N--CA 1.449 -0.495 0 CA-C-N 115.636 -0.711 . . . . 0.0 112.563 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 149' ' ' LYS . . . . . 0.505 ' HE2' ' O ' ' B' ' 146' ' ' LEU . 1.0 OUTLIER -127.79 175.01 8.66 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 110.21 -0.292 . . . . 0.0 110.21 177.13 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 150' ' ' ASN . . . . . 0.553 ' O ' HG23 ' B' ' 154' ' ' VAL . 44.0 m-80 -111.7 93.15 4.32 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 108.582 -0.895 . . . . 0.0 108.582 179.48 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 151' ' ' ILE . . . . . 0.868 HG13 HD12 ' B' ' 108' ' ' LEU . 1.8 mp -41.74 -65.03 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 O-C-N 124.366 1.041 . . . . 0.0 113.662 -169.167 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 152' ' ' GLU . . . . . 0.524 ' HG3' HD11 ' B' ' 112' ' ' LEU . 1.7 mp0 -55.14 -42.83 73.54 Favored 'General case' 0 C--O 1.219 -0.535 0 CA-C-N 117.879 0.309 . . . . 0.0 111.52 -174.26 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 153' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -69.05 -28.61 66.7 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.523 179.696 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 154' ' ' VAL . . . . . 0.837 ' HB ' HD12 ' B' ' 155' ' ' ILE . 61.1 t -61.29 -51.36 73.88 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 CA-C-O 121.691 0.757 . . . . 0.0 109.071 171.208 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 155' ' ' ILE . . . . . 0.837 HD12 ' HB ' ' B' ' 154' ' ' VAL . 1.9 mp -101.15 33.29 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.496 -177.223 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . -98.69 -4.97 32.47 Favored 'General case' 0 C--N 1.308 -1.228 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 168.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 157' ' ' GLN . . . . . . . . . . . . . 67.5 mm-40 -142.85 14.72 1.92 Allowed 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 113.563 -1.653 . . . . 0.0 110.047 174.648 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 158' ' ' GLY . . . . . . . . . . . . . . . -146.83 46.34 0.74 Allowed Glycine 0 C--N 1.336 0.567 0 C-N-CA 120.707 -0.758 . . . . 0.0 113.727 -170.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 159' ' ' ILE . . . . . 0.887 ' HB ' HG13 ' A' ' 60' ' ' ILE . 1.8 mp -66.79 -14.76 18.44 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 CA-C-O 121.244 0.545 . . . . 0.0 110.889 178.29 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 160' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.616 0 C-N-CA 120.848 -0.691 . . . . 0.0 111.908 -176.122 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.481 1.082 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.663 ' HB3' HD13 ' A' ' 7' ' ' LEU . . . -115.83 -167.59 1.28 Allowed 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 175.792 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.62 ' HB2' ' HG3' ' A' ' 6' ' ' GLU . 4.0 m -89.91 125.06 35.22 Favored 'General case' 0 N--CA 1.438 -1.041 0 N-CA-C 107.254 -1.388 . . . . 0.0 107.254 165.186 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.767 HG13 ' HG ' ' B' ' 112' ' ' LEU . 2.0 t -52.29 -23.49 4.42 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.704 -179.382 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.739 ' HB2' ' HA ' ' A' ' 39' ' ' VAL . 15.8 p -68.08 -53.89 22.21 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.633 0.73 . . . . 0.0 109.328 175.212 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.62 ' HG3' ' HB2' ' A' ' 3' ' ' SER . 31.0 mt-10 -57.74 -52.06 66.99 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 115.009 -0.996 . . . . 0.0 109.661 178.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.821 ' HA ' HD12 ' A' ' 10' ' ' ILE . 2.0 tp -57.79 -35.88 71.42 Favored 'General case' 0 N--CA 1.447 -0.575 0 CA-C-N 115.085 -0.961 . . . . 0.0 111.789 177.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -66.33 -40.26 89.75 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-O 121.245 0.545 . . . . 0.0 110.938 178.52 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.575 ' HB2' HG11 ' A' ' 39' ' ' VAL . 8.4 t -65.88 -40.89 92.01 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 179.856 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.821 HD12 ' HA ' ' A' ' 7' ' ' LEU . 57.6 mt -47.9 -57.25 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.851 0 CA-C-N 113.646 -1.616 . . . . 0.0 109.927 172.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.903 ' HB2' HD13 ' B' ' 109' ' ' LEU . 21.2 m-85 -65.95 -40.83 91.66 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.604 -173.696 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.513 ' HB2' HG23 ' A' ' 28' ' ' ILE . 14.9 m -53.78 -43.27 69.12 Favored 'General case' 0 C--O 1.243 0.738 0 CA-C-O 121.709 0.766 . . . . 0.0 109.49 176.259 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -67.53 -32.52 73.35 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-N 115.192 -0.913 . . . . 0.0 110.166 176.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.645 ' HB3' ' CB ' ' B' ' 105' ' ' ALA . 0.3 OUTLIER -62.51 -56.87 13.93 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.113 179.467 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.466 HG12 ' H ' ' A' ' 15' ' ' ILE . 0.0 OUTLIER -54.36 -42.19 56.75 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 N-CA-C 109.897 -0.408 . . . . 0.0 109.897 177.421 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.483 ' HA ' HD12 ' A' ' 16' ' ' LEU . 3.9 tp -56.64 -37.81 71.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.26 176.832 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.448 ' CD2' ' HB ' ' A' ' 56' ' ' ILE . 72.0 m-70 -77.78 -9.64 59.13 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 112.493 0.553 . . . . 0.0 112.493 178.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.521 ' HA ' ' N ' ' B' ' 100' ' ' ALA . 5.4 t70 -78.61 -29.14 45.87 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 119.513 -0.875 . . . . 0.0 109.807 -177.511 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -107.32 -8.15 16.45 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 173.666 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.416 ' HG2' ' O ' ' A' ' 17' ' ' HIS . 5.2 mm-40 51.89 50.14 19.25 Favored 'General case' 0 CA--C 1.511 -0.545 0 CA-C-N 113.925 -1.489 . . . . 0.0 110.633 -174.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.442 HG22 ' H ' ' A' ' 22' ' ' THR . 7.3 p -99.13 168.76 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.424 -1.743 0 CA-C-N 114.678 -1.147 . . . . 0.0 108.624 -174.439 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.442 ' H ' HG22 ' A' ' 21' ' ' VAL . 48.5 p -52.45 139.73 24.23 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-O 121.958 0.885 . . . . 0.0 113.377 -169.677 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.609 HG12 ' HA ' ' A' ' 48' ' ' ALA . 58.7 t -109.32 106.39 20.61 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.012 0 CA-C-N 114.339 -1.301 . . . . 0.0 110.536 -174.638 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.556 ' OG1' ' HB2' ' A' ' 27' ' ' LYS . 70.8 p -131.23 156.04 46.06 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.979 178.465 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -54.35 -43.57 71.39 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.226 0.536 . . . . 0.0 109.856 178.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -68.49 -25.58 65.04 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.295 -0.866 . . . . 0.0 111.458 -179.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.556 ' HB2' ' OG1' ' A' ' 24' ' ' THR . 3.7 tppt? -70.34 -52.24 24.13 Favored 'General case' 0 C--O 1.239 0.53 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 178.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.513 HG23 ' HB2' ' A' ' 12' ' ' SER . 70.9 mt -61.08 -40.68 86.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 114.547 -1.206 . . . . 0.0 110.315 177.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.592 ' HA ' HD12 ' A' ' 32' ' ' ILE . 44.7 t-20 -60.19 -39.45 86.59 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.936 176.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -60.98 -44.6 97.14 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.016 177.549 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.579 HD12 HG23 ' B' ' 126' ' ' ILE . 1.4 mm? -59.79 -49.39 77.9 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 121.01 0.434 . . . . 0.0 110.315 173.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.602 HG23 ' O ' ' A' ' 37' ' ' VAL . 75.5 mt -46.98 -52.53 4.04 Favored 'Isoleucine or valine' 0 C--O 1.239 0.538 0 CA-C-N 115.184 -0.916 . . . . 0.0 111.366 178.037 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 46.5 mmtm -72.37 -33.41 67.23 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.542 -0.753 . . . . 0.0 111.543 -176.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -62.85 -44.34 96.39 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.062 -179.089 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.5 ' HB3' HG12 ' A' ' 37' ' ' VAL . . . -82.01 -30.61 31.44 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.918 178.743 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 95.3 15.64 43.51 Favored Glycine 0 N--CA 1.447 -0.62 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.75 -178.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.987 ' HB ' ' HA3' ' B' ' 113' ' ' GLY . 5.1 p -115.8 118.85 60.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.758 0.79 . . . . 0.0 110.708 -174.778 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.449 ' HA ' HG23 ' A' ' 32' ' ' ILE . 64.3 t30 -96.52 158.59 15.36 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 114.581 -1.19 . . . . 0.0 111.256 -167.486 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.739 ' HA ' ' HB2' ' A' ' 5' ' ' SER . 67.9 t -127.75 163.42 31.38 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.972 0 CA-C-N 114.966 -1.015 . . . . 0.0 110.551 -172.07 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.561 ' HB3' ' HD1' ' A' ' 43' ' ' TRP . 8.2 tp10 -71.24 106.46 1.89 Allowed Pre-proline 0 N--CA 1.44 -0.928 0 N-CA-C 107.429 -1.323 . . . . 0.0 107.429 167.721 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.529 ' C ' ' HD2' ' A' ' 44' ' ' PRO . 77.6 Cg_exo -51.26 -27.69 23.98 Favored 'Trans proline' 0 C--O 1.25 1.112 0 C-N-CA 123.883 3.055 . . . . 0.0 115.532 -164.221 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.432 ' HD2' ' HG3' ' A' ' 40' ' ' GLU . 0.5 OUTLIER -61.38 -28.17 69.05 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 177.471 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . 0.611 ' CE3' ' HE1' ' A' ' 47' ' ' PHE . 18.8 m95 -64.56 -59.65 10.16 Favored Pre-proline 0 C--O 1.205 -1.26 0 CA-C-O 118.383 -0.817 . . . . 0.0 110.949 176.068 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.529 ' HD2' ' C ' ' A' ' 41' ' ' PRO . 97.6 Cg_exo -45.81 -42.84 19.67 Favored 'Trans proline' 0 C--N 1.359 1.119 0 C-N-CA 121.766 1.644 . . . . 0.0 111.871 174.532 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -60.4 -61.0 7.56 Favored Glycine 0 CA--C 1.525 0.701 0 C-N-CA 120.231 -0.985 . . . . 0.0 112.516 175.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.567 ' O ' ' HB2' ' A' ' 49' ' ' LYS . 8.7 tp -63.26 -32.1 73.42 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.196 0.599 . . . . 0.0 111.973 -177.417 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.611 ' HE1' ' CE3' ' A' ' 43' ' ' TRP . 3.6 m-85 -64.14 -48.13 77.24 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.192 176.237 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.609 ' HA ' HG12 ' A' ' 23' ' ' VAL . . . -65.25 -31.44 72.59 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.56 0.695 . . . . 0.0 109.396 -179.516 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.567 ' HB2' ' O ' ' A' ' 46' ' ' LEU . 9.3 mmmt -59.28 -54.92 41.27 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 114.589 -1.187 . . . . 0.0 111.748 172.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -86.61 -43.49 12.62 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 113.802 1.038 . . . . 0.0 113.802 -168.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.587 HD11 ' CD2' ' A' ' 47' ' ' PHE . 21.5 mt -65.87 -7.23 15.26 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 113.721 1.008 . . . . 0.0 113.721 -168.556 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -81.01 -2.2 46.97 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.892 0.377 . . . . 0.0 110.425 176.374 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 10.5 t30 -143.01 -41.71 0.31 Allowed 'General case' 0 C--O 1.235 0.294 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.251 -179.568 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 4.3 m -83.01 -179.6 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 121.429 0.633 . . . . 0.0 110.61 -178.542 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 11.5 m120 -112.15 155.98 23.03 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 115.505 -0.771 . . . . 0.0 111.135 177.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.632 HD11 HD22 ' A' ' 14' ' ' LEU . 3.5 tp -60.01 -21.3 21.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 114.773 -1.103 . . . . 0.0 110.83 179.732 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -69.67 -15.4 71.0 Favored Glycine 0 N--CA 1.444 -0.821 0 C-N-CA 120.779 -0.724 . . . . 0.0 111.392 177.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 35.1 t -75.99 -22.77 55.49 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-O 121.477 0.656 . . . . 0.0 109.76 178.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.828 ' HB2' HG21 ' B' ' 159' ' ' ILE . 19.7 mt -65.12 -25.67 67.87 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.958 -178.423 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.854 HG13 ' HB ' ' B' ' 159' ' ' ILE . 0.2 OUTLIER -67.85 -19.72 25.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 114.935 -1.03 . . . . 0.0 110.595 178.539 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 41.3 t -98.67 -37.73 9.39 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.063 -0.972 . . . . 0.0 110.395 178.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 5.3 p30 35.25 59.81 0.74 Allowed 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.107 0.879 . . . . 0.0 113.0 -176.287 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.422 HG22 ' O ' ' A' ' 63' ' ' VAL . 11.5 p 34.19 43.7 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.795 0 CA-C-N 113.725 -1.579 . . . . 0.0 113.243 179.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -161.57 -54.72 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.021 178.375 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . 52.03 50.91 17.51 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.172 0.51 . . . . 0.0 111.673 179.423 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -97.2 152.76 20.11 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.057 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -114.74 -80.63 0.92 Allowed Glycine 0 N--CA 1.448 -0.526 0 N-CA-C 111.224 -0.75 . . . . 0.0 111.224 177.532 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_endo -81.81 -169.46 0.77 Allowed 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 122.698 2.265 . . . . 0.0 111.276 174.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.002 0 CA-C-O 118.762 -0.637 . . . . 0.0 110.183 178.122 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 100' ' ' ALA . . . . . 0.521 ' N ' ' HA ' ' A' ' 18' ' ' ASP . . . . . . . . 0 N--CA 1.481 1.076 0 CA-C-O 120.693 0.282 . . . . 0.0 111.221 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 101' ' ' MET . . . . . 0.535 ' CE ' HD12 ' A' ' 14' ' ' LEU . 0.0 OUTLIER -131.12 -3.39 3.95 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.092 0.472 . . . . 0.0 109.877 -178.447 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 102' ' ' ARG . . . . . 0.429 ' HB2' ' O ' ' B' ' 101' ' ' MET . 59.4 mtm180 79.36 -162.84 0.03 OUTLIER 'General case' 0 C--O 1.232 0.176 0 CA-C-N 114.961 -1.018 . . . . 0.0 111.928 174.53 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 103' ' ' TYR . . . . . 0.999 ' HB2' HG11 ' B' ' 142' ' ' VAL . 43.2 m-85 -73.67 6.41 3.17 Favored 'General case' 0 C--O 1.242 0.671 0 CA-C-N 114.698 -1.137 . . . . 0.0 113.119 -163.787 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 104' ' ' VAL . . . . . 0.605 HG21 ' HB3' ' B' ' 163' ' ' ALA . 44.9 t -50.51 -49.99 23.09 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.448 0 CA-C-O 121.639 0.733 . . . . 0.0 110.034 177.316 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 105' ' ' ALA . . . . . 0.645 ' CB ' ' HB3' ' A' ' 14' ' ' LEU . . . -64.68 -39.36 93.54 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 114.683 -1.144 . . . . 0.0 111.798 -173.249 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 106' ' ' SER . . . . . 0.609 ' HB2' HG23 ' B' ' 123' ' ' ILE . 0.7 OUTLIER -61.06 -38.92 87.91 Favored 'General case' 0 C--O 1.24 0.582 0 CA-C-O 121.786 0.803 . . . . 0.0 109.123 177.905 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 107' ' ' TYR . . . . . 0.756 ' HD2' HG12 ' B' ' 143' ' ' ILE . 41.5 t80 -61.88 -48.7 79.32 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-N 114.08 -1.418 . . . . 0.0 109.067 179.037 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 108' ' ' LEU . . . . . 0.835 HD12 HG13 ' B' ' 151' ' ' ILE . 0.0 OUTLIER -58.14 -46.18 86.08 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-N 115.327 -0.852 . . . . 0.0 111.417 179.553 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 109' ' ' LEU . . . . . 0.903 HD13 ' HB2' ' A' ' 11' ' ' TYR . 8.5 tp -54.19 -56.07 21.77 Favored 'General case' 0 C--O 1.247 0.929 0 CA-C-O 121.393 0.616 . . . . 0.0 110.777 178.54 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 110' ' ' ALA . . . . . 0.427 ' HB3' ' HB3' ' B' ' 118' ' ' PRO . . . -56.05 -41.38 74.94 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 114.991 -1.004 . . . . 0.0 110.372 -177.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 111' ' ' ALA . . . . . 0.78 ' HA ' ' O ' ' B' ' 115' ' ' ASN . . . -75.03 -22.25 58.56 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.881 -177.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 112' ' ' LEU . . . . . 0.767 ' HG ' HG13 ' A' ' 4' ' ' VAL . 4.3 tp -77.66 -39.51 44.8 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.415 -177.661 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 113' ' ' GLY . . . . . 0.987 ' HA3' ' HB ' ' A' ' 37' ' ' VAL . . . -140.01 33.09 2.14 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 118.652 -1.737 . . . . 0.0 115.155 -174.652 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 114' ' ' GLY . . . . . . . . . . . . . . . -159.45 -47.1 0.01 OUTLIER Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 119.299 -1.429 . . . . 0.0 112.969 176.804 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 115' ' ' ASN . . . . . 0.78 ' O ' ' HA ' ' B' ' 111' ' ' ALA . 8.0 t30 -158.33 112.34 2.49 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 -173.055 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 5.9 m -80.77 28.36 0.35 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 122.083 0.944 . . . . 0.0 111.019 -169.051 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 117' ' ' SER . . . . . 0.478 ' N ' ' HD3' ' B' ' 118' ' ' PRO . 28.3 t -168.01 68.88 0.83 Allowed Pre-proline 0 C--N 1.312 -1.044 0 CA-C-N 113.857 -1.52 . . . . 0.0 108.045 177.65 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 118' ' ' PRO . . . . . 0.679 ' HD2' ' CZ ' ' B' ' 107' ' ' TYR . 34.5 Cg_exo -65.7 155.43 69.15 Favored 'Trans proline' 0 CA--C 1.514 -0.512 0 C-N-CA 125.281 3.988 . . . . 0.0 112.389 -172.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 119' ' ' SER . . . . . 0.534 ' C ' HD13 ' B' ' 143' ' ' ILE . 89.8 p -126.57 -176.14 3.59 Favored 'General case' 0 N--CA 1.443 -0.821 0 C-N-CA 120.18 -0.608 . . . . 0.0 111.525 177.74 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 120' ' ' ALA . . . . . 0.821 ' HB1' HD13 ' B' ' 139' ' ' LEU . . . -63.21 -36.5 83.85 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 122.222 1.011 . . . . 0.0 109.409 -169.617 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 121' ' ' LYS . . . . . 0.477 ' HD2' ' N ' ' B' ' 121' ' ' LYS . 0.9 OUTLIER -68.14 -32.91 73.51 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 113.489 -1.687 . . . . 0.0 110.898 178.91 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 122' ' ' ASP . . . . . 0.511 ' O ' ' HB3' ' B' ' 125' ' ' LYS . 10.6 m-20 -71.66 -36.75 70.76 Favored 'General case' 0 CA--C 1.515 -0.372 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 178.412 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 123' ' ' ILE . . . . . 0.779 ' CG1' HD11 ' B' ' 143' ' ' ILE . 36.9 mm -62.9 -48.38 88.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.108 176.591 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 124' ' ' LYS . . . . . 0.838 ' HD3' HD21 ' B' ' 139' ' ' LEU . 2.9 mmmp? -57.59 -45.21 85.55 Favored 'General case' 0 C--O 1.21 -0.996 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 -179.357 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 125' ' ' LYS . . . . . 0.511 ' HB3' ' O ' ' B' ' 122' ' ' ASP . 0.1 OUTLIER -47.18 -63.99 0.9 Allowed 'General case' 0 N--CA 1.416 -2.149 0 N-CA-C 112.777 0.658 . . . . 0.0 112.777 172.743 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 126' ' ' ILE . . . . . 0.579 HG23 HD12 ' A' ' 31' ' ' LEU . 1.7 mp -56.69 -46.01 82.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.298 -0.865 . . . . 0.0 111.367 -174.859 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 127' ' ' LEU . . . . . 0.757 ' HG ' ' O ' ' B' ' 123' ' ' ILE . 2.2 pp -78.47 -24.82 45.77 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 120.284 -0.567 . . . . 0.0 111.909 -177.822 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 128' ' ' ASP . . . . . 0.509 ' HB2' ' O ' ' B' ' 124' ' ' LYS . 17.0 t70 -67.1 -35.92 80.82 Favored 'General case' 0 CA--C 1.514 -0.407 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 179.861 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 129' ' ' SER . . . . . . . . . . . . . 83.3 p -58.71 -30.14 67.21 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 115.75 -0.659 . . . . 0.0 112.32 -179.23 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 130' ' ' VAL . . . . . . . . . . . . . 3.1 m -108.41 6.02 9.45 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 CA-C-O 120.856 0.36 . . . . 0.0 111.506 177.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 131' ' ' GLY . . . . . . . . . . . . . . . 74.32 30.42 60.62 Favored Glycine 0 CA--C 1.52 0.357 0 C-N-CA 121.075 -0.583 . . . . 0.0 113.722 175.531 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 132' ' ' ILE . . . . . 0.52 ' O ' HD13 ' B' ' 127' ' ' LEU . 18.6 mt -90.08 130.11 39.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.955 0.377 . . . . 0.0 110.026 176.691 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 133' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -81.15 146.73 30.39 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-O 120.922 0.392 . . . . 0.0 110.937 -174.536 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 134' ' ' ALA . . . . . 0.434 ' HB2' HD22 ' B' ' 127' ' ' LEU . . . -146.23 144.07 29.64 Favored 'General case' 0 N--CA 1.442 -0.849 0 CA-C-N 115.795 -0.638 . . . . 0.0 111.639 -176.033 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 135' ' ' ASP . . . . . 0.746 ' HB2' ' HG3' ' B' ' 138' ' ' ARG . 16.3 m-20 -94.03 132.91 38.04 Favored 'General case' 0 C--O 1.251 1.146 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 174.114 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 136' ' ' ASP . . . . . 0.952 ' HA ' HD11 ' B' ' 139' ' ' LEU . 5.5 m-20 -71.53 -11.45 60.87 Favored 'General case' 0 CA--C 1.511 -0.525 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.547 -167.042 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 137' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -97.32 -31.06 12.6 Favored 'General case' 0 N--CA 1.434 -1.228 0 C-N-CA 120.103 -0.639 . . . . 0.0 110.444 174.441 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 138' ' ' ARG . . . . . 0.746 ' HG3' ' HB2' ' B' ' 135' ' ' ASP . 52.4 mmt-85 -66.02 -43.96 86.12 Favored 'General case' 0 CA--C 1.506 -0.725 0 CA-C-O 121.553 0.692 . . . . 0.0 109.565 -174.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 139' ' ' LEU . . . . . 0.952 HD11 ' HA ' ' B' ' 136' ' ' ASP . 0.3 OUTLIER -75.91 -36.71 59.34 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.152 -0.931 . . . . 0.0 111.417 179.688 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 140' ' ' ASN . . . . . 0.615 ' H ' HD12 ' B' ' 139' ' ' LEU . 61.6 t30 -63.19 -25.95 68.58 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 177.699 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 141' ' ' LYS . . . . . . . . . . . . . 35.9 tptt -76.26 -49.09 17.96 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.632 -1.167 . . . . 0.0 110.838 177.639 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 142' ' ' VAL . . . . . 0.999 HG11 ' HB2' ' B' ' 103' ' ' TYR . 13.7 p -57.92 -45.95 87.61 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.367 0 CA-C-O 121.212 0.53 . . . . 0.0 109.716 179.561 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 143' ' ' ILE . . . . . 0.779 HD11 ' CG1' ' B' ' 123' ' ' ILE . 34.7 mt -58.56 -46.25 90.05 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.802 0 C-N-CA 124.124 0.97 . . . . 0.0 112.198 173.581 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 144' ' ' SER . . . . . . . . . . . . . 46.5 t -51.59 -39.23 57.52 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.917 176.225 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 145' ' ' GLU . . . . . . . . . . . . . 15.6 mm-40 -73.86 -50.86 18.3 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 121.765 0.793 . . . . 0.0 110.431 175.505 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 146' ' ' LEU . . . . . 0.57 ' O ' ' HE2' ' B' ' 149' ' ' LYS . 2.2 mm? -61.28 -32.7 72.53 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 114.56 -1.2 . . . . 0.0 112.973 -175.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 147' ' ' ASN . . . . . . . . . . . . . 50.6 t30 -54.69 116.99 3.0 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.74 -172.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 148' ' ' GLY . . . . . 0.44 ' O ' ' HD3' ' B' ' 149' ' ' LYS . . . 98.97 36.15 4.57 Favored Glycine 0 N--CA 1.448 -0.533 0 CA-C-N 115.52 -0.764 . . . . 0.0 112.446 -179.577 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 149' ' ' LYS . . . . . 0.57 ' HE2' ' O ' ' B' ' 146' ' ' LEU . 0.5 OUTLIER -130.48 164.02 25.71 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 110.04 -0.355 . . . . 0.0 110.04 177.898 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 150' ' ' ASN . . . . . 0.507 ' O ' HG23 ' B' ' 154' ' ' VAL . 4.8 m-20 -102.14 90.13 3.83 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 -178.437 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 151' ' ' ILE . . . . . 0.835 HG13 HD12 ' B' ' 108' ' ' LEU . 1.8 mp -34.58 -68.52 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 O-C-N 124.734 1.271 . . . . 0.0 113.251 -172.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 152' ' ' GLU . . . . . 0.49 ' N ' HG22 ' B' ' 151' ' ' ILE . 1.5 mm-40 -46.14 -56.68 5.32 Favored 'General case' 0 C--O 1.213 -0.84 0 N-CA-C 112.549 0.574 . . . . 0.0 112.549 -179.482 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 153' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -57.3 -35.67 70.13 Favored 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 120.85 -0.34 . . . . 0.0 111.673 -178.683 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 154' ' ' VAL . . . . . 0.738 ' HB ' HD12 ' B' ' 155' ' ' ILE . 64.4 t -57.87 -53.94 38.52 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 CA-C-O 121.273 0.558 . . . . 0.0 110.1 177.37 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 155' ' ' ILE . . . . . 0.738 HD12 ' HB ' ' B' ' 154' ' ' VAL . 3.6 mp -87.76 -19.78 7.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.56 -0.746 . . . . 0.0 111.729 -173.542 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . -57.21 -16.67 8.72 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.022 0.439 . . . . 0.0 110.919 179.585 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 157' ' ' GLN . . . . . . . . . . . . . 49.8 mt-30 -130.89 26.77 4.95 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.921 170.231 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 158' ' ' GLY . . . . . . . . . . . . . . . -160.04 46.85 0.41 Allowed Glycine 0 CA--C 1.526 0.76 0 CA-C-N 115.989 -0.551 . . . . 0.0 113.943 -172.297 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 159' ' ' ILE . . . . . 0.854 ' HB ' HG13 ' A' ' 60' ' ' ILE . 1.9 mp -61.16 -12.17 5.53 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 CA-C-O 121.875 0.845 . . . . 0.0 110.162 171.748 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 160' ' ' GLY . . . . . . . . . . . . . . . -134.24 162.2 24.51 Favored Glycine 0 N--CA 1.439 -1.143 0 N-CA-C 109.977 -1.249 . . . . 0.0 109.977 -178.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 161' ' ' LYS . . . . . 0.539 ' HB3' HG22 ' B' ' 165' ' ' VAL . 3.7 mppt? 52.07 29.41 6.31 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.589 0.589 . . . . 0.0 112.589 -174.184 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 162' ' ' LEU . . . . . 0.473 ' HB3' HG11 ' B' ' 104' ' ' VAL . 9.1 mp -38.08 116.82 0.55 Allowed 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 113.037 0.754 . . . . 0.0 113.037 175.183 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 163' ' ' ALA . . . . . 0.605 ' HB3' HG21 ' B' ' 104' ' ' VAL . . . 46.39 -78.29 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 114.588 1.329 . . . . 0.0 114.588 179.586 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 164' ' ' SER . . . . . . . . . . . . . 5.4 m -89.43 109.3 20.23 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 121.018 0.437 . . . . 0.0 110.955 -179.179 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 165' ' ' VAL . . . . . 0.539 HG22 ' HB3' ' B' ' 161' ' ' LYS . 27.9 t -79.21 125.06 84.09 Favored Pre-proline 0 C--N 1.325 -0.479 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.074 179.068 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 166' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_exo -16.99 115.74 0.01 OUTLIER 'Trans proline' 0 N--CA 1.438 -1.751 1 C-N-CA 127.438 5.425 . . . . 0.0 115.545 179.235 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 167' ' ' ALA . . . . . . . . . . . . . . . -84.18 115.66 22.54 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.826 -176.345 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 168' ' ' GLY . . . . . . . . . . . . . . . -109.33 103.55 1.79 Allowed Glycine 0 N--CA 1.446 -0.7 0 CA-C-N 115.899 -0.591 . . . . 0.0 112.212 -178.251 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 169' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.106 0 CA-C-O 118.819 -0.99 . . . . 0.0 112.076 178.536 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 49.3 ttm . . . . . 0 N--CA 1.483 1.2 0 CA-C-O 121.021 0.438 . . . . 0.0 110.577 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.816 ' HB3' HD13 ' A' ' 7' ' ' LEU . . . -76.61 158.33 31.21 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.1 179.51 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.503 ' HB2' ' HG3' ' A' ' 6' ' ' GLU . 1.5 m -70.87 135.43 48.03 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 171.86 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.974 HG13 ' HG ' ' B' ' 112' ' ' LEU . 2.1 t -54.33 -24.86 12.82 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-N 115.128 -0.942 . . . . 0.0 112.348 -177.446 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.849 ' HB3' ' HA ' ' A' ' 39' ' ' VAL . 49.7 m -71.27 -48.55 50.21 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.446 0.641 . . . . 0.0 109.304 175.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.57 ' HG2' ' HE1' ' A' ' 43' ' ' TRP . 28.4 mt-10 -61.57 -49.42 76.72 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.322 -0.853 . . . . 0.0 109.274 179.18 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.856 HD12 HD12 ' A' ' 10' ' ' ILE . 4.7 tp -60.24 -35.12 74.76 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 114.831 -1.077 . . . . 0.0 111.47 177.136 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.686 ' HB2' HD23 ' B' ' 112' ' ' LEU . . . -67.87 -37.15 81.45 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 120.933 0.397 . . . . 0.0 110.871 179.029 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.508 ' HB2' HG11 ' A' ' 39' ' ' VAL . 8.4 t -67.81 -39.58 83.95 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 178.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.856 HD12 HD12 ' A' ' 7' ' ' LEU . 68.9 mt -48.48 -55.56 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.694 0 CA-C-N 114.264 -1.335 . . . . 0.0 109.726 170.03 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.858 ' HB2' HD13 ' B' ' 109' ' ' LEU . 23.0 m-85 -67.11 -39.03 86.63 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.698 -173.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.477 ' OG ' HG23 ' A' ' 28' ' ' ILE . 73.1 p -57.1 -40.42 76.97 Favored 'General case' 0 C--O 1.237 0.395 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 177.209 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -65.94 -33.02 74.87 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 115.195 -0.911 . . . . 0.0 110.574 173.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.899 HD22 HD11 ' A' ' 56' ' ' ILE . 0.4 OUTLIER -66.12 -50.52 63.73 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.967 -179.774 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.494 HG12 ' O ' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -63.11 -42.43 96.56 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 177.497 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.618 HD21 ' HA ' ' A' ' 23' ' ' VAL . 6.1 tp -56.12 -38.16 70.4 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.37 0.605 . . . . 0.0 110.388 173.859 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 45.9 t60 -78.78 -7.61 57.98 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.018 -0.992 . . . . 0.0 111.598 178.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -66.62 -52.74 41.84 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 175.188 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -93.1 -10.84 34.56 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 122.098 0.952 . . . . 0.0 108.896 178.512 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 55.79 53.45 9.4 Favored 'General case' 0 CA--C 1.51 -0.576 0 CA-C-N 113.871 -1.513 . . . . 0.0 109.597 -175.026 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.404 HG13 HD12 ' A' ' 16' ' ' LEU . 7.6 p -99.87 160.07 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.723 0 CA-C-N 113.971 -1.468 . . . . 0.0 108.667 -176.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.509 ' O ' ' HG3' ' A' ' 27' ' ' LYS . 50.8 p -43.37 131.28 4.84 Favored 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 113.525 0.935 . . . . 0.0 113.525 -171.661 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.618 ' HA ' HD21 ' A' ' 16' ' ' LEU . 57.7 t -96.82 109.31 22.83 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.04 0 CA-C-N 114.283 -1.326 . . . . 0.0 110.863 -177.071 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.747 ' OG1' ' HG2' ' A' ' 27' ' ' LYS . 21.3 p -133.31 157.13 46.24 Favored 'General case' 0 C--O 1.245 0.855 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.186 179.457 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -53.27 -44.71 68.42 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.601 177.313 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -68.76 -24.97 64.5 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.282 179.589 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.747 ' HG2' ' OG1' ' A' ' 24' ' ' THR . 2.8 mmtm -61.44 -56.43 20.24 Favored 'General case' 0 CA--C 1.514 -0.407 0 N-CA-C 107.937 -1.135 . . . . 0.0 107.937 173.644 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.477 HG23 ' OG ' ' A' ' 12' ' ' SER . 83.5 mt -55.73 -43.3 73.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 113.728 -1.578 . . . . 0.0 110.818 -178.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.418 ' HA ' HD12 ' A' ' 32' ' ' ILE . 29.4 m-80 -65.52 -33.17 75.3 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.065 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.23 -48.88 76.41 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.333 176.072 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.674 ' HB3' HD21 ' B' ' 109' ' ' LEU . 1.9 mm? -59.53 -47.6 84.92 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-O 120.917 0.389 . . . . 0.0 110.617 175.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.564 HG23 ' O ' ' A' ' 37' ' ' VAL . 44.0 mt -48.58 -48.98 14.47 Favored 'Isoleucine or valine' 0 C--O 1.241 0.647 0 CA-C-N 115.227 -0.897 . . . . 0.0 111.277 178.166 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 42.5 tptt -72.57 -42.46 64.6 Favored 'General case' 0 N--CA 1.431 -1.399 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.607 -176.461 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -60.74 -40.4 92.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.948 0.404 . . . . 0.0 111.217 -177.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.467 ' HA ' HD11 ' B' ' 126' ' ' ILE . . . -79.96 -34.79 38.44 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.178 0.513 . . . . 0.0 111.105 178.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 97.75 17.66 29.93 Favored Glycine 0 N--CA 1.448 -0.548 0 CA-C-N 115.672 -0.695 . . . . 0.0 112.003 -179.567 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.909 ' HB ' ' HA2' ' B' ' 113' ' ' GLY . 2.9 p -119.69 119.32 60.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-O 121.599 0.714 . . . . 0.0 110.618 -176.567 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.457 ' HA ' HG23 ' A' ' 32' ' ' ILE . 13.6 t-20 -97.57 150.99 20.52 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 114.816 -1.084 . . . . 0.0 110.342 -170.345 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.849 ' HA ' ' HB3' ' A' ' 5' ' ' SER . 99.0 t -121.56 162.55 20.59 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.028 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.381 -169.497 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.48 ' HB3' ' HD1' ' A' ' 43' ' ' TRP . 5.1 tp10 -70.69 106.58 1.84 Allowed Pre-proline 0 N--CA 1.438 -1.04 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 169.665 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.502 ' C ' ' HD2' ' A' ' 44' ' ' PRO . 77.7 Cg_exo -51.71 -26.36 23.09 Favored 'Trans proline' 0 C--O 1.247 0.925 0 C-N-CA 123.818 3.012 . . . . 0.0 115.503 -164.199 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.418 ' HD2' ' HG3' ' A' ' 40' ' ' GLU . 0.6 OUTLIER -61.91 -27.32 68.73 Favored 'General case' 0 CA--C 1.526 0.048 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 177.898 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . 0.57 ' HE1' ' HG2' ' A' ' 6' ' ' GLU . 20.8 m95 -64.31 -59.63 10.48 Favored Pre-proline 0 C--O 1.208 -1.107 0 CA-C-O 118.626 -0.702 . . . . 0.0 110.977 176.04 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.502 ' HD2' ' C ' ' A' ' 41' ' ' PRO . 90.7 Cg_exo -45.26 -43.97 16.29 Favored 'Trans proline' 0 C--N 1.358 1.035 0 C-N-CA 121.733 1.622 . . . . 0.0 112.031 173.474 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -60.21 -59.11 10.95 Favored Glycine 0 CA--C 1.525 0.671 0 C-N-CA 120.36 -0.924 . . . . 0.0 112.581 176.649 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.439 ' O ' ' HB2' ' A' ' 49' ' ' LYS . 5.9 tp -67.46 -26.9 66.61 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 122.909 0.483 . . . . 0.0 112.108 -176.785 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.545 ' HE1' ' CE3' ' A' ' 43' ' ' TRP . 3.0 m-85 -69.05 -46.78 67.01 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 110.19 -0.3 . . . . 0.0 110.19 176.317 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.436 ' HA ' HG12 ' A' ' 23' ' ' VAL . . . -65.47 -32.02 73.42 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.322 -0.622 . . . . 0.0 109.322 178.229 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.439 ' HB2' ' O ' ' A' ' 46' ' ' LEU . 8.0 mmmt -60.44 -55.33 34.83 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 114.832 -1.077 . . . . 0.0 111.707 171.289 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.605 ' O ' HG22 ' A' ' 54' ' ' VAL . . . -76.4 -41.09 49.01 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 -170.211 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.568 ' HB2' HG11 ' A' ' 23' ' ' VAL . 12.7 mt -74.21 45.47 0.22 Allowed 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 121.473 0.654 . . . . 0.0 111.925 -173.279 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -134.68 -24.58 1.52 Allowed 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.05 -0.977 . . . . 0.0 109.026 172.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -121.39 -25.28 5.23 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 115.56 -0.746 . . . . 0.0 111.13 178.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.605 HG22 ' O ' ' A' ' 50' ' ' ALA . 10.4 m -99.64 -170.37 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 174.853 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 34.9 p30 -129.67 -178.39 4.67 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.794 175.59 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.899 HD11 HD22 ' A' ' 14' ' ' LEU . 3.1 tp -68.32 -28.69 41.58 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-O 120.642 0.258 . . . . 0.0 110.94 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -72.14 -11.05 74.74 Favored Glycine 0 N--CA 1.448 -0.5 0 C-N-CA 120.447 -0.882 . . . . 0.0 111.016 177.326 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 14.8 t -82.46 -19.21 39.34 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-O 121.598 0.713 . . . . 0.0 109.356 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.703 ' HB2' HG21 ' B' ' 159' ' ' ILE . 22.0 mt -64.0 -31.65 72.92 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.208 -0.906 . . . . 0.0 110.258 177.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.789 HG13 ' HB ' ' B' ' 159' ' ' ILE . 0.2 OUTLIER -63.22 -16.22 17.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 114.898 -1.047 . . . . 0.0 110.483 177.798 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 7.1 t -96.73 16.19 19.77 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 115.117 -0.947 . . . . 0.0 110.834 -178.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -56.86 -23.79 46.84 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.802 0.334 . . . . 0.0 111.451 -176.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 23.2 m -80.23 32.67 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 121.452 0.644 . . . . 0.0 111.475 178.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 179.59 -67.64 0.07 OUTLIER Glycine 0 N--CA 1.444 -0.768 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.879 -178.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . 53.47 30.66 10.88 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 123.02 0.528 . . . . 0.0 111.672 -178.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 138.12 -95.57 0.22 Allowed Glycine 0 N--CA 1.445 -0.712 0 N-CA-C 111.225 -0.75 . . . . 0.0 111.225 -176.151 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 170.47 115.67 0.35 Allowed Glycine 0 N--CA 1.446 -0.665 0 C-N-CA 120.714 -0.755 . . . . 0.0 111.852 178.494 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -61.24 109.26 0.69 Allowed 'Trans proline' 0 C--O 1.235 0.342 0 C-N-CA 122.591 2.194 . . . . 0.0 111.917 179.501 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.993 0 CA-C-O 118.732 -0.651 . . . . 0.0 110.082 -179.404 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 100' ' ' ALA . . . . . 0.59 ' N ' ' HG ' ' B' ' 164' ' ' SER . . . . . . . . 0 N--CA 1.479 0.976 0 CA-C-O 120.704 0.288 . . . . 0.0 110.658 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 101' ' ' MET . . . . . 0.54 ' HE3' HD12 ' A' ' 14' ' ' LEU . 1.2 tmt? -127.02 128.19 45.94 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.54 177.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 102' ' ' ARG . . . . . . . . . . . . . 74.3 mtt180 -152.99 -92.15 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 O-C-N 123.759 0.662 . . . . 0.0 110.31 172.636 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 103' ' ' TYR . . . . . 0.88 ' HB2' HG11 ' B' ' 142' ' ' VAL . 39.8 m-85 -79.1 -10.06 59.72 Favored 'General case' 0 C--O 1.24 0.556 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.076 -174.847 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 104' ' ' VAL . . . . . 0.707 HG11 ' HB3' ' B' ' 162' ' ' LEU . 97.8 t -43.64 -49.31 1.66 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.242 0 CA-C-O 121.701 0.763 . . . . 0.0 109.099 172.399 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 105' ' ' ALA . . . . . 0.652 ' CB ' ' HB3' ' A' ' 14' ' ' LEU . . . -64.17 -42.34 96.76 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 114.273 -1.331 . . . . 0.0 112.175 -173.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 106' ' ' SER . . . . . 0.773 ' HB2' HG23 ' B' ' 123' ' ' ILE . 0.8 OUTLIER -62.59 -37.68 87.17 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.687 0.756 . . . . 0.0 109.666 -179.747 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 107' ' ' TYR . . . . . 0.685 ' O ' ' HG2' ' B' ' 118' ' ' PRO . 43.6 t80 -63.41 -47.44 81.97 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 114.652 -1.158 . . . . 0.0 108.662 178.235 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 108' ' ' LEU . . . . . 0.831 HD12 HG13 ' B' ' 151' ' ' ILE . 0.0 OUTLIER -57.87 -46.44 84.85 Favored 'General case' 0 N--CA 1.442 -0.842 0 CA-C-N 114.766 -1.106 . . . . 0.0 110.866 177.194 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 109' ' ' LEU . . . . . 0.858 HD13 ' HB2' ' A' ' 11' ' ' TYR . 8.4 tp -54.85 -47.32 74.33 Favored 'General case' 0 CA--C 1.511 -0.543 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.916 179.047 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 110' ' ' ALA . . . . . 0.48 ' HB3' ' HB3' ' B' ' 118' ' ' PRO . . . -68.01 -36.61 80.27 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.59 -0.444 . . . . 0.0 111.334 -176.772 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 111' ' ' ALA . . . . . 0.788 ' HA ' ' O ' ' B' ' 115' ' ' ASN . . . -70.91 -20.0 62.53 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.411 0.624 . . . . 0.0 110.703 178.51 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 112' ' ' LEU . . . . . 0.974 ' HG ' HG13 ' A' ' 4' ' ' VAL . 2.8 mp -84.5 -40.18 17.97 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 114.962 -1.017 . . . . 0.0 109.762 172.191 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 113' ' ' GLY . . . . . 0.909 ' HA2' ' HB ' ' A' ' 37' ' ' VAL . . . -61.54 -53.65 42.22 Favored Glycine 0 N--CA 1.442 -0.904 0 CA-C-N 114.928 -1.033 . . . . 0.0 112.155 -177.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 114' ' ' GLY . . . . . . . . . . . . . . . 177.33 4.03 0.02 OUTLIER Glycine 0 N--CA 1.441 -1.01 0 C-N-CA 119.55 -1.31 . . . . 0.0 113.909 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 115' ' ' ASN . . . . . 0.788 ' O ' ' HA ' ' B' ' 111' ' ' ALA . 38.2 m-20 -126.78 98.89 5.54 Favored 'General case' 0 CA--C 1.497 -1.076 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 14.1 m -77.04 26.8 0.14 Allowed 'General case' 0 C--N 1.315 -0.9 0 CA-C-O 122.107 0.956 . . . . 0.0 109.763 -175.562 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 117' ' ' SER . . . . . 0.579 ' H ' ' C ' ' B' ' 115' ' ' ASN . 34.8 t -168.8 70.39 0.75 Allowed Pre-proline 0 C--N 1.321 -0.633 0 CA-C-N 113.738 -1.573 . . . . 0.0 108.385 178.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 118' ' ' PRO . . . . . 0.685 ' HG2' ' O ' ' B' ' 107' ' ' TYR . 34.1 Cg_exo -66.82 158.77 54.73 Favored 'Trans proline' 0 C--N 1.328 -0.547 0 C-N-CA 125.167 3.911 . . . . 0.0 111.675 -176.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 119' ' ' SER . . . . . 0.58 ' O ' HG12 ' B' ' 123' ' ' ILE . 8.6 m -122.31 -179.39 4.17 Favored 'General case' 0 C--N 1.316 -0.882 0 C-N-CA 120.555 -0.458 . . . . 0.0 110.875 176.175 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 120' ' ' ALA . . . . . 0.904 ' HB1' HD13 ' B' ' 139' ' ' LEU . . . -65.99 -36.46 83.36 Favored 'General case' 0 CA--C 1.504 -0.812 0 CA-C-O 122.219 1.009 . . . . 0.0 109.236 -173.347 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 121' ' ' LYS . . . . . 0.447 ' HD2' ' N ' ' B' ' 121' ' ' LYS . 0.4 OUTLIER -63.61 -34.86 78.77 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 113.332 -1.758 . . . . 0.0 110.101 176.782 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 122' ' ' ASP . . . . . 0.475 ' O ' HD13 ' B' ' 126' ' ' ILE . 18.5 m-20 -71.1 -37.6 72.38 Favored 'General case' 0 CA--C 1.517 -0.314 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 176.486 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 123' ' ' ILE . . . . . 0.773 HG23 ' HB2' ' B' ' 106' ' ' SER . 34.1 mm -61.83 -49.9 82.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.132 177.453 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 124' ' ' LYS . . . . . 0.818 ' HD3' HD21 ' B' ' 139' ' ' LEU . 4.2 mmmp? -58.91 -43.61 91.12 Favored 'General case' 0 C--O 1.213 -0.839 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.228 -178.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 125' ' ' LYS . . . . . 0.523 ' HA ' ' HD3' ' B' ' 125' ' ' LYS . 10.0 tppt? -50.51 -59.82 3.64 Favored 'General case' 0 N--CA 1.418 -2.056 0 O-C-N 123.721 0.638 . . . . 0.0 112.132 174.105 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 126' ' ' ILE . . . . . 0.579 HG23 HD12 ' A' ' 31' ' ' LEU . 1.7 mp -56.53 -47.63 81.61 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 CA-C-N 115.426 -0.806 . . . . 0.0 111.487 -176.282 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 127' ' ' LEU . . . . . 0.745 ' HG ' ' O ' ' B' ' 123' ' ' ILE . 2.2 pp -80.59 -19.59 45.2 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.306 -0.557 . . . . 0.0 112.103 -177.11 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 128' ' ' ASP . . . . . 0.516 ' HB2' ' O ' ' B' ' 124' ' ' LYS . 13.6 t70 -73.98 -31.16 62.86 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 179.367 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 129' ' ' SER . . . . . . . . . . . . . 84.1 p -52.63 -37.62 58.77 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.219 176.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 130' ' ' VAL . . . . . 0.559 HG23 HG13 ' B' ' 132' ' ' ILE . 7.5 m -103.95 5.85 10.35 Favored 'Isoleucine or valine' 0 C--O 1.232 0.137 0 CA-C-O 120.801 0.334 . . . . 0.0 111.536 179.324 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 131' ' ' GLY . . . . . . . . . . . . . . . 67.83 48.97 52.07 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 121.192 -0.528 . . . . 0.0 113.163 177.308 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 132' ' ' ILE . . . . . 0.565 ' HB ' ' HB2' ' B' ' 127' ' ' LEU . 8.7 mt -101.54 128.58 53.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-O 120.919 0.39 . . . . 0.0 110.963 178.229 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 133' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -67.47 136.45 54.65 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.187 -177.558 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 134' ' ' ALA . . . . . . . . . . . . . . . -152.57 143.61 23.07 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.182 -177.137 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 135' ' ' ASP . . . . . 0.733 ' HB2' ' HG3' ' B' ' 138' ' ' ARG . 34.1 m-20 -93.27 129.51 39.31 Favored 'General case' 0 C--O 1.251 1.149 0 CA-C-O 120.973 0.416 . . . . 0.0 110.12 174.772 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 136' ' ' ASP . . . . . 0.989 ' HA ' HD11 ' B' ' 139' ' ' LEU . 3.1 m-20 -71.22 -5.37 31.48 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-N 115.239 -0.892 . . . . 0.0 111.191 -169.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 137' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -100.53 -34.99 9.68 Favored 'General case' 0 N--CA 1.433 -1.282 0 C-N-CA 120.487 -0.485 . . . . 0.0 110.097 175.662 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 138' ' ' ARG . . . . . 0.733 ' HG3' ' HB2' ' B' ' 135' ' ' ASP . 43.7 mmt-85 -63.91 -46.23 85.74 Favored 'General case' 0 CA--C 1.503 -0.841 0 CA-C-O 122.118 0.961 . . . . 0.0 109.234 -176.323 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 139' ' ' LEU . . . . . 0.989 HD11 ' HA ' ' B' ' 136' ' ' ASP . 0.3 OUTLIER -74.16 -34.39 63.8 Favored 'General case' 0 C--O 1.209 -1.037 0 CA-C-N 114.529 -1.214 . . . . 0.0 111.6 -178.828 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 140' ' ' ASN . . . . . 0.628 ' H ' HD12 ' B' ' 139' ' ' LEU . 60.8 t30 -65.02 -27.98 69.18 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 122.331 1.062 . . . . 0.0 108.703 177.538 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 141' ' ' LYS . . . . . 0.607 ' O ' ' HG2' ' B' ' 145' ' ' GLU . 30.0 tttp -67.89 -56.0 10.72 Favored 'General case' 0 N--CA 1.44 -0.959 0 CA-C-N 114.141 -1.39 . . . . 0.0 108.882 175.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 142' ' ' VAL . . . . . 0.88 HG11 ' HB2' ' B' ' 103' ' ' TYR . 8.5 p -57.93 -31.57 41.22 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.236 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.449 178.827 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 143' ' ' ILE . . . . . 0.841 HG12 ' O ' ' B' ' 139' ' ' LEU . 28.1 mm -51.99 -67.41 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.513 -0.45 0 CA-C-O 121.151 0.501 . . . . 0.0 110.514 170.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 144' ' ' SER . . . . . . . . . . . . . 79.2 p -57.42 -25.42 59.58 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 114.96 -1.018 . . . . 0.0 111.89 -178.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 145' ' ' GLU . . . . . 0.607 ' HG2' ' O ' ' B' ' 141' ' ' LYS . 5.8 mm-40 -73.16 -46.47 50.6 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 120.898 0.38 . . . . 0.0 110.555 178.143 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 146' ' ' LEU . . . . . 0.722 ' HG ' ' O ' ' B' ' 142' ' ' VAL . 6.9 mt -82.63 -17.05 46.06 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.486 -0.324 . . . . 0.0 111.09 -176.593 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 147' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -56.54 111.84 1.11 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.207 0.527 . . . . 0.0 111.426 -175.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . 111.72 7.76 23.43 Favored Glycine 0 CA--C 1.519 0.33 0 CA-C-N 115.527 -0.76 . . . . 0.0 112.806 -179.285 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 149' ' ' LYS . . . . . 0.514 ' HE2' ' O ' ' B' ' 146' ' ' LEU . 0.8 OUTLIER -104.19 167.88 9.47 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.1 0.476 . . . . 0.0 111.038 -179.749 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 150' ' ' ASN . . . . . 0.511 ' O ' HG23 ' B' ' 154' ' ' VAL . 0.9 OUTLIER -103.93 91.01 3.79 Favored 'General case' 0 CA--C 1.511 -0.545 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 176.788 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 151' ' ' ILE . . . . . 0.831 HG13 HD12 ' B' ' 108' ' ' LEU . 1.8 mp -41.9 -62.87 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 O-C-N 124.376 1.048 . . . . 0.0 113.247 -168.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 152' ' ' GLU . . . . . 0.714 ' HG3' HD11 ' B' ' 112' ' ' LEU . 3.0 mp0 -57.42 -33.22 67.67 Favored 'General case' 0 C--O 1.219 -0.532 0 N-CA-C 111.839 0.311 . . . . 0.0 111.839 -174.487 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 153' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -78.52 -33.4 48.01 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.609 179.498 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 154' ' ' VAL . . . . . 0.783 ' HB ' HD12 ' B' ' 155' ' ' ILE . 58.2 t -54.84 -46.31 75.17 Favored 'Isoleucine or valine' 0 C--O 1.233 0.185 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 172.253 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 155' ' ' ILE . . . . . 0.783 HD12 ' HB ' ' B' ' 154' ' ' VAL . 2.3 mp -106.71 33.84 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 114.97 -1.014 . . . . 0.0 110.448 -179.314 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 156' ' ' ALA . . . . . 0.433 ' HB2' ' O ' ' B' ' 152' ' ' GLU . . . -101.75 2.99 39.1 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 167.526 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 157' ' ' GLN . . . . . . . . . . . . . 46.4 mt-30 -138.93 -1.42 1.79 Allowed 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 113.55 -1.659 . . . . 0.0 109.844 173.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 158' ' ' GLY . . . . . 0.406 ' O ' HG23 ' B' ' 155' ' ' ILE . . . -139.62 46.34 0.96 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.379 -0.915 . . . . 0.0 114.575 -167.274 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 159' ' ' ILE . . . . . 0.789 ' HB ' HG13 ' A' ' 60' ' ' ILE . 1.8 mp -61.59 -15.56 13.43 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 CA-C-O 122.039 0.923 . . . . 0.0 109.733 173.584 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 160' ' ' GLY . . . . . . . . . . . . . . . -129.49 144.57 15.62 Favored Glycine 0 N--CA 1.437 -1.29 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 178.509 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 161' ' ' LYS . . . . . 0.64 ' HG2' ' HD2' ' B' ' 166' ' ' PRO . 0.1 OUTLIER 51.8 41.83 29.53 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.777 0.289 . . . . 0.0 111.395 -168.343 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 162' ' ' LEU . . . . . 0.707 ' HB3' HG11 ' B' ' 104' ' ' VAL . 9.8 mp -29.12 123.39 0.13 Allowed 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 113.2 0.815 . . . . 0.0 113.2 172.302 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 163' ' ' ALA . . . . . . . . . . . . . . . 61.05 -68.58 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 O-C-N 124.383 1.052 . . . . 0.0 113.491 -178.542 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 164' ' ' SER . . . . . 0.59 ' HG ' ' N ' ' B' ' 100' ' ' ALA . 7.1 t -103.5 132.22 49.95 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-O 121.554 0.693 . . . . 0.0 112.173 -174.623 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 165' ' ' VAL . . . . . . . . . . . . . 23.0 t -114.37 132.48 22.78 Favored Pre-proline 0 C--N 1.317 -0.818 0 CA-C-N 114.763 -1.108 . . . . 0.0 109.217 178.654 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 166' ' ' PRO . . . . . 0.64 ' HD2' ' HG2' ' B' ' 161' ' ' LYS . 19.6 Cg_exo -12.51 116.44 0.01 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.369 1 C-N-CA 127.155 5.237 . . . . 0.0 117.009 -175.772 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 167' ' ' ALA . . . . . . . . . . . . . . . -130.96 66.41 1.53 Allowed 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 114.862 -1.063 . . . . 0.0 110.13 -179.239 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 168' ' ' GLY . . . . . . . . . . . . . . . 119.79 57.2 0.25 Allowed Glycine 0 N--CA 1.446 -0.654 0 CA-C-N 115.674 -0.693 . . . . 0.0 111.626 -176.29 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 169' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.984 0 CA-C-O 118.537 -1.146 . . . . 0.0 111.763 -179.049 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.4 ' HA ' ' CE ' ' A' ' 1' ' ' MET . 0.8 OUTLIER . . . . . 0 N--CA 1.481 1.116 0 N-CA-C 110.108 -0.33 . . . . 0.0 110.108 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.506 ' HB1' HD13 ' A' ' 7' ' ' LEU . . . 176.35 149.38 0.12 Allowed 'General case' 0 CA--C 1.508 -0.64 0 CA-C-N 115.45 -0.795 . . . . 0.0 109.21 178.618 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.745 ' HB2' ' HG3' ' A' ' 6' ' ' GLU . 6.2 m -83.27 119.16 24.24 Favored 'General case' 0 N--CA 1.439 -1.023 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 167.673 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.888 HG13 ' HG ' ' B' ' 112' ' ' LEU . 2.2 t -52.93 -28.22 13.64 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.78 0 CA-C-N 115.294 -0.866 . . . . 0.0 112.073 -179.573 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.746 ' HB3' ' HA ' ' A' ' 39' ' ' VAL . 71.7 m -68.45 -43.99 75.85 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.229 0.538 . . . . 0.0 109.784 175.723 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.745 ' HG3' ' HB2' ' A' ' 3' ' ' SER . 30.2 mt-10 -68.21 -49.04 63.44 Favored 'General case' 0 N--CA 1.444 -0.726 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 -178.209 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.877 ' HA ' HD12 ' A' ' 10' ' ' ILE . 2.9 tp -58.34 -35.01 71.27 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 114.443 -1.253 . . . . 0.0 111.949 175.396 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.579 ' HB2' HD23 ' B' ' 112' ' ' LEU . . . -68.37 -37.25 80.26 Favored 'General case' 0 CA--C 1.512 -0.484 0 CA-C-O 121.04 0.448 . . . . 0.0 110.786 179.054 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.528 ' HB2' HG11 ' A' ' 39' ' ' VAL . 4.6 t -67.35 -40.79 85.86 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 178.633 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.877 HD12 ' HA ' ' A' ' 7' ' ' LEU . 73.8 mt -48.92 -55.76 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.685 0 CA-C-N 113.896 -1.502 . . . . 0.0 110.051 171.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.852 ' HB2' HD13 ' B' ' 109' ' ' LEU . 23.9 m-85 -66.36 -41.46 89.46 Favored 'General case' 0 C--O 1.22 -0.455 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.557 -174.103 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.436 ' HA ' ' HG ' ' A' ' 31' ' ' LEU . 15.6 m -54.01 -42.09 68.7 Favored 'General case' 0 C--O 1.242 0.692 0 CA-C-O 121.489 0.661 . . . . 0.0 109.27 175.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -68.67 -28.94 67.32 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.39 176.154 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.693 HD22 HD11 ' A' ' 56' ' ' ILE . 0.2 OUTLIER -67.25 -55.58 13.41 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.49 179.34 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.404 HG12 ' O ' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -55.72 -43.84 74.99 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 176.889 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.597 HD12 HG13 ' A' ' 21' ' ' VAL . 3.8 tp -57.69 -44.27 85.73 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.501 177.75 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 25.1 t60 -75.73 -13.43 60.31 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.258 -0.883 . . . . 0.0 111.726 178.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.534 ' OD2' ' HA ' ' B' ' 102' ' ' ARG . 12.1 t0 -69.09 -42.31 76.34 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.247 0.546 . . . . 0.0 109.61 179.377 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.412 ' HB2' HG23 ' B' ' 132' ' ' ILE . 36.5 t70 -100.08 -7.04 25.4 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 122.032 0.92 . . . . 0.0 109.226 177.014 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 52.29 56.55 7.56 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-N 113.784 -1.553 . . . . 0.0 110.262 -175.286 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.597 HG13 HD12 ' A' ' 16' ' ' LEU . 6.1 p -106.21 159.45 6.18 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.679 0 CA-C-N 114.13 -1.396 . . . . 0.0 108.814 -178.825 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 82.2 p -49.8 139.1 13.74 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 114.193 1.183 . . . . 0.0 114.193 -169.48 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.604 HG12 ' HA ' ' A' ' 48' ' ' ALA . 63.1 t -103.77 111.86 35.06 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-N 114.216 -1.356 . . . . 0.0 110.986 -177.094 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.51 ' OG1' ' HE2' ' A' ' 27' ' ' LYS . 77.3 p -135.66 157.83 45.89 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 175.575 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -57.49 -41.23 80.29 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 120.71 -0.396 . . . . 0.0 110.094 -177.434 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -65.16 -29.92 70.8 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.08 178.344 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.51 ' HE2' ' OG1' ' A' ' 24' ' ' THR . 3.8 tppt? -66.53 -53.0 39.72 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 179.844 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 66.4 mt -60.41 -39.69 81.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 114.394 -1.275 . . . . 0.0 110.491 178.321 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 -61.97 -36.01 80.16 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.74 176.045 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.67 -45.59 92.1 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-N 116.552 -0.294 . . . . 0.0 110.484 177.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.562 ' HB3' HD21 ' B' ' 109' ' ' LEU . 1.3 mm? -58.35 -51.15 71.02 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 121.085 0.469 . . . . 0.0 110.13 173.838 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.561 HG23 ' O ' ' A' ' 37' ' ' VAL . 57.1 mt -48.28 -50.86 10.99 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 CA-C-N 114.873 -1.058 . . . . 0.0 111.646 178.686 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -69.82 -40.08 76.13 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.079 -0.51 . . . . 0.0 112.03 -176.748 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -64.2 -45.54 87.86 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-O 120.918 0.39 . . . . 0.0 111.093 -177.384 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.423 ' HB3' HG12 ' A' ' 37' ' ' VAL . . . -74.84 -34.82 62.36 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.429 178.669 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 96.96 18.48 29.36 Favored Glycine 0 N--CA 1.448 -0.554 0 CA-C-N 115.379 -0.828 . . . . 0.0 112.019 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.868 ' HB ' ' HA3' ' B' ' 113' ' ' GLY . 5.5 p -121.04 121.92 66.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 121.422 0.63 . . . . 0.0 111.059 -173.061 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 62.9 t30 -99.33 157.33 16.48 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.049 -0.978 . . . . 0.0 111.035 -169.308 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.746 ' HA ' ' HB3' ' A' ' 5' ' ' SER . 94.6 t -125.28 161.66 29.19 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.759 0 CA-C-N 115.056 -0.974 . . . . 0.0 110.937 -170.214 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.566 ' HB3' ' HD1' ' A' ' 43' ' ' TRP . 3.9 tp10 -67.65 105.41 0.9 Allowed Pre-proline 0 N--CA 1.441 -0.884 0 N-CA-C 107.756 -1.201 . . . . 0.0 107.756 169.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.522 ' C ' ' HD2' ' A' ' 44' ' ' PRO . 86.0 Cg_exo -49.54 -29.73 19.58 Favored 'Trans proline' 0 C--O 1.252 1.195 0 C-N-CA 123.602 2.868 . . . . 0.0 115.675 -163.767 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -60.76 -27.65 68.13 Favored 'General case' 0 C--N 1.333 -0.14 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 177.647 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . 0.566 ' HD1' ' HB3' ' A' ' 40' ' ' GLU . 9.6 m95 -65.08 -59.41 10.09 Favored Pre-proline 0 C--O 1.204 -1.337 0 CA-C-O 118.303 -0.856 . . . . 0.0 111.147 176.416 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.522 ' HD2' ' C ' ' A' ' 41' ' ' PRO . 83.3 Cg_exo -45.52 -44.46 17.0 Favored 'Trans proline' 0 C--N 1.359 1.086 0 C-N-CA 121.652 1.568 . . . . 0.0 111.913 174.622 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -60.4 -60.56 8.34 Favored Glycine 0 CA--C 1.525 0.68 0 C-N-CA 120.176 -1.012 . . . . 0.0 112.322 175.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 12.7 tp -65.79 -21.92 66.53 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.136 0.574 . . . . 0.0 112.11 -177.057 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.676 ' HD2' HD11 ' A' ' 51' ' ' LEU . 2.6 m-85 -74.72 -45.07 46.59 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 176.625 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.604 ' HA ' HG12 ' A' ' 23' ' ' VAL . . . -64.8 -30.23 71.22 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-O 121.821 0.82 . . . . 0.0 108.864 177.602 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 9.6 mmmt -66.27 -58.0 6.32 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 114.276 -1.329 . . . . 0.0 111.713 172.167 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.489 ' O ' HG22 ' A' ' 54' ' ' VAL . . . -76.03 -39.1 56.38 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 113.457 0.91 . . . . 0.0 113.457 -168.786 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.676 HD11 ' HD2' ' A' ' 47' ' ' PHE . 12.3 mt -68.85 -4.51 16.57 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 117.922 0.328 . . . . 0.0 111.7 -173.641 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -95.67 9.68 39.45 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.138 0.494 . . . . 0.0 110.296 174.726 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -143.62 -48.2 0.29 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.505 -178.697 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.489 HG22 ' O ' ' A' ' 50' ' ' ALA . 9.2 m -94.77 -169.55 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.282 179.851 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 11.3 m120 -121.59 -175.94 3.2 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.962 0.411 . . . . 0.0 111.3 178.199 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.693 HD11 HD22 ' A' ' 14' ' ' LEU . 3.0 tp -75.06 -28.46 20.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.356 -179.669 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -69.84 -15.5 71.49 Favored Glycine 0 N--CA 1.447 -0.571 0 N-CA-C 110.613 -0.995 . . . . 0.0 110.613 175.461 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 16.5 m -78.02 -19.61 54.05 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-O 121.174 0.511 . . . . 0.0 110.201 179.594 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.652 ' HB2' HG21 ' B' ' 159' ' ' ILE . 25.0 mt -64.16 -30.47 71.53 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.589 179.814 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.686 ' CD1' ' HB ' ' B' ' 159' ' ' ILE . 0.4 OUTLIER -67.11 -26.65 37.02 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-N 115.147 -0.933 . . . . 0.0 109.955 176.574 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.426 ' C ' ' H ' ' A' ' 63' ' ' VAL . 23.8 t -82.07 -45.12 15.66 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-N 115.168 -0.924 . . . . 0.0 110.065 178.746 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 10.1 p30 54.53 -13.83 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 116.247 1.944 . . . . 0.0 116.247 173.675 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.426 ' H ' ' C ' ' A' ' 61' ' ' CYS . 31.0 m -82.6 34.62 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-O 121.27 0.557 . . . . 0.0 111.597 179.369 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 57.94 62.94 5.73 Favored Glycine 0 N--CA 1.451 -0.301 0 CA-C-N 115.474 -0.785 . . . . 0.0 112.787 178.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -84.24 52.65 2.39 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.169 0.509 . . . . 0.0 110.846 -178.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -161.78 32.69 0.34 Allowed Glycine 0 N--CA 1.447 -0.602 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.802 -179.062 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -176.96 73.75 0.08 OUTLIER Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 120.684 -0.77 . . . . 0.0 111.975 -179.679 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -60.41 -52.26 4.21 Favored 'Trans proline' 0 C--O 1.233 0.271 0 C-N-CA 122.793 2.329 . . . . 0.0 112.267 -179.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.905 0 CA-C-O 118.658 -0.687 . . . . 0.0 110.411 179.211 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.971 0 CA-C-O 120.637 0.256 . . . . 0.0 110.493 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 101' ' ' MET . . . . . 0.603 ' HE1' HD12 ' A' ' 14' ' ' LEU . 4.3 ttt -137.57 129.22 28.45 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 111.884 0.327 . . . . 0.0 111.884 179.579 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 102' ' ' ARG . . . . . 0.534 ' HA ' ' OD2' ' A' ' 18' ' ' ASP . 4.7 ptp180 -170.02 125.9 0.81 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.303 166.713 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 103' ' ' TYR . . . . . 0.663 ' HB2' HG11 ' B' ' 142' ' ' VAL . 47.6 m-85 71.66 -25.66 0.17 Allowed 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.97 0.908 . . . . 0.0 112.087 177.762 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 104' ' ' VAL . . . . . 0.6 HG11 ' H ' ' B' ' 163' ' ' ALA . 82.9 t -45.42 -44.34 3.76 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.256 0 CA-C-O 121.515 0.674 . . . . 0.0 110.404 175.777 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 105' ' ' ALA . . . . . 0.669 ' CB ' ' HB3' ' A' ' 14' ' ' LEU . . . -67.41 -38.78 85.16 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 114.925 -1.034 . . . . 0.0 111.559 -174.853 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 106' ' ' SER . . . . . 0.829 ' HB2' HG23 ' B' ' 123' ' ' ILE . 1.8 m -60.79 -38.44 85.34 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-O 121.784 0.802 . . . . 0.0 109.189 175.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 107' ' ' TYR . . . . . 0.759 ' O ' ' HG2' ' B' ' 118' ' ' PRO . 38.4 t80 -63.27 -49.33 74.52 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-N 114.016 -1.447 . . . . 0.0 108.706 178.814 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 108' ' ' LEU . . . . . 0.679 HD12 HG13 ' B' ' 151' ' ' ILE . 0.0 OUTLIER -56.4 -50.49 71.44 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.164 -0.926 . . . . 0.0 111.711 178.772 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 109' ' ' LEU . . . . . 0.852 HD13 ' HB2' ' A' ' 11' ' ' TYR . 7.8 tp -53.93 -54.91 32.25 Favored 'General case' 0 C--O 1.246 0.906 0 CA-C-O 121.4 0.619 . . . . 0.0 111.011 178.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -57.05 -39.14 74.3 Favored 'General case' 0 C--O 1.22 -0.458 0 CA-C-N 114.975 -1.011 . . . . 0.0 110.423 -178.259 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 111' ' ' ALA . . . . . 0.734 ' HA ' ' O ' ' B' ' 115' ' ' ASN . . . -77.83 -19.54 54.74 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.706 -178.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 112' ' ' LEU . . . . . 0.888 ' HG ' HG13 ' A' ' 4' ' ' VAL . 4.4 tp -77.19 -40.0 46.78 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.418 -179.047 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 113' ' ' GLY . . . . . 0.868 ' HA3' ' HB ' ' A' ' 37' ' ' VAL . . . -144.95 44.68 0.88 Allowed Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 118.819 -1.658 . . . . 0.0 114.354 -176.75 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 114' ' ' GLY . . . . . . . . . . . . . . . -166.25 -49.21 0.02 OUTLIER Glycine 0 N--CA 1.444 -0.792 0 C-N-CA 119.214 -1.47 . . . . 0.0 113.139 175.489 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 115' ' ' ASN . . . . . 0.734 ' O ' ' HA ' ' B' ' 111' ' ' ALA . 10.0 t30 -155.47 113.63 3.43 Favored 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 109.227 -0.656 . . . . 0.0 109.227 -171.757 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 4.0 m -79.97 26.01 0.35 Allowed 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 122.152 0.977 . . . . 0.0 111.02 -168.33 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 117' ' ' SER . . . . . 0.494 ' N ' ' HD3' ' B' ' 118' ' ' PRO . 8.9 t -172.31 69.82 0.43 Allowed Pre-proline 0 C--N 1.312 -1.022 0 CA-C-N 113.789 -1.55 . . . . 0.0 108.346 178.668 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 118' ' ' PRO . . . . . 0.759 ' HG2' ' O ' ' B' ' 107' ' ' TYR . 33.3 Cg_exo -62.07 157.44 44.25 Favored 'Trans proline' 0 CA--C 1.511 -0.651 1 C-N-CA 125.605 4.203 . . . . 0.0 112.155 -173.934 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 119' ' ' SER . . . . . 0.55 ' O ' HG12 ' B' ' 123' ' ' ILE . 14.7 m -131.73 -174.98 3.57 Favored 'General case' 0 C--N 1.317 -0.828 0 C-N-CA 119.715 -0.794 . . . . 0.0 111.842 178.784 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 120' ' ' ALA . . . . . 0.745 ' HB1' HD13 ' B' ' 139' ' ' LEU . . . -63.27 -40.77 98.33 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.719 0.771 . . . . 0.0 109.611 -165.177 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 121' ' ' LYS . . . . . . . . . . . . . 1.8 mptm? -62.71 -36.83 84.22 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 114.078 -1.419 . . . . 0.0 110.86 177.304 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 122' ' ' ASP . . . . . . . . . . . . . 44.8 m-20 -70.42 -40.13 74.01 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 120.182 -0.607 . . . . 0.0 109.55 -178.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 123' ' ' ILE . . . . . 0.829 HG23 ' HB2' ' B' ' 106' ' ' SER . 23.3 mm -60.19 -42.94 92.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.52 175.581 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 124' ' ' LYS . . . . . 0.845 ' HD3' HD21 ' B' ' 139' ' ' LEU . 2.2 mmmp? -59.02 -39.73 82.84 Favored 'General case' 0 CA--C 1.504 -0.819 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 -178.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 125' ' ' LYS . . . . . . . . . . . . . 86.8 mttt -56.81 -61.69 2.26 Favored 'General case' 0 CA--C 1.489 -1.382 0 C-N-CA 119.274 -0.97 . . . . 0.0 110.841 173.653 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 126' ' ' ILE . . . . . 0.49 HG23 HD12 ' A' ' 31' ' ' LEU . 1.8 mp -57.44 -36.99 55.26 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.118 0 CA-C-N 114.282 -1.326 . . . . 0.0 110.951 -166.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 127' ' ' LEU . . . . . 0.75 ' HG ' ' O ' ' B' ' 123' ' ' ILE . 1.2 pp -80.68 -39.29 27.47 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.172 -0.611 . . . . 0.0 111.648 178.126 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 128' ' ' ASP . . . . . 0.459 ' N ' HD12 ' B' ' 127' ' ' LEU . 9.8 m-20 -70.0 -26.39 64.05 Favored 'General case' 0 N--CA 1.466 0.331 0 O-C-N 122.096 -0.377 . . . . 0.0 111.109 -179.438 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 129' ' ' SER . . . . . . . . . . . . . 84.4 p -60.11 -33.86 72.69 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.72 -177.169 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 130' ' ' VAL . . . . . . . . . . . . . 4.7 m -99.11 -34.16 4.3 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.398 175.679 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 131' ' ' GLY . . . . . . . . . . . . . . . 122.11 45.01 0.34 Allowed Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.233 179.664 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 132' ' ' ILE . . . . . 0.419 ' HB ' ' HB2' ' B' ' 127' ' ' LEU . 24.4 mt -112.17 136.32 48.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 179.424 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 133' ' ' GLU . . . . . . . . . . . . . 26.9 mm-40 -89.86 154.65 19.72 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.235 0.541 . . . . 0.0 111.743 -174.748 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 134' ' ' ALA . . . . . 0.543 ' HB2' HD22 ' B' ' 127' ' ' LEU . . . -153.21 145.26 23.74 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.078 -0.964 . . . . 0.0 112.049 -172.771 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 135' ' ' ASP . . . . . 0.682 ' HB2' ' CG ' ' B' ' 138' ' ' ARG . 53.9 m-20 -93.91 133.52 37.25 Favored 'General case' 0 C--O 1.251 1.161 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 170.728 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 136' ' ' ASP . . . . . 1.001 ' HA ' HD11 ' B' ' 139' ' ' LEU . 10.1 p-10 -72.03 -5.15 33.03 Favored 'General case' 0 CA--C 1.513 -0.464 0 CA-C-N 115.109 -0.951 . . . . 0.0 111.006 -169.654 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 137' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -101.04 -30.74 11.44 Favored 'General case' 0 N--CA 1.433 -1.293 0 C-N-CA 120.225 -0.59 . . . . 0.0 110.286 173.018 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 138' ' ' ARG . . . . . 0.682 ' CG ' ' HB2' ' B' ' 135' ' ' ASP . 36.3 mmt180 -66.22 -44.89 82.53 Favored 'General case' 0 CA--C 1.503 -0.855 0 CA-C-O 121.59 0.71 . . . . 0.0 109.86 -175.849 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 139' ' ' LEU . . . . . 1.001 HD11 ' HA ' ' B' ' 136' ' ' ASP . 0.3 OUTLIER -74.55 -33.79 62.81 Favored 'General case' 0 C--N 1.313 -0.981 0 C-N-CA 119.53 -0.868 . . . . 0.0 111.238 178.271 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 140' ' ' ASN . . . . . 0.482 ' H ' HD12 ' B' ' 139' ' ' LEU . 58.8 t30 -68.97 -27.61 65.88 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 -176.809 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 141' ' ' LYS . . . . . 0.669 ' HG3' ' O ' ' B' ' 138' ' ' ARG . 0.0 OUTLIER -86.2 -38.25 17.85 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.02 -0.991 . . . . 0.0 110.46 -177.944 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 142' ' ' VAL . . . . . 0.663 HG11 ' HB2' ' B' ' 103' ' ' TYR . 11.1 p -60.99 -44.8 98.95 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.636 0 N-CA-C 108.82 -0.808 . . . . 0.0 108.82 175.679 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 143' ' ' ILE . . . . . 0.754 HD11 ' CG1' ' B' ' 123' ' ' ILE . 16.1 mt -58.9 -45.61 91.71 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.88 0 C-N-CA 123.752 0.821 . . . . 0.0 112.36 171.219 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 144' ' ' SER . . . . . . . . . . . . . 30.9 t -52.82 -34.77 55.38 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.983 177.188 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 145' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -86.26 -40.49 15.48 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.369 177.729 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 146' ' ' LEU . . . . . 0.573 ' HB3' ' CZ ' ' B' ' 107' ' ' TYR . 2.6 mm? -61.72 -41.25 97.38 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 123.557 0.743 . . . . 0.0 112.388 177.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 147' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -45.84 124.3 5.16 Favored 'General case' 0 C--O 1.233 0.202 0 O-C-N 123.906 0.754 . . . . 0.0 111.788 -171.725 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . 86.96 59.2 1.8 Allowed Glycine 0 N--CA 1.447 -0.589 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.301 -175.544 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 149' ' ' LYS . . . . . 0.535 ' HB2' ' O ' ' B' ' 146' ' ' LEU . 3.3 tppt? -143.25 160.22 40.88 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 -177.538 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 150' ' ' ASN . . . . . 0.59 ' O ' HG23 ' B' ' 154' ' ' VAL . 17.5 m120 -105.33 88.72 2.92 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 176.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 151' ' ' ILE . . . . . 0.679 HG13 HD12 ' B' ' 108' ' ' LEU . 1.7 mp -42.92 -61.46 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 114.694 -1.139 . . . . 0.0 113.445 -168.59 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 152' ' ' GLU . . . . . 0.405 ' N ' HG22 ' B' ' 151' ' ' ILE . 30.9 mt-10 -54.6 -41.24 69.71 Favored 'General case' 0 C--O 1.216 -0.687 0 N-CA-C 112.271 0.471 . . . . 0.0 112.271 -174.038 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 153' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -74.78 -30.77 61.55 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.816 -0.354 . . . . 0.0 110.589 -177.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 154' ' ' VAL . . . . . 0.832 ' HB ' HD12 ' B' ' 155' ' ' ILE . 44.9 t -56.01 -48.58 78.59 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 CA-C-O 121.86 0.838 . . . . 0.0 109.141 171.077 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 155' ' ' ILE . . . . . 0.832 HD12 ' HB ' ' B' ' 154' ' ' VAL . 1.8 mp -109.15 44.1 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.096 -0.956 . . . . 0.0 110.961 -178.479 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . -112.65 3.02 16.39 Favored 'General case' 0 C--N 1.306 -1.283 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 167.428 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 157' ' ' GLN . . . . . . . . . . . . . 24.3 mt-30 -138.51 -5.02 1.6 Allowed 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 113.5 -1.682 . . . . 0.0 110.002 176.276 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 158' ' ' GLY . . . . . 0.55 ' O ' HD12 ' B' ' 162' ' ' LEU . . . -137.85 44.9 1.09 Allowed Glycine 0 C--O 1.223 -0.539 0 C-N-CA 120.153 -1.023 . . . . 0.0 113.86 -172.503 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 159' ' ' ILE . . . . . 0.686 ' HB ' ' CD1' ' A' ' 60' ' ' ILE . 1.8 mp -57.62 -28.49 32.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 CA-C-O 121.015 0.436 . . . . 0.0 110.983 175.7 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 160' ' ' GLY . . . . . . . . . . . . . . . -96.92 -54.78 1.26 Allowed Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.524 -0.846 . . . . 0.0 112.944 -179.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 161' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.75 -34.47 78.26 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 113.905 1.076 . . . . 0.0 113.905 -177.652 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 162' ' ' LEU . . . . . 0.55 HD12 ' O ' ' B' ' 158' ' ' GLY . 5.3 mp 45.03 -162.7 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 113.914 1.079 . . . . 0.0 113.914 -171.295 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 163' ' ' ALA . . . . . 0.6 ' H ' HG11 ' B' ' 104' ' ' VAL . . . 50.56 -90.85 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.168 0 C-N-CA 124.191 0.996 . . . . 0.0 113.257 -179.776 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 164' ' ' SER . . . . . . . . . . . . . 7.3 p -144.39 111.82 6.04 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.202 0.525 . . . . 0.0 110.748 179.317 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 165' ' ' VAL . . . . . 0.454 ' HA ' ' HD2' ' B' ' 166' ' ' PRO . 2.2 t -106.34 123.67 38.17 Favored Pre-proline 0 C--N 1.322 -0.62 0 CA-C-N 115.692 -0.686 . . . . 0.0 109.265 178.002 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 166' ' ' PRO . . . . . 0.454 ' HD2' ' HA ' ' B' ' 165' ' ' VAL . 45.0 Cg_exo -17.1 110.65 0.01 OUTLIER 'Trans proline' 0 N--CA 1.44 -1.671 1 C-N-CA 126.964 5.11 . . . . 0.0 115.727 -178.328 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 167' ' ' ALA . . . . . . . . . . . . . . . -115.42 -24.33 8.43 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.509 -176.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 168' ' ' GLY . . . . . . . . . . . . . . . -129.75 -40.78 0.26 Allowed Glycine 0 N--CA 1.446 -0.653 0 N-CA-C 111.169 -0.772 . . . . 0.0 111.169 175.574 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 169' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.934 0 CA-C-O 118.635 -1.092 . . . . 0.0 111.363 176.269 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.644 ' HA ' ' HB1' ' B' ' 156' ' ' ALA . 23.6 ttt . . . . . 0 N--CA 1.479 1.011 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.866 ' HB3' HD13 ' A' ' 7' ' ' LEU . . . -130.75 157.49 42.68 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.087 -177.831 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.574 ' HB2' ' HG3' ' A' ' 6' ' ' GLU . 14.5 m -69.57 139.33 53.71 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 170.134 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.853 HG13 ' HG ' ' B' ' 112' ' ' LEU . 2.4 t -58.04 -23.72 22.02 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 CA-C-N 115.005 -0.998 . . . . 0.0 111.693 -177.084 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.703 ' HB2' ' HA ' ' A' ' 39' ' ' VAL . 11.4 p -70.5 -53.92 14.27 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.855 0.836 . . . . 0.0 109.044 174.662 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.574 ' HG3' ' HB2' ' A' ' 3' ' ' SER . 32.1 mt-10 -56.29 -47.74 78.04 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 114.862 -1.063 . . . . 0.0 109.899 177.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.866 HD13 ' HB3' ' A' ' 2' ' ' ALA . 3.6 tp -61.22 -39.73 91.35 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.522 178.791 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -60.94 -37.72 83.32 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 121.162 0.506 . . . . 0.0 110.937 176.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.538 ' HB2' HG11 ' A' ' 39' ' ' VAL . 7.4 t -69.94 -43.09 72.31 Favored 'General case' 0 C--O 1.24 0.587 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.833 HD12 HD12 ' A' ' 7' ' ' LEU . 72.6 mt -46.2 -56.4 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 CA-C-N 113.993 -1.458 . . . . 0.0 109.715 171.703 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.632 ' OH ' ' HB ' ' B' ' 155' ' ' ILE . 23.5 m-85 -63.33 -40.03 96.17 Favored 'General case' 0 C--O 1.216 -0.689 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.448 -175.413 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.618 ' HB2' HG23 ' A' ' 28' ' ' ILE . 19.4 m -56.76 -41.49 77.71 Favored 'General case' 0 C--O 1.24 0.593 0 CA-C-O 121.482 0.658 . . . . 0.0 109.403 179.005 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -65.85 -34.32 77.87 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.124 174.595 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.804 HD22 HD11 ' A' ' 56' ' ' ILE . 0.3 OUTLIER -63.01 -53.37 54.94 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.437 179.719 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.832 HD11 HD12 ' B' ' 109' ' ' LEU . 0.0 OUTLIER -58.9 -37.6 68.04 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.542 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 178.146 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.575 HD21 ' HA ' ' A' ' 23' ' ' VAL . 1.6 tp -58.88 -35.04 72.35 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.429 175.805 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.495 ' O ' ' HG2' ' A' ' 20' ' ' GLU . 80.4 m-70 -73.76 -16.5 61.17 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 112.776 0.658 . . . . 0.0 112.776 175.243 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.467 ' OD2' ' HG2' ' B' ' 102' ' ' ARG . 6.8 t70 -59.07 -46.96 86.94 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 121.063 0.459 . . . . 0.0 109.829 178.422 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.632 ' HB2' HG23 ' B' ' 132' ' ' ILE . 29.9 t70 -100.91 -13.06 18.49 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.597 0.713 . . . . 0.0 109.397 177.407 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.495 ' HG2' ' O ' ' A' ' 17' ' ' HIS . 5.3 mm-40 63.18 44.56 5.63 Favored 'General case' 0 CA--C 1.519 -0.245 0 CA-C-N 114.496 -1.229 . . . . 0.0 109.689 -175.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.681 HG22 ' H ' ' A' ' 22' ' ' THR . 14.8 p -99.92 177.96 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.134 0 CA-C-N 114.518 -1.219 . . . . 0.0 110.233 -168.873 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.681 ' H ' HG22 ' A' ' 21' ' ' VAL . 23.6 p -49.62 137.88 14.9 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 113.874 1.065 . . . . 0.0 113.874 -174.372 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.655 HG12 ' HA ' ' A' ' 48' ' ' ALA . 46.2 t -109.7 109.07 27.03 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.177 0 CA-C-N 113.961 -1.472 . . . . 0.0 110.193 -179.546 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.598 ' OG1' ' HB2' ' A' ' 27' ' ' LYS . 69.1 p -136.08 158.23 44.91 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.158 178.284 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -52.87 -46.57 67.94 Favored 'General case' 0 C--N 1.32 -0.7 0 O-C-N 123.508 0.505 . . . . 0.0 110.094 178.09 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -67.39 -26.3 66.38 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.582 -0.735 . . . . 0.0 111.364 -179.543 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.598 ' HB2' ' OG1' ' A' ' 24' ' ' THR . 3.7 tppt? -70.67 -54.43 11.91 Favored 'General case' 0 C--O 1.24 0.597 0 CA-C-O 121.856 0.836 . . . . 0.0 108.823 -179.1 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.618 HG23 ' HB2' ' A' ' 12' ' ' SER . 77.7 mt -59.04 -43.17 88.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 114.253 -1.339 . . . . 0.0 110.349 178.498 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.472 ' HA ' ' HB ' ' A' ' 32' ' ' ILE . 6.1 m-20 -68.61 -26.53 65.4 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.212 178.705 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.62 -47.73 80.19 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 174.144 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.557 ' HG ' HG13 ' A' ' 15' ' ' ILE . 1.5 mm? -58.48 -51.54 69.43 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 121.296 0.569 . . . . 0.0 110.093 174.204 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.67 HG23 ' O ' ' A' ' 37' ' ' VAL . 64.7 mt -48.42 -48.46 13.97 Favored 'Isoleucine or valine' 0 C--O 1.243 0.747 0 CA-C-N 114.652 -1.158 . . . . 0.0 112.111 179.099 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 53.0 tptt -75.34 -43.6 49.79 Favored 'General case' 0 N--CA 1.434 -1.231 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.781 -175.619 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -62.21 -37.26 84.67 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.619 0.247 . . . . 0.0 110.855 -178.252 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -80.04 -36.83 35.15 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.03 0.443 . . . . 0.0 110.951 177.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 103.11 16.03 22.16 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.599 176.462 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.805 ' HB ' ' HA2' ' B' ' 113' ' ' GLY . 2.7 p -118.24 118.27 57.52 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.546 0 CA-C-O 121.385 0.612 . . . . 0.0 110.455 -177.642 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 -95.87 158.85 15.26 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 114.85 -1.068 . . . . 0.0 110.832 -169.169 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.703 ' HA ' ' HB2' ' A' ' 5' ' ' SER . 96.0 t -129.63 164.95 30.86 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.781 0 CA-C-N 115.055 -0.975 . . . . 0.0 110.442 -168.836 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.56 ' HB2' ' CD1' ' A' ' 43' ' ' TRP . 21.9 mt-10 -65.85 111.88 7.48 Favored Pre-proline 0 CA--C 1.489 -1.367 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 167.481 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.456 ' HD3' ' HA ' ' A' ' 40' ' ' GLU . 69.9 Cg_exo -54.41 -29.64 59.71 Favored 'Trans proline' 0 C--N 1.311 -1.421 0 C-N-CA 123.244 2.629 . . . . 0.0 113.713 -167.776 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 1.7 p90 -61.36 -29.07 69.68 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 175.332 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . 0.56 ' CD1' ' HB2' ' A' ' 40' ' ' GLU . 8.2 m95 -62.72 -60.31 10.23 Favored Pre-proline 0 C--O 1.208 -1.119 0 CA-C-O 118.474 -0.774 . . . . 0.0 110.677 176.646 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.463 ' HD3' ' HB2' ' A' ' 43' ' ' TRP . 86.7 Cg_exo -47.15 -43.26 25.76 Favored 'Trans proline' 0 C--N 1.361 1.209 0 C-N-CA 121.894 1.73 . . . . 0.0 112.224 174.261 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -60.74 -59.18 10.64 Favored Glycine 0 CA--C 1.526 0.736 0 C-N-CA 120.124 -1.036 . . . . 0.0 112.444 176.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 4.5 tp -66.91 -26.57 66.93 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.467 0.707 . . . . 0.0 111.912 -176.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.728 ' HD2' HD11 ' A' ' 51' ' ' LEU . 2.9 m-85 -70.7 -46.67 62.69 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 175.615 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.655 ' HA ' HG12 ' A' ' 23' ' ' VAL . . . -62.66 -32.96 74.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.738 0.78 . . . . 0.0 109.115 179.198 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 9.2 mmmt -63.49 -62.77 1.45 Allowed 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 114.34 -1.3 . . . . 0.0 111.666 172.493 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -75.62 -31.68 59.99 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 113.709 1.003 . . . . 0.0 113.709 -167.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.728 HD11 ' HD2' ' A' ' 47' ' ' PHE . 13.1 mt -70.96 7.41 1.18 Allowed 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 112.843 0.683 . . . . 0.0 112.843 -174.136 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -101.88 5.26 40.88 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.49 0.662 . . . . 0.0 109.821 171.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 25.8 t30 -139.52 -52.8 0.54 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.421 -178.117 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 4.3 m -82.2 175.08 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.012 -179.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -113.69 165.31 12.66 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.253 176.511 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.804 HD11 HD22 ' A' ' 14' ' ' LEU . 3.9 tp -62.03 -25.18 36.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 120.838 0.352 . . . . 0.0 110.638 179.296 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -70.46 -14.95 72.53 Favored Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.816 -0.707 . . . . 0.0 111.548 177.048 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 20.4 t -78.04 -20.34 52.59 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-O 121.543 0.687 . . . . 0.0 109.549 179.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.692 ' HB2' HG21 ' B' ' 159' ' ' ILE . 19.8 mt -64.63 -29.63 70.64 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.434 179.515 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.766 HG13 ' HB ' ' B' ' 159' ' ' ILE . 0.2 OUTLIER -65.99 -16.28 20.34 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-N 114.737 -1.12 . . . . 0.0 110.613 179.358 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 14.4 t -95.68 -5.54 42.02 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.646 -178.116 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 7.4 m120 -65.05 -19.09 65.82 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-O 121.076 0.465 . . . . 0.0 111.188 -175.626 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.407 ' O ' HG13 ' A' ' 63' ' ' VAL . 9.0 p -82.89 60.87 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 122.894 1.331 . . . . 0.0 109.351 173.727 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 154.15 -41.99 0.63 Allowed Glycine 0 N--CA 1.447 -0.571 0 CA-C-N 114.146 -1.388 . . . . 0.0 111.398 -177.75 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -96.6 64.15 2.12 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.339 0.59 . . . . 0.0 109.937 177.682 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 173.82 43.02 0.05 OUTLIER Glycine 0 N--CA 1.448 -0.537 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.966 178.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.446 ' HA3' ' HD3' ' A' ' 68' ' ' PRO . . . -116.32 -98.82 2.11 Favored Glycine 0 N--CA 1.446 -0.633 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.143 -179.389 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.446 ' HD3' ' HA3' ' A' ' 67' ' ' GLY . 10.4 Cg_exo -71.47 77.46 1.72 Allowed 'Trans proline' 0 C--O 1.235 0.336 0 C-N-CA 123.362 2.708 . . . . 0.0 112.745 -177.801 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.921 0 CA-C-O 118.41 -0.805 . . . . 0.0 109.747 175.981 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 100' ' ' ALA . . . . . 0.507 ' O ' HG21 ' B' ' 104' ' ' VAL . . . . . . . . 0 N--CA 1.478 0.943 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 101' ' ' MET . . . . . 0.642 ' HG2' HD22 ' B' ' 162' ' ' LEU . 1.4 tmt? -119.61 130.86 55.31 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 120.761 -0.375 . . . . 0.0 111.381 -177.12 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 102' ' ' ARG . . . . . 0.467 ' HG2' ' OD2' ' A' ' 18' ' ' ASP . 1.0 OUTLIER -172.52 -91.12 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.236 -0.893 . . . . 0.0 109.189 171.039 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 103' ' ' TYR . . . . . 0.663 ' HB2' HG11 ' B' ' 142' ' ' VAL . 51.7 m-85 -81.01 -10.08 59.75 Favored 'General case' 0 C--O 1.239 0.501 0 CA-C-O 121.102 0.477 . . . . 0.0 110.275 179.024 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 104' ' ' VAL . . . . . 0.594 HG11 ' HB3' ' B' ' 162' ' ' LEU . 61.2 t -46.61 -47.21 7.44 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.534 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.088 174.798 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 105' ' ' ALA . . . . . 0.608 ' CB ' ' HB3' ' A' ' 14' ' ' LEU . . . -67.0 -38.1 85.38 Favored 'General case' 0 N--CA 1.443 -0.81 0 CA-C-N 114.826 -1.079 . . . . 0.0 111.425 -173.776 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 106' ' ' SER . . . . . 0.833 ' HB2' HG23 ' B' ' 123' ' ' ILE . 1.3 m -60.48 -38.83 85.54 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 121.815 0.817 . . . . 0.0 109.251 176.167 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 107' ' ' TYR . . . . . 0.799 ' HD2' HG12 ' B' ' 143' ' ' ILE . 32.5 t80 -63.07 -49.11 75.81 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 114.272 -1.331 . . . . 0.0 108.945 179.097 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 108' ' ' LEU . . . . . 0.724 HD12 HG13 ' B' ' 151' ' ' ILE . 0.0 OUTLIER -58.92 -49.2 78.7 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 114.987 -1.006 . . . . 0.0 111.337 179.029 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 109' ' ' LEU . . . . . 0.832 HD12 HD11 ' A' ' 15' ' ' ILE . 0.3 OUTLIER -55.42 -43.16 75.05 Favored 'General case' 0 CA--C 1.506 -0.746 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.613 178.671 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.5 -43.45 90.09 Favored 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 120.496 -0.482 . . . . 0.0 110.819 -178.514 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 111' ' ' ALA . . . . . 0.664 ' HA ' ' O ' ' B' ' 115' ' ' ASN . . . -64.71 -26.23 68.28 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.607 179.174 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 112' ' ' LEU . . . . . 0.853 ' HG ' HG13 ' A' ' 4' ' ' VAL . 3.5 mp -80.39 -38.32 30.52 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.245 -0.889 . . . . 0.0 110.244 174.128 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 113' ' ' GLY . . . . . 0.805 ' HA2' ' HB ' ' A' ' 37' ' ' VAL . . . -68.5 -17.21 70.47 Favored Glycine 0 N--CA 1.449 -0.497 0 CA-C-N 115.263 -0.88 . . . . 0.0 112.348 -176.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 114' ' ' GLY . . . . . . . . . . . . . . . 133.33 3.4 3.45 Favored Glycine 0 N--CA 1.437 -1.299 0 C-N-CA 120.394 -0.908 . . . . 0.0 113.168 176.738 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 115' ' ' ASN . . . . . 0.664 ' O ' ' HA ' ' B' ' 111' ' ' ALA . 47.9 t30 -118.69 86.27 2.51 Favored 'General case' 0 N--CA 1.441 -0.884 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 178.224 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 7.4 m -80.23 31.09 0.27 Allowed 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 122.488 1.137 . . . . 0.0 110.748 -167.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 117' ' ' SER . . . . . 0.528 ' N ' ' HD3' ' B' ' 118' ' ' PRO . 15.6 t -171.0 67.64 0.47 Allowed Pre-proline 0 C--N 1.309 -1.172 0 CA-C-N 113.12 -1.855 . . . . 0.0 107.971 178.248 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 118' ' ' PRO . . . . . 0.607 ' HD2' ' CZ ' ' B' ' 107' ' ' TYR . 31.9 Cg_exo -66.08 166.67 20.17 Favored 'Trans proline' 0 CA--C 1.515 -0.431 0 C-N-CA 125.275 3.983 . . . . 0.0 111.58 -174.72 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 119' ' ' SER . . . . . 0.652 ' O ' HG12 ' B' ' 123' ' ' ILE . 16.4 m -145.59 -178.51 6.13 Favored 'General case' 0 C--N 1.317 -0.809 0 C-N-CA 120.225 -0.59 . . . . 0.0 111.592 178.622 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 120' ' ' ALA . . . . . 0.788 ' HB1' HD13 ' B' ' 139' ' ' LEU . . . -62.68 -45.8 91.12 Favored 'General case' 0 CA--C 1.508 -0.639 0 CA-C-O 122.036 0.922 . . . . 0.0 110.173 -163.888 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 121' ' ' LYS . . . . . 0.415 ' HD2' ' N ' ' B' ' 121' ' ' LYS . 12.9 mptt -66.72 -30.39 70.61 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 113.674 -1.603 . . . . 0.0 110.871 178.538 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 122' ' ' ASP . . . . . 0.437 ' O ' ' HB2' ' B' ' 125' ' ' LYS . 18.0 t0 -72.91 -39.09 66.61 Favored 'General case' 0 C--O 1.24 0.58 0 CA-C-O 122.004 0.907 . . . . 0.0 109.025 179.744 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 123' ' ' ILE . . . . . 0.833 HG23 ' HB2' ' B' ' 106' ' ' SER . 39.8 mm -59.93 -42.97 91.18 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.264 0 CA-C-N 114.549 -1.205 . . . . 0.0 109.657 173.236 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 124' ' ' LYS . . . . . 0.817 ' HD3' HD21 ' B' ' 139' ' ' LEU . 3.9 mmmp? -59.17 -42.52 90.97 Favored 'General case' 0 CA--C 1.504 -0.797 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.444 -178.784 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 125' ' ' LYS . . . . . 0.529 ' HD3' ' HA ' ' B' ' 125' ' ' LYS . 30.3 mmtt -50.38 -64.72 0.72 Allowed 'General case' 0 CA--C 1.502 -0.879 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 169.72 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 126' ' ' ILE . . . . . 0.48 HG23 HD12 ' A' ' 31' ' ' LEU . 1.7 mp -53.96 -44.41 61.58 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.857 0 CA-C-N 114.841 -1.072 . . . . 0.0 111.256 -170.217 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 127' ' ' LEU . . . . . 0.63 ' HG ' ' O ' ' B' ' 123' ' ' ILE . 3.6 pp -80.31 -24.74 39.74 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 -177.387 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 128' ' ' ASP . . . . . 0.434 ' N ' HD12 ' B' ' 127' ' ' LEU . 34.6 t70 -71.39 -27.51 63.37 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.584 -0.525 . . . . 0.0 109.584 178.831 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 129' ' ' SER . . . . . . . . . . . . . 17.4 t -60.92 -27.73 68.41 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.602 177.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 130' ' ' VAL . . . . . 0.46 HG23 HG13 ' B' ' 132' ' ' ILE . 3.7 m -107.38 -13.42 10.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 C-N-CA 120.813 -0.355 . . . . 0.0 111.483 177.521 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 131' ' ' GLY . . . . . . . . . . . . . . . 85.15 49.16 4.57 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 121.149 -0.548 . . . . 0.0 112.389 177.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 132' ' ' ILE . . . . . 0.632 HG23 ' HB2' ' A' ' 19' ' ' ASP . 11.5 mt -105.5 138.89 28.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-O 120.462 0.172 . . . . 0.0 111.078 -179.321 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 133' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -69.65 127.31 32.51 Favored 'General case' 0 CA--C 1.513 -0.456 0 CA-C-O 121.47 0.652 . . . . 0.0 111.478 -176.226 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 134' ' ' ALA . . . . . 0.513 ' HA ' ' OH ' ' B' ' 103' ' ' TYR . . . -136.21 141.04 43.96 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.15 -0.932 . . . . 0.0 111.473 -177.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 135' ' ' ASP . . . . . 0.815 ' HB2' ' HG3' ' B' ' 138' ' ' ARG . 49.3 m-20 -103.56 132.77 49.53 Favored 'General case' 0 C--O 1.25 1.094 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.024 172.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 136' ' ' ASP . . . . . 0.996 ' HA ' HD11 ' B' ' 139' ' ' LEU . 32.5 t70 -71.26 -7.92 50.2 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 115.095 -0.957 . . . . 0.0 111.236 -168.271 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 137' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -101.27 -30.16 11.67 Favored 'General case' 0 N--CA 1.438 -1.069 0 C-N-CA 120.017 -0.673 . . . . 0.0 110.653 174.555 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 138' ' ' ARG . . . . . 0.815 ' HG3' ' HB2' ' B' ' 135' ' ' ASP . 20.9 mmt180 -65.31 -45.92 82.43 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.793 0.806 . . . . 0.0 109.513 -176.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 139' ' ' LEU . . . . . 0.996 HD11 ' HA ' ' B' ' 136' ' ' ASP . 0.3 OUTLIER -74.2 -37.77 63.79 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 114.933 -1.03 . . . . 0.0 111.001 178.928 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 140' ' ' ASN . . . . . 0.665 ' H ' HD12 ' B' ' 139' ' ' LEU . 57.0 t30 -61.49 -31.25 71.23 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.687 0.756 . . . . 0.0 109.148 -179.773 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 141' ' ' LYS . . . . . 0.44 ' O ' ' HD3' ' B' ' 141' ' ' LYS . 4.3 tppt? -76.4 -50.06 15.14 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 114.585 -1.189 . . . . 0.0 110.43 179.279 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 142' ' ' VAL . . . . . 0.663 HG11 ' HB2' ' B' ' 103' ' ' TYR . 12.6 p -56.0 -44.48 78.51 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.581 0 C-N-CA 120.359 -0.537 . . . . 0.0 109.814 -179.716 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 143' ' ' ILE . . . . . 0.799 HG12 ' HD2' ' B' ' 107' ' ' TYR . 38.7 mt -58.55 -46.21 90.05 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 C-N-CA 124.163 0.985 . . . . 0.0 112.498 172.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 144' ' ' SER . . . . . . . . . . . . . 47.1 t -54.19 -33.68 58.73 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.927 176.744 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 145' ' ' GLU . . . . . 0.431 ' HG2' ' O ' ' B' ' 141' ' ' LYS . 6.9 mm-40 -83.98 -42.31 16.37 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 121.498 0.666 . . . . 0.0 110.63 178.029 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 146' ' ' LEU . . . . . 0.532 ' HB3' ' CZ ' ' B' ' 107' ' ' TYR . 2.2 mm? -62.7 -38.81 91.89 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 114.977 -1.01 . . . . 0.0 112.345 179.817 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 147' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -54.16 120.03 5.91 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.124 -172.212 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . 99.4 40.33 3.24 Favored Glycine 0 N--CA 1.445 -0.703 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.549 -176.307 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 149' ' ' LYS . . . . . 0.482 ' HB2' ' O ' ' B' ' 146' ' ' LEU . 0.1 OUTLIER -134.79 168.56 18.83 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 -179.964 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 150' ' ' ASN . . . . . 0.588 ' O ' HG23 ' B' ' 154' ' ' VAL . 31.9 m-20 -106.82 90.57 3.36 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 107.702 -1.222 . . . . 0.0 107.702 179.068 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 151' ' ' ILE . . . . . 0.724 HG13 HD12 ' B' ' 108' ' ' LEU . 1.8 mp -41.69 -64.17 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 N-CA-C 113.571 0.952 . . . . 0.0 113.571 -168.089 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 152' ' ' GLU . . . . . 0.7 ' HG3' HD11 ' B' ' 112' ' ' LEU . 3.4 mp0 -57.31 -42.92 82.72 Favored 'General case' 0 C--O 1.209 -1.03 0 C-N-CA 120.93 -0.308 . . . . 0.0 111.365 -175.301 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 153' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -66.94 -29.57 69.47 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 120.548 0.214 . . . . 0.0 111.363 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 154' ' ' VAL . . . . . 0.818 ' HB ' HD12 ' B' ' 155' ' ' ILE . 61.8 t -61.15 -51.07 77.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 171.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 155' ' ' ILE . . . . . 0.818 HD12 ' HB ' ' B' ' 154' ' ' VAL . 1.6 mp -104.66 36.19 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-O 121.979 0.895 . . . . 0.0 110.368 -177.718 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 156' ' ' ALA . . . . . 0.644 ' HB1' ' HA ' ' A' ' 1' ' ' MET . . . -100.96 0.42 38.24 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 107.246 -1.391 . . . . 0.0 107.246 169.168 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 157' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -137.36 -34.83 0.69 Allowed 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 113.043 -1.889 . . . . 0.0 109.357 173.346 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 158' ' ' GLY . . . . . 0.487 ' O ' HD12 ' B' ' 162' ' ' LEU . . . -98.36 47.44 1.46 Allowed Glycine 0 CA--C 1.521 0.468 0 CA-C-N 115.548 -0.751 . . . . 0.0 114.357 -172.444 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 159' ' ' ILE . . . . . 0.766 ' HB ' HG13 ' A' ' 60' ' ' ILE . 1.8 mp -59.52 -18.0 13.76 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 CA-C-O 121.244 0.545 . . . . 0.0 111.045 176.213 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 160' ' ' GLY . . . . . . . . . . . . . . . -111.16 -65.05 0.51 Allowed Glycine 0 N--CA 1.447 -0.584 0 N-CA-C 111.384 -0.686 . . . . 0.0 111.384 -178.664 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 161' ' ' LYS . . . . . 0.481 ' HD3' ' N ' ' B' ' 161' ' ' LYS . 2.8 mppt? -78.14 61.74 2.73 Favored 'General case' 0 N--CA 1.441 -0.879 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 175.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 162' ' ' LEU . . . . . 0.642 HD22 ' HG2' ' B' ' 101' ' ' MET . 10.9 mp -46.8 146.32 1.65 Allowed 'General case' 0 C--O 1.236 0.345 0 CA-C-N 115.69 -0.687 . . . . 0.0 111.751 170.55 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 163' ' ' ALA . . . . . . . . . . . . . . . 50.55 51.82 16.1 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 115.505 -0.771 . . . . 0.0 112.75 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 164' ' ' SER . . . . . . . . . . . . . 90.2 p 62.43 159.13 0.07 Allowed 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.267 1.027 . . . . 0.0 113.32 173.521 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 165' ' ' VAL . . . . . 0.446 ' HA ' ' HD2' ' B' ' 166' ' ' PRO . 4.0 t -91.41 132.09 34.61 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 115.41 -0.813 . . . . 0.0 109.546 178.267 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 166' ' ' PRO . . . . . 0.446 ' HD2' ' HA ' ' B' ' 165' ' ' VAL . 21.1 Cg_exo -13.7 121.13 0.01 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.371 1 C-N-CA 127.237 5.292 . . . . 0.0 116.104 -179.165 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 167' ' ' ALA . . . . . . . . . . . . . . . -91.76 -54.81 3.72 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.772 -177.202 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 168' ' ' GLY . . . . . . . . . . . . . . . -119.51 -2.36 13.25 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.106 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 169' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.121 0 CA-C-O 118.234 -1.315 . . . . 0.0 111.243 -179.111 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 47.9 ttm . . . . . 0 N--CA 1.478 0.972 0 CA-C-O 120.848 0.356 . . . . 0.0 110.131 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.875 ' HB3' HD13 ' A' ' 7' ' ' LEU . . . -86.29 166.87 15.31 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.257 -179.164 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.7 p -78.72 131.82 36.74 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 171.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.681 HG13 ' HG ' ' B' ' 112' ' ' LEU . 2.2 t -53.6 -27.2 14.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 115.191 -0.913 . . . . 0.0 112.238 -175.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.778 ' HB3' ' HA ' ' A' ' 39' ' ' VAL . 2.1 m -67.46 -52.68 36.52 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 122.204 1.002 . . . . 0.0 108.468 176.068 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.522 ' O ' HG13 ' A' ' 10' ' ' ILE . 33.9 tt0 -55.83 -52.84 62.61 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-N 113.985 -1.461 . . . . 0.0 110.171 177.205 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.89 HD12 HD12 ' A' ' 10' ' ' ILE . 4.4 tp -59.46 -34.97 73.2 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.091 -0.958 . . . . 0.0 111.758 179.178 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.647 ' HB2' HD23 ' B' ' 112' ' ' LEU . . . -69.85 -33.25 72.02 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-O 121.011 0.434 . . . . 0.0 110.847 179.252 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.594 ' HB2' HG11 ' A' ' 39' ' ' VAL . 7.5 t -70.88 -37.43 73.02 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 177.38 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.89 HD12 HD12 ' A' ' 7' ' ' LEU . 74.2 mt -51.67 -55.53 8.6 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.887 0 CA-C-N 114.168 -1.378 . . . . 0.0 109.824 170.682 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.729 ' HB2' HD13 ' B' ' 109' ' ' LEU . 23.4 m-85 -67.04 -41.0 87.29 Favored 'General case' 0 C--O 1.22 -0.479 0 CA-C-N 115.615 -0.721 . . . . 0.0 111.596 -173.741 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.453 ' O ' ' HB2' ' A' ' 16' ' ' LEU . 2.5 p -57.43 -41.45 80.47 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 176.612 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.04 -33.43 75.42 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.895 172.471 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.789 HD22 HD11 ' A' ' 56' ' ' ILE . 0.3 OUTLIER -64.87 -57.99 7.36 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.488 -179.612 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -54.82 -47.34 74.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 177.277 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.706 HD12 HG13 ' A' ' 21' ' ' VAL . 6.2 tp -53.19 -41.47 65.3 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.928 178.65 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 26.3 t60 -78.89 -13.68 59.66 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.178 -0.919 . . . . 0.0 112.065 -178.605 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -70.62 -47.99 57.32 Favored 'General case' 0 N--CA 1.467 0.389 0 O-C-N 121.895 -0.503 . . . . 0.0 110.051 176.558 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.772 ' HB2' HG23 ' B' ' 132' ' ' ILE . 28.7 t70 -91.31 -11.19 38.74 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.938 0.875 . . . . 0.0 109.575 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 55.61 52.43 11.06 Favored 'General case' 0 CA--C 1.509 -0.604 0 CA-C-N 113.641 -1.618 . . . . 0.0 110.125 -176.813 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.706 HG13 HD12 ' A' ' 16' ' ' LEU . 2.9 p -100.03 152.64 4.69 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.739 0 CA-C-N 113.581 -1.645 . . . . 0.0 109.073 -176.072 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.476 ' O ' ' HG2' ' A' ' 27' ' ' LYS . 30.6 p -34.96 127.97 0.5 Allowed 'General case' 0 C--N 1.317 -0.808 0 O-C-N 124.672 1.232 . . . . 0.0 114.077 -174.064 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.551 HG12 ' HA ' ' A' ' 48' ' ' ALA . 51.2 t -100.55 106.03 18.65 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.927 0 CA-C-N 114.376 -1.283 . . . . 0.0 110.473 -176.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.44 ' OG1' ' HB2' ' A' ' 27' ' ' LYS . 80.6 p -141.05 153.77 45.65 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.769 -179.169 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -51.42 -46.49 62.96 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.12 0.486 . . . . 0.0 110.773 179.633 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -58.26 -38.38 76.82 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.382 -0.826 . . . . 0.0 111.356 177.482 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.483 ' HG2' HD11 ' A' ' 16' ' ' LEU . 4.3 tppt? -64.48 -50.03 69.07 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-O 121.965 0.888 . . . . 0.0 109.285 -178.229 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 80.8 mt -61.7 -38.96 81.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 114.393 -1.276 . . . . 0.0 110.458 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.682 ' HA ' HD12 ' A' ' 32' ' ' ILE . 30.7 m-80 -68.41 -30.0 68.8 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.862 176.436 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -65.98 -38.91 89.73 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.562 -0.29 . . . . 0.0 110.397 176.21 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.617 ' HB3' HD21 ' B' ' 109' ' ' LEU . 1.2 mm? -65.17 -45.79 83.49 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 120.646 -0.422 . . . . 0.0 110.106 171.747 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.682 HD12 ' HA ' ' A' ' 29' ' ' ASN . 57.8 mt -49.23 -50.0 16.22 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 CA-C-N 115.294 -0.867 . . . . 0.0 111.361 177.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 23.0 tptp -71.89 -37.7 70.1 Favored 'General case' 0 N--CA 1.435 -1.177 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.624 -179.384 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.673 ' HB1' ' HA ' ' B' ' 126' ' ' ILE . . . -59.26 -41.97 90.08 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.001 0.429 . . . . 0.0 111.451 179.526 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.477 ' CB ' ' HG ' ' B' ' 109' ' ' LEU . . . -84.61 -33.19 23.38 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.254 179.756 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 96.29 19.23 28.67 Favored Glycine 0 N--CA 1.447 -0.569 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.765 -179.041 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.814 ' HB ' ' HA2' ' B' ' 113' ' ' GLY . 2.9 p -121.6 117.73 53.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 121.981 0.896 . . . . 0.0 111.204 -177.079 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.431 ' HA ' HG23 ' A' ' 32' ' ' ILE . 57.8 t30 -88.51 157.06 18.75 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 113.966 -1.47 . . . . 0.0 110.726 -172.051 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.778 ' HA ' ' HB3' ' A' ' 5' ' ' SER . 97.3 t -126.91 161.38 33.82 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.002 0 CA-C-N 114.878 -1.056 . . . . 0.0 110.381 -173.257 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.536 ' HB3' ' HD1' ' A' ' 43' ' ' TRP . 7.5 tp10 -68.54 106.45 1.38 Allowed Pre-proline 0 N--CA 1.439 -1.012 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 170.151 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.46 ' C ' ' HD2' ' A' ' 44' ' ' PRO . 83.0 Cg_exo -50.22 -31.06 27.78 Favored 'Trans proline' 0 C--O 1.252 1.179 0 C-N-CA 123.698 2.932 . . . . 0.0 115.478 -163.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.448 ' HD2' ' HG3' ' A' ' 40' ' ' GLU . 0.8 OUTLIER -59.93 -26.8 66.23 Favored 'General case' 0 C--N 1.334 -0.107 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 178.456 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . 0.536 ' HD1' ' HB3' ' A' ' 40' ' ' GLU . 11.2 m95 -65.02 -61.67 5.9 Favored Pre-proline 0 C--O 1.207 -1.138 0 CA-C-O 118.423 -0.799 . . . . 0.0 110.723 176.313 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.468 ' HD3' ' HB2' ' A' ' 43' ' ' TRP . 85.5 Cg_exo -43.92 -45.04 11.73 Favored 'Trans proline' 0 C--N 1.358 1.069 0 C-N-CA 121.837 1.691 . . . . 0.0 112.242 174.747 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -60.55 -60.36 8.65 Favored Glycine 0 CA--C 1.526 0.757 0 C-N-CA 120.088 -1.054 . . . . 0.0 112.315 176.598 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.401 ' O ' ' HB2' ' A' ' 49' ' ' LYS . 10.2 tp -64.29 -24.02 67.51 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 123.069 0.547 . . . . 0.0 111.988 -177.527 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.554 ' HD2' HD11 ' A' ' 51' ' ' LEU . 2.7 m-85 -73.66 -43.91 58.16 Favored 'General case' 0 C--N 1.315 -0.899 0 C-N-CA 122.296 0.238 . . . . 0.0 110.375 177.511 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.551 ' HA ' HG12 ' A' ' 23' ' ' VAL . . . -64.81 -32.13 73.68 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 176.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.401 ' HB2' ' O ' ' A' ' 46' ' ' LEU . 9.5 mmmt -65.29 -51.56 59.89 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 114.247 -1.342 . . . . 0.0 111.815 173.243 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.453 ' O ' HG22 ' A' ' 54' ' ' VAL . . . -80.03 -40.72 27.19 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 113.187 0.81 . . . . 0.0 113.187 -170.069 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.554 HD11 ' HD2' ' A' ' 47' ' ' PHE . 8.7 mt -66.9 0.77 2.25 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 -172.099 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -88.16 -17.92 29.88 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.883 0.373 . . . . 0.0 110.607 174.484 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 91.4 m-20 -130.69 -38.26 1.31 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.823 -175.225 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.453 HG22 ' O ' ' A' ' 50' ' ' ALA . 4.6 m -85.39 -176.62 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 121.022 0.439 . . . . 0.0 110.141 -179.833 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 23.1 t-20 -119.41 168.39 11.0 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.76 -0.654 . . . . 0.0 109.585 176.776 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.789 HD11 HD22 ' A' ' 14' ' ' LEU . 3.2 tp -66.29 -27.94 42.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-O 121.058 0.456 . . . . 0.0 109.934 178.406 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -72.25 -14.81 76.78 Favored Glycine 0 N--CA 1.446 -0.666 0 N-CA-C 111.05 -0.82 . . . . 0.0 111.05 175.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 20.3 m -78.68 -21.31 48.42 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-O 121.229 0.537 . . . . 0.0 109.849 179.07 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.599 ' HB2' HG21 ' B' ' 159' ' ' ILE . 30.0 mt -60.78 -36.41 78.91 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.617 -179.736 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.701 HG13 ' HB ' ' B' ' 159' ' ' ILE . 0.2 OUTLIER -60.11 -20.89 20.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 115.041 -0.981 . . . . 0.0 110.829 179.131 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 5.6 t -95.76 13.79 25.37 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.417 -0.811 . . . . 0.0 111.285 -175.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.498 ' OD1' HG13 ' A' ' 63' ' ' VAL . 9.0 p30 -57.9 -35.15 70.64 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.961 -0.296 . . . . 0.0 111.456 -175.841 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.498 HG13 ' OD1' ' A' ' 62' ' ' ASN . 14.9 m -101.5 19.26 3.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.609 0.719 . . . . 0.0 110.994 176.792 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -121.75 0.93 11.07 Favored Glycine 0 C--N 1.312 -0.753 0 CA-C-N 114.946 -1.025 . . . . 0.0 111.522 179.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -87.31 -6.54 58.47 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.226 0.536 . . . . 0.0 110.275 178.225 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -105.11 116.85 5.4 Favored Glycine 0 N--CA 1.445 -0.756 0 N-CA-C 111.104 -0.799 . . . . 0.0 111.104 175.679 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 150.74 -79.39 0.21 Allowed Glycine 0 N--CA 1.447 -0.63 0 N-CA-C 111.617 -0.593 . . . . 0.0 111.617 -176.226 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -86.55 38.63 0.58 Allowed 'Trans proline' 0 N--CA 1.459 -0.506 0 C-N-CA 122.959 2.44 . . . . 0.0 112.458 178.34 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.909 0 CA-C-O 118.387 -0.816 . . . . 0.0 110.513 -179.584 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.061 0 CA-C-O 121.162 0.506 . . . . 0.0 110.572 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 101' ' ' MET . . . . . 0.697 ' HG2' HD22 ' B' ' 162' ' ' LEU . 1.3 tmt? -90.61 135.78 33.49 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.057 -178.358 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 102' ' ' ARG . . . . . 0.502 HH12 ' HE2' ' B' ' 141' ' ' LYS . 29.1 ptt180 -170.24 -147.26 0.05 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.834 -175.198 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 103' ' ' TYR . . . . . 0.922 ' HB2' HG11 ' B' ' 142' ' ' VAL . 69.4 m-85 -61.89 -8.19 4.7 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 120.705 0.288 . . . . 0.0 111.688 179.276 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 104' ' ' VAL . . . . . 0.746 HG23 HD23 ' B' ' 162' ' ' LEU . 4.1 m -45.03 -45.43 2.97 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.221 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.161 171.765 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 105' ' ' ALA . . . . . 0.561 ' CB ' ' HB3' ' A' ' 14' ' ' LEU . . . -64.31 -30.25 71.31 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 115.291 -0.868 . . . . 0.0 111.289 -174.051 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 106' ' ' SER . . . . . 0.814 ' HB2' HG23 ' B' ' 123' ' ' ILE . 1.4 m -76.53 -36.39 57.74 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.796 0.808 . . . . 0.0 108.971 -178.529 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 107' ' ' TYR . . . . . 0.678 ' CG ' HD12 ' B' ' 146' ' ' LEU . 36.5 t80 -63.96 -46.02 86.51 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 114.139 -1.391 . . . . 0.0 108.336 176.883 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 108' ' ' LEU . . . . . 0.844 HD12 HG13 ' B' ' 151' ' ' ILE . 0.0 OUTLIER -58.62 -45.93 88.13 Favored 'General case' 0 N--CA 1.443 -0.801 0 CA-C-N 114.393 -1.276 . . . . 0.0 110.792 177.072 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 109' ' ' LEU . . . . . 0.729 HD13 ' HB2' ' A' ' 11' ' ' TYR . 8.6 tp -55.65 -50.96 68.83 Favored 'General case' 0 CA--C 1.514 -0.426 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.893 178.445 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 110' ' ' ALA . . . . . 0.469 ' HB3' ' HB3' ' B' ' 118' ' ' PRO . . . -63.18 -40.58 97.94 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.24 -176.135 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 111' ' ' ALA . . . . . 0.664 ' HA ' ' O ' ' B' ' 115' ' ' ASN . . . -64.61 -33.98 77.19 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.559 178.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 112' ' ' LEU . . . . . 0.757 HD11 ' HG3' ' B' ' 152' ' ' GLU . 5.5 mp -71.47 -38.23 71.27 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.053 173.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 113' ' ' GLY . . . . . 0.814 ' HA2' ' HB ' ' A' ' 37' ' ' VAL . . . -61.87 -23.53 63.56 Favored Glycine 0 N--CA 1.446 -0.643 0 CA-C-N 115.198 -0.91 . . . . 0.0 111.843 179.548 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 114' ' ' GLY . . . . . . . . . . . . . . . 133.48 4.66 3.11 Favored Glycine 0 N--CA 1.436 -1.344 0 C-N-CA 120.569 -0.824 . . . . 0.0 112.876 177.496 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 115' ' ' ASN . . . . . 0.664 ' O ' ' HA ' ' B' ' 111' ' ' ALA . 47.2 t30 -116.94 91.15 3.5 Favored 'General case' 0 N--CA 1.439 -0.988 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 -179.533 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -76.96 25.61 0.15 Allowed 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 122.211 1.005 . . . . 0.0 110.787 -167.815 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 117' ' ' SER . . . . . 0.538 ' N ' ' HD3' ' B' ' 118' ' ' PRO . 35.2 t -169.83 68.12 0.59 Allowed Pre-proline 0 C--N 1.311 -1.102 0 CA-C-N 113.648 -1.614 . . . . 0.0 108.809 -178.198 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 118' ' ' PRO . . . . . 0.661 ' HG2' ' O ' ' B' ' 107' ' ' TYR . 26.7 Cg_exo -67.71 154.15 74.03 Favored 'Trans proline' 0 C--N 1.327 -0.583 0 C-N-CA 125.066 3.844 . . . . 0.0 111.572 -176.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 119' ' ' SER . . . . . 0.596 ' O ' HG12 ' B' ' 123' ' ' ILE . 92.0 p -121.73 -178.58 3.86 Favored 'General case' 0 C--N 1.315 -0.892 0 C-N-CA 120.104 -0.639 . . . . 0.0 110.958 178.327 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 120' ' ' ALA . . . . . 0.807 ' HB1' HD13 ' B' ' 139' ' ' LEU . . . -64.95 -38.74 91.97 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-O 121.886 0.851 . . . . 0.0 109.366 -172.061 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 121' ' ' LYS . . . . . 0.493 ' HD2' ' N ' ' B' ' 121' ' ' LYS . 4.7 mptp? -64.83 -31.96 73.43 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 113.952 -1.476 . . . . 0.0 110.912 176.718 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 122' ' ' ASP . . . . . 0.811 ' HA ' ' HE3' ' B' ' 125' ' ' LYS . 19.2 m-20 -72.61 -43.6 63.09 Favored 'General case' 0 CA--C 1.515 -0.377 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 176.282 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 123' ' ' ILE . . . . . 0.814 HG23 ' HB2' ' B' ' 106' ' ' SER . 33.8 mm -55.38 -50.36 66.01 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.421 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 175.798 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 124' ' ' LYS . . . . . 0.5 ' HD3' HD11 ' B' ' 127' ' ' LEU . 4.0 tppp? -61.21 -35.92 78.51 Favored 'General case' 0 N--CA 1.443 -0.788 0 CA-C-N 114.38 -1.282 . . . . 0.0 109.486 -177.628 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 125' ' ' LYS . . . . . 0.811 ' HE3' ' HA ' ' B' ' 122' ' ' ASP . 0.0 OUTLIER -72.44 -44.14 62.81 Favored 'General case' 0 N--CA 1.432 -1.359 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.931 -177.328 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 126' ' ' ILE . . . . . 0.702 HD12 ' HD2' ' B' ' 125' ' ' LYS . 1.4 mp -54.93 -51.81 49.51 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 CA-C-N 116.539 -0.301 . . . . 0.0 110.726 173.745 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 127' ' ' LEU . . . . . 0.945 ' HB2' ' HB ' ' B' ' 132' ' ' ILE . 3.1 pp -77.14 -25.97 52.6 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.614 -0.435 . . . . 0.0 111.788 -175.704 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 128' ' ' ASP . . . . . 0.474 ' HB2' ' O ' ' B' ' 124' ' ' LYS . 19.5 t70 -67.18 -33.5 75.54 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 110.024 -0.362 . . . . 0.0 110.024 177.606 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 129' ' ' SER . . . . . 0.445 ' CB ' ' HB2' ' A' ' 34' ' ' ALA . 22.7 t -51.97 -43.06 63.37 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.351 176.619 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 130' ' ' VAL . . . . . 0.6 HG23 HG13 ' B' ' 132' ' ' ILE . 5.0 m -100.76 -6.34 9.13 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 N-CA-C 112.242 0.46 . . . . 0.0 112.242 -179.589 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 131' ' ' GLY . . . . . . . . . . . . . . . 83.22 46.55 6.12 Favored Glycine 0 CA--C 1.518 0.257 0 C-N-CA 120.941 -0.647 . . . . 0.0 113.112 177.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 132' ' ' ILE . . . . . 0.945 ' HB ' ' HB2' ' B' ' 127' ' ' LEU . 14.9 mt -95.35 134.53 32.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 120.671 0.272 . . . . 0.0 110.46 176.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 133' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -79.98 131.73 35.87 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.895 0.379 . . . . 0.0 111.114 -178.047 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 134' ' ' ALA . . . . . . . . . . . . . . . -145.29 154.14 42.03 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.493 -175.544 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 135' ' ' ASP . . . . . 0.747 ' HB2' ' CG ' ' B' ' 138' ' ' ARG . 18.1 m-20 -102.11 135.17 44.15 Favored 'General case' 0 C--O 1.252 1.19 0 CA-C-O 121.124 0.488 . . . . 0.0 109.736 172.241 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 136' ' ' ASP . . . . . 0.915 ' HA ' HD11 ' B' ' 139' ' ' LEU . 10.4 t70 -73.28 -11.61 60.56 Favored 'General case' 0 CA--C 1.514 -0.426 0 CA-C-N 115.14 -0.936 . . . . 0.0 110.995 -166.649 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 137' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -96.79 -30.06 13.39 Favored 'General case' 0 N--CA 1.438 -1.062 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.723 175.334 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 138' ' ' ARG . . . . . 0.747 ' CG ' ' HB2' ' B' ' 135' ' ' ASP . 17.5 mmt180 -66.81 -46.26 75.75 Favored 'General case' 0 CA--C 1.504 -0.79 0 CA-C-O 121.977 0.894 . . . . 0.0 109.224 -175.624 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 139' ' ' LEU . . . . . 0.915 HD11 ' HA ' ' B' ' 136' ' ' ASP . 0.3 OUTLIER -72.46 -36.68 68.55 Favored 'General case' 0 C--O 1.209 -1.072 0 CA-C-N 114.607 -1.179 . . . . 0.0 111.148 179.03 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 140' ' ' ASN . . . . . 0.597 ' O ' ' HB ' ' B' ' 143' ' ' ILE . 9.7 t30 -64.27 -26.92 68.71 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.925 0.869 . . . . 0.0 109.565 177.75 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 141' ' ' LYS . . . . . 0.502 ' HE2' HH12 ' B' ' 102' ' ' ARG . 44.4 tttt -69.93 -51.63 31.25 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 114.391 -1.277 . . . . 0.0 109.354 177.226 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 142' ' ' VAL . . . . . 0.922 HG11 ' HB2' ' B' ' 103' ' ' TYR . 8.6 p -62.55 -32.12 54.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.889 177.853 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 143' ' ' ILE . . . . . 0.86 HG12 ' O ' ' B' ' 139' ' ' LEU . 34.6 mm -50.47 -66.62 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.513 -0.455 0 CA-C-O 121.082 0.467 . . . . 0.0 110.439 170.388 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 144' ' ' SER . . . . . . . . . . . . . 70.6 p -54.41 -31.56 55.34 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.188 -0.915 . . . . 0.0 111.838 -178.669 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 145' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -74.97 -37.07 62.02 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 112.072 0.397 . . . . 0.0 112.072 179.254 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 146' ' ' LEU . . . . . 0.711 HD11 ' HA ' ' B' ' 104' ' ' VAL . 6.9 mt -86.98 -19.53 28.59 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.813 -0.355 . . . . 0.0 110.712 -178.325 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 147' ' ' ASN . . . . . 0.409 ' HA ' ' OH ' ' B' ' 107' ' ' TYR . 26.3 t-20 -54.31 117.96 3.71 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.041 -176.335 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . 96.9 36.25 5.07 Favored Glycine 0 N--CA 1.448 -0.52 0 CA-C-N 115.544 -0.753 . . . . 0.0 112.275 -178.297 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 149' ' ' LYS . . . . . 0.478 ' HB2' ' O ' ' B' ' 146' ' ' LEU . 0.3 OUTLIER -130.08 165.28 22.57 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.837 0.351 . . . . 0.0 110.601 179.842 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 150' ' ' ASN . . . . . 0.515 ' O ' HG23 ' B' ' 154' ' ' VAL . 85.3 m-20 -104.28 88.84 3.08 Favored 'General case' 0 CA--C 1.513 -0.468 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 177.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 151' ' ' ILE . . . . . 0.844 HG13 HD12 ' B' ' 108' ' ' LEU . 1.8 mp -39.26 -64.52 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 113.845 1.054 . . . . 0.0 113.845 -169.806 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 152' ' ' GLU . . . . . 0.757 ' HG3' HD11 ' B' ' 112' ' ' LEU . 3.1 mp0 -57.97 -35.38 71.09 Favored 'General case' 0 C--O 1.216 -0.66 0 O-C-N 122.355 -0.216 . . . . 0.0 111.263 -174.268 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 153' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -71.28 -37.98 71.84 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.855 177.784 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 154' ' ' VAL . . . . . 0.81 ' HB ' HD12 ' B' ' 155' ' ' ILE . 62.0 t -53.47 -47.97 58.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 121.49 0.662 . . . . 0.0 109.321 173.76 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 155' ' ' ILE . . . . . 0.81 HD12 ' HB ' ' B' ' 154' ' ' VAL . 1.6 mp -107.51 35.73 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-O 121.929 0.871 . . . . 0.0 110.804 -178.613 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 156' ' ' ALA . . . . . 0.454 ' HB2' ' O ' ' B' ' 152' ' ' GLU . . . -100.85 1.9 40.51 Favored 'General case' 0 C--N 1.311 -1.096 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 169.062 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 157' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 -142.05 16.08 2.09 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 113.946 -1.479 . . . . 0.0 110.515 177.378 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 158' ' ' GLY . . . . . 0.787 ' HA3' HG21 ' B' ' 165' ' ' VAL . . . -159.5 45.54 0.44 Allowed Glycine 0 C--N 1.338 0.69 0 C-N-CA 119.507 -1.33 . . . . 0.0 115.204 -172.64 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 159' ' ' ILE . . . . . 0.701 ' HB ' HG13 ' A' ' 60' ' ' ILE . 1.8 mp -58.57 -25.88 29.48 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 C-N-CA 122.959 0.504 . . . . 0.0 111.736 176.638 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 160' ' ' GLY . . . . . . . . . . . . . . . -91.71 -67.21 1.14 Allowed Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.048 -1.072 . . . . 0.0 112.993 -178.321 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 161' ' ' LYS . . . . . 0.668 ' HB2' HG22 ' B' ' 165' ' ' VAL . 31.3 mmmt -65.11 -30.02 70.93 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 113.469 0.915 . . . . 0.0 113.469 -174.709 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 162' ' ' LEU . . . . . 0.746 HD23 HG23 ' B' ' 104' ' ' VAL . 7.4 mp 48.27 175.88 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 114.504 1.298 . . . . 0.0 114.504 -171.013 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 163' ' ' ALA . . . . . 0.473 ' HB2' HG11 ' B' ' 104' ' ' VAL . . . 55.13 -88.57 0.02 OUTLIER 'General case' 0 C--N 1.339 0.147 0 CA-C-N 115.092 -0.958 . . . . 0.0 112.748 -175.401 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 164' ' ' SER . . . . . . . . . . . . . 6.7 m -117.95 116.2 26.45 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 120.877 0.37 . . . . 0.0 110.156 178.025 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 165' ' ' VAL . . . . . 0.787 HG21 ' HA3' ' B' ' 158' ' ' GLY . 5.2 t -128.77 120.25 20.47 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.546 -176.439 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 166' ' ' PRO . . . . . 0.44 ' HD2' ' HA ' ' B' ' 165' ' ' VAL . 50.1 Cg_exo -19.63 114.85 0.02 OUTLIER 'Trans proline' 0 N--CA 1.437 -1.831 1 C-N-CA 127.154 5.236 . . . . 0.0 116.003 177.516 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 167' ' ' ALA . . . . . . . . . . . . . . . -105.85 -24.84 12.37 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.832 179.171 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 168' ' ' GLY . . . . . . . . . . . . . . . -141.87 100.4 0.26 Allowed Glycine 0 N--CA 1.445 -0.702 0 CA-C-N 115.152 -0.931 . . . . 0.0 111.422 175.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 169' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.927 0 CA-C-O 119.047 -0.863 . . . . 0.0 111.776 -179.99 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.557 ' HG2' ' H ' ' A' ' 2' ' ' ALA . 17.3 ttt . . . . . 0 N--CA 1.481 1.091 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.615 ' HB3' HD13 ' A' ' 7' ' ' LEU . . . -116.09 167.92 10.56 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 120.936 0.398 . . . . 0.0 111.07 -176.727 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 11.4 m -90.15 136.66 32.91 Favored 'General case' 0 N--CA 1.441 -0.904 0 N-CA-C 107.783 -1.191 . . . . 0.0 107.783 164.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.867 HG13 ' HG ' ' B' ' 112' ' ' LEU . 2.1 t -51.85 -24.58 4.85 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-N 114.947 -1.024 . . . . 0.0 112.17 -178.63 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.723 ' HB3' ' HA ' ' A' ' 39' ' ' VAL . 8.5 m -69.65 -51.86 31.04 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 176.219 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.509 ' O ' HG13 ' A' ' 10' ' ' ILE . 30.6 mt-10 -58.85 -52.15 66.97 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 115.008 -0.996 . . . . 0.0 109.796 178.239 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.853 HD12 HD12 ' A' ' 10' ' ' ILE . 3.2 tp -57.83 -36.85 72.84 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 115.317 -0.856 . . . . 0.0 112.097 178.279 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.632 ' HB2' HD23 ' B' ' 112' ' ' LEU . . . -67.09 -35.47 79.88 Favored 'General case' 0 CA--C 1.516 -0.361 0 CA-C-O 120.957 0.408 . . . . 0.0 110.855 178.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.526 ' HB2' HG11 ' A' ' 39' ' ' VAL . 5.6 t -69.7 -41.09 75.85 Favored 'General case' 0 C--O 1.242 0.672 0 N-CA-C 108.188 -1.042 . . . . 0.0 108.188 178.467 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.853 HD12 HD12 ' A' ' 7' ' ' LEU . 68.0 mt -47.14 -54.1 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.671 0 CA-C-N 114.214 -1.357 . . . . 0.0 109.627 170.532 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.882 ' HB2' HD13 ' B' ' 109' ' ' LEU . 23.4 m-85 -66.32 -39.48 89.29 Favored 'General case' 0 C--O 1.219 -0.511 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.877 -174.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.563 ' HB2' HD23 ' A' ' 31' ' ' LEU . 79.4 p -56.78 -44.79 82.22 Favored 'General case' 0 C--O 1.243 0.739 0 CA-C-O 121.475 0.655 . . . . 0.0 109.383 179.148 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.532 ' HB1' ' HG ' ' A' ' 51' ' ' LEU . . . -63.2 -34.32 77.38 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 115.09 -0.959 . . . . 0.0 110.42 173.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.66 HD22 HD11 ' A' ' 56' ' ' ILE . 0.2 OUTLIER -61.36 -55.49 31.05 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.456 179.342 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.479 HG12 ' O ' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -55.27 -41.5 61.59 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 178.322 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.672 HD21 ' HA ' ' A' ' 23' ' ' VAL . 2.3 tp -55.46 -38.64 69.33 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.31 176.212 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.468 ' CD2' ' HB ' ' A' ' 56' ' ' ILE . 93.8 m-70 -73.77 -14.28 61.09 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 176.228 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -68.96 -44.4 73.05 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.911 0.386 . . . . 0.0 110.281 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.736 ' HB2' HG23 ' B' ' 132' ' ' ILE . 37.7 t70 -97.92 -6.99 31.11 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.835 0.826 . . . . 0.0 109.178 177.639 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 53.32 52.57 13.27 Favored 'General case' 0 CA--C 1.516 -0.359 0 CA-C-N 113.803 -1.544 . . . . 0.0 109.976 -177.034 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.43 HG13 HD12 ' A' ' 16' ' ' LEU . 7.3 p -106.62 163.97 4.73 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 CA-C-N 114.319 -1.31 . . . . 0.0 109.365 -174.051 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 18.6 p -48.32 142.01 5.98 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 113.312 0.856 . . . . 0.0 113.312 -174.719 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.672 ' HA ' HD21 ' A' ' 16' ' ' LEU . 58.3 t -107.27 114.29 45.79 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 CA-C-N 114.305 -1.316 . . . . 0.0 110.769 -175.471 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.502 ' OG1' ' HD2' ' A' ' 27' ' ' LYS . 22.1 p -136.69 159.57 41.44 Favored 'General case' 0 C--O 1.245 0.848 0 CA-C-O 120.925 0.393 . . . . 0.0 110.511 176.346 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -56.57 -34.14 66.83 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.596 176.106 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -68.79 -31.95 71.33 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.17 177.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.606 ' HG2' HD11 ' A' ' 16' ' ' LEU . 0.3 OUTLIER -62.67 -58.1 8.69 Favored 'General case' 0 CA--C 1.512 -0.505 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 175.043 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.511 HG23 ' OG ' ' A' ' 12' ' ' SER . 37.0 mt -56.51 -40.95 71.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 114.184 -1.371 . . . . 0.0 110.999 -178.348 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 41.1 t-20 -59.37 -45.53 91.16 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.934 -0.575 . . . . 0.0 109.955 177.272 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -59.31 -47.79 84.06 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.405 179.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.722 ' HB3' HD21 ' B' ' 109' ' ' LEU . 0.9 OUTLIER -57.61 -50.43 73.17 Favored 'General case' 0 C--O 1.239 0.504 0 CA-C-O 121.006 0.431 . . . . 0.0 110.595 177.174 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.593 HG23 ' O ' ' A' ' 37' ' ' VAL . 67.1 mt -47.76 -51.48 7.95 Favored 'Isoleucine or valine' 0 C--O 1.242 0.698 0 CA-C-N 115.067 -0.97 . . . . 0.0 111.267 177.839 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 47.5 mmtm -74.2 -39.49 63.12 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.022 -0.99 . . . . 0.0 111.781 -174.036 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -63.24 -41.39 99.07 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-O 120.783 0.325 . . . . 0.0 110.97 -178.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.504 ' HA ' HD11 ' B' ' 126' ' ' ILE . . . -79.41 -31.8 42.77 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.079 179.784 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 97.38 16.16 35.58 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 121.021 -0.609 . . . . 0.0 111.91 178.316 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.881 ' HB ' ' HA2' ' B' ' 113' ' ' GLY . 2.5 p -119.57 119.99 62.14 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 CA-C-O 121.433 0.635 . . . . 0.0 110.458 -176.694 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.577 ' HA ' HG23 ' A' ' 32' ' ' ILE . 12.8 t30 -96.59 153.71 17.69 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 114.826 -1.079 . . . . 0.0 111.142 -167.673 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.723 ' HA ' ' HB3' ' A' ' 5' ' ' SER . 93.5 t -130.03 158.79 42.49 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.964 0 CA-C-N 114.982 -1.008 . . . . 0.0 109.923 -170.347 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.595 ' HB2' ' CD1' ' A' ' 43' ' ' TRP . 30.6 mt-10 -63.83 112.7 7.9 Favored Pre-proline 0 CA--C 1.487 -1.454 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 170.003 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.447 ' C ' ' HD2' ' A' ' 44' ' ' PRO . 54.4 Cg_exo -55.8 -27.75 63.73 Favored 'Trans proline' 0 C--N 1.312 -1.349 0 C-N-CA 123.042 2.495 . . . . 0.0 113.509 -167.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 1.6 p90 -62.0 -28.95 69.93 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.746 175.03 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . 0.595 ' CD1' ' HB2' ' A' ' 40' ' ' GLU . 9.8 m95 -62.47 -59.35 13.08 Favored Pre-proline 0 C--O 1.204 -1.338 0 CA-C-O 118.374 -0.822 . . . . 0.0 110.32 175.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.459 ' HD2' ' O ' ' A' ' 40' ' ' GLU . 84.8 Cg_exo -44.38 -45.28 12.72 Favored 'Trans proline' 0 C--N 1.36 1.165 0 C-N-CA 121.716 1.61 . . . . 0.0 112.527 172.483 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -60.26 -59.36 10.49 Favored Glycine 0 CA--C 1.529 0.962 0 C-N-CA 120.025 -1.084 . . . . 0.0 112.759 177.367 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 5.4 tp -65.41 -32.03 73.44 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 123.276 0.63 . . . . 0.0 111.791 -177.388 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.499 ' HE1' ' CE3' ' A' ' 43' ' ' TRP . 2.7 m-85 -65.32 -49.02 71.04 Favored 'General case' 0 C--N 1.317 -0.81 0 C-N-CA 122.685 0.394 . . . . 0.0 110.263 176.533 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.418 ' HA ' HG12 ' A' ' 23' ' ' VAL . . . -64.6 -31.11 72.18 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.505 0.669 . . . . 0.0 109.539 -179.757 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.549 ' HD2' ' O ' ' A' ' 49' ' ' LYS . 0.4 OUTLIER -66.82 -35.76 80.81 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 114.883 -1.053 . . . . 0.0 110.622 173.094 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.426 ' C ' HG22 ' A' ' 54' ' ' VAL . . . -85.03 -58.71 2.58 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.809 0.67 . . . . 0.0 112.809 -175.253 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.589 ' HB2' HG11 ' A' ' 23' ' ' VAL . 3.2 mm? -62.0 -11.71 14.95 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 112.746 0.647 . . . . 0.0 112.746 -170.437 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -74.34 -26.41 60.12 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.061 0.457 . . . . 0.0 110.426 175.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 84.1 m-20 -116.4 -39.13 3.41 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.048 -177.284 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.426 HG22 ' C ' ' A' ' 50' ' ' ALA . 4.1 m -98.43 -174.28 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.949 0.404 . . . . 0.0 110.789 -176.435 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 26.9 p-10 -111.71 178.71 4.23 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.334 179.364 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.66 HD11 HD22 ' A' ' 14' ' ' LEU . 4.7 tp -74.57 -25.1 18.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 120.971 0.415 . . . . 0.0 109.992 -179.183 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -70.32 -13.75 70.92 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.435 -0.888 . . . . 0.0 110.937 175.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 32.2 t -77.53 -21.75 52.17 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-O 121.27 0.557 . . . . 0.0 109.677 179.284 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.649 ' HB2' HG21 ' B' ' 159' ' ' ILE . 20.0 mt -64.98 -26.38 68.27 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.565 179.616 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.573 ' CD1' ' HB ' ' B' ' 159' ' ' ILE . 0.1 OUTLIER -66.01 -12.37 14.11 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 CA-C-N 114.602 -1.181 . . . . 0.0 110.558 179.867 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.575 ' HA ' ' HB3' ' A' ' 65' ' ' ALA . 16.4 t -93.41 -5.91 48.29 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.036 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.4 HD22 ' HA ' ' A' ' 62' ' ' ASN . 13.2 m120 -78.0 -7.13 56.45 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.655 -177.175 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 18.8 m -122.98 29.49 2.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.284 0.564 . . . . 0.0 110.691 177.61 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 131.52 -120.06 2.76 Favored Glycine 0 N--CA 1.451 -0.331 0 CA-C-N 115.544 -0.753 . . . . 0.0 112.518 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.575 ' HB3' ' HA ' ' A' ' 61' ' ' CYS . . . 52.03 48.8 22.01 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 123.015 0.526 . . . . 0.0 111.781 -179.263 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -122.85 -43.94 0.35 Allowed Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.847 -0.692 . . . . 0.0 111.952 179.14 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 127.89 -142.48 13.56 Favored Glycine 0 N--CA 1.445 -0.75 0 C-N-CA 120.866 -0.683 . . . . 0.0 111.752 -178.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -63.81 -45.39 10.91 Favored 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 122.754 2.303 . . . . 0.0 111.505 178.026 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.025 0 CA-C-O 118.246 -0.883 . . . . 0.0 109.914 178.308 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.126 0 CA-C-O 120.796 0.332 . . . . 0.0 110.977 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 101' ' ' MET . . . . . 0.54 ' HE3' HD12 ' A' ' 14' ' ' LEU . 1.3 tmt? -79.83 124.56 28.74 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.15 -0.477 . . . . 0.0 109.883 178.3 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 102' ' ' ARG . . . . . . . . . . . . . 29.8 ptt180 -162.74 -122.74 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.707 -0.678 . . . . 0.0 109.766 176.414 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 103' ' ' TYR . . . . . 0.664 ' HB3' HG21 ' B' ' 123' ' ' ILE . 41.5 m-85 -61.51 -10.17 7.31 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-O 120.902 0.382 . . . . 0.0 111.234 179.581 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 104' ' ' VAL . . . . . 0.603 ' O ' HD22 ' B' ' 108' ' ' LEU . 63.4 t -44.15 -47.06 2.24 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.269 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.973 170.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 105' ' ' ALA . . . . . 0.623 ' CB ' ' HB3' ' A' ' 14' ' ' LEU . . . -65.95 -38.91 89.83 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.008 -0.996 . . . . 0.0 111.593 -173.879 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 106' ' ' SER . . . . . 0.881 ' HB2' HG23 ' B' ' 123' ' ' ILE . 1.4 m -63.75 -36.38 83.69 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-O 121.596 0.712 . . . . 0.0 109.683 177.427 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 107' ' ' TYR . . . . . 0.654 ' CZ ' ' HD2' ' B' ' 118' ' ' PRO . 31.8 t80 -62.93 -51.06 68.39 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 114.509 -1.223 . . . . 0.0 108.665 178.583 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 108' ' ' LEU . . . . . 0.907 HD12 HG13 ' B' ' 151' ' ' ILE . 0.0 OUTLIER -56.96 -45.36 82.92 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 114.652 -1.158 . . . . 0.0 110.971 178.341 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 109' ' ' LEU . . . . . 0.882 HD13 ' HB2' ' A' ' 11' ' ' TYR . 7.7 tp -56.41 -47.49 78.93 Favored 'General case' 0 CA--C 1.51 -0.574 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.033 179.099 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 110' ' ' ALA . . . . . 0.562 ' HB3' ' HB3' ' B' ' 118' ' ' PRO . . . -65.73 -38.98 90.63 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-O 120.998 0.428 . . . . 0.0 111.155 -177.358 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 111' ' ' ALA . . . . . 0.658 ' HA ' ' O ' ' B' ' 115' ' ' ASN . . . -69.01 -23.74 64.12 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.637 178.733 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 112' ' ' LEU . . . . . 0.867 ' HG ' HG13 ' A' ' 4' ' ' VAL . 1.4 mp -80.23 -37.54 32.87 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.058 172.831 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 113' ' ' GLY . . . . . 0.881 ' HA2' ' HB ' ' A' ' 37' ' ' VAL . . . -64.07 -20.99 65.43 Favored Glycine 0 N--CA 1.449 -0.499 0 CA-C-N 115.204 -0.907 . . . . 0.0 111.801 177.809 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 114' ' ' GLY . . . . . . . . . . . . . . . 130.01 9.64 3.02 Favored Glycine 0 N--CA 1.439 -1.16 0 C-N-CA 120.354 -0.927 . . . . 0.0 113.416 174.563 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 115' ' ' ASN . . . . . 0.658 ' O ' ' HA ' ' B' ' 111' ' ' ALA . 33.7 t30 -115.11 95.31 5.14 Favored 'General case' 0 N--CA 1.44 -0.962 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 178.5 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 2.3 p -80.21 29.87 0.28 Allowed 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 114.895 -1.048 . . . . 0.0 110.75 -167.024 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 117' ' ' SER . . . . . 0.526 ' N ' ' HD3' ' B' ' 118' ' ' PRO . 41.9 t -175.78 67.96 0.25 Allowed Pre-proline 0 C--N 1.307 -1.252 0 CA-C-N 113.377 -1.738 . . . . 0.0 108.411 -179.05 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 118' ' ' PRO . . . . . 0.654 ' HD2' ' CZ ' ' B' ' 107' ' ' TYR . 32.1 Cg_exo -66.04 148.7 85.86 Favored 'Trans proline' 0 CA--C 1.513 -0.557 0 C-N-CA 125.115 3.877 . . . . 0.0 111.827 -175.268 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 119' ' ' SER . . . . . 0.648 ' O ' HG12 ' B' ' 123' ' ' ILE . 78.6 p -116.39 -178.42 3.41 Favored 'General case' 0 C--N 1.316 -0.858 0 C-N-CA 120.221 -0.591 . . . . 0.0 111.324 178.318 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 120' ' ' ALA . . . . . 0.838 ' HB1' HD13 ' B' ' 139' ' ' LEU . . . -66.81 -34.19 77.28 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 122.057 0.932 . . . . 0.0 109.77 -173.868 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 121' ' ' LYS . . . . . 0.603 ' HD2' ' N ' ' B' ' 121' ' ' LYS . 0.0 OUTLIER -69.74 -29.97 67.46 Favored 'General case' 0 N--CA 1.437 -1.084 0 CA-C-N 113.956 -1.475 . . . . 0.0 110.173 177.805 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 122' ' ' ASP . . . . . 0.428 ' O ' HD13 ' B' ' 126' ' ' ILE . 20.1 m-20 -70.41 -44.73 67.34 Favored 'General case' 0 CA--C 1.517 -0.306 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 174.517 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 123' ' ' ILE . . . . . 0.881 HG23 ' HB2' ' B' ' 106' ' ' SER . 25.1 mm -54.19 -49.57 61.57 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 CA-C-N 114.944 -1.026 . . . . 0.0 109.869 176.38 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 124' ' ' LYS . . . . . 0.984 ' HD2' HD11 ' B' ' 127' ' ' LEU . 1.7 mmmm -62.34 -41.59 98.7 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.23 -175.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 125' ' ' LYS . . . . . . . . . . . . . 44.3 mmtt -49.73 -60.95 2.41 Favored 'General case' 0 CA--C 1.496 -1.134 0 CA-C-O 121.931 0.872 . . . . 0.0 111.225 171.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 126' ' ' ILE . . . . . 0.635 HG23 HD12 ' A' ' 31' ' ' LEU . 1.6 mp -59.03 -41.89 84.68 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.667 0 CA-C-N 113.706 -1.588 . . . . 0.0 110.694 -169.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 127' ' ' LEU . . . . . 0.984 HD11 ' HD2' ' B' ' 124' ' ' LYS . 3.5 pp -78.94 -32.25 45.45 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 111.924 0.342 . . . . 0.0 111.924 -178.628 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 128' ' ' ASP . . . . . 0.484 ' N ' HD12 ' B' ' 127' ' ' LEU . 11.5 m-20 -70.33 -24.58 63.02 Favored 'General case' 0 CA--C 1.518 -0.281 0 O-C-N 122.232 -0.293 . . . . 0.0 111.03 -178.588 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 129' ' ' SER . . . . . . . . . . . . . 94.4 p -59.45 -42.83 92.87 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-O 120.715 0.293 . . . . 0.0 111.206 177.217 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 130' ' ' VAL . . . . . 0.566 HG23 HG13 ' B' ' 132' ' ' ILE . 13.1 m -93.41 -7.4 10.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.814 0.34 . . . . 0.0 111.776 -179.745 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 131' ' ' GLY . . . . . . . . . . . . . . . 85.62 39.75 8.08 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.478 177.474 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 132' ' ' ILE . . . . . 0.736 HG23 ' HB2' ' A' ' 19' ' ' ASP . 14.3 mt -94.7 126.94 47.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 110.195 -0.298 . . . . 0.0 110.195 176.617 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 133' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -80.53 127.04 31.98 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.227 0.536 . . . . 0.0 111.283 -176.171 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 134' ' ' ALA . . . . . 0.421 ' HB2' HD22 ' B' ' 127' ' ' LEU . . . -140.37 146.13 38.01 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.706 -173.253 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 135' ' ' ASP . . . . . 0.696 ' HB3' ' HG3' ' B' ' 138' ' ' ARG . 7.7 t70 -93.65 131.04 39.34 Favored 'General case' 0 C--O 1.253 1.253 0 CA-C-O 121.173 0.511 . . . . 0.0 110.447 175.352 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 136' ' ' ASP . . . . . 1.032 ' HA ' HD11 ' B' ' 139' ' ' LEU . 6.2 p-10 -77.42 5.21 9.23 Favored 'General case' 0 CA--C 1.517 -0.297 0 CA-C-N 115.029 -0.987 . . . . 0.0 111.627 -168.276 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 137' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -108.83 -30.94 7.89 Favored 'General case' 0 N--CA 1.434 -1.255 0 CA-C-O 121.059 0.457 . . . . 0.0 110.372 172.013 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 138' ' ' ARG . . . . . 0.73 ' HA ' ' HE2' ' B' ' 141' ' ' LYS . 9.3 mmt180 -67.4 -48.44 67.36 Favored 'General case' 0 CA--C 1.505 -0.76 0 CA-C-O 122.179 0.99 . . . . 0.0 109.155 -178.69 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 139' ' ' LEU . . . . . 1.032 HD11 ' HA ' ' B' ' 136' ' ' ASP . 0.3 OUTLIER -69.63 -26.09 64.25 Favored 'General case' 0 C--O 1.207 -1.147 0 CA-C-N 114.588 -1.187 . . . . 0.0 111.025 179.112 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 140' ' ' ASN . . . . . 0.608 ' O ' ' HB ' ' B' ' 143' ' ' ILE . 32.9 t30 -79.26 -26.44 42.42 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.875 0.845 . . . . 0.0 109.938 -178.39 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 141' ' ' LYS . . . . . 0.73 ' HE2' ' HA ' ' B' ' 138' ' ' ARG . 0.2 OUTLIER -80.69 -35.35 33.76 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 115.435 -0.802 . . . . 0.0 108.972 179.907 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 142' ' ' VAL . . . . . 0.624 HG12 ' O ' ' B' ' 139' ' ' LEU . 9.8 p -66.6 -39.12 83.09 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.444 0 C-N-CA 119.922 -0.711 . . . . 0.0 109.204 172.127 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 143' ' ' ILE . . . . . 0.903 HG12 ' O ' ' B' ' 139' ' ' LEU . 32.2 mm -45.51 -59.82 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.36 0 CA-C-O 121.778 0.799 . . . . 0.0 110.081 168.762 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 144' ' ' SER . . . . . . . . . . . . . 20.8 m -51.8 -42.61 62.6 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 113.97 -1.468 . . . . 0.0 112.298 -179.656 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 145' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -76.16 -23.63 54.77 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 120.948 0.404 . . . . 0.0 111.625 179.35 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 146' ' ' LEU . . . . . 0.575 ' HB3' ' CZ ' ' B' ' 107' ' ' TYR . 0.3 OUTLIER -86.0 -36.96 19.44 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.569 -177.416 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 147' ' ' ASN . . . . . . . . . . . . . 16.0 t-20 -43.6 113.04 0.45 Allowed 'General case' 0 C--N 1.331 -0.203 0 O-C-N 124.157 0.911 . . . . 0.0 112.424 -173.168 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . 97.23 61.22 0.94 Allowed Glycine 0 N--CA 1.448 -0.56 0 CA-C-N 115.277 -0.874 . . . . 0.0 111.807 -178.14 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 149' ' ' LYS . . . . . . . . . . . . . 2.5 tppt? -144.49 162.54 36.29 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 -178.168 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 150' ' ' ASN . . . . . 0.619 ' O ' HG23 ' B' ' 154' ' ' VAL . 42.2 m-80 -106.08 90.26 3.32 Favored 'General case' 0 CA--C 1.514 -0.427 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 178.079 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 151' ' ' ILE . . . . . 0.907 HG13 HD12 ' B' ' 108' ' ' LEU . 1.8 mp -43.45 -66.01 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 O-C-N 124.528 1.142 . . . . 0.0 113.744 -169.028 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 152' ' ' GLU . . . . . 0.579 ' OE1' HD22 ' A' ' 7' ' ' LEU . 2.4 mt-10 -48.94 -52.61 23.7 Favored 'General case' 0 C--O 1.207 -1.149 0 CA-C-N 118.249 0.477 . . . . 0.0 111.981 -177.775 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 153' ' ' ASP . . . . . . . . . . . . . 26.5 m-20 -64.76 -27.77 69.12 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 119.983 -0.687 . . . . 0.0 111.103 -176.014 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 154' ' ' VAL . . . . . 0.855 ' HB ' HD12 ' B' ' 155' ' ' ILE . 49.6 t -57.6 -52.97 50.7 Favored 'Isoleucine or valine' 0 C--O 1.233 0.189 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 170.374 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 155' ' ' ILE . . . . . 0.855 HD12 ' HB ' ' B' ' 154' ' ' VAL . 1.8 mp -105.25 34.4 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.706 -176.613 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . -105.03 0.59 27.79 Favored 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 171.405 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 157' ' ' GLN . . . . . . . . . . . . . 49.9 mt-30 -141.69 1.85 1.55 Allowed 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 113.353 -1.749 . . . . 0.0 109.908 175.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 158' ' ' GLY . . . . . . . . . . . . . . . -142.34 46.26 0.88 Allowed Glycine 0 C--N 1.334 0.456 0 C-N-CA 120.695 -0.764 . . . . 0.0 113.588 -170.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 159' ' ' ILE . . . . . 0.649 HG21 ' HB2' ' A' ' 59' ' ' LEU . 1.8 mp -60.41 -15.81 11.3 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.775 0 C-N-CA 123.127 0.571 . . . . 0.0 111.721 178.859 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 160' ' ' GLY . . . . . 0.402 ' HA2' HG23 ' A' ' 56' ' ' ILE . . . -105.56 -80.35 1.35 Allowed Glycine 0 N--CA 1.446 -0.676 0 C-N-CA 120.59 -0.814 . . . . 0.0 112.204 -174.591 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 161' ' ' LYS . . . . . 0.41 ' HA ' ' HD2' ' B' ' 161' ' ' LYS . 31.0 mmmt -77.18 61.4 2.08 Favored 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 113.178 0.807 . . . . 0.0 113.178 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 162' ' ' LEU . . . . . 0.463 ' HB2' ' HG2' ' B' ' 101' ' ' MET . 9.9 mp -41.3 136.7 1.61 Allowed 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.828 168.801 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 163' ' ' ALA . . . . . . . . . . . . . . . 55.82 44.44 26.02 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 115.716 -0.675 . . . . 0.0 112.789 179.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 164' ' ' SER . . . . . . . . . . . . . 80.1 p 56.9 169.49 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 113.968 1.099 . . . . 0.0 113.968 173.685 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 165' ' ' VAL . . . . . 0.402 ' HA ' ' HD2' ' B' ' 166' ' ' PRO . 11.0 t -102.17 129.96 25.22 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-N 114.831 -1.077 . . . . 0.0 108.968 175.155 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 166' ' ' PRO . . . . . 0.402 ' HD2' ' HA ' ' B' ' 165' ' ' VAL . 39.6 Cg_exo -13.52 112.96 0.01 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.421 1 C-N-CA 127.112 5.208 . . . . 0.0 116.149 -174.693 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 167' ' ' ALA . . . . . . . . . . . . . . . -103.88 46.43 0.92 Allowed 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.968 -175.283 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 168' ' ' GLY . . . . . . . . . . . . . . . 128.01 -41.86 1.52 Allowed Glycine 0 N--CA 1.448 -0.525 0 N-CA-C 111.071 -0.812 . . . . 0.0 111.071 -176.554 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 169' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.192 -1.338 . . . . 0.0 111.223 178.183 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.493 ' HA ' ' HB1' ' B' ' 156' ' ' ALA . 26.6 ttm . . . . . 0 N--CA 1.479 1.02 0 N-CA-C 110.249 -0.278 . . . . 0.0 110.249 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.863 ' HB3' HD13 ' A' ' 7' ' ' LEU . . . -84.4 166.96 16.91 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.379 -178.247 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.498 ' HB2' ' HG3' ' A' ' 6' ' ' GLU . 5.8 m -74.53 130.0 38.78 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 173.285 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.539 HG13 ' HG ' ' B' ' 112' ' ' LEU . 2.1 t -52.57 -26.59 10.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.053 -0.976 . . . . 0.0 112.496 -178.301 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.424 ' HB2' ' HA ' ' A' ' 39' ' ' VAL . 10.9 p -68.71 -53.26 23.21 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 177.471 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.552 ' O ' HG13 ' A' ' 10' ' ' ILE . 31.3 mt-10 -56.95 -50.27 73.13 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 114.816 -1.083 . . . . 0.0 109.614 176.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.868 HD12 HD12 ' A' ' 10' ' ' ILE . 4.4 tp -61.61 -36.6 81.19 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 115.12 -0.945 . . . . 0.0 111.841 -179.404 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.685 ' HB2' HD23 ' B' ' 112' ' ' LEU . . . -69.21 -35.11 75.85 Favored 'General case' 0 CA--C 1.513 -0.456 0 CA-C-O 121.023 0.439 . . . . 0.0 110.719 179.11 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.46 ' HB2' HG11 ' A' ' 39' ' ' VAL . 5.0 t -67.63 -41.11 84.44 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 178.337 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.868 HD12 HD12 ' A' ' 7' ' ' LEU . 68.5 mt -47.92 -56.57 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 CA-C-N 113.859 -1.518 . . . . 0.0 109.905 170.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.873 ' HB2' HD13 ' B' ' 109' ' ' LEU . 22.9 m-85 -65.13 -39.64 93.32 Favored 'General case' 0 C--O 1.218 -0.586 0 CA-C-N 115.685 -0.688 . . . . 0.0 111.413 -174.194 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.467 ' HB2' HG23 ' A' ' 28' ' ' ILE . 16.0 m -57.34 -40.84 78.87 Favored 'General case' 0 C--O 1.24 0.588 0 CA-C-O 121.463 0.649 . . . . 0.0 109.315 177.197 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.438 ' CB ' HD11 ' A' ' 51' ' ' LEU . . . -67.13 -30.93 71.07 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 115.186 -0.915 . . . . 0.0 110.212 175.067 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.704 HD22 HD11 ' A' ' 56' ' ' ILE . 0.3 OUTLIER -66.98 -53.63 29.68 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.591 179.684 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.455 HG12 ' H ' ' A' ' 15' ' ' ILE . 0.0 OUTLIER -57.77 -41.66 80.13 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 CA-C-O 120.961 0.41 . . . . 0.0 109.955 176.8 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.574 HD11 ' HG2' ' A' ' 27' ' ' LYS . 2.6 tp -60.08 -41.94 93.54 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.821 176.816 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 47.4 t60 -80.47 -8.31 59.5 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.316 179.594 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -73.8 -43.34 59.15 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 178.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -97.71 -14.55 20.81 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-O 121.991 0.901 . . . . 0.0 109.045 177.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 61.0 52.69 3.97 Favored 'General case' 0 CA--C 1.51 -0.566 0 CA-C-N 113.753 -1.567 . . . . 0.0 109.979 -174.735 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.511 HG13 HD12 ' A' ' 16' ' ' LEU . 7.3 p -102.08 171.64 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.426 -1.643 0 CA-C-N 114.445 -1.252 . . . . 0.0 108.506 -178.216 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.503 ' H ' HG22 ' A' ' 21' ' ' VAL . 41.2 p -54.19 138.65 37.87 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 113.365 0.876 . . . . 0.0 113.365 -170.595 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.587 HG12 ' HA ' ' A' ' 48' ' ' ALA . 59.4 t -107.19 108.7 25.85 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.995 0 CA-C-N 114.371 -1.286 . . . . 0.0 110.54 -176.649 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.508 ' OG1' ' HE2' ' A' ' 27' ' ' LYS . 68.5 p -140.24 155.14 47.0 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.61 179.029 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -54.83 -43.36 72.92 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.228 0.537 . . . . 0.0 109.788 178.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 -60.5 -34.55 74.24 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.168 -0.923 . . . . 0.0 110.76 178.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.574 ' HG2' HD11 ' A' ' 16' ' ' LEU . 3.9 tppt? -67.53 -54.12 22.74 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-O 121.881 0.848 . . . . 0.0 109.233 -178.66 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.467 HG23 ' HB2' ' A' ' 12' ' ' SER . 88.1 mt -58.76 -39.35 76.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 114.459 -1.246 . . . . 0.0 110.287 178.262 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 42.8 t-20 -58.14 -42.85 86.76 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.109 176.538 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -60.42 -46.85 88.53 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.243 177.636 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.512 ' HB3' HD21 ' B' ' 109' ' ' LEU . 1.1 mm? -55.54 -51.46 66.98 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 121.221 0.534 . . . . 0.0 110.216 175.348 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.621 HG23 ' O ' ' A' ' 37' ' ' VAL . 67.8 mt -47.71 -49.46 10.24 Favored 'Isoleucine or valine' 0 C--O 1.242 0.665 0 CA-C-N 114.655 -1.157 . . . . 0.0 111.936 179.199 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.431 ' HA ' ' HD2' ' A' ' 33' ' ' LYS . 3.0 mmmp? -78.45 -31.26 47.93 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.528 0.566 . . . . 0.0 112.528 -173.669 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.521 ' HB2' ' HB3' ' B' ' 129' ' ' SER . . . -68.83 -38.15 79.66 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 120.641 -0.423 . . . . 0.0 110.463 177.719 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.549 ' CB ' ' HG ' ' B' ' 109' ' ' LEU . . . -77.6 -36.3 51.96 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.412 177.02 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 97.62 13.25 44.83 Favored Glycine 0 N--CA 1.445 -0.715 0 CA-C-N 115.427 -0.806 . . . . 0.0 111.959 178.6 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.953 ' HB ' ' HA2' ' B' ' 113' ' ' GLY . 2.6 p -116.13 116.96 53.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-O 121.818 0.818 . . . . 0.0 110.969 -175.126 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -90.12 152.82 20.95 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 114.268 -1.333 . . . . 0.0 110.551 -171.684 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.504 HG12 ' N ' ' A' ' 40' ' ' GLU . 96.3 t -120.51 166.13 15.26 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.07 0 CA-C-N 114.555 -1.202 . . . . 0.0 109.935 -173.056 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.635 ' HB3' ' HD1' ' A' ' 43' ' ' TRP . 28.3 tp10 -72.62 106.35 2.11 Favored Pre-proline 0 N--CA 1.439 -1.023 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 168.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.529 ' C ' ' HD2' ' A' ' 44' ' ' PRO . 86.8 Cg_exo -50.09 -30.71 25.81 Favored 'Trans proline' 0 C--O 1.253 1.243 0 C-N-CA 123.709 2.94 . . . . 0.0 115.65 -163.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.402 ' HD2' ' HG3' ' A' ' 40' ' ' GLU . 0.5 OUTLIER -59.43 -28.4 66.91 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 177.246 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . 0.635 ' HD1' ' HB3' ' A' ' 40' ' ' GLU . 17.4 m95 -64.2 -60.44 8.72 Favored Pre-proline 0 C--O 1.206 -1.214 0 CA-C-O 118.369 -0.824 . . . . 0.0 111.153 176.083 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.529 ' HD2' ' C ' ' A' ' 41' ' ' PRO . 93.1 Cg_exo -44.99 -44.89 14.61 Favored 'Trans proline' 0 C--N 1.36 1.155 0 C-N-CA 121.849 1.699 . . . . 0.0 112.167 175.094 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -61.55 -55.77 26.95 Favored Glycine 0 CA--C 1.525 0.68 0 C-N-CA 120.035 -1.079 . . . . 0.0 112.525 177.17 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 8.9 tp -67.42 -27.92 67.47 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 122.849 0.459 . . . . 0.0 112.025 -177.366 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.513 ' HE1' ' CE3' ' A' ' 43' ' ' TRP . 2.8 m-85 -69.89 -46.8 64.66 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 177.112 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.587 ' HA ' HG12 ' A' ' 23' ' ' VAL . . . -62.84 -34.34 77.13 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.81 0.814 . . . . 0.0 109.592 178.26 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.471 ' HD2' ' C ' ' A' ' 49' ' ' LYS . 0.3 OUTLIER -70.85 -42.26 70.36 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 114.291 -1.322 . . . . 0.0 111.484 177.085 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.415 ' O ' HG22 ' A' ' 54' ' ' VAL . . . -82.23 -44.96 15.68 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 112.687 0.625 . . . . 0.0 112.687 -173.569 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.537 ' HB2' HG11 ' A' ' 23' ' ' VAL . 11.1 mt -63.71 -13.15 40.65 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 112.87 0.693 . . . . 0.0 112.87 -171.835 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -83.1 -10.25 58.78 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.135 0.493 . . . . 0.0 110.579 176.623 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 33.9 m-80 -122.6 -47.6 2.08 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.261 -176.55 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.415 HG22 ' O ' ' A' ' 50' ' ' ALA . 13.7 m -99.55 -169.93 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 176.601 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -130.59 -173.1 2.98 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 120.484 -0.486 . . . . 0.0 111.338 178.149 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.704 HD11 HD22 ' A' ' 14' ' ' LEU . 3.4 tp -66.03 -26.99 39.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-O 121.006 0.431 . . . . 0.0 111.08 -174.262 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -71.15 -14.99 74.26 Favored Glycine 0 N--CA 1.442 -0.904 0 C-N-CA 120.459 -0.877 . . . . 0.0 111.21 179.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 14.8 t -79.99 -21.27 43.85 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-O 121.157 0.504 . . . . 0.0 110.054 179.631 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.545 ' HB2' HG21 ' B' ' 159' ' ' ILE . 26.0 mt -62.67 -33.05 74.28 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.518 -0.764 . . . . 0.0 110.848 -178.298 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.648 ' CD1' ' HB ' ' B' ' 159' ' ' ILE . 0.1 OUTLIER -65.64 -15.36 18.55 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.914 -179.299 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 25.8 t -96.45 -7.9 33.64 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.69 -178.237 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.482 ' HB3' ' HH2' ' A' ' 43' ' ' TRP . 9.4 m120 -63.24 -30.92 71.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.914 0.387 . . . . 0.0 111.228 -175.06 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 18.2 m -100.91 29.93 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 121.415 0.626 . . . . 0.0 111.095 -179.661 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -175.15 55.1 0.12 Allowed Glycine 0 N--CA 1.447 -0.598 0 CA-C-N 115.427 -0.806 . . . . 0.0 111.561 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -116.02 20.12 14.61 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.935 0.398 . . . . 0.0 110.769 -177.199 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -91.67 53.24 3.02 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.951 -0.642 . . . . 0.0 111.634 178.597 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.417 ' HA2' ' HD3' ' A' ' 68' ' ' PRO . . . 132.26 124.92 2.6 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.911 -0.662 . . . . 0.0 111.986 -178.372 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.417 ' HD3' ' HA2' ' A' ' 67' ' ' GLY . 13.7 Cg_exo -69.64 170.37 16.6 Favored 'Trans proline' 0 C--O 1.237 0.43 0 C-N-CA 122.912 2.408 . . . . 0.0 112.533 -179.496 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.039 0 CA-C-O 118.509 -0.757 . . . . 0.0 110.068 179.795 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.067 0 CA-C-O 120.968 0.413 . . . . 0.0 110.732 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 101' ' ' MET . . . . . 0.529 ' CE ' HD12 ' A' ' 14' ' ' LEU . 0.6 OUTLIER -97.12 99.73 11.22 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 120.878 -0.329 . . . . 0.0 111.287 -178.868 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 102' ' ' ARG . . . . . 0.414 ' C ' ' H ' ' B' ' 104' ' ' VAL . 14.9 mmt180 -143.67 112.28 6.49 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 170.042 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 103' ' ' TYR . . . . . 0.827 ' HB2' HG11 ' B' ' 142' ' ' VAL . 52.2 m-85 72.91 -15.16 0.53 Allowed 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.478 0.711 . . . . 0.0 111.807 178.765 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 104' ' ' VAL . . . . . 0.526 ' O ' HD22 ' B' ' 108' ' ' LEU . 50.1 t -43.17 -50.28 1.24 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.371 0 CA-C-O 121.736 0.779 . . . . 0.0 110.255 174.069 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 105' ' ' ALA . . . . . 0.655 ' CB ' ' HB3' ' A' ' 14' ' ' LEU . . . -64.67 -37.85 88.98 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-N 114.519 -1.219 . . . . 0.0 111.669 -174.306 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 106' ' ' SER . . . . . 0.703 ' HB2' HG23 ' B' ' 123' ' ' ILE . 1.4 m -62.82 -37.78 88.11 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.533 0.682 . . . . 0.0 109.391 178.533 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 107' ' ' TYR . . . . . 0.683 ' CG ' HD12 ' B' ' 146' ' ' LEU . 34.2 t80 -63.99 -47.58 79.81 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 114.727 -1.124 . . . . 0.0 108.689 178.285 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 108' ' ' LEU . . . . . 0.836 HD12 HG13 ' B' ' 151' ' ' ILE . 0.0 OUTLIER -58.21 -47.54 83.17 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.103 -0.953 . . . . 0.0 110.943 177.522 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 109' ' ' LEU . . . . . 0.873 HD13 ' HB2' ' A' ' 11' ' ' TYR . 8.1 tp -54.19 -48.76 70.61 Favored 'General case' 0 CA--C 1.511 -0.541 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.193 179.11 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 110' ' ' ALA . . . . . 0.43 ' HB3' ' HB3' ' B' ' 118' ' ' PRO . . . -64.65 -41.13 96.33 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.975 0.417 . . . . 0.0 111.044 -177.442 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 111' ' ' ALA . . . . . 0.665 ' HA ' ' O ' ' B' ' 115' ' ' ASN . . . -68.65 -20.17 64.44 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.275 0.56 . . . . 0.0 110.802 179.318 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 112' ' ' LEU . . . . . 0.685 HD23 ' HB2' ' A' ' 8' ' ' ALA . 1.4 mp -85.14 -37.11 20.59 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.966 173.723 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 113' ' ' GLY . . . . . 0.953 ' HA2' ' HB ' ' A' ' 37' ' ' VAL . . . -62.81 -39.23 97.73 Favored Glycine 0 N--CA 1.445 -0.705 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.769 -179.123 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 114' ' ' GLY . . . . . . . . . . . . . . . 155.09 6.21 0.08 OUTLIER Glycine 0 N--CA 1.44 -1.09 0 C-N-CA 120.217 -0.992 . . . . 0.0 112.928 177.216 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 115' ' ' ASN . . . . . 0.665 ' O ' ' HA ' ' B' ' 111' ' ' ALA . 37.4 t30 -119.63 92.62 3.83 Favored 'General case' 0 N--CA 1.444 -0.77 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 -179.454 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 5.2 p -80.59 27.53 0.36 Allowed 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 122.325 1.059 . . . . 0.0 111.038 -166.049 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 117' ' ' SER . . . . . 0.521 ' N ' ' HD3' ' B' ' 118' ' ' PRO . 33.0 t -172.14 68.29 0.42 Allowed Pre-proline 0 C--N 1.31 -1.137 0 CA-C-N 113.419 -1.719 . . . . 0.0 108.098 178.55 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 118' ' ' PRO . . . . . 0.679 ' HG2' ' O ' ' B' ' 107' ' ' TYR . 37.1 Cg_exo -64.09 156.25 60.07 Favored 'Trans proline' 0 CA--C 1.512 -0.611 0 C-N-CA 125.028 3.818 . . . . 0.0 111.718 -174.291 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 119' ' ' SER . . . . . 0.67 ' O ' HG12 ' B' ' 123' ' ' ILE . 90.2 p -123.75 179.78 4.67 Favored 'General case' 0 C--N 1.314 -0.961 0 C-N-CA 120.079 -0.648 . . . . 0.0 110.831 177.837 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 120' ' ' ALA . . . . . 0.834 ' HB1' HD13 ' B' ' 139' ' ' LEU . . . -65.9 -39.2 90.39 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-O 121.75 0.786 . . . . 0.0 109.617 -172.577 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 121' ' ' LYS . . . . . . . . . . . . . 13.9 mptt -60.33 -37.91 82.12 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 114.076 -1.42 . . . . 0.0 110.538 175.169 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 122' ' ' ASP . . . . . 0.628 ' O ' ' HB2' ' B' ' 125' ' ' LYS . 2.6 t0 -74.44 -35.06 63.33 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 121.665 0.745 . . . . 0.0 109.105 -178.644 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 123' ' ' ILE . . . . . 0.746 ' O ' ' HG ' ' B' ' 127' ' ' LEU . 42.7 mm -60.01 -44.3 94.43 Favored 'Isoleucine or valine' 0 C--O 1.235 0.301 0 CA-C-N 115.43 -0.805 . . . . 0.0 109.511 172.762 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 124' ' ' LYS . . . . . 0.687 ' HD3' HD21 ' B' ' 139' ' ' LEU . 5.2 mmmp? -58.66 -44.59 90.18 Favored 'General case' 0 CA--C 1.503 -0.864 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 -179.27 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 125' ' ' LYS . . . . . 0.628 ' HB2' ' O ' ' B' ' 122' ' ' ASP . 17.6 mmtp -45.03 -66.76 0.36 Allowed 'General case' 0 C--O 1.248 0.975 0 CA-C-O 121.609 0.719 . . . . 0.0 112.54 169.724 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 126' ' ' ILE . . . . . 0.453 HD11 ' HA ' ' A' ' 35' ' ' ALA . 1.7 mp -54.65 -43.23 64.76 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.13 0 CA-C-N 113.801 -1.545 . . . . 0.0 111.112 -168.701 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 127' ' ' LEU . . . . . 0.746 ' HG ' ' O ' ' B' ' 123' ' ' ILE . 1.5 pp -84.27 -23.46 30.35 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.505 0.557 . . . . 0.0 112.505 -178.299 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 128' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -70.44 -27.88 64.6 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 120.784 0.326 . . . . 0.0 110.22 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 129' ' ' SER . . . . . 0.521 ' HB3' ' HB2' ' A' ' 34' ' ' ALA . 89.2 p -55.87 -45.86 78.43 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.292 177.556 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 130' ' ' VAL . . . . . 0.499 HG23 HG13 ' B' ' 132' ' ' ILE . 10.9 m -88.88 -17.93 8.11 Favored 'Isoleucine or valine' 0 C--O 1.231 0.083 0 CA-C-O 120.727 0.299 . . . . 0.0 111.563 179.369 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 131' ' ' GLY . . . . . . . . . . . . . . . 100.74 18.76 19.65 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.661 -0.78 . . . . 0.0 112.686 177.321 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 132' ' ' ILE . . . . . 0.539 ' O ' HD13 ' B' ' 127' ' ' LEU . 27.5 mt -78.16 114.93 19.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.788 0.327 . . . . 0.0 110.271 178.334 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 133' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -79.02 138.47 38.03 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.386 -175.263 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 134' ' ' ALA . . . . . . . . . . . . . . . -139.79 143.69 37.0 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.774 -0.648 . . . . 0.0 112.103 -169.442 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 135' ' ' ASP . . . . . 0.783 ' HB2' ' HG3' ' B' ' 138' ' ' ARG . 6.3 m-20 -84.05 128.17 34.38 Favored 'General case' 0 C--O 1.252 1.201 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 175.104 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 136' ' ' ASP . . . . . 1.031 ' HA ' HD11 ' B' ' 139' ' ' LEU . 1.3 p-10 -77.14 -0.34 24.55 Favored 'General case' 0 CA--C 1.518 -0.261 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.26 -166.438 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 137' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -103.22 -31.74 9.96 Favored 'General case' 0 N--CA 1.439 -1.01 0 CA-C-O 121.186 0.517 . . . . 0.0 110.14 172.44 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 138' ' ' ARG . . . . . 0.783 ' HG3' ' HB2' ' B' ' 135' ' ' ASP . 44.9 mmt-85 -63.26 -54.37 38.28 Favored 'General case' 0 CA--C 1.504 -0.803 0 CA-C-O 122.108 0.956 . . . . 0.0 109.177 -177.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 139' ' ' LEU . . . . . 1.031 HD11 ' HA ' ' B' ' 136' ' ' ASP . 0.3 OUTLIER -66.88 -28.02 67.99 Favored 'General case' 0 C--O 1.211 -0.96 0 CA-C-N 114.383 -1.28 . . . . 0.0 110.996 -179.942 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 140' ' ' ASN . . . . . 0.721 ' O ' ' HB ' ' B' ' 143' ' ' ILE . 11.1 t30 -75.98 -25.77 56.13 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.712 0.768 . . . . 0.0 110.029 -177.461 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 141' ' ' LYS . . . . . 0.522 ' HG2' ' O ' ' B' ' 138' ' ' ARG . 10.5 ptmt -84.34 -31.39 24.84 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.364 -0.835 . . . . 0.0 109.649 -179.477 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 142' ' ' VAL . . . . . 0.827 HG11 ' HB2' ' B' ' 103' ' ' TYR . 9.6 p -70.22 -33.68 55.58 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.119 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 170.583 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 143' ' ' ILE . . . . . 0.88 HG12 ' O ' ' B' ' 139' ' ' LEU . 29.5 mm -47.84 -61.87 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.376 0 CA-C-O 121.463 0.649 . . . . 0.0 109.375 166.514 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 144' ' ' SER . . . . . . . . . . . . . 25.4 m -49.27 -44.38 43.86 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 114.545 -1.207 . . . . 0.0 112.355 177.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 145' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -70.88 -30.36 66.71 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 112.368 0.507 . . . . 0.0 112.368 -177.606 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 146' ' ' LEU . . . . . 0.683 HD12 ' CG ' ' B' ' 107' ' ' TYR . 5.3 mt -93.55 -17.88 22.86 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.346 -0.541 . . . . 0.0 111.023 -177.763 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 147' ' ' ASN . . . . . . . . . . . . . 39.3 t30 -57.79 115.46 2.84 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.08 -177.702 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . 104.27 15.93 20.0 Favored Glycine 0 N--CA 1.448 -0.536 0 CA-C-N 115.745 -0.662 . . . . 0.0 112.518 -179.248 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 149' ' ' LYS . . . . . 0.428 ' HB2' ' O ' ' B' ' 146' ' ' LEU . 0.6 OUTLIER -112.6 158.59 19.78 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.599 0.238 . . . . 0.0 110.659 179.11 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 150' ' ' ASN . . . . . 0.536 ' O ' HG23 ' B' ' 154' ' ' VAL . 25.9 t-20 -97.7 95.87 7.87 Favored 'General case' 0 CA--C 1.511 -0.529 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 175.523 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 151' ' ' ILE . . . . . 0.836 HG13 HD12 ' B' ' 108' ' ' LEU . 1.8 mp -43.61 -60.79 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 O-C-N 124.621 1.2 . . . . 0.0 113.148 -169.4 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 152' ' ' GLU . . . . . 0.409 ' N ' HG22 ' B' ' 151' ' ' ILE . 47.0 mt-10 -56.2 -39.93 73.19 Favored 'General case' 0 C--O 1.212 -0.87 0 N-CA-C 111.708 0.262 . . . . 0.0 111.708 -174.426 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 153' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -74.56 -26.4 59.93 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 120.707 -0.397 . . . . 0.0 110.96 -179.051 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 154' ' ' VAL . . . . . 0.816 ' HB ' HD12 ' B' ' 155' ' ' ILE . 53.9 t -59.56 -50.06 81.36 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 170.172 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 155' ' ' ILE . . . . . 0.816 HD12 ' HB ' ' B' ' 154' ' ' VAL . 3.0 mp -107.47 34.29 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.19 -177.05 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 156' ' ' ALA . . . . . 0.493 ' HB1' ' HA ' ' A' ' 1' ' ' MET . . . -95.77 -4.29 44.21 Favored 'General case' 0 C--N 1.309 -1.157 0 N-CA-C 107.505 -1.294 . . . . 0.0 107.505 169.51 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 157' ' ' GLN . . . . . . . . . . . . . 70.0 mm-40 -135.63 -27.83 1.14 Allowed 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 113.289 -1.778 . . . . 0.0 110.682 175.415 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 158' ' ' GLY . . . . . 0.539 ' O ' HD12 ' B' ' 162' ' ' LEU . . . -105.85 46.56 1.16 Allowed Glycine 0 C--O 1.222 -0.595 0 CA-C-O 119.581 -0.566 . . . . 0.0 114.511 -171.377 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 159' ' ' ILE . . . . . 0.648 ' HB ' ' CD1' ' A' ' 60' ' ' ILE . 1.8 mp -56.5 -24.0 18.01 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.094 0 CA-C-N 117.385 0.593 . . . . 0.0 110.876 176.043 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 160' ' ' GLY . . . . . . . . . . . . . . . -113.88 -42.11 0.88 Allowed Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 120.835 -0.698 . . . . 0.0 111.805 179.382 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 161' ' ' LYS . . . . . 0.477 ' HD3' ' N ' ' B' ' 161' ' ' LYS . 3.3 mppt? -76.48 39.5 0.21 Allowed 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 112.813 0.671 . . . . 0.0 112.813 -179.736 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 162' ' ' LEU . . . . . 0.539 HD12 ' O ' ' B' ' 158' ' ' GLY . 11.2 mp -48.88 129.73 17.4 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 176.425 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 163' ' ' ALA . . . . . . . . . . . . . . . 47.99 54.75 9.6 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 115.24 -0.891 . . . . 0.0 112.877 178.776 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 164' ' ' SER . . . . . . . . . . . . . 55.3 p 59.2 113.57 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 113.924 1.083 . . . . 0.0 113.924 171.585 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 165' ' ' VAL . . . . . 0.404 HG23 ' HD2' ' B' ' 166' ' ' PRO . 7.8 p -69.2 132.09 90.16 Favored Pre-proline 0 C--N 1.326 -0.446 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 170.781 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 166' ' ' PRO . . . . . 0.404 ' HD2' HG23 ' B' ' 165' ' ' VAL . 10.2 Cg_exo -5.12 109.6 0.0 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.162 1 C-N-CA 127.03 5.153 . . . . 0.0 116.663 -165.364 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 167' ' ' ALA . . . . . . . . . . . . . . . -82.91 94.69 7.77 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 114.349 -1.296 . . . . 0.0 111.477 -171.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 168' ' ' GLY . . . . . . . . . . . . . . . 176.03 -152.55 13.07 Favored Glycine 0 N--CA 1.438 -1.216 0 C-N-CA 120.787 -0.72 . . . . 0.0 111.978 178.04 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 169' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.933 0 CA-C-O 118.781 -1.011 . . . . 0.0 111.618 -175.538 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 52.8 ttm . . . . . 0 N--CA 1.48 1.05 0 CA-C-O 121.026 0.441 . . . . 0.0 110.646 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.884 ' HB3' HD13 ' A' ' 7' ' ' LEU . . . -66.05 148.05 52.4 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.8 -0.637 . . . . 0.0 111.182 175.512 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.538 ' HB2' ' OE1' ' A' ' 6' ' ' GLU . 0.7 OUTLIER -70.2 143.65 52.16 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 173.165 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.548 HG13 ' HG ' ' B' ' 112' ' ' LEU . 2.1 t -51.77 -22.86 2.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-N 114.189 -1.368 . . . . 0.0 112.825 -177.215 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.523 ' HB3' ' HA ' ' A' ' 39' ' ' VAL . 16.8 m -71.32 -58.22 3.74 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 179.162 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.542 ' O ' HG13 ' A' ' 10' ' ' ILE . 2.3 mp0 -54.69 -52.45 62.36 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.657 176.004 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.884 HD13 ' HB3' ' A' ' 2' ' ' ALA . 3.6 tp -56.42 -37.14 69.79 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 115.344 -0.843 . . . . 0.0 112.503 179.782 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.64 ' HB2' HD23 ' B' ' 112' ' ' LEU . . . -70.04 -33.38 71.9 Favored 'General case' 0 N--CA 1.468 0.447 0 O-C-N 122.007 -0.433 . . . . 0.0 110.849 179.059 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.605 ' HB2' HG11 ' A' ' 39' ' ' VAL . 8.2 t -70.32 -38.7 74.97 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 177.686 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.875 HD12 ' HA ' ' A' ' 7' ' ' LEU . 67.4 mt -49.22 -55.88 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.74 0 CA-C-N 114.071 -1.422 . . . . 0.0 109.661 170.679 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.672 ' OH ' ' HB ' ' B' ' 155' ' ' ILE . 23.1 m-85 -67.59 -44.18 78.76 Favored 'General case' 0 C--O 1.22 -0.458 0 CA-C-N 115.771 -0.65 . . . . 0.0 112.164 -173.043 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.0 p -54.56 -46.06 73.58 Favored 'General case' 0 C--O 1.243 0.754 0 CA-C-O 121.447 0.642 . . . . 0.0 109.802 177.305 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.04 -36.94 78.39 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.57 172.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.705 ' HG ' HD21 ' B' ' 162' ' ' LEU . 0.2 OUTLIER -60.84 -55.85 28.2 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.264 -179.537 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.465 HG12 ' O ' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -52.85 -44.81 49.54 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.54 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 177.612 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.543 HD21 ' HA ' ' A' ' 23' ' ' VAL . 3.4 tp -54.7 -35.6 63.8 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.282 178.135 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.483 ' NE2' HD22 ' A' ' 51' ' ' LEU . 30.5 m-70 -83.48 -14.71 51.84 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 177.574 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 1.005 ' HA ' ' HA ' ' B' ' 100' ' ' ALA . 6.1 t0 -76.4 -33.69 58.85 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.314 0.578 . . . . 0.0 109.593 -178.676 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.818 ' HB2' HG23 ' B' ' 132' ' ' ILE . 15.1 t70 -96.07 -12.34 25.0 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 174.625 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 55.24 50.05 15.91 Favored 'General case' 0 CA--C 1.518 -0.274 0 CA-C-N 113.861 -1.518 . . . . 0.0 109.979 -175.191 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.624 HG22 ' H ' ' A' ' 22' ' ' THR . 7.9 p -108.08 175.08 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.321 0 CA-C-N 114.589 -1.187 . . . . 0.0 109.286 -174.204 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.624 ' H ' HG22 ' A' ' 21' ' ' VAL . 63.2 p -54.53 137.61 42.66 Favored 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 113.606 0.965 . . . . 0.0 113.606 -170.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.572 HG12 ' HA ' ' A' ' 48' ' ' ALA . 54.0 t -104.91 109.01 26.28 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.758 0 CA-C-N 114.182 -1.372 . . . . 0.0 110.469 -177.484 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.591 ' OG1' ' HB2' ' A' ' 27' ' ' LYS . 82.4 p -144.77 155.8 43.72 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.719 -179.429 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 49.7 tt0 -57.2 -41.7 79.87 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.429 -0.351 . . . . 0.0 110.748 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -66.7 -27.42 67.63 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-O 120.962 0.41 . . . . 0.0 110.449 179.547 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.591 ' HB2' ' OG1' ' A' ' 24' ' ' THR . 3.3 tppt? -71.12 -52.17 20.88 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 -179.195 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 45.9 mt -58.98 -38.65 74.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 114.547 -1.206 . . . . 0.0 110.401 176.685 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 7.8 m-20 -58.02 -43.5 86.77 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.868 173.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -58.02 -46.61 85.01 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.675 178.015 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.592 ' HB3' HD21 ' B' ' 109' ' ' LEU . 1.3 mm? -59.03 -51.99 67.7 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 121.045 0.45 . . . . 0.0 110.65 175.495 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.617 HG23 ' O ' ' A' ' 37' ' ' VAL . 56.0 mt -49.91 -51.19 17.15 Favored 'Isoleucine or valine' 0 C--O 1.239 0.543 0 CA-C-N 115.155 -0.929 . . . . 0.0 111.916 -178.842 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.606 ' HD2' HG22 ' A' ' 32' ' ' ILE . 14.0 mptt -77.16 -28.14 54.02 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.66 -0.7 . . . . 0.0 112.103 -175.598 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -68.45 -41.43 80.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.902 0.382 . . . . 0.0 110.525 177.464 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -79.26 -38.65 34.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.255 0.55 . . . . 0.0 110.858 178.231 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 101.15 16.94 23.98 Favored Glycine 0 N--CA 1.447 -0.614 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.848 -179.313 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.906 ' HB ' ' HA2' ' B' ' 113' ' ' GLY . 3.0 p -121.11 121.17 64.24 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.423 0 CA-C-O 121.241 0.543 . . . . 0.0 110.827 -177.264 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.528 ' HA ' HG23 ' A' ' 32' ' ' ILE . 8.0 t-20 -100.59 167.65 10.21 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.153 -0.931 . . . . 0.0 110.869 -171.356 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.605 HG11 ' HB2' ' A' ' 9' ' ' CYS . 94.7 t -132.79 165.07 33.47 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 CA-C-N 115.01 -0.996 . . . . 0.0 110.477 -170.585 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.549 ' HB3' ' HD1' ' A' ' 43' ' ' TRP . 4.7 tp10 -68.44 108.07 2.53 Favored Pre-proline 0 N--CA 1.444 -0.726 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 168.353 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.489 ' C ' ' HD2' ' A' ' 44' ' ' PRO . 81.1 Cg_exo -51.77 -28.77 31.55 Favored 'Trans proline' 0 C--O 1.251 1.145 0 C-N-CA 123.582 2.855 . . . . 0.0 115.855 -164.243 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -61.41 -27.77 68.78 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 120.39 -0.524 . . . . 0.0 109.627 177.562 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . 0.568 ' CE3' ' HE1' ' A' ' 47' ' ' PHE . 14.1 m95 -64.46 -60.63 8.08 Favored Pre-proline 0 C--O 1.206 -1.222 0 CA-C-O 118.467 -0.778 . . . . 0.0 110.914 176.566 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.517 ' HD3' ' HB2' ' A' ' 43' ' ' TRP . 96.8 Cg_exo -46.13 -44.37 19.55 Favored 'Trans proline' 0 C--N 1.359 1.13 0 C-N-CA 121.811 1.674 . . . . 0.0 111.88 175.176 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -58.7 -62.24 6.47 Favored Glycine 0 CA--C 1.525 0.684 0 C-N-CA 120.187 -1.006 . . . . 0.0 112.631 176.428 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.411 ' O ' ' HB2' ' A' ' 49' ' ' LYS . 4.2 tp -64.44 -32.31 73.89 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 123.081 0.552 . . . . 0.0 111.99 -176.789 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.568 ' HE1' ' CE3' ' A' ' 43' ' ' TRP . 3.2 m-85 -61.81 -50.69 71.31 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 120.826 0.346 . . . . 0.0 110.089 175.483 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.572 ' HA ' HG12 ' A' ' 23' ' ' VAL . . . -66.37 -28.58 68.76 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.572 0.701 . . . . 0.0 109.891 -178.645 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.411 ' HB2' ' O ' ' A' ' 46' ' ' LEU . 9.4 mmmt -65.66 -51.08 62.25 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 114.546 -1.206 . . . . 0.0 112.08 174.538 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.41 ' O ' HG22 ' A' ' 54' ' ' VAL . . . -88.36 -36.69 16.45 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 113.215 0.821 . . . . 0.0 113.215 -169.471 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.511 ' HB2' HG11 ' A' ' 23' ' ' VAL . 24.0 mt -68.65 -0.7 5.53 Favored 'General case' 0 N--CA 1.464 0.227 0 N-CA-C 112.456 0.539 . . . . 0.0 112.456 -172.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -84.96 -1.75 57.08 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.818 0.342 . . . . 0.0 110.307 173.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 9.6 t30 -143.97 -39.66 0.29 Allowed 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.228 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.41 HG22 ' O ' ' A' ' 50' ' ' ALA . 6.4 m -82.27 -171.49 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 178.309 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 18.3 m120 -121.32 175.93 5.9 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.044 0.45 . . . . 0.0 110.758 177.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.646 HD11 HD22 ' A' ' 14' ' ' LEU . 4.3 tp -75.78 -26.22 17.78 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 177.69 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -72.64 -9.52 74.44 Favored Glycine 0 N--CA 1.445 -0.713 0 N-CA-C 111.058 -0.817 . . . . 0.0 111.058 175.167 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 21.2 m -80.48 -24.56 39.37 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-O 121.346 0.593 . . . . 0.0 109.523 177.045 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.47 HD11 HD12 ' A' ' 56' ' ' ILE . 24.9 mt -60.79 -32.83 72.16 Favored 'General case' 0 CA--C 1.517 -0.304 0 CA-C-N 115.443 -0.798 . . . . 0.0 110.957 -178.848 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.613 ' CD1' ' HB ' ' B' ' 159' ' ' ILE . 0.1 OUTLIER -63.46 -14.72 15.02 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 CA-C-N 114.786 -1.097 . . . . 0.0 111.18 -177.999 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 25.3 t -88.37 -3.15 58.89 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.844 -176.494 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -58.6 -28.47 65.62 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.388 -173.531 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 16.5 m -87.99 29.66 0.12 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.201 0 CA-C-O 121.283 0.563 . . . . 0.0 111.639 -177.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 101.27 -94.1 1.21 Allowed Glycine 0 N--CA 1.446 -0.647 0 CA-C-N 115.564 -0.744 . . . . 0.0 112.438 177.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . 60.37 13.88 4.34 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 113.027 0.751 . . . . 0.0 113.027 179.11 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 59.07 56.21 26.59 Favored Glycine 0 C--N 1.332 0.339 0 CA-C-N 116.012 -0.54 . . . . 0.0 112.908 179.259 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.453 ' HA2' ' HD3' ' A' ' 68' ' ' PRO . . . -58.43 134.63 52.36 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.979 -0.629 . . . . 0.0 112.837 -177.614 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.453 ' HD3' ' HA2' ' A' ' 67' ' ' GLY . 26.0 Cg_exo -62.9 -58.51 0.31 Allowed 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.975 2.45 . . . . 0.0 111.876 179.593 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.097 0 CA-C-O 118.579 -0.724 . . . . 0.0 110.331 179.639 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 100' ' ' ALA . . . . . 1.005 ' HA ' ' HA ' ' A' ' 18' ' ' ASP . . . . . . . . 0 N--CA 1.478 0.958 0 CA-C-O 120.782 0.325 . . . . 0.0 110.532 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 101' ' ' MET . . . . . 0.63 ' CE ' HD12 ' A' ' 14' ' ' LEU . 0.0 OUTLIER -132.37 -81.19 0.5 Allowed 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.758 176.427 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 102' ' ' ARG . . . . . 0.589 ' HB2' ' O ' ' B' ' 101' ' ' MET . 54.3 ttp180 168.1 60.06 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.412 0 O-C-N 123.785 0.678 . . . . 0.0 111.568 176.582 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 103' ' ' TYR . . . . . 0.614 ' HB2' HG11 ' B' ' 142' ' ' VAL . 39.6 m-85 66.62 -4.2 0.78 Allowed 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 168.372 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 104' ' ' VAL . . . . . 0.689 HG11 ' HB3' ' B' ' 162' ' ' LEU . 96.1 t -44.42 -46.45 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 CA-C-O 121.864 0.84 . . . . 0.0 109.391 174.153 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 105' ' ' ALA . . . . . 0.638 ' CB ' ' HB3' ' A' ' 14' ' ' LEU . . . -66.8 -38.47 86.57 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-N 114.288 -1.324 . . . . 0.0 112.226 -173.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 106' ' ' SER . . . . . 0.737 ' HB2' HG23 ' B' ' 123' ' ' ILE . 3.2 m -63.82 -37.86 88.96 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-O 121.625 0.726 . . . . 0.0 109.611 178.536 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 107' ' ' TYR . . . . . 0.736 ' O ' ' HG2' ' B' ' 118' ' ' PRO . 33.1 t80 -62.28 -49.57 75.14 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 114.684 -1.144 . . . . 0.0 108.316 177.549 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 108' ' ' LEU . . . . . 0.855 HD12 HG13 ' B' ' 151' ' ' ILE . 0.0 OUTLIER -56.28 -47.49 78.5 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 114.542 -1.208 . . . . 0.0 111.313 177.866 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 109' ' ' LEU . . . . . 0.62 HD13 ' HB2' ' A' ' 11' ' ' TYR . 8.9 tp -56.6 -47.75 78.93 Favored 'General case' 0 CA--C 1.515 -0.398 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.908 179.759 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 110' ' ' ALA . . . . . 0.421 ' HB3' ' HB3' ' B' ' 118' ' ' PRO . . . -64.26 -39.76 94.62 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.583 -0.447 . . . . 0.0 110.985 -177.149 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 111' ' ' ALA . . . . . 0.68 ' HA ' ' O ' ' B' ' 115' ' ' ASN . . . -66.66 -28.89 68.83 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.53 179.862 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 112' ' ' LEU . . . . . 0.64 HD23 ' HB2' ' A' ' 8' ' ' ALA . 1.8 mp -80.37 -34.85 36.13 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.35 175.558 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 113' ' ' GLY . . . . . 0.906 ' HA2' ' HB ' ' A' ' 37' ' ' VAL . . . -64.15 -25.05 69.32 Favored Glycine 0 CA--C 1.504 -0.619 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.814 179.363 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 114' ' ' GLY . . . . . . . . . . . . . . . 144.17 -4.73 1.6 Allowed Glycine 0 N--CA 1.436 -1.326 0 C-N-CA 120.25 -0.976 . . . . 0.0 112.993 176.604 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 115' ' ' ASN . . . . . 0.68 ' O ' ' HA ' ' B' ' 111' ' ' ALA . 8.9 t30 -117.06 90.83 3.42 Favored 'General case' 0 CA--C 1.507 -0.688 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 -176.236 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 7.5 p -77.44 23.64 0.21 Allowed 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.062 -0.972 . . . . 0.0 111.836 -164.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 117' ' ' SER . . . . . 0.546 ' N ' ' HD3' ' B' ' 118' ' ' PRO . 8.5 t -164.92 66.93 1.25 Allowed Pre-proline 0 C--N 1.311 -1.092 0 CA-C-N 114.293 -1.321 . . . . 0.0 108.664 179.648 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 118' ' ' PRO . . . . . 0.736 ' HG2' ' O ' ' B' ' 107' ' ' TYR . 33.9 Cg_exo -64.56 157.8 53.32 Favored 'Trans proline' 0 C--N 1.328 -0.517 1 C-N-CA 125.444 4.096 . . . . 0.0 112.351 -174.091 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 119' ' ' SER . . . . . 0.63 ' O ' HG12 ' B' ' 123' ' ' ILE . 27.2 m -126.02 -175.56 3.39 Favored 'General case' 0 C--N 1.316 -0.856 0 C-N-CA 120.597 -0.441 . . . . 0.0 110.943 177.076 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 120' ' ' ALA . . . . . 0.863 ' HB1' HD13 ' B' ' 139' ' ' LEU . . . -67.84 -35.24 78.24 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 122.214 1.007 . . . . 0.0 110.014 -166.532 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 121' ' ' LYS . . . . . 0.473 ' HD2' ' N ' ' B' ' 121' ' ' LYS . 4.4 mptp? -74.24 -26.76 60.42 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 113.681 -1.6 . . . . 0.0 109.756 -179.07 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 122' ' ' ASP . . . . . . . . . . . . . 25.8 m-20 -72.57 -41.31 65.85 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 174.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 123' ' ' ILE . . . . . 0.737 HG23 ' HB2' ' B' ' 106' ' ' SER . 36.8 mm -54.11 -48.05 65.78 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.368 0 CA-C-N 114.988 -1.005 . . . . 0.0 109.489 173.655 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 124' ' ' LYS . . . . . 0.867 ' HD2' HD11 ' B' ' 127' ' ' LEU . 2.7 mmmt -62.58 -40.71 97.75 Favored 'General case' 0 N--CA 1.439 -1.011 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.785 -176.545 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 125' ' ' LYS . . . . . . . . . . . . . 42.0 mmtt -50.65 -62.68 1.45 Allowed 'General case' 0 CA--C 1.498 -1.023 0 CA-C-O 121.776 0.798 . . . . 0.0 111.367 170.421 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 126' ' ' ILE . . . . . . . . . . . . . 1.7 mp -56.77 -41.48 75.35 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 CA-C-N 113.756 -1.565 . . . . 0.0 110.758 -169.733 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 127' ' ' LEU . . . . . 0.867 HD11 ' HD2' ' B' ' 124' ' ' LYS . 3.9 pp -79.08 -32.73 44.79 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 -178.548 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 128' ' ' ASP . . . . . 0.513 ' HB2' ' O ' ' B' ' 124' ' ' LYS . 0.6 OUTLIER -70.24 -24.78 63.14 Favored 'General case' 0 CA--C 1.517 -0.323 0 C-N-CA 121.326 -0.15 . . . . 0.0 111.261 -177.587 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 129' ' ' SER . . . . . . . . . . . . . 93.7 p -56.72 -37.19 70.6 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-O 120.928 0.394 . . . . 0.0 111.2 176.722 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 130' ' ' VAL . . . . . 0.784 HG23 HG13 ' B' ' 132' ' ' ILE . 13.0 m -104.69 -2.9 9.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.391 179.471 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 131' ' ' GLY . . . . . . . . . . . . . . . 81.01 36.04 22.76 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 121.029 -0.605 . . . . 0.0 112.882 177.328 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 132' ' ' ILE . . . . . 0.818 HG23 ' HB2' ' A' ' 19' ' ' ASP . 18.6 mt -78.86 131.94 33.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 110.443 -0.206 . . . . 0.0 110.443 177.402 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 133' ' ' GLU . . . . . . . . . . . . . 87.5 mt-10 -77.0 125.24 29.0 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.361 0.6 . . . . 0.0 110.663 -176.197 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 134' ' ' ALA . . . . . 0.491 ' HA ' ' OH ' ' B' ' 103' ' ' TYR . . . -134.99 143.7 46.97 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.381 -0.827 . . . . 0.0 112.135 -173.202 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 135' ' ' ASP . . . . . 0.774 ' HB2' ' HG3' ' B' ' 138' ' ' ARG . 16.2 m-20 -103.11 132.43 49.37 Favored 'General case' 0 C--O 1.252 1.223 0 CA-C-N 115.65 -0.704 . . . . 0.0 109.358 170.515 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 136' ' ' ASP . . . . . 0.987 ' HA ' HD11 ' B' ' 139' ' ' LEU . 17.4 t70 -73.8 -8.61 56.69 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.061 -166.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 137' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -96.11 -29.77 13.9 Favored 'General case' 0 N--CA 1.44 -0.953 0 C-N-CA 120.17 -0.612 . . . . 0.0 110.54 174.374 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 138' ' ' ARG . . . . . 0.774 ' HG3' ' HB2' ' B' ' 135' ' ' ASP . 12.8 mmt180 -68.26 -52.12 37.41 Favored 'General case' 0 CA--C 1.503 -0.86 0 CA-C-O 122.176 0.988 . . . . 0.0 108.665 -175.595 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 139' ' ' LEU . . . . . 0.987 HD11 ' HA ' ' B' ' 136' ' ' ASP . 0.4 OUTLIER -67.47 -30.3 69.97 Favored 'General case' 0 C--O 1.209 -1.038 0 CA-C-N 114.024 -1.444 . . . . 0.0 110.878 -179.528 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 140' ' ' ASN . . . . . 0.624 ' O ' ' HB ' ' B' ' 143' ' ' ILE . 12.1 t30 -75.94 -25.41 55.92 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.591 0.71 . . . . 0.0 109.805 -177.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 141' ' ' LYS . . . . . 0.524 ' HG2' ' O ' ' B' ' 138' ' ' ARG . 2.6 ptmm? -77.94 -38.55 45.13 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 179.056 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 142' ' ' VAL . . . . . 0.628 HG12 ' O ' ' B' ' 139' ' ' LEU . 7.2 p -69.38 -32.98 55.38 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.401 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 175.05 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 143' ' ' ILE . . . . . 0.878 HG12 ' O ' ' B' ' 139' ' ' LEU . 23.5 mm -49.14 -62.56 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.512 -0.486 0 CA-C-O 121.41 0.624 . . . . 0.0 110.001 166.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 144' ' ' SER . . . . . . . . . . . . . 47.4 t -54.08 -34.2 59.52 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 114.608 -1.178 . . . . 0.0 111.695 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 145' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -79.52 -30.79 42.02 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.426 0.528 . . . . 0.0 112.426 -178.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 146' ' ' LEU . . . . . 0.72 HD12 ' CG ' ' B' ' 107' ' ' TYR . 6.6 mt -89.55 -31.79 17.44 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.63 -0.428 . . . . 0.0 110.99 179.021 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 147' ' ' ASN . . . . . 0.489 ' HA ' ' OH ' ' B' ' 107' ' ' TYR . 8.3 t30 -40.52 120.34 1.23 Allowed 'General case' 0 N--CA 1.471 0.587 0 O-C-N 124.079 0.862 . . . . 0.0 112.838 -169.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . 90.89 36.36 6.79 Favored Glycine 0 N--CA 1.447 -0.57 0 CA-C-N 115.342 -0.844 . . . . 0.0 111.905 -177.7 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 149' ' ' LYS . . . . . 0.684 ' HB2' ' O ' ' B' ' 146' ' ' LEU . 5.2 tppt? -116.92 159.29 22.66 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 110.231 -0.285 . . . . 0.0 110.231 -177.45 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 150' ' ' ASN . . . . . 0.573 ' O ' HG23 ' B' ' 154' ' ' VAL . 92.5 m-20 -106.19 89.95 3.21 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 177.056 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 151' ' ' ILE . . . . . 0.855 HG13 HD12 ' B' ' 108' ' ' LEU . 1.8 mp -46.69 -61.87 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 114.223 -1.353 . . . . 0.0 113.604 -166.797 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 152' ' ' GLU . . . . . 0.454 ' O ' ' HB2' ' B' ' 156' ' ' ALA . 22.5 mt-10 -53.96 -34.1 58.75 Favored 'General case' 0 C--O 1.216 -0.672 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 -173.281 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 153' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -81.36 -32.94 32.69 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 120.744 -0.382 . . . . 0.0 110.794 -179.575 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 154' ' ' VAL . . . . . 0.885 ' HB ' HD12 ' B' ' 155' ' ' ILE . 40.0 t -53.26 -48.83 54.73 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 169.828 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 155' ' ' ILE . . . . . 0.885 HD12 ' HB ' ' B' ' 154' ' ' VAL . 1.5 mp -108.5 38.6 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.005 -0.998 . . . . 0.0 110.893 -178.069 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 156' ' ' ALA . . . . . 0.454 ' HB2' ' O ' ' B' ' 152' ' ' GLU . . . -99.25 7.14 45.97 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 107.115 -1.439 . . . . 0.0 107.115 166.179 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 157' ' ' GLN . . . . . . . . . . . . . 25.5 mt-30 -143.05 -43.83 0.3 Allowed 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 112.844 -1.98 . . . . 0.0 109.459 175.748 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 158' ' ' GLY . . . . . . . . . . . . . . . -86.57 47.2 3.69 Favored Glycine 0 CA--C 1.521 0.46 0 CA-C-N 115.439 -0.801 . . . . 0.0 114.217 -173.577 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 159' ' ' ILE . . . . . 0.613 ' HB ' ' CD1' ' A' ' 60' ' ' ILE . 1.8 mp -63.63 -14.6 15.04 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 CA-C-O 121.8 0.81 . . . . 0.0 110.104 176.395 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 160' ' ' GLY . . . . . . . . . . . . . . . -130.8 139.51 11.0 Favored Glycine 0 N--CA 1.441 -0.994 0 N-CA-C 110.349 -1.1 . . . . 0.0 110.349 179.648 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 161' ' ' LYS . . . . . 0.596 ' HZ2' ' HB2' ' B' ' 161' ' ' LYS . 0.1 OUTLIER 55.14 40.31 31.75 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.931 0.396 . . . . 0.0 111.201 -172.355 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 162' ' ' LEU . . . . . 0.705 HD21 ' HG ' ' A' ' 14' ' ' LEU . 6.8 mp -28.29 119.23 0.11 Allowed 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 114.437 -1.256 . . . . 0.0 114.042 173.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 163' ' ' ALA . . . . . . . . . . . . . . . 46.1 -90.2 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 O-C-N 124.648 1.217 . . . . 0.0 113.646 177.394 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 164' ' ' SER . . . . . . . . . . . . . 13.7 p -79.55 104.27 10.03 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.176 0.512 . . . . 0.0 111.165 -178.722 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 165' ' ' VAL . . . . . 0.422 ' HA ' ' HD2' ' B' ' 166' ' ' PRO . 34.9 t -75.5 131.19 77.87 Favored Pre-proline 0 C--N 1.32 -0.703 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.869 -179.369 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 166' ' ' PRO . . . . . 0.422 ' HD2' ' HA ' ' B' ' 165' ' ' VAL . 40.3 Cg_exo -17.54 118.76 0.01 OUTLIER 'Trans proline' 0 N--CA 1.443 -1.47 1 C-N-CA 127.131 5.22 . . . . 0.0 115.545 177.976 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 167' ' ' ALA . . . . . . . . . . . . . . . 50.61 56.4 8.02 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.804 -176.413 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 168' ' ' GLY . . . . . . . . . . . . . . . -87.08 64.77 3.81 Favored Glycine 0 N--CA 1.447 -0.61 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.905 -178.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 169' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.919 0 CA-C-O 118.667 -1.074 . . . . 0.0 111.291 178.942 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.2 ttt . . . . . 0 N--CA 1.478 0.96 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.828 ' HB3' HD13 ' A' ' 7' ' ' LEU . . . -63.29 150.07 44.12 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.784 178.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 12.0 m -80.06 131.19 35.72 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 173.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.777 HG13 ' HG ' ' B' ' 112' ' ' LEU . 2.0 t -47.05 -28.61 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.254 -0.884 . . . . 0.0 113.38 -177.027 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.905 ' HB3' ' HA ' ' A' ' 39' ' ' VAL . 69.1 m -70.64 -50.93 31.59 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.864 0.84 . . . . 0.0 109.001 176.278 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.481 ' O ' HG13 ' A' ' 10' ' ' ILE . 40.4 tt0 -57.31 -51.18 70.41 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 114.598 -1.183 . . . . 0.0 109.81 176.454 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.95 HD12 HD12 ' A' ' 10' ' ' ILE . 5.7 tp -58.9 -36.28 74.44 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.547 177.568 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.586 ' HB2' HD23 ' B' ' 112' ' ' LEU . . . -66.65 -35.99 81.49 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 121.199 0.523 . . . . 0.0 110.889 178.532 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.541 ' HB2' HG11 ' A' ' 39' ' ' VAL . 7.4 t -68.0 -42.97 79.9 Favored 'General case' 0 C--O 1.242 0.687 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 179.027 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.95 HD12 HD12 ' A' ' 7' ' ' LEU . 72.0 mt -46.34 -56.77 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.605 0 CA-C-N 113.669 -1.605 . . . . 0.0 109.982 170.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.871 ' HB2' HD13 ' B' ' 109' ' ' LEU . 23.9 m-85 -64.3 -36.76 85.15 Favored 'General case' 0 CA--C 1.512 -0.484 0 CA-C-N 115.441 -0.799 . . . . 0.0 111.271 -174.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.465 ' HA ' ' HG ' ' A' ' 31' ' ' LEU . 18.9 m -56.97 -42.93 81.05 Favored 'General case' 0 C--O 1.243 0.712 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 177.574 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.418 ' HB2' HD11 ' A' ' 51' ' ' LEU . . . -67.17 -31.97 72.74 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.195 175.846 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.734 HD22 HD11 ' A' ' 56' ' ' ILE . 0.3 OUTLIER -63.58 -54.3 38.2 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.316 179.689 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.542 HG12 ' O ' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -60.23 -35.85 64.65 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.412 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 178.868 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.507 ' HA ' HD12 ' A' ' 16' ' ' LEU . 2.3 tp -59.85 -36.06 76.06 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.904 175.616 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.524 ' CD2' ' HB ' ' A' ' 56' ' ' ILE . 70.2 m-70 -73.12 -18.7 61.26 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 116.145 -0.48 . . . . 0.0 112.254 176.479 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -59.37 -38.48 80.56 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 121.074 0.464 . . . . 0.0 110.171 179.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.441 ' CB ' HG12 ' B' ' 132' ' ' ILE . 32.0 t70 -111.25 -4.75 14.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.822 0.82 . . . . 0.0 109.827 176.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.462 ' HG2' ' O ' ' A' ' 17' ' ' HIS . 5.5 mm-40 53.1 48.38 22.39 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-N 114.446 -1.252 . . . . 0.0 110.266 -175.398 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.755 HG22 ' H ' ' A' ' 22' ' ' THR . 13.8 p -100.84 -179.55 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.156 0 CA-C-N 114.903 -1.044 . . . . 0.0 109.966 -170.327 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.755 ' H ' HG22 ' A' ' 21' ' ' VAL . 32.6 p -50.2 141.8 10.82 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 113.608 0.966 . . . . 0.0 113.608 -173.456 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.642 HG12 ' HA ' ' A' ' 48' ' ' ALA . 58.3 t -118.86 111.01 31.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 114.343 -1.298 . . . . 0.0 110.332 -175.2 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.542 ' OG1' ' HE2' ' A' ' 27' ' ' LYS . 77.0 p -143.54 156.67 44.67 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.002 177.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -56.64 -40.23 75.06 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.954 0.407 . . . . 0.0 110.259 177.309 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -56.95 -39.26 74.21 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.294 173.314 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.542 ' HE2' ' OG1' ' A' ' 24' ' ' THR . 1.6 tppt? -63.31 -52.04 63.53 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-O 121.94 0.876 . . . . 0.0 109.093 -179.178 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 27.8 mt -61.0 -38.96 80.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 114.628 -1.169 . . . . 0.0 110.72 179.144 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 11.3 m-80 -61.27 -35.49 77.43 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.782 175.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.91 -47.92 78.67 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.513 176.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.766 ' HB3' HD21 ' B' ' 109' ' ' LEU . 1.2 mm? -58.01 -50.13 74.46 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 121.113 0.482 . . . . 0.0 110.418 174.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.626 HG23 ' O ' ' A' ' 37' ' ' VAL . 57.7 mt -48.34 -48.18 13.77 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 CA-C-N 115.039 -0.982 . . . . 0.0 111.925 178.387 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 22.8 tptm -75.95 -38.82 57.15 Favored 'General case' 0 N--CA 1.433 -1.306 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.799 -174.343 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -67.39 -33.59 75.52 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.964 0.411 . . . . 0.0 110.787 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.529 ' CB ' ' HG ' ' B' ' 109' ' ' LEU . . . -82.44 -36.57 26.49 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.856 177.625 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 97.29 18.15 29.57 Favored Glycine 0 N--CA 1.447 -0.591 0 CA-C-N 115.733 -0.667 . . . . 0.0 112.017 179.483 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.891 ' HB ' ' HA2' ' B' ' 113' ' ' GLY . 2.7 p -121.91 120.84 62.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 121.583 0.706 . . . . 0.0 111.104 -176.216 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -93.69 155.22 17.37 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 114.504 -1.226 . . . . 0.0 110.891 -170.599 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.905 ' HA ' ' HB3' ' A' ' 5' ' ' SER . 97.8 t -127.22 161.3 34.72 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-N 115.102 -0.954 . . . . 0.0 110.593 -170.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.511 ' HB3' ' HD1' ' A' ' 43' ' ' TRP . 3.8 tp10 -67.55 105.49 0.92 Allowed Pre-proline 0 N--CA 1.444 -0.731 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 170.882 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.49 ' C ' ' HD2' ' A' ' 44' ' ' PRO . 76.9 Cg_exo -50.93 -30.5 30.69 Favored 'Trans proline' 0 C--O 1.252 1.175 0 C-N-CA 123.599 2.866 . . . . 0.0 115.6 -163.657 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.402 ' CE2' ' HG2' ' A' ' 40' ' ' GLU . 0.8 OUTLIER -60.04 -28.3 67.65 Favored 'General case' 0 C--N 1.334 -0.097 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 178.167 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . 0.511 ' HD1' ' HB3' ' A' ' 40' ' ' GLU . 7.9 m95 -62.82 -61.66 7.09 Favored Pre-proline 0 C--O 1.205 -1.24 0 CA-C-O 118.27 -0.871 . . . . 0.0 110.725 176.56 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.49 ' HD2' ' C ' ' A' ' 41' ' ' PRO . 99.3 Cg_exo -44.98 -46.24 13.27 Favored 'Trans proline' 0 C--N 1.36 1.145 0 C-N-CA 121.811 1.674 . . . . 0.0 111.981 175.346 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -59.12 -61.58 7.18 Favored Glycine 0 CA--C 1.525 0.68 0 C-N-CA 120.172 -1.013 . . . . 0.0 112.491 177.771 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 4.5 tp -67.08 -22.61 65.83 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 122.887 0.475 . . . . 0.0 111.714 -176.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.461 ' HD2' HD11 ' A' ' 51' ' ' LEU . 2.0 m-85 -69.76 -46.41 65.88 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 175.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.642 ' HA ' HG12 ' A' ' 23' ' ' VAL . . . -65.05 -32.22 73.83 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.805 0.812 . . . . 0.0 109.237 178.216 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 11.1 mmmt -66.72 -49.44 66.03 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 114.303 -1.317 . . . . 0.0 111.938 174.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -84.74 -34.75 22.81 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 113.3 0.852 . . . . 0.0 113.3 -169.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.503 ' HB2' HG11 ' A' ' 23' ' ' VAL . 9.7 mt -67.07 -0.8 3.51 Favored 'General case' 0 N--CA 1.462 0.165 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 -175.281 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -85.89 -14.99 43.18 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.974 0.416 . . . . 0.0 110.353 174.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 91.8 m-20 -123.05 -49.89 1.94 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.717 -179.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 3.8 m -88.28 166.97 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.584 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.399 -179.242 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 -113.95 179.38 3.97 Favored 'General case' 0 C--N 1.312 -1.023 0 C-N-CA 120.475 -0.49 . . . . 0.0 109.783 176.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.734 HD11 HD22 ' A' ' 14' ' ' LEU . 4.6 tp -64.16 -25.35 37.86 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 CA-C-O 120.868 0.366 . . . . 0.0 111.025 -176.345 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -70.47 -15.26 72.79 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.631 -0.795 . . . . 0.0 111.151 178.132 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 33.3 t -78.64 -20.98 49.08 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-O 120.911 0.386 . . . . 0.0 110.184 179.544 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.733 ' HB2' HG21 ' B' ' 159' ' ' ILE . 20.9 mt -65.98 -26.96 67.8 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.859 0.838 . . . . 0.0 110.482 -178.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.706 HG13 ' HB ' ' B' ' 159' ' ' ILE . 0.2 OUTLIER -67.27 -13.28 16.46 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-N 114.418 -1.264 . . . . 0.0 110.509 178.685 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 33.9 t -94.63 -15.41 24.03 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.782 179.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -75.82 -51.03 13.47 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.996 -175.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.4 HG22 ' O ' ' A' ' 63' ' ' VAL . 9.1 p -88.19 33.01 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 122.239 1.019 . . . . 0.0 110.662 -177.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 97.39 111.31 2.88 Favored Glycine 0 N--CA 1.446 -0.657 0 CA-C-N 115.193 -0.912 . . . . 0.0 111.666 -177.734 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -77.08 51.09 0.79 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.247 0.546 . . . . 0.0 111.622 -176.68 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 175.63 153.64 10.57 Favored Glycine 0 N--CA 1.445 -0.736 0 N-CA-C 111.271 -0.732 . . . . 0.0 111.271 179.607 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -128.45 112.62 1.45 Allowed Glycine 0 N--CA 1.446 -0.676 0 C-N-CA 120.463 -0.875 . . . . 0.0 112.196 -178.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -71.04 148.48 56.92 Favored 'Trans proline' 0 C--O 1.235 0.35 0 C-N-CA 122.568 2.179 . . . . 0.0 111.932 178.07 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.932 0 CA-C-O 118.574 -0.727 . . . . 0.0 110.401 179.536 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 100' ' ' ALA . . . . . 0.71 ' N ' ' HG ' ' B' ' 164' ' ' SER . . . . . . . . 0 N--CA 1.48 1.047 0 CA-C-O 121.198 0.523 . . . . 0.0 110.518 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 101' ' ' MET . . . . . 0.863 ' HG2' HD22 ' B' ' 162' ' ' LEU . 1.1 tmt? -81.86 124.18 29.47 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.167 179.849 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 102' ' ' ARG . . . . . 0.411 ' HG3' ' O ' ' B' ' 101' ' ' MET . 8.7 mtp180 -164.51 -99.41 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 O-C-N 123.792 0.682 . . . . 0.0 109.792 173.486 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 103' ' ' TYR . . . . . 0.887 ' HB2' HG11 ' B' ' 142' ' ' VAL . 58.1 m-85 -81.22 -8.79 59.82 Favored 'General case' 0 C--O 1.242 0.662 0 CA-C-O 121.023 0.439 . . . . 0.0 110.616 -178.388 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 104' ' ' VAL . . . . . 0.729 ' HA ' HD11 ' B' ' 146' ' ' LEU . 90.2 t -45.0 -49.08 2.72 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.353 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.31 172.201 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 105' ' ' ALA . . . . . 0.67 ' HA ' HD22 ' B' ' 108' ' ' LEU . . . -62.86 -41.1 99.24 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.271 -1.331 . . . . 0.0 112.088 -174.323 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 106' ' ' SER . . . . . 0.872 ' HB2' HG23 ' B' ' 123' ' ' ILE . 1.0 OUTLIER -62.73 -38.92 92.42 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.58 0.705 . . . . 0.0 109.538 179.296 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 107' ' ' TYR . . . . . 0.696 ' CG ' HD12 ' B' ' 146' ' ' LEU . 39.5 t80 -62.04 -46.71 87.94 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 114.443 -1.253 . . . . 0.0 108.748 178.48 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 108' ' ' LEU . . . . . 0.832 HD12 HG13 ' B' ' 151' ' ' ILE . 0.0 OUTLIER -58.66 -46.92 86.12 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 114.409 -1.268 . . . . 0.0 111.088 177.882 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 109' ' ' LEU . . . . . 0.871 HD13 ' HB2' ' A' ' 11' ' ' TYR . 7.2 tp -55.43 -49.33 72.7 Favored 'General case' 0 CA--C 1.513 -0.474 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.793 179.672 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -62.76 -42.63 99.77 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.809 -177.625 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 111' ' ' ALA . . . . . 0.606 ' HA ' ' O ' ' B' ' 115' ' ' ASN . . . -65.64 -27.66 68.55 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.874 179.659 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 112' ' ' LEU . . . . . 0.777 ' HG ' HG13 ' A' ' 4' ' ' VAL . 2.3 mp -78.5 -37.79 42.35 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.007 175.351 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 113' ' ' GLY . . . . . 0.891 ' HA2' ' HB ' ' A' ' 37' ' ' VAL . . . -63.5 -38.88 97.01 Favored Glycine 0 CA--C 1.503 -0.657 0 CA-C-N 115.125 -0.943 . . . . 0.0 111.972 -179.038 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 114' ' ' GLY . . . . . . . . . . . . . . . 159.78 -4.08 0.1 Allowed Glycine 0 N--CA 1.44 -1.072 0 C-N-CA 120.144 -1.027 . . . . 0.0 113.029 177.456 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 115' ' ' ASN . . . . . 0.606 ' O ' ' HA ' ' B' ' 111' ' ' ALA . 45.0 t30 -116.18 86.04 2.41 Favored 'General case' 0 N--CA 1.44 -0.956 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 -176.571 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 116' ' ' SER . . . . . 0.482 ' HA ' ' CB ' ' B' ' 111' ' ' ALA . 3.3 m -78.56 28.46 0.2 Allowed 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 122.239 1.019 . . . . 0.0 110.763 -169.181 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 117' ' ' SER . . . . . 0.536 ' N ' ' HD3' ' B' ' 118' ' ' PRO . 22.7 t -166.19 67.3 1.05 Allowed Pre-proline 0 C--N 1.308 -1.222 0 CA-C-N 113.495 -1.684 . . . . 0.0 107.92 178.211 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 118' ' ' PRO . . . . . 0.635 ' HD2' ' CZ ' ' B' ' 107' ' ' TYR . 26.9 Cg_exo -67.36 165.35 27.24 Favored 'Trans proline' 0 C--O 1.235 0.36 1 C-N-CA 125.44 4.093 . . . . 0.0 112.257 -173.36 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 119' ' ' SER . . . . . 0.664 ' O ' HG12 ' B' ' 123' ' ' ILE . 96.9 p -130.82 -178.5 4.83 Favored 'General case' 0 C--N 1.319 -0.753 0 C-N-CA 120.464 -0.494 . . . . 0.0 110.784 176.258 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 120' ' ' ALA . . . . . 0.813 ' HB1' HD13 ' B' ' 139' ' ' LEU . . . -67.7 -37.75 82.72 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 122.117 0.96 . . . . 0.0 109.387 -172.886 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 121' ' ' LYS . . . . . 0.439 ' HD2' ' N ' ' B' ' 121' ' ' LYS . 0.5 OUTLIER -61.51 -36.26 80.03 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 113.588 -1.642 . . . . 0.0 109.944 176.046 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 122' ' ' ASP . . . . . 0.424 ' O ' ' HB2' ' B' ' 125' ' ' LYS . 16.8 t0 -71.94 -39.01 69.72 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 115.529 -0.76 . . . . 0.0 109.18 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 123' ' ' ILE . . . . . 0.872 HG23 ' HB2' ' B' ' 106' ' ' SER . 27.9 mm -59.93 -45.66 94.9 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 CA-C-N 115.43 -0.805 . . . . 0.0 109.847 175.243 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 124' ' ' LYS . . . . . 0.71 ' HD3' HD21 ' B' ' 139' ' ' LEU . 5.5 mmmp? -59.21 -41.62 89.03 Favored 'General case' 0 CA--C 1.501 -0.927 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.559 -178.771 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 125' ' ' LYS . . . . . 0.424 ' HB2' ' O ' ' B' ' 122' ' ' ASP . 43.5 mmtt -52.45 -63.49 1.13 Allowed 'General case' 0 CA--C 1.496 -1.111 0 CA-C-O 121.668 0.747 . . . . 0.0 111.502 172.793 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 126' ' ' ILE . . . . . . . . . . . . . 1.7 mp -55.3 -42.73 68.01 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.416 0 CA-C-N 113.963 -1.471 . . . . 0.0 111.368 -168.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 127' ' ' LEU . . . . . 0.713 ' HG ' ' O ' ' B' ' 123' ' ' ILE . 2.6 pp -82.04 -26.17 33.98 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.619 -0.433 . . . . 0.0 112.117 -177.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 128' ' ' ASP . . . . . 0.42 ' N ' HD12 ' B' ' 127' ' ' LEU . 20.4 t70 -71.83 -30.11 65.12 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 120.982 -0.287 . . . . 0.0 110.478 -179.283 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 129' ' ' SER . . . . . . . . . . . . . 90.2 p -52.81 -44.26 66.52 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.382 179.144 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 130' ' ' VAL . . . . . 0.417 ' CG2' HD12 ' B' ' 132' ' ' ILE . 12.7 m -88.03 -24.58 6.16 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 116.539 -0.301 . . . . 0.0 111.447 178.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 131' ' ' GLY . . . . . . . . . . . . . . . 109.74 25.06 5.58 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.306 -0.95 . . . . 0.0 113.175 176.04 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 132' ' ' ILE . . . . . 0.441 HG12 ' CB ' ' A' ' 19' ' ' ASP . 3.2 mt -85.26 132.82 30.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 116.943 0.371 . . . . 0.0 110.092 176.334 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 133' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -91.03 137.11 32.61 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.192 0.52 . . . . 0.0 110.457 -177.614 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 134' ' ' ALA . . . . . . . . . . . . . . . -143.14 143.83 31.97 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.608 -172.397 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 135' ' ' ASP . . . . . 0.759 ' HB2' ' CG ' ' B' ' 138' ' ' ARG . 4.1 m-20 -80.53 125.6 30.18 Favored 'General case' 0 C--O 1.258 1.523 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 172.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 136' ' ' ASP . . . . . 1.021 ' HA ' HD11 ' B' ' 139' ' ' LEU . 5.4 p-10 -72.11 2.06 6.43 Favored 'General case' 0 CA--C 1.514 -0.406 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.524 -173.261 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 137' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -102.93 -36.49 8.19 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.398 174.729 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 138' ' ' ARG . . . . . 0.759 ' CG ' ' HB2' ' B' ' 135' ' ' ASP . 24.9 mmt180 -67.23 -43.5 81.85 Favored 'General case' 0 CA--C 1.505 -0.766 0 CA-C-O 122.317 1.056 . . . . 0.0 108.626 -174.544 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 139' ' ' LEU . . . . . 1.021 HD11 ' HA ' ' B' ' 136' ' ' ASP . 0.4 OUTLIER -72.96 -32.29 65.13 Favored 'General case' 0 C--O 1.209 -1.053 0 CA-C-N 114.423 -1.262 . . . . 0.0 111.034 179.183 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 140' ' ' ASN . . . . . 0.581 ' O ' ' HB ' ' B' ' 143' ' ' ILE . 67.1 t30 -66.36 -25.53 66.85 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 122.29 1.043 . . . . 0.0 108.871 177.41 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 141' ' ' LYS . . . . . 0.513 ' HB3' ' O ' ' B' ' 138' ' ' ARG . 11.8 tppt? -70.4 -52.24 23.79 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 114.199 -1.364 . . . . 0.0 109.707 176.027 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 142' ' ' VAL . . . . . 0.887 HG11 ' HB2' ' B' ' 103' ' ' TYR . 7.9 p -61.82 -33.07 56.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.181 -0.463 . . . . 0.0 109.92 177.422 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 143' ' ' ILE . . . . . 0.87 HG12 ' O ' ' B' ' 139' ' ' LEU . 29.9 mm -50.24 -61.75 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.374 0 CA-C-O 121.426 0.632 . . . . 0.0 110.052 169.532 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 144' ' ' SER . . . . . . . . . . . . . 45.3 t -54.88 -32.26 60.68 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 114.331 -1.304 . . . . 0.0 111.716 -179.759 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 145' ' ' GLU . . . . . . . . . . . . . 68.4 mm-40 -80.01 -34.69 38.25 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.378 0.51 . . . . 0.0 112.378 -179.281 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 146' ' ' LEU . . . . . 0.729 HD11 ' HA ' ' B' ' 104' ' ' VAL . 7.2 mt -87.63 -19.99 26.97 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 121.021 -0.272 . . . . 0.0 110.832 -178.568 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 147' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -53.97 108.79 0.39 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.13 -177.255 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . 108.99 18.99 8.84 Favored Glycine 0 N--CA 1.449 -0.436 0 CA-C-N 115.356 -0.838 . . . . 0.0 112.454 -179.283 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 149' ' ' LYS . . . . . 0.458 ' HB2' ' O ' ' B' ' 146' ' ' LEU . 0.2 OUTLIER -109.09 171.54 7.37 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.87 0.367 . . . . 0.0 110.646 -178.937 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 150' ' ' ASN . . . . . 0.591 ' O ' HG23 ' B' ' 154' ' ' VAL . 10.6 m-80 -110.24 89.12 2.93 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 178.423 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 151' ' ' ILE . . . . . 0.832 HG13 HD12 ' B' ' 108' ' ' LEU . 1.8 mp -41.87 -63.74 0.17 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.357 0 N-CA-C 113.775 1.028 . . . . 0.0 113.775 -166.447 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 152' ' ' GLU . . . . . 0.702 ' HG3' HD11 ' B' ' 112' ' ' LEU . 3.3 mp0 -59.85 -36.4 76.77 Favored 'General case' 0 C--O 1.209 -1.046 0 C-N-CA 120.508 -0.477 . . . . 0.0 111.105 -174.698 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 153' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -73.51 -27.72 61.51 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 120.73 0.3 . . . . 0.0 110.815 -179.329 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 154' ' ' VAL . . . . . 0.834 ' HB ' HD12 ' B' ' 155' ' ' ILE . 46.4 t -60.3 -48.78 86.84 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 171.15 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 155' ' ' ILE . . . . . 0.834 HD12 ' HB ' ' B' ' 154' ' ' VAL . 3.3 mp -106.65 33.94 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 122.11 0.957 . . . . 0.0 110.973 -177.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 156' ' ' ALA . . . . . 0.413 ' HB2' ' O ' ' B' ' 152' ' ' GLU . . . -99.37 -1.34 39.01 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 169.531 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 157' ' ' GLN . . . . . . . . . . . . . 23.2 mt-30 -139.55 -2.76 1.55 Allowed 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 113.333 -1.758 . . . . 0.0 109.678 175.141 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 158' ' ' GLY . . . . . . . . . . . . . . . -134.48 45.79 1.09 Allowed Glycine 0 C--O 1.225 -0.411 0 C-N-CA 120.603 -0.808 . . . . 0.0 114.077 -168.383 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 159' ' ' ILE . . . . . 0.733 HG21 ' HB2' ' A' ' 59' ' ' LEU . 1.8 mp -59.26 -25.76 31.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 CA-C-O 121.011 0.434 . . . . 0.0 110.854 176.757 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 160' ' ' GLY . . . . . . . . . . . . . . . -104.67 -45.24 1.44 Allowed Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.562 -0.828 . . . . 0.0 112.653 179.279 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 161' ' ' LYS . . . . . 0.446 ' HD2' ' HA ' ' B' ' 161' ' ' LYS . 30.5 mmmt -81.51 -15.05 56.11 Favored 'General case' 0 N--CA 1.444 -0.741 0 N-CA-C 113.486 0.921 . . . . 0.0 113.486 -176.257 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 162' ' ' LEU . . . . . 0.863 HD22 ' HG2' ' B' ' 101' ' ' MET . 8.9 mp 42.28 -144.27 0.07 Allowed 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 123.346 0.658 . . . . 0.0 112.579 -173.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 163' ' ' ALA . . . . . 0.562 ' H ' HG11 ' B' ' 104' ' ' VAL . . . -73.19 60.38 0.58 Allowed 'General case' 0 N--CA 1.442 -0.831 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 -178.77 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 164' ' ' SER . . . . . 0.71 ' HG ' ' N ' ' B' ' 100' ' ' ALA . 20.5 p -170.88 155.5 4.64 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.696 176.084 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 165' ' ' VAL . . . . . 0.494 ' HA ' ' HD2' ' B' ' 166' ' ' PRO . 3.8 t 61.61 121.51 0.02 OUTLIER Pre-proline 0 CA--C 1.538 0.502 0 N-CA-C 113.814 1.042 . . . . 0.0 113.814 -178.14 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 166' ' ' PRO . . . . . 0.494 ' HD2' ' HA ' ' B' ' 165' ' ' VAL . 53.2 Cg_exo -20.05 118.93 0.02 OUTLIER 'Trans proline' 0 N--CA 1.44 -1.636 1 C-N-CA 128.07 5.846 . . . . 0.0 116.395 179.869 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 167' ' ' ALA . . . . . . . . . . . . . . . -89.7 69.26 7.7 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.493 178.161 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 168' ' ' GLY . . . . . . . . . . . . . . . 138.95 150.63 5.6 Favored Glycine 0 N--CA 1.443 -0.838 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.153 -179.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 169' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.231 -1.316 . . . . 0.0 111.534 177.526 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.2 ttt . . . . . 0 N--CA 1.479 1.013 0 N-CA-C 109.503 -0.555 . . . . 0.0 109.503 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.695 ' HB3' HD13 ' A' ' 7' ' ' LEU . . . -63.4 138.59 58.58 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.679 0.276 . . . . 0.0 110.883 179.691 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 92.9 p -71.78 142.29 49.71 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 173.038 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.678 HG13 ' HG ' ' B' ' 112' ' ' LEU . 1.9 t -50.85 -22.47 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 CA-C-N 114.373 -1.285 . . . . 0.0 112.442 -179.773 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.83 ' HB3' ' HA ' ' A' ' 39' ' ' VAL . 63.0 m -73.17 -52.25 14.86 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.209 0.528 . . . . 0.0 109.598 175.773 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.624 ' HG2' ' NE1' ' A' ' 43' ' ' TRP . 36.7 mt-10 -57.86 -51.22 70.52 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.67 177.805 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.792 HD12 HD12 ' A' ' 10' ' ' ILE . 3.6 tp -58.2 -37.28 74.47 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.178 -0.919 . . . . 0.0 111.746 177.741 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.6 ' HB2' HD23 ' B' ' 112' ' ' LEU . . . -67.43 -34.0 76.33 Favored 'General case' 0 N--CA 1.468 0.428 0 O-C-N 121.958 -0.464 . . . . 0.0 111.115 178.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.523 ' HB2' HG11 ' A' ' 39' ' ' VAL . 6.8 t -71.29 -37.2 71.85 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 178.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.792 HD12 HD12 ' A' ' 7' ' ' LEU . 66.9 mt -50.53 -55.57 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.809 0 CA-C-N 114.29 -1.323 . . . . 0.0 109.684 170.202 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.72 ' HB2' HD13 ' B' ' 109' ' ' LEU . 23.5 m-85 -67.04 -43.7 82.09 Favored 'General case' 0 C--O 1.219 -0.514 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.964 -173.454 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.7 p -55.08 -41.82 72.03 Favored 'General case' 0 C--O 1.239 0.526 0 CA-C-O 121.15 0.5 . . . . 0.0 109.947 176.409 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.416 ' CB ' HD11 ' A' ' 51' ' ' LEU . . . -62.64 -35.33 79.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.913 172.681 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.778 HD22 HD11 ' A' ' 56' ' ' ILE . 0.4 OUTLIER -62.73 -54.48 38.5 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.868 179.573 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.432 HG12 ' H ' ' A' ' 15' ' ' ILE . 0.0 OUTLIER -57.39 -45.65 85.48 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 CA-C-O 121.048 0.451 . . . . 0.0 110.048 177.302 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.511 HD11 ' HG2' ' A' ' 27' ' ' LYS . 5.7 tp -55.85 -40.54 73.03 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.577 0.703 . . . . 0.0 110.845 177.589 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 15.0 t60 -75.68 -11.28 59.97 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 114.722 -1.126 . . . . 0.0 111.999 -179.294 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.422 ' CG ' ' HG3' ' B' ' 102' ' ' ARG . 37.4 t70 -74.93 -45.83 39.82 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 121.871 -0.518 . . . . 0.0 110.437 178.178 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.501 ' OD2' ' HB ' ' A' ' 21' ' ' VAL . 29.3 t70 -88.89 -11.49 44.45 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.732 0.777 . . . . 0.0 109.085 177.713 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 56.18 48.98 16.3 Favored 'General case' 0 CA--C 1.516 -0.348 0 CA-C-N 113.975 -1.466 . . . . 0.0 109.626 -175.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.501 ' HB ' ' OD2' ' A' ' 19' ' ' ASP . 7.6 p -101.75 168.41 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.479 0 CA-C-N 114.519 -1.219 . . . . 0.0 109.586 -170.596 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.445 ' N ' HG22 ' A' ' 21' ' ' VAL . 45.5 p -43.97 129.52 5.89 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-O 121.77 0.795 . . . . 0.0 113.105 -175.147 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.699 HG12 ' HA ' ' A' ' 48' ' ' ALA . 60.0 t -103.97 108.63 25.06 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.041 0 CA-C-N 114.299 -1.319 . . . . 0.0 110.182 -176.058 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.534 ' OG1' ' HB2' ' A' ' 27' ' ' LYS . 70.4 p -140.61 151.98 45.09 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.02 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -51.78 -45.56 63.84 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.082 0.467 . . . . 0.0 110.258 177.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -62.54 -31.13 71.87 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.736 179.163 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.534 ' HB2' ' OG1' ' A' ' 24' ' ' THR . 4.0 tppt? -67.48 -49.42 63.59 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-O 122.032 0.92 . . . . 0.0 108.573 178.075 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 86.3 mt -60.75 -40.54 85.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 114.296 -1.32 . . . . 0.0 110.445 177.549 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -61.15 -35.41 77.01 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.567 175.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.82 -45.69 91.44 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.724 175.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.672 ' HB3' HD21 ' B' ' 109' ' ' LEU . 1.4 mm? -61.99 -46.31 89.8 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 121.017 0.437 . . . . 0.0 110.438 174.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.579 HG23 ' O ' ' A' ' 37' ' ' VAL . 44.2 mt -50.07 -48.18 23.63 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 CA-C-N 115.273 -0.876 . . . . 0.0 111.412 177.799 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 22.7 tptp -72.78 -39.68 66.55 Favored 'General case' 0 N--CA 1.438 -1.055 0 CA-C-N 115.707 -0.678 . . . . 0.0 111.45 -178.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.655 ' HB1' ' HA ' ' B' ' 126' ' ' ILE . . . -56.89 -48.75 77.45 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.195 0.521 . . . . 0.0 110.845 179.842 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.442 ' CB ' ' HG ' ' B' ' 109' ' ' LEU . . . -76.83 -37.41 55.71 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.066 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 99.06 20.74 17.44 Favored Glycine 0 N--CA 1.449 -0.438 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.767 -178.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.839 ' HB ' ' HA2' ' B' ' 113' ' ' GLY . 3.0 p -122.57 121.87 64.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 121.443 0.639 . . . . 0.0 110.646 -176.742 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.462 ' HA ' HG23 ' A' ' 32' ' ' ILE . 61.5 t30 -96.41 156.54 16.3 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 114.773 -1.103 . . . . 0.0 111.0 -170.012 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.83 ' HA ' ' HB3' ' A' ' 5' ' ' SER . 93.3 t -126.82 159.95 35.85 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.075 0 CA-C-N 115.01 -0.995 . . . . 0.0 110.356 -172.561 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.511 ' HB3' ' HD1' ' A' ' 43' ' ' TRP . 3.5 tp10 -67.44 107.23 1.61 Allowed Pre-proline 0 N--CA 1.44 -0.932 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 169.6 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.477 ' C ' ' HD2' ' A' ' 44' ' ' PRO . 73.7 Cg_exo -51.35 -28.07 25.84 Favored 'Trans proline' 0 C--O 1.249 1.034 0 C-N-CA 123.598 2.866 . . . . 0.0 115.304 -164.828 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.43 ' HD2' ' CG ' ' A' ' 40' ' ' GLU . 0.5 OUTLIER -60.19 -27.01 66.79 Favored 'General case' 0 C--N 1.333 -0.15 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 177.645 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . 0.624 ' NE1' ' HG2' ' A' ' 6' ' ' GLU . 22.5 m95 -65.36 -60.12 8.33 Favored Pre-proline 0 C--O 1.204 -1.331 0 CA-C-O 118.373 -0.822 . . . . 0.0 110.743 175.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.477 ' HD2' ' C ' ' A' ' 41' ' ' PRO . 74.7 Cg_exo -44.1 -44.66 12.37 Favored 'Trans proline' 0 C--N 1.357 1.004 0 C-N-CA 121.671 1.58 . . . . 0.0 112.203 173.654 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -62.0 -56.49 22.13 Favored Glycine 0 CA--C 1.525 0.712 0 C-N-CA 120.238 -0.982 . . . . 0.0 112.952 176.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.461 ' O ' ' HB2' ' A' ' 49' ' ' LYS . 9.4 tp -69.78 -23.01 63.28 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 122.91 0.484 . . . . 0.0 111.821 -176.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.519 ' HE1' ' CE3' ' A' ' 43' ' ' TRP . 3.1 m-85 -73.48 -43.78 59.4 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 109.962 -0.384 . . . . 0.0 109.962 175.605 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.699 ' HA ' HG12 ' A' ' 23' ' ' VAL . . . -63.67 -33.14 74.97 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 177.074 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.461 ' HB2' ' O ' ' A' ' 46' ' ' LEU . 9.6 mmmt -62.68 -62.26 1.85 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 114.569 -1.196 . . . . 0.0 111.701 171.187 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.473 ' O ' HG22 ' A' ' 54' ' ' VAL . . . -69.77 -41.26 75.4 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 113.114 0.783 . . . . 0.0 113.114 -169.408 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.542 ' HB2' HG11 ' A' ' 23' ' ' VAL . 12.4 mt -65.64 -10.98 40.78 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.75 0.309 . . . . 0.0 111.792 -174.37 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -84.59 0.22 50.86 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.303 177.217 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -141.22 -47.03 0.39 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.234 -179.119 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.473 HG22 ' O ' ' A' ' 50' ' ' ALA . 5.8 m -91.08 -175.19 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.847 0.356 . . . . 0.0 110.33 -177.473 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 16.4 m120 -116.03 169.47 9.23 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.734 178.16 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.778 HD11 HD22 ' A' ' 14' ' ' LEU . 3.2 tp -61.35 -25.09 35.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.551 178.603 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -70.83 -11.94 70.18 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.691 -0.766 . . . . 0.0 111.36 179.277 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 22.9 t -81.34 -23.71 37.59 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-O 121.323 0.582 . . . . 0.0 109.817 179.433 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.743 ' HB2' HG21 ' B' ' 159' ' ' ILE . 26.3 mt -62.32 -31.19 71.78 Favored 'General case' 0 CA--C 1.517 -0.314 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.751 -178.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.887 HG13 ' HB ' ' B' ' 159' ' ' ILE . 0.1 OUTLIER -62.3 -18.64 20.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 114.904 -1.044 . . . . 0.0 110.888 -179.647 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.434 ' O ' ' HB2' ' A' ' 65' ' ' ALA . 5.4 t -96.18 -10.02 29.14 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.315 -176.1 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.4 HD22 ' HA ' ' A' ' 62' ' ' ASN . 12.0 m120 -69.76 -26.36 64.26 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.909 0.385 . . . . 0.0 110.943 -177.096 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 16.5 m -93.97 36.63 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.053 179.321 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 141.1 96.83 0.29 Allowed Glycine 0 N--CA 1.447 -0.625 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.919 177.148 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.434 ' HB2' ' O ' ' A' ' 61' ' ' CYS . . . -142.84 -65.5 0.39 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.026 0.441 . . . . 0.0 111.549 -177.746 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 114.96 -135.01 12.0 Favored Glycine 0 N--CA 1.448 -0.541 0 N-CA-C 110.92 -0.872 . . . . 0.0 110.92 -174.615 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.459 ' HA2' ' HD3' ' A' ' 68' ' ' PRO . . . 166.88 140.9 3.0 Favored Glycine 0 N--CA 1.449 -0.433 0 C-N-CA 120.222 -0.99 . . . . 0.0 112.69 178.402 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.459 ' HD3' ' HA2' ' A' ' 67' ' ' GLY . 15.4 Cg_exo -68.65 99.76 0.65 Allowed 'Trans proline' 0 C--O 1.234 0.302 0 C-N-CA 123.024 2.483 . . . . 0.0 112.058 178.167 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.896 0 CA-C-O 118.445 -0.788 . . . . 0.0 110.1 178.453 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.122 0 CA-C-O 120.609 0.243 . . . . 0.0 110.349 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 101' ' ' MET . . . . . 0.67 ' HG2' HD22 ' B' ' 162' ' ' LEU . 1.3 tmt? -91.87 126.02 36.8 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.985 0.422 . . . . 0.0 111.445 -177.366 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 102' ' ' ARG . . . . . 0.422 ' HG3' ' CG ' ' A' ' 18' ' ' ASP . 18.9 ttt180 -164.67 -94.87 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.221 168.192 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 103' ' ' TYR . . . . . 0.565 ' HB2' HG11 ' B' ' 142' ' ' VAL . 47.3 m-85 -77.21 -11.29 59.8 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.354 0.597 . . . . 0.0 109.766 -177.888 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 104' ' ' VAL . . . . . 0.555 HG12 ' CD2' ' B' ' 108' ' ' LEU . 48.2 t -46.45 -45.95 6.78 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.519 0 CA-C-N 114.71 -1.132 . . . . 0.0 110.13 173.806 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 105' ' ' ALA . . . . . 0.613 ' CB ' ' HB3' ' A' ' 14' ' ' LEU . . . -66.22 -39.37 89.54 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 114.822 -1.081 . . . . 0.0 111.656 -174.703 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 106' ' ' SER . . . . . 0.713 ' HB2' HG23 ' B' ' 123' ' ' ILE . 1.0 OUTLIER -62.87 -35.39 79.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.666 0.746 . . . . 0.0 109.066 176.567 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 107' ' ' TYR . . . . . 0.779 ' HD2' HG12 ' B' ' 143' ' ' ILE . 32.7 t80 -65.23 -51.61 59.86 Favored 'General case' 0 N--CA 1.445 -0.722 0 CA-C-N 114.483 -1.235 . . . . 0.0 108.625 179.093 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 108' ' ' LEU . . . . . 0.868 HD12 HG13 ' B' ' 151' ' ' ILE . 0.0 OUTLIER -56.62 -46.83 80.71 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-N 114.99 -1.004 . . . . 0.0 110.769 177.227 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 109' ' ' LEU . . . . . 0.72 HD13 ' HB2' ' A' ' 11' ' ' TYR . 9.4 tp -52.98 -49.06 66.9 Favored 'General case' 0 CA--C 1.512 -0.494 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.665 178.434 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 110' ' ' ALA . . . . . 0.583 ' HB3' ' HB3' ' B' ' 118' ' ' PRO . . . -66.45 -36.43 82.75 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.134 -176.719 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 111' ' ' ALA . . . . . 0.816 ' HA ' ' O ' ' B' ' 115' ' ' ASN . . . -70.63 -19.99 62.77 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.354 0.597 . . . . 0.0 111.023 179.101 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 112' ' ' LEU . . . . . 0.751 ' HB3' HG21 ' A' ' 37' ' ' VAL . 5.6 mp -86.53 -37.24 18.39 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.084 171.284 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 113' ' ' GLY . . . . . 0.839 ' HA2' ' HB ' ' A' ' 37' ' ' VAL . . . -66.26 -39.35 94.36 Favored Glycine 0 N--CA 1.444 -0.798 0 CA-C-N 115.054 -0.975 . . . . 0.0 113.117 -176.389 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 114' ' ' GLY . . . . . . . . . . . . . . . 164.17 6.97 0.04 OUTLIER Glycine 0 N--CA 1.442 -0.901 0 C-N-CA 119.514 -1.327 . . . . 0.0 114.051 178.457 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 115' ' ' ASN . . . . . 0.816 ' O ' ' HA ' ' B' ' 111' ' ' ALA . 95.7 m-20 -130.92 98.0 4.48 Favored 'General case' 0 CA--C 1.494 -1.183 0 CA-C-N 118.061 0.93 . . . . 0.0 108.827 178.165 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 2.5 p -76.02 29.08 0.11 Allowed 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 122.533 1.158 . . . . 0.0 109.818 -178.352 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 117' ' ' SER . . . . . 0.614 ' H ' ' C ' ' B' ' 115' ' ' ASN . 23.2 t -169.95 71.18 0.63 Allowed Pre-proline 0 N--CA 1.447 -0.61 0 CA-C-N 113.261 -1.79 . . . . 0.0 107.93 179.694 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 118' ' ' PRO . . . . . 0.616 ' HD2' ' CZ ' ' B' ' 107' ' ' TYR . 21.0 Cg_exo -71.81 152.39 58.23 Favored 'Trans proline' 0 C--N 1.33 -0.42 1 C-N-CA 125.352 4.034 . . . . 0.0 111.722 -177.102 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 119' ' ' SER . . . . . 0.536 ' O ' HG12 ' B' ' 123' ' ' ILE . 78.9 p -123.09 -175.47 3.19 Favored 'General case' 0 C--N 1.317 -0.824 0 C-N-CA 119.998 -0.681 . . . . 0.0 111.606 178.003 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 120' ' ' ALA . . . . . 0.78 ' HB1' HD13 ' B' ' 139' ' ' LEU . . . -66.58 -39.98 88.72 Favored 'General case' 0 CA--C 1.507 -0.682 0 CA-C-O 121.785 0.802 . . . . 0.0 109.315 -170.347 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 121' ' ' LYS . . . . . 0.406 ' HD2' ' N ' ' B' ' 121' ' ' LYS . 13.8 mptt -58.99 -37.38 76.71 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 113.932 -1.485 . . . . 0.0 111.108 174.642 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 122' ' ' ASP . . . . . 0.401 ' O ' ' HD2' ' B' ' 125' ' ' LYS . 21.1 m-20 -69.56 -40.04 77.02 Favored 'General case' 0 CA--C 1.517 -0.299 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.33 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 123' ' ' ILE . . . . . 0.75 ' CG1' HD11 ' B' ' 143' ' ' ILE . 33.2 mm -59.29 -50.84 78.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.959 176.236 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 124' ' ' LYS . . . . . 0.85 ' HD3' HD21 ' B' ' 139' ' ' LEU . 3.7 mmmp? -59.91 -31.66 70.03 Favored 'General case' 0 C--O 1.216 -0.686 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.789 -178.802 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 125' ' ' LYS . . . . . 0.735 ' HD2' HD12 ' B' ' 126' ' ' ILE . 0.0 OUTLIER -71.92 -48.08 47.94 Favored 'General case' 0 N--CA 1.431 -1.384 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.935 -179.773 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 126' ' ' ILE . . . . . 0.735 HD12 ' HD2' ' B' ' 125' ' ' LYS . 1.1 mp -55.56 -51.01 62.54 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 CA-C-O 120.604 0.24 . . . . 0.0 110.941 176.031 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 127' ' ' LEU . . . . . 0.689 ' HG ' ' O ' ' B' ' 123' ' ' ILE . 1.8 pp -76.82 -24.09 52.76 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.605 -0.438 . . . . 0.0 111.629 -175.852 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 128' ' ' ASP . . . . . 0.533 ' HB2' ' O ' ' B' ' 124' ' ' LYS . 24.9 t70 -65.53 -32.86 74.69 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 175.589 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 129' ' ' SER . . . . . 0.508 ' HB2' ' HB2' ' A' ' 34' ' ' ALA . 7.1 t -56.5 -33.12 65.71 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-N 115.714 -0.676 . . . . 0.0 111.827 176.835 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 130' ' ' VAL . . . . . 0.443 HG23 HG13 ' B' ' 132' ' ' ILE . 2.5 m -108.63 -8.48 11.12 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 O-C-N 122.098 -0.376 . . . . 0.0 111.904 178.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 131' ' ' GLY . . . . . . . . . . . . . . . 87.26 27.11 28.86 Favored Glycine 0 CA--C 1.519 0.342 0 C-N-CA 121.036 -0.602 . . . . 0.0 113.18 175.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 132' ' ' ILE . . . . . 0.525 ' O ' HD13 ' B' ' 127' ' ' LEU . 17.9 mt -85.09 128.3 39.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.669 0.234 . . . . 0.0 110.854 -179.059 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 133' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -76.53 133.16 39.81 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.124 0.487 . . . . 0.0 111.385 -176.185 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 134' ' ' ALA . . . . . 0.493 ' HB2' HD22 ' B' ' 127' ' ' LEU . . . -139.9 143.94 36.92 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.769 -174.677 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 135' ' ' ASP . . . . . 0.808 ' HB2' ' HG3' ' B' ' 138' ' ' ARG . 5.5 m-20 -88.88 127.97 35.65 Favored 'General case' 0 C--O 1.256 1.416 0 CA-C-O 121.261 0.553 . . . . 0.0 109.712 176.234 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 136' ' ' ASP . . . . . 0.993 ' HA ' HD11 ' B' ' 139' ' ' LEU . 9.0 p-10 -78.07 2.08 18.99 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-N 115.127 -0.942 . . . . 0.0 111.587 -166.593 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 137' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -105.57 -32.76 8.34 Favored 'General case' 0 N--CA 1.44 -0.932 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.189 170.65 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 138' ' ' ARG . . . . . 0.808 ' HG3' ' HB2' ' B' ' 135' ' ' ASP . 11.8 mmt85 -63.32 -47.6 81.53 Favored 'General case' 0 CA--C 1.504 -0.803 0 CA-C-O 121.781 0.8 . . . . 0.0 109.425 -175.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 139' ' ' LEU . . . . . 0.993 HD11 ' HA ' ' B' ' 136' ' ' ASP . 0.3 OUTLIER -71.81 -39.43 69.84 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 114.653 -1.158 . . . . 0.0 111.356 -179.151 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 140' ' ' ASN . . . . . 0.682 ' H ' HD12 ' B' ' 139' ' ' LEU . 11.0 t30 -62.98 -29.38 70.77 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-O 121.571 0.701 . . . . 0.0 109.11 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 141' ' ' LYS . . . . . . . . . . . . . 18.4 tttm -72.09 -52.42 16.86 Favored 'General case' 0 C--O 1.242 0.699 0 CA-C-N 114.672 -1.149 . . . . 0.0 110.358 178.271 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 142' ' ' VAL . . . . . 0.62 HG12 ' O ' ' B' ' 139' ' ' LEU . 11.7 p -56.93 -42.34 78.48 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.743 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.721 -179.013 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 143' ' ' ILE . . . . . 0.779 HG12 ' HD2' ' B' ' 107' ' ' TYR . 34.6 mt -59.39 -49.73 82.45 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 C-N-CA 123.554 0.742 . . . . 0.0 112.792 174.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 144' ' ' SER . . . . . . . . . . . . . 66.3 m -53.26 -33.93 55.14 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 115.668 -0.697 . . . . 0.0 111.294 178.191 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 145' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -87.5 -33.63 18.92 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 120.981 0.419 . . . . 0.0 111.606 176.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 146' ' ' LEU . . . . . 0.529 HD11 HG13 ' B' ' 104' ' ' VAL . 0.3 OUTLIER -70.83 -31.92 68.8 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 123.374 0.67 . . . . 0.0 111.511 -179.01 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 147' ' ' ASN . . . . . . . . . . . . . 23.3 t-20 -56.04 124.86 19.19 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.973 -177.502 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . 101.86 28.37 6.62 Favored Glycine 0 N--CA 1.449 -0.495 0 CA-C-N 115.636 -0.711 . . . . 0.0 112.563 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 149' ' ' LYS . . . . . 0.505 ' HE2' ' O ' ' B' ' 146' ' ' LEU . 1.0 OUTLIER -127.79 175.01 8.66 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 110.21 -0.292 . . . . 0.0 110.21 177.13 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 150' ' ' ASN . . . . . 0.553 ' O ' HG23 ' B' ' 154' ' ' VAL . 44.0 m-80 -111.7 93.15 4.32 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 108.582 -0.895 . . . . 0.0 108.582 179.48 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 151' ' ' ILE . . . . . 0.868 HG13 HD12 ' B' ' 108' ' ' LEU . 1.8 mp -41.74 -65.03 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 O-C-N 124.366 1.041 . . . . 0.0 113.662 -169.167 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 152' ' ' GLU . . . . . 0.524 ' HG3' HD11 ' B' ' 112' ' ' LEU . 1.7 mp0 -55.14 -42.83 73.54 Favored 'General case' 0 C--O 1.219 -0.535 0 CA-C-N 117.879 0.309 . . . . 0.0 111.52 -174.26 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 153' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -69.05 -28.61 66.7 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.523 179.696 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 154' ' ' VAL . . . . . 0.837 ' HB ' HD12 ' B' ' 155' ' ' ILE . 61.1 t -61.29 -51.36 73.88 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 CA-C-O 121.691 0.757 . . . . 0.0 109.071 171.208 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 155' ' ' ILE . . . . . 0.837 HD12 ' HB ' ' B' ' 154' ' ' VAL . 1.9 mp -101.15 33.29 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.496 -177.223 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . -98.69 -4.97 32.47 Favored 'General case' 0 C--N 1.308 -1.228 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 168.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 157' ' ' GLN . . . . . . . . . . . . . 67.5 mm-40 -142.85 14.72 1.92 Allowed 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 113.563 -1.653 . . . . 0.0 110.047 174.648 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 158' ' ' GLY . . . . . . . . . . . . . . . -146.83 46.34 0.74 Allowed Glycine 0 C--N 1.336 0.567 0 C-N-CA 120.707 -0.758 . . . . 0.0 113.727 -170.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 159' ' ' ILE . . . . . 0.887 ' HB ' HG13 ' A' ' 60' ' ' ILE . 1.8 mp -66.79 -14.76 18.44 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 CA-C-O 121.244 0.545 . . . . 0.0 110.889 178.29 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 160' ' ' GLY . . . . . . . . . . . . . . . -114.86 -62.81 0.39 Allowed Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 120.848 -0.691 . . . . 0.0 111.908 -176.122 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 161' ' ' LYS . . . . . 0.513 ' HD3' ' N ' ' B' ' 161' ' ' LYS . 3.2 mppt? -78.66 57.45 2.04 Favored 'General case' 0 N--CA 1.442 -0.837 0 N-CA-C 111.822 0.304 . . . . 0.0 111.822 178.018 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 162' ' ' LEU . . . . . 0.67 HD22 ' HG2' ' B' ' 101' ' ' MET . 10.8 mp -49.72 142.24 8.81 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.165 -0.47 . . . . 0.0 112.022 173.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 163' ' ' ALA . . . . . . . . . . . . . . . 51.91 55.91 8.57 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.62 -0.718 . . . . 0.0 112.858 179.109 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 164' ' ' SER . . . . . . . . . . . . . 79.9 p 66.63 154.71 0.09 Allowed 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.308 1.043 . . . . 0.0 113.274 171.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 165' ' ' VAL . . . . . . . . . . . . . 12.8 t -86.32 135.83 36.26 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 114.766 -1.106 . . . . 0.0 109.974 -179.741 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 166' ' ' PRO . . . . . . . . . . . . . 17.5 Cg_exo -13.72 118.91 0.01 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.272 1 C-N-CA 127.355 5.37 . . . . 0.0 116.124 179.563 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 167' ' ' ALA . . . . . . . . . . . . . . . -72.24 95.6 1.71 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.337 -0.847 . . . . 0.0 111.753 -174.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 168' ' ' GLY . . . . . . . . . . . . . . . 86.67 -10.87 65.8 Favored Glycine 0 N--CA 1.452 -0.27 0 CA-C-N 115.788 -0.642 . . . . 0.0 112.292 177.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 169' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.855 0 CA-C-O 118.667 -1.074 . . . . 0.0 111.433 -178.156 . . . . . . . . 0 0 . 1 stop_ save_